PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bornman, PC; Beckingham, IJ				Bornman, PC; Beckingham, IJ			ABC of diseases of liver, pancreas, and biliary, system - Pancreatic tumours	BRITISH MEDICAL JOURNAL			English	Review									Univ Cape Town, ZA-7700 Rondebosch, South Africa; Queens Med Ctr, Dept Surg, Nottingham NG7 2UH, England	University of Cape Town; University of Nottingham	Bornman, PC (corresponding author), Univ Cape Town, ZA-7700 Rondebosch, South Africa.							CAMERON JL, 1995, HEPATOB PANCREAT DIS, P475; COTTON P, 1996, PRACTICAL GASTROINTE, P167; TREDE M, 1997, SURG PANCREAS, P383	3	19	22	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 24	2001	322	7288					721	723		10.1136/bmj.322.7288.721	http://dx.doi.org/10.1136/bmj.322.7288.721			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416GB	11264214	Green Published			2022-12-28	WOS:000167771000029
J	Helenius, A; Aebi, M				Helenius, A; Aebi, M			Intracellular functions of N-linked glycans	SCIENCE			English	Review							GOLGI INTERMEDIATE COMPARTMENT; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; SACCHAROMYCES-CEREVISIAE; 3-DIMENSIONAL STRUCTURE; MEMBRANE-PROTEIN; MAMMALIAN-CELL; GLYCOPROTEIN; OLIGOSACCHARIDE; CALNEXIN	N-Linked oligosaccharides arise when blocks of 14 sugars are added cotranslationally to newly synthesized polypeptides in the endoplasmic reticulum (ER), These glycans are then subjected to extensive modification as the glycoproteins mature and move through the ER via the Golgi complex to their final destinations inside and outside the cell. in the ER and in the early secretory pathway, where the repertoire of oligosaccharide structures is still rather small, the glycans play a pivotal role in protein folding, oligomerization, quality control, sorting, and transport. They are used as universal "tags" that allow specific Lectins and modifying enzymes to establish order among the diversity of maturing glycoproteins. in the Golgi complex, the glycans acquire more complex structures and a new set of functions. The division of synthesis and processing between the ER and the Golgi complex represents an evolutionary adaptation that allows efficient exploitation of the potential of oligosaccharides.	Swiss Fed Inst Technol, Inst Biochem, CH-8092 Zurich, Switzerland; Swiss Fed Inst Technol, Inst Microbiol, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Helenius, A (corresponding author), Swiss Fed Inst Technol, Inst Biochem, Univ Str 16, CH-8092 Zurich, Switzerland.							ARAR C, 1995, J BIOL CHEM, V270, P3551, DOI 10.1074/jbc.270.8.3551; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; BEINTEMA JJ, 1986, BIOSCIENCE REP, V6, P709, DOI 10.1007/BF01116537; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Bouvier M, 2000, BIOCHEMISTRY-US, V39, P14950, DOI 10.1021/bi0019545; BUGG TDH, 1994, FEMS MICROBIOL LETT, V119, P255; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Cannon KS, 1999, J BIOL CHEM, V274, P7537, DOI 10.1074/jbc.274.11.7537; CHA Y, 1990, J BIOL CHEM, V265, P5008; De Praeter CM, 2000, AM J HUM GENET, V66, P1744, DOI 10.1086/302948; ELBEIN AD, 1991, FASEB J, V5, P3055, DOI 10.1096/fasebj.5.15.1743438; Ellgaard L, 2001, FEBS LETT, V488, P69, DOI 10.1016/S0014-5793(00)02382-6; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; FIELDER K, 1994, EMBO J, V13, P1729; Fullekrug J, 1999, J CELL SCI, V112, P2813; Gahmberg CG, 1996, TRENDS BIOCHEM SCI, V21, P308, DOI 10.1016/0968-0004(96)10034-7; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; GRANGER BL, 1990, J BIOL CHEM, V265, P12036; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hara-Kuge S, 1999, GLYCOBIOLOGY, V9, P833, DOI 10.1093/glycob/9.8.833; Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Huppa JB, 1998, CELL, V92, P145, DOI 10.1016/S0092-8674(00)80907-1; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; IMPERIALI B, 1995, P NATL ACAD SCI USA, V92, P97, DOI 10.1073/pnas.92.1.97; Imperiali B, 1999, CURR OPIN CHEM BIOL, V3, P643, DOI 10.1016/S1367-5931(99)00021-6; JAENICKE R, 1991, BIOCHEMISTRY-US, V30, P3147, DOI 10.1021/bi00227a001; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; KERN G, 1993, PROTEIN SCI, V2, P1862, DOI 10.1002/pro.5560021108; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; Knauer R, 1999, J BIOL CHEM, V274, P17249, DOI 10.1074/jbc.274.24.17249; Knop M, 1996, YEAST, V12, P1229, DOI 10.1002/(SICI)1097-0061(19960930)12:12<1229::AID-YEA15>3.0.CO;2-H; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KORNFELD S, 1990, BIOCHEM SOC T, V18, P367, DOI 10.1042/bst0180367; Kundra R, 1999, J BIOL CHEM, V274, P31039, DOI 10.1074/jbc.274.43.31039; LAHTINEN U, 1992, J CELL SCI, V103, P321; LECHNER J, 1989, ANNU REV BIOCHEM, V58, P173, DOI 10.1146/annurev.bi.58.070189.001133; Liu Y, 1997, J BIOL CHEM, V272, P7946, DOI 10.1074/jbc.272.12.7946; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Messner P, 1997, FEMS MICROBIOL REV, V20, P25, DOI 10.1016/S0168-6445(97)00041-7; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; MOREMEN KW, 1994, GLYCOBIOLOGY, V4, P113, DOI 10.1093/glycob/4.2.113; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Nishikawa A, 1999, J BIOL CHEM, V274, P19309, DOI 10.1074/jbc.274.27.19309; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; OConnor SE, 1996, CHEM BIOL, V3, P803, DOI 10.1016/S1074-5521(96)90064-2; OLDEN K, 1982, BIOCHIM BIOPHYS ACTA, V650, P209, DOI 10.1016/0304-4157(82)90017-X; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; PAULSON JC, 1989, TRENDS BIOCHEM SCI, V14, P272, DOI 10.1016/0968-0004(89)90062-5; Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; QUINN P, 1984, J CELL BIOL, V98, P2142, DOI 10.1083/jcb.98.6.2142; Ritter C, 2000, NAT STRUCT BIOL, V7, P278; Roberts DL, 1998, CELL, V93, P639, DOI 10.1016/S0092-8674(00)81192-7; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; Spirig U, 1997, MOL GEN GENET, V256, P628, DOI 10.1007/s004380050611; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; SPIRO RG, 2000, CARBOHYDRATES CHEM B, V3, P65; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; SU K, 1993, J BIOL CHEM, V268, P14301; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tokunaga F, 2000, J BIOL CHEM, V275, P40757, DOI 10.1074/jbc.M001073200; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Trombetta ES, 1999, EMBO J, V18, P3282, DOI 10.1093/emboj/18.12.3282; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A., 1999, ESSENTIALS GLYCOBIOL; Wang J, 2000, BIOCHEMISTRY-US, V39, P8993, DOI 10.1021/bi000027v; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Wormald MR, 1999, STRUCTURE, V7, pR155, DOI 10.1016/S0969-2126(99)80095-1; Zapun A, 1999, STRUCT FOLD DES, V7, pR173, DOI 10.1016/S0969-2126(99)80112-9	83	1873	1956	9	400	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2001	291	5512					2364	2369		10.1126/science.291.5512.2364	http://dx.doi.org/10.1126/science.291.5512.2364			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11269317				2022-12-28	WOS:000167618700044
J	Altkorn, D; Vokes, T				Altkorn, D; Vokes, T			Treatment of postmenopausal osteoporosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HORMONE REPLACEMENT THERAPY; BONE-MINERAL DENSITY; RANDOMIZED-TRIAL; VERTEBRAL FRACTURES; BIOCHEMICAL MARKERS; SALMON-CALCITONIN; WOMEN; ALENDRONATE; ESTROGEN; RALOXIFENE		Univ Chicago, Dept Med, Sect Internal Med, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Endocrinol Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Altkorn, D (corresponding author), Univ Chicago, Dept Med, Sect Internal Med, 5841 S Maryland ,MC 3051, Chicago, IL 60637 USA.	daltkorn@medicine.bsd.uchicago.edu						Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Bone HG, 2000, J CLIN ENDOCR METAB, V85, P720, DOI 10.1210/jc.85.2.720; Bush TL, 1996, JAMA-J AM MED ASSOC, V276, P1389, DOI 10.1001/jama.276.17.1389; CAULEY JA, 1995, ANN INTERN MED, V122, P9, DOI 10.7326/0003-4819-122-1-199501010-00002; Chesnut CH, 2000, AM J MED, V109, P267, DOI 10.1016/S0002-9343(00)00490-3; Chesnut CH, 1997, AM J MED, V102, P29, DOI 10.1016/S0002-9343(96)00387-7; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Downs RW, 2000, J CLIN ENDOCR METAB, V85, P1783, DOI 10.1210/jc.85.5.1783; ETTINGER B, 1987, ANN INTERN MED, V106, P40, DOI 10.7326/0003-4819-106-1-40; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; GARNERO P, 1994, J CLIN ENDOCR METAB, V79, P1693, DOI 10.1210/jc.79.6.1693; Genant HK, 1997, ARCH INTERN MED, V157, P2609, DOI 10.1001/archinte.157.22.2609; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Hodsman AB, 1997, J CLIN ENDOCR METAB, V82, P620, DOI 10.1210/jc.82.2.620; Hosking D, 1998, NEW ENGL J MED, V338, P485, DOI 10.1056/NEJM199802193380801; HUI SL, 1988, J CLIN INVEST, V81, P1804, DOI 10.1172/JCI113523; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; LANE NE, 1997, ARTHRITIS ALLIED CON, P153; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Lindsay R, 1999, J CLIN ENDOCR METAB, V84, P3076, DOI 10.1210/jc.84.9.3076; Looker AC, 2000, OSTEOPOROSIS INT, V11, P467, DOI 10.1007/s001980070088; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; LYRITIS GP, 1991, CALCIFIED TISSUE INT, V49, P369, DOI 10.1007/BF02555844; McNagny SE, 1999, ANN INTERN MED, V131, P605, DOI 10.7326/0003-4819-131-8-199910190-00010; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; National Osteoporosis Foundation, 1999, PHYS GUID PREV TREAT; NEER RM, 2000, END SOC 82 ANN M, P42; *NIH CONS DEV C, 2001, OST PREV DIAGN THER; Prestwood KM, 2000, J CLIN ENDOCR METAB, V85, P2197, DOI 10.1210/jc.85.6.2197; Recker RR, 1999, ANN INTERN MED, V130, P897, DOI 10.7326/0003-4819-130-11-199906010-00005; Schnitzer T, 2000, AGING CLIN EXP RES, V12, P1	35	32	34	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1415	1418		10.1001/jama.285.11.1415	http://dx.doi.org/10.1001/jama.285.11.1415			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410VQ	11255400				2022-12-28	WOS:000167462100002
J	Cooper, RJ; Hoffman, JR; Bartlett, JC; Besser, RE; Gonzales, R; Hickner, JM; Sande, MA				Cooper, RJ; Hoffman, JR; Bartlett, JC; Besser, RE; Gonzales, R; Hickner, JM; Sande, MA			Principles of appropriate antibiotic use for acute pharyngitis in adults: Background	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE RHEUMATIC-FEVER; BETA-HEMOLYTIC STREPTOCOCCI; GROUP-A STREPTOCOCCI; RANDOMIZED CONTROLLED-TRIAL; MANAGING SORE THROAT; GENERAL-PRACTICE; PRESCRIBING STRATEGIES; OPTICAL IMMUNOASSAY; PENICILLIN THERAPY; UNITED-STATES	The following principles of appropriate antibiotic use for adults with acute pharyngitis apply to immunocompetent adults without complicated comorbid conditions, such as chronic lung or heart disease, and history of rheumatic fever. They do not apply during known outbreaks of group A streptococcus. 1. Group A beta -hemolytic streptococcus (GABHS) is the causal agent in approximately 10% of adult cases of pharyngitis. The large majority of adults with acute pharyngitis have a self-limited illness, for which supportive care only is needed. 2. Antibiotic treatment of adult pharyngitis benefits only those patients with GABHS infection. All patients with pharyngitis should be offered appropriate doses of analgesics and antipyretics, as well as other supportive care. 3. Limit antibiotic prescriptions to patients who are most likely to have GABHS infection. Clinically screen all adult patients with pharyngitis for the presence of the four Center criteria: history of fever, tonsillar exudates, no cough, and tender anterior cervical lymphadenopathy (lymphadenitis). Do not test or treat patients with none or only one of these criteria, since these patients are unlikely to have GABHS infection. For patients with two or more criteria the following strategies are appropriate: a) Test patients with two, three, or four criteria by using a rapid antigen test, and limit antibiotic therapy to patients with positive test results; b) test patients with two or three criteria by using a rapid antigen test and limit antibiotic therapy to patients with positive test results or patients with four criteria; or c) do not use any diagnostic tests, and limit antibiotic therapy to patients with three or four criteria. 4. Throat cultures are not recommended for the routine primary evaluation of adults with pharyngitis or for confirmation of negative results on rapid antigen tests when the test sensitivity exceeds 80%. Throat cultures may be indicated as part of investigations of outbreaks of GABHS disease, for monitoring the development and spread of antibiotic resistance, or when such pathogens as gonococcus are being considered. 5. The preferred antibiotic for treatment of acute GABHS pharyngitis is penicillin, or erythromycin in a penicillin-allergic patient.	Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Michigan State Univ, E Lansing, MI 48824 USA; Univ Utah, Salt Lake City, UT USA	Centers for Disease Control & Prevention - USA; University of California System; University of California Los Angeles; Johns Hopkins University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Michigan State University; Utah System of Higher Education; University of Utah	Besser, RE (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, C-23,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	rbesser0@cdc.gov			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS000134] Funding Source: NIH RePORTER; AHRQ HHS [F32 HS00134-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		BELLI DC, 1984, AM J DIS CHILD, V138, P274, DOI 10.1001/archpedi.1984.02140410052016; BENNIKE T, 1951, ACTA MED SCAND, V139, P253; Bisno AL, 1997, CLIN INFECT DIS, V25, P574, DOI 10.1086/513768; BREESE BB, 1977, AM J DIS CHILD, V131, P514, DOI 10.1001/archpedi.1977.02120180028003; BRIEN JH, 1985, J PEDIATR-US, V106, P781, DOI 10.1016/S0022-3476(85)80354-1; BRINK WR, 1951, AM J MED, V10, P300, DOI 10.1016/0002-9343(51)90274-4; BROOK I, 1980, JAMA-J AM MED ASSOC, V244, P1696, DOI 10.1001/jama.244.15.1696; BRUMFITT W, 1957, LANCET, V1, P8; BURKE P, 1988, BRIT MED J, V296, P1646, DOI 10.1136/bmj.296.6637.1646; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; CATANZARO FJ, 1954, AM J MED, V17, P749, DOI 10.1016/0002-9343(54)90219-3; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; CHAMOVITZ R, 1954, NEW ENGL J MED, V251, P466, DOI 10.1056/NEJM195409162511203; COONAN KM, 1994, PEDIATR INFECT DIS J, V13, P630, DOI 10.1097/00006454-199407000-00009; Dagnelie CF, 1998, BRIT J GEN PRACT, V48, P959; Dagnelie CF, 1996, BRIT J GEN PRACT, V46, P589; DAJANI A, 1995, PEDIATRICS, V96, P758; DELMAR CB, 1999, COCHRANE LIB; DEMEYERE M, 1992, EUR J CLIN PHARMACOL, V43, P581, DOI 10.1007/BF02284954; DENNY FW, 1950, JAMA-J AM MED ASSOC, V143, P151, DOI 10.1001/jama.1950.02910370001001; DENNY FW, 1953, PEDIATRICS, V11, P7; Dobbs F, 1996, BRIT J GEN PRACT, V46, P461; Ebell MH, 2000, JAMA-J AM MED ASSOC, V284, P2912, DOI 10.1001/jama.284.22.2912; Feuer J, 1997, J RHEUMATOL, V24, P337; Gerber MA, 1997, JAMA-J AM MED ASSOC, V277, P899, DOI 10.1001/jama.277.11.899; GILBERT DN, 2000, SANFORD GUIDE ANTIBI; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; GOSLINGS WR, 1963, NEW ENGL J MED, V268, P687, DOI 10.1056/NEJM196303282681301; GRAHAM L, 1986, J CLIN MICROBIOL, V24, P644, DOI 10.1128/JCM.24.4.644-646.1986; Gunnarsson RK, 1997, SCAND J PRIM HEALTH, V15, P149, DOI 10.3109/02813439709018506; GWALTNEY JM, 2000, MANDELL DOUGLAS BENN, P656; Hamm RM, 1996, J FAM PRACTICE, V43, P56; Hart AP, 1997, DIAGN MICR INFEC DIS, V29, P139, DOI 10.1016/S0732-8893(97)81803-2; HOSIER DM, 1987, AM J DIS CHILD, V141, P730, DOI 10.1001/archpedi.1987.04460070032015; Howe RW, 1997, BRIT J GEN PRACT, V47, P280; HUOVINEN P, 1989, ANN INTERN MED, V110, P612, DOI 10.7326/0003-4819-110-8-612; KAPLAN EL, 1971, J INFECT DIS, V123, P490, DOI 10.1093/infdis/123.5.490; Kaplan EL, 1999, PEDIATR INFECT DIS J, V18, P1069, DOI 10.1097/00006454-199912000-00008; KELLOGG JA, 1986, JAMA-J AM MED ASSOC, V255, P2638, DOI 10.1001/jama.255.19.2638; KELLOGG JA, 1990, J CLIN MICROBIOL, V28, P165, DOI 10.1128/JCM.28.2.165-169.1990; KOMAROFF AL, 1986, J GEN INTERN MED, V1, P1, DOI 10.1007/BF02596317; KROBER MS, 1985, JAMA-J AM MED ASSOC, V253, P1271, DOI 10.1001/jama.253.9.1271; LANDSMAN JB, 1951, BRIT MED J, V1, P326, DOI 10.1136/bmj.1.4702.326; LARSSON P, 1983, SCAND J INFECT DIS, P79; Little P, 1996, FAM PRACT, V13, P317, DOI 10.1093/fampra/13.3.317; Little P, 1997, BRIT MED J, V315, P350; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Little P, 1999, BRIT MED J, V319, P736, DOI 10.1136/bmj.319.7212.736; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Mangione-Smith R, 1999, PEDIATRICS, V103, P711, DOI 10.1542/peds.103.4.711; MARKOWITZ M, 1993, J PEDIATR-US, V123, P679, DOI 10.1016/S0022-3476(05)80840-6; McIsaac WJ, 2000, CAN MED ASSOC J, V163, P811; McIsaac WJ, 1998, CAN MED ASSOC J, V158, P75; MIDDLETON DB, 1988, J PEDIATR-US, V113, P1089, DOI 10.1016/S0022-3476(88)80588-2; PICKERING LK, 2000, 2000 RED BOOK, P553; POSES RM, 1985, JAMA-J AM MED ASSOC, V254, P925, DOI 10.1001/jama.254.7.925; PUTTO A, 1987, PEDIATRICS, V80, P6; RANDOLPH MF, 1985, J PEDIATR-US, V106, P870, DOI 10.1016/S0022-3476(85)80228-6; RODDEY OF, 1995, J PEDIATR-US, V126, P931, DOI 10.1016/S0022-3476(95)70212-1; SANCHEZMENEGAY C, 1992, J GEN INTERN MED, V7, P432, DOI 10.1007/BF02599162; SCHAPPERT SM, 1998, AMBULATORY CARE VISI; Schlager TA, 1996, ARCH PEDIAT ADOL MED, V150, P245, DOI 10.1001/archpedi.1996.02170280015002; SHULMAN ST, 1994, PEDIATR INFECT DIS J, V13, P1, DOI 10.1097/00006454-199401000-00002; SIEGEL AC, 1961, NEW ENGL J MED, V265, P559, DOI 10.1056/NEJM196109212651201; VEASY LG, 1994, J PEDIATR-US, V124, P9, DOI 10.1016/S0022-3476(94)70247-0; VEASY LG, 1987, NEW ENGL J MED, V316, P421, DOI 10.1056/NEJM198702193160801; WALD ER, 1987, PEDIATRICS, V80, P371; WALLACE MR, 1989, JAMA-J AM MED ASSOC, V262, P2557, DOI 10.1001/jama.262.18.2557; WALSH BT, 1975, ARCH INTERN MED, V135, P1493, DOI 10.1001/archinte.135.11.1493; WANNAMAKER LW, 1951, AM J MED, V10, P673, DOI 10.1016/0002-9343(51)90336-1; Webb KH, 2000, J FAM PRACTICE, V49, P34; Zwart S, 2000, BRIT MED J, V320, P150, DOI 10.1136/bmj.320.7228.150; 2000, NATL POPULATION ESTI; 1998, MMWR MORB MORTAL WKL, V37, P519; 1994, MMWR MORB MORTAL WKL, V42, P1; 1988, MMWR MORB MORTAL WKL, V37, P101	76	192	205	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					509	517		10.7326/0003-4819-134-6-200103200-00019	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00019			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409VF	11255530				2022-12-28	WOS:000167405800013
J	Fraser, S; Bunce, C; Wormald, R; Brunner, E				Fraser, S; Bunce, C; Wormald, R; Brunner, E			Deprivation and late presentation of glaucoma: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OPEN-ANGLE GLAUCOMA; RISK-FACTORS; PROGRESSION; PREVALENCE; AMERICANS; CANCER	Objective To identify socioeconomic risk factors for first presentation advanced glaucomatous visual field loss. Design Hospital based case-control study with prospective identification of patients. Setting Three hospital eye departments. Participants Consecutive patients newly diagnosed with glaucoma (n = 220). Cases (late presenters) were those presenting with advanced glaucoma (n = 110), controls were those with early glaucoma (n = 110). Results Median underprivileged area scores were higher among late presenters (29.5; interquartile range 9.0-42.2) than in the control group (21.3; 6.1-37.4) (P = 0.035). Late presenters were more likely to be of lower occupational class (odds ratio adjusted for age and referral centre 20.1 (95% confidence interval 2.6 to 155) for group III compared with group I-Il and 86.0 (11.0 to 673 for group TV-V compared with group I-IT), to have no access to a car (2.2; 1.2 to 4.0), to have left full time education at age 14 or less (7.5; 2.3 to 24.7), and to be tenants rather than owner occupiers (local authority tenants 3.2; 1.7 to 5.8, private tenants 2.1; 0.7 to 5.8). Effects of deprivation were paltry accounted for by family history of glaucoma, time since last visit to an optometrist and lack of an initial diagnosis of glaucoma by an optometrist Conclusions Area and individual level deprivation were both associated with late presentation of glaucoma. Existing evidence shows that late presentation is an important risk factor for subsequent blindness. Deprived groups thus seem to be at greater risk of going blind from glaucoma. Material deprivation may be associated with more aggressive disease as well as later presentation.	UCL, Inst Ophthalmol, Glaxo Dept Ophthalm Epidemiol, London EC1V 2PD, England; UCL, Int Ctr Hlth & Soc, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	GlaxoSmithKline; University of London; University College London; University of London; University College London	Wormald, R (corresponding author), UCL, Inst Ophthalmol, Glaxo Dept Ophthalm Epidemiol, London EC1V 2PD, England.	r.wormald@ucl.ac.uk	Brunner, Eric/H-2114-2011	Brunner, Eric/0000-0002-0595-4474; Bunce, Catey/0000-0002-0935-3713				BRUNNER E, 1999, SOCIAL DETERMINANTS; CALLE EE, 1993, AM J PUBLIC HEALTH, V83, P53, DOI 10.2105/AJPH.83.1.53; Evans J., 1996, HEALTH TRENDS, V28, P5; Fraser S, 1999, INVEST OPHTH VIS SCI, V40, P2251; Fraser S, 1999, BRIT J OPHTHALMOL, V83, P24, DOI 10.1136/bjo.83.1.24; *GOV STAT SERV, 1995, GEN HOUS SURV AN OPH; GRANT WM, 1982, OPHTHALMOLOGY, V89, P991; Griffiths PG, 1997, BRIT MED J, V315, P318, DOI 10.1136/bmj.315.7103.318; JARMAN B, 1983, BRIT MED J, V286, P1705, DOI 10.1136/bmj.286.6379.1705; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; MIKELBERG FS, 1986, AM J OPHTHALMOL, V101, P1; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS; POWE BD, 1995, CANCER NURS, V18, P385; QUIGLEY H, 2000, PREVALENCE GLAUCOMA; ROBINSON JK, 1995, ARCH DERMATOL, V131, P428, DOI 10.1001/archderm.131.4.428; SCHWARTZ B, 1987, ARCH OPHTHALMOL-CHIC, V105, P1060; SLOGGETT A, 1994, BRIT MED J, V309, P1470, DOI 10.1136/bmj.309.6967.1470; Smeeth L, 1999, BMJ-BRIT MED J, V318, P1020, DOI 10.1136/bmj.318.7190.1020; SMITH GD, 1992, BRIT MED J, V305, P757, DOI 10.1136/bmj.305.6856.757; SMITH LK, 1994, J PUBLIC HEALTH MED, V16, P348; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Stallone DD, 1997, EUR J CLIN NUTR, V51, P815, DOI 10.1038/sj.ejcn.1600491; *STAT CORP, 1997, STAT STAT SOFTW REL; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; TIELSCH JM, 1991, ARCH OPHTHALMOL-CHIC, V109, P637, DOI 10.1001/archopht.1991.01080050051027; Tielsch JM, 1991, OPHTHALMOL CLIN N AM, V4, P649; WELLS BL, 1992, AM J PUBLIC HEALTH, V82, P1383, DOI 10.2105/AJPH.82.10.1383; WILSON R, 1982, ARCH OPHTHALMOL-CHIC, V100, P737, DOI 10.1001/archopht.1982.01030030741002; Wormald R P, 1995, J Med Screen, V2, P109; 1998, REPORT INDEPENDENT I	30	121	125	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2001	322	7287					639	643		10.1136/bmj.322.7287.639	http://dx.doi.org/10.1136/bmj.322.7287.639			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413QE	11250847	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000167622600022
J	Lothian, K; Philp, I				Lothian, K; Philp, I			Care of older people - Maintaining the dignity and autonomy of older people in the healthcare setting	BRITISH MEDICAL JOURNAL			English	Article							ELDERLY PERSONS; ATTITUDES; NURSES; EDUCATION; TRAINEES; FUTURE; PAIN		No Gen Hosp, Community Sci Ctr, Shelfield Inst Studies Ageing, Sheffield S5 7AU, S Yorkshire, England	Northern General Hospital	Philp, I (corresponding author), No Gen Hosp, Community Sci Ctr, Shelfield Inst Studies Ageing, Sheffield S5 7AU, S Yorkshire, England.			philp, ian/0000-0002-3972-6496				*AG CONC, 1999, TURN YOUR BACK US; Badzek LA, 1998, J NURS LAW, V5, P51; Bates MS, 1997, SOC SCI MED, V45, P1433, DOI 10.1016/S0277-9536(97)00068-3; Bernard M, 1998, J ADV NURS, V27, P633, DOI 10.1046/j.1365-2648.1998.00531.x; *BRIT GER SOC, 1997, STAND MED CAR OLD PE; Bull M J, 1994, J Nurs Care Qual, V8, P47; CARTWRIGHT A, 1991, AGE AGEING, V20, P271, DOI 10.1093/ageing/20.4.271; Castellucci DT, 1998, NURS CLIN N AM, V33, P265; Davies S, 1999, J ADV NURS, V29, P208, DOI 10.1046/j.1365-2648.1999.00879.x; Ebrahim S, 1999, BRIT MED J, V319, P1358, DOI 10.1136/bmj.319.7221.1358; Eisemann M, 1999, EUR J PUBLIC HEALTH, V9, P41, DOI 10.1093/eurpub/9.1.41; GREEN JH, 1995, THESIS U UTAH SALT L; HAIGHT BK, 1994, J ADV NURS, V20, P382, DOI 10.1046/j.1365-2648.1994.20020382.x; Harrison A, 1996, J ADV NURS, V24, P229, DOI 10.1046/j.1365-2648.1996.02011.x; Henwood M, 1998, IGNORED INVISIBLE CA; *HLTH ADV SERV, 2000, NOT BEC THEY AR OLD; *HLTH ED AUTH, 1998, PREV HOM ACC OLD PEO; HOPE KW, 1994, J ADV NURS, V20, P605, DOI 10.1046/j.1365-2648.1994.20040605.x; KELSON M, 1998, STROKE REHABILITATIO; Lindsay J, 1998, Home Healthc Nurse, V16, P693, DOI 10.1097/00004045-199810000-00008; LITWIN H, 1994, BRIT J SOC WORK, V24, P53; LOOKINLAND S, 1995, J ADV NURS, V21, P47, DOI 10.1046/j.1365-2648.1995.21010047.x; MCWILLIAM CL, 1994, SOC SCI MED, V38, P327, DOI 10.1016/0277-9536(94)90402-2; Moriarty J., 2000, PART THEIR LIVES COM; Mukai CPSW, 1999, GERIATR NURS, V20, P18, DOI 10.1016/S0197-4572(99)70051-0; *NAT I AD CONT ED, 1999, CARR LEARN LEARN OPP; Peach H, 1982, Age Ageing, V11, P196, DOI 10.1093/ageing/11.3.196; ROSIN AJ, 1998, HLTH CARE LATER LIFE, V3, P159; Roy O, 1996, Can Nurse, V92, P42; *ROYAL COLL NURS, 1998, NURS CAR OLD PAT BLA; *SERV 1 NAT CONS C, 1999, INV US IMPR DEL HEAL; Skog M, 1999, NURS EDUC TODAY, V19, P472, DOI 10.1054/nedt.1999.0329; Smith M, 1997, Nurs Times, V93, P52; Stevenson FA, 2000, SOC SCI MED, V50, P829, DOI 10.1016/S0277-9536(99)00376-7; STEVENSON O, 1989, AGE VULNERABILITY; Turner K, 1996, J PALLIAT CARE, V12, P7, DOI 10.1177/082585979601200203; 1999, UNPUB HELP AGED AN L; 1999, UNPUB SELECTED QUOTE; 1999, VIEWS OLDER PEOPLE H; 1999, DIGNITY WARD PROMOTI	40	89	90	0	14	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 17	2001	322	7287					668	670		10.1136/bmj.322.7287.668	http://dx.doi.org/10.1136/bmj.322.7287.668			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	413QE	11250856	Green Published			2022-12-28	WOS:000167622600031
J	Mitton, S				Mitton, S			The universe weighed and found wanting	LANCET			English	Editorial Material									Univ Cambridge, St Edmunds Coll, Cambridge CB3 0BN, England	University of Cambridge	Mitton, S (corresponding author), Univ Cambridge, St Edmunds Coll, Cambridge CB3 0BN, England.		Mitton, Simon A/A-5899-2012	Mitton, Simon A/0000-0003-3695-9806				Peacock JA, 2001, NATURE, V410, P169, DOI 10.1038/35065528	1	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 17	2001	357	9259					824	824		10.1016/S0140-6736(00)04194-5	http://dx.doi.org/10.1016/S0140-6736(00)04194-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265949				2022-12-28	WOS:000167586300007
J	Visser, HKA				Visser, HKA			Non-therapeutic research in the EU in adults incapable of giving consent?	LANCET			English	Editorial Material							DEMENTIA				Visser, HKA (corresponding author), Ghisebrecht Bokellaan 29, NL-3054 CA Rotterdam, Netherlands.	H.K.A.Visser@rotan.nl						BERGHMANS RLP, 1995, INT J GERIATR PSYCH, V10, P647, DOI 10.1002/gps.930100803; Chapman PF, 2000, NATURE, V408, P915, DOI 10.1038/35050179; Fletcher L, 2001, NAT BIOTECHNOL, V19, P104, DOI 10.1038/84340; Kauffman Ralph E., 1995, Current Opinion in Pediatrics, V7, P195, DOI 10.1097/00008480-199504000-00014; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; Normand C, 2000, ARCH DIS CHILD, V82, P177; SMYTH RL, 1999, LANCET S2, V354, P21	7	27	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2001	357	9259					818	819		10.1016/S0140-6736(00)04189-1	http://dx.doi.org/10.1016/S0140-6736(00)04189-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265944				2022-12-28	WOS:000167586300002
J	Brouwer, AM; Frochot, C; Gatti, FG; Leigh, DA; Mottier, L; Paolucci, F; Roffia, S; Wurpel, GWH				Brouwer, AM; Frochot, C; Gatti, FG; Leigh, DA; Mottier, L; Paolucci, F; Roffia, S; Wurpel, GWH			Photoinduction of fast, reversible translational motion in a hydrogen-bonded molecular shuttle	SCIENCE			English	Article							ROTAXANES; REDOX; RECOGNITION; DYNAMICS	A rotaxane is described in which a macrocycle moves reversibly between two hydrogen-bonding stations after a nanosecond Laser pulse. Observation of transient changes in the optical absorption spectrum after photoexcitation allows direct quantitative monitoring of the submolecular translational process. The rate of shuttling was determined and the influence of the surrounding medium was studied: At room temperature in acetonitrile, the photoinduced movement of the macrocycle to the second station takes about 1 microsecond and, after charge recombination (about 100 microseconds), the macrocycle shuttles back to its original position. The process is reversible and cyclable and has properties characteristic of an energy-driven piston.	Univ Warwick, Dept Chem, Ctr Supramol & Macromol Chem, Coventry CV4 7AL, W Midlands, England; Univ Amsterdam, Organ Chem Lab, NL-1018 WS Amsterdam, Netherlands; Univ Bologna, Dipartimento Chim G Ciamician, I-40126 Bologna, Italy	University of Warwick; University of Amsterdam; University of Bologna	Leigh, DA (corresponding author), Univ Warwick, Dept Chem, Ctr Supramol & Macromol Chem, Coventry CV4 7AL, W Midlands, England.		Gatti, Francesco G/G-9315-2012; Leigh, David/K-5965-2015; Paolucci, Francesco/A-8708-2008; Brouwer, Albert/A-2366-2010	Gatti, Francesco G/0000-0003-0837-4616; Leigh, David/0000-0002-1202-4507; Paolucci, Francesco/0000-0003-4614-8740; Brouwer, Albert/0000-0002-1731-3869				Armaroli N, 1999, J AM CHEM SOC, V121, P4397, DOI 10.1021/ja984051w; Asakawa M, 1999, CHEM-EUR J, V5, P860, DOI 10.1002/(SICI)1521-3765(19990301)5:3<860::AID-CHEM860>3.0.CO;2-K; Ashton PR, 1998, J AM CHEM SOC, V120, P11190, DOI 10.1021/ja981889a; Ashton PR, 2000, CHEM-EUR J, V6, P3558, DOI 10.1002/1521-3765(20001002)6:19<3558::AID-CHEM3558>3.0.CO;2-M; BAIZANI V, 2000, ANGEW CHEM INT EDIT, V39, P3348; Benniston AC, 1996, CHEM SOC REV, V25, P427, DOI 10.1039/cs9962500427; BISSELL RA, 1994, NATURE, V369, P133, DOI 10.1038/369133a0; Blanco MJ, 1999, CHEM SOC REV, V28, P293, DOI 10.1039/a901205b; Block SM, 1998, CELL, V93, P5, DOI 10.1016/S0092-8674(00)81138-1; Collin JP, 1997, NEW J CHEM, V21, P525; Fyfe MCT, 1997, ANGEW CHEM INT EDIT, V36, P2068, DOI 10.1002/anie.199720681; Ge Y, 1996, J AM CHEM SOC, V118, P3976, DOI 10.1021/ja954283k; Gimzewski JK, 1998, SCIENCE, V281, P531, DOI 10.1126/science.281.5376.531; Jeffery G.A., 1997, INTRO HYDROGEN BONDI; Kelly TR, 1999, NATURE, V401, P150, DOI 10.1038/43639; Koumura N, 1999, NATURE, V401, P152, DOI 10.1038/43646; Lane AS, 1997, J AM CHEM SOC, V119, P11092, DOI 10.1021/ja971224t; Lauteslager XY, 1999, J PHYS CHEM A, V103, P653, DOI 10.1021/jp983595h; Leigh DA, 2000, ANGEW CHEM INT EDIT, V39, P350, DOI 10.1002/(SICI)1521-3773(20000117)39:2<350::AID-ANIE350>3.3.CO;2-4; Leigh DA, 1997, ANGEW CHEM INT EDIT, V36, P728, DOI 10.1002/anie.199707281; Murakami H, 1997, J AM CHEM SOC, V119, P7605, DOI 10.1021/ja971438a; Niemz A, 1999, ACCOUNTS CHEM RES, V32, P44, DOI 10.1021/ar980046l; Omberg KM, 1997, J AM CHEM SOC, V119, P7013, DOI 10.1021/ja970511u; Sauvage, 1999, MOL CATENANES ROTAXA; WALDECK DH, 1991, CHEM REV, V91, P415, DOI 10.1021/cr00003a007; WINTGENS V, 1994, J CHEM SOC FARADAY T, V90, P411, DOI 10.1039/ft9949000411	26	594	600	1	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2124	2128		10.1126/science.1057886	http://dx.doi.org/10.1126/science.1057886			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251112				2022-12-28	WOS:000167563800032
J	Sethna, JP; Dahmen, KA; Myers, CR				Sethna, JP; Dahmen, KA; Myers, CR			Crackling noise	NATURE			English	Review							SELF-ORGANIZED CRITICALITY; CHARGE-DENSITY WAVES; DOMAIN-WALL DYNAMICS; FIELD ISING-MODEL; METALLIC FERROMAGNETIC MATERIALS; SHERRINGTON-KIRKPATRICK MODEL; THRESHOLD CRITICAL-DYNAMICS; HIGHLY OPTIMIZED TOLERANCE; BARKHAUSEN NOISE; CRITICAL-BEHAVIOR	Crackling noise arises when a system responds to changing external conditions through discrete, impulsive events spanning a broad range of sizes. A wide variety of physical systems exhibiting crackling noise have been studied, from earthquakes on faults to paper crumpling. Because these systems exhibit regular behaviour over a huge range of sizes, their behaviour is likely to be independent of microscopic and macroscopic details, and progress can be made by the use of simple models. The fact that these models and real systems can share the same behaviour on many scales is called universality. We illustrate these ideas by using results for our model of crackling noise in magnets, explaining the use of the renormalization group and scaling collapses, and we highlight some continuing challenges in this still-evolving field.	Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Cornell Univ, Cornell Theory Ctr, Ithaca, NY 14853 USA	Cornell University; University of Illinois System; University of Illinois Urbana-Champaign; Cornell University	Sethna, JP (corresponding author), Cornell Univ, Atom & Solid State Phys Lab, Clark Hall, Ithaca, NY 14853 USA.	sethna@lassp.cornell.edu; dahmen@physics.uiuc.edu; myers@tc.cornell.edu	Myers, Christopher R/I-8516-2017					ALESSANDRO B, 1990, J APPL PHYS, V68, P2901, DOI 10.1063/1.346423; ALESSANDRO B, 1990, J APPL PHYS, V68, P2908, DOI 10.1063/1.346424; AMENGUAL A, 1987, THERMOCHIM ACTA, V116, P195, DOI 10.1016/0040-6031(87)88179-0; BAK P, 1989, J GEOPHYS RES-SOLID, V94, P15635, DOI 10.1029/JB094iB11p15635; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bak P, 1997, PHYSICA A, V246, P430, DOI 10.1016/S0378-4371(97)00401-9; BEN-ZION Y, 1995, J GEOPHYS RES-SOL EA, V100, P12959, DOI 10.1029/94JB03037; Berger A, 2000, PHYS REV LETT, V85, P4176, DOI 10.1103/PhysRevLett.85.4176; BERTOTTI G, 1990, J APPL PHYS, V67, P5574, DOI 10.1063/1.345889; BERTOTTI G, 1994, J APPL PHYS, V75, P5490, DOI 10.1063/1.355666; BITTEL H, 1969, IEEE T MAGN, VMAG5, P359, DOI 10.1109/TMAG.1969.1066547; BOUCHAUD JP, CONDMAT0008103; BOUCHAUD JP, IN PRESS J QUANT FIN; Brezin E, 1999, CR ACAD SCI II B, V327, P383, DOI 10.1016/S1287-4620(99)80079-9; BURRIDGE R, 1967, B SEISMOL SOC AM, V57, P341; Carlson JM, 1999, PHYS REV E, V60, P1412, DOI 10.1103/PhysRevE.60.1412; Carlson JM, 2000, PHYS REV LETT, V84, P2529, DOI 10.1103/PhysRevLett.84.2529; CARLSON JM, 1989, PHYS REV A, V40, P6470, DOI 10.1103/PhysRevA.40.6470; CARLSON JM, 1994, REV MOD PHYS, V66, P657, DOI 10.1103/RevModPhys.66.657; CARLSON JM, 1990, PHYS REV LETT, V65, P2547, DOI 10.1103/PhysRevLett.65.2547; Carreras B. A., 2000, P 33 HAW INT C SYST; CHAKRABARTI BK, 1997, STAT PHYSICS FRACTUR; CHEN K, 1991, PHYS REV A, V43, P625, DOI 10.1103/PhysRevA.43.625; CIEPLAK M, 1988, PHYS REV LETT, V60, P2042, DOI 10.1103/PhysRevLett.60.2042; COPPERSMITH SN, 1987, PHYS REV B, V36, P311, DOI 10.1103/PhysRevB.36.311; COTE PJ, 1991, PHYS REV LETT, V67, P1334, DOI 10.1103/PhysRevLett.67.1334; CROWIE PA, 1993, J GEOPHYS RES SOLID, V98, P21809; CURTIN WA, 1991, PHYS REV LETT, V67, P2457, DOI 10.1103/PhysRevLett.67.2457; da Silveira R, 1999, PHYS REV E, V59, P1355, DOI 10.1103/PhysRevE.59.1355; Dahmen K, 1996, PHYS REV B, V53, P14872, DOI 10.1103/PhysRevB.53.14872; DAHMEN K, 1993, PHYS REV LETT, V71, P3222, DOI 10.1103/PhysRevLett.71.3222; DEDOMINICIS C, 1978, PHYS REV B, V18, P4913, DOI 10.1103/PhysRevB.18.4913; DEGENNES PG, 1966, SUPERCONDUCTIVITY ME, P83; Dhar D, 1999, PHYSICA A, V263, P4, DOI 10.1016/S0378-4371(98)00493-2; DOTSENKO VS, 1993, PHYS REV LETT, V71, P811, DOI 10.1103/PhysRevLett.71.811; Durin G, 2000, PHYS REV LETT, V84, P4705, DOI 10.1103/PhysRevLett.84.4705; Ertas D, 1996, PHYS REV B, V53, P3520, DOI 10.1103/PhysRevB.53.3520; ERTAS D, 1994, PHYS REV LETT, V73, P1703, DOI 10.1103/PhysRevLett.73.1703; FAMILY F, 1985, PHYS REV LETT, V55, P641, DOI 10.1103/PhysRevLett.55.641; FEYNMAN RP, 1963, FEYNMAN LECT PHYSICS, V2; FIELD S, 1995, PHYS REV LETT, V74, P1206, DOI 10.1103/PhysRevLett.74.1206; Fisher DS, 1997, PHYS REV LETT, V78, P4885, DOI 10.1103/PhysRevLett.78.4885; FISHER DS, 1983, PHYS REV LETT, V50, P1486, DOI 10.1103/PhysRevLett.50.1486; FISHER DS, 1985, PHYS REV B, V31, P1396, DOI 10.1103/PhysRevB.31.1396; FLEMING RM, 1986, PHYS REV B, V33, P2930, DOI 10.1103/PhysRevB.33.2930; Galam S, 1997, PHYSICA A, V238, P66, DOI 10.1016/S0378-4371(96)00456-6; Garcimartin A, 1997, PHYS REV LETT, V79, P3202, DOI 10.1103/PhysRevLett.79.3202; GLANZ J, 2000, NY TIMES        0601, pA14; GRINSTEIN G, 1990, PHYS REV LETT, V64, P1927, DOI 10.1103/PhysRevLett.64.1927; Gutenberg B., 1954, SEISMICITY EARTH ASS; Guyer RA, 1996, PHYS REV B, V54, P18, DOI 10.1103/PhysRevB.54.18; Herrman H. J., 1990, STAT MODELS FRACTURE; Houle PA, 1996, PHYS REV E, V54, P278, DOI 10.1103/PhysRevE.54.278; HWA T, 1989, PHYS REV LETT, V62, P1813, DOI 10.1103/PhysRevLett.62.1813; JAEGER HM, 1989, PHYS REV LETT, V62, P40, DOI 10.1103/PhysRevLett.62.40; Kadanoff L.P., 1966, PHYSICS, V2, P263, DOI DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.2.263; KADANOFF LP, 1989, PHYS REV A, V40, P4527, DOI 10.1103/PhysRevA.40.4527; KADANOFF LP, 1989, PHYS REV A, V39, P6524, DOI 10.1103/PhysRevA.39.6524; Koiller B, 2000, PHYS REV B, V62, P5771, DOI 10.1103/PhysRevB.62.5771; Kramer EM, 1996, PHYS REV E, V53, P1465, DOI 10.1103/PhysRevE.53.1465; Krysac LC, 1998, PHYS REV LETT, V81, P4428, DOI 10.1103/PhysRevLett.81.4428; Kuntz MC, 2000, PHYS REV B, V62, P11699, DOI 10.1103/PhysRevB.62.11699; Kuntz MC, 1999, COMPUT SCI ENG, V1, P73, DOI 10.1109/5992.774844; KUNTZ MC, 1998, HYSTERESIS AVALANCHE; Leschhorn H, 1997, ANN PHYS-LEIPZIG, V6, P1, DOI 10.1002/andp.19975090102; LIENEWEG U, 1974, IEEE T MAGN, VMA10, P118, DOI 10.1109/TMAG.1974.1058310; Lilly MP, 1996, PHYS REV LETT, V77, P4222, DOI 10.1103/PhysRevLett.77.4222; LITTLEWOOD PB, 1986, PHYS REV B, V33, P6694, DOI 10.1103/PhysRevB.33.6694; LU ET, 1993, ASTROPHYS J, V412, P841, DOI 10.1086/172966; Malcai O, 1997, PHYS REV E, V56, P2817, DOI 10.1103/PhysRevE.56.2817; MARTIN PC, 1973, PHYS REV A, V8, P423, DOI 10.1103/PhysRevA.8.423; MEISEL LV, 1992, PHYS REV B, V46, P10822, DOI 10.1103/PhysRevB.46.10822; MIDDLETON AA, 1993, PHYS REV B, V47, P3530, DOI 10.1103/PhysRevB.47.3530; MIDDLETON AA, 1992, PHYS REV LETT, V68, P670, DOI 10.1103/PhysRevLett.68.670; MILTENBERGER P, 1993, PHYS REV LETT, V71, P3604, DOI 10.1103/PhysRevLett.71.3604; MONTALENTI G, 1970, Z ANGEW PHYSIK, V28, P295; Myers CR, 1996, PHYS REV LETT, V77, P972, DOI 10.1103/PhysRevLett.77.972; MYERS CR, 1993, PHYS REV B, V47, P11171, DOI 10.1103/PhysRevB.47.11171; NAGEL SR, 1992, REV MOD PHYS, V64, P321, DOI 10.1103/RevModPhys.64.321; Narayan O, 1996, PHYS REV LETT, V77, P3855, DOI 10.1103/PhysRevLett.77.3855; NARAYAN O, 1992, PHYS REV B, V46, P11520, DOI 10.1103/PhysRevB.46.11520; NARAYAN O, 1993, PHYS REV B, V48, P7030, DOI 10.1103/PhysRevB.48.7030; NATTERMANN T, 1992, J PHYS II, V2, P1483, DOI 10.1051/jp2:1992214; Newman M, 2000, NATURE, V405, P412, DOI 10.1038/35013189; Newman MEJ, 1996, P ROY SOC B-BIOL SCI, V263, P1605, DOI 10.1098/rspb.1996.0235; NEWMAN MEJ, 1999, ADAPORG9908002; OLAMI Z, 1992, PHYS REV LETT, V68, P1244, DOI 10.1103/PhysRevLett.68.1244; Ortin J, 1995, J PHYS IV, V5, P209, DOI 10.1051/jp4:1995828; Paczuski M, 1996, PHYS REV E, V53, P414, DOI 10.1103/PhysRevE.53.414; Pazmandi F, 1999, PHYS REV LETT, V83, P1034, DOI 10.1103/PhysRevLett.83.1034; Pazmandi F, 2000, PHYSICA B, V275, P207, DOI 10.1016/S0921-4526(99)00780-2; PEPKE SL, 1994, J GEOPHYS RES-SOL EA, V99, P6769, DOI 10.1029/93JB03125; Perkovic O, 1999, PHYS REV B, V59, P6106, DOI 10.1103/PhysRevB.59.6106; PERKOVIC O, 1995, PHYS REV LETT, V75, P4528, DOI 10.1103/PhysRevLett.75.4528; Perkovic O, 1997, J APPL PHYS, V81, P1590, DOI 10.1063/1.364088; PERKOVIC O, 1996, CONDMAT9609072; PETRI A, 1994, PHYS REV LETT, V73, P3423, DOI 10.1103/PhysRevLett.73.3423; Petta JR, 1998, PHYS REV E, V57, P6363, DOI 10.1103/PhysRevE.57.6363; Pfeuty P, 1977, INTRO RENORMALIZATIO; RICE JR, 1983, J APPL MECH-T ASME, V50, P343, DOI 10.1115/1.3167042; Roters L, 1999, PHYS REV E, V60, P5202, DOI 10.1103/PhysRevE.60.5202; SETHNA JP, 1993, PHYS REV LETT, V70, P3347, DOI 10.1103/PhysRevLett.70.3347; SETHNA JP, 1999, CRACKLING NOISE; SETHNA JP, 1996, HYSTERESIS AVALANCHE; Shaw BE, 2000, J GEOPHYS RES-SOL EA, V105, P23791, DOI 10.1029/2000JB900203; Sole RV, 1996, PHYS REV E, V54, pR42, DOI 10.1103/PhysRevE.54.R42; SOMPOLINSKY H, 1982, PHYS REV B, V25, P6860, DOI 10.1103/PhysRevB.25.6860; SORNETTE D, 1994, J PHYS I, V4, P209, DOI 10.1051/jp1:1994133; Spasojevic D, 1996, PHYS REV E, V54, P2531, DOI 10.1103/PhysRevE.54.2531; STIERSTADT K, 1965, Z PHYS, V186, P154, DOI 10.1007/BF01380732; Sykes LR, 1999, PURE APPL GEOPHYS, V155, P207, DOI 10.1007/s000240050263; Tewari S, 1999, PHYS REV E, V60, P4385, DOI 10.1103/PhysRevE.60.4385; Thorne RE, 1996, PHYS TODAY, V49, P42, DOI 10.1063/1.881498; URBACH JS, 1995, PHYS REV LETT, V75, P276, DOI 10.1103/PhysRevLett.75.276; *US GEOL SURV NAT, 2001, EARTHQ INF WORLD; VISSCHER PB, 1985, J STAT PHYS, V38, P989, DOI 10.1007/BF01010426; Walsh B, 1998, J APPL PHYS, V84, P5709, DOI 10.1063/1.368835; Yeomans J.M., 1992, STAT MECH PHASE TRAN, VVolume 19; Zapperi S, 1997, PHYS REV LETT, V78, P1408, DOI 10.1103/PhysRevLett.78.1408; Zapperi S, 1998, PHYS REV B, V58, P6353, DOI 10.1103/PhysRevB.58.6353; ZIPPELIUS A, 1984, PHYS REV B, V29, P2717, DOI 10.1103/PhysRevB.29.2717; [No title captured]	126	848	854	7	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2001	410	6825					242	250		10.1038/35065675	http://dx.doi.org/10.1038/35065675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11258379	Green Submitted			2022-12-28	WOS:000167320500058
J	Yamada, M; Miyakawa, T; Duttaroy, A; Yamanaka, A; Moriguchi, T; Makita, R; Ogawa, M; Chou, CJ; Xia, B; Crawley, JN; Felder, CC; Deng, CX; Wess, J				Yamada, M; Miyakawa, T; Duttaroy, A; Yamanaka, A; Moriguchi, T; Makita, R; Ogawa, M; Chou, CJ; Xia, B; Crawley, JN; Felder, CC; Deng, CX; Wess, J			Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean	NATURE			English	Article							MELANIN-CONCENTRATING HORMONE; LATERAL HYPOTHALAMIC AREA; KNOCKOUT MICE; FEEDING-BEHAVIOR; FOOD-INTAKE; RAT-BRAIN; PROTEIN; GENE; LOCALIZATION; PROJECTIONS	Members of the muscarinic acetylcholine receptor family (M1-M5) have central roles in the regulation of many fundamental physiological functions(1,2). Identifying the specific receptor subtype( s) that mediate the diverse muscarinic actions of acetylcholine is of considerable therapeutic interest, but has proved difficult primarily because of a lack of subtype-selective ligands(3). Here we show that mice deficient in the M3 muscarinic receptor (M3R(-/-) mice) display a significant decrease in food intake, reduced body weight and peripheral fat deposits, and very low levels of serum leptin and insulin. Paradoxically, hypothalamic messenger RNA levels of melanin-concentrating hormone (MCH), which are normally upregulated in fasted animals leading to an increase in food intake(4,5), are significantly reduced in M3R(-/-) mice. Intra-cerebroventricular injection studies show that an agouti-related peptide analogue lacked orexigenic (appetite-stimulating) activity in M3R(-/-) mice. However, M3R(-/-) mice remained responsive to the orexigenic effects of MCH. Our data indicate that there may be a cholinergic pathway that involves M3-receptor-mediated facilitation of food intake at a site downstream of the hypothalamic leptin/melanocortin system and upstream of the MCH system.	NIDDKD, Bioorgan Chem Lab, Bethesda, MD 20892 USA; NIDDKD, Diabet Branch, Bethesda, MD 20892 USA; NIDDKD, Biochem & Metab Lab, Bethesda, MD 20892 USA; RIKEN, Brain Sci Inst, Lab Cell Culture Dev, Wako, Saitama 3510198, Japan; NIMH, Sect Behav Pharmacol, Expt Therapeut Branch, Bethesda, MD 20892 USA; Univ Tsukuba, Inst Basic Med Sci, Dept Pharmacol, Tsukuba, Ibaraki 3058575, Japan; NIAAA, Lab Membrane Biochem & Biophys, Rockville, MD 20852 USA; Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); RIKEN; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Tsukuba; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Eli Lilly	Wess, J (corresponding author), NIDDKD, Bioorgan Chem Lab, Bethesda, MD 20892 USA.		deng, chuxia/N-6713-2016; Miyakawa, Tsuyoshi/A-7741-2008; Duttaroy, Asim K./J-9499-2016	Miyakawa, Tsuyoshi/0000-0003-0137-8200; Duttaroy, Asim K./0000-0003-1619-3778; Felder, Christian/0000-0003-1134-8881	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056001, ZIADK056001, Z01DK032003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002179, Z01MH002179] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bayer L, 1999, NEUROSCIENCE, V91, P1087, DOI 10.1016/S0306-4522(98)00678-2; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; BOSCHERO AC, 1995, AM J PHYSIOL-ENDOC M, V268, pE336, DOI 10.1152/ajpendo.1995.268.2.E336; Broberger C, 1998, J COMP NEUROL, V402, P460; BROWN JH, 1996, PHARMACOL BASIS THER, P141; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; Crawley JN, 1997, HORM BEHAV, V31, P197, DOI 10.1006/hbeh.1997.1382; Eglen RM, 1996, PHARMACOL REV, V48, P531; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P10483, DOI 10.1073/pnas.96.18.10483; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; KLEIBER M, 1975, FIRE LIFE, P179; LEVEY AI, 1993, LIFE SCI, V52, P441, DOI 10.1016/0024-3205(93)90300-R; LEVEY AI, 1994, NEUROSCIENCE, V63, P207, DOI 10.1016/0306-4522(94)90017-5; Matsui M, 2000, P NATL ACAD SCI USA, V97, P9579, DOI 10.1073/pnas.97.17.9579; Mystkowski P, 2000, J NEUROSCI, V20, P8637, DOI 10.1523/JNEUROSCI.20-22-08637.2000; PARKES MW, 1972, BRIT J PHARMACOL, V46, P315, DOI 10.1111/j.1476-5381.1972.tb06876.x; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; ROGERS P, 1980, BRIT J NUTR, V43, P83, DOI 10.1079/BJN19800066; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; WESS J, 1990, COMPREHENSIVE MED CH, V3, P423; Zeng FY, 1999, J BIOL CHEM, V274, P16629, DOI 10.1074/jbc.274.23.16629	30	300	315	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					207	212		10.1038/35065604	http://dx.doi.org/10.1038/35065604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242080				2022-12-28	WOS:000167320500046
J	Choi, JY; Muallem, D; Kiselyov, K; Lee, MG; Thomas, PJ; Muallem, S				Choi, JY; Muallem, D; Kiselyov, K; Lee, MG; Thomas, PJ; Muallem, S			Aberrant CFTR-dependent HCO3- transport in mutations associated with cystic fibrosis	NATURE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE-ASSOCIATED MUTATIONS; CHLORIDE CHANNEL ACTIVITY; CYTOPLASMIC LOOP; BINDING; MUCIN; PH; IDENTIFICATION; VISCOSITY; CURRENTS	Cystic fibrosis (CF) is a disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). Initially, Cl- conductance in the sweat duct was discovered to be impaired in CF1, a finding that has been extended to all CFTR-expressing cells(2-4). Subsequent cloning of the gene(5,6) showed that CFTR functions as a cyclic-AMP-regulated Cl- channel(7); and some CF-causing mutations inhibit CFTR Cl- channel activity(2-4,8). The identification of additional C-causing mutants with normal Cl- channel activity indicates, however, that other CFTR-dependent processes contribute to the disease. Indeed, CFTR regulates other transporters(3,4), including Cl- -coupled HCO3- transport(9,10). Alkaline fluids are secreted by normal tissues, whereas acidic fluids are secreted by mutant CFTR-expressing tissues(11), indicating the importance of this activity. HCO3- and pH affect mucin viscosity(12,13) and bacterial binding(14,15). We have examined Cl- -coupled HCO3- transport by CFTR mutants that retain substantial or normal Cl- channel activity. Here we show that mutants reported to be associated with CF with pancreatic insufficiency do not support HCO3- transport, and those associated with pancreatic sufficiency show reduced HCO3- transport. Our findings demonstrate the importance of HCO3- transport in the function of secretory epithelia and in CF.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Yonsei Univ, Coll Med, Dept Pharmacol, Seoul 120752, South Korea; Yonsei Univ, Coll Med, Brain Korea 21 Project Med Sci, Seoul 120752, South Korea	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Muallem, S (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA.		Lee, Min Goo/AAS-4636-2020; Lee, Min Goo/D-5635-2012; Thomas, Philip J/F-7115-2012	Lee, Min Goo/0000-0001-7436-012X; Lee, Min Goo/0000-0001-7436-012X; Kiselyov, Kirill/0000-0001-6683-2895	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049835] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK049835] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; ARGENT BE, 1994, PHYSL GASTROINTESTIN, P1478; BHASKAR KR, 1991, AM J PHYSIOL, V261, pG827, DOI 10.1152/ajpgi.1991.261.5.G827; FULMER SB, 1995, P NATL ACAD SCI USA, V92, P6832, DOI 10.1073/pnas.92.15.6832; GRAY MA, 1993, AM J PHYSIOL, V264, pC591, DOI 10.1152/ajpcell.1993.264.3.C591; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Illek B, 1999, AM J PHYSIOL-CELL PH, V277, pC833, DOI 10.1152/ajpcell.1999.277.4.C833; KOPELMAN H, 1988, GASTROENTEROLOGY, V95, P349, DOI 10.1016/0016-5085(88)90490-8; Lee MG, 1999, J BIOL CHEM, V274, P3414, DOI 10.1074/jbc.274.6.3414; Lee MG, 1999, J BIOL CHEM, V274, P14670, DOI 10.1074/jbc.274.21.14670; Linsdell P, 1997, J GEN PHYSIOL, V110, P355, DOI 10.1085/jgp.110.4.355; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; McNicholas CM, 1996, P NATL ACAD SCI USA, V93, P8083, DOI 10.1073/pnas.93.15.8083; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; QUINTON PM, 1983, NATURE, V301, P421, DOI 10.1038/301421a0; Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Sheppard David N., 1999, Physiological Reviews, V79, pS23; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Vankeerberghen A, 1998, HUM MOL GENET, V7, P1761, DOI 10.1093/hmg/7.11.1761; Veerman ECI, 1997, GLYCOBIOLOGY, V7, P737, DOI 10.1093/glycob/7.6.737; VEERMAN ECI, 1989, J BIOL BUCCALE, V17, P297; WANKE CA, 1990, INFECT IMMUN, V58, P794, DOI 10.1128/IAI.58.3.794-800.1990	30	295	308	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					94	97		10.1038/35065099	http://dx.doi.org/10.1038/35065099			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242048	Green Accepted			2022-12-28	WOS:000167194300049
J	Tucker, M; Valencia-Sanchez, MA; Staples, RR; Chen, JJ; Denis, CL; Parker, R				Tucker, M; Valencia-Sanchez, MA; Staples, RR; Chen, JJ; Denis, CL; Parker, R			The transcription factor associated Ccr4 and Caf1 proteins are components of the major cytoplasmic mRNA deadenylase in Saccharomyces cerevisiae	CELL			English	Article							MESSENGER-RNA TURNOVER; GENE-EXPRESSION; REGULATORY COMPLEX; POLY(A)-BINDING PROTEIN; TRANSLATION INITIATION; MEIOTIC MATURATION; POLY(A) NUCLEASE; DECAPPING ENZYME; YEAST; MUTATIONS	The major pathways of mRNA turnover in eukaryotes initiate with shortening of the poly(A) tail. We demonstrate by several criteria that CCR4 and CAF1 encode critical components of the major cytoplasmic deadenylase in yeast. First, both Ccr4p and Caf1p are required for normal mRNA deadenylation in vivo. Second, both proteins localize to the cytoplasm. Third, purification of Caf1p copurifies with a Ccr4p-dependent poly(A)-specific exonuclease activity. We also provide evidence that the Pan2p/Pan3p nuclease complex encodes the predominant alternative deadenylase. These results, and previous work on Pan2p/Pan3p, define the mRNA deadenylases in yeast. The strong conservation of Ccr4p, Caf1p, Pan2p, and Pan3p indicates that they will function as deadenylases in other eukaryotes. Interestingly, because Ccr4p and Caf1p interact with transcription factors, these results suggest an unexpected link between mRNA synthesis and turnover.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA; Univ New Hampshire, Dept Biochem & Mol Biol, Durham, NH 03824 USA	University of Arizona; Howard Hughes Medical Institute; University of Arizona; University System Of New Hampshire; University of New Hampshire	Parker, R (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	rrparker@u.arizona.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045443, R01GM041215, R01GM045443] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45443, GM41215] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Badarinarayana V, 2000, GENETICS, V155, P1045; Bai YL, 1999, MOL CELL BIOL, V19, P6642; Barkoff A, 1998, EMBO J, V17, P3168, DOI 10.1093/emboj/17.11.3168; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; Benson JD, 1998, EMBO J, V17, P6714, DOI 10.1093/emboj/17.22.6714; Boeck R, 1996, J BIOL CHEM, V271, P432, DOI 10.1074/jbc.271.1.432; Brown CE, 1996, MOL CELL BIOL, V16, P5744; Brown CE, 1998, MOL CELL BIOL, V18, P6548, DOI 10.1128/MCB.18.11.6548; Caponigro G, 1996, NUCLEIC ACIDS RES, V24, P4304, DOI 10.1093/nar/24.21.4304; CAPONIGRO G, 1993, MOL CELL BIOL, V13, P5141, DOI 10.1128/MCB.13.9.5141; Chang MP, 1999, MOL CELL BIOL, V19, P1056; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dehlin E, 2000, EMBO J, V19, P1079, DOI 10.1093/emboj/19.5.1079; DENIS CL, 1990, GENETICS, V124, P283; Dlakic M, 2000, TRENDS BIOCHEM SCI, V25, P272, DOI 10.1016/S0968-0004(00)01582-6; DRAPER MP, 1995, MOL CELL BIOL, V15, P3487; Gao M, 2000, MOL CELL, V5, P479, DOI 10.1016/S1097-2765(00)80442-6; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Grosset C, 2000, CELL, V103, P29, DOI 10.1016/S0092-8674(00)00102-1; Hata H, 1998, GENETICS, V148, P571; Hatfield L, 1996, MOL CELL BIOL, V16, P5830; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Ikematsu N, 1999, ONCOGENE, V18, P7432, DOI 10.1038/sj.onc.1203193; Korner CG, 1997, J BIOL CHEM, V272, P10448; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; LaGrandeur TE, 1998, EMBO J, V17, P1487, DOI 10.1093/emboj/17.5.1487; Lemaire M, 2000, J BIOL CHEM, V275, P26925; Liu HY, 1997, EMBO J, V16, P5289, DOI 10.1093/emboj/16.17.5289; Liu HY, 1998, EMBO J, V17, P1096, DOI 10.1093/emboj/17.4.1096; LIU HY, 2001, IN PRESS J BIOL CHEM; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOWELL JE, 1992, GENE DEV, V6, P2088, DOI 10.1101/gad.6.11.2088; Martinez J, 2000, J BIOL CHEM, V275, P24222, DOI 10.1074/jbc.M001705200; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; MUHLRAD D, 1992, GENE DEV, V6, P2100, DOI 10.1101/gad.6.11.2100; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Oberholzer U, 1998, GENE, V207, P61, DOI 10.1016/S0378-1119(97)00605-7; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Puisieux A, 1999, B CANCER, V86, P358; SACHS AB, 1987, MOL CELL BIOL, V7, P3268, DOI 10.1128/MCB.7.9.3268; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; SAKAI A, 1992, NUCLEIC ACIDS RES, V20, P6227, DOI 10.1093/nar/20.23.6227; SCHENA M, 1991, METHOD ENZYMOL, V194, P389; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; Tharun S, 1999, GENETICS, V151, P1273; van Hoof A, 1999, CELL, V99, P347, DOI 10.1016/S0092-8674(00)81520-2; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; Wreden C, 1997, DEVELOPMENT, V124, P3015	52	462	472	2	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2001	104	3					377	386		10.1016/S0092-8674(01)00225-2	http://dx.doi.org/10.1016/S0092-8674(01)00225-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239395	Bronze			2022-12-28	WOS:000167003100008
J	Cassoux, P				Cassoux, P			Perspectives: Molecular metals - Staying neutral for a change	SCIENCE			English	Editorial Material							CONDUCTIVITY		CNRS, Lab Chim Coordinat Toulouse, F-31077 Toulouse, France	Centre National de la Recherche Scientifique (CNRS)	Cassoux, P (corresponding author), CNRS, Lab Chim Coordinat Toulouse, 205 Route Narbonne, F-31077 Toulouse, France.							AKAMATU H, 1954, NATURE, V173, P168, DOI 10.1038/173168a0; BELO D, IN PRESS EUR J INORG; Cassoux P, 1998, CHEMISTRY OF ADVANCED MATERIALS, P19; COLEMAN LB, 1973, SOLID STATE COMMUN, V12, P1125, DOI 10.1016/0038-1098(73)90127-0; FERRARIS J, 1973, J AM CHEM SOC, V95, P948, DOI 10.1021/ja00784a066; Jerome D., 1980, J PHYS LETT, V41, P95, DOI DOI 10.1051/JPHYSLET:0198000410409500; Kobayashi A, 1999, J AM CHEM SOC, V121, P10763, DOI 10.1021/ja9921017; KURMOO M, 1995, J AM CHEM SOC, V117, P12209, DOI 10.1021/ja00154a022; LENARVOR N, 1996, J CHEM SOC CHEM COMM, P1363; McCoy HN, 1911, J AM CHEM SOC, V33, P273, DOI 10.1021/ja02216a003; Schon JH, 2000, SCIENCE, V287, P1022, DOI 10.1126/science.287.5455.1022; Tanaka H, 2001, SCIENCE, V291, P285, DOI 10.1126/science.291.5502.285; WILLIAMS JF, 1992, OROTIC ACID IN CARDIOLOGY, P1	13	24	24	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					263	264		10.1126/science.291.5502.263	http://dx.doi.org/10.1126/science.291.5502.263			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11253216				2022-12-28	WOS:000166352900033
J	van Walraven, C; Forster, AJ; Parish, DC; Dane, FC; Chandra, KMD; Durham, MD; Whaley, C; Stiell, I				van Walraven, C; Forster, AJ; Parish, DC; Dane, FC; Chandra, KMD; Durham, MD; Whaley, C; Stiell, I			Validation of a clinical decision aid to discontinue in-hospital cardiac arrest resuscitations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOPULMONARY-RESUSCITATION; PREDICTION RULES; SURVIVAL; MORBIDITY; FAILURE	Context Most patients undergoing in-hospital cardiac resuscitation do not survive to hospital discharge. In a previous study, we developed a clinical decision aid for identifying all patients undergoing resuscitation who survived to hospital discharge. Objective To validate our previously derived clinical decision aid. Design, Setting, and Participants Data from a large registry of in-hospital resuscitations at a community teaching hospital in Georgia were analyzed to determine whether patients would be predicted to survive to hospital discharge (ie, whether their arrest was witnessed or their initial cardiac rhythm was either ventricular tachycardia or ventricular fibrillation or they regained a pulse during the first 10 minutes of chest compressions). Data from 2181 in-hospital cardiac resuscitation attempts in 1987-1996 involving 1884 pulseless patients were analyzed. Main Outcome Measure Comparison of predictions based on the decision aid with whether patients were actually discharged alive from the hospital. Results For 327 resuscitations (15.0%), the patient survived to hospital discharge, For 324 of these resuscitations, the patients were predicted to survive to hospital discharge (sensitivity=99.1%, 95% confidence interval, 97.1%-99.8%). In 269 resuscitations, patients did not satisfy the decision aid and were predicted to have no chance of being discharged from the hospital. Only 3 of these patients (1.1%) were discharged from the hospital (negative predictive value=98.9%), none of whom were able to live independently following discharge from the hospital. Conclusion This decision aid can be used to help physicians identify patients who are extremely unlikely to benefit from continued resuscitative efforts.	Univ Ottawa, Dept Med, Ottawa, ON, Canada; Mercer Univ, Sch Med, Dept Internal Med, Macon, GA 31207 USA; Ottawa Hosp, Leob Hlth Res Inst, Clin Epidemiol Unit, Ottawa, ON, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Ottawa; Mercer University; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto	van Walraven, C (corresponding author), F-660,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.	carlv@lri.ca	Dane, Francis/AAI-9660-2020	Dane, Francis/0000-0002-4120-0565; Stiell, Ian/0000-0002-2583-6408				BALLEW KA, 1994, ARCH INTERN MED, V154, P2426, DOI 10.1001/archinte.154.21.2426; BEDELL SE, 1983, NEW ENGL J MED, V309, P569, DOI 10.1056/NEJM198309083091001; BEURET P, 1993, RESUSCITATION, V25, P171, DOI 10.1016/0300-9572(93)90093-6; BIALECKI L, 1995, CHEST, V108, P1009, DOI 10.1378/chest.108.4.1009; Cummins RO, 1997, ANN EMERG MED, V29, P650, DOI 10.1016/S0196-0644(97)70256-7; de Vos R, 1999, ARCH INTERN MED, V159, P845, DOI 10.1001/archinte.159.8.845; Ebell M H, 1993, Fam Med, V25, P191; Ebell MH, 1997, MED DECIS MAKING, V17, P171, DOI 10.1177/0272989X9701700207; GEORGE AL, 1989, AM J MED, V87, P28; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LERER G, 1994, SOC WORK HEALTH CARE, V20, P109; MARWICK TH, 1991, RESUSCITATION, V22, P129, DOI 10.1016/0300-9572(91)90003-H; OKEEFFE S, 1994, RESUSCITATION, V28, P21, DOI 10.1016/0300-9572(94)90050-7; Parish DC, 1999, CRIT CARE MED, V27, P2137, DOI 10.1097/00003246-199910000-00010; ROBERTS JC, 1988, ACTA MED SCAND, V224, P141; Sanders AB, 1999, ARCH INTERN MED, V159, P119, DOI 10.1001/archinte.159.2.119; Schultz SC, 1996, RESUSCITATION, V33, P13, DOI 10.1016/S0300-9572(96)00986-0; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Stiell IG, 1996, JAMA-J AM MED ASSOC, V275, P1417, DOI 10.1001/jama.275.18.1417; STIELL IG, 1992, NEW ENGL J MED, V327, P1045, DOI 10.1056/NEJM199210083271502; SUCHMAN AL, 1991, DIAGNOSTIC STRATEGIE, P17; van Walraven C, 1999, ARCH INTERN MED, V159, P129, DOI 10.1001/archinte.159.2.129; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; WOODHOUSE SP, 1992, RESUSCITATION, V23, P77, DOI 10.1016/0300-9572(92)90164-8; 2000, CIRCULATION S1, V102, P1; 2000, CIRCULATION S1, V102, P142	26	73	74	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2001	285	12					1602	1606		10.1001/jama.285.12.1602	http://dx.doi.org/10.1001/jama.285.12.1602			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413HH	11268268				2022-12-28	WOS:000167606600027
J	Erlebacher, J; Aziz, MJ; Karma, A; Dimitrov, N; Sieradzki, K				Erlebacher, J; Aziz, MJ; Karma, A; Dimitrov, N; Sieradzki, K			Evolution of nanoporosity in dealloying	NATURE			English	Article							BINARY-ALLOYS; CORROSION; DISSOLUTION	Dealloying is a common corrosion process during which an alloy is 'parted' by the selective dissolution of the most electrochemically active of its elements. This process results in the formation of a nanoporous sponge composed almost entirely of the more noble alloy constituents(1). Although considerable attention has been devoted to the morphological aspects of the dealloying process, its underlying physical mechanism has remained unclear(2). Here we propose a continuum model that is fully consistent with experiments and theoretical simulations of alloy dissolution, and demonstrate that nanoporosity in metals is due to an intrinsic dynamical pattern formation process. That is, pores form because the more noble atoms are chemically driven to aggregate into two-dimensional clusters by a phase separation process (spinodal decomposition) at the solid-electrolyte interface, and the surface area continuously increases owing to etching. Together, these processes evolve porosity with a characteristic length scale predicted by our continuum model. We expect that chemically tailored nanoporous gold made by dealloying Ag-Au should be suitable for sensor applications, particularly in a biomaterials context.	Northeastern Univ, Dept Phys, Boston, MA 02115 USA; Northeastern Univ, Ctr Interdisciplinary Res Complex Syst, Boston, MA 02115 USA; Arizona State Univ, Dept Mech & Aerosp Engn, Tempe, AZ 85287 USA; Arizona State Univ, Ctr Solid State Sci, Tempe, AZ 85287 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Northeastern University; Northeastern University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Harvard University	Erlebacher, J (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.		Karma, Alain/AAL-7090-2020; Dimitrov, Nikolay/AAE-9148-2021; Erlebacher, Jonah/A-3231-2010; T, Maiyalagan/C-5716-2011; Aziz, Michael/AAK-4866-2020	Karma, Alain/0000-0001-7032-9862; Dimitrov, Nikolay/0000-0003-1787-4575; T, Maiyalagan/0000-0003-3528-3824; Aziz, Michael/0000-0001-9657-9456				Barabasi A.-L., 1995, FRACTAL CONCEPTS SUR; BENJACOB E, 1983, PHYS REV LETT, V51, P1930, DOI 10.1103/PhysRevLett.51.1930; CAHN JW, 1958, J CHEM PHYS, V28, P258, DOI 10.1063/1.1744102; CAHN JW, 1959, J CHEM PHYS, V31, P688, DOI 10.1063/1.1730447; CORCORAN S, 2000, CRITICAL FACTORS LOC, V3, P500; ERLEBACHER J, 1997, DYNAMICS CRYSTAL SUR, P24; FORTY AJ, 1979, NATURE, V282, P597, DOI 10.1038/282597a0; FORTY AJ, 1991, C FRANK 80 BIRTHDAY, P164; HAASEN P, 1986, PHYSICAL METALLURGY; HILLIARD JE, 1971, SOLIDIFICATION, P497; HOU TY, 1994, J COMPUT PHYS, V114, P312, DOI 10.1006/jcph.1994.1170; KESSLER DA, 1984, PHYS REV A, V30, P3161, DOI 10.1103/PhysRevA.30.3161; LECHTMAN H, 1984, SCI AM, V250, P56, DOI 10.1038/scientificamerican0684-56; LI R, 1992, PHYS REV LETT, V68, P1168, DOI 10.1103/PhysRevLett.68.1168; Masinc G, 1921, Z ANORG ALLG CHEM, V118, P293, DOI 10.1002/zaac.19211180127; MULLINS WW, 1957, J APPL PHYS, V28, P333, DOI 10.1063/1.1722742; NEWMAN RC, 1994, SCIENCE, V263, P1708, DOI 10.1126/science.263.5154.1708; PICKERING HW, 1983, CORROS SCI, V23, P1107, DOI 10.1016/0010-938X(83)90092-6; PICKERING HW, 1967, J ELECTROCHEM SOC, V114, P698, DOI 10.1149/1.2426709; SIERADZKI K, 1989, PHILOS MAG A, V59, P713, DOI 10.1080/01418618908209817; SIERADZKI K, 1993, J ELECTROCHEM SOC, V140, P2868, DOI 10.1149/1.2220924; Tulimieri DJ, 1999, PHYS REV LETT, V82, P121, DOI 10.1103/PhysRevLett.82.121; WAGNER C, 1954, J ELECTROCHEM SOC, V101, P225, DOI 10.1149/1.2781235; Wagner K, 1997, J ELECTROCHEM SOC, V144, P3545, DOI 10.1149/1.1838046; WILLIAMS DE, 1991, NATURE, V350, P216, DOI 10.1038/350216a0	25	2183	2264	41	1309	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					450	453		10.1038/35068529	http://dx.doi.org/10.1038/35068529			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260708	Green Submitted			2022-12-28	WOS:000167583800036
J	Polyak, L; Edwards, MH; Coakley, BJ; Jakobsson, M				Polyak, L; Edwards, MH; Coakley, BJ; Jakobsson, M			Ice shelves in the Pleistocene Arctic Ocean inferred from glaciogenic deep-sea bedforms	NATURE			English	Article							YERMAK PLATEAU; ICEBERG PLOWMARKS; SHEET; SIDESCAN; HISTORY; FRONTS	It has been proposed that during Pleistocene glaciations, an ice cap of 1 kilometre or greater thickness covered the Arctic Ocean(1-3). This notion contrasts with the prevailing view that the Arctic Ocean was covered only by perennial sea ice with scattered icebergs(4-6). Detailed mapping of the ocean floor is the best means to resolve this issue. Although sea-floor imagery has been used to reconstruct the glacial history of the Antarctic shelf(7-9), little data have been collected in the Arctic Ocean because of operational constraints(10,11). The use of a geophysical mapping system during the submarine SCICEX expedition in 1999(12) provided the opportunity to perform such an investigation over a large portion of the Arctic Ocean. Here we analyse backscatter images and sub-bottom profiler records obtained during this expedition from depths as great as 1 kilometre. These records show multiple bedforms indicative of glacial scouring and moulding of sea floor, combined with large-scale erosion of submarine ridge crests. These distinct glaciogenic features demonstrate that immense, Antarctic-type ice shelves up to 1 kilometre thick and hundreds of kilometres long existed in the Arctic Ocean during Pleistocene glaciations.	Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA; Univ Hawaii, Hawaii Inst Geophys & Planetol, Hawaii Mapping Res Grp, Honolulu, HI 96822 USA; Tulane Univ, Dept Geol, New Orleans, LA 70118 USA; Univ Stockholm, Dept Geol & Geochem, S-10691 Stockholm, Sweden	University System of Ohio; Ohio State University; University of Hawaii System; Tulane University; Stockholm University	Polyak, L (corresponding author), Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA.	polyak.1@osu.edu	Jakobsson, Martin/F-6214-2010	Jakobsson, Martin/0000-0002-9033-3559				Anderson J.B., 1999, ANTARCTIC MARINE GEO; BARNES PW, 1988, GEOLOGY, V16, P1130, DOI 10.1130/0091-7613(1988)016<1130:IRSSTM>2.3.CO;2; Bischof JF, 1997, SCIENCE, V277, P74, DOI 10.1126/science.277.5322.74; Canals M, 2000, GEOLOGY, V28, P31, DOI 10.1130/0091-7613(2000)028<0031:DSFEOP>2.3.CO;2; CLARK CD, IN PRESS QUAT INT; CLARK DL, 1982, NATURE, V300, P321, DOI 10.1038/300321a0; Darby DA, 1997, DEEP-SEA RES PT II, V44, P1745, DOI 10.1016/S0967-0645(97)00039-8; Davies T.A., 1997, GLACIATED CONTINENTA; DOWDESWELL JA, 1993, MAR GEOL, V111, P37, DOI 10.1016/0025-3227(93)90187-Z; DYKE AS, 1992, GEOL SURV CAN MEM, V433; Edwards MH, 2001, NATURE, V409, P808, DOI 10.1038/35057258; Faleide JI, 1996, GLOBAL PLANET CHANGE, V12, P53, DOI 10.1016/0921-8181(95)00012-7; Flower BP, 1997, GEOLOGY, V25, P147, DOI 10.1130/0091-7613(1997)025<0147:OSOTYP>2.3.CO;2; Grosswald M.G., 1999, POLAR GEOGRAPHY, V23, P23, DOI DOI 10.1080/10889379909377663; Jakobsson M, 1999, MAR GEOL, V158, P111, DOI 10.1016/S0025-3227(98)00186-8; JAKOBSSON M, IN PRESS GLOBAL PLAN; Jakobsson M., 2000, EOS T AM GEOPHYS UN, V81, P89, DOI [DOI 10.1029/00EO00059, DOI 10.1130/G32153.1]; Jakobsson M, 2000, EOS T AGU, V81, P93, DOI DOI 10.1029/00E000059; JOSENHANS HW, 1990, MAR GEOL, V92, P1, DOI 10.1016/0025-3227(90)90024-E; LINDSTROM DR, 1989, SCIENCE, V245, P628, DOI 10.1126/science.245.4918.628; MERCER JH, 1970, PALAEOGEOGR PALAEOCL, V8, P19, DOI 10.1016/0031-0182(70)90076-3; Oppenheimer M, 1998, NATURE, V393, P325, DOI 10.1038/30661; Phillips RL, 1997, GEOL SOC AM BULL, V109, P1101; Polyak L, 1997, MAR GEOL, V143, P169, DOI 10.1016/S0025-3227(97)00096-0; Poore RZ, 1999, GEOLOGY, V27, P759, DOI 10.1130/0091-7613(1999)027<0759:LPAHME>2.3.CO;2; Robe R. Q., 1980, DYNAMICS SNOW ICE MA, P211; Shipp S, 1999, GEOL SOC AM BULL, V111, P1486, DOI 10.1130/0016-7606(1999)111<1486:LPHROT>2.3.CO;2; SOLHEIM A, 1990, GEOL SOC SPEC PUBL, V53, P253, DOI 10.1144/GSL.SP.1990.053.01.14; Spielhagen RF, 1997, GEOLOGY, V25, P783, DOI 10.1130/0091-7613(1997)025<0783:AOEFLQ>2.3.CO;2; VOGT PR, 1995, GEOLOGY, V23, P477; VOGT PR, 1994, GEOLOGY, V22, P403, DOI 10.1130/0091-7613(1994)022<0403:DPIPOT>2.3.CO;2	31	157	165	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2001	410	6827					453	457		10.1038/35068536	http://dx.doi.org/10.1038/35068536			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260709				2022-12-28	WOS:000167583800037
J	Jay, SJ				Jay, SJ			Orthostatic hypotension and chronic fatigue syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Indiana Univ, Sch Med, Dept Publ Hlth, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Jay, SJ (corresponding author), Indiana Univ, Sch Med, Dept Publ Hlth, Indianapolis, IN 46202 USA.							Fukuda H, 1997, STROKE, V28, P1461, DOI 10.1161/01.STR.28.7.1461; Grassi G, 2000, CONTRIB NEPHROL, V130, P21, DOI 10.1159/000060052; Orleans CT, 1993, NICOTINE ADDICTION P; Rowe PC, 2001, JAMA-J AM MED ASSOC, V285, P52, DOI 10.1001/jama.285.1.52; *US DEP HHS, 1983, DHHS PUBL 1	5	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1442	1443						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410VQ	11255416				2022-12-28	WOS:000167462100022
J	Bebenek, K; Tissier, A; Frank, EG; McDonald, JP; Prasad, R; Wilson, SH; Woodgate, R; Kunkel, TA				Bebenek, K; Tissier, A; Frank, EG; McDonald, JP; Prasad, R; Wilson, SH; Woodgate, R; Kunkel, TA			5 '-Deoxyribose phosphate lyase activity of human DNA polymerase iota in vitro	SCIENCE			English	Article							BASE EXCISION-REPAIR; ESCHERICHIA-COLI; BETA; SITE; FIDELITY; ENZYME; IDENTIFICATION; MUTAGENESIS; BYPASS	DNA polymerase iota (pol iota) is one of several recently discovered DNA polymerases in mammalian cells whose function is unknown. We report here that human pol iota has an intrinsic 5'-deoxyribose phosphate (dRP) Lyase activity. In reactions reconstituted with uracil-DNA glycosylase (UDC), apurinic/apyrimidinic (AP) endonuclease and DNA Ligase I, pol iota can use its dRP Lyase and polymerase activities to repair G . U and A . U pairs in DNA, These data and three distinct catalytic properties of pol iota implicate it in specialized forms of base excision repair (BER).	NIEHS, Genet Mol Lab, NIH, Res Triangle Pk, NC 27709 USA; NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; NICHHD, Sect DNA Replicat Repair & Mutagenesis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kunkel, TA (corresponding author), NIEHS, Genet Mol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	kunkel@niehs.nih.gov	Wilson, Samuel H/E-6644-2019; Tissier, Agnes/I-4850-2018; Kunkel, Thomas A./D-5088-2019	Wilson, Samuel H/0000-0002-1702-5293; Kunkel, Thomas A./0000-0002-9900-1788; Woodgate, Roger/0000-0001-5581-4616; TISSIER, Agnes/0000-0002-5676-8719	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050158, ZIAES065070, Z01ES050158, Z01ES065070] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Berdal KG, 1998, EMBO J, V17, P363, DOI 10.1093/emboj/17.2.363; Deterding LJ, 2000, J BIOL CHEM, V275, P10463, DOI 10.1074/jbc.275.14.10463; Friedberg EC, 2000, P NATL ACAD SCI USA, V97, P5681, DOI 10.1073/pnas.120152397; Gerlach VL, 2001, J BIOL CHEM, V276, P92, DOI 10.1074/jbc.M004413200; Goodman MF, 2000, NAT REV MOL CELL BIO, V1, P101, DOI 10.1038/35040051; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, P NATL ACAD SCI USA, V96, P12224, DOI 10.1073/pnas.96.22.12224; LU AL, 1988, CELL, V54, P805, DOI 10.1016/S0092-8674(88)91109-9; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; McDonald JP, 1999, GENOMICS, V60, P20, DOI 10.1006/geno.1999.5906; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; Mullen GP, 1997, BIOCHEMISTRY-US, V36, P4713, DOI 10.1021/bi962363a; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355; Osheroff WP, 1999, J BIOL CHEM, V274, P3642, DOI 10.1074/jbc.274.6.3642; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Poltoratsky V, 2000, J EXP MED, V192, pF27, DOI 10.1084/jem.192.10.F27; Prasad R, 1998, J BIOL CHEM, V273, P11121, DOI 10.1074/jbc.273.18.11121; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Tissier A, 2000, GENE DEV, V14, P1642; Tissier A, 2000, EMBO J, V19, P5259, DOI 10.1093/emboj/19.19.5259; Wilson SH, 2000, COLD SPRING HARB SYM, V65, P143, DOI 10.1101/sqb.2000.65.143; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000	27	163	173	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2001	291	5511					2156	2159		10.1126/science.1058386	http://dx.doi.org/10.1126/science.1058386			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251121	Green Published			2022-12-28	WOS:000167563800041
J	Mukhopadhyay, S; Farley, KA; Montanari, A				Mukhopadhyay, S; Farley, KA; Montanari, A			A short duration of the Cretaceous-Tertiary boundary event: Evidence from extraterrestrial helium-3	SCIENCE			English	Article							INTERPLANETARY DUST; MASS EXTINCTION; IMPACT; STRATIGRAPHY; CONSTRAINTS; PARTICLES; METEORITE; COMETS	Analyses of marine carbonates through the interval 63.9 to 65.4 million years ago indicate a near-constant flux of extraterrestrial helium-3, a tracer of the accretion rate of interplanetary dust to Earth. This observation indicates that the bolide associated with the Cretaceous-Tertiary (K-T) extinction event was not accompanied by enhanced solar system dustiness and so could not have been a member of a comet shower. The use of helium-3 as a constant-flux proxy of sedimentation rate implies deposition of the K-T boundary clay in (10 +/- 2) x 10(3) years, precluding the possibility of a Long hiatus at the boundary and requiring extremely rapid faunal turnover.	CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Osservatorio Geol Coldigioco, I-62020 Frontale Di Apiro, Italy	California Institute of Technology	Mukhopadhyay, S (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.		Farley, Kenneth/AAE-7735-2020	Farley, Kenneth/0000-0002-7846-7546				ALVAREZ LW, 1980, SCIENCE, V208, P1097; Becker L, 2000, P NATL ACAD SCI USA, V97, P2979, DOI 10.1073/pnas.050519397; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; D'Hondt S, 1998, SCIENCE, V282, P276, DOI 10.1126/science.282.5387.276; DUPUIS C, 1998, INT WORKSH CRET TERT; Farley KA, 1997, GEOCHIM COSMOCHIM AC, V61, P2309, DOI 10.1016/S0016-7037(97)00068-9; Farley KA, 1998, SCIENCE, V280, P1250, DOI 10.1126/science.280.5367.1250; FARLEY KA, ACCRETION EXTRATERRE; HERBERT TD, 1990, EARTH PLANET SC LETT, V99, P263, DOI 10.1016/0012-821X(90)90115-E; Hofmann C, 2000, EARTH PLANET SC LETT, V180, P13, DOI 10.1016/S0012-821X(00)00159-X; HSU KJ, 1982, GEOL SOC AM SPEC PAP, V190, P317; HUT P, 1987, NATURE, V329, P118, DOI 10.1038/329118a0; KELLER G, 1993, GEOL SOC AM BULL, V105, P979, DOI 10.1130/0016-7606(1993)105<0979:GMESSA>2.3.CO;2; Kortenkamp SJ, 1998, SCIENCE, V280, P874, DOI 10.1126/science.280.5365.874; KRING DA, 2000, GSA TODAY, V8, P2; Kyte FT, 1998, NATURE, V396, P237, DOI 10.1038/24322; MONTANARI A, 1991, J SEDIMENT PETROL, V61, P315; Mukhopadhyay S, 2001, GEOCHIM COSMOCHIM AC, V65, P653, DOI 10.1016/S0016-7037(00)00555-X; NIER AO, 1990, METEORITICS, V25, P263, DOI 10.1111/j.1945-5100.1990.tb00710.x; OFFICER CB, 1987, NATURE, V326, P143, DOI 10.1038/326143a0; OZIMA M, 1984, NATURE, V311, P449; Patterson DB, 1998, EARTH PLANET SC LETT, V163, P315, DOI 10.1016/S0012-821X(98)00197-6; Patterson DB, 1999, GEOCHIM COSMOCHIM AC, V63, P615, DOI 10.1016/S0016-7037(99)00077-0; Shukolyukov A, 1998, SCIENCE, V282, P927, DOI 10.1126/science.282.5390.927; SMIT J, 1990, GEOL MIJNBOUW, V69, P187; SMIT J, 1985, EARTH PLANET SC LETT, V74, P155, DOI 10.1016/0012-821X(85)90019-6; Smit J, 1999, ANNU REV EARTH PL SC, V27, P75, DOI 10.1146/annurev.earth.27.1.75; SYKES MV, 1986, SCIENCE, V232, P1115, DOI 10.1126/science.232.4754.1115; Weissman PR, 1997, ANN NY ACAD SCI, V822, P67, DOI 10.1111/j.1749-6632.1997.tb48335.x	29	74	77	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1952	1955		10.1126/science.291.5510.1952	http://dx.doi.org/10.1126/science.291.5510.1952			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239153				2022-12-28	WOS:000167401600043
J	Leung, KT; Jozsa, L; Ravasz, M; Neda, Z				Leung, KT; Jozsa, L; Ravasz, M; Neda, Z			Pattern formation - Spiral cracks without twisting	NATURE			English	Article							FRACTURE		Acad Sinica, Inst Phys, Taipei 11529, Taiwan; Univ Babes Bolyai, Dept Chem, RO-3400 Cluj Napoca, Romania; Univ Babes Bolyai, Dept Phys, RO-3400 Cluj Napoca, Romania; Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA	Academia Sinica - Taiwan; Babes Bolyai University from Cluj; Babes Bolyai University from Cluj; University of Notre Dame	Leung, KT (corresponding author), Acad Sinica, Inst Phys, Taipei 11529, Taiwan.		Néda, Zoltán/C-3754-2011; Leung, KT/AAQ-3766-2021; Ravasz, Maria Ercsey/E-2098-2017	Leung, KT/0000-0003-3049-9562; Ravasz, Maria Ercsey/0000-0003-4428-9953				Bai T, 2000, NATURE, V403, P753, DOI 10.1038/35001550; BOSTMAN OM, 1986, J BONE JOINT SURG BR, V68, P462, DOI 10.1302/0301-620X.68B3.3733815; GROISMAN A, 1994, EUROPHYS LETT, V25, P415, DOI 10.1209/0295-5075/25/6/004; Lawn P.R, 1993, CAMBRIDGE SOLID STAT, Vsecond; Leung K, 2000, PHYS REV LETT, V85, P662, DOI 10.1103/PhysRevLett.85.662; Shorlin KA, 2000, PHYS REV E, V61, P6950, DOI 10.1103/PhysRevE.61.6950; SKJELTORP AT, 1988, NATURE, V335, P424, DOI 10.1038/335424a0; Xia ZC, 2000, J MECH PHYS SOLIDS, V48, P1107, DOI 10.1016/S0022-5096(99)00081-2; YUSE A, 1993, NATURE, V362, P329, DOI 10.1038/362329a0	9	45	46	3	54	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					166	166		10.1038/35065517	http://dx.doi.org/10.1038/35065517			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242065	Green Submitted			2022-12-28	WOS:000167320500031
J	Vineis, P; Schulte, P; McMichael, AJ				Vineis, P; Schulte, P; McMichael, AJ			Misconceptions about the use of genetic tests in populations	LANCET			English	Editorial Material							BREAST-CANCER; RANDOMIZED TRIAL; PUBLIC-HEALTH; DNA-REPAIR; RISK; PREVENTION; TAMOXIFEN; SUSCEPTIBILITY; MUTATIONS; PHENOTYPE		Dipartimento Sci Biomed & Oncol Umana, Canc Epidemiol Unit, I-10126 Turin, Italy; CPO Piemonte, I-10126 Turin, Italy; NIOSH, Educ & Informat Div, Cincinnati, OH 45226 USA; Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England	Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); University of London; London School of Hygiene & Tropical Medicine	Vineis, P (corresponding author), Dipartimento Sci Biomed & Oncol Umana, Canc Epidemiol Unit, Via Santena 7, I-10126 Turin, Italy.	paolo.vineis@unito.it						Bartell SM, 2000, RISK ANAL, V20, P87, DOI 10.1111/0272-4332.00009; Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; Berwick M, 2000, JNCI-J NATL CANCER I, V92, P874, DOI 10.1093/jnci/92.11.874; Coughlin SS, 1999, AM J PREV MED, V16, P91, DOI 10.1016/S0749-3797(98)00136-6; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Dybdahl M, 1999, CANCER EPIDEM BIOMAR, V8, P77; EYFJORD JE, 2000, P WORKSH MOL EP NEW; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; International Agency for Research on Cancer, 1986, IARC MON EV CARC RIS, V38; Lewis J, 1999, PERSPECT BIOL MED, V43, P112; Meirhaeghe A, 1999, LANCET, V353, P896, DOI 10.1016/S0140-6736(99)00251-2; Motulsky AG, 2000, ANNU REV PUBL HEALTH, V21, P65, DOI 10.1146/annurev.publhealth.21.1.65; Nicas M, 1999, J OCCUP ENVIRON MED, V41, P535, DOI 10.1097/00043764-199907000-00002; OTTMAN R, 1995, AM J HUM GENET, V56, P821; Powles T, 1998, LANCET, V352, P98; Veronesi U, 1998, LANCET, V352, P93; Vineis P, 1996, CANCER CAUSE CONTROL, V7, P479, DOI 10.1007/BF00052675; Vineis P, 1999, IARC SCI PUBLICATION, V148; Vogelstein B., 1998, GENETIC BASIS HUMAN; Yang Q, 2000, BRIT J CANCER, V82, P763, DOI 10.1054/bjoc.1999.0995; 1996, SCIENCE, V274, P317	24	101	101	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2001	357	9257					709	712		10.1016/S0140-6736(00)04136-2	http://dx.doi.org/10.1016/S0140-6736(00)04136-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247571				2022-12-28	WOS:000167282400038
J	Jolly, A				Jolly, A			Monkeys in the back garden	SCIENCE			English	Editorial Material									Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Jolly, A (corresponding author), Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England.								0	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1705	1706		10.1126/science.1057629	http://dx.doi.org/10.1126/science.1057629			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11253192				2022-12-28	WOS:000167320600028
J	Scheffer, JR; Scott, C				Scheffer, JR; Scott, C			Solid state organic chemistry - Stepping it up	SCIENCE			English	Editorial Material							PHOTOCHEMISTRY; LENSES		Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	University of British Columbia	Scheffer, JR (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.							[Anonymous], 1991, PHOTOCHEMISTRY ORG C; COHEN MD, 1975, ANGEW CHEM INT EDIT, V14, P386, DOI 10.1002/anie.197503861; COHEN MD, 1964, J CHEM SOC, P1996, DOI 10.1039/jr9640001996; COWAN DO, 1986, CHEM ENG NEWS   0721, P28; Crano JC, 1996, PURE APPL CHEM, V68, P1395, DOI 10.1351/pac199668071395; Dunitz JD, 1984, T AM CRYSTALLOGR ASS, V20, P1; DURR H, 1990, PHOTOCHROMISM; Irie M, 2001, SCIENCE, V291, P1769, DOI 10.1126/science.291.5509.1769; KAUPP G, 1996, COMPREHENSIVE SUPRAM, V8, P381; KEATING AE, 1998, ORGANIC INORGANIC PH, V2, pCH5; Schmidt G.M.J., 1967, REACTIVITY PHOTOEXCI, P227; Van Gemert B, 2000, MOL CRYST LIQ CRYST, V344, P57, DOI 10.1080/10587250008023814; WEISS RG, 1993, ACCOUNTS CHEM RES, V26, P530, DOI 10.1021/ar00034a003	13	9	9	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1712	1713		10.1126/science.291.5509.1712	http://dx.doi.org/10.1126/science.291.5509.1712			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11253194				2022-12-28	WOS:000167320600032
J	Mao, YX; Chen, J; Maynard, JA; Zhang, B; Quiocho, FA				Mao, YX; Chen, J; Maynard, JA; Zhang, B; Quiocho, FA			A novel all helix fold of the AP180 amino-terminal domain for phosphoinositide binding and clathrin assembly in synaptic vesicle endocytosis	CELL			English	Article							TRANSMITTER RELEASE; CRYSTAL-STRUCTURE; PROTEIN; AP-3; LOCALIZATION; MEMBRANE; ADAPTER; COMPLEX; SIZE; IDENTIFICATION	Clathrin-mediated endocytosis plays a major role in retrieving synaptic Vesicles from the plasma membrane following exocytosis. This endocytic process requires AP180 (or a homolog), which promotes the assembly and restricts the size of clathrin-coated vesicles. The highly conserved 33 kDa amino-terminal domain of AP180 plays a critical role in binding to phosphoinositides and in regulating the clathrin assembly activity of AP180. The crystal structure of the aminoterminal domain reported herein reveals a never fold consisting of a large double layer of sheets of ten alpha helices and a unique site for binding phosphoinositides. The finding that the clathrin-box motif is mostly buried and lies in a helix indicates a different site and mechanism for binding of the domain to clathrins than previously assumed.	Baylor Coll Med, Struct & Computat Biol & Mol Biophys Grad Program, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas, Inst Neurosci, Neurobiol Sect, Austin, TX 78712 USA; Univ Texas, Dept Chem Engn, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Quiocho, FA (corresponding author), Baylor Coll Med, Struct & Computat Biol & Mol Biophys Grad Program, Houston, TX 77030 USA.	faq@bcm.tmc.edu		Mao, Yuxin/0000-0002-5064-1397				AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Hao WH, 1997, J BIOL CHEM, V272, P6393, DOI 10.1074/jbc.272.10.6393; HE JJ, 1993, PROTEIN SCI, V2, P1643, DOI 10.1002/pro.5560021010; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang KM, 1999, EMBO J, V18, P3897, DOI 10.1093/emboj/18.14.3897; Hyman J, 2000, J CELL BIOL, V149, P537, DOI 10.1083/jcb.149.3.537; Ibata K, 1998, J BIOL CHEM, V273, P12267, DOI 10.1074/jbc.273.20.12267; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KEEN JH, 1979, CELL, V16, P303, DOI 10.1016/0092-8674(79)90007-2; KOENIG JH, 1989, J NEUROSCI, V9, P3844; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; McMahon HT, 1999, CURR BIOL, V9, pR332, DOI 10.1016/S0960-9822(99)80206-1; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Morgan JR, 2000, J NEUROSCI, V20, P8667; Morgan JR, 1999, J NEUROSCI, V19, P10201; MORRIS SA, 1993, EMBO J, V12, P667, DOI 10.1002/j.1460-2075.1993.tb05700.x; MURPHY JE, 1991, J BIOL CHEM, V266, P4401; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; NORRIS FA, 1995, J BIOL CHEM, V270, P214, DOI 10.1074/jbc.270.1.214; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PFLUGRATH JW, 1985, NATURE, V314, P257, DOI 10.1038/314257a0; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; SOUSA R, 1992, J NEUROSCI, V12, P2130; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71; YE W, 1995, J NEUROSCI RES, V41, P15, DOI 10.1002/jnr.490410104; YE WL, 1995, J BIOL CHEM, V270, P10933, DOI 10.1074/jbc.270.18.10933; Zhang B, 1999, NEURON, V23, P419, DOI 10.1016/S0896-6273(00)80794-1; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; ZHANG B, 1999, FRONTIERS MOL BIOL N, P389	50	72	74	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2001	104	3					433	440		10.1016/S0092-8674(01)00230-6	http://dx.doi.org/10.1016/S0092-8674(01)00230-6			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239400	Bronze			2022-12-28	WOS:000167003100013
J	Pierfitte, C; Macouillard, G; Thicoipe, M; Chaslerie, A; Pehourcq, F; Aissou, M; Martinez, B; Lagnaoui, R; Fourrier, A; Begaud, B; Dangoumau, J; Moore, N				Pierfitte, C; Macouillard, G; Thicoipe, M; Chaslerie, A; Pehourcq, F; Aissou, M; Martinez, B; Lagnaoui, R; Fourrier, A; Begaud, B; Dangoumau, J; Moore, N			Benzodiazepines and hip fractures in elderly people: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NURSING-HOME RESIDENTS; ELIMINATION HALF-LIFE; RISK-FACTORS; COGNITIVE IMPAIRMENT; THIAZIDE DIURETICS; FALLS; COMMUNITY; ANTIDEPRESSANTS; DEMENTIA	Objective To determine whether benzodiazepines are associated with an increased risk of hip facture. Design Case-control study. Participants All incident cases of hip fracture not related to traffic accidents or cancer in patients ol er 65 years of age. 245 cases were matched to 817 controls. Setting Emergency department of a university hospital. Main outcome measures Exposure to benzodiazepines and other potential risk ol protective factors or lifestyle items. Results The use of benzodiazepines as determined from questionnaires, medical records, or plasma samples at admission to hospital was not associated with an increased risk of hip fracture (odds ratio 0.9, 95% confidence interval 0.5 to 1.5). Hip fracture was, however, associated with the use of two of more benzodiazepines, as determined from questionnaires or medical records but not from plasma samples. Of the individual drugs, only lorazepam was significantly associated with an increased risk of hip fracture (1.8, 1.1 to 3.1). Conclusion Except for lorazepam, the presence of benzodiazepines in plasma was not associated with an increased risk of hip fracture. nle method used to ascertain exposure could influence the results of case-control studies.	CHU Bordeaux, Hop Pellegrin, Serv Urgencies, Bordeaux, France; CHU Bordeaux, Hop Pellegrin, Serv Urgencies, F-33076 Bordeaux, France; CHU Bordeaux, Dept Pharmacol, Clin Pharmacol Unit, F-33076 Bordeaux, France; CHU Bordeaux, Hop Pellegrin, Dept Anesthesie Reanimat, F-33076 Bordeaux, France	CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux	Moore, N (corresponding author), Victor Segalen Univ, Dept Pharmacol, F-33076 Bordeaux, France.	nicholas.moore@pharmaco.u-bordeaux2.fr	Moore, Nicholas/B-2368-2013	Moore, Nicholas/0000-0003-1212-2817				BARBERGERGATEAU P, 1992, J AM GERIATR SOC, V40, P1129, DOI 10.1111/j.1532-5415.1992.tb01802.x; BOONEN S, 1993, ACTA CLIN BELG, V48, P190, DOI 10.1080/17843286.1993.11718306; BRUNELLI MP, 1998, CLIN ORTHOP RELAT R, V348, P15; CUMMING RG, 1993, MED J AUSTRALIA, V158, P414, DOI 10.5694/j.1326-5377.1993.tb121839.x; Cumming RG, 1998, DRUG AGING, V12, P43, DOI 10.2165/00002512-199812010-00005; CUMMING RG, 1994, AGE AGEING, V23, P468, DOI 10.1093/ageing/23.6.468; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; DARTIGUES JF, 1992, NEUROEPIDEMIOLOGY, V11, P14, DOI 10.1159/000110955; Emeriau JP, 1998, B ACAD NAT MED PARIS, V182, P1419; Franssen EH, 1999, J AM GERIATR SOC, V47, P463, DOI 10.1111/j.1532-5415.1999.tb07240.x; Grisso JA, 1997, AM J EPIDEMIOL, V145, P786, DOI 10.1093/oxfordjournals.aje.a009171; HABOUBI NY, 1991, GERONTOLOGY, V37, P335; HANSEN S, 1988, ACTA OTO-LARYNGOL, P165; HERINGS RMC, 1995, ARCH INTERN MED, V155, P1801, DOI 10.1001/archinte.155.16.1801; Jacqmin-Gadda H, 1998, EPIDEMIOLOGY, V9, P417, DOI 10.1097/00001648-199807000-00012; Johansson C, 1996, AGING CLIN EXP RES, V8, P189, DOI 10.1007/BF03339676; JONES G, 1995, J BONE MINER RES, V10, P106; KATZ S, 1976, INT J HEALTH SERV, V6, P493, DOI 10.2190/UURL-2RYU-WRYD-EY3K; Kirby M, 1999, INT J GERIATR PSYCH, V14, P280, DOI 10.1002/(SICI)1099-1166(199904)14:4<280::AID-GPS898>3.3.CO;2-F; LAURITZEN JB, 1992, DAN MED BULL, V39, P91; LICHTENSTEIN MJ, 1994, AM J EPIDEMIOL, V140, P830, DOI 10.1093/oxfordjournals.aje.a117331; Liu B, 1998, LANCET, V351, P1303, DOI 10.1016/S0140-6736(97)09528-7; Moore N, 1993, POST MARK SURVEILL, V7, P355; Moritz DJ, 1997, AM J EPIDEMIOL, V145, P653; RAY WA, 1989, JAMA-J AM MED ASSOC, V262, P3303, DOI 10.1001/jama.262.23.3303; RYYNANEN OP, 1993, SCAND J SOC MED, V21, P264, DOI 10.1177/140349489302100406; SLEMENDA C, 1997, AM J MED, V103, P65; Slovik D M, 1983, Spec Top Endocrinol Metab, V5, P83; Thapa PB, 1996, J AM GERIATR SOC, V44, P273, DOI 10.1111/j.1532-5415.1996.tb00913.x; Thapa PB, 1998, NEW ENGL J MED, V339, P875, DOI 10.1056/NEJM199809243391303; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; WEINTRAUB M, 1993, CLIN PHARMACOL THER, V54, P252, DOI 10.1038/clpt.1993.145; Wysowski DK, 1996, J CLIN EPIDEMIOL, V49, P111, DOI 10.1016/0895-4356(95)00057-7	33	94	96	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2001	322	7288					704	708		10.1136/bmj.322.7288.704	http://dx.doi.org/10.1136/bmj.322.7288.704			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	416GB	11264208	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000167771000024
J	Kohara, K; Kitamura, A; Morishima, M; Tsumoto, T				Kohara, K; Kitamura, A; Morishima, M; Tsumoto, T			Activity-dependent transfer of brain-derived neurotrophic factor to postsynaptic neurons	SCIENCE			English	Article							NERVE GROWTH-FACTOR; PRIMARY SENSORY NEURONS; HIPPOCAMPAL-NEURONS; VISUAL-CORTEX; ANTEROGRADE TRANSPORT; MESSENGER-RNA; PLASTICITY; BDNF; CNS; RELEASE	Neurotrophins such as brain-derived neurotrophic factor (BDNF) are thought to be transferred from post- to presynaptic neurons and to be involved in the formation and plasticity of neural circuits, However, direct evidence for a transneuronal transfer of BDNF and its relation to neuronal activity remains elusive, We simultaneously injected complementary DNAs of green fluorescent protein (GFP)-tagged BDNF and red fluorescence protein into the nucleus of single neurons and visualized expression, localization, and transport of BDNF in living neurons. Fluorescent puncta representing BDNF moved in axons in the anterograde direction, though some moved retrogradely, and transferred to postsynaptic neurons in an activity-dependent manner.	Osaka Univ, Grad Sch Med, Biomed Res Ctr, Div Neurophysiol, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan	Osaka University; Japan Science & Technology Agency (JST)	Tsumoto, T (corresponding author), Osaka Univ, Grad Sch Med, Biomed Res Ctr, Div Neurophysiol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.							Akaneya Y, 1997, J NEUROSCI, V17, P6707; Aloyz R, 1999, LEARN MEMORY, V6, P216; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; Cellerino A, 1996, PROG NEUROBIOL, V49, P53, DOI 10.1016/0301-0082(96)00008-1; Conner JM, 1997, J NEUROSCI, V17, P2295; Fawcett JP, 2000, J NEUROSCI, V20, P274, DOI 10.1523/JNEUROSCI.20-01-00274.2000; Fawcett JP, 1997, J BIOL CHEM, V272, P8837; Fawcett JP, 1998, J NEUROSCI, V18, P2808; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Griesbeck O, 1999, MICROSC RES TECHNIQ, V45, P262, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<262::AID-JEMT10>3.0.CO;2-K; Haubensak W, 1998, J CELL SCI, V111, P1483; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kojima M., 1999, Society for Neuroscience Abstracts, V25, P1785; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Otsu Y, 1995, J NEUROPHYSIOL, V74, P2437, DOI 10.1152/jn.1995.74.6.2437; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; vonBartheld CS, 1996, NATURE, V379, P830, DOI 10.1038/379830a0; WETMORE C, 1991, P NATL ACAD SCI USA, V88, P9843, DOI 10.1073/pnas.88.21.9843; Zhou XF, 1996, NEUROSCIENCE, V74, P945, DOI 10.1016/S0306-4522(96)00237-0	29	282	285	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2419	2423		10.1126/science.1057415	http://dx.doi.org/10.1126/science.1057415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264540				2022-12-28	WOS:000167618700059
J	Schievink, WI				Schievink, WI			Current concepts: Spontaneous dissection of the carotid and vertebral arteries.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CONNECTIVE-TISSUE DISORDERS; TERM FOLLOW-UP; MR-ANGIOGRAPHY; FIBROMUSCULAR DYSPLASIA; INTRACRANIAL ANEURYSMS; HORNERS-SYNDROME; STENT PLACEMENT; HELICAL CT; DIAGNOSIS; MUTATIONS		Cedars Cinai Neurosurg Inst, Los Angeles, CA USA; Univ Calif Irvine, Dept Neurosurg, Irvine, CA USA	University of California System; University of California Irvine	Schievink, WI (corresponding author), Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, 8631 W 3rd St,800E, Los Angeles, CA 90048 USA.							BARBOUR PJ, 1994, STROKE, V25, P1201, DOI 10.1161/01.STR.25.6.1201; Bassetti C, 1996, STROKE, V27, P1804, DOI 10.1161/01.STR.27.10.1804; BIOUSSE V, 1994, CEPHALALGIA, V14, P33, DOI 10.1046/j.1468-2982.1994.1401033.x; Biousse V, 1998, AM J OPHTHALMOL, V126, P565, DOI 10.1016/S0002-9394(98)00136-6; BIOUSSE V, 1995, STROKE, V26, P235, DOI 10.1161/01.STR.26.2.235; BOSTROM K, 1967, NEUROLOGY, V17, P179, DOI 10.1212/WNL.17.2.179; Brandt T, 1998, ANN NEUROL, V44, P281, DOI 10.1002/ana.410440224; CAPLAN LR, 1985, STROKE, V16, P1030, DOI 10.1161/01.STR.16.6.1030; Crum B, 2000, NEUROLOGY, V55, P304, DOI 10.1212/WNL.55.2.304; DANGLEJANCHATILLON J, 1989, HEADACHE, V29, P560, DOI 10.1111/j.1526-4610.1989.hed2909560.x; de Bray JM, 1998, REV NEUROL, V154, P762; DEBRAY JM, 1994, J ULTRAS MED, V13, P659; deBray JM, 1997, J NEUROL NEUROSUR PS, V63, P46, DOI 10.1136/jnnp.63.1.46; Derex L, 2000, NEUROLOGY, V54, P2159, DOI 10.1212/WNL.54.11.2159; Djouhri H, 2000, AM J ROENTGENOL, V174, P1137, DOI 10.2214/ajr.174.4.1741137; Ducrocq X, 1999, REV NEUROL-FRANCE, V155, P575; FISHER CM, 1978, CAN J NEUROL SCI, V5, P9, DOI 10.1017/S0317167100024690; FRIEDMAN DP, 1992, AM J NEURORADIOL, V13, P283; GIROUD M, 1994, J NEUROL NEUROSUR PS, V57, P1443, DOI 10.1136/jnnp.57.11.1443; GOULD DB, 1994, STROKE, V25, P1276, DOI 10.1161/01.STR.25.6.1276; Gout O, 1999, STROKE, V30, P681, DOI 10.1161/01.STR.30.3.681; Grau AJ, 1999, ARCH NEUROL-CHICAGO, V56, P851, DOI 10.1001/archneur.56.7.851; Grond-Ginsbach C, 1999, STROKE, V30, P1887, DOI 10.1161/01.STR.30.9.1887; Grond-Ginsbach C, 2000, STROKE, V31, P1935, DOI 10.1161/01.STR.31.8.1935; Guillon B, 1998, CEPHALALGIA, V18, P222, DOI 10.1046/j.1468-2982.1998.1804222.x; Guillon B, 2000, NEUROLOGY, V55, P663, DOI 10.1212/WNL.55.5.663; Guillon B, 1999, NEUROLOGY, V53, P117, DOI 10.1212/WNL.53.1.117; Hart R G, 1983, Neurol Clin, V1, P155; HOUSER OW, 1984, AM J NEURORADIOL, V5, P27; Hufnagel A, 1999, J NEUROL, V246, P683, DOI 10.1007/s004150050432; Kasner SE, 1997, STROKE, V28, P1993, DOI 10.1161/01.STR.28.10.1993; Kirsch E, 1998, NEURORADIOLOGY, V40, P704; KUIVANIEMI H, 1993, NEUROLOGY, V43, P2652, DOI 10.1212/WNL.43.12.2652; Leclerc X, 1999, AM J NEURORADIOL, V20, P1482; Leclerc X, 1996, STROKE, V27, P461, DOI 10.1161/01.STR.27.3.461; Leclerc X, 1998, AM J NEURORADIOL, V19, P831; LEYS D, 1995, CEREBROVASC DIS, V5, P43, DOI 10.1159/000107817; Liu AY, 1999, NEUROSURGERY, V45, P1368, DOI 10.1097/00006123-199912000-00022; Lu CJ, 2000, J ULTRAS MED, V19, P263, DOI 10.7863/jum.2000.19.4.263; Lucas C, 1998, STROKE, V29, P2646, DOI 10.1161/01.STR.29.12.2646; LYRER P, 2000, COCHRANE DATABASE SY, V4; Malek AM, 2000, AM J NEURORADIOL, V21, P1280; Mokri B, 1996, NEUROLOGY, V46, P356, DOI 10.1212/WNL.46.2.356; MOKRI B, 1979, ARCH NEUROL-CHICAGO, V36, P677, DOI 10.1001/archneur.1979.00500470047008; MOKRI B, 1986, ANN NEUROL, V19, P126, DOI 10.1002/ana.410190204; MORGAN MK, 1994, J NEUROSURG, V80, P237, DOI 10.3171/jns.1994.80.2.0237; Norris JW, 2000, CAN MED ASSOC J, V163, P38; Opeskin K, 1997, AM J FOREN MED PATH, V18, P251, DOI 10.1097/00000433-199709000-00005; SCHIEVINK WI, 1995, NEW ENGL J MED, V332, P576, DOI 10.1056/NEJM199503023320905; SCHIEVINK WI, 1995, STROKE, V26, P1935, DOI 10.1161/01.STR.26.10.1935; Schievink WI, 1997, LANCET, V350, P260, DOI 10.1016/S0140-6736(97)03403-X; Schievink WI, 1998, J NEUROSURG, V89, P101, DOI 10.3171/jns.1998.89.1.0101; SCHIEVINK WI, 1994, NEW ENGL J MED, V330, P393, DOI 10.1056/NEJM199402103300604; Schievink WI, 2000, MAYO CLIN PROC, V75, P1087, DOI 10.4065/75.10.1087; Schievink WI, 1998, NEUROLOGY, V50, P1166, DOI 10.1212/WNL.50.4.1166; Schievink WI, 1997, ANGIOLOGY, V48, P985, DOI 10.1177/000331979704801108; SCHIEVINK WI, 1994, STROKE, V25, P2492, DOI 10.1161/01.STR.25.12.2492; SCHIEVINK WI, 1994, NEUROSURGERY, V35, P809, DOI 10.1227/00006123-199411000-00002; Schievink WI, 1998, NEUROSURGERY, V43, P229, DOI 10.1097/00006123-199808000-00022; Schievink WI, 1998, AM J EMERG MED, V16, P179, DOI 10.1016/S0735-6757(98)90042-0; Schievink WI, 1996, STROKE, V27, P622, DOI 10.1161/01.STR.27.4.622; SCHIEVINK WI, 1994, NEUROLOGY, V44, P1607, DOI 10.1212/WNL.44.9.1607; SCHIEVINK WI, 1994, STROKE, V25, P889, DOI 10.1161/01.STR.25.4.889; SCHIEVINK WI, 1993, STROKE, V24, P1678, DOI 10.1161/01.STR.24.11.1678; SCHIEVINK WI, 1992, J NEUROSURG, V76, P62, DOI 10.3171/jns.1992.76.1.0062; SCHIEVINK WI, 1996, J NEUROL, V243, pS92; SILBERT PL, 1995, NEUROLOGY, V45, P1517, DOI 10.1212/WNL.45.8.1517; Srinivasan J, 1996, STROKE, V27, P1226, DOI 10.1161/01.STR.27.7.1226; STURZENEGGER M, 1995, NEUROLOGY, V45, P691, DOI 10.1212/WNL.45.4.691; SUNDT TM, 1986, J NEUROSURG, V64, P169, DOI 10.3171/jns.1986.64.2.0169; TROSCH RM, 1989, NEW ENGL J MED, V320, P1564; Tzourio C, 1997, CIRCULATION, V95, P2351, DOI 10.1161/01.CIR.95.10.2351; Venketasubramanian N, 1998, AVIAT SPACE ENVIR MD, V69, P307; Vickers A, 1999, BRIT MED J, V319, P1176, DOI 10.1136/bmj.319.7218.1176; Weidauer S, 1999, J NEUROL NEUROSUR PS, V67, P550; WEINTRAUB MI, 1993, JAMA-J AM MED ASSOC, V269, P2085, DOI 10.1001/jama.1993.03500160051022	76	1022	1109	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2001	344	12					898	906		10.1056/NEJM200103223441206	http://dx.doi.org/10.1056/NEJM200103223441206			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412PN	11259724				2022-12-28	WOS:000167563700006
J	Horon, IL; Cheng, D				Horon, IL; Cheng, D			Enhanced surveillance for pregnancy-associated mortality - Maryland, 1993-1998	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MATERNAL MORTALITY	Context Deaths occurring among women who are pregnant or who have had a recent pregnancy have a devastating impact on the family and community. It is important to understand the magnitude and causes of pregnancy-associated mortality so that comprehensive strategies can be formulated to prevent such deaths. Objective To ascertain the number and causes of pregnancy-associated deaths using enhanced surveillance techniques. Design, Setting, and Subjects Retrospective, cross-sectional analysis of death certificate data of reproductive-age women, live birth and fetal death records, and medical examiner records in Maryland during 1993-1998. Main Outcome Measure Number of pregnancy-associated deaths, defined as death from any cause during pregnancy or within 1 year of delivery or pregnancy termination, by source of data and cause of death. Results A total of 247 pregnancy-associated deaths were ascertained. Twenty-seven percent (n=67) were identified through cause-of-death information obtained from death certificates, 70% (n=174) through linkage of death records with birth and fetal death records, and 47% (n=116) through review of medical examiner records. Homicide was the leading cause of pregnancy-associated death (n=50; 20%), and cardiovascular disorders were the second-leading cause (n=48; 19%). Conclusions In this Maryland sample, comprehensive identification of pregnancy-associated deaths was accomplished only after collecting information from multiple sources and including all deaths occurring up to 1 year after delivery or pregnancy termination. This enhanced pregnancy mortality surveillance led to the disturbing finding that a pregnant or recently pregnant woman is more likely to be a victim of homicide than to die of any other cause. By broadening pregnancy mortality to include all possible causes, previously neglected factors may assume increased importance in prenatal and postpartum care.	Maryland Dept Hlth & Mental Hyg, Vital Stat Adm, Baltimore, MD 21201 USA; Maryland Dept Hlth & Mental Hyg, Ctr Maternal & Child Hlth, Baltimore, MD 21201 USA	Maryland Department of Health & Mental Hygiene; Maryland Department of Health & Mental Hygiene	Horon, IL (corresponding author), Maryland Dept Hlth & Mental Hyg, Vital Stat Adm, 201 W Preston St, Baltimore, MD 21201 USA.	horoni@dhmh.state.md.us						ALLEN MH, 1991, AM J PUBLIC HEALTH, V81, P380, DOI 10.2105/AJPH.81.3.380; ATRASH HK, 1995, OBSTET GYNECOL, V86, P700, DOI 10.1016/0029-7844(95)00200-B; ATRASH HK, 1992, CURR OPIN OBSTET GYN, V4, P61; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P93; Centers for Disease Control (CDC), 1986, MMWR Morb Mortal Wkly Rep, V35, P621; COMAS A, 1991, MMWR-MORBID MORTAL W, V40, P521; Dietz PM, 1998, AM J PUBLIC HEALTH, V88, P641, DOI 10.2105/AJPH.88.4.641; DYE TD, 1992, AM J OBSTET GYNECOL, V167, P72, DOI 10.1016/S0002-9378(11)91629-9; Jocums SB, 1998, OBSTET GYNECOL, V91, P766, DOI 10.1016/S0029-7844(98)00063-5; Parsons LH, 1999, OBSTET GYNECOL, V94, P990, DOI 10.1016/S0029-7844(99)00466-4; *WHO, 1992, INT CLASS IDS 10 REV; WHO (World Health Organization), 1977, MAN INT STAT CLASS D	12	104	105	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1455	1459		10.1001/jama.285.11.1455	http://dx.doi.org/10.1001/jama.285.11.1455			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410VQ	11255421				2022-12-28	WOS:000167462100027
J	Gonzales, R; Bartlett, JG; Besser, RE; Cooper, RJ; Hickner, JM; Hoffman, LR; Sande, MA				Gonzales, R; Bartlett, JG; Besser, RE; Cooper, RJ; Hickner, JM; Hoffman, LR; Sande, MA			Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: Background	ANNALS OF INTERNAL MEDICINE			English	Article							RESPIRATORY-TRACT INFECTIONS; NEURAMINIDASE INHIBITOR ZANAMIVIR; COMMUNITY-ACQUIRED PNEUMONIA; DOUBLE-BLIND TRIAL; INFLUENZA-A; ACUTE COUGH; CLINICAL-PREDICTION; AMBULATORY PRACTICE; PULMONARY-FUNCTION; PERSISTENT COUGH	The following principles of appropriate antibiotic use for adults with acute bronchitis apply to immunocompetent adults without complicating comorbid conditions, such as chronic lung or heart disease. 1. The evaluation of adults with an acute cough illness or a presumptive diagnosis of uncomplicated acute bronchitis should focus on ruling out serious illness, particularly pneumonia. In healthy, nonelderly adults, pneumonia is uncommon in the absence of vital sign abnormalities or asymmetrical lung sounds, and chest radiography is usually not indicated. In patients with cough lasting 3 weeks or longer, chest radiography may be warranted in the absence of other known causes. 2. Routine antibiotic treatment of uncomplicated acute bronchitis is not recommended, regardless of duration of cough. If pertussis infection is suspected (an unusual circumstance), a diagnostic test should be performed and antimicrobial therapy initiated. 3. Patient satisfaction with care for acute bronchitis depends most on physician-patient communication rather than on antibiotic treatment.	Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Calif Los Angeles, Los Angeles, CA USA; Michigan State Univ, E Lansing, MI 48824 USA; Univ Utah, Salt Lake City, UT USA	Centers for Disease Control & Prevention - USA; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Johns Hopkins University; University of California System; University of California Los Angeles; Michigan State University; Utah System of Higher Education; University of Utah	Besser, RE (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, C-23,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	rbesser@cdc.gov			AHRQ HHS [F32 HS00134-1] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS000134] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Adams P.F., 1999, CURRENT ESTIMATES NA; Bent S, 1999, AM J MED, V107, P62, DOI 10.1016/S0002-9343(99)00167-9; BERGQUIST SO, 1987, PEDIATR INFECT DIS J, V6, P458, DOI 10.1097/00006454-198705000-00009; BOLDY DAR, 1990, RESP MED, V84, P377, DOI 10.1016/S0954-6111(08)80072-8; BRICKFIELD FX, 1986, J FAM PRACTICE, V23, P119; DIEHR P, 1984, J CHRON DIS, V37, P215, DOI 10.1016/0021-9681(84)90149-8; DUNLAY J, 1987, J FAM PRACTICE, V25, P137; EMERMAN CL, 1991, ANN EMERG MED, V20, P1215, DOI 10.1016/S0196-0644(05)81474-X; EVANS AS, 1967, MED CLIN N AM, V51, P803, DOI 10.1016/S0025-7125(16)33048-6; Fahey T, 1998, BRIT MED J, V316, P906, DOI 10.1136/bmj.316.7135.906; FRANKS P, 1984, J FAM PRACTICE, V19, P185; Gennis P, 1989, J Emerg Med, V7, P263, DOI 10.1016/0736-4679(89)90358-2; Gonzales R, 2001, ANN INTERN MED, V134, P479, DOI 10.7326/0003-4819-134-6-200103200-00013; Gonzales R, 2000, J GEN INTERN MED, V15, P118; Gonzales R, 1999, J GEN INTERN MED, V14, P151, DOI 10.1046/j.1525-1497.1999.00306.x; Gonzales R, 1999, JAMA-J AM MED ASSOC, V281, P1512, DOI 10.1001/jama.281.16.1512; Gonzales R, 2000, AM J MED, V108, P83, DOI 10.1016/S0002-9343(99)00314-9; GRAYSTON JT, 1993, J INFECT DIS, V168, P1231, DOI 10.1093/infdis/168.5.1231; GRAYSTON JT, 1986, NEW ENGL J MED, V315, P161, DOI 10.1056/NEJM198607173150305; Hamm RM, 1996, J FAM PRACTICE, V43, P56; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; HEALD A, 1993, J GEN INTERN MED, V8, P667, DOI 10.1007/BF02598283; HECKERLING PS, 1990, ANN INTERN MED, V113, P664, DOI 10.7326/0003-4819-113-9-664; Houston MS, 1997, ARCH INTERN MED, V157, P2190, DOI 10.1001/archinte.157.19.2190; HOWIE JGR, 1970, LANCET, V2, P1099; HUESTON WJ, 1991, J FAM PRACTICE, V33, P476; HUESTON WJ, 1994, J FAM PRACTICE, V39, P437; Irwin RS, 1998, CHEST, V114, p133S, DOI 10.1378/chest.114.2_Supplement.133S; JEFFERSON TO, 2000, COCHRANE DATABASE SY; JOHNSON D, 1991, J ASTHMA, V28, P85, DOI 10.3109/02770909109082732; Jonsson JS, 1997, SCAND J PRIM HEALTH, V15, P156, DOI 10.3109/02813439709018507; Kaiser L, 1999, J CLIN VIROL, V14, P191, DOI 10.1016/S1386-6532(99)00058-X; King DE, 1996, J FAM PRACTICE, V42, P601; MACFARLANE JT, 1993, LANCET, V341, P511, DOI 10.1016/0140-6736(93)90275-L; MacKay DN, 1996, J GEN INTERN MED, V11, P557, DOI 10.1007/BF02599608; Mainous AG, 1997, J FAM PRACTICE, V45, P75; Mainous AG, 1997, LANCET, V350, P1077, DOI 10.1016/S0140-6736(05)70457-8; MELBYE H, 1991, FAM PRACT, V8, P216, DOI 10.1093/fampra/8.3.216; MELBYE H, 1994, EUR RESPIR J, V7, P1239, DOI 10.1183/09031936.94.07071239; Melbye Hasse, 1994, Tidsskrift for den Norske Laegeforening, V114, P814; Metlay JP, 1998, ARCH INTERN MED, V158, P1813, DOI 10.1001/archinte.158.16.1813; Metlay JP, 1997, ARCH INTERN MED, V157, P1453, DOI 10.1001/archinte.157.13.1453; Metlay JP, 1997, JAMA-J AM MED ASSOC, V278, P1440, DOI 10.1001/jama.278.17.1440; Mitamura K, 1999, Kansenshogaku Zasshi, V73, P1069; Monto AS, 1999, J INFECT DIS, V180, P254, DOI 10.1086/314904; NELSON C, 1988, VITAL HLTH STAT S 13, V93; Nennig ME, 1996, JAMA-J AM MED ASSOC, V275, P1672, DOI 10.1001/jama.275.21.1672; Nicholson KG, 1997, BRIT MED J, V315, P1060, DOI 10.1136/bmj.315.7115.1060; Noyola DE, 2000, J CLIN MICROBIOL, V38, P1161, DOI 10.1128/JCM.38.3.1161-1165.2000; Oeffinger KC, 1997, J FAM PRACTICE, V45, P402; ORR PH, 1993, J FAM PRACTICE, V36, P507; Pasternack M S, 1997, Curr Clin Top Infect Dis, V17, P24; PENDER E S, 1990, Journal of Emergency Medicine, V8, P727, DOI 10.1016/0736-4679(90)90287-6; ROBERTSON AJ, 1952, LANCET, V262, P12; SCHAPPERT SM, 1992, VITAL HLTH STAT S 13, V110; SCHAPPERT SM, 1995, VITAL HLTH STAT S 13, V129; SCHAPPERT SM, 1994, VITAL HLTH STAT S 13, V116; SCHAPPERT SM, 1992, NATL AMBULATORY MED; SCHAPPERT SM, 1994, NATL AMBULATORY MED; SCHAPPERT SM, 1999, VITAL HLTH STAT S 13, V143; Scherl E R, 1987, J Ky Med Assoc, V85, P539; Silagy C, 1998, LANCET, V352, P1877, DOI 10.1016/S0140-6736(98)10190-3; SINGAL BM, 1989, ANN EMERG MED, V18, P13, DOI 10.1016/S0196-0644(89)80304-X; Smucny JJ, 1998, J FAM PRACTICE, V47, P453; SPRAUER MA, 1992, AM J DIS CHILD, V146, P177, DOI 10.1001/archpedi.1992.02160140043018; STOTT NCH, 1976, BRIT MED J, V2, P556, DOI 10.1136/bmj.2.6035.556; VANVORIS LP, 1981, JAMA-J AM MED ASSOC, V245, P1128, DOI 10.1001/jama.245.11.1128; VERHEIJ TJM, 1994, BRIT J GEN PRACT, V44, P400; von Konig CHW, 1998, EUR J PEDIATR, V157, P391, DOI 10.1007/s004310050836; WILLIAMSON HA, 1987, J FAM PRACTICE, V25, P251; WILLIAMSON HA, 1984, J FAM PRACTICE, V19, P481; WINGFIELD WL, 1969, NEW ENGL J MED, V281, P579, DOI 10.1056/NEJM196909112811102; Wright SW, 1997, ACAD EMERG MED, V4, P179, DOI 10.1111/j.1553-2712.1997.tb03737.x; WRIGHT SW, 1995, JAMA-J AM MED ASSOC, V273, P1044, DOI 10.1001/jama.273.13.1044; 1999, MMWR MORB MORTAL WKL, V48, P1	75	111	115	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					521	529		10.7326/0003-4819-134-6-200103200-00021	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00021			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409VF	11255532	Green Published			2022-12-28	WOS:000167405800015
J	Ferrie, JE; Martikainen, P; Shipley, MJ; Marmot, MG; Stansfeld, SA; Smith, GD				Ferrie, JE; Martikainen, P; Shipley, MJ; Marmot, MG; Stansfeld, SA; Smith, GD			Employment status and health after privatisation in white collar civil servants: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOCIOECONOMIC-STATUS; MODERATING ROLE; JOB INSECURITY; MENTAL-HEALTH; UNEMPLOYMENT; STRAIN; CONSULTATION; ANTECEDENTS; MORBIDITY; DISTRESS	Objectives To determine whether employment status after job loss due to privatisation influences health and use of health services and whether financial strain, psychosocial measures, or health related behaviours can explain any findings. Design Data collected before and 18 months after privatisation. Setting One department of the civil service that was sold to the private sector, Participants 666 employees during baseline screening in the department to be privatised. Main outcome measures Health and health service outcomes associated with insecure re-employment, permanent exit from paid employment, and unemployment after privatisation compared with outcomes associated with secure re-employment Results Insecure re-employment and unemployment were associated with relative increases in minor psychiatric morbidity (mean difference 1.56 (95% confidence intervals interval 1.0 to 2.2) and 1.25 (0.6 to 2.0) respectively) and having four or more consultations with a general practitioner in the past year (odds ratio 2.04 (1.1 to 3.8) and 2.39 (1.3 to 4.7) respectively). Health outcomes for respondents permanently out of paid employment closely resembled those in secure re-employment, except for a substantial relative increase in longstanding illness (2.25; 1.1 to 4.4), Financial strain and change in psychosocial measures and health related behaviours accounted for little of the observed associations. Adjustment for change in minor psychiatric morbidity attenuated the association between insecure re-employment or unemployment and general practitioner consultations by 26% and 27%, respectively. Conclusions Insecure re-employment and unemployment after privatisation result in increases in minor psychiatric morbidity and consultations with a general practitioner, which are possibly due to the increased minor psychiatric morbidity.	UCL, Sch Med, Int Ctr Hlth & Soc, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; Univ Helsinki, Dept Sociol, FIN-00014 Helsinki, Finland; Queen Mary Univ London, Dept Psychiat, London E1 4NS, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of London; University College London; UCL Medical School; University of Helsinki; University of London; Queen Mary University London; University of Bristol	Ferrie, JE (corresponding author), UCL, Sch Med, Int Ctr Hlth & Soc, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	j.ferrie@public-health.ac.uk	Davey Smith, George/A-7407-2013; Ferrie, Jane/AAZ-2009-2020; Marmot, M G/Y-3920-2019	Davey Smith, George/0000-0002-1407-8314; Marmot, M G/0000-0002-2431-6419; Martikainen, Pekka/0000-0001-9374-1438	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196] Funding Source: NIH RePORTER; AHRQ HHS [R01-HS06516] Funding Source: Medline; Medical Research Council [G19/35, G8802774] Funding Source: Medline; NHLBI NIH HHS [R01-HL36310, R01 HL036310] Funding Source: Medline; NIA NIH HHS [R01-AG13196, R01 AG013196] Funding Source: Medline; Wellcome Trust Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome Trust(Wellcome Trust)		Amick BC, 1998, SCAND J WORK ENV HEA, V24, P54, DOI 10.5271/sjweh.278; Barling J, 1996, STRESS MEDICINE, V12, P253; Bartley M, 1996, BRIT MED J, V313, P445; BEALE N, 1985, J ROY COLL GEN PRACT, V35, P510; Bjorklund A, 1998, SCAND J SOC WELFARE, V7, P219; Bradburn N.M., 1969, STRUCTURE PSYCHOL WE, DOI DOI 10.1037/T10756-000; CarrHill RA, 1996, BRIT MED J, V312, P1008; CLAUSSEN B, 1993, J EPIDEMIOL COMMUN H, V47, P14, DOI 10.1136/jech.47.1.14; COBB S, 1977, DHEW NIOSH PUBLICATI; DARCY C, 1985, INT J HEALTH SERV, V15, P609, DOI 10.2190/0Q1G-RJG7-DPR9-V6XN; DEW MA, 1992, PSYCHOL MED, V22, P751, DOI 10.1017/S0033291700038198; DRAPER P, 1995, GOVT PURCHASING  MAY, P8; Ferrie J E, 2001, J Occup Health Psychol, V6, P26, DOI 10.1037/1076-8998.6.1.26; FERRIE JE, 1995, BRIT MED J, V311, P1264, DOI 10.1136/bmj.311.7015.1264; Ferrie JE, 1998, AM J PUBLIC HEALTH, V88, P1030, DOI 10.2105/AJPH.88.7.1030; Goldberg DP, 1979, MANUAL GEN HLTH QUES; GRAYSON JP, 1993, INT J HEALTH SERV, V23, P743, DOI 10.2190/W5NR-A7A4-BX4A-T4F7; HAMILTON VL, 1993, J PERS SOC PSYCHOL, V65, P234, DOI 10.1037/0022-3514.65.2.234; HUTTON W, 1995, STATE WERE IN; IVERSEN L, 1988, J SOC ISSUES, V44, P141, DOI 10.1111/j.1540-4560.1988.tb02096.x; JACKSON PR, 1984, PSYCHOL MED, V14, P605, DOI 10.1017/S003329170001521X; Janlert U, 1991, WORK DEPRIVATION HLT; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kivimaki M, 2000, BRIT MED J, V320, P971, DOI 10.1136/bmj.320.7240.971; KUHNERT KW, 1989, GROUP ORGAN STUD, V14, P399, DOI 10.1177/105960118901400403; LAHELMA E, 1992, INT J HEALTH SERV, V22, P261, DOI 10.2190/LKDE-1E0K-TANM-HQUY; LEANA CR, 1995, HUM RELAT, V48, P1381, DOI 10.1177/001872679504801201; Leino-Arjas P, 1999, BRIT MED J, V319, P600, DOI 10.1136/bmj.319.7210.600; MACLEOD J, 1999, J EPIDEMIOL COMMUNIT, V53, P660; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Mathers CD, 1998, MED J AUSTRALIA, V168, P178, DOI 10.5694/j.1326-5377.1998.tb126776.x; MATTIASSON I, 1990, BRIT MED J, V301, P461, DOI 10.1136/bmj.301.6750.461; Murphy GC, 1999, J OCCUP ORGAN PSYCH, V72, P83, DOI 10.1348/096317999166518; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; RODGERS B, 1991, SOC PSYCH PSYCH EPID, V26, P104, DOI 10.1007/BF00782949; Rodriguez E., 1994, EUR J PUBLIC HEALTH, V4, P245; ROSKIES E, 1990, J ORGAN BEHAV, V11, P345, DOI 10.1002/job.4030110503; ROWLANDS P, 1995, INT J SOC PSYCHIATR, V41, P21, DOI 10.1177/002076409504100102; Vogler C., 1994, SOCIAL CHANGE EXPERI, P188; WHELAN CT, 1992, J OCCUP ORGAN PSYCH, V65, P331, DOI 10.1111/j.2044-8325.1992.tb00509.x; YUEN P, 1989, BRIT MED J, V298, P1212, DOI 10.1136/bmj.298.6682.1212	41	59	60	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2001	322	7287					647	651		10.1136/bmj.322.7287.647	http://dx.doi.org/10.1136/bmj.322.7287.647			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	413QE	11250849	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000167622600024
J	Anderson, MC; Green, C				Anderson, MC; Green, C			Suppressing unwanted memories by executive control	NATURE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; INHIBITORY CONTROL; FUNCTIONAL MRI; RETRIEVAL	Freud proposed that unwanted memories can be forgotten by pushing them into the unconscious, a process called repression(1). The existence of repression has remained controversial for more than a century, in part because of its strong coupling with trauma, and the ethical and practical difficulties of studying such processes in controlled experiments. However, behavioural and neurobiological research on memory and attention shows that people have executive control processes directed at minimizing perceptual distraction(2,3), overcoming interference during short and long-term memory tasks(3-7) and stopping strong habitual responses to stimuli(8-13). Here we show that these mechanisms can be recruited to prevent unwanted declarative memories from entering awareness, and that this cognitive act has enduring consequences for the rejected memories. When people encounter cues that remind them of an unwanted memory and they consistently try to prevent awareness of it, the later recall of the rejected memory becomes more difficult. The forgetting increases with the number of times the memory is avoided, resists incentives for accurate recall and is caused by processes that suppress the memory itself. These results show that executive control processes not uniquely tied to trauma may provide a viable model for repression.	Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	University of Oregon	Anderson, MC (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.	mcanders@darkwing.uoregon.edu		Anderson, Michael/0000-0001-9505-9299				ANDERSON MC, 1995, PSYCHOL REV, V102, P68, DOI 10.1037/0033-295X.102.1.68; ANDERSON MC, IN PRESS J AGRESSION; Bjork R.A., 1989, VARIETIES MEMORY CON, P309; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; CHAO LL, 1995, NEUROREPORT, V6, P1605, DOI 10.1097/00001756-199508000-00005; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; Conway MA, 2000, J MEM LANG, V43, P409, DOI 10.1006/jmla.2000.2706; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Dagenbach D., 1994, INHIBITORY PROCESSES; de Zubicaray GI, 2000, NEUROPSYCHOLOGIA, V38, P1280, DOI 10.1016/S0028-3932(00)00033-6; FREUD S, 1966, STANDARD EDITION COM, V1, P117; Freyd J.J., 1996, BETRAYAL TRAUMA LOGI; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; GEISELMAN RE, 1983, J EXP PSYCHOL GEN, V112, P58, DOI 10.1037/0096-3445.112.1.58; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Luria A.R., 1966, HIGHER CORTICAL FUNC, P3; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mayr U, 2000, J EXP PSYCHOL GEN, V129, P4, DOI 10.1037/0096-3445.129.1.4; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; SAKAGAMI M, 1994, EXP BRAIN RES, V100, P165; Schacter DL, 1998, SCIENCE, V280, P59, DOI 10.1126/science.280.5360.59; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; WEGNER DM, 1994, PSYCHOL REV, V101, P34, DOI 10.1037/0033-295X.101.1.34	30	664	678	11	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2001	410	6826					366	369		10.1038/35066572	http://dx.doi.org/10.1038/35066572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	410WM	11268212				2022-12-28	WOS:000167464100050
J	Bozzette, SA; Joyce, G; McCaffrey, DF; Leibowitz, AA; Morton, SC; Berry, SH; Rastegar, A; Timberlake, D; Shapiro, MF; Goldman, DP				Bozzette, SA; Joyce, G; McCaffrey, DF; Leibowitz, AA; Morton, SC; Berry, SH; Rastegar, A; Timberlake, D; Shapiro, MF; Goldman, DP		HIV Cost Services Utilization Stud	Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; UNITED-STATES; SERVICES UTILIZATION; MEDICAL-CARE; COSTS; AIDS; PREVALENCE; SAMPLES; ADULTS	Background: The introduction of expensive but very effective antiviral medications has led to questions about the effects on the total use of resources for the care of patients with human immunodeficiency virus (HIV) infection. We examined expenditures for the care of HIV-infected patients since the introduction of highly active antiretroviral therapy. Methods: We interviewed a random sample of 2864 patients who were representative of all American adults receiving care for HIV infection in early 1996, and followed them for up to 36 months. We estimated the average expenditure per patient per month on the basis of self-reported information about care received. Results: The mean expenditure was $1,792 per patient per month at base line, but it declined to $1,359 for survivors in 1997, since the increases in pharmaceutical expenditures were smaller than the reductions in hospital costs. Use of highly active antiretroviral therapy was independently associated with a reduction in expenditures. After adjustments for the interview date, clinical status, and deaths, the estimated annual expenditure declined from $20,300 per patient in 1996 to $18,300 in 1998. Expenditures among subgroups of patients varied by a factor of as much as three. Pharmaceutical costs were lowest and hospital costs highest among underserved groups, including blacks, women, and patients without private insurance. Conclusions: The total cost of care for adults with HIV infection has declined since the introduction of highly active antiretroviral therapy. Expenditures have increased for medications but have declined for other services. However, there are large variations in expenditures across subgroups of patients. (N Engl J Med 2001;344:817-23.) Copyright (C) 2001 Massachusetts Medical Society.	RAND Corp, Hlth, Santa Monica, CA 90407 USA; Univ Calif San Diego, San Diego, CA 92103 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	RAND Corporation; University of California System; University of California San Diego; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Bozzette, SA (corresponding author), RAND Corp, Hlth, 1700 Main St, Santa Monica, CA 90407 USA.		Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U01HS008578] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035040] Funding Source: NIH RePORTER; AHRQ HHS [HS08578] Funding Source: Medline; NICHD NIH HHS [R01-HD35040] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BERRY SH, IN PRESS HCSUC BAS P; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Cunningham WE, 2000, J ACQ IMMUN DEF SYND, V25, P115, DOI 10.1097/00126334-200010010-00005; Frankel MR, 1999, HEALTH SERV RES, V34, P969; Gebo KA, 1999, AIDS, V13, P963, DOI 10.1097/00002030-199905280-00013; Goldman DP, 2001, MED CARE RES REV, V58, P31, DOI 10.1177/107755870105800102; HAY JW, 1988, J ACQ IMMUN DEF SYND, V1, P466; Hellinger FJ, 2000, J ACQ IMMUN DEF SYND, V24, P182; HELLINGER FJ, 1993, JAMA-J AM MED ASSOC, V270, P474, DOI 10.1001/jama.270.4.474; KALTON G, 1983, COMPENSATING MISSING; Keiser P, 1999, J ACQ IMMUN DEF SYND, V20, P28, DOI 10.1097/00042560-199901010-00004; KISH L, 1974, J ROY STAT SOC B MET, V36, P1; Lam NSN, 1996, PROF GEOGR, V48, P321, DOI 10.1111/j.0033-0124.1996.00321.x; LANDON BE, 1999, 16 ANN M ASS HLTH SE, P135; LORD LJ, 1987, US NEWS WORLD R 0615, P16; Moore RD, 2000, PHARMACOECONOMICS, V17, P325, DOI 10.2165/00019053-200017040-00002; Murphy S, 1998, J Health Serv Res Policy, V3, P215; NEWHOUSE JP, 1993, HEALTH AFFAIR, V12, P152, DOI 10.1377/hlthaff.12.suppl_1.152; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Rabeneck L, 1999, MED CARE, V37, P748, DOI 10.1097/00005650-199908000-00005; Schwarcz SK, 2000, AM J EPIDEMIOL, V152, P178, DOI 10.1093/aje/152.2.178; SCITOVSKY AA, 1987, PUBLIC HEALTH REP, V102, P5; SCITOVSKY AA, 1990, J ACQ IMMUN DEF SYND, V3, P904; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; SISK JE, 1987, HEALTH AFFAIR, V6, P5, DOI 10.1377/hlthaff.6.2.5; Weissman JS, 1996, AIDS, V10, P775, DOI 10.1097/00002030-199606001-00013	26	208	210	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2001	344	11					817	823		10.1056/NEJM200103153441107	http://dx.doi.org/10.1056/NEJM200103153441107			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410LA	11248159	Green Published			2022-12-28	WOS:000167440400007
J	Rodriguez, J; Tintore, J; Allen, JT; Blanco, JM; Gomis, D; Reul, A; Ruiz, J; Rodriguez, V; Echevarria, F; Jimenez-Gomez, F				Rodriguez, J; Tintore, J; Allen, JT; Blanco, JM; Gomis, D; Reul, A; Ruiz, J; Rodriguez, V; Echevarria, F; Jimenez-Gomez, F			Mesoscale vertical motion and the size structure of phytoplankton in the ocean	NATURE			English	Article							DEEP CHLOROPHYLL MAXIMUM; ALBORAN SEA; POTENTIAL VORTICITY; PACIFIC-OCEAN; PRODUCTIVITY; CIRCULATION; COMMUNITY; PATTERNS; BIOMASS; FRONT	Phytoplankton size structure is acknowledged as a fundamental property determining energy flow through 'microbial' or 'herbivore' pathways(1). The balance between these two pathways determines the ability of the ecosystem to recycle carbon within the upper layer or to export it to the ocean interior(1). Small cells are usually characteristic of oligotrophic, stratified ocean waters, in which regenerated ammonium is the only available form of inorganic nitrogen and recycling dominates. Large cells seem to characterize phytoplankton in which inputs of nitrate enter the euphotic layer and exported production is higher(2-4). But the size structure of phytoplankton may depend more directly on hydrodynamical forces than on the source of available nitrogen(5-7). Here we present an empirical model that relates the magnitude of mesoscale vertical motion to the slope of the size-abundance spectrum(8-10) of phytoplankton in a frontal ecosystem. Our model indicates that the relative proportion of large cells increases with the magnitude of the upward velocity. This suggests that mesoscale vertical motion-a ubiquitous feature of eddies and unstable fronts-controls directly the size structure of phytoplankton in the ocean.	Univ Malaga, Dept Ecol, E-29071 Malaga, Spain; UIB, CSIC, Inst Mediterrani Estudis Avancats, Palma de Mallorca 07071, Spain; Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Univ Cadiz, Fac Ciencias Mar, Dept Biol Anim Biol Vegetal & Ecol, Cadiz 11510, Spain	Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; NERC National Oceanography Centre; University of Southampton; Universidad de Cadiz	Rodriguez, J (corresponding author), Univ Malaga, Dept Ecol, Campus Teatinos, E-29071 Malaga, Spain.	jaime@uma.es	Reul, Andreas/L-7291-2014; Reul, Andreas/AAI-6720-2020; GOMEZ, FRANCISCO JIMENEZ/E-7093-2012; Ruiz, Javier/G-3184-2016; Echevarria, Fidel/AAM-8826-2020; Gómez, Francisco Jiménez/AAA-1425-2021	Reul, Andreas/0000-0002-1951-8948; Reul, Andreas/0000-0002-1951-8948; GOMEZ, FRANCISCO JIMENEZ/0000-0001-8644-7089; Ruiz, Javier/0000-0002-3375-2327; Echevarria, Fidel/0000-0002-2662-5506; Gómez, Francisco Jiménez/0000-0001-8644-7089; Rodriguez, Jaime/0000-0002-4143-883X; Rodriguez Martinez, Valeriano/0000-0003-1150-600X; Tintore, Joaquin/0000-0002-6311-0093				Allen JT, 1996, J PHYS OCEANOGR, V26, P2611, DOI 10.1175/1520-0485(1996)026<2611:PVAVVA>2.0.CO;2; ALLEN JT, IN PRESS DEEP SEA RE; CHISHOLM SW, 1992, ENVIR SCI R, V43, P213; CULLEN JJ, 1982, CAN J FISH AQUAT SCI, V39, P791, DOI 10.1139/f82-108; CUSHMANROISIN B, 1994, INTRO GEOPHYSICAL FL; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; ESTRADA M, 1993, MAR ECOL PROG SER, V92, P289, DOI 10.3354/meps092289; FIEKAS V, 1994, J PHYS OCEANOGR, V24, P1750, DOI 10.1175/1520-0485(1994)024<1750:MIAUPO>2.0.CO;2; FURUYA K, 1983, J PLANKTON RES, V5, P393, DOI 10.1093/plankt/5.3.393; Gomis D, 2001, DEEP-SEA RES PT I, V48, P269, DOI 10.1016/S0967-0637(00)00060-1; HARRIS GP, 1987, J PLANKTON RES, V9, P1003, DOI 10.1093/plankt/9.5.1003; LEACH H, 1987, DEEP-SEA RES, V34, P2005, DOI 10.1016/0198-0149(87)90095-1; LEGENDRE L, 1989, LIFE SCI R, V44, P49; MALONE TC, 1980, PHYSL ECOLOGY PHYTOP, P433; PENA MA, 1990, DEEP-SEA RES, V37, P295, DOI 10.1016/0198-0149(90)90129-J; Platt T., 1978, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V173, P60; POLLARD RT, 1990, NATURE, V348, P227, DOI 10.1038/348227a0; RODRIGUEZ J, 1986, LIMNOL OCEANOGR, V31, P361, DOI 10.4319/lo.1986.31.2.0361; Rodriguez J, 1998, DEEP-SEA RES PT I, V45, P1577, DOI 10.1016/S0967-0637(98)00030-2; Rodriguez Jaime, 1994, Scientia Marina, V58, P1; Ruiz J, 1996, J MARINE SYST, V9, P269, DOI 10.1016/S0924-7963(96)00045-0; SEMINA H J, 1972, Internationale Revue der Gesamten Hydrobiologie, V57, P177, DOI 10.1002/iroh.19720570202; SEMINA H J, 1968, Sarsia, V34, P267; Smayda T. J., 1970, Oceanogr. mar. Biol., V8, P353; STRASS VH, 1992, DEEP-SEA RES, V39, P75, DOI 10.1016/0198-0149(92)90021-K; TINTORE J, 1991, J PHYS OCEANOGR, V21, P811, DOI 10.1175/1520-0485(1991)021<0811:MDAVMI>2.0.CO;2; Viudez A, 1996, J PHYS OCEANOGR, V26, P684, DOI 10.1175/1520-0485(1996)026<0684:CITASA>2.0.CO;2	27	165	168	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2001	410	6826					360	363		10.1038/35066560	http://dx.doi.org/10.1038/35066560			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268210				2022-12-28	WOS:000167464100048
J	Boscaro, M; Barzon, L; Fallo, F; Sonino, N				Boscaro, M; Barzon, L; Fallo, F; Sonino, N			Cushing's syndrome	LANCET			English	Review							CORTICOTROPIN-RELEASING HORMONE; INFERIOR PETROSAL SINUS; ECTOPIC ADRENOCORTICOTROPIN SYNDROME; PITUITARY-ADRENAL AXIS; DIFFERENTIAL-DIAGNOSIS; TRANSSPHENOIDAL SURGERY; ACTH SYNDROME; RISK-FACTORS; DISEASE; THERAPY	During the past 30 years, there have been advances in understanding of the pathogenesis of Cushing's syndrome and in differential diagnosis of its various forms. Improved diagnostic tests and procedures have increased the ability to recognise even mild hypercortisolism and have provided the means to obtain an accurate diagnosis. Despite these advances, the occurrence of unusual clinical presentations and laboratory shortcomings may produce diagnostic problems and challenge clinical intuition. This article reviews recent pathogenic views, new tests, and new diagnostic problems in the evaluation of Cushing's syndrome. Atypical clinical presentations of hypercortisolism and some laboratory shortcomings that may confuse the diagnosis of Cushing's syndrome are also reported.	Univ Padua, Dept Med & Surg Sci, Div Endocrinol, Padua, Italy	University of Padua	Boscaro, M (corresponding author), Univ Ancona, Osped Gen Reg Torrette, Clin Endocrinol, I-60100 Ancona, Italy.	clendo@popcsi.unian.it	Lumachi, Franco/K-9501-2015; Barzon, Luisa/K-7961-2016	Lumachi, Franco/0000-0001-8349-631X; Barzon, Luisa/0000-0003-0720-8456; BOSCARO, MARCO/0000-0003-2596-1652; FALLO, FRANCESCO/0000-0002-7511-0226				Al-Saadi N, 1998, CLIN ENDOCRINOL, V48, P45; ARON DC, 1981, AM J MED, V71, P302, DOI 10.1016/0002-9343(81)90132-7; Barzon L, 1999, J CLIN ENDOCR METAB, V84, P520, DOI 10.1210/jc.84.2.520; Barzon L, 1998, J CLIN ENDOCR METAB, V83, P55, DOI 10.1210/jc.83.1.55; BECKER M, 1994, ENDOCRIN METAB CLIN, V23, P585, DOI 10.1016/S0889-8529(18)30086-0; BECKERS A, 1990, J ENDOCRINOL INVEST, V13, P923, DOI 10.1007/BF03349657; Bertagna Xavier, 1995, P478; BOCHICCHIO D, 1995, J CLIN ENDOCR METAB, V80, P3114, DOI 10.1210/jcem.80.11.7593411; Bornstein SR, 1999, J CLIN ENDOCR METAB, V84, P1729; Boscaro M, 2000, ARCH INTERN MED, V160, P3045, DOI 10.1001/archinte.160.20.3045; CAREY RM, 1984, NEW ENGL J MED, V311, P13, DOI 10.1056/NEJM198407053110103; Casonato A, 1999, BLOOD COAGUL FIBRIN, V10, P145, DOI 10.1097/00001721-199904000-00006; Cizza G, 1996, J CLIN ENDOCR METAB, V81, P3573, DOI 10.1210/jc.81.10.3573; Colombo P, 2000, EUR J ENDOCRINOL, V143, P227, DOI 10.1530/eje.0.1430227; CRAPO L, 1979, METABOLISM, V28, P955, DOI 10.1016/0026-0495(79)90097-0; Dahia PLM, 1999, ENDOCR REV, V20, P136, DOI 10.1210/er.20.2.136; de Herder WW, 1999, J CLIN ENDOCR METAB, V84, P1184, DOI 10.1210/jc.84.4.1184; Doppman JL, 1999, J CLIN ENDOCR METAB, V84, P533, DOI 10.1210/jc.84.2.533; Estrada J, 1997, NEW ENGL J MED, V336, P172, DOI 10.1056/NEJM199701163360303; Findling JW, 2000, J ENDOCRINOL INVEST, V23, P193, DOI 10.1007/BF03343706; Freda PU, 1999, J CLIN ENDOCR METAB, V84, P3859, DOI 10.1210/jc.84.11.3859; HALE AC, 1988, CLIN ENDOCRINOL, V28, P215, DOI 10.1111/j.1365-2265.1988.tb03658.x; Henry JF, 2000, WORLD J SURG, V24, P1342, DOI 10.1007/s002680010222; HERMUS AR, 1988, NEW ENGL J MED, V318, P966, DOI 10.1056/NEJM198804143181506; Hogervorst GOV, 1996, J CLIN ENDOCR METAB, V81, P652; Hoh CK, 1997, SEMIN NUCL MED, V27, P94, DOI 10.1016/S0001-2998(97)80042-6; JENKINS PJ, 1995, J CLIN ENDOCR METAB, V80, P165, DOI 10.1210/jc.80.1.165; Kaltsas GA, 2000, J CLIN ENDOCR METAB, V85, P1741, DOI 10.1210/jc.85.4.1741; Kaltsas GA, 1999, J CLIN ENDOCR METAB, V84, P487, DOI 10.1210/jc.84.2.487; KEMINK L, 1994, J CLIN ENDOCR METAB, V79, P887, DOI 10.1210/jc.79.3.887; Kertesz G, 1998, CLIN CHEM, V44, P78; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; KRUSE A, 1992, CLIN ENDOCRINOL, V37, P254, DOI 10.1111/j.1365-2265.1992.tb02319.x; Lanzi R, 1998, SURGERY, V123, P144, DOI 10.1016/S0039-6060(98)70251-X; LUDECKE DK, 1991, PATHOL RES PRACT, V187, P608; MAGIAKOU MA, 1994, NEW ENGL J MED, V331, P629, DOI 10.1056/NEJM199409083311002; MAMPALAM TJ, 1988, ANN INTERN MED, V109, P487, DOI 10.7326/0003-4819-109-6-487; Miller KK, 1998, CLIN INFECT DIS, V27, P68, DOI 10.1086/514638; Newell-Price J, 1998, ENDOCR REV, V19, P647, DOI 10.1210/er.19.5.647; Newell-Price J, 1999, LANCET, V353, P2087, DOI 10.1016/S0140-6736(99)99091-8; NewellPrice J, 1997, J CLIN ENDOCR METAB, V82, P176, DOI 10.1210/jc.82.1.176; Newfield RS, 2000, J CLIN ENDOCR METAB, V85, P14, DOI 10.1210/jc.85.1.14; NIEMAN LK, 1993, J CLIN ENDOCR METAB, V77, P1308, DOI 10.1210/jc.77.5.1308; ORTH DN, 1998, WILLIAMS TXB ENDOCRI, P517; Perry LA, 1997, ANN CLIN BIOCHEM, V34, P345, DOI 10.1177/000456329703400403; Plotsky PM, 1998, PSYCHIAT CLIN N AM, V21, P293, DOI 10.1016/S0193-953X(05)70006-X; RAMOS IM, 1998, ACTA NEUROCHIR WIEN, V140, P437; ROSS EJ, 1982, LANCET, V2, P646; Samuels MH, 2000, J CLIN ENDOCR METAB, V85, P22, DOI 10.1210/jc.85.1.22; SMITH AI, 1988, ENDOCR REV, V9, P159, DOI 10.1210/edrv-9-1-159; SONINO N, 1987, NEW ENGL J MED, V317, P812, DOI 10.1056/NEJM198709243171307; Sonino N, 2000, Pituitary, V3, P55, DOI 10.1023/A:1009986822146; SONINO N, 1986, IRCS MED SCI-BIOCHEM, V14, P485; Sonino N, 1998, PSYCHOTHER PSYCHOSOM, V67, P140, DOI 10.1159/000012274; Sonino N, 2000, PSYCHOTHER PSYCHOSOM, V69, P216, DOI 10.1159/000012396; Sonino N, 1996, J CLIN ENDOCR METAB, V81, P2647, DOI 10.1210/jc.81.7.2647; SONINO N, 1991, CLIN ENDOCRINOL, V35, P347, DOI 10.1111/j.1365-2265.1991.tb03547.x; SONINO N, 1993, CLIN ENDOCRINOL, V38, P261, DOI 10.1111/j.1365-2265.1993.tb01004.x; Sonino N, 1999, ENDOCRIN METAB CLIN, V28, P211, DOI 10.1016/S0889-8529(05)70064-5; SONINO N, IN PRESS CNS DRUGS; Stratakis CA, 1996, J CLIN INVEST, V97, P699, DOI 10.1172/JCI118467; Tabarin A, 1999, J CLIN ENDOCR METAB, V84, P1193, DOI 10.1210/jc.84.4.1193; TRAINER PJ, 1995, J CLIN ENDOCR METAB, V80, P412, DOI 10.1210/jc.80.2.412; Veldman RG, 1996, ENDOCR REV, V17, P262, DOI 10.1210/edrv-17-3-262; Walker AB, 1997, POSTGRAD MED J, V73, P426, DOI 10.1136/pgmj.73.861.426; Watson JC, 1998, J NEUROSURG, V89, P927, DOI 10.3171/jns.1998.89.6.0927; White A, 1998, CLIN ENDOCRINOL, V48, P251, DOI 10.1046/j.1365-2265.1998.00451.x; Wigg SJ, 1999, CLIN ENDOCRINOL, V50, P675, DOI 10.1046/j.1365-2265.1999.00726.x	68	254	282	1	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2001	357	9258					783	791		10.1016/S0140-6736(00)04172-6	http://dx.doi.org/10.1016/S0140-6736(00)04172-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253984				2022-12-28	WOS:000167400900039
J	Scott, K; Brady, R; Cravchik, A; Morozov, P; Rzhetsky, A; Zuker, C; Axel, R				Scott, K; Brady, R; Cravchik, A; Morozov, P; Rzhetsky, A; Zuker, C; Axel, R			A chemosensory gene family encoding candidate gustatory and olfactory receptors in Drosophila	CELL			English	Article							PUTATIVE PHEROMONE RECEPTORS; MAMMALIAN TASTE RECEPTORS; C-ELEGANS; ODORANT RECEPTORS; SENSORY PROJECTIONS; MULTIGENE FAMILY; ANTENNAL LOBE; SOUR TASTE; MELANOGASTER; EXPRESSION	A novel family of candidate gustatory receptors (GRs) was recently identified in searches of the Drosophila genome. We have performed in situ hybridization and transgene experiments that reveal expression of these genes in both gustatory and olfactory neurons in adult flies and larvae. This gene family is likely to encode both odorant and taste receptors. We have visualized the projections of chemosensory neurons in the larval brain and observe that neurons expressing different GRs project to discrete loci in the antennal lobe and subesophageal ganglion. These data provide insight into the diversity of chemosensory recognition and an initial view of the representation of gustatory information in the fly brain.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Columbia Genome Ctr, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med Informat, New York, NY 10032 USA; Celera Genom, Med Affairs Dept, Rockville, MD 20850 USA; Univ Calif San Diego, Howard Hughes Med Inst, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, La Jolla, CA 92093 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Axel, R (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, 701 W 168th St, New York, NY 10032 USA.	ra27@columbia.edu	rzhetsky, andrey/B-6118-2012	rzhetsky, andrey/0000-0001-6959-7405; Axel, Richard/0000-0002-3141-4076	NATIONAL CANCER INSTITUTE [P01CA023767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS029832] Funding Source: NIH RePORTER; NCI NIH HHS [2POICA23767-22] Funding Source: Medline; NINDS NIH HHS [NS 29832-09] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARORA K, 1987, NATURE, V330, P62, DOI 10.1038/330062a0; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Dethier VG, 1976, HUNGRY FLY; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; FALK R, 1976, J MORPHOL, V150, P327, DOI 10.1002/jmor.1051500206; FUJISHIRO N, 1984, J INSECT PHYSIOL, V30, P317, DOI 10.1016/0022-1910(84)90133-1; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Gilbertson TA, 2000, CURR OPIN NEUROBIOL, V10, P519, DOI 10.1016/S0959-4388(00)00118-5; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HARTENSTEIN V, 1984, ROUX ARCH DEV BIOL, V193, P308, DOI 10.1007/BF00848159; HARTENSTEIN V, 1987, W ROUXS ARCH DEV BIO, V198, P264; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Heimbeck G, 1999, J NEUROSCI, V19, P6599; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Ishimoto H, 2000, SCIENCE, V289, P116, DOI 10.1126/science.289.5476.116; KINNAMON SC, 1988, P NATL ACAD SCI USA, V85, P7023, DOI 10.1073/pnas.85.18.7023; Kinnamon SC, 1996, CURR OPIN NEUROBIOL, V6, P506, DOI 10.1016/S0959-4388(96)80057-2; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nassif C, 1998, J COMP NEUROL, V402, P10; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; POSSIDENTE DR, 1989, DEV BIOL, V132, P448, DOI 10.1016/0012-1606(89)90241-8; POWER ME, 1948, J COMP NEUROL, V88, P347, DOI 10.1002/cne.900880303; RAJASHEKHAR KP, 1994, J COMP NEUROL, V349, P633, DOI 10.1002/cne.903490410; RAY K, 1993, DEV BIOL, V155, P26, DOI 10.1006/dbio.1993.1003; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; RICE MJ, 1977, NATURE, V268, P747, DOI 10.1038/268747a0; RODRIGUES V, 1978, P INDIAN ACAD SCI B, V87, P147; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; RUBIN GM, 1985, COLD SPRING HARB SYM, V50, P329, DOI 10.1101/SQB.1985.050.01.042; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHANBHAG SR, 1992, CELL TISSUE RES, V267, P273, DOI 10.1007/BF00302965; Singh RN, 1997, MICROSC RES TECHNIQ, V39, P547, DOI 10.1002/(SICI)1097-0029(19971215)39:6<547::AID-JEMT7>3.0.CO;2-A; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1981, CELL TISSUE RES, V216, P513; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; STRUHL G, 1981, NATURE, V293, P36, DOI 10.1038/293036a0; TAYLOR BJ, 1989, J NEUROGENET, V5, P193, DOI 10.3109/01677068909066208; TOMPKINS L, 1983, BEHAV GENET, V13, P565, DOI 10.1007/BF01076402; Troemel ER, 1999, BIOESSAYS, V21, P1011, DOI 10.1002/(SICI)1521-1878(199912)22:1&lt;1011::AID-BIES5&gt;3.0.CO;2-V; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Truman James W., 1993, P1245; Ugawa S, 1998, NATURE, V395, P555, DOI 10.1038/26882; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0	77	490	504	4	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2001	104	5					661	673		10.1016/S0092-8674(01)00263-X	http://dx.doi.org/10.1016/S0092-8674(01)00263-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257221	Bronze			2022-12-28	WOS:000167531100007
J	Prouteau, G; Scaillet, B; Pichavant, M; Maury, R				Prouteau, G; Scaillet, B; Pichavant, M; Maury, R			Evidence for mantle metasomatism by hydrous silicic melts derived from subducted oceanic crust	NATURE			English	Article							SUB-ARC MANTLE; CONTINENTAL-CRUST; MAGMAS; PERIDOTITE; NB; DIFFERENTIATION; AMPHIBOLITES; GEOCHEMISTRY; GENERATION; DEPLETION	The low concentrations of niobium, tantalum and titanium observed in island-arc basalts are thought to result from modification of the sub-arc mantle by a metasomatic agent, deficient in these elements, that originates from within the subducted oceanic crust(1). Whether this agent is an hydrous fluid(2) or a silica-rich melt(3) has been discussed using mainly a trace-element approach(4) and related to variable thermal regimes of subduction zones(5). Melting of basalt in the absence of fluid both requires high temperatures and yields melt compositions unlike those found in most modern or Mesozoic island arcs(6,7). Thus, metasomatism by fluids has been thought to be the most common situation. Here, however, we show that the melting of basalt under both H2O-added and low-temperature conditions can yield extremely alkali-rich silicic liquids, the alkali content of which increases with pressure. These liquids are deficient in titanium and in the elements niobium and tantalum and are virtually identical to glasses preserved in mantle xenoliths found in subduction zones(6) and to veins found in exhumed metamorphic terranes of fossil convergent zones(7). We also found that the interaction between such liquids and mantle olivine produces modal mineralogies that are identical to those observed in metasomatized Alpine-type peridotites(8). We therefore suggest that mantle metasomatism by slab-derived melt is a more common process than previously thought.	ISTO, UMR, F-45071 Orleans, France; UBO, UMR 6538, F-29285 Brest, France	Bureau de Recherches Geologiques et Minieres (BRGM); Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Bretagne Occidentale	Scaillet, B (corresponding author), ISTO, UMR, G113,1A Rue Ferollerie, F-45071 Orleans, France.		Scaillet, Bruno/A-5846-2012; Pichavant, Michel cha/C-1371-2012; Maury, Rene/F-8046-2012	Pichavant, Michel cha/0000-0001-8346-5302; Scaillet, Bruno/0000-0003-1561-0226				ATHERTON MP, 1993, NATURE, V362, P144, DOI 10.1038/362144a0; BEARD JS, 1991, J PETROL, V32, P365, DOI 10.1093/petrology/32.2.365; CARROLL MR, 1989, J PETROL, V30, P1351, DOI 10.1093/petrology/30.6.1351; DEFANT MJ, 1990, NATURE, V347, P662, DOI 10.1038/347662a0; Drummond MS, 1996, T ROY SOC EDIN-EARTH, V87, P205, DOI 10.1017/S0263593300006611; Eiler JM, 1998, NATURE, V393, P777, DOI 10.1038/31679; Eiler JM, 2000, J PETROL, V41, P229, DOI 10.1093/petrology/41.2.229; Hawkesworth CJ, 1997, SCIENCE, V276, P551, DOI 10.1126/science.276.5312.551; Hirschmann MM, 1998, GEOCHIM COSMOCHIM AC, V62, P883, DOI 10.1016/S0016-7037(98)00028-3; HOFMANN AW, 1988, EARTH PLANET SC LETT, V90, P297, DOI 10.1016/0012-821X(88)90132-X; IONOV DA, 1995, EARTH PLANET SC LETT, V131, P341, DOI 10.1016/0012-821X(95)00037-D; KELEMEN PB, 1993, EARTH PLANET SC LETT, V120, P111, DOI 10.1016/0012-821X(93)90234-Z; Kepezhinskas PK, 1995, J PETROL, V36, P1505; MARTIN H, 1986, GEOLOGY, V14, P753, DOI 10.1130/0091-7613(1986)14<753:EOSAGG>2.0.CO;2; NICHOLLS IA, 1973, J GEOL, V81, P285; PEACOCK SM, 1994, EARTH PLANET SC LETT, V121, P227, DOI 10.1016/0012-821X(94)90042-6; Prouteau G, 1999, GEOLOGY, V27, P1111, DOI 10.1130/0091-7613(1999)027<1111:FPMOOC>2.3.CO;2; Rapp RP, 1999, CHEM GEOL, V160, P335, DOI 10.1016/S0009-2541(99)00106-0; RAPP RP, 1995, J PETROL, V36, P891, DOI 10.1093/petrology/36.4.891; RYERSON FJ, 1987, EARTH PLANET SC LETT, V86, P225, DOI 10.1016/0012-821X(87)90223-8; SCHIANO P, 1995, NATURE, V377, P595, DOI 10.1038/377595a0; Schmidt MW, 1998, EARTH PLANET SC LETT, V163, P361, DOI 10.1016/S0012-821X(98)00142-3; SCHNEIDER ME, 1986, GEOCHIM COSMOCHIM AC, V50, P711, DOI 10.1016/0016-7037(86)90347-9; SEN C, 1994, CONTRIB MINERAL PETR, V117, P394, DOI 10.1007/BF00307273; Sen C., 1994, CONTRIB MINERAL PETR, V119, P422; SORENSEN SS, 1989, GEOCHIM COSMOCHIM AC, V53, P3155, DOI 10.1016/0016-7037(89)90096-3; SPULBER SD, 1983, J PETROL, V24, P1; TATSUMI Y, 1989, J GEOPHYS RES-SOLID, V94, P4697, DOI 10.1029/JB094iB04p04697; ULMER P, 1995, SCIENCE, V268, P858, DOI 10.1126/science.268.5212.858; WHINTER KT, 1991, B GEOL SOC DENMARK, V39, P213; YOGODZINSKI GM, 1994, J PETROL, V34, P163; Zanetti A, 1999, CONTRIB MINERAL PETR, V134, P107, DOI 10.1007/s004100050472	32	413	460	1	113	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					197	200		10.1038/35065583	http://dx.doi.org/10.1038/35065583			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242077	Green Submitted			2022-12-28	WOS:000167320500043
J	Toyoshima-Morimoto, F; Taniguchi, E; Shinya, N; Iwamatsu, A; Nishida, E				Toyoshima-Morimoto, F; Taniguchi, E; Shinya, N; Iwamatsu, A; Nishida, E			Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase	NATURE			English	Article							CELL-CYCLE; SUBCELLULAR-LOCALIZATION; DNA-DAMAGE; M-PHASE; EXPORT; MITOSIS; SIGNAL; PLX1; TRANSPORT; CRM1	In vertebrate cells, the nuclear entry of Cdc2-cyclin B1 (MPF1-3) during prophase(4-6) is thought to be essential for the induction and coordination of M-phase events(7-12). Phosphorylation of cyclin B1 is central to its nuclear translocation(8,13,14), but the kinases that are responsible remain unknown. Here we have purified a protein kinase from Xenopus M-phase extracts that phosphorylates a crucial serine residue (S147) in the middle of the nuclear export signal sequence(10,13,15) of cyclin B1. We have identified this kinase as Plx1 (ref. 16), a Xenopus homologue of Polo-like kinase (Plk)-1 (refs 17, 18). During cell-cycle progression in HeLa cells, a change in the kinase activity of endogenous Plk1 toward S147 and/or S133 correlates with a kinase activity in the cell extracts. An anti-Plk1 antibody depletes the M-phase extracts of the kinase activity toward S147 and/or S133. An anti-phospho-S147 antibody reacts specifically with cyclin B1 only during G2/M phase. A mutant cyclin B1 in which S133 and S147 are replaced by alanines remains in the cytoplasm, whereas wild-type cyclin B1 accumulates in the nucleus during prophase. Co-expression of constitutively active Plk1 stimulates nuclear entry of cyclin B1. Our results indicate that Plk1 may be involved in targeting MPF to the nucleus during prophase.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; Kirin Brewery Co Ltd, Cent Labs Key Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Kyoto University; Kyoto University; Kirin Brewery Company Limited	Nishida, E (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.			Toyoshima, Fumiko/0000-0002-3698-0034				Borgne A, 1999, J BIOL CHEM, V274, P11977, DOI 10.1074/jbc.274.17.11977; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Hagting A, 1999, CURR BIOL, V9, P680, DOI 10.1016/S0960-9822(99)80308-X; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Hunt T, 1991, Semin Cell Biol, V2, P213; IWAMATSU A, 1992, ELECTROPHORESIS, V13, P142, DOI 10.1002/elps.1150130129; IZUMI T, 1991, MOL CELL BIOL, V11, P3860, DOI 10.1128/MCB.11.8.3860; JACKMAN M, 1995, EMBO J, V14, P1646, DOI 10.1002/j.1460-2075.1995.tb07153.x; Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.0.CO;2-5; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Li J, 1997, P NATL ACAD SCI USA, V94, P502, DOI 10.1073/pnas.94.2.502; LI JK, 1995, MOL BIOL CELL, V6, P1111, DOI 10.1091/mbc.6.9.1111; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; NIGG E A, 1992, Current Opinion in Cell Biology, V4, P105, DOI 10.1016/0955-0674(92)90066-L; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OOKATA K, 1992, EMBO J, V11, P1763, DOI 10.1002/j.1460-2075.1992.tb05228.x; PINES J, 1994, EMBO J, V13, P3772, DOI 10.1002/j.1460-2075.1994.tb06688.x; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Qian YW, 1999, MOL CELL BIOL, V19, P8625; Qian YW, 1998, MOL CELL BIOL, V18, P4262, DOI 10.1128/MCB.18.7.4262; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Yang J, 1999, TRENDS CELL BIOL, V9, P207, DOI 10.1016/S0962-8924(99)01577-9; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131	30	309	319	0	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					215	220		10.1038/35065617	http://dx.doi.org/10.1038/35065617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242082				2022-12-28	WOS:000167320500048
J	Valenstein, M; Vijan, S; Zeber, JE; Boehm, K; Buttar, A				Valenstein, M; Vijan, S; Zeber, JE; Boehm, K; Buttar, A			The cost-utility of screening for depression in primary care	ANNALS OF INTERNAL MEDICINE			English	Review							CASE-FINDING INSTRUMENTS; SEROTONIN REUPTAKE INHIBITORS; NATIONAL-COMORBIDITY-SURVEY; RANDOMIZED CLINICAL-TRIAL; TREATING MAJOR DEPRESSION; PRIMARY MEDICAL-CARE; LATE-LIFE DEPRESSION; QUALITY-OF-LIFE; MENTAL-DISORDERS; HEALTH-CARE	Background: Depressive disorders are common in primary care and cause substantial disability, but they often remain undiagnosed. Screening is a frequently proposed strategy for increasing detection of depression. Objective: To examine the cost-utility of screening for depression compared with no screening. Design: Nonstationary Markov model. Data Sources: The published literature. Time Horizon: Lifetime. Perspective: Health care payer and societal. Interventions: Self-administered questionnaire followed by provider assessment. Outcome Measures: costs and quality-adjusted life-years (QALYs). Results of Base-Case Analysis: Compared with no screening, the cost to society of annual screening for depression in primary care patients is $192 444/QALY. Screening every 5 years and one-time screening cost $50 988/QALY and $32 053/QALY, respectively, compared with no screening. From the payer perspective, the cost of annual screening is $225 467. Results of Sensitivity Analyses: Cost-utility ratios are most sensitive to the prevalence of major depression, the costs of screening, rates of treatment initiation, and remission rates with treatment. In Monte Carlo sensitivity analyses, the cost-utility of annual screening is less than $50 000/QALY only 2.2% of the time. In multiway analyses, four model variables must be changed to extreme values for the cost-utility of annual screening to fall below $50 000/QALY, but a change in only one variable increases the cost-utility of one-time screening to more than $50 000/QALY. One-time screening is more robustly cost-effective if screening costs are low and effective treatments are being given. Conclusions: Annual and periodic screening for depression cost more than $50 000/QALY, but one-time screening is cost-effective. The cost-effectiveness of screening is likely to improve if treatment becomes more effective.	Dept Vet Affairs Med Ctr, Hlth Serv Res & Dev, Ann Arbor, MI USA; Univ Michigan, Ann Arbor, MI 48109 USA; Med Coll Ohio, Toledo, OH 43699 USA	University of Michigan System; University of Michigan	Valenstein, M (corresponding author), Dept Vet Affairs Med Ctr, Hlth Serv Res & Dev, Box 130170, Ann Arbor, MI USA.		Boehm, Katja/AAN-5232-2021	Boehm, Katja/0000-0002-3405-1442				*AM AC FAM PHYS, 2000, AV CONT PER PERS PRI; American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Angst J, 1997, J AFFECT DISORDERS, V45, P31, DOI 10.1016/S0165-0327(97)00057-8; Ballenger JC, 1999, J CLIN PSYCHIAT, V60, P54; Bartels SJ, 1997, INT J PSYCHIAT MED, V27, P215, DOI 10.2190/VKBR-1AR6-9NBD-0N25; BEASLEY CM, 1991, BMJ-BRIT MED J, V303, P685, DOI 10.1136/bmj.303.6804.685; Briggs A, 2000, BRIT MED J, V320, P246, DOI 10.1136/bmj.320.7229.246; BROADHEAD WE, 1990, JAMA-J AM MED ASSOC, V264, P2524, DOI 10.1001/jama.264.19.2524; BROWN JB, 1995, JOINT COMM J QUAL IM, V21, P5, DOI 10.1016/S1070-3241(16)30123-7; *BUR LAB STAT, 2000, EC GLANC 1999; Callahan CM, 1996, J GEN INTERN MED, V11, P218, DOI 10.1007/BF02642478; CALLAHAN CM, 1994, J AM GERIATR SOC, V42, P839, DOI 10.1111/j.1532-5415.1994.tb06555.x; Campbell T L, 1987, J Fam Pract, V25, P184; COULEHAN JL, 1989, J GEN INTERN MED, V4, P541, DOI 10.1007/BF02599556; Coulehan JL, 1997, ARCH INTERN MED, V157, P1113, DOI 10.1001/archinte.157.10.1113; COYNE JC, 1995, GEN HOSP PSYCHIAT, V17, P3, DOI 10.1016/0163-8343(94)00056-J; COYNE JC, 1994, GEN HOSP PSYCHIAT, V16, P267, DOI 10.1016/0163-8343(94)90006-X; Craven M, 1997, CAN J PSYCHIAT, V42, P943, DOI 10.1177/070674379704200905; Croghan TW, 1998, HEALTH AFFAIR, V17, P198, DOI 10.1377/hlthaff.17.4.198; Croghan TW, 1997, PSYCHIATR SERV, V48, P1420; Croghan TW, 1999, MED CARE, V37, pAS20, DOI 10.1097/00005650-199904001-00004; CRUM RM, 1994, PSYCHOSOM MED, V56, P109, DOI 10.1097/00006842-199403000-00006; Davidson JRT, 1999, J CLIN PSYCHIAT, V60, P4; *DEPR GUID PAN, 1993, AHCPR PUBL; *DEPR GUID PAN, 1993, CLIN PRACT GUID, V5; Dunn RL, 1999, J PSYCHOPHARMACOL, V13, P136, DOI 10.1177/026988119901300204; FEIGHTNER JW, 1994, CANADIAN GUIDE CLIN, P450; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; GAFNI A, 1993, CAN MED ASSOC J, V148, P913; Gold MR, 1996, COST EFFECTIVENESS H; Greenberg P.E., 1996, SELECTIVE SEROTONIN; GREENBERG PE, 1993, J CLIN PSYCHIAT, V54, P405; GREGOR KJ, 1994, CLIN THER, V16, P306; HAYS RD, 1995, ARCH GEN PSYCHIAT, V52, P11; Henk HJ, 1996, ARCH GEN PSYCHIAT, V53, P899; Higgins E S, 1994, Arch Fam Med, V3, P908, DOI 10.1001/archfami.3.10.908; Hirschfield RMA, 1997, JAMA-J AM MED ASSOC, V277, P333, DOI 10.1001/jama.277.4.333; *HLTH CAR FIN ADM, 2000, NAT PHYS FEE SCHED R; HOEPER EW, 1984, LANCET, V1, P33; HORWATH E, 1992, ARCH GEN PSYCHIAT, V49, P817; JOHNSON J, 1992, JAMA-J AM MED ASSOC, V267, P1478, DOI 10.1001/jama.267.11.1478; Judd LL, 1998, ARCH GEN PSYCHIAT, V55, P694, DOI 10.1001/archpsyc.55.8.694; Judd LL, 2000, ARCH GEN PSYCHIAT, V57, P375, DOI 10.1001/archpsyc.57.4.375; KATON W, 1992, MED CARE, V30, P67, DOI 10.1097/00005650-199201000-00007; KATON W, 1987, INT J PSYCHIAT MED, V17, P93, DOI 10.2190/XE8W-GLCJ-KEM6-39FH; KATON W, 1995, GEN HOSP PSYCHIAT, V17, P1, DOI 10.1016/0163-8343(94)00055-I; Katon W, 1999, ARCH GEN PSYCHIAT, V56, P1109, DOI 10.1001/archpsyc.56.12.1109; Katon W, 1996, ARCH GEN PSYCHIAT, V53, P924; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Katzelnick DJ, 1997, PSYCHIATR SERV, V48, P59; Kessler RC, 1999, AM J PSYCHIAT, V156, P115, DOI 10.1176/ajp.156.1.115; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; KIRMAYER LJ, 1993, AM J PSYCHIAT, V150, P734; Klinkman MS, 1997, ARCH FAM MED, V6, P567, DOI 10.1001/archfami.6.6.567; Kobak KA, 1997, JAMA-J AM MED ASSOC, V278, P905, DOI 10.1001/jama.278.11.905; KOUZIS AC, 1994, AM J PUBLIC HEALTH, V84, P1304, DOI 10.2105/AJPH.84.8.1304; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Lave JR, 1998, ARCH GEN PSYCHIAT, V55, P645, DOI 10.1001/archpsyc.55.7.645; Lefevre F, 1999, J GEN INTERN MED, V14, P425, DOI 10.1046/j.1525-1497.1999.07238.x; Leon A C, 1995, Arch Fam Med, V4, P857, DOI 10.1001/archfami.4.10.857; Leon AC, 1996, J GEN INTERN MED, V11, P426, DOI 10.1007/BF02600191; Lepine JP, 1997, INT CLIN PSYCHOPHARM, V12, P19, DOI 10.1097/00004850-199701000-00003; LEVIN BL, 1988, AM J PUBLIC HEALTH, V78, P1222, DOI 10.2105/AJPH.78.9.1222; LIMA MS, 2000, COCHRANE DATABASE SY, V4; Lin EHB, 1997, MED CARE, V35, P831, DOI 10.1097/00005650-199708000-00008; LIN EHB, 1995, MED CARE, V33, P67, DOI 10.1097/00005650-199501000-00006; LINN LS, 1984, PSYCHOSOMATICS, V25, P593, DOI 10.1016/S0033-3182(84)72994-X; LINN LS, 1980, J MED EDUC, V55, P942; LINN LS, 1982, MED CARE, V20, P1233, DOI 10.1097/00005650-198212000-00009; Lyness JM, 1999, J AM GERIATR SOC, V47, P647, DOI 10.1111/j.1532-5415.1999.tb01584.x; Lyness JM, 1997, ARCH INTERN MED, V157, P449, DOI 10.1001/archinte.157.4.449; Magruder KM, 1999, J CLIN PSYCHIAT, V60, P45; MAGRUDERHABIB K, 1990, MED CARE, V28, P239, DOI 10.1097/00005650-199003000-00004; MANDERSCHEID RW, 1992, MENT HLTH US; *MED EC, 1999, DRUG TOP RED BOOK; MINTZ J, 1992, ARCH GEN PSYCHIAT, V49, P761; MOORE JT, 1978, J FAM PRACTICE, V7, P509; MULROW CD, 1995, ANN INTERN MED, V122, P913, DOI 10.7326/0003-4819-122-12-199506150-00004; MUMFORD E, 1984, AM J PSYCHIAT, V141, P1145; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Nagel R, 1998, Fam Med, V30, P362; NARROW WE, 1993, ARCH GEN PSYCHIAT, V50, P95; Olfson M, 1996, ARCH GEN PSYCHIAT, V53, P880; Olfson M, 1997, AM J PSYCHIAT, V154, P1734, DOI 10.1176/ajp.154.12.1734; ORMEL J, 1994, JAMA-J AM MED ASSOC, V272, P1741, DOI 10.1001/jama.272.22.1741; ORMEL J, 1993, ARCH GEN PSYCHIAT, V50, P759; ORMEL J, 1991, ARCH GEN PSYCHIAT, V48, P700; PEREZSTABLE EJ, 1990, ARCH INTERN MED, V150, P1083, DOI 10.1001/archinte.150.5.1083; Pincus HA, 1998, JAMA-J AM MED ASSOC, V279, P526, DOI 10.1001/jama.279.7.526; Pyne JM, 1997, PSYCHIAT SERV, V48, P224; RAND EH, 1988, GEN HOSP PSYCHIAT, V10, P189, DOI 10.1016/0163-8343(88)90018-7; REGIER DA, 1993, ARCH GEN PSYCHIAT, V50, P85; Revicki DA, 1997, J CLIN PSYCHIAT, V58, P47, DOI 10.4088/JCP.v58n0201; Revicki DA, 1998, J AFFECT DISORDERS, V48, P25, DOI 10.1016/S0165-0327(97)00117-1; RICE DP, 1995, BRIT J PSYCHIAT, V166, P34; Rollman BL, 1999, J AM GERIATR SOC, V47, P757, DOI 10.1111/j.1532-5415.1999.tb01605.x; Rost K, 1998, GEN HOSP PSYCHIAT, V20, P12, DOI 10.1016/S0163-8343(97)00095-9; SACKETT DL, 1978, J CHRON DIS, V31, P697, DOI 10.1016/0021-9681(78)90072-3; SASICH LD, 2000, INT COMP PRICES ANTI; Schade CP, 1998, PSYCHIAT SERV, V49, P55, DOI 10.1176/ps.49.1.55; Schulberg HC, 1999, J CLIN PSYCHIAT, V60, P19; Schulberg HC, 1998, ARCH GEN PSYCHIAT, V55, P1121, DOI 10.1001/archpsyc.55.12.1121; Schulberg HC, 1996, ARCH GEN PSYCHIAT, V53, P913; SCHURMAN RA, 1985, ARCH GEN PSYCHIAT, V42, P89; Schwenk TL, 1996, J GEN INTERN MED, V11, P437, DOI 10.1007/BF02600194; SHAPIRO S, 1984, ARCH GEN PSYCHIAT, V41, P971; SHAPIRO S, 1987, MED CARE, V25, P327, DOI 10.1097/00005650-198704000-00006; Shasha M, 1997, INT J PSYCHIAT MED, V27, P83, DOI 10.2190/YVBE-MXAF-Q09Q-Y02Q; SHERBOURNE CD, 1994, AM J PSYCHIAT, V151, P1777; SIMON G, 1995, AM J PSYCHIAT, V152, P352; Simon GE, 1998, AM J EPIDEMIOL, V147, P155; Simon GE, 1999, GEN HOSP PSYCHIAT, V21, P97, DOI 10.1016/S0163-8343(98)00072-3; Simon GE, 1998, PSYCHOL MED, V28, P693, DOI 10.1017/S0033291798006588; SIMON GE, 1995, ARCH GEN PSYCHIAT, V52, P850; Simon GE, 1997, J PSYCHOSOM RES, V42, P333, DOI 10.1016/S0022-3999(96)00367-4; Simon GE, 1995, J GEN INTERN MED, V10, P663, DOI 10.1007/BF02602759; Simon GE, 1996, JAMA-J AM MED ASSOC, V275, P1897, DOI 10.1001/jama.275.24.1897; Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550; Snow V, 2000, ANN INTERN MED, V132, P738, DOI 10.7326/0003-4819-132-9-200005020-00010; SPITZER RL, 1995, JAMA-J AM MED ASSOC, V274, P1511, DOI 10.1001/jama.274.19.1511; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Steer RA, 1999, GEN HOSP PSYCHIAT, V21, P106, DOI 10.1016/S0163-8343(98)00070-X; Stone PW, 2000, AM J PREV MED, V19, P15, DOI 10.1016/S0749-3797(00)00151-3; Tiemens BG, 1996, AM J PSYCHIAT, V153, P636; Tiemens BG, 1999, GEN HOSP PSYCHIAT, V21, P87, DOI 10.1016/S0163-8343(98)00077-2; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Valenstein M, 1999, J FAM PRACTICE, V48, P180; *VET HLTH ADM, 1996, CLIN GUID MAJ DEPR D; VONKORFF M, 1992, ARCH GEN PSYCHIAT, V49, P91; Voris JC, 1999, J CLIN PSYCHOL, V55, P129, DOI 10.1002/(SICI)1097-4679(199901)55:1<129::AID-JCLP13>3.0.CO;2-0; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Weinstein MC, 1980, CLIN DECISION ANAL; Weissman MM, 1998, GEN HOSP PSYCHIAT, V20, P1, DOI 10.1016/S0163-8343(97)00122-9; WELLS K, 1996, CARING DEPRESSION; WELLS KB, 1994, AM J PSYCHIAT, V151, P694; Wells KB, 1999, ARCH GEN PSYCHIAT, V56, P897, DOI 10.1001/archpsyc.56.10.897; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P3298, DOI 10.1001/jama.262.23.3298; WELLS KB, 1992, ARCH GEN PSYCHIAT, V49, P788; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Williams JW, 1999, AM J MED, V106, P36, DOI 10.1016/S0002-9343(98)00371-4; WILLIAMS JW, 1995, J GEN INTERN MED, V10, P7, DOI 10.1007/BF02599568; Williams JW, 2000, ANN INTERN MED, V132, P743, DOI 10.7326/0003-4819-132-9-200005020-00011; Zhang ML, 1999, PSYCHIATR SERV, V50, P1209, DOI 10.1176/ps.50.9.1209; ZUNG WWK, 1983, J CLIN PSYCHIAT, V44, P3; 2000, AM HOSP DIRECTORY	148	182	184	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2001	134	5					345	360		10.7326/0003-4819-134-5-200103060-00007	http://dx.doi.org/10.7326/0003-4819-134-5-200103060-00007			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	405ZJ	11242495				2022-12-28	WOS:000167190200001
J	Joy, M; Carlstrom, JE				Joy, M; Carlstrom, JE			Cosmology - Probing the early universe with the SZ effect	SCIENCE			English	Editorial Material							ZELDOVICH; SPECTRUM		NASA, George C Marshall Space Flight Ctr, Dept Space Sci, Huntsville, AL 35812 USA; Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA	National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; University of Chicago	Joy, M (corresponding author), NASA, George C Marshall Space Flight Ctr, Dept Space Sci, SD50, Huntsville, AL 35812 USA.	marshall.joy@msfc.nasa.gov; jc@hyde.uchicago.edu						Birkinshaw M, 1999, PHYS REP, V310, P98; Burles S, 1999, PHYS REV LETT, V82, P4176, DOI 10.1103/PhysRevLett.82.4176; CALSTROM JE, 2000, CONSTRUCTING UNIVERS; de Bernardis P, 2000, NATURE, V404, P955, DOI 10.1038/35010035; Fixsen DJ, 1996, ASTROPHYS J, V473, P576, DOI 10.1086/178173; GREGO L, IN PRESS ASTROPHYS J; HAIMAN Z, IN PRESS ASTROPHYS J; Hanany S, 2000, ASTROPHYS J, V545, pL5, DOI 10.1086/317322; Holder GP, 2000, ASTROPHYS J, V544, P629, DOI 10.1086/317227; Holzapfel WL, 1997, ASTROPHYS J, V481, P35, DOI 10.1086/304019; LAROQUE SJ, UNPUB; MASON BD, IN PRESS ASTROPHYS J; Miller AD, 1999, ASTROPHYS J, V524, pL1, DOI 10.1086/312293; Myers ST, 1997, ASTROPHYS J, V485, P1, DOI 10.1086/304389; Reese ED, 2000, ASTROPHYS J, V533, P38, DOI 10.1086/308662; SUNYAEV RA, 1970, COMMENTS ASTROPHYS S, V2, P66	17	2	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2001	291	5509					1715	+		10.1126/science.291.5509.1715	http://dx.doi.org/10.1126/science.291.5509.1715			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11253197				2022-12-28	WOS:000167320600035
J	Julien, JP				Julien, JP			Amyotrophic lateral sclerosis: Unfolding the toxicity of the misfolded	CELL			English	Review							TRANSGENIC MOUSE MODEL; CU/ZN SUPEROXIDE-DISMUTASE; GLUTAMATE TRANSPORTER EAAT2; HEAVY NEUROFILAMENT SUBUNIT; NITRIC-OXIDE SYNTHASE; MOTOR-NEURON DEATH; SPINAL-CORD; CELL-DEATH; INTRACELLULAR CALCIUM; AXONAL-TRANSPORT		McGill Univ, Montreal Gen Hosp, Res Inst, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada	McGill University	Julien, JP (corresponding author), McGill Univ, Montreal Gen Hosp, Res Inst, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada.	mdju@musica.mcgill.ca						Ackerley S, 2000, J CELL BIOL, V150, P165, DOI 10.1083/jcb.150.1.165; Al-Chalabi A, 1999, HUM MOL GENET, V8, P157, DOI 10.1093/hmg/8.2.157; Almer G, 1999, J NEUROCHEM, V72, P2415, DOI 10.1046/j.1471-4159.1999.0722415.x; Andreassen OA, 2000, ANN NEUROL, V47, P447, DOI 10.1002/1531-8249(200004)47:4<447::AID-ANA7>3.3.CO;2-I; Aoki M, 1998, ANN NEUROL, V43, P645, DOI 10.1002/ana.410430514; Azzouz M, 2000, HUM MOL GENET, V9, P803, DOI 10.1093/hmg/9.5.803; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; Beaulieu JM, 1999, J CELL BIOL, V147, P531, DOI 10.1083/jcb.147.3.531; Beaulieu JM, 2000, J NEUROSCI, V20, P5321, DOI 10.1523/JNEUROSCI.20-14-05321.2000; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; Berger MM, 2000, NEUROLOGY, V54, P20, DOI 10.1212/WNL.54.1.20; Bogdanov MB, 1998, J NEUROCHEM, V71, P1321; Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8; Bruijn LI, 1997, P NATL ACAD SCI USA, V94, P7606, DOI 10.1073/pnas.94.14.7606; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Chance PF, 1998, AM J HUM GENET, V62, P633, DOI 10.1086/301769; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; Colom LV, 1997, EXP NEUROL, V146, P354, DOI 10.1006/exnr.1997.6541; CORBO M, 1992, J NEUROPATH EXP NEUR, V51, P531, DOI 10.1097/00005072-199209000-00008; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; Couillard-Despres S, 2000, NEUROBIOL DIS, V7, P462, DOI 10.1006/nbdi.2000.0296; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; Dupuis L, 2000, NEUROBIOL DIS, V7, P274, DOI 10.1006/nbdi.2000.0292; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Ende N, 2000, LIFE SCI, V67, P53, DOI 10.1016/S0024-3205(00)00602-0; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Eyer J, 1998, NATURE, V391, P584, DOI 10.1038/35378; Facchinetti F, 1999, NEUROSCIENCE, V90, P1483, DOI 10.1016/S0306-4522(98)00492-8; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; FIGLEWICZ DA, 1994, HUM MOL GENET, V3, P1757, DOI 10.1093/hmg/3.10.1757; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Hentati A, 1998, NEUROGENETICS, V2, P55, DOI 10.1007/s100480050052; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P471, DOI 10.1097/00005072-198409000-00002; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Houseweart MK, 1999, J NEUROSCI, V19, P6446; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Kaal ECA, 2000, J NEUROCHEM, V74, P1158; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Kong JM, 2000, NEUROSCI LETT, V281, P72, DOI 10.1016/S0304-3940(00)00808-9; Kong JM, 1998, J NEUROSCI, V18, P3241; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Kriz J, 2000, EXP NEUROL, V163, P414, DOI 10.1006/exnr.2000.7378; Kuntz C, 2000, EXP NEUROL, V165, P184, DOI 10.1006/exnr.2000.7464; LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1; Levine JB, 1999, GLIA, V28, P215; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005; Meier J, 1999, J NEUROPATH EXP NEUR, V58, P1099, DOI 10.1097/00005072-199910000-00009; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Meyer T, 1999, J NEUROL SCI, V170, P45, DOI 10.1016/S0022-510X(99)00196-3; Migheli A, 1999, NAT MED, V5, P966, DOI 10.1038/12381; Nguyen MD, 2000, P NATL ACAD SCI USA, V97, P12306, DOI 10.1073/pnas.97.22.12306; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; Pedersen WA, 2000, FASEB J, V14, P913, DOI 10.1096/fasebj.14.7.913; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rouleau GA, 1996, ANN NEUROL, V39, P128, DOI 10.1002/ana.410390119; Siklos L, 1998, J NEUROPATH EXP NEUR, V57, P571, DOI 10.1097/00005072-199806000-00005; Spooren WPJM, 2000, CELL MOL BIOL, V46, P63; Strong MJ, 1998, BIOCHEM BIOPH RES CO, V248, P157, DOI 10.1006/bbrc.1998.8930; Trotti D, 2001, J BIOL CHEM, V276, P576, DOI 10.1074/jbc.M003779200; Trotti D, 1999, NAT NEUROSCI, V2, P427, DOI 10.1038/8091; Vukosavic S, 1999, J NEUROCHEM, V73, P2460, DOI 10.1046/j.1471-4159.1999.0732460.x; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Williamson T L, 2000, Science, V288, P399; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631; Wong NKY, 2000, J NEUROPATH EXP NEUR, V59, P972, DOI 10.1093/jnen/59.11.972; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; Yi FH, 2000, J NEUROIMMUNOL, V109, P211, DOI 10.1016/S0165-5728(00)00288-5	75	346	353	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2001	104	4					581	591		10.1016/S0092-8674(01)00244-6	http://dx.doi.org/10.1016/S0092-8674(01)00244-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	405VP	11239414	Bronze			2022-12-28	WOS:000167181500012
J	Lehn, JM; Eliseev, AV				Lehn, JM; Eliseev, AV			Chemistry - Dynamic combinatorial chemistry	SCIENCE			English	Editorial Material							MOLECULAR AMPLIFICATION; RECOGNITION; GENERATION; LIBRARIES; SELECTION; RECEPTOR		Univ Strasbourg, ISIS, F-67000 Strasbourg, France; Therascope AG, D-69123 Heidelberg, Germany	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lehn, JM (corresponding author), Univ Strasbourg, ISIS, F-67000 Strasbourg, France.	lehn@chimie.u-strasbg.fr						Berl V, 2000, CHEM-EUR J, V6, P1938; Berl V, 1999, EUR J ORG CHEM, V1999, P3089; BUNYAPAIBOONSRI T, IN PRESS CHEMBIOCHEM; Calama MC, 2000, ANGEW CHEM INT EDIT, V39, P755, DOI 10.1002/(SICI)1521-3773(20000218)39:4<755::AID-ANIE755>3.0.CO;2-6; Cousins GRL, 2000, CURR OPIN CHEM BIOL, V4, P270, DOI 10.1016/S1367-5931(00)00088-0; Cousins GRL, 2001, ANGEW CHEM INT EDIT, V40, P423, DOI 10.1002/1521-3773(20010119)40:2<423::AID-ANIE423>3.0.CO;2-6; Eliseev AV, 1999, CURR TOP MICROBIOL, V243, P159; Furlan RLE, 2000, CHEM COMMUN, P1761, DOI 10.1039/b006149m; Ganesan A, 1998, ANGEW CHEM INT EDIT, V37, P2828, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2828::AID-ANIE2828>3.0.CO;2-G; Goral V, 2001, P NATL ACAD SCI USA, V98, P1347, DOI 10.1073/pnas.98.4.1347; Hiraoka S, 2000, CHEM COMMUN, P1509, DOI 10.1039/b004271o; Hof F, 2000, J AM CHEM SOC, V122, P4251, DOI 10.1021/ja0005136; Lehn JM, 1999, CHEM-EUR J, V5, P2455; Lehn JM, 2000, SUPRAMOLECULAR POLYMERS, P615; Lehn JM, 1999, NATO ADV SCI I C-MAT, V527, P287; Moore JS, 2000, ORG LETT, V2, P915, DOI 10.1021/ol0055723; Nicolaou KC, 2000, ANGEW CHEM INT EDIT, V39, P3823, DOI 10.1002/1521-3773(20001103)39:21<3823::AID-ANIE3823>3.0.CO;2-3; Ramstrom O, 2000, CHEMBIOCHEM, V1, P41, DOI 10.1002/1439-7633(20000703)1:1<41::AID-CBIC41>3.0.CO;2-L; Star A, 2000, ANGEW CHEM INT EDIT, V39, P2685, DOI 10.1002/1521-3773(20000804)39:15<2685::AID-ANIE2685>3.3.CO;2-F	19	344	353	4	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2001	291	5512					2331	2332		10.1126/science.1060066	http://dx.doi.org/10.1126/science.1060066			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11269307				2022-12-28	WOS:000167618700033
J	de Costa, C				de Costa, C			A place on the map	LANCET			English	Editorial Material									James Cook Univ N Queensland, Cairns Base Hosp, Cairns Dist Hlth Serv, Sch Med, Cairns, Qld 4870, Australia	James Cook University	de Costa, C (corresponding author), James Cook Univ N Queensland, Cairns Base Hosp, Cairns Dist Hlth Serv, Sch Med, Cairns, Qld 4870, Australia.								0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 17	2001	357	9259					878	879		10.1016/S0140-6736(00)04204-5	http://dx.doi.org/10.1016/S0140-6736(00)04204-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265970				2022-12-28	WOS:000167586300037
J	Shakir, SAW; Wilton, LV; Boshier, A; Layton, D; Heeley, E				Shakir, SAW; Wilton, LV; Boshier, A; Layton, D; Heeley, E			Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England	BRITISH MEDICAL JOURNAL			English	Article									Drug Safety Unit, Southampton SO31 1AA, Hants, England		Shakir, SAW (corresponding author), Drug Safety Unit, Bursledon Hall, Southampton SO31 1AA, Hants, England.			Heeley, Emma/0000-0001-9190-2832				Arora RR, 1999, NEW ENGL J MED, V341, P700, DOI 10.1056/NEJM199908263410915; BAJEKAL M, 1999, HLTH SURVEY ENGLAND; Mann RD, 1998, BRIT J CLIN PHARMACO, V46, P195, DOI 10.1046/j.1365-2125.1998.00774.x; *OFF NAT STAT, 2000, MORT STAT GEN REV RE; *PFIZ, 1998, VIAGR SUMM PROD CHAR	5	86	92	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 17	2001	322	7287					651	652		10.1136/bmj.322.7287.651	http://dx.doi.org/10.1136/bmj.322.7287.651			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413QE	11250850	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000167622600025
J	Miller, MA; Nguyen, VQ; Lee, MH; Kosinski, M; Schedl, T; Caprioli, RM; Greenstein, D				Miller, MA; Nguyen, VQ; Lee, MH; Kosinski, M; Schedl, T; Caprioli, RM; Greenstein, D			A sperm cytoskeletal protein that signals oocyte meiotic maturation and ovulation	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; MEMBRANE-PROTEIN; MSP; ACTIN	Caenorhabditis elegans oocytes, Like those of most animals, arrest during meiotic prophase, Sperm promote the resumption of meiosis (maturation) and contraction of smooth muscle-like gonadal sheath cells, which are required for ovulation, We show that the major sperm cytoskeletal protein (MSP) is a bipartite signal for oocyte maturation and sheath contraction. MSP also functions in sperm Locomotion, playing a role analogous to actin, Thus, during evolution, MSP has acquired extracellular signaling and intracellular cytoskeletal functions for reproduction. Proteins with MSP-like domains are found in plants, fungi, and other animals, suggesting that related signaling functions may exist in other phyla.	Vanderbilt Univ, Dept Cell Biol, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Mass Spectrometry Res Ctr, Sch Med, Nashville, TN 37232 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Vanderbilt University; Vanderbilt University; Washington University (WUSTL)	Greenstein, D (corresponding author), Vanderbilt Univ, Dept Cell Biol, Sch Med, Nashville, TN 37232 USA.			Miller, Michael/0000-0003-4872-7121; Greenstein, David/0000-0001-8189-2087	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025614] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058008, R56GM057173, R01GM057173] Funding Source: NIH RePORTER; NCI NIH HHS [CA09592] Funding Source: Medline; NICHD NIH HHS [HD25614, HD07043] Funding Source: Medline; NIGMS NIH HHS [R01 GM057173, GM57173, GM58008] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bullock TL, 1996, J MOL BIOL, V263, P284, DOI 10.1006/jmbi.1996.0575; Ferrell JE, 1999, BIOESSAYS, V21, P833, DOI 10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P; Italiano JE, 1996, CELL, V84, P105, DOI 10.1016/S0092-8674(00)80997-6; KAUFMANN R, 1993, RAPID COMMUN MASS SP, V7, P902, DOI 10.1002/rcm.1290071010; KLASS MR, 1981, DEV BIOL, V84, P299, DOI 10.1016/0012-1606(81)90398-5; L'Hernault SW, 1997, C ELEGANS, P271; Lackner MR, 1998, GENETICS, V150, P103; LHERNAULT SW, 1992, J CELL BIOL, V119, P55, DOI 10.1083/jcb.119.1.55; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Miller M. M., UNPUB; NELSON GA, 1982, J CELL BIOL, V92, P121, DOI 10.1083/jcb.92.1.121; Ramalho-Santos J, 2000, DEV BIOL, V223, P54, DOI 10.1006/dbio.2000.9745; Roberts TM, 2000, J CELL BIOL, V149, P7, DOI 10.1083/jcb.149.1.7; SCHEDL T, 1988, GENETICS, V119, P43; Schulz JR, 1998, J BIOL CHEM, V273, P24355, DOI 10.1074/jbc.273.38.24355; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Smith HE, 1998, J MOL BIOL, V279, P605, DOI 10.1006/jmbi.1998.1793; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; WARD S, 1988, J MOL BIOL, V199, P1, DOI 10.1016/0022-2836(88)90374-9; Yung Y, 1997, FEBS LETT, V408, P292, DOI 10.1016/S0014-5793(97)00442-0	21	282	296	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2144	2147		10.1126/science.1057586	http://dx.doi.org/10.1126/science.1057586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251118				2022-12-28	WOS:000167563800038
J	Thompson, AM; Witte, JC; Hudson, RD; Guo, H; Herman, JR; Fujiwara, M				Thompson, AM; Witte, JC; Hudson, RD; Guo, H; Herman, JR; Fujiwara, M			Tropical tropospheric ozone and biomass burning	SCIENCE			English	Article							SOUTH-ATLANTIC; MAPPING SPECTROMETER; EL-NINO; AEROSOL; TOMS; TRANSPORT; OCEAN; TRACE; INDONESIA; MAXIMUM	New methods for retrieving tropospheric ozone column depth and absorbing aerosol (smoke and dust) from the Earth Probe-Total Ozone Mapping Spectrometer (EP/TOMS) are used to follow pollution and to determine interannual variability and trends. During intense fires over Indonesia (August to November 1997), ozone plumes, decoupled from the smoke below, extended as far as India, This ozone overlay a regional ozone increase triggered by atmospheric responses to the El Nino and Indian Ocean Dipole. Tropospheric ozone and smoke aerosol measurements from the Nimbus 7 TOMS instrument show El Nino signals but no tropospheric ozone trend in the 1980s. Offsets between smoke and ozone seasonal maxima point to multiple factors determining tropical tropospheric ozone variability.	NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; Univ Maryland, Dept Meteorol, College Pk, MD 20742 USA; Sci Syst & Applicat, Lanham, MD 20706 USA; Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Hokkaido University	Thompson, AM (corresponding author), NASA, Goddard Space Flight Ctr, Code 916, Greenbelt, MD 20771 USA.	anne.m.thompson@gsfc.nasa.gov	Thompson, Anne M/C-3649-2014; Fujiwara, Masatomo/F-7852-2012; Thompson, Anne Mee/V-5862-2019; Hudson, Robert D/F-4506-2010; Witte, Jacquelyn/H-7393-2013	Thompson, Anne M/0000-0002-7829-0920; Fujiwara, Masatomo/0000-0001-5567-4692; Thompson, Anne Mee/0000-0002-7829-0920; Witte, Jacquelyn/0000-0002-4110-5277; Herman, Jay/0000-0002-9146-1632				ANDREAE MO, 1994, J GEOPHYS RES-ATMOS, V99, P12793, DOI 10.1029/94JD00263; Burrows JP, 1999, J ATMOS SCI, V56, P151, DOI 10.1175/1520-0469(1999)056<0151:TGOMEG>2.0.CO;2; Chandra S, 1998, GEOPHYS RES LETT, V25, P3867, DOI 10.1029/98GL02695; Chandra S, 1999, GEOPHYS RES LETT, V26, P185, DOI 10.1029/1998GL900272; CHATFIELD RB, 1990, J GEOPHYS RES-ATMOS, V95, P18473, DOI 10.1029/JD095iD11p18473; Fishman J, 1997, J GEOPHYS RES-ATMOS, V102, P19275, DOI 10.1029/97JD01373; Fujiwara M, 1999, GEOPHYS RES LETT, V26, P2417, DOI 10.1029/1999GL900117; Fujiwara M, 2000, J GEOPHYS RES-ATMOS, V105, P1879, DOI 10.1029/1999JD900916; Gleason JF, 1998, J GEOPHYS RES-ATMOS, V103, P31969, DOI 10.1029/98JD00160; Hauglustaine DA, 1999, GEOPHYS RES LETT, V26, P3305, DOI 10.1029/1999GL900610; Herman JR, 1997, J GEOPHYS RES-ATMOS, V102, P16911, DOI 10.1029/96JD03680; HOLLANDSWORTH SM, 1995, GEOPHYS RES LETT, V22, P905, DOI 10.1029/95GL00605; Hsu NC, 1999, J GEOPHYS RES-ATMOS, V104, P6269, DOI 10.1029/1998JD200086; HUDSON RD, 1995, J GEOPHYS RES-ATMOS, V100, P11137, DOI 10.1029/94JD02435; Hudson RD, 1998, J GEOPHYS RES-ATMOS, V103, P22129, DOI 10.1029/98JD00729; HUDSON RD, UNPUB; Jacob DJ, 1996, J GEOPHYS RES-ATMOS, V101, P24235, DOI 10.1029/96JD00336; Jonquieres I, 1998, J GEOPHYS RES-ATMOS, V103, P19059, DOI 10.1029/98JD00819; KIRCHHOFF VWJH, 1991, J GEOPHYS RES-ATMOS, V96, P10899, DOI 10.1029/91JD01212; Kita K, 2000, ATMOS ENVIRON, V34, P2681, DOI 10.1016/S1352-2310(99)00522-1; Krishnamurti TN, 1996, J GEOPHYS RES-ATMOS, V101, P23889, DOI 10.1029/95JD02419; Martin RV, 2000, GEOPHYS RES LETT, V27, P1639, DOI 10.1029/1999GL011181; Matsueda H, 1999, GEOPHYS RES LETT, V26, P2413, DOI 10.1029/1999GL900089; Moxim WJ, 2000, J GEOPHYS RES-ATMOS, V105, P17393, DOI 10.1029/2000JD900175; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43854; Schoeberl MR, 1995, J GEOPHYS RES-ATMOS, V100, P25801, DOI 10.1029/95JD02414; Taupin FG, 1999, J GEOPHYS RES-ATMOS, V104, P8057, DOI 10.1029/98JD02456; Thompson AM, 2000, GEOPHYS RES LETT, V27, P3317, DOI 10.1029/1999GL011273; Thompson AM, 1999, J GEOPHYS RES-ATMOS, V104, P26961, DOI 10.1029/1999JD900470; Thompson AM, 1996, J GEOPHYS RES-ATMOS, V101, P24251, DOI 10.1029/96JD01463; Torres O, 1999, J GEOPHYS RES-ATMOS, V104, P21569, DOI 10.1029/1999JD900410; TSURUTA H, 2001, SE AS INT GLOB ATM C; Tsutsumi Y, 1999, GEOPHYS RES LETT, V26, P595, DOI 10.1029/1999GL900054; Weller R, 1996, J GEOPHYS RES-ATMOS, V101, P1387, DOI 10.1029/95JD02838; Wooster MJ, 1998, INT J REMOTE SENS, V19, P383, DOI 10.1080/014311698216035; Ziemke JR, 1998, J GEOPHYS RES-ATMOS, V103, P13903, DOI 10.1029/97JD00550	36	175	179	5	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2001	291	5511					2128	2132		10.1126/science.291.5511.2128	http://dx.doi.org/10.1126/science.291.5511.2128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251113				2022-12-28	WOS:000167563800033
J	Di Blasi, Z; Harkness, E; Ernst, E; Georgiou, A; Kleijnen, J				Di Blasi, Z; Harkness, E; Ernst, E; Georgiou, A; Kleijnen, J			Influence of context effects on health outcomes: a systematic review	LANCET			English	Review							INFORMED CONSENT; POWERFUL PLACEBO; CLINICAL-TRIAL; PATIENT; SIDE; INSTRUCTIONS; EXPECTATIONS; CARE	Background Throughout history, doctor-patient relationships have been acknowledged as having an important therapeutic effect, irrespective of any prescribed drug or treatment. We did a systematic review to determine whether there was any empirical evidence to support this theory. Methods A comprehensive search strategy was developed to include 11 medical, psychological, and sociological electronic databases. The quality of eligible trials was objectively assessed by two reviewers, and the type of nontreatment care given in each trial was categorised as cognitive or emotional. Cognitive care aims to influence patients' expectations about the illness or the treatment, whereas emotional care refers to the style of the consultation (eg, warm, empathic), and aims to reduce negative feelings such as anxiety and fear. Findings We identified 25 eligible randomised controlled trials. 19 examined the effects of influencing patients' expectations about treatment, half of which found significant effects. None of the studies examined the effects of emotional care alone, but four trials assessed a combination of both cognitive and emotional care. Three of these studies showed that enhancing patients' expectations through positive information about the treatment or the illness, while providing support or reassurance, significantly influenced health outcomes. Interpretation There is much inconsistency regarding emotional and cognitive care, although one relatively consistent finding is that physicians who adopt a warm, friendly, and reassuring manner are mor effective than those who keep consultations formal and do not offer reassurance.	Univ York, Dept Hlth Sci & Clin Evaluat, York YO10 5DD, N Yorkshire, England; Univ York, NHS Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; Univ Exeter, Dept Complementary Med, Exeter EX4 4QJ, Devon, England; Univ Leeds, Div Publ Hlth, Leeds LS2 9JT, W Yorkshire, England	University of York - UK; University of York - UK; University of Exeter; University of Leeds	Di Blasi, Z (corresponding author), Univ York, Dept Hlth Sci & Clin Evaluat, York YO10 5DD, N Yorkshire, England.	zdb1@york.ac.uk		Di Blasi, Zelda/0000-0001-8950-4958; Harkness, Elaine/0000-0001-6625-7739	PHS HHS [026ROO286 01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AGRAS WS, 1982, PSYCHOSOM MED, V44, P389; AMIGO I, 1993, J HYPERTENS, V11, P293, DOI 10.1097/00004872-199303000-00010; BALINT M, 1955, LANCET, V1, P683; BERGMANN JF, 1994, CLIN TRIAL META-ANAL, V29, P41; BERK SN, 1977, J CONSULT CLIN PSYCH, V45, P612, DOI 10.1037/0022-006X.45.4.612; BUTLER C, 1986, BRIT J CLIN PSYCHOL, V25, P173, DOI 10.1111/j.2044-8260.1986.tb00693.x; COOPER WD, 1983, BRIT J CLIN PRACT, V37, P99; Crow R., 1999, HEALTH TECHNOL ASSES, V3, P1, DOI [DOI 10.3310/HTA3030, DOI 10.3310/hta3030]; DAHAN R, 1986, BRIT MED J, V293, P363, DOI 10.1136/bmj.293.6543.363; de Craen AJM, 2000, J NEUROL, V247, P183, DOI 10.1007/s004150050560; de Craen AJM, 1999, BRIT J CLIN PHARMACO, V48, P853, DOI 10.1046/j.1365-2125.1999.00094.x; deCraen AJM, 1996, BRIT MED J, V313, P1624, DOI 10.1136/bmj.313.7072.1624; DECRAEN AJM, 1998, THESIS U AMSTERDAM; DEEKS J, 1994, UNDERTAKING SYSTEMAT; DESAINTONGE DMC, 1994, LANCET, V344, P995, DOI 10.1016/S0140-6736(94)91647-0; DEVINE EC, 1992, PATIENT EDUC COUNS, V19, P129, DOI 10.1016/0738-3991(92)90193-M; FREUND J, 1972, CLIN PHARMACOL THER, V13, P172; GRYLL SL, 1978, PSYCHOPHARMACOLOGY, V57, P253, DOI 10.1007/BF00426747; KALDOR A, 1973, BMJ-BRIT MED J, V1, P352, DOI 10.1136/bmj.1.5849.352-b; Kaptchuk TJ, 1998, LANCET, V351, P1722, DOI 10.1016/S0140-6736(97)10111-8; Kienle GS, 1997, J CLIN EPIDEMIOL, V50, P1311, DOI 10.1016/S0895-4356(97)00203-5; Kincheloe J E, 1991, Quintessence Int, V22, P311; KLEIJNEN J, 1994, LANCET, V344, P1347, DOI 10.1016/S0140-6736(94)90699-8; LAMB GC, 1994, ARCH INTERN MED, V154, P2753, DOI 10.1001/archinte.1994.00420230150018; LAPORTE JR, 1994, LANCET, V344, P1206, DOI 10.1016/S0140-6736(94)90515-0; LEVENTHAL H, 1982, PSYCHOSOCIAL EPIDEMI, V3, P55; LINDEN W, 1989, CAN MED ASSOC J, V141, P409; LUPARELLO TJ, 1970, PSYCHOSOM MED, V32, P509, DOI 10.1097/00006842-197009000-00009; NEILD JE, 1985, BRIT MED J, V290, P674, DOI 10.1136/bmj.290.6469.674; Novack Dennis, 1995, MED INTERVIEW CLIN C, P32; OConnor AM, 1996, J CLIN EPIDEMIOL, V49, P1271, DOI 10.1016/S0895-4356(96)00177-1; OLSSON B, 1989, FAM PRACT, V6, P188, DOI 10.1093/fampra/6.3.188; REDELMEIER DA, 1995, LANCET, V345, P1131, DOI 10.1016/S0140-6736(95)90975-3; ROSE S, 1993, AM J GASTROENTEROL, V88, P20; SHAPIRO AK, 1984, BEHAV HLTH; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; THOMAS KB, 1987, BRIT MED J, V294, P1200, DOI 10.1136/bmj.294.6581.1200; THOMAS KB, 1978, BRIT MED J, V1, P1327, DOI 10.1136/bmj.1.6123.1327; THOMAS KB, 1994, LANCET, V344, P1066, DOI 10.1016/S0140-6736(94)91716-7; TURNER JA, 1994, JAMA-J AM MED ASSOC, V271, P1609, DOI 10.1001/jama.271.20.1609; VANWEEL C, 1985, FAM PRACT, V2, P147, DOI 10.1093/fampra/2.3.147; WIED G L, 1953, Arztl Wochensch, V8, P623; 1923, HIPPOCRATES, V2	43	849	855	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2001	357	9258					757	762		10.1016/S0140-6736(00)04169-6	http://dx.doi.org/10.1016/S0140-6736(00)04169-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253970				2022-12-28	WOS:000167400900014
J	Stein, E; Zou, YM; Poo, MM; Tessier-Lavigne, M				Stein, E; Zou, YM; Poo, MM; Tessier-Lavigne, M			Binding of DCC by netrin-1 to mediate axon guidance independent of adenosine A2B receptor activation	SCIENCE			English	Article							COLORECTAL-CANCER DCC; GROWTH CONE GUIDANCE; NERVOUS-SYSTEM; DROSOPHILA; OUTGROWTH; ENCODES; UNC-6; CNS	Netrins stimulate and orient axon growth through a mechanism requiring receptors of the DCC family. it has been unclear, however, whether DCC proteins are involved directly in signaling or are mere accessory proteins in a receptor complex. Further, although netrins bind cells expressing DCC, direct binding to DCC has not been demonstrated. Here we show that netrin-1 binds DCC and that the DCC cytoplasmic domain fused to a heterologous receptor ectodomain can mediate guidance through a mechanism involving derepression of cytoplasmic domain multimerization. Activation of the adenosine A2B receptor, proposed to contribute to netrin effects on axons, is not required for rat commissural axon outgrowth or Xenopus spinal axon attraction to netrin-1: Thus, DCC plays a central role in netrin signaling of axon growth and guidance independent of A2B receptor activation.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Tessier-Lavigne, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.		Stein, Elke/E-8107-2013	Stein, Elke/0000-0001-8965-5692	NINDS NIH HHS [F32 NS010273] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010273] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARGMANN C, COMMUNICATION; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEARON IM, 1998, EUR J PHARMACOL, V26, P342; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Meyerhardt JA, 1999, CELL GROWTH DIFFER, V10, P35; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Schultz J, 1997, PROTEIN SCI, V6, P249; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; STEIN E, UNPUB; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5	21	197	202	4	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1976	1982		10.1126/science.1059391	http://dx.doi.org/10.1126/science.1059391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239160				2022-12-28	WOS:000167401600050
J	Wilson, KL; Zastrow, MS; Lee, KK				Wilson, KL; Zastrow, MS; Lee, KK			Lamins and disease: Insights into nuclear infrastructure	CELL			English	Review							DREIFUSS MUSCULAR-DYSTROPHY; MEMBRANE PROTEIN; DNA-REPLICATION; ORGANIZATION; ENVELOPE; GENE; POLYPEPTIDE-2; DOMAIN; CELLS		Johns Hopkins Univ, Sch Med, Dept Cell Biol & Anat, Baltimore, MD 21205 USA	Johns Hopkins University	Wilson, KL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol & Anat, Baltimore, MD 21205 USA.							Barton RM, 1999, J BIOL CHEM, V274, P30008, DOI 10.1074/jbc.274.42.30008; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J; Cohen M, 2001, TRENDS BIOCHEM SCI, V26, P41, DOI 10.1016/S0968-0004(00)01727-8; Dechat T, 2000, J STRUCT BIOL, V129, P335, DOI 10.1006/jsbi.2000.4212; Furukawa K, 1999, J CELL SCI, V112, P2485; Garg A, 2000, AM J MED, V108, P143, DOI 10.1016/S0002-9343(99)00414-3; HOLT IH, 2001, IN PRESS EUR J HUM G; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Mansharamani M, 2001, J BIOL CHEM, V276, P3641, DOI 10.1074/jbc.M004231200; Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Steen RL, 2000, J CELL BIOL, V150, P1251, DOI 10.1083/jcb.150.6.1251; Stuurman N, 1999, EUR J CELL BIOL, V78, P278, DOI 10.1016/S0171-9335(99)80061-2; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983; Zheng RL, 2000, P NATL ACAD SCI USA, V97, P8997, DOI 10.1073/pnas.150240197	20	127	131	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2001	104	5					647	650		10.1016/S0092-8674(02)01452-6	http://dx.doi.org/10.1016/S0092-8674(02)01452-6			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257219	Bronze			2022-12-28	WOS:000167531100005
J	Silverman, ME; Hurst, JW				Silverman, ME; Hurst, JW			James Edgar Paullin: Internist to Franklin Delano Roosevelt, Oslerian, and forgotten leader of American medicine	ANNALS OF INTERNAL MEDICINE			English	Biographical-Item									Piedmont Hosp, Fuqua Heart Ctr, Atlanta, GA 30309 USA		Silverman, ME (corresponding author), 1968 Peachtree Rd NW, Atlanta, GA 30309 USA.	marksil@mindspring.com						PAULLIN JE, PUBLICATION LIST	1	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2001	134	5					428	431		10.7326/0003-4819-134-5-200103060-00024	http://dx.doi.org/10.7326/0003-4819-134-5-200103060-00024			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405ZJ	11242512				2022-12-28	WOS:000167190200018
J	Chen, J				Chen, J			Materials science - All chopped up	NATURE			English	Editorial Material																		Koike K, 2001, APPL PHYS LETT, V78, P784, DOI 10.1063/1.1345804	1	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					31	31		10.1038/35065196	http://dx.doi.org/10.1038/35065196			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242028	Bronze			2022-12-28	WOS:000167194300029
J	Srinivasula, SM; Hegde, R; Saleh, A; Datta, P; Shiozaki, E; Chai, JJ; Lee, RA; Robbins, PD; Fernandes-Alnemri, T; Shi, YG; Alnemri, ES				Srinivasula, SM; Hegde, R; Saleh, A; Datta, P; Shiozaki, E; Chai, JJ; Lee, RA; Robbins, PD; Fernandes-Alnemri, T; Shi, YG; Alnemri, ES			A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis	NATURE			English	Article							STRUCTURAL BASIS; PROTEIN XIAP; OLIGOMERIZATION; PROCASPASE-9; DROSOPHILA; ACTIVATION; INHIBITOR; CLEAVAGE; BINDING; DOMAIN	X-linked inhibitor-of-apoptosis protein (XIAP) interacts with caspase-9 and inhibits its activity(1-3), whereas Smac (also known as DIABLO) relieves this inhibition through interaction with XIAP(4-7). Here we show that XIAP associates with the active caspase-9-Apaf-1 holoenzyme complex through binding to the amino terminus of the linker peptide on the small subunit of caspase-9, which becomes exposed after proteolytic processing of procaspase-9 at Asp 315. Supporting this observation, point mutations that abrogate the proteolytic processing but not the catalytic activity of caspase-9, or deletion of the linker peptide, prevented caspase-9 association with XIAP and its concomitant inhibition. We note that the N-terminal four residues of caspase-9 linker peptide share significant homology with the N-terminal tetra-peptide in mature Smac and in the Drosophila proteins Hid/Grim/Reaper(8,9), defining a conserved class of IAP-binding motifs. Consistent with this finding, binding of the caspase-9 linker peptide and Smac to the BIR3 domain of XIAP is mutually exclusive, suggesting that Smac potentiates caspase-9 activity by disrupting the interaction of the linker peptide of caspase-9 with BIR3. Our studies reveal a mechanism in which binding to the BIR3 domain by two conserved peptides, one from Smac and the other one from caspase-9, has opposing effects on caspase activity and apoptosis.	Thomas Jefferson Univ, Kimmel Canc Inst, Ctr Apoptosis Res, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Kimmel Canc Inst, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Univ Pittsburgh, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA	Jefferson University; Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Princeton University	Alnemri, ES (corresponding author), Thomas Jefferson Univ, Kimmel Canc Inst, Ctr Apoptosis Res, Philadelphia, PA 19107 USA.		Alnemri, Emad S/B-4526-2010	Saleh, Ayman M/0000-0003-1126-6018; Shi, Yigong/0000-0003-2030-168X; Chai, Jijie/0000-0001-7591-3873				Abrams JM, 1999, TRENDS CELL BIOL, V9, P435, DOI 10.1016/S0962-8924(99)01646-3; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Datta R, 2000, J BIOL CHEM, V275, P31733, DOI 10.1074/jbc.M910231199; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012	14	800	869	0	103	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					112	116		10.1038/35065125	http://dx.doi.org/10.1038/35065125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242052				2022-12-28	WOS:000167194300053
J	[Anonymous]				[Anonymous]			Politics, ethics and collaborations	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2001	410	6824					11	11						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242011				2022-12-28	WOS:000167194300014
J	Malim, MH; Emerman, M				Malim, MH; Emerman, M			HIV-1 sequence variation: Drift, shift, and attenuation	CELL			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; GENETIC DIVERSITY; PROGRESSION; EVOLUTION; INFECTION; VARIANTS; FITNESS; ESCAPE; AIDS		Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA	University of Pennsylvania; University of Pennsylvania; Fred Hutchinson Cancer Center	Malim, MH (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.			Malim, Michael/0000-0002-7699-2064				Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Crandall KA, 1999, AIDS, V13, pS39; DUARTE E, 1992, P NATL ACAD SCI USA, V89, P6015, DOI 10.1073/pnas.89.13.6015; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Gratton S, 2000, P NATL ACAD SCI USA, V97, P14566, DOI 10.1073/pnas.97.26.14566; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; KEWALRAMANI VN, 1992, J VIROL, V66, P3026, DOI 10.1128/JVI.66.5.3026-3031.1992; Kimata JT, 1999, NAT MED, V5, P535, DOI 10.1038/8414; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; McCutchan FE, 2000, AIDS, V14, pS31; Neilson JR, 1999, J VIROL, V73, P4393, DOI 10.1128/JVI.73.5.4393-4403.1999; Parren PWHI, 1999, AIDS, V13, pS137; Peeters M, 2000, AIDS, V14, pS129; Quinones-Mateu ME, 2000, J VIROL, V74, P9222, DOI 10.1128/JVI.74.19.9222-9233.2000; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Rowland-Jones S, 2001, CELL, V104, P473, DOI 10.1016/S0092-8674(01)00235-5; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537	19	158	165	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 23	2001	104	4					469	472		10.1016/S0092-8674(01)00234-3	http://dx.doi.org/10.1016/S0092-8674(01)00234-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	405VP	11239404	Bronze			2022-12-28	WOS:000167181500002
J	Ioannidis, JPA; Lau, J				Ioannidis, JPA; Lau, J			Completeness of safety reporting in randomized trials - An evaluation of 7 medical areas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-TRIALS; CUMULATIVE METAANALYSIS	Context Randomized trials with adequate sample size offer an opportunity to assess the safety of new medications in a controlled setting; however, generalizable data on drug safety reporting are sparse, Objective To scrutinize the completeness of safety reporting in randomized trials. Design, Setting, and Patients Survey of safety reporting in 192 randomized drug trials 7 diverse topics with sample sizes of at least 100 patients and at least 50 patients in a study arm (N =130 074 patients). Trial reports were identified from comprehensive meta-analyses in 7 medical areas. Main Outcome Measures Adequate reporting of specific adverse effects and frequency and reasons for withdrawals due to toxic effects; article space allocated to safety reporting and predictors of such reporting. Results Severity of clinical adverse effects and laboratory-determined toxicity was adequately defined in only 39% and 29% of trial reports, respectively. Only 46% of trials stated the frequency of specific reasons for discontinuation of study treatment due to toxicity. For these 3 parameters, there was significant heterogeneity in rates of adequate reporting across topics (P=.003, P<.001, and P=.02, respectively). Over all, the median space allocated to safety results was 0.3 page. A similar amount of space was devoted to contributor names and affiliations (P=.16). On average, the percentage of space devoted to safety in the results section was 9.3% larger in trials involving dose comparisons than in those that did not (P<.001) and 3.8% smaller in trials reporting statistically significant results for efficacy outcomes (P=.047), Conclusions The quality and quantity of safety reporting vary across medical areas, study designs, and settings but they are largely inadequate. Current standards for safety reporting in randomized trials should be revised to address this inadequacy.	Tufts Univ New England Med Ctr, Dept Med, Div Clin Care Res, Boston, MA 02111 USA; Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin Trial & Evidence Based Med Unit, GR-45110 Ioannina, Greece	Tufts Medical Center; University of Ioannina	Lau, J (corresponding author), Tufts Univ New England Med Ctr, Dept Med, Div Clin Care Res, 750 Washington St,Box 63, Boston, MA 02111 USA.	JLau1@Lifespan.org	Ioannidis, John P. A./G-9836-2011		AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS010345] Funding Source: NIH RePORTER; AHRQ HHS [R03 HS10345] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		AERDTS SJA, 1993, BRIT MED J, V307, P525; *AG HLTH CAR POL R, 1998, AHCPR PUBL; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; CHALMERS TC, 1988, ALIMENT PHARM THERAP, V2, P9; Edwards JE, 1999, J PAIN SYMPTOM MANAG, V18, P427, DOI 10.1016/S0885-3924(99)00093-7; Fackler ML, 1996, ANN INTERN MED, V124, P741, DOI 10.7326/0003-4819-124-8-199604150-00007; GOTZSCHE PC, 1990, J CLIN EPIDEMIOL, V43, P1313; *I SCI INF, 1998, J CITATION INDEX; INSUA JT, 1994, ANN INTERN MED, V121, P355, DOI 10.7326/0003-4819-121-5-199409010-00008; Ioannidis JPA, 1997, CONTROL CLIN TRIALS, V18, P431, DOI 10.1016/S0197-2456(97)00097-4; Ioannidis JPA, 1998, LANCET, V352, P1752, DOI 10.1016/S0140-6736(05)79825-1; KESSLER DA, 1993, JAMA-J AM MED ASSOC, V269, P2765, DOI 10.1001/jama.269.21.2765; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; LAU J, 1995, J CLIN EPIDEMIOL, V48, P45, DOI 10.1016/0895-4356(94)00106-Z; MULROW C, 2000, PHARMACOTHERAPY HYPE; Petitti D, 1994, METAANALYSIS DECISIO; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; Schmid C H, 1999, Am J Ther, V6, P25, DOI 10.1097/00045391-199901000-00005; VANDENBROUCKEGRAULS CMJE, 1991, LANCET, V338, P859, DOI 10.1016/0140-6736(91)91510-2; VANZANTEN SJOV, 1994, CAN MED ASSOC J, V150, P189; VENNING GR, 1983, BRIT MED J, V286, P289, DOI 10.1136/bmj.286.6361.289; VOLLSET SE, 1993, STAT MED, V12, P809, DOI 10.1002/sim.4780120902	22	401	412	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2001	285	4					437	443		10.1001/jama.285.4.437	http://dx.doi.org/10.1001/jama.285.4.437			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394CG	11242428				2022-12-28	WOS:000166506000031
J	Simkin, T; Siebert, L; Blong, R				Simkin, T; Siebert, L; Blong, R			Policy forum: Disasters - Volcano fatalities - Lessons from the historical record	SCIENCE			English	Editorial Material									Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; Macquarie Univ, Natl Hazards Res Ctr, N Ryde, NSW 2109, Australia	Smithsonian Institution; Smithsonian National Museum of Natural History; Macquarie University	Simkin, T (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA.							SIMKIN T, 1994, VOLCANOES WORLD, P162; *SMITHS I, 1994, GLOB VOLC NETW B, V19; Tanguy JC, 1998, B VOLCANOL, V60, P137, DOI 10.1007/s004450050222	4	31	31	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					255	255		10.1126/science.291.5502.255	http://dx.doi.org/10.1126/science.291.5502.255			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11253213				2022-12-28	WOS:000166352900028
J	Ball, P; Ziemelis, K; Allen, L				Ball, P; Ziemelis, K; Allen, L			Biocatalysis: Synthesis methods that exploit enzymatic activities	NATURE			English	Editorial Material																			0	15	15	1	13	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2001	409	6817					225	225						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390UV	11241995				2022-12-28	WOS:000166316200052
J	Milne, GA; Davis, JL; Mitrovica, JX; Scherneck, HG; Johansson, JM; Vermeer, M; Koivula, H				Milne, GA; Davis, JL; Mitrovica, JX; Scherneck, HG; Johansson, JM; Vermeer, M; Koivula, H			Space-geodetic constraints on glacial isostatic adjustment in Fennoscandia	SCIENCE			English	Article							SEA-LEVEL CHANGE; COMPUTING 3-DIMENSIONAL DEFORMATIONS; PLEISTOCENE DEGLACIATION; SPECTRAL FORMALISM; NORTH-AMERICA; SURFACE LOADS; RISE; VISCOSITY; RECORDS; MANTLE	Analysis of Global Positioning System (GPS) data demonstrates that ongoing three-dimensional crustal deformation in Fennoscandia is dominated by glacial isostatic adjustment. Our comparison of these CPS observations with numerical predictions yields an Earth model that satisfies independent geologic constraints and bounds both the average viscosity in the upper mantle (5 x 10(20) to 1 X 10(21) pascal seconds) and the elastic thickness of the Lithosphere (90 to 170 kilometers), We combined GPS-derived radial motions with Fennoscandian tide gauge records to estimate a regional sea surface rise of 2.1 +/- 0.3 mm/year. furthermore, ongoing horizontal tectonic motions greater than similar to1 mm/year are ruled out on the basis of the CPS-derived three-dimensional crustal velocity field.	Univ Durham, Dept Geol Sci, Durham DH1 3LE, England; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; Chalmers, Onsala Space Observ, SE-43992 Onsala, Sweden; Finnish Geodet Inst, FI-02431 Masala, Finland	Durham University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Toronto; Chalmers University of Technology; The National Land Survey of Finland; Finnish Geospatial Research Institute (FGI)	Milne, GA (corresponding author), Univ Durham, Dept Geol Sci, Durham DH1 3LE, England.	g.a.milne@durham.ac.uk	Scherneck, Hans-Georg/AAY-2469-2020; Davis, James/D-8766-2013; Scherneck, Hans-Georg/AHD-9884-2022; Vermeer, Martin/G-2468-2013	Davis, James/0000-0003-3057-477X; Vermeer, Martin/0000-0003-3107-6342; Koivula, Hannu/0000-0002-2950-796X; /0000-0002-7672-2558				*BIFROST PROJ, 1996, EOS T AGU, V77, P337; Davis JL, 1996, NATURE, V379, P331, DOI 10.1038/379331a0; Davis JL, 1999, J GEOPHYS RES-SOL EA, V104, P2733, DOI 10.1029/1998JB900057; Dore AG, 1997, J GEOL SOC LONDON, V154, P85, DOI 10.1144/gsjgs.154.1.0085; Douglas BC, 1997, SURV GEOPHYS, V18, P279, DOI 10.1023/A:1006544227856; DOUGLAS BC, 1991, J GEOPHYS RES-OCEANS, V96, P6981, DOI 10.1029/91JC00064; Ekman M, 1996, GEOPHYS J INT, V126, P229, DOI 10.1111/j.1365-246X.1996.tb05281.x; Ekman M, 1996, TERRA NOVA, V8, P158, DOI 10.1111/j.1365-3121.1996.tb00739.x; FJELDSKAAR W, 1994, EARTH PLANET SC LETT, V126, P399, DOI 10.1016/0012-821X(94)90120-1; GORNITZ V, 1995, EARTH SURF PROC LAND, V20, P7, DOI 10.1002/esp.3290200103; HASKELL NA, 1935, PHYSICS, V6, P256; Jaldehag RTK, 1996, GEOPHYS RES LETT, V23, P1601, DOI 10.1029/96GL00970; JAMES TS, 1993, GEOPHYS RES LETT, V20, P871, DOI 10.1029/93GL00865; JOHANSSON JM, IN PRESS J GEOPHYS R; Lambeck K, 1998, GEOPHYS J INT, V134, P102, DOI 10.1046/j.1365-246x.1998.00541.x; Lambeck K, 1998, GEOPHYS J INT, V135, P375, DOI 10.1046/j.1365-246X.1998.00643.x; MCCONNELL RK, 1968, J GEOPHYS RES, V73, P7089, DOI 10.1029/JB073i022p07089; MEINESZ FAV, 1937, K AKAD WET, V40, P654; Milne GA, 1999, GEOPHYS J INT, V139, P464, DOI 10.1046/j.1365-246x.1999.00971.x; MITROVICA JX, 1995, GEOPHYS RES LETT, V22, P2529, DOI 10.1029/95GL02240; MITROVICA JX, 1991, J GEOPHYS RES-SOL EA, V96, P20053, DOI 10.1029/91JB01284; MITROVICA JX, 1994, J GEOPHYS RES-SOL EA, V99, P7075, DOI 10.1029/93JB03401; Mitrovica JX, 1996, J GEOPHYS RES-SOL EA, V101, P555, DOI 10.1029/95JB03208; MITROVICA JX, 1993, GEOPHYS RES LETT, V20, P2387, DOI 10.1029/93GL02043; MITROVICA JX, 1994, J GEOPHYS RES-SOL EA, V99, P7057, DOI 10.1029/93JB03128; MITROVICA JX, 1989, J GEOPHYS RES-SOLID, V94, P13651, DOI 10.1029/JB094iB10p13651; Pan M, 1999, GEOPHYS RES LETT, V26, P771, DOI 10.1029/1999GL900057; PELTIER WR, 1989, SCIENCE, V244, P806, DOI 10.1126/science.244.4906.806; PELTIER WR, 1974, REV GEOPHYS, V12, P649, DOI 10.1029/RG012i004p00649; PELTIER WR, 1991, J GEOPHYS RES-SOLID, V96, P6779, DOI 10.1029/90JB02067; PELTIER WR, 1995, GEOPHYS RES LETT, V22, P465, DOI 10.1029/94GL03213; PUGH DT, 1987, DATA HOLDINGS PERMAN; TALBOT CJ, 1989, NATO ADV SCI I C-MAT, V266, P441; TRUPIN A, 1990, GEOPHYS J INT, V100, P441, DOI 10.1111/j.1365-246X.1990.tb00697.x; TUSHINGHAM AM, 1991, J GEOPHYS RES-SOLID, V96, P4497, DOI 10.1029/90JB01583; Wessel P., 1995, EOS T AM GEOPHYS UN, V79, P329, DOI [10.1029/95EO00198, DOI 10.1029/95EO00198]; Wieczerkowski K, 1999, GEOPHYS J INT, V139, P69, DOI 10.1046/j.1365-246X.1999.00924.x; WOLF D, 1987, J GEOPHYS-Z GEOPHYS, V61, P141; Wu P., 1978, THESIS U TORONTO; [No title captured]	40	278	284	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2381	2385		10.1126/science.1057022	http://dx.doi.org/10.1126/science.1057022			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264528	Green Published			2022-12-28	WOS:000167618700047
J	Chang, CB; Holtzman, DA; Chau, S; Chickering, T; Woolf, EA; Holmgren, LM; Bodorova, J; Gearing, DP; Holmes, WE; Brivanlou, AH				Chang, CB; Holtzman, DA; Chau, S; Chickering, T; Woolf, EA; Holmgren, LM; Bodorova, J; Gearing, DP; Holmes, WE; Brivanlou, AH			Twisted gastrulation can function as a BMP antagonist	NATURE			English	Article							BONE MORPHOGENETIC PROTEIN-4; DORSAL-VENTRAL PATTERN; DROSOPHILA EMBRYO; PRECHORDAL MESODERM; NEURAL INDUCTION; XENOPUS EMBRYOS; GROWTH-FACTOR; GENE; SIGNALS; SPECIFICATION	Bone morphogenetic proteins (BMPs), including the fly homologue Decapentaplegic (DPP), are important regulators of early vertebrate and invertebrate dorsal-ventral development(1-6). An evolutionarily conserved BMP regulatory mechanism operates from fly to fish, frog and mouse to control the dorsal-ventral axis determination. Several secreted factors, including the BMP antagonist chordin/Short gastrulation (SOG)(7-12), modulate the activity of BMPs. In Drosophila, Twisted gastrulation (TSG) is also involved in dorsal-ventral patterning(13-15), yet the mechanism of its function is unclear. Here we report the characterization of the vertebrate Tsg homologues. We show that Tsg can block BMP function in Xenopus embryonic explants and inhibits several ventral markers in whole-frog embryos. Tsg binds directly to BMPs and forms a ternary complex with chordin and BMPs. Coexpression of Tsg with chordin leads to a more efficient inhibition of the BMP activity in ectodermal explants. Unlike other known BMP antagonists, however, Tsg also reduces several anterior markers at late developmental stages. Our data suggest that Tsg can function as a BMP inhibitor in Xenopus; furthermore, Tsg may have additional functions during frog embryogenesis.	Rockefeller Univ, Lab Vertebrate Mol Embryol, New York, NY 10021 USA; Millennium Pharmaceut, Cambridge, MA 02139 USA	Rockefeller University; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Brivanlou, AH (corresponding author), Rockefeller Univ, Lab Vertebrate Mol Embryol, Box 32,1230 York Ave, New York, NY 10021 USA.							Biehs B, 1996, GENE DEV, V10, P2922, DOI 10.1101/gad.10.22.2922; Chang CB, 1999, DEVELOPMENT, V126, P3347; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; DALE L, 1992, DEVELOPMENT, V115, P573; FAINSOD A, 1994, EMBO J, V13, P5015, DOI 10.1002/j.1460-2075.1994.tb06830.x; FERGUSON EL, 1992, DEVELOPMENT, V114, P583; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; Hammerschmidt M, 1996, GENE DEV, V10, P2452, DOI 10.1101/gad.10.19.2452; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; HEMMATIBRIVANLOU A, 1995, DEV GENET, V17, P78, DOI 10.1002/dvg.1020170109; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; IRISH VF, 1987, GENE DEV, V1, P868, DOI 10.1101/gad.1.8.868; Jones CM, 1996, DEVELOPMENT, V122, P1545; MASON ED, 1994, GENE DEV, V8, P1489, DOI 10.1101/gad.8.13.1489; Mason ED, 1997, MECH DEVELOP, V64, P61, DOI 10.1016/S0925-4773(97)00049-X; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; Schmidt J, 1995, DEVELOPMENT, V121, P4319; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Shi YQ, 2000, DEV BIOL, V224, P226, DOI 10.1006/dbio.2000.9802; Vesque C, 2000, DEVELOPMENT, V127, P2795; WHARTON KA, 1993, DEVELOPMENT, V117, P807; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Yu K, 2000, DEVELOPMENT, V127, P2143; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; ZUSMAN SB, 1985, DEV BIOL, V111, P359, DOI 10.1016/0012-1606(85)90490-7	30	154	165	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					483	487		10.1038/35068583	http://dx.doi.org/10.1038/35068583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260717				2022-12-28	WOS:000167583800045
J	Krusin-Elbaum, L; Shibauchi, T; Argyle, B; Gignac, L; Weller, D				Krusin-Elbaum, L; Shibauchi, T; Argyle, B; Gignac, L; Weller, D			Stable ultrahigh-density magnetooptical recordings using introduced linear defects	NATURE			English	Article							DATA-STORAGE; ANISOTROPY; FILMS; MICROSCOPY; VORTICES; CREEP	The stability of data bits in magnetic recording media(1,2) at ultrahigh densities is compromised by the thermal 'flips'-magnetic spin reversals-of nano-sized spin domains(3), which erase the stored information. Media that are magnetized perpendicular to the plane of the film, such as ultrathin cobalt films or multilayered structures(4,5), are more stable against thermal self-erasure(2,6) than conventional memory devices. In this context, magnetooptical memories seem particularly promising for ultrahigh-density recording on portable disks, and bit densities of similar to 100 Gbit inch(-2) (ref. 7) have been demonstrated using recent advances in the bit writing and reading techniques(7-11). But the roughness and mobility of the magnetic domain walls(12,13) prevents closer packing of the magnetic bits, and therefore presents a challenge to reaching even higher bit densities. Here we report that the strain imposed by a linear defect in a magnetic thin film can smooth rough domain walls over regions hundreds of micrometres in size, and halt their motion. A scaling analysis of this process, based on the generic physics of disorder-controlled elastic lines(14-17), points to a simple way by which magnetic media might be prepared that can store data at densities in excess of 1 Tbit inch(-2).	IBM Corp, Thomas J Watson Res Ctr, Yorktown Heights, NY 10598 USA; Univ Calif Los Alamos Natl Lab, MST STC, Los Alamos, NM 87545 USA; IBM Corp, Almaden Res Ctr, San Jose, CA 95120 USA	International Business Machines (IBM); United States Department of Energy (DOE); Los Alamos National Laboratory; International Business Machines (IBM)	Krusin-Elbaum, L (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Yorktown Heights, NY 10598 USA.		Shibauchi, Takasada/B-9349-2008	Shibauchi, Takasada/0000-0001-5831-4924				ALLENSPACH R, 1990, PHYS REV LETT, V65, P3344, DOI 10.1103/PhysRevLett.65.3344; Argyle BE, 2000, J APPL PHYS, V87, P6487, DOI 10.1063/1.372746; BETZIG E, 1991, SCIENCE, V251, P1468, DOI 10.1126/science.251.5000.1468; BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; CHUANG DS, 1994, PHYS REV B, V49, P15084, DOI 10.1103/PhysRevB.49.15084; Daniel E.D., 1998, MAGNETIC RECORDING 1; Deng H, 1997, J APPL PHYS, V81, P4510, DOI 10.1063/1.364933; FEIGELMAN MV, 1989, PHYS REV LETT, V63, P2303, DOI 10.1103/PhysRevLett.63.2303; HALPINHEALY T, 1995, PHYS REP, V254, P215, DOI 10.1016/0370-1573(94)00087-J; Han SK, 1996, J APPL PHYS, V79, P4260, DOI 10.1063/1.361794; HEANUE JF, 1994, SCIENCE, V265, P749, DOI 10.1126/science.265.5173.749; Hubert A, 1998, MAGNETIC DOMAINS; Hwa T, 1999, NATURE, V399, P17, DOI 10.1038/19854; KANEKO M, 1995, J MAGN MAGN MATER, V148, P351, DOI 10.1016/0304-8853(95)00268-5; KIRBY RD, 1994, PHYS REV B, V49, P10810, DOI 10.1103/PhysRevB.49.10810; KrusinElbaum L, 1997, NATURE, V389, P243, DOI 10.1038/38415; Lemerle S, 1998, PHYS REV LETT, V80, P849, DOI 10.1103/PhysRevLett.80.849; NAKAMURA J, 1995, J APPL PHYS, V77, P779, DOI 10.1063/1.359000; Partovi A, 1999, APPL PHYS LETT, V75, P1515, DOI 10.1063/1.124740; Partovi A, 1999, P SOC PHOTO-OPT INS, V3864, P352; Thompson DA, 2000, IBM J RES DEV, V44, P311, DOI 10.1147/rd.443.0311; Weller D, 1999, IEEE T MAGN, V35, P4423, DOI 10.1109/20.809134; Weller D, 2000, J APPL PHYS, V87, P5768, DOI 10.1063/1.372516; 1998, Patent No. 5835477	24	115	115	0	20	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					444	446		10.1038/35068515	http://dx.doi.org/10.1038/35068515			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260706	Green Submitted			2022-12-28	WOS:000167583800034
J	Rodriguez, C; Patel, AV; Calle, EE; Jacob, EJ; Thun, MJ				Rodriguez, C; Patel, AV; Calle, EE; Jacob, EJ; Thun, MJ			Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STATES CASE-CONTROL; UNITED-STATES; COLLABORATIVE ANALYSIS; RISK-FACTORS; WHITE WOMEN; CARCINOMA; DETERMINANTS; PATHOGENESIS; PROGESTINS; MENOPAUSE	Context Postmenopausal estrogen use is associated with increased risk of endometrial and breast cancer, 2 hormone-related cancers. The effect of postmenopausal estrogen use on ovarian cancer is not established. Objectives To examine the association between postmenopausal estrogen use and ovarian cancer mortality and to determine whether the association differs according to duration and recency of use. Design and Setting The American Cancer Society's Cancer Prevention Study II, a prospective US cohort study with mortality follow-up from 1982 to 1996. Participants A total of 211581 postmenopausal women who completed a baseline questionnaire in 1982 and had no history of cancer, hysterectomy, or ovarian surgery at enrollment. Main Outcome Measure Ovarian cancer mortality, compared among never users, users at baseline, and former users as well as by total years of use of estrogen replacement therapy (ERT). Results A total of 944 ovarian cancer deaths were recorded in 14 years of follow-up. Women who were using ERT at baseline had higher death rates from ovarian cancer than never users (rate ratio [RR], 1.51; 95% confidence interval [CI], 1.16-1.96). Risk was slightly but not significantly increased among former estrogen users (RR, 1.16; 95 % CI, 0.99-1.37). Duration of use was associated with increased risk in both baseline and former users, Baseline users with 10 or more years of use had an RR of 2.20 (95% CI, 1.53-3.17), while former users with 10 or more years of use had an RR of 1.59 (95 % CI, 1.13-2.25). Annual age-adjusted ovarian cancer death rates per 100000 Women were 64.4 for baseline users with 10 or more years of use, 38.3 for former users with 10 or more years of use, and 26.4 for never users. Among former users with 10 or more years of use, risk decreased with time since last use reported at study entry (RR for last use <15 years ago, 2.05; 95% CI, 1.29-3.25; RR for last use <greater than or equal to>15 years ago, 1.31;95% CI, 0.79-2.17). Conclusions In this population, postmenopausal estrogen use for 10 or more years was associated with increased risk of ovarian cancer mortality that persisted up to 29 years after cessation of use.	Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA	American Cancer Society	Rodriguez, C (corresponding author), Amer Canc Soc, Dept Epidemiol & Surveillance Res, 1599 Clifton Rd NE, Atlanta, GA 30329 USA.							ANNEGERS JF, 1979, CANCER, V43, P723, DOI 10.1002/1097-0142(197902)43:2<723::AID-CNCR2820430248>3.0.CO;2-1; Barrett-Connor E, 1998, BMJ-BRIT MED J, V317, P457; BOOTH M, 1989, BRIT J CANCER, V60, P592, DOI 10.1038/bjc.1989.320; CHIEN CH, 1994, MOL CELL ENDOCRINOL, V99, P11; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P711; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P717; DAVIDSON NE, 1995, NEW ENGL J MED, V332, P1638, DOI 10.1056/NEJM199506153322409; Garg PP, 1998, OBSTET GYNECOL, V92, P472, DOI 10.1016/S0029-7844(98)00139-2; GORSKY RD, 1994, OBSTET GYNECOL, V83, P161; HARLOW BL, 1988, CANCER RES, V48, P5849; HARRIS R, 1992, AM J EPIDEMIOL, V136, P1204, DOI 10.1093/oxfordjournals.aje.a116428; HARTGE P, 1988, AM J EPIDEMIOL, V127, P990, DOI 10.1093/oxfordjournals.aje.a114902; HELZLSOUER KJ, 1995, JAMA-J AM MED ASSOC, V274, P1926, DOI 10.1001/jama.274.24.1926; Hempling RE, 1997, OBSTET GYNECOL, V89, P1012, DOI 10.1016/S0029-7844(97)00118-X; HILDRETH NG, 1981, AM J EPIDEMIOL, V114, P398, DOI 10.1093/oxfordjournals.aje.a113207; HOOVER R, 1977, LANCET, V2, P533; Judd HL, 1996, JAMA-J AM MED ASSOC, V275, P370, DOI 10.1001/jama.1996.03530290040035; KAUFMAN DW, 1989, AM J EPIDEMIOL, V130, P1142, DOI 10.1093/oxfordjournals.aje.a115441; KENNEDY DL, 1985, OBSTET GYNECOL, V65, P441; LARSSONCOHN U, 1977, BRIT J OBSTET GYNAEC, V85, P367; LAVECCHIA C, 1982, J NATL CANCER I, V69, P1207; LEE NC, 1986, AGING REPROD CLIMACT; Markman M, 1996, GYNECOL ONCOL, V62, P4, DOI 10.1006/gyno.1996.0181; Negri E, 1999, INT J CANCER, V80, P848; PARAZZINI F, 1994, INT J CANCER, V57, P135, DOI 10.1002/ijc.2910570124; POLYCHRONOPOULOU A, 1993, INT J CANCER, V55, P402, DOI 10.1002/ijc.2910550312; Purdie DM, 1999, BRIT J CANCER, V81, P559, DOI 10.1038/sj.bjc.6690731; Ries L. A. G., 1999, SEER CANC STAT REV 1; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; RISCH HA, 1996, GYNECOL ONCOL, V63, P533; RODRIGUEZ C, 1995, AM J EPIDEMIOL, V141, P828, DOI 10.1093/oxfordjournals.aje.a117518; Rodriguez C, 1998, LANCET, V352, P1354, DOI 10.1016/S0140-6736(05)60745-3; SMITH DC, 1975, NEW ENGL J MED, V293, P1164, DOI 10.1056/NEJM197512042932302; STELLMAN SD, 1986, JNCI-J NATL CANCER I, V76, P1057; TZONOU A, 1984, EUR J CANC CLIN ONCO, V20, P2045; WEISS NS, 1982, J NATL CANCER I, V68, P95; WHITTEMORE AS, 1992, AM J EPIDEMIOL, V136, P1212, DOI 10.1093/oxfordjournals.aje.a116429; WHITTEMORE AS, 1992, AM J EPIDEMIOL, V136, P1184, DOI 10.1093/oxfordjournals.aje.a116427; *WHO, 1979, INT CLASS DIS MAN ST; WYSOWSKI DK, 1995, OBSTET GYNECOL, V85, P6, DOI 10.1016/0029-7844(94)00339-F; Young R.C., 1993, CANC PRINCIPLES PRAC, P1226; ZEIL HK, 1975, NEW ENGL J MED, V293, P1167	43	301	318	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1460	1465		10.1001/jama.285.11.1460	http://dx.doi.org/10.1001/jama.285.11.1460			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410VQ	11255422	Bronze			2022-12-28	WOS:000167462100028
J	Schnaufer, A; Panigrahi, AK; Panicucci, B; Igo, RP; Salavati, R; Stuart, K				Schnaufer, A; Panigrahi, AK; Panicucci, B; Igo, RP; Salavati, R; Stuart, K			An RNA ligase essential for RNA editing and survival of the bloodstream form of Trypanosoma brucei	SCIENCE			English	Article							NADH DEHYDROGENASE; MESSENGER-RNA; GENE; MITOCHONDRIA; EXPRESSION; ENZYME; SITE	RNA editing in trypanosomes occurs by a series of enzymatic steps that are catalyzed by a macromolecular complex. The TbMP52 protein is shown to be a component of this complex, to have RNA Ligase activity, and to be one of two adenylatable proteins in the complex. Regulated repression of TbMP52 blocks editing, which shows that it is a functional component of the editing complex. This repression is lethal in bloodforms of the parasite, indicating that editing is essential in the mammalian stage of the life cycle. The editing complex, which is present in all kinetoplastid parasites, may thus be a chemotherapeutic target.	Seattle Biomed Res Inst, Seattle, WA 98109 USA; Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Stuart, K (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St,Suite 200, Seattle, WA 98109 USA.		Igo, Rob/P-3438-2019	Igo, Rob/0000-0002-0024-1993; Schnaufer, Achim/0000-0003-2132-5560	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014102, R01AI014102] Funding Source: NIH RePORTER; NIAID NIH HHS [AI14102] Funding Source: Medline; NIGMS NIH HHS [GM42188] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beattie DS, 1996, EUR J BIOCHEM, V241, P888, DOI 10.1111/j.1432-1033.1996.00888.x; Estevez AM, 1999, GENE, V240, P247, DOI 10.1016/S0378-1119(99)00437-0; FEAGIN JE, 1988, MOL CELL BIOL, V8, P1259, DOI 10.1128/MCB.8.3.1259; Hajduk Steven L., 1997, Nucleic Acids Symposium Series, V36, P15; Igo RP, 2000, MOL CELL BIOL, V20, P8447, DOI 10.1128/MCB.20.22.8447-8457.2000; KOSLOWSKY DJ, 1990, CELL, V62, P901, DOI 10.1016/0092-8674(90)90265-G; Missel A, 1997, MOL CELL BIOL, V17, P4895, DOI 10.1128/MCB.17.9.4895; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; Ochatt CM, 1999, MOL BIOCHEM PARASIT, V103, P35, DOI 10.1016/S0166-6851(99)00111-5; Panigrahi AK, 2001, MOL CELL BIOL, V21, P380, DOI 10.1128/MCB.21.2.380-389.2001; PANIGRAHI AK, UNPUB; Peris M, 1997, MOL BIOCHEM PARASIT, V85, P9, DOI 10.1016/S0166-6851(96)02795-8; PRIEST JW, 1994, J BIOENERG BIOMEMBR, V26, P179, DOI 10.1007/BF00763067; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; SABATINI R, 1995, J BIOL CHEM, V270, P7233, DOI 10.1074/jbc.270.13.7233; SHUMAN S, 1995, MOL MICROBIOL, V17, P405, DOI 10.1111/j.1365-2958.1995.mmi_17030405.x; Stuart K, 1997, MICROBIOL MOL BIOL R, V61, P105, DOI 10.1128/.61.1.105-120.1997; STUART KD, 1971, J CELL BIOL, V49, P189, DOI 10.1083/jcb.49.1.189; TOMKINSON AE, 1991, P NATL ACAD SCI USA, V88, P400, DOI 10.1073/pnas.88.2.400; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	20	212	218	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2159	2162		10.1126/science.1058655	http://dx.doi.org/10.1126/science.1058655			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251122				2022-12-28	WOS:000167563800042
J	West, LJ; Pollock-Barziv, SM; Dipchand, AI; Lee, KJ; Cardella, CJ; Benson, LN; Rebeyka, IM; Coles, JG				West, LJ; Pollock-Barziv, SM; Dipchand, AI; Lee, KJ; Cardella, CJ; Benson, LN; Rebeyka, IM; Coles, JG			ABO-incompatible heart transplantation in infants.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIVER-TRANSPLANTATION; ENDOTHELIAL-CELLS; RENAL-TRANSPLANT; POLYSACCHARIDE VACCINES; CARDIAC TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; INTERNATIONAL-SOCIETY; HYPERACUTE REJECTION; EXPERIENCE; PLASMAPHERESIS	Background: Transplantation of hearts from ABO-incompatible donors is contraindicated because of the risk of hyperacute rejection mediated by preformed antibodies in the recipient to blood-group antigens of the donor. This contraindication may not apply to newborn infants, who do not yet produce antibodies to T-cell-independent antigens, including the major blood-group antigens. Methods: We studied 10 infants, 4 hours to 14 months old (median, 2 months), who had congenital heart disease or cardiomyopathy and who received heart transplants from donors of incompatible blood type between 1996 and 2000. Serum isohemagglutinin titers were measured before and after transplantation. Plasma exchange was performed during cardiopulmonary bypass; no other procedures for the removal of antibodies were used. Standard immunosuppressive therapy was given, and rejection was monitored by means of endomyocardial biopsy. The results were compared with those in 10 infants who received heart transplants from ABO-compatible donors. Results: The overall survival rate among the 10 recipients with ABO-incompatible donors was 80 percent, with 2 early deaths due to causes presumed to be unrelated to ABO incompatibility. The duration of follow-up ranged from 11 months to 4.6 years. Two infants had serum antibodies to antigens of the donor's blood group before transplantation. No hyperacute rejection occurred; mild humoral rejection was noted at autopsy in one of the infants with antibodies. No morbidity attributable to ABO incompatibility has been observed. Despite the eventual development of antibodies to antigens of the donor's blood group in two infants, no damage to the graft has occurred. Because of the use of ABO-incompatible donors, the mortality rate among infants on the waiting list declined from 58 percent to 7 percent. Conclusions: ABO-incompatible heart transplantation can be performed safely during infancy before the onset of isohemagglutinin production; this technique thus contributes to a marked reduction in mortality among infants on the waiting list. (N Engl J Med 2001;344:793-800.) Copyright (C) 2001 Massachusetts Medical Society.	Hosp Sick Children, Dept Pediat, Div Cardiol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Surg, Div Cardiovasc Surg, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON, Canada; Toronto Gen Hosp, Dept Med, Div Nephrol, Toronto, ON M5G 1L7, Canada; Univ Alberta Hosp, Dept Surg, Edmonton, AB T6G 2B7, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Alberta	West, LJ (corresponding author), Hosp Sick Children, Dept Pediat, Div Cardiol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.			West, Lori/0000-0002-1990-3651				Ahmad H, 1999, INFECT DIS CLIN N AM, V13, P113, DOI 10.1016/S0891-5520(05)70046-5; ALEXANDRE GPJ, 1987, TRANSPLANT P, V19, P4538; ATKISON P, 1995, LANCET, V345, P894, DOI 10.1016/S0140-6736(95)90011-X; Bach FH, 1997, NAT MED, V3, P196, DOI 10.1038/nm0297-196; BAILEY LL, 1993, J THORAC CARDIOV SUR, V105, P805; BANNETT AD, 1987, TRANSPLANTATION, V43, P909; Becker BN, 1999, TRANSPLANT P, V31, P2777, DOI 10.1016/S0041-1345(99)00563-1; Billingham M E, 1990, J Heart Transplant, V9, P587; Boucek MM, 1999, J HEART LUNG TRANSPL, V18, P1151, DOI 10.1016/S1053-2498(99)00114-X; Cadoz M, 1998, VACCINE, V16, P1391, DOI 10.1016/S0264-410X(98)00097-8; COOPER DKC, 1993, TRANSPLANTATION, V56, P769, DOI 10.1097/00007890-199310000-00001; COOPER DKC, 1990, J HEART TRANSPLANT, V9, P376; DALMASSO AP, 1993, TRANSPLANTATION, V56, P1171, DOI 10.1097/00007890-199311000-00024; Dapper F, 1998, EUR J CARDIO-THORAC, V14, P1, DOI 10.1016/S1010-7940(98)00136-5; DINTZIS RZ, 1983, J IMMUNOL, V131, P2196; Eid A, 1998, TRANSPLANT P, V30, P701, DOI 10.1016/S0041-1345(98)00014-1; FERRIANI VPL, 1990, ACTA PAEDIATR SCAND, V79, P322, DOI 10.1111/j.1651-2227.1990.tb11464.x; FONG SW, 1974, TRANSFUSION, V14, P551, DOI 10.1111/j.1537-2995.1974.tb04576.x; Fredrich R, 1999, TRANSPLANTATION, V67, P385, DOI 10.1097/00007890-199902150-00008; GUGENHEIM J, 1990, LANCET, V336, P519, DOI 10.1016/0140-6736(90)92082-S; Klinman NR, 1996, IMMUNITY, V5, P189, DOI 10.1016/S1074-7613(00)80314-3; LARSON DF, 1985, LIFE SCI, V36, P2477, DOI 10.1016/0024-3205(85)90144-4; Morrow WR, 1997, J HEART LUNG TRANSPL, V16, P1255; Osorio A V, 1998, Pediatr Transplant, V2, P26; PAUL LC, 1987, TRANSPL P, V19, P4463; PLATT JL, 1994, IMMUNOL REV, V141, P127, DOI 10.1111/j.1600-065X.1994.tb00875.x; RIEBEN R, 1992, EUR J IMMUNOL, V22, P2713, DOI 10.1002/eji.1830221035; RIEBEN R, 1995, TRANSPLANTATION, V60, P425, DOI 10.1097/00007890-199509000-00004; Seebacher G, 1999, TRANSPLANT P, V31, P3291, DOI 10.1016/S0041-1345(99)00729-0; SLAPAK M, 1981, TRANSPLANTATION, V31, P4, DOI 10.1097/00007890-198101000-00002; SPRINGER GF, 1969, J CLIN INVEST, V48, P1280, DOI 10.1172/JCI106094; STARZL TE, 1974, TRANSPLANT P, V6, P129; STOCK P, 1987, TRANSPLANT P, V19, P711; SUTHERLAND DER, 1984, TRANSPLANTATION, V38, P619, DOI 10.1097/00007890-198412000-00015; TAKAHASHI K, 1993, TRANSPLANT P, V25, P271; TANABE K, 1995, TRANSPLANT P, V27, P1020; Thompson JS, 2000, TRANSPLANTATION, V69, P2178, DOI 10.1097/00007890-200005270-00038; WERNER JC, 1992, J PEDIATR-US, V120, P286, DOI 10.1016/S0022-3476(05)80446-9; YANDZA T, 1994, TRANSPLANTATION, V58, P46, DOI 10.1097/00007890-199407000-00009	39	269	271	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2001	344	11					793	800		10.1056/NEJM200103153441102	http://dx.doi.org/10.1056/NEJM200103153441102			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410LA	11248154				2022-12-28	WOS:000167440400002
J	Gomez, TM; Robles, E; Poo, MM; Spitzer, NC				Gomez, TM; Robles, E; Poo, MM; Spitzer, NC			Filopodial calcium transients promote substrate-dependent growth cone turning	SCIENCE			English	Article							NERVE GROWTH; CELL-ADHESION; INTEGRINS; LAMININ; FIBRONECTIN; CONTACTS; NEURONS; SIGNALS; CA2+	Filopodia that extend from neuronal growth cones sample the environment for extracellular guidance cues, but the signals they transmit to growth cones are unknown. Filopodia were observed generating Localized transient elevations of intracellular calcium ([Ca2+](i)) that propagate back to the growth cone and stimulate global Ca2+ elevations, The frequency of filopodial Ca2+ transients was substrate-dependent and may be due in part to influx of Ca2+ through channels activated by integrin receptors. These transients slowed neurite outgrowth by reducing filopodial motility and promoted turning when stimulated differentially within filopodia on one side of the growth cone. These rapid signals appear to serve both as autonomous regulators of filopodial movement and as frequency-coded signals integrated within the growth cone and could be a common signaling process for many motile cells.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Gomez, TM (corresponding author), Univ Wisconsin, Sch Med, Dept Anat, Madison, WI 53706 USA.			Gomez, Timothy/0000-0002-1515-8228; Robles, Estuardo/0000-0002-1202-2050; Spitzer, Nicholas/0000-0002-3523-1103				ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; BOURDON MA, 1989, J CELL BIOL, V108, P1149, DOI 10.1083/jcb.108.3.1149; BRAY D, 1985, J NEUROSCI, V5, P3204; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Gomez TM, 1996, J NEUROBIOL, V29, P18, DOI 10.1002/(SICI)1097-4695(199601)29:1<18::AID-NEU2>3.0.CO;2-A; GOMEZ TM, 1995, NEURON, V14, P1233, DOI 10.1016/0896-6273(95)90270-8; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; GOMEZ TM, 1994, J NEUROSCI, V14, P5959; Grabham PW, 1997, J NEUROSCI, V17, P5455; GU XN, 1994, J NEUROSCI, V14, P6325; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kater S. B., 1995, Current Opinion in Neurobiology, V5, P68, DOI 10.1016/0959-4388(95)80089-1; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; Kuhn TB, 1998, J NEUROSCI, V18, P184; LETOURNEAU PC, 1989, DEVELOPMENT, V105, P505; LIPP P, 1993, CELL CALCIUM, V14, P359, DOI 10.1016/0143-4160(93)90040-D; Lu M, 1997, J CELL BIOL, V138, P1279, DOI 10.1083/jcb.138.6.1279; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; Sakaguchi DS, 1996, DEV BRAIN RES, V97, P235, DOI 10.1016/S0165-3806(96)00142-3; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501	26	214	217	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1983	1987		10.1126/science.1056490	http://dx.doi.org/10.1126/science.1056490			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239161				2022-12-28	WOS:000167401600051
J	Will, CL; Luhrmann, R				Will, CL; Luhrmann, R			Molecular biology - RNP remodeling with DExH/D boxes	SCIENCE			English	Editorial Material							UNWINDING RNA; PROTEIN		Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany	Max Planck Society	Will, CL (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37077 Gottingen, Germany.							Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Chen JYF, 2001, MOL CELL, V7, P227, DOI 10.1016/S1097-2765(01)00170-8; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; HEINRICHS V, 1990, SCIENCE, V247, P69, DOI 10.1126/science.2136774; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319; Staley JP, 1999, MOL CELL, V3, P55, DOI 10.1016/S1097-2765(00)80174-4; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Zhang M, 2001, GENE DEV, V15, P30, DOI 10.1101/gad.851701	13	21	21	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1916	1917		10.1126/science.1059682	http://dx.doi.org/10.1126/science.1059682			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11245200				2022-12-28	WOS:000167401600035
J	Domb, LG; Pagel, M				Domb, LG; Pagel, M			Sexual swellings advertise female quality in wild baboons	NATURE			English	Article							PAPIO-ANUBIS; EVOLUTION; PRIMATES	The females of many Old World primate species produce prominent and conspicuous swellings of the perineal skin around the time of ovulation. These sexual swellings have been proposed to increase competition among males for females(1) or to increase the likelihood of a female getting fertilized, by signalling either a female's general reproductive status(1-5), or the timing of her ovulation(6). Here we show that sexual swellings in wild baboons reliably advertise a female's reproductive value over her lifetime, in accordance with a theoretical model of honest signalling(7). Females with larger swellings attained sexual maturity earlier, produced both more offspring and more surviving offspring per year than females with smaller swellings, and had a higher overall proportion of their offspring survive. Male baboons use the size of the sexual swelling to determine their mating effort, fighting more aggressively to consort females with larger swellings, and spending more time grooming these females. Our results document an unusual case of a sexually selected ornament in females, and show how males, by mating selectively on the basis of the size of the sexual swelling, increase their probability of mating with females more likely to produce surviving offspring.	Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England	Harvard University; University of Reading	Domb, LG (corresponding author), Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA.							Alberts SC, 1996, ANIM BEHAV, V51, P1269, DOI 10.1006/anbe.1996.0131; BIELERT C, 1983, PHYSIOL BEHAV, V30, P103, DOI 10.1016/0031-9384(83)90045-8; BORGERHOFF MM, 1989, BEHAV ECOL SOCIOBIOL, V24, P145; CLUTTONBROCK TH, 1976, GROWING POINTS ETHOL, P195; Collins DA, 1984, INFANTICIDE COMP EVO, P193; CRITESCU M, 1975, J HUM EVOL, V4, P521; David P, 2000, NATURE, V406, P186, DOI 10.1038/35018079; Ellison PT, 1996, AM J HUM BIOL, V8, P725, DOI 10.1002/(SICI)1520-6300(1996)8:6<725::AID-AJHB4>3.0.CO;2-S; Hamilton W.J. III, 1984, P309; Hausfater G., 1975, Contributions Primatol, V7, P1; Heistermann M, 1996, BIOL REPROD, V55, P844, DOI 10.1095/biolreprod55.4.844; Hrdy S.B., 1987, P370; Hrdy S.B., 1988, P101; NASH LT, 1976, AM J PHYS ANTHROPOL, V44, P63, DOI 10.1002/ajpa.1330440109; Nunn CL, 1999, ANIM BEHAV, V58, P229, DOI 10.1006/anbe.1999.1159; OWENS NW, 1976, BEHAVIOUR, V57, P241, DOI 10.1163/156853976X00541; PACKER C, 1979, ANIM BEHAV, V27, P1, DOI 10.1016/0003-3472(79)90126-X; Packer C, 1998, NATURE, V392, P807, DOI 10.1038/33910; PACKER C, 1975, NATURE, V255, P219, DOI 10.1038/255219a0; PACKER C, 1995, NATURE, V373, P60, DOI 10.1038/373060a0; PACKER C, 1979, ANIM BEHAV, V27, P37, DOI 10.1016/0003-3472(79)90127-1; PAGEL M, 1994, ANIM BEHAV, V47, P1333, DOI 10.1006/anbe.1994.1181; Ransom TW., 1981, BEACH TROOP GOMBE; RYAN SM, 1990, OXFORD SURV EVOL BIO, V5, P156; RYDER NB, 1971, REPROD US; SILLENTULLBERG B, 1993, AM NAT, V141, P1, DOI 10.1086/285458; STRUSAKER TT, 1975, RED COLOBUS MONKEY; THOMSON JA, 1992, BIOL REPROD, V46, P879, DOI 10.1095/biolreprod46.5.879; Whitten PL, 1996, AM J PRIMATOL, V40, P67, DOI 10.1002/(SICI)1098-2345(1996)40:1<67::AID-AJP5>3.0.CO;2-Z	29	153	154	0	53	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					204	206		10.1038/35065597	http://dx.doi.org/10.1038/35065597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242079				2022-12-28	WOS:000167320500045
J	Schneider, RK; Levenson, JL; Schnoll, SH				Schneider, RK; Levenson, JL; Schnoll, SH			Update in addiction medicine	ANNALS OF INTERNAL MEDICINE			English	Review							SUSTAINED-RELEASE BUPROPION; SMOKING-CESSATION; FLUNITRAZEPAM; KETAMINE; ABUSE		Virginia Commonwealth Univ, Richmond, VA 23298 USA	Virginia Commonwealth University	Schneider, RK (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia Campus,POB 980268, Richmond, VA 23298 USA.							Anglin D, 1997, ACAD EMERG MED, V4, P323, DOI 10.1111/j.1553-2712.1997.tb03557.x; Breslau N, 1999, ARCH GEN PSYCHIAT, V56, P1141, DOI 10.1001/archpsyc.56.12.1141; Curran HV, 2000, ADDICTION, V95, P575, DOI 10.1046/j.1360-0443.2000.9545759.x; Fiore MC, 2000, JAMA-J AM MED ASSOC, V283, P3244; Garbutt JC, 1999, JAMA-J AM MED ASSOC, V281, P1318, DOI 10.1001/jama.281.14.1318; Hall SM, 1998, ARCH GEN PSYCHIAT, V55, P683, DOI 10.1001/archpsyc.55.8.683; Hurt RD, 1997, NEW ENGL J MED, V337, P1195, DOI 10.1056/NEJM199710233371703; Klitzman RL, 2000, AM J PSYCHIAT, V157, P1162, DOI 10.1176/appi.ajp.157.7.1162; Nielsen K, 2000, PREV MED, V30, P209, DOI 10.1006/pmed.1999.0627; Pettinati HM, 2000, J ADDICT DIS, V19, P71, DOI 10.1300/J069v19n01_06; RAY B, 1997, DHHS PUBLICATION; REGIER DA, 1978, ARCH GEN PSYCHIAT, V35, P685; Rickert VI, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.1.e6; Simmons MM, 1998, ANN PHARMACOTHER, V32, P117, DOI 10.1345/aph.17027; Weiner AL, 2000, J EMERG MED, V18, P447, DOI 10.1016/S0736-4679(00)00162-1	15	5	5	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2001	134	5					387	395		10.7326/0003-4819-134-5-200103060-00011	http://dx.doi.org/10.7326/0003-4819-134-5-200103060-00011			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	405ZJ	11242499				2022-12-28	WOS:000167190200005
J	Curtis, CF				Curtis, CF			Insecticide resistance and mosquito-borne disease	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Curtis, CF (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.							CURTIS CF, 1981, T ROY SOC TROP MED H, V75, P736, DOI 10.1016/0035-9203(81)90166-8; CURTIS CF, 1981, B ENTOMOL RES, V71, P153, DOI 10.1017/S0007485300051129; Hawking F, 1976, Trop Dis Bull, V73, P967; McCarroll L, 2000, NATURE, V407, P961, DOI 10.1038/35039671; Nicolas L, 1997, PARASITE, V4, P253, DOI 10.1051/parasite/1997043253	5	5	5	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					656	656		10.1016/S0140-6736(00)04152-0	http://dx.doi.org/10.1016/S0140-6736(00)04152-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247547				2022-12-28	WOS:000167282400006
J	Welsh, J				Welsh, J			Torture widespread in China	LANCET			English	Editorial Material									Amnesty Int, Program Med, London WC1X 0DW, England		Welsh, J (corresponding author), Amnesty Int, Program Med, 1 Easton St, London WC1X 0DW, England.							*AMN INT, 2001, TORT GROW SCOURG CHI	1	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					713	713		10.1016/S0140-6736(00)04155-6	http://dx.doi.org/10.1016/S0140-6736(00)04155-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247572				2022-12-28	WOS:000167282400040
J	Nagamatsu, J; Nakagawa, N; Muranaka, T; Zenitani, Y; Akimitsu, J				Nagamatsu, J; Nakagawa, N; Muranaka, T; Zenitani, Y; Akimitsu, J			Superconductivity at 39 K in magnesium diboride	NATURE			English	Article								In the light of the tremendous progress that has been made in raising the transition temperature of the copper oxide superconductors (for a review, see ref. 1), it is natural to wonder how high the transition temperature, Tc, can be pushed in other classes of materials. At present, the highest reported values of T-c for non-copper-oxide bulk superconductivity are 33 K in electron-doped CsxRbyC60 (ref. 2), and 30 K in Ba1-xKxBiO3 (ref. 3). (Hole-doped C-60 was recently found(4) to be superconducting with a T-c as high as 52 K, although the nature of the experiment meant that the supercurrents were confined to the surface of the C-60 crystal, rather than probing the bulk.) Here we report the discovery of bulk superconductivity in magnesium diboride, MgB2. Magnetization and resistivity measurements establish a transition temperature of 39 K, which we believe to be the highest yet determined for a non-copper-oxide bulk superconductor.	Aoyama Gakuin Univ, Dept Phys, Setagaya Ku, Tokyo 1578572, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan	Aoyama Gakuin University; Japan Science & Technology Agency (JST)	Akimitsu, J (corresponding author), Aoyama Gakuin Univ, Dept Phys, Setagaya Ku, Tokyo 1578572, Japan.							CAVA RJ, 1988, NATURE, V332, P814, DOI 10.1038/332814a0; JONES ME, 1954, J AM CHEM SOC, V76, P1434, DOI 10.1021/ja01634a089; Schon JH, 2000, NATURE, V408, P549, DOI 10.1038/35046008; Takagi H, 2000, PHYSICA C, V341, P3, DOI 10.1016/S0921-4534(00)00377-4; TANIGAKI K, 1991, NATURE, V352, P222, DOI 10.1038/352222a0	5	5317	5502	60	1426	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					63	64		10.1038/35065039	http://dx.doi.org/10.1038/35065039			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242039				2022-12-28	WOS:000167194300040
J	Locksley, RM; Killeen, N; Lenardo, MJ				Locksley, RM; Killeen, N; Lenardo, MJ			The TNF and TNF receptor superfamilies: Integrating mammalian biology	CELL			English	Review							TUMOR-NECROSIS-FACTOR; SECONDARY LYMPHOID-TISSUES; P75 NEUROTROPHIN RECEPTOR; ALPHA-DEFICIENT MICE; FAMILY MEMBER TRANCE; CELL-DEATH; OSTEOPROTEGERIN-LIGAND; LYMPHOTOXIN-ALPHA; CRYSTAL-STRUCTURE; NODE DEVELOPMENT		Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Locksley, RM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.		Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000717, Z01AI000769, ZIAAI000718, ZIAAI000769, ZIAAI000717, Z01AI000718] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Adkins HB, 2000, J VIROL, V74, P3572, DOI 10.1128/JVI.74.8.3572-3578.2000; Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Aukrust P, 1999, CIRCULATION, V100, P614, DOI 10.1161/01.CIR.100.6.614; BANKS TA, 1995, J IMMUNOL, V155, P1685; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BEUTLER B, 1986, NATURE, V320, P584, DOI 10.1038/320584a0; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Blobel CP, 1997, CELL, V90, P589, DOI 10.1016/S0092-8674(00)80519-X; Botchkareva NV, 1999, DEV BIOL, V216, P135, DOI 10.1006/dbio.1999.9464; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Chan FKM, 2000, IMMUNITY, V13, P419, DOI 10.1016/S1074-7613(00)00041-8; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Cuff CA, 1999, J IMMUNOL, V162, P5965; Cyster JG, 2000, IMMUNOL REV, V176, P181; de Fougerolles AR, 2000, IMMUNITY, V13, P749, DOI 10.1016/S1074-7613(00)00073-X; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; ECK MJ, 1989, J BIOL CHEM, V264, P17595; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; FAUCI AS, 1991, ANN INTERN MED, V114, P678, DOI 10.7326/0003-4819-114-8-678; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Galon J, 2000, CURR OPIN IMMUNOL, V12, P479, DOI 10.1016/S0952-7915(00)00124-2; GARRONE P, 1995, J EXP MED, V182, P1265, DOI 10.1084/jem.182.5.1265; GRANGER GA, 1969, NATURE, V221, P1155, DOI 10.1038/2211155a0; GRAY PW, 1984, NATURE, V312, P721, DOI 10.1038/312721a0; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; HAAKFRENDSCHO M, 1994, J IMMUNOL, V152, P1347; Hallbook F, 1999, CURR OPIN NEUROBIOL, V9, P616, DOI 10.1016/S0959-4388(99)00011-2; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Hirono I, 2000, J IMMUNOL, V165, P4423, DOI 10.4049/jimmunol.165.8.4423; Hughes AE, 2000, NAT GENET, V24, P45, DOI 10.1038/71667; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; JACOB CO, 1991, IMMUNOL RES, V10, P156, DOI 10.1007/BF02918162; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Khush RS, 2000, TRENDS GENET, V16, P442, DOI 10.1016/S0168-9525(00)02095-3; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kojima T, 2000, J BIOL CHEM, V275, P20742, DOI 10.1074/jbc.M002691200; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; Laabi Y, 2000, SCIENCE, V289, P883, DOI 10.1126/science.289.5481.883; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li M, 2000, J VIROL, V74, P7470, DOI 10.1128/JVI.74.16.7470-7477.2000; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Long QM, 2000, NAT CELL BIOL, V2, P549, DOI 10.1038/35019592; Lutgens E, 1999, NAT MED, V5, P1313, DOI 10.1038/15271; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Maini RN, 2000, ANNU REV MED, V51, P207, DOI 10.1146/annurev.med.51.1.207; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; Nishikawa S, 2000, CURR OPIN IMMUNOL, V12, P342, DOI 10.1016/S0952-7915(00)00097-2; Notarangelo LD, 2000, CLIN EXP IMMUNOL, V120, P399, DOI 10.1046/j.1365-2249.2000.01142.x; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Phipps RP, 2000, P NATL ACAD SCI USA, V97, P6930, DOI 10.1073/pnas.97.13.6930; Puglielli MT, 1999, NAT MED, V5, P1370; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033; Salehi AH, 2000, NEURON, V27, P279, DOI 10.1016/S0896-6273(00)00036-2; Scaffidi C, 1999, CURR OPIN IMMUNOL, V11, P277, DOI 10.1016/S0952-7915(99)80045-4; Screaton G, 2000, CURR OPIN IMMUNOL, V12, P316, DOI 10.1016/S0952-7915(00)00093-5; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Song J, 2000, J CLIN INVEST, V106, P1209, DOI 10.1172/JCI10411; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Tamada K, 2000, J IMMUNOL, V164, P4105, DOI 10.4049/jimmunol.164.8.4105; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Teng YTA, 2000, J CLIN INVEST, V106, pR59, DOI 10.1172/JCI10763; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Villunger A, 2000, J IMMUNOL, V165, P1337, DOI 10.4049/jimmunol.165.3.1337; Wajant H, 1999, CYTOKINE GROWTH F R, V10, P15, DOI 10.1016/S1359-6101(98)00023-9; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2	109	2799	2997	5	260	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 23	2001	104	4					487	501		10.1016/S0092-8674(01)00237-9	http://dx.doi.org/10.1016/S0092-8674(01)00237-9			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	405VP	11239407	Bronze			2022-12-28	WOS:000167181500005
J	Kramer, MS; Chalmers, B; Hodnett, ED; Sevkovskaya, Z; Dzikovich, I; Shapiro, S; Collet, JP; Vanilovich, I; Mezen, I; Ducruet, T; Shishko, G; Zubovich, V; Mknuik, D; Gluchanina, E; Dombrovskiy, V; Ustinovitch, A; Kot, T; Bogdanovich, N; Ovchinikova, L; Helsing, E				Kramer, MS; Chalmers, B; Hodnett, ED; Sevkovskaya, Z; Dzikovich, I; Shapiro, S; Collet, JP; Vanilovich, I; Mezen, I; Ducruet, T; Shishko, G; Zubovich, V; Mknuik, D; Gluchanina, E; Dombrovskiy, V; Ustinovitch, A; Kot, T; Bogdanovich, N; Ovchinikova, L; Helsing, E		PROBIT Study Grp	Promotion of breastfeeding intervention trial (PROBIT) - A randomized trial in the Republic of Belarus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFANT; ASSOCIATION; MORBIDITY; DISEASES; CHILDREN; ILLNESS; ASTHMA; RISK	Context Current evidence that breastfeeding is beneficial for infant and child health is based exclusively on observational studies. Potential sources of bias in such studies have led to doubts about the magnitude of these health benefits in industrialized countries. Objective To assess the effects of breastfeeding promotion on breastfeeding duration and exclusivity and gastrointestinal and respiratory infection and atopic eczema among infants. Design The Promotion of Breastfeeding Intervention Trial (PROBIT), a cluster-randomized trial conducted June 1996-December 1997 with a 1-year follow-up. Setting Thirty-one maternity hospitals and polyclinics in the Republic of Belarus. Participants A total of 17046 mother-infant pairs consisting of full-term singleton infants weighing at least 2500 g and their healthy mothers who intended to breastfeed, 16 491 (96.7%) of which completed the entire 12 months of follow-up. Interventions Sites were randomly assigned to receive an experimental intervention (n=16) modeled on the Baby-Friendly Hospital Initiative of the World Health Organization and United Nations Children's Fund, which emphasizes health care worker assistance with initiating and maintaining breastfeeding and lactation and postnatal breastfeeding support, or a control intervention (n = 15) of continuing usual infant feeding practices and policies. Main Outcome Measures Duration of any breastfeeding, prevalence of predominant and exclusive breastfeeding at 3 and 6 months of life and occurrence of 1 or more episodes of gastrointestinal tract infection, 2 or more episodes of respiratory tract infection, and atopic eczema during the first 12 months of life, compared between the intervention and control groups. Results Infants from the intervention sites were significantly more likely than control infants to be breastfed to any degree at 12 months (19.7% vs 11.4%; adjusted odds ratio [OR], 0.47; 95% confidence interval [CI], 0.32-0.69), were more likely to be exclusively breastfed at 3 months (43.3% vs 6.4%; P<.001) and at 6 months (7.9% vs 0.6%; P=.01), and had a significant reduction in the risk of 1 or more gastrointestinal tract infections (9.1% vs 13.2%; adjusted OR, 0.60; 95% CI, 0.40-0.91) and of atopic eczema (3.3% vs 6.3%; adjusted OR, 0.54; 95% CI, 0.31-0.95), but no significant reduction in respiratory tract infection (intervention group, 39.2%; control group, 39.4%; adjusted OR, 0.87; 95% CI, 0.59-1.28). Conclusions Our experimental intervention increased the duration and degree (exclusivity) of breastfeeding and decreased the risk of gastrointestinal tract infection and atopic eczema in the first year of life. These results provide a solid scientific underpinning for future interventions to promote breastfeeding.	McGill Univ, Fac Med, Dept Pediat, Montreal, PQ, Canada; McGill Univ, Fac Med, Dept Epidemiol & Biostat, Montreal, PQ, Canada; Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Ctr Res Womens Hlth, Toronto, ON, Canada; Univ Toronto, Fac Nursing, Toronto, ON, Canada; Belarussian Minist Hlth, Dept Maternal & Child Hlth, Minsk, BELARUS; Belarussian Minist Hlth, Dept Foreign Relat, Minsk, BELARUS; Belarussian Maternal & Child Hlth Res Inst, Minsk, BELARUS; WHO, Reg Off Europe, Nutr Unit, DK-2100 Copenhagen, Denmark	McGill University; McGill University; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; World Health Organization	Kramer, MS (corresponding author), 1020 Pine Ave W, Montreal, PQ H3A 1A2, Canada.	mkrame@po-box.mcgill.ca		Chalmers, Beverley/0000-0002-9345-4284				BAUCHNER H, 1986, JAMA-J AM MED ASSOC, V256, P887, DOI 10.1001/jama.256.7.887; BEAUDRY M, 1995, J PEDIATR-US, V126, P191, DOI 10.1016/S0022-3476(95)70544-9; COLLET JP, 1994, PEDIATRICS, V94, P997; CUNNINGHAM AS, 1991, J PEDIATR-US, V118, P659, DOI 10.1016/S0022-3476(05)80023-X; DEWEY KG, 1995, J PEDIATR-US, V126, P696, DOI 10.1016/S0022-3476(95)70395-0; FEACHEM RG, 1984, B WORLD HEALTH ORGAN, V62, P271; FORD RPK, 1993, INT J EPIDEMIOL, V22, P885, DOI 10.1093/ije/22.5.885; GAIL MH, 1992, CONTROL CLIN TRIALS, V13, P6, DOI 10.1016/0197-2456(92)90026-V; Golding J, 1997, EARLY HUM DEV, V49, pS121, DOI 10.1016/S0378-3782(97)00058-3; HABICHT JP, 1986, AM J EPIDEMIOL, V123, P279, DOI 10.1093/oxfordjournals.aje.a114236; HIDE DW, 1981, ARCH DIS CHILD, V56, P172, DOI 10.1136/adc.56.3.172; HILL AB, 1977, SHORT TXB MED STAT, P27; HOWIE PW, 1990, BRIT MED J, V300, P11, DOI 10.1136/bmj.300.6716.11; JASON JM, 1984, PEDIATRICS, V74, P702; KOVAR MG, 1984, PEDIATRICS, V74, P615; LOSCH M, 1995, J PEDIATR-US, V126, P507, DOI 10.1016/S0022-3476(95)70342-X; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Oddy WH, 1999, BMJ-BRIT MED J, V319, P815, DOI 10.1136/bmj.319.7213.815; Raisler J, 1999, AM J PUBLIC HEALTH, V89, P25, DOI 10.2105/AJPH.89.1.25; RENFREW MJ, 2000, EARLY VS DELAYED INI; RENFREW MJ, 2000, INTERVENTIONS IMPROV; RENFREW MJ, 2000, FEEDING SCHEDULES HO; RUBIN DH, 1990, PEDIATRICS, V85, P464; SAARINEN UM, 1979, LANCET, V2, P163; SAULS HS, 1979, PEDIATRICS, V64, P523; SHIPLEY MJ, 1989, INT J EPIDEMIOL, V18, P457, DOI 10.1093/ije/18.2.457; SIKORSKI J, 2000, SUPPORT BREASTFEEDIN; VICTORA CG, 1987, LANCET, V2, P319; WHO/UNICEF, 1989, PROT PROM SUPP BREAS; World Health Organization, 1991, WHOCDDSER9114	30	1012	1039	2	74	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2001	285	4					413	420		10.1001/jama.285.4.413	http://dx.doi.org/10.1001/jama.285.4.413			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394CG	11242425	Bronze			2022-12-28	WOS:000166506000028
J	Ozuah, PO; Ozuah, TP; Stein, REK; Burton, W; Mulvihill, M				Ozuah, PO; Ozuah, TP; Stein, REK; Burton, W; Mulvihill, M			Evaluation of a risk assessment questionnaire used to target tuberculin skin testing in children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFECTION	Context Universal tuberculin skin testing of children has been shown to be costly and inefficient. In response, several authorities have recommended targeted screening based on epidemiological risk. In 1996, the New York City Department of Health (NYCDOH) developed questions to identify children who require a tuberculin skin test, Objective To determine the sensitivity, specificity, and predictive validity of the NYCDOH tuberculosis risk assessment questionnaire. Design Prospective criterion standard study in which tuberculin skin tests and the NYCDOH questionnaire were administered simultaneously between August 1996 and January 1998, Specific questions asked about contact with a tuberculosis case, birth in or travel to endemic areas, regular contact with high-risk adults, and human immunodeficiency virus infection in the child. Setting Ambulatory clinic in South Bronx, New York, NY. Participants Consecutive sample of 2920 children aged 1 to 18 years. Main Outcome Measures Sensitivity, specificity, positive and negative predictive values of the questionnaire, and odds ratio (OR) of reactive skin test results. Results The NYCDOH questionnaire identified 413 children (14%) as having at least 1 risk factor. Of these, 23 (5.6%) had a positive skin test result; 4 (0.16%) of the 2507 without risk factors had a positive result. Results for the full NYCDOH questionnaire were sensitivity, 85.2%; specificity, 86.0%; negative predictive value, 99.8%; positive predictive value, 5.4%; and OR, 35.2 (95% confidence interval, 12.1-102.4), Conclusion The NYCDOH questionnaire is a valid instrument for identifying children for tuberculin skin testing.	Childrens Hosp Montefiore, Dept Pediat, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Family Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Yeshiva University; Albert Einstein College of Medicine	Ozuah, PO (corresponding author), Childrens Hosp Montefiore, Dept Pediat, 3544 Jerome Ave, Bronx, NY 10467 USA.							*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_; BARRY MA, 1990, AM J PUBLIC HEALTH, V80, P439, DOI 10.2105/AJPH.80.4.439; *BUR TUB CONTR, 1996, INF SUMM, P32; CANTWELL MF, 1994, JAMA-J AM MED ASSOC, V272, P535, DOI 10.1001/jama.272.7.535; Centers for Disease Control, 1989, US DEP HLTH HUM SERV, P89; DAVIDSON P T, 1990, American Review of Respiratory Disease, V141, pA336; HALL CB, 1994, PEDIATRICS, V93, P131; Halsey NA, 1996, PEDIATRICS, V97, P282; Herrera J. L., 1993, Morbidity and Mortality Weekly Report, V42, P1; MOHLEBOETANI JC, 1995, JAMA-J AM MED ASSOC, V274, P613, DOI 10.1001/jama.274.8.613; STARKE JR, 1992, J PEDIATR-US, V120, P839, DOI 10.1016/S0022-3476(05)81949-3; STARKE JR, 1993, PEDIATR ANN, V22, P550, DOI 10.3928/0090-4481-19930901-07; STARKE JR, 1995, JAMA-J AM MED ASSOC, V274, P652, DOI 10.1001/jama.274.8.652	13	34	35	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2001	285	4					451	453		10.1001/jama.285.4.451	http://dx.doi.org/10.1001/jama.285.4.451			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394CG	11242430	Bronze			2022-12-28	WOS:000166506000033
J	Thompson, RS; Krugman, R				Thompson, RS; Krugman, R			Screening mothers for intimate partner abuse at well-baby care visits - The right thing to do	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DOMESTIC VIOLENCE; CHILDHOOD ABUSE; SEXUAL-BEHAVIOR; BATTERED WOMEN; EMERGENCY; PHYSICIAN; INTERVIEW; QUESTIONS; PROTOCOL; IMPACT		Grp Hlth Cooperat, Dept Prevent Care, Seattle, WA 98101 USA; Univ Colorado, Sch Med, Denver, CO USA	Group Health Cooperative; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Thompson, RS (corresponding author), Grp Hlth Cooperat, Dept Prevent Care, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.							*ADV BOARD CHILD A, 1990, CHILD AB NEGL CRIT 1; *ADV BOARD CHILD A, 1991, CREAT CAR COMM BLUEP; Bays JA, 1998, PEDIATRICS, V101, P1091; BERGMAN B, 1991, AM J PUBLIC HEALTH, V81, P1486, DOI 10.2105/AJPH.81.11.1486; Campbell JC, 2001, ACAD EMERG MED, V8, P131, DOI 10.1111/j.1553-2712.2001.tb01277.x; Canterino JC, 1999, AM J OBSTET GYNECOL, V181, P1049, DOI 10.1016/S0002-9378(99)70079-7; CHALK R, 1998, VIOLENCE FAMILIES AS, P9; Coker A L, 2001, J Am Med Womens Assoc (1972), V56, P19; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; DAVIS DA, 1992, JAMA-J AM MED ASSOC, V268, P1111, DOI 10.1001/jama.268.9.1111; EDLESON J, 2001, OVERLAP DHILD MALTRE; Fanslow JL, 1998, AUST NZ J PUBL HEAL, V22, P598, DOI 10.1111/j.1467-842X.1998.tb01445.x; Feldhaus KM, 1997, JAMA-J AM MED ASSOC, V277, P1357, DOI 10.1001/jama.277.17.1357; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Green L. W., 1999, HLTH PROMOTION PLANN; Harwell TS, 1998, AM J PREV MED, V15, P235, DOI 10.1016/S0749-3797(98)00070-1; Kissinger P, 1999, AM J EPIDEMIOL, V149, P950, DOI 10.1093/oxfordjournals.aje.a009739; Martin SL, 2001, JAMA-J AM MED ASSOC, V285, P1581, DOI 10.1001/jama.285.12.1581; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; MCFARLANE J, 1991, PUBLIC HEALTH NURS, V8, P245, DOI 10.1111/j.1525-1446.1991.tb00664.x; MCKIBBEN L, 1989, PEDIATRICS, V84, P531; MCLEER SV, 1989, AM J PUBLIC HEALTH, V79, P65, DOI 10.2105/AJPH.79.1.65; *MMWR, 2000, MMWR-MORBID MORTAL W, V49, P485; *NAT RES COUNC PAN, 1993, UND CHILD AB NEGL; OBRIEN MAT, 2000, COCHRANE LIB; OBRIEN MAT, 2001, COCHRANE LIB; Olson L, 1996, ANN EMERG MED, V27, P741, DOI 10.1016/S0196-0644(96)70193-2; Rhodes KV, 2001, ANN EMERG MED, V37, P284, DOI 10.1067/mem.2001.110818; SALBER P, 1997, MANAGED CARE DOMESTI; Thompson RS, 2000, AM J PREV MED, V19, P253, DOI 10.1016/S0749-3797(00)00231-2; Thompson RS, 1996, MILBANK Q, V74, P469, DOI 10.2307/3350390; Tjaden P, 2000, EXTENT NATURE CONSEQ; Tourangeau R, 1996, PUBLIC OPIN QUART, V60, P275, DOI 10.1086/297751; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P562; Walker EA, 1999, AM J MED, V107, P332, DOI 10.1016/S0002-9343(99)00235-1; WALSH JME, 1992, HEALTH EDUC QUART, V19, P157, DOI 10.1177/109019819201900202; Wiist WH, 1999, AM J PUBLIC HEALTH, V89, P1217, DOI 10.2105/AJPH.89.8.1217; ZUCKERMAN B, 1995, PEDIATRICS, V96, P511	39	16	18	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2001	285	12					1628	1630		10.1001/jama.285.12.1628	http://dx.doi.org/10.1001/jama.285.12.1628			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	413HH	11268272				2022-12-28	WOS:000167606600031
J	Robertson, MC; Devlin, N; Gardner, MM; Campbell, AJ				Robertson, MC; Devlin, N; Gardner, MM; Campbell, AJ			Effectiveness and economic evaluation of a nurse delivered home exercise programme to prevent falls. 1: Randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE UTILIZATION; COST-EFFECTIVENESS; OLDER PERSONS; COMMUNITY; WOMEN; RISK; BALANCE; POPULATION; STRENGTH; INJURIES	Objectives To assess the effectiveness of a trained district nurse individually prescribing a home based exercise programme to reduce falls and injuries in elderly people and to estimate the cost effectiveness of the programme. Design Randomised controlled trial with one year's follow up. Setting Community health service at a New Zealand hospital. Participants 240 women and men aged 75 years and older. Intervention 121 participants received the exercise programme (exercise group) and 119 received usual care (control group); 90% (211 of 233) completed the trial. Main outcome measures Number of falls, number of injuries resulting from falls, costs of implementing the programme, and hospital costs as a result of falls. Results Falls were reduced by 46% (incidence rate ratio 0.54, 95% confidence interval 0.32 to 0.90). Five hospital admissions were due to injuries caused by falls in the control group and none in the exercise group. The programme cost $NZ1803 (pound 523) (at 1998 prices) per fall prevented for delivering the programme and $NZ155 per fall prevented when hospital costs averted were considered. Conclusion A home exercise programme, previously shown to be successful when delivered by a physiotherapist, was also effective in reducing falls when delivered by a trained nurse from within a home health service. Serious injuries and hospital admissions due to falls were also reduced. The programme was cost effective in participants aged 80 years and older compared with younger participants.	Otago Med Sch, Dept Med & Surg Sci, Dunedin, New Zealand; Univ Otago, Dept Econ, Dunedin, New Zealand	University of Otago; University of Otago	Robertson, MC (corresponding author), Otago Med Sch, Dept Med & Surg Sci, POB 913, Dunedin, New Zealand.		Robertson, Mary Clare/A-3964-2009					BUCHNER DM, 1993, J AM GERIATR SOC, V41, P297, DOI 10.1111/j.1532-5415.1993.tb06708.x; Buchner DM, 1997, J GERONTOL A-BIOL, V52, pM218, DOI 10.1093/gerona/52A.4.M218; Campbell AJ, 1999, AGE AGEING, V28, P513, DOI 10.1093/ageing/28.6.513; Campbell AJ, 1999, J AM GERIATR SOC, V47, P850, DOI 10.1111/j.1532-5415.1999.tb03843.x; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; *CROWN CO MON ADV, 1999, HOSP HLTH SERV PERF; Cumming RG, 1999, J AM GERIATR SOC, V47, P1397, DOI 10.1111/j.1532-5415.1999.tb01556.x; Drummond MF, 2015, METHODS EC EVALUATIO; Gardner MM, 2000, BRIT J SPORT MED, V34, P7, DOI 10.1136/bjsm.34.1.7; Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606; KIEL DP, 1991, MED CARE, V29, P221; LORD SR, 1995, J AM GERIATR SOC, V43, P1198, DOI 10.1111/j.1532-5415.1995.tb07394.x; MacRae PG, 1994, J AGING PHYS ACTIV, V2, P127, DOI DOI 10.1123/JAPA.2.2.127; McMurdo MET, 1997, BRIT MED J, V314, P569, DOI 10.1136/bmj.314.7080.569; NEVITT MC, 1991, J GERONTOL, V46, pM164, DOI 10.1093/geronj/46.5.M164; REINSCH S, 1992, GERONTOLOGIST, V32, P450, DOI 10.1093/geront/32.4.450; Rizzo JA, 1998, MED CARE, V36, P1174, DOI 10.1097/00005650-199808000-00006; Rizzo JA, 1996, MED CARE, V34, P954, DOI 10.1097/00005650-199609000-00007; Robertson MC, 2001, BRIT MED J, V322, P701, DOI 10.1136/bmj.322.7288.701; ROBERTSON MC, 2001, IN PRESS J EPIDEMIOL; RUBENSTEIN LZ, 1990, ANN INTERN MED, V113, P308, DOI 10.7326/0003-4819-113-4-308; Salkeld G, 2000, AUST NZ J PUBL HEAL, V24, P265, DOI 10.1111/j.1467-842X.2000.tb01566.x; *STAT CORP, 1999, STAT STAT SOFTW; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; TINETTI ME, 1994, J GERONTOL, V49, pM140, DOI 10.1093/geronj/49.3.M140; Wolf SL, 1996, J AM GERIATR SOC, V44, P489, DOI 10.1111/j.1532-5415.1996.tb01432.x	27	315	325	0	32	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 24	2001	322	7288					697	701		10.1136/bmj.322.7288.697	http://dx.doi.org/10.1136/bmj.322.7288.697			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	416GB	11264206	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000167771000022
J	Janetopoulos, C; Jin, T; Devreotes, P				Janetopoulos, C; Jin, T; Devreotes, P			Receptor-mediated activation of heterotrimeric G-proteins in living cells	SCIENCE			English	Article							GTP-GAMMA-S; CHEMOATTRACTANT RECEPTOR; IN-VIVO; DICTYOSTELIUM; CHEMOTAXIS; PHOSPHORYLATION; DESENSITIZATION; STIMULATION; SUBUNITS; BINDING	Receptor-mediated activation of heterotrimeric CTP-binding proteins (C-proteins) was visualized in living Dictyostelium discoideum cells by monitoring fluorescence resonance energy transfer (FRET) between alpha- and beta- subunits fused to cyan and yellow fluorescent proteins. The G-protein heterotrimer rapidly dissociated and reassociated upon addition and removal of chemoattractant, During continuous stimulation, C-protein activation reached a dose-dependent steady-state Level. Even though physiological responses subsided, the activation did not decline. Thus, adaptation occurs at another point in the signaling pathway, and occupied receptors, whether or not they are phosphorylated, catalyze the C-protein cycle. Construction of similar energy-transfer pairs of mammalian G-proteins should enable direct in situ mechanistic studies and applications such as drug screening and identifying Ligands of newly found C-protein-coupled receptors.	Johns Hopkins Med Inst, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Devreotes, P (corresponding author), Johns Hopkins Med Inst, Dept Cell Biol & Anat, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028007, R01GM034933, R37GM028007] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28007, GM34933] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; CATERINA MJ, 1995, J BIOL CHEM, V270, P8667, DOI 10.1074/jbc.270.15.8667; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Cubitt AB, 1999, METHOD CELL BIOL, V58, P19; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; JANETOPOULOS C, UNPUB; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; JOHNSON RL, 1992, J BIOL CHEM, V267, P4600; KUMAGAI A, 1989, CELL, V57, P265, DOI 10.1016/0092-8674(89)90964-1; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LILLY PJ, 1995, J CELL BIOL, V129, P1659, DOI 10.1083/jcb.129.6.1659; Mendez A, 2000, METHOD ENZYMOL, V316, P167; NEUBIG RR, 1994, FEBS LETT, V355, P251, DOI 10.1016/0014-5793(94)01212-1; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; SNAARJAGALSKA BE, 1991, EUR J BIOCHEM, V195, P715, DOI 10.1111/j.1432-1033.1991.tb15758.x; van Es S, 1999, CELL MOL LIFE SCI, V55, P1341, DOI 10.1007/s000180050374; VAUGHAN RA, 1988, J BIOL CHEM, V263, P14538; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WU LJ, 1991, BIOCHEM BIOPH RES CO, V179, P1141, DOI 10.1016/0006-291X(91)91690-E; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; Zigmond SH, 1997, J CELL BIOL, V138, P363, DOI 10.1083/jcb.138.2.363	28	362	379	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2001	291	5512					2408	2411		10.1126/science.1055835	http://dx.doi.org/10.1126/science.1055835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264536				2022-12-28	WOS:000167618700055
J	Sears, P; Wong, CH				Sears, P; Wong, CH			Toward automated synthesis of oligosaccharides and glycoproteins	SCIENCE			English	Review							SOLID-PHASE SYNTHESIS; SIALYL-LEWIS-X; CHEMOENZYMATIC SYNTHESIS; BETA-MANNOPYRANOSIDES; ENZYMATIC-SYNTHESIS; GLYCOPEPTIDE; GLYCOSIDES; GLYCOSYLATION; CHEMISTRY; ACID	The discovery of previously unknown functions associated with carbohydrates and the study of their structure-function relations are of current interest in carbohydrate chemistry and biology. Progress in this area is, however, hampered by the lack of convenient and effective tools for the synthesis and analysis of oligosaccharides and glycoconjugates. Development of automated synthesis of such materials is necessary to facilitate research in this field. This review describes recent advances in carbohydrate synthesis, with particular focus on developments that have potential application to the automated synthesis of oligosaccharides, glycopeptides, and glycoproteins.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wong, CH (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pine Rd, La Jolla, CA 92037 USA.	wong@scripps.edu						BARRESI F, 1991, J AM CHEM SOC, V113, P9376, DOI 10.1021/ja00024a057; Bergbreiter DE, 1996, J AM CHEM SOC, V118, P6092, DOI 10.1021/ja954065r; BURKHART F, IN PRESS ANGEW CHEM; Chen X, 2001, J AM CHEM SOC, V123, P2081, DOI 10.1021/ja005738v; Crich D, 1998, J AM CHEM SOC, V120, P435, DOI 10.1021/ja9734814; Danishefsky SJ, 1997, CHEM-EUR J, V3, P1617, DOI 10.1002/chem.19970031011; DANISHEFSKY SJ, 1993, SCIENCE, V260, P1307, DOI 10.1126/science.8493573; Douglas NL, 1998, J CHEM SOC PERK T 1, P51, DOI 10.1039/a705275h; DOUGLAS SP, 1991, J AM CHEM SOC, V113, P5095, DOI 10.1021/ja00013a075; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Ernst B., 2000, CARBOHYDRATES CHEM B, V1-4; FERRIER RJ, 1973, CARBOHYD RES, V27, P55, DOI 10.1016/S0008-6215(00)82424-6; FLITSCH SL, 1997, GLYCOPEPTIDES RELATE, P207; FRASERREID B, 1993, PURE APPL CHEM, V65, P779, DOI 10.1351/pac199365040779; Garegg PJ, 1997, ADV CARBOHYD CHEM BI, V52, P179, DOI 10.1016/S0065-2318(08)60091-8; HANESSIAN S, 1980, CARBOHYD RES, V80, pC17, DOI 10.1016/S0008-6215(00)84882-X; HASHIMOTO S, 1989, J CHEM SOC CHEM COMM, P685, DOI 10.1039/c39890000685; HEIDLAS JE, 1992, ACCOUNTS CHEM RES, V25, P307, DOI 10.1021/ar00019a006; Herzner H, 2000, CHEM REV, V100, P4495, DOI 10.1021/cr990308c; Ito Y, 1997, J AM CHEM SOC, V119, P5562, DOI 10.1021/ja964093p; JACKSON DY, 1994, SCIENCE, V266, P243, DOI 10.1126/science.7939659; Kanie O, 2000, ANGEW CHEM INT EDIT, V39, P4545, DOI 10.1002/1521-3773(20001215)39:24<4545::AID-ANIE4545>3.3.CO;2-M; Kochendoerfer GG, 1999, CURR OPIN CHEM BIOL, V3, P665, DOI 10.1016/S1367-5931(99)00024-1; Koeller KM, 2000, J AM CHEM SOC, V122, P4241, DOI 10.1021/ja0004938; Koeller KM, 2000, CHEM REV, V100, P4465, DOI 10.1021/cr990297n; Kolter T, 1999, ANGEW CHEM INT EDIT, V38, P1532, DOI 10.1002/(SICI)1521-3773(19990601)38:11<1532::AID-ANIE1532>3.0.CO;2-U; KONDO H, 1992, J AM CHEM SOC, V114, P8748, DOI 10.1021/ja00048a085; LEMIEUX RU, 1975, J AM CHEM SOC, V97, P4056, DOI 10.1021/ja00847a032; Liang R, 1996, SCIENCE, V274, P1520, DOI 10.1126/science.274.5292.1520; LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x; LONN H, 1992, TETRAHEDRON LETT, V33, P115, DOI 10.1016/S0040-4039(00)77688-X; Mackenzie LF, 1998, J AM CHEM SOC, V120, P5583, DOI 10.1021/ja980833d; MARTIN TJ, 1992, TETRAHEDRON LETT, V33, P6123; Mathews DH, 1997, RNA, V3, P1; Meinjohanns E, 1998, J CHEM SOC PERK T 1, P549, DOI 10.1039/a705528e; Mizuno M, 1999, J AM CHEM SOC, V121, P284, DOI 10.1021/ja9831305; NICOLAOU KC, 1995, ANGEW CHEM INT EDIT, V34, P2289, DOI 10.1002/anie.199522891; Nicolaou KC, 1998, ANGEW CHEM INT EDIT, V37, P1559, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1559::AID-ANIE1559>3.0.CO;2-E; NICOLAOU KC, 1983, J AM CHEM SOC, V105, P2430, DOI 10.1021/ja00346a053; Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450; O'Connor SE, 1998, CHEM BIOL, V5, P427, DOI 10.1016/S1074-5521(98)90159-4; PAULSEN H, 1982, ANGEW CHEM INT EDIT, V21, P155, DOI 10.1002/anie.198201553; PETERS S, 1992, TETRAHEDRON LETT, V33, P6445, DOI 10.1016/S0040-4039(00)79011-3; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; Rademann J, 1998, ANGEW CHEM INT EDIT, V37, P1241, DOI 10.1002/(SICI)1521-3773(19980518)37:9<1241::AID-ANIE1241>3.0.CO;2-6; RANDOLPH JT, 1995, J AM CHEM SOC, V117, P5712, DOI 10.1021/ja00126a012; SCHUSTER M, 1994, J AM CHEM SOC, V116, P1135, DOI 10.1021/ja00082a047; Sears P, 1998, CELL MOL LIFE SCI, V54, P223, DOI 10.1007/s000180050146; SEARS P, 1994, J AM CHEM SOC, V116, P6521, DOI 10.1021/ja00094a005; Seeberger PH, 2000, CHEM REV, V100, P4349, DOI 10.1021/cr9903104; Seitz O, 1997, J AM CHEM SOC, V119, P8766, DOI 10.1021/ja971383c; Seitz O, 2000, CHEMBIOCHEM, V1, P215; Shin Y, 1999, J AM CHEM SOC, V121, P11684, DOI 10.1021/ja992881j; St Hilaire PM, 2000, ANGEW CHEM INT EDIT, V39, P1162, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1162::AID-ANIE1162>3.0.CO;2-6; Stork G, 1996, J AM CHEM SOC, V118, P247, DOI 10.1021/ja9532291; Tolbert TJ, 2000, J AM CHEM SOC, V122, P5421, DOI 10.1021/ja0000192; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wang LX, 1997, J AM CHEM SOC, V119, P11137, DOI 10.1021/ja9712027; Witte K, 1998, J AM CHEM SOC, V120, P1979, DOI 10.1021/ja9736727; Witte K, 1997, J AM CHEM SOC, V119, P2114, DOI 10.1021/ja961846z; WONG CH, 1982, J ORG CHEM, V47, P5416, DOI 10.1021/jo00148a045; WONG CH, 1995, ANGEW CHEM INT EDIT, V34, P412, DOI 10.1002/anie.199504121; YAMAMOTO K, 1993, AMINO ACIDS, V5, P1, DOI 10.1007/BF00806187; Zhang ZY, 1999, J AM CHEM SOC, V121, P734, DOI 10.1021/ja982232s	64	417	460	7	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2001	291	5512					2344	2350		10.1126/science.1058899	http://dx.doi.org/10.1126/science.1058899			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11269314				2022-12-28	WOS:000167618700041
J	Geerlings, MI; Ruitenberg, A; Witteman, JCM; van Swieten, JC; Hofman, A; van Duijn, CM; Breteler, MMB; Launer, LJ				Geerlings, MI; Ruitenberg, A; Witteman, JCM; van Swieten, JC; Hofman, A; van Duijn, CM; Breteler, MMB; Launer, LJ			Reproductive period and risk of dementia in postmenopausal women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESTROGEN-REPLACEMENT THERAPY; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; NATURAL MENOPAUSE; OLDER WOMEN; CARDIOVASCULAR-DISEASE; MENTAL STATE; DECLINE; ROTTERDAM; HEALTH	Context Exogenous estrogen use may lower risk of dementia in postmenopausal women. A relationship between long-term exposure to endogenous estrogens and incident dementia has been hypothesized but not studied, Objective To determine whether a longer reproductive period, as an indicator of longer exposure to endogenous estrogens, is associated with lower risk of dementia and Alzheimer disease (AD) in women who have natural menopause. Design and Setting The Rotterdam Study, a population-based prospective cohort study conducted in the Netherlands. Participants A total of 3601 women aged 55 years or older who did not have dementia at baseline (1990-1993) and had information on age at menarche, age at menopause, and type of menopause. Participants were reexamined in 1993-1994 and 1997-1999 and were continuously monitored for development of dementia. Main Outcome Measures Incidence of dementia, based on Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition criteria, and AD, based on National Institute of Neurological Disorders and Stroke/Alzheimer's Disease and Related Disorders Association criteria, compared by quartiles of reproductive period among women with natural menopause. Results During 21046 person-years of follow-up (median follow-up, 6.3 years), 199 women developed dementia, including 159 who developed AD. After adjusting for age, dementia was not clearly associated with length of reproductive period. However, after adjusting for multiple covariates, women with natural menopause and more reproductive years had an increased risk of dementia (adjusted rate ratio [RR] for women with >39 reproductive years [highest quartile] compared with <34 reproductive years [lowest quartile], 1.78; 95 % confidence interval [CI], 1.12-2.84), The adjusted RR per year of increase was 1.04 (95 % CI, 1.01-1.08), For risk of AD, the adjusted RRs were 1.51 (95% CI, 0.91-2.50) and 1.03 (95% CI, 1.00-1.07), respectively. Risk of dementia associated with a longer reproductive period was most pronounced in APOE <epsilon>4 carriers (adjusted RR for >39 reproductive years compared with <34 reproductive years, 4.20 [95% CI, 1.97-8.92] for dementia and 3.42 [95% CI, 1.51-7.75] for AD), whereas in noncarriers, no clear association with dementia or AD was observed. Conclusion Our findings do not support the hypothesis that a longer reproductive period reduces risk of dementia in women who have natural menopause.	Erasmus Univ, Med Ctr, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Neurol, NL-3000 DR Rotterdam, Netherlands; NIA, NIH, Bethesda, MD 20892 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Geerlings, MI (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol & Biostat, POB 1738, NL-3000 DR Rotterdam, Netherlands.	geerlings@epib.fgg.eur.nl	Geerlings, Mirjam I/F-4087-2015; Breteler, Monique M.B./J-5058-2014	Geerlings, Mirjam I/0000-0002-4037-036X; Breteler, Monique M.B./0000-0002-0626-9305; van Swieten, John/0000-0001-6278-6844				American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Baldereschi M, 1998, NEUROLOGY, V50, P996, DOI 10.1212/WNL.50.4.996; Barrett-Connor E, 1999, J AM GERIATR SOC, V47, P1289, DOI 10.1111/j.1532-5415.1999.tb07427.x; BARRETTCONNOR E, 1993, JAMA-J AM MED ASSOC, V269, P2637, DOI 10.1001/jama.269.20.2637; Birge SJ, 1996, J AM GERIATR SOC, V44, P865, DOI 10.1111/j.1532-5415.1996.tb03749.x; BRETELER MMB, 1994, BRIT MED J, V308, P1604, DOI 10.1136/bmj.308.6944.1604; Christiansen C, 1990, Osteoporos Int, V1, P7; CLAYTON D, 1996, STAT MODELS EPIDEMIO; Cooper GS, 1998, ANN EPIDEMIOL, V8, P229, DOI 10.1016/S1047-2797(97)00207-X; COPELAND JRM, 1976, PSYCHOL MED, V6, P439, DOI 10.1017/S0033291700015889; Costa MM, 1999, BIOL PSYCHIAT, V46, P182, DOI 10.1016/S0006-3223(98)00355-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gibbs RB, 1998, HORM BEHAV, V34, P98, DOI 10.1006/hbeh.1998.1451; Haskell SG, 1997, J CLIN EPIDEMIOL, V50, P1249, DOI 10.1016/S0895-4356(97)00169-8; Henderson VW, 2000, NEUROLOGY, V54, P295, DOI 10.1212/WNL.54.2.295; Henderson VW, 1997, NEUROLOGY, V48, pS27, DOI 10.1212/WNL.48.5_Suppl_7.27S; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hu FB, 1999, ARCH INTERN MED, V159, P1061, DOI 10.1001/archinte.159.10.1061; Jacobs H. M., 1998, LAND USE LAW ZONING, V50, P3; Jacobsen BK, 1999, J CLIN EPIDEMIOL, V52, P303, DOI 10.1016/S0895-4356(98)00170-X; KAMPEN DL, 1994, OBSTET GYNECOL, V83, P979, DOI 10.1097/00006250-199406000-00017; Kawas C, 1997, NEUROLOGY, V48, P1517, DOI 10.1212/WNL.48.6.1517; Klipstein-Grobusch K, 1998, EUR J CLIN NUTR, V52, P588, DOI 10.1038/sj.ejcn.1600611; Luoto R, 2000, J AM GERIATR SOC, V48, P467, DOI 10.1111/j.1532-5415.2000.tb04990.x; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Monk D, 2000, DEMENT GERIATR COGN, V11, P1, DOI 10.1159/000017206; Mulnard RI, 2000, JAMA-J AM MED ASSOC, V283, P1007, DOI 10.1001/jama.283.8.1007; OTT A, 1995, BRIT MED J, V310, P970, DOI 10.1136/bmj.310.6985.970; Ott A, 1998, AM J EPIDEMIOL, V147, P574; PaganiniHill A, 1996, ARCH INTERN MED, V156, P2213, DOI 10.1001/archinte.156.19.2213; PAGANINIHILL A, 1994, AM J EPIDEMIOL, V140, P256, DOI 10.1093/oxfordjournals.aje.a117244; Payami H, 1996, AM J HUM GENET, V58, P803; Peters HW, 1999, J INTERN MED, V246, P521, DOI 10.1046/j.1365-2796.1999.00547.x; Rao VS, 1996, AM J HUM GENET, V59, P664; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Skoog I, 1999, J Epidemiol Biostat, V4, P227; Slooter AJC, 1999, J NEUROL NEUROSUR PS, V67, P779, DOI 10.1136/jnnp.67.6.779; SNOWDON DA, 1989, AM J PUBLIC HEALTH, V79, P709, DOI 10.2105/AJPH.79.6.709; Solerte SB, 1999, MATURITAS, V31, P95, DOI 10.1016/S0378-5122(98)00111-X; Srivastava RAK, 1996, BIOCHEM MOL BIOL INT, V38, P91; Steffens DC, 1999, J AM GERIATR SOC, V47, P1171, DOI 10.1111/j.1532-5415.1999.tb05195.x; Szklo M, 1996, AM J EPIDEMIOL, V144, P1048; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; Waring SC, 1999, NEUROLOGY, V52, P965, DOI 10.1212/WNL.52.5.965; Yaffe K, 2000, NEUROLOGY, V54, P1949, DOI 10.1212/WNL.54.10.1949; Yaffe K, 1998, JAMA-J AM MED ASSOC, V279, P688, DOI 10.1001/jama.279.9.688; Yaffe K, 2000, LANCET, V356, P708, DOI 10.1016/S0140-6736(00)02628-3; Yaffe K, 1998, J AM GERIATR SOC, V46, P816, DOI 10.1111/j.1532-5415.1998.tb02713.x	49	92	95	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1475	1481		10.1001/jama.285.11.1475	http://dx.doi.org/10.1001/jama.285.11.1475			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410VQ	11255424	Bronze, Green Published			2022-12-28	WOS:000167462100030
J	Post, JC; Goessier, MC				Post, JC; Goessier, MC			Is pacifier use a risk factor for otitis media?	LANCET			English	Editorial Material							SUDDEN-INFANT-DEATH; CHILDREN; DUMMY; COT		Allegheny Gen Hosp, Dept Paediat Otolaryngol, Pittsburgh, PA 15212 USA; Allegheny Gen Hosp, Dept Paediat, Pittsburgh, PA 15212 USA	Allegheny General Hospital; Allegheny General Hospital	Post, JC (corresponding author), Allegheny Gen Hosp, Dept Paediat Otolaryngol, Pittsburgh, PA 15212 USA.							Adair Steven M., 1995, Pediatric Dentistry, V17, P437; Arnestad M, 1997, EUR J PEDIATR, V156, P968, DOI 10.1007/s004310050753; Baker M, 2000, PEDIATR INFECT DIS J, V19, P983, DOI 10.1097/00006454-200010000-00009; Brook I, 1997, J LARYNGOL OTOL, V111, P614, DOI 10.1017/S0022215100138113; Fleming PJ, 1999, ARCH DIS CHILD, V81, P112, DOI 10.1136/adc.81.2.112; Jackson Jonathan M., 1999, Pediatric Dentistry, V21, P255; L'Hoir MP, 1999, EUR J PEDIATR, V158, P896, DOI 10.1007/s004310051237; MITCHELL EA, 1993, ARCH DIS CHILD, V68, P501, DOI 10.1136/adc.68.4.501; NIEMELA M, 1995, PEDIATRICS, V96, P884; NIEMELA M, 1994, INT J PEDIATR OTORHI, V29, P121, DOI 10.1016/0165-5876(94)90091-4; Niemela M, 2000, PEDIATRICS, V106, P483, DOI 10.1542/peds.106.3.483; North K, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.3.e34; Ollila P, 1998, ACTA ODONTOL SCAND, V56, P233, DOI 10.1080/00016359850142853; Righard L, 1998, BIRTH-ISS PERINAT C, V25, P128, DOI 10.1046/j.1523-536x.1998.00128.x; SIO JO, 1987, ARCH DIS CHILD, V4, P406	15	4	4	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 17	2001	357	9259					823	824		10.1016/S0140-6736(00)04193-3	http://dx.doi.org/10.1016/S0140-6736(00)04193-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265948				2022-12-28	WOS:000167586300006
J	Stephenson, A; Higgs, R; Sugarman, J				Stephenson, A; Higgs, R; Sugarman, J			Teaching professional development in medical schools	LANCET			English	Article							STUDENTS; CURRICULUM; EDUCATION; DOCTORS; ETHICS; CARE	Doctors must increasingly be aware of what they should be, as well as what they should know. Professionalism, including a value system that supports the compassionate care of patients, is a means of encapsulating and prioritising these competing responsibilities. Accordingly, in this article, we assume that professionalism is an essential aspect of medical practice that needs to be taught to those entering medicine. We first describe critiques of professionalism and current challenges to it, in practice and in medical education. We then assess the current efforts of curriculum reform to incorporate professionalism and the methods used to teach it. Adopting and assessing such approaches to ensure that they are effective is of central importance in the education of future clinicians.	Kings Coll London, GKT Sch Med, Dept Gen Practice & Primary Care, London SE5 9RJ, England; Duke Univ, Durham, NC USA	University of London; King's College London; Duke University	Stephenson, A (corresponding author), Kings Coll London, GKT Sch Med, Dept Gen Practice & Primary Care, London SE5 9RJ, England.	anne.stephenson@kcl.ac.uk		Sugarman, Jeremy/0000-0001-7022-8332				Asch E, 1998, Acad Med, V73, P575, DOI 10.1097/00001888-199805000-00034; Becker Howard, 1961, BOYS WHITE STUDENT C; Boaden N, 2000, MED EDUC, V34, P921, DOI 10.1046/j.1365-2923.2000.00794.x; Cribb A, 1999, STUD HIGH EDUC, V24, P195, DOI 10.1080/03075079912331379888; *ED COMM GEN MED C, 1993, TOM DOCT; Epstein RM, 1998, ARCH FAM MED, V7, P149, DOI 10.1001/archfami.7.2.149; Eron LD, 1955, J MED EDUC, V30, P559; Flexner A., 1910, MEDICAL ED US CANADA; Fowell SL, 1998, POSTGRAD MED J, V74, P18, DOI 10.1136/pgmj.74.867.18; FRIEDSON P, 1970, PROFESSION MED; *GEN MED COUNC, 1998, GOOD MED PRACT; HIGGS R, 1994, J ROY COLL PHYS LOND, V28, P538; Jolly B, 1997, MED EDUC, V31, P20, DOI 10.1111/j.1365-2923.1997.tb02582.x; Konner M., 1987, BECOMING DOCTOR JOUR; MANSFIELD F, 1991, MED EDUC, V25, P485, DOI 10.1111/j.1365-2923.1991.tb00102.x; Maudsley G, 1999, BMJ-BRIT MED J, V318, P657, DOI 10.1136/bmj.318.7184.657; McManus IC, 1998, BRIT MED J, V317, P1111; Parry N., 2019, RISE MED PROFESSION; Physicians for the Twenty-First Century, 1984, J MED EDUC, V59, P1; Ramsden P., 1992, LEARNING TEACH HIGHE; REISER SJ, 1994, ACAD MED, V69, P872, DOI 10.1097/00001888-199411000-00002; REZLER AG, 1974, J MED EDUC, V49, P1023; SELF DJ, 1992, MED EDUC, V26, P178, DOI 10.1111/j.1365-2923.1992.tb00151.x; Shaw George Bernard, 1987, DOCTORS DILEMMA TRAG; SINCLAIR S., 1997, MAKING DOCTORS I APP; SMITH AC, 1989, SOC PSYCHOL QUART, V52, P56, DOI 10.2307/2786904; Swick HM, 1999, JAMA-J AM MED ASSOC, V282, P830, DOI 10.1001/jama.282.9.830; van der Vleuten C, 2000, BRIT MED J, V321, P1217, DOI 10.1136/bmj.321.7270.1217; van Gennep A., 1960, RITES PASSAGE; Wallace AG, 1997, ACAD MED, V72, P253, DOI 10.1097/00001888-199704000-00008	30	103	107	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 17	2001	357	9259					867	870		10.1016/S0140-6736(00)04201-X	http://dx.doi.org/10.1016/S0140-6736(00)04201-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265967				2022-12-28	WOS:000167586300034
J	Lee, LM; Karon, JM; Selik, R; Neal, JJ; Fleming, PL				Lee, LM; Karon, JM; Selik, R; Neal, JJ; Fleming, PL			Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; PNEUMOCYSTIS-CARINII PNEUMONIA; NATIONAL DEATH INDEX; ANTIRETROVIRAL THERAPY; HIV-INFECTION; COMPLETENESS; MORTALITY; TIME; CHEMOPROPHYLAXIS; EXPERIENCE	Context Declines in the number of acquired immunodeficiency syndrome (AIDS) deaths were first observed in 1996, attributed to improvements in antiretroviral therapy and an increase in the proportion of persons receiving therapy. Objective To examine national trends in survival time among persons diagnosed as having AIDS in 1984-1997. Design, Setting, and Subjects Retrospective cohort study using data from a population-based registry of AIDS cases and deaths reported in the United States. Main Outcome Measure Months of survival after AIDS diagnosis through December 31, 1998, compared by year of diagnosis. Results Among 394705 persons with an AIDS-defining opportunistic illness (OI) diagnosed in 1984-1997, median survival time improved from 11 months for 1984 diagnoses to 46 months for 1995 diagnoses. Among persons with an OI diagnosed in 1996 and 1997, 67% were alive at least 36 months after diagnosis and 77% were alive at least 24 months after diagnosis, respectively. Among 296621 AIDS cases diagnosed during 1993-1997, 65% were based on immunologic criteria and 35% on OI criteria; 80% were among men; and 42% were among non-Hispanic blacks, 40% among non-Hispanic whites, 17% among Hispanics, 1% among Asians/Pacific islanders, and less than 1% among American Indians/Alaska natives. The probability of surviving at least 24 months increased from 67% for those with immunologic diagnoses in 1993 to 90% in 1997 and from 49% for those with OI diagnoses in 1993 to 80% in 1997, Survival time increased with each year of diagnosis from 1984 to 1997 for blacks, whites, and Hispanics. The greatest annual survival gains occurred among per sons receiving an AIDS diagnosis in 1995 and 1996. Conclusions Survival time after AIDS diagnosis improved from 1984 to 1997, While AIDS incidence is declining, improved survival times present a growing public health challenge as the number of persons living with chronic human immunodeficiency virus disease/AIDS increases.	Ctr Dis Control & Prevent, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Lee, LM (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, MS E-47,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	LMLee@cdc.gov		Lee, Lisa M/0000-0002-3397-3269				AMATO DA, 1988, COMMUN STAT-THEOR M, V17, P263, DOI 10.1080/03610928808829621; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 1981, MORBIDITY MORTALITY, V30, P250; Baillargeon J, 1999, INT J STD AIDS, V10, P22, DOI 10.1258/0956462991913033; BLUM S, 1994, AM J EPIDEMIOL, V139, P351, DOI 10.1093/oxfordjournals.aje.a117007; BUEHLER JW, 1992, J ACQ IMMUN DEF SYND, V5, P257; *CDCP, 2000, HIV AIDS SURV REP, V12; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P165; CHANG HGH, 1993, AM J EPIDEMIOL, V138, P341, DOI 10.1093/oxfordjournals.aje.a116864; CHU SY, 1993, 9 INT C AIDS JUN 6 1; Collett D, 1994, MODELLING SURVIVAL D; CURTIS JR, 1993, AM J PUBLIC HEALTH, V83, P1425, DOI 10.2105/AJPH.83.10.1425; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; EASTERBROOK PJ, 1991, JAMA-J AM MED ASSOC, V266, P2713, DOI 10.1001/jama.266.19.2713; EDLAVITCH SA, 1988, AM J EPIDEMIOL, V127, P1164, DOI 10.1093/oxfordjournals.aje.a114910; FISCHL MA, 1988, JAMA-J AM MED ASSOC, V259, P1185, DOI 10.1001/jama.259.8.1185; GREENBERG AE, 1993, JAMA-J AM MED ASSOC, V269, P2995, DOI 10.1001/jama.269.23.2995; HANKINS CA, 1992, J ACQ IMMUN DEF SYND, V5, P957; HARRIS JE, 1990, JAMA-J AM MED ASSOC, V263, P397, DOI 10.1001/jama.263.3.397; JONES JL, 1992, MMWR-MORBID MORTAL W, V48, P1; Karon JM, 1996, JAMA-J AM MED ASSOC, V276, P126, DOI 10.1001/jama.276.2.126; Klevens RM, 1998, INT J EPIDEMIOL, V27, P1105, DOI 10.1093/ije/27.6.1105; LEMP GF, 1990, JAMA-J AM MED ASSOC, V263, P402, DOI 10.1001/jama.263.3.402; Lobato MN, 1999, J ACQ IMMUN DEF SYND, V22, P71, DOI 10.1097/00042560-199909010-00009; Martins-Corder MP, 1998, SILVAE GENET, V47, P6; McNaghten AD, 1999, AIDS, V13, P1687, DOI 10.1097/00002030-199909100-00012; MONCROFT A, 1996, AIDS, V10, P1057; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Peters K D, 1998, Natl Vital Stat Rep, V47, P1; Pezzotti P, 1999, AIDS, V13, P249, DOI 10.1097/00002030-199902040-00013; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; ROSENBLUM L, 1992, AM J PUBLIC HEALTH, V82, P1495, DOI 10.2105/AJPH.82.11.1495; ROTHENBERG R, 1987, NEW ENGL J MED, V317, P1297, DOI 10.1056/NEJM198711193172101; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Solomon L, 1998, J ACQ IMMUN DEF SYND, V17, P253, DOI 10.1097/00042560-199803010-00011; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; TU SM, 1993, J ACQ IMMUN DEF SYND, V6, P1150; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; WILLIAMS BC, 1992, AM J PUBLIC HEALTH, V82, P1145, DOI 10.2105/AJPH.82.8.1145	40	145	157	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2001	285	10					1308	1315		10.1001/jama.285.10.1308	http://dx.doi.org/10.1001/jama.285.10.1308			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408QK	11255385				2022-12-28	WOS:000167339000022
J	Topinka, MA; LeRoy, BJ; Westervelt, RM; Shaw, SEJ; Fleischmann, R; Heller, EJ; Maranowski, KD; Gossard, AC				Topinka, MA; LeRoy, BJ; Westervelt, RM; Shaw, SEJ; Fleischmann, R; Heller, EJ; Maranowski, KD; Gossard, AC			Coherent branched flow in a two-dimensional electron gas	NATURE			English	Article							SPECTROSCOPY; MICROSCOPY	Semiconductor nanostructures based on two-dimensional electron gases (2DEGs) could form the basis of future devices for sensing, information processing and quantum computation. Although electron transport in 2DEG nanostructures has been well studied, and many remarkable phenomena have already been discovered (for example, weak localization, quantum chaos, universal conductance fluctuations(1,2)), fundamental aspects of the electron flow through these structures have so far not been clarified. However, it has recently become possible to image current directly through 2DEG devices using scanning probe microscope techniques(3-13). Here, we use such a technique to observe electron flow through a narrow constriction in a 2DEG-a quantum point contact. The images show that the electron flow from the point contact forms narrow, branching strands instead of smoothly spreading fans. Our theoretical study of this flow indicates that this branching of current flux is due to focusing of the electron paths by ripples in the background potential. The strands are decorated by interference fringes separated by half the Fermi wavelength, indicating the persistence of quantum mechanical phase coherence in the electron flow. These findings may have important implications for a better understanding of electron transport in 2DEGs and for the design of future nanostructure devices.	Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Max Planck Inst Stromungsforsch, D-37073 Gottingen, Germany; Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	Harvard University; Harvard University; Harvard University; Max Planck Society; University of California System; University of California Santa Barbara	Westervelt, RM (corresponding author), Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA.	westervelt@deas.harvard.edu	LeRoy, Brian J/J-9112-2012; Fleischmann, Ragnar/H-4441-2013	LeRoy, Brian J/0000-0003-1610-5424; Fleischmann, Ragnar/0000-0001-6843-8146				BEENAKKER CWJ, 1991, SOLID STATE PHYS, V44, P1; Crook R, 2000, PHYS REV B, V62, P5174, DOI 10.1103/PhysRevB.62.5174; Crook R, 2000, J PHYS-CONDENS MAT, V12, pL167, DOI 10.1088/0953-8984/12/8/102; DAVIES JH, 1998, PHYSICS LOW DIMENSIO; Eriksson MA, 1996, SUPERLATTICE MICROST, V20, P435, DOI 10.1006/spmi.1996.0100; Eriksson MA, 1996, APPL PHYS LETT, V69, P671, DOI 10.1063/1.117801; Finkelstein G, 2000, SCIENCE, V289, P90, DOI 10.1126/science.289.5476.90; Grill R, 1999, PHYS REV B, V59, P10769, DOI 10.1103/PhysRevB.59.10769; Gurevich L, 2000, APPL PHYS LETT, V76, P384, DOI 10.1063/1.125761; Jamneala T, 2000, PHYS REV B, V61, P9990, DOI 10.1103/PhysRevB.61.9990; Manoharan HC, 2000, NATURE, V403, P512, DOI 10.1038/35000508; McCormick KL, 1999, PHYS REV B, V59, P4654, DOI 10.1103/PhysRevB.59.4654; Sohn L.L., 1997, MESOSCOPIC ELECT TRA; Topinka MA, 2000, SCIENCE, V289, P2323, DOI 10.1126/science.289.5488.2323; WOLFSON MA, 2000, CD0002030; Yoo MJ, 1997, SCIENCE, V276, P579, DOI 10.1126/science.276.5312.579; Zhitenev NB, 2000, NATURE, V404, P473, DOI 10.1038/35006591	18	389	393	0	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2001	410	6825					183	186		10.1038/35065553	http://dx.doi.org/10.1038/35065553			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242072	Green Submitted			2022-12-28	WOS:000167320500038
J	Cranshaw, J; Evans, TW				Cranshaw, J; Evans, TW			Lung volume reduction surgery: a quality operation?	LANCET			English	Editorial Material							SEVERE EMPHYSEMA; OF-LIFE; EXERCISE; COPD		Royal Brompton Hosp, Imperial Coll Sch Med, Crit Care Unit, London SW3 6NP, England	Imperial College London; Royal Brompton Hospital	Evans, TW (corresponding author), Royal Brompton Hosp, Imperial Coll Sch Med, Crit Care Unit, London SW3 6NP, England.	t.evans@rbh.nthames.nhs.uk						BRANTIGAN O C, 1957, Am Surg, V23, P789; Cooper JD, 1996, J THORAC CARDIOV SUR, V112, P1319, DOI 10.1016/S0022-5223(96)70147-2; Cordova F, 1997, CHEST, V112, P907, DOI 10.1378/chest.112.4.907; CURTIS JR, 1994, THORAX, V49, P162, DOI 10.1136/thx.49.2.162; DIMANGO AM, 1996, CHEST S, V110, pS180; Geddes D, 2000, NEW ENGL J MED, V343, P239, DOI 10.1056/NEJM200007273430402; Gelb AF, 1996, CHEST, V110, P1407, DOI 10.1378/chest.110.6.1407; Leyenson N, 2000, CHEST, V118, P728, DOI 10.1378/chest.118.3.728; Malthaner RA, 2000, CAN J SURG, V43, P377; Marchand E, 1999, EUR RESPIR J, V13, P686, DOI 10.1183/09031936.99.13368699; Miller J D, 2000, Can Respir J, V7, P329; Roue C, 1996, CHEST, V110, P28, DOI 10.1378/chest.110.1.28; Russi EW, 1999, EUR RESPIR J, V13, P480, DOI 10.1183/09031936.99.13348099; *STAND CAR COMM BR, 1997, THORAX, V52, pS1; Szekely LA, 1997, CHEST, V111, P550, DOI 10.1378/chest.111.3.550; Utz JP, 1998, MAYO CLIN PROC, V73, P552, DOI 10.4065/73.6.552; YUSEN RD, 1997, AM J RESP CRIT CARE, V155, pA794	17	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2001	357	9257					650	651		10.1016/S0140-6736(00)04148-9	http://dx.doi.org/10.1016/S0140-6736(00)04148-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247543				2022-12-28	WOS:000167282400002
J	Nemery, B; Hoet, PHM; Nemmar, A				Nemery, B; Hoet, PHM; Nemmar, A			The Meuse Valley fog of 1930: an air pollution disaster	LANCET			English	Article							MORTALITY		Katholieke Univ Leuven, Unit Lung Toxicol, Lab Pneumol, B-3000 Louvain, Belgium	KU Leuven	Nemery, B (corresponding author), Katholieke Univ Leuven, Unit Lung Toxicol, Lab Pneumol, B-3000 Louvain, Belgium.	ben.nemery@med.kuleuven.ac.be	Nemery, Benoit/D-1224-2013; Hoet, Peter/H-9987-2013; Nemery, Benoit/N-3155-2019	Hoet, Peter/0000-0002-0292-6603; Nemery, Benoit/0000-0003-0571-4689				ABRAMSON M, 1991, MED J AUSTRALIA, V154, P543, DOI 10.5694/j.1326-5377.1991.tb119453.x; ALKE A, 1931, MUNCHEN MED WOCHEN, V78, P160; ANDERSON HR, 1999, AIR POLLUTION HLTH, P461; BALMES JR, 1996, OCCUPATIONAL ENV RES, P808; BATTA G, 1933, PROBLEMES POLLUTION, P1; BELLELLI F, 1931, RIFORMA MED, V47, P386; BERTYN F, 1931, ANN GEMBLOUX, V37, P20; Bertyn F., 1913, ANN GEMBLOUX, V25, P153; Brimblecombe P., 1999, AIR POLLUTION HLTH, P5; BRIMBLECOMBE P, 1988, BIG SMOKE HIST AIR P, P1; Brody H, 2000, LANCET, V356, P64, DOI 10.1016/S0140-6736(00)02442-9; *COMM DEP OFF EXP, 1958, MORT MORB LOND FOG D; Committee on Public Health Relations of the New York Academy of Medicine, 1931, B NY ACAD MED, V7, P751; COSTA DL, 1996, CASARETT DOULLS TOXI, P857; FENNER G, 1931, CHEM ZEITUNG, V55, P69; Firket J, 1936, T FARADAY SOC, V32, P1192, DOI 10.1039/tf9363201192; FIRKET J, 1958, P ROY SOC MED, V51, P347, DOI 10.1177/003591575805100511; Firket J., 1931, 1930 B ACAD ROYAL ME, V11, P683; GODLEE F, 1991, BMJ-BRIT MED J, V303, P1459, DOI 10.1136/bmj.303.6815.1459; GONG H, 1992, CLIN CHEST MED, V13, P201; GRAM HC, 1931, UGESKRIFT LAEGER, V93, P109; GRIMM G, 1931, MUNCHEN MED WOCHEN, V78, P283; Haldane JS, 1931, BRIT MED J, V1931, P366, DOI 10.1136/bmj.1.3660.366; LAMBRETTE A, 1931, CHEM ZEITUNG, V55, P260; LIPFERT FW, 1994, AIR POLLUTION COMMUN, P111; LOGAN WPD, 1953, LANCET, V264, P336; MAGE J, 1932, CHIMIE IND, V27, P961; MAGE J, 1933, CHIMIE IND, V30, P787; Moureau P, 1965, Mem Acad R Med Belg, V5, P5; ROHOLM K., 1937, Journal of Industrial Hygiene and Toxicology, V19, P126; SCHENKER M, 1993, NEW ENGL J MED, V329, P1807, DOI 10.1056/NEJM199312093292410; SCHWARTZ J, 1994, ENVIRON RES, V64, P36, DOI 10.1006/enrs.1994.1005; VANLEEUWEN WS, 1931, MUNCHEN MED WOCHEN, V78, P4; WOLTER F, 1931, KLIN WOCHENSCHR, V10, P785; 1931, BMJ, V1, P277	35	163	174	4	50	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2001	357	9257					704	708		10.1016/S0140-6736(00)04135-0	http://dx.doi.org/10.1016/S0140-6736(00)04135-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247570				2022-12-28	WOS:000167282400037
J	Ambrose, SH				Ambrose, SH			Paleolithic technology and human evolution	SCIENCE			English	Review							BONOBO PAN-PANISCUS; STONE TOOL-MAKING; EARLY HOMINIDS; ARCHAEOLOGICAL EVIDENCE; WILD CHIMPANZEES; OLDUVAI GORGE; KOOBI-FORA; PLEISTOCENE; BEHAVIOR; AFRICAN	Human biological and cultural evolution are closely Linked to technological innovations. Direct evidence for tool manufacture and use is absent before 2.5 million years ago (Ma), so reconstructions of australopithecine technology are based mainly on the behavior and anatomy of chimpanzees. Stone tool technology, robust australopithecines, and the genus Homo appeared almost simultaneously 2.5 Ma. Once this adaptive threshold was crossed, technological evolution was accompanied by increased brain size, population size, and geographical range. Aspects of behavior, economy, mental capacities, neurological functions, the origin of grammatical Language, and social and symbolic systems have been inferred from the archaeological record of Paleolithic technology.	Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Ambrose, SH (corresponding author), Univ Illinois, Dept Anthropol, 109 Davenport Hall,607 S Mathews Ave, Urbana, IL 61801 USA.	ambrose@uiuc.edu						AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Ambrose SH, 1998, J HUM EVOL, V34, P623, DOI 10.1006/jhev.1998.0219; Ambrose SH, 1998, J ARCHAEOL SCI, V25, P377, DOI 10.1006/jasc.1997.0277; AMBROSE SH, IN PRESS SETTLEMENT; Anderson-Gerfaud P., 1990, EMERGENCE MODERN HUM, P389; [Anonymous], 1997, PROJECTILE TECHNOLOG; ASFAW B, 1992, NATURE, V360, P732, DOI 10.1038/360732a0; BACKWELL LR, P NATL ACAD SCI US, V98; Bar-Yosef O, 1999, AM ANTHROPOL, V101, P322, DOI 10.1525/aa.1999.101.2.322; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; Boeda E, 1996, NATURE, V380, P336, DOI 10.1038/380336a0; BOESCH C, 1984, J HUM EVOL, V13, P415, DOI 10.1016/S0047-2484(84)80055-X; Boesch-Achermann Hedwige, 1994, Evolutionary Anthropology, V3, P9, DOI 10.1002/evan.1360030106; Brain C.K., 1981, HUNTERS HUNTED INTRO; BRAIN CK, 1988, S AFR J SCI, V84, P828; BRAIN CK, 1983, MONOGRAPH TRANSVAAL, V8, P229; BUNN HT, 1981, NATURE, V291, P574, DOI 10.1038/291574a0; BYRNE RW, 1998, CREATIVITY HUMAN EVO, P110; Clark J. D., 1974, KALAMBO FALLS PREHIS, V2; Clark J. D., 1994, INTEGRATIVE PATHS PA, P451; CLARK JD, 1994, SCIENCE, V264, P1907, DOI 10.1126/science.8009220; CLARK JD, 1992, PHILOS T ROY SOC B, V337, P201, DOI 10.1098/rstb.1992.0098; CLARK JD, 1985, AFR ARCHAEOL REV, V3; Cotterell B, 1979, LITHIC USE WEAR ANAL, P97; DART RA, 1957, 3RD P PAN AFR C PREH, P161; Darwin Charles, 1871, DESCENT MAN; de Heinzelin J, 1999, SCIENCE, V284, P625; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Dibble H.L., 1995, DEFINITION INTERPRET; Dibble Harold L., 1995, J ARCHAEOL METHOD TH, V2, P299, DOI [10.1007/BF02229003, DOI 10.1007/BF02229003]; FALK D, 1983, SCIENCE, V221, P1072, DOI 10.1126/science.221.4615.1072; Feblot-Augustins J., 1999, MIDDLE PALAEOLITHIC, P193; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; Gowlett J. A. J., 1984, HOMINID EVOLUTION CO, P167; GREENFIELD PM, 1991, BEHAV BRAIN SCI, V14, P531, DOI 10.1017/S0140525X00071235; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HAY RL, 1976, GEOLOGY OLDUVAL GORG; Hou YM, 2000, SCIENCE, V287, P1622, DOI 10.1126/science.287.5458.1622; Isaac G., 1983, EVOLUTION MOL MEN, P509; Isaac G.L., 1977, OLORGESAILIE; Isaac G.L., 1986, STONE AGE PREHISTORY, P221; Isaac G. L. L., 1972, MODELS ARCHAEOLOGY, P167; Jelinek A. J., 1990, EMERGENCE MODERN HUM, P81; JONES PR, 1981, PHILOS T ROY SOC B, V292, P189, DOI 10.1098/rstb.1981.0027; Keeley L.H., 1980, EXPT DETERMINATION S; KEELEY LH, 1981, NATURE, V293, P464, DOI 10.1038/293464a0; KEMPLER D, 1992, TOOLS LANGUAGE COGNI, P193; Klein R.G., 1999, HUMAN CAREER; KLEIN RG, 1989, HUMAN REVOLUTION, P529; Kleindienst M. R., 1962, ACT 4 C PAN PREH ET, P81; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Kubrick Stanley, 2001, A SPACE ODYSSEY; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; LAWN BR, 1979, LITHIC USE WEAR ANAL, P63; Leakey M., 1969, P PREHIST SOC, V35, P48, DOI DOI 10.1017/S0079497X00013402; Leakey M.D., 1971, OLDUVAI GORGE; Leakey MD., 1975, AUSTRALOPITHECINES, P477, DOI [10.1515/9783110878837.477, DOI 10.1515/9783110878837.477]; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; LIEBERMAN P, 1989, HUMAN REVOLUTION, P391; Marzke MW, 2000, J ANAT, V197, P121, DOI 10.1046/j.1469-7580.2000.19710121.x; MATSUZAWA T, 1966, GREAT APE SOC, P196; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; MCGREW WC, 1966, GREAT APE SOC, P255; McPherron SP, 2000, J ARCHAEOL SCI, V27, P655, DOI 10.1006/jasc.1999.0467; MERRICK HV, 1976, HUMAN ORIGINS L LEAK, P461; Miller GH, 1999, SCIENCE, V283, P205, DOI 10.1126/science.283.5399.205; MILTON K, 1981, AM ANTHROPOL, V83, P534, DOI 10.1525/aa.1981.83.3.02a00020; NAPIER J, 1962, NATURE, V196, P409, DOI 10.1038/196409a0; Noll M. P., 2000, THESIS U ILLINOIS UR; Oakley K.P., 1956, MAN TOOL MAKER, V3rd; OBRIEN EM, 1981, CURR ANTHROPOL, V22, P76, DOI 10.1086/202607; Oswalt W. H, 1976, ANTHR ANAL FOOD GETT; PILBEAM D, 1974, SCIENCE, V186, P892, DOI 10.1126/science.186.4167.892; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; Potts R, 1999, EVOL ANTHROPOL, V7, P81, DOI 10.1002/(SICI)1520-6505(1998)7:3<81::AID-EVAN3>3.3.CO;2-1; Richmond BG, 2000, NATURE, V404, P382, DOI 10.1038/35006045; Ricklan D.E., 1990, P171; Roche H, 1999, NATURE, V399, P57, DOI 10.1038/19959; Schick K. D., 1993, MAKING SILENT STONES; Schick KD, 1999, J ARCHAEOL SCI, V26, P821, DOI 10.1006/jasc.1998.0350; SCHICK KD, INTEGRATIVE PATHS PA, P569; Schlanger N., 1994, ANCIENT MIND ELEMENT, P143, DOI DOI 10.1017/CBO9780511598388.015; Semaw S, 2000, J ARCHAEOL SCI, V27, P1197, DOI 10.1006/jasc.1999.0592; Soffer O, 2000, ANTIQUITY, V74, P812, DOI 10.1017/S0003598X00060464; STAHL AB, 1984, CURR ANTHROPOL, V25, P151, DOI 10.1086/203106; Stanford CB, 1996, AM ANTHROPOL, V98, P96, DOI 10.1525/aa.1996.98.1.02a00090; Stiner MC, 1999, SCIENCE, V283, P190, DOI 10.1126/science.283.5399.190; Stout D, 2000, J ARCHAEOL SCI, V27, P1215, DOI 10.1006/jasc.2000.0595; Susman RL, 1998, J HUM EVOL, V35, P23, DOI 10.1006/jhev.1998.0220; SWISHER CC, 1994, SCIENCE, V263, P1118, DOI 10.1126/science.8108729; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; Tobias P.V., 1991, OLDUVAI GORGE, V4; TOTH N, 1985, J HUM EVOL, V14, P607, DOI 10.1016/S0047-2484(85)80087-7; TOTH N, 1993, J ARCHAEOL SCI, V20, P81, DOI 10.1006/jasc.1993.1006; TOTH N, 1985, J ARCHAEOL SCI, V12, P101, DOI 10.1016/0305-4403(85)90056-1; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wood B, 2000, J ANAT, V197, P19, DOI 10.1046/j.1469-7580.2000.19710019.x; WYNN T, 1990, AM ANTHROPOL, V92, P73, DOI 10.1525/aa.1990.92.1.02a00050; Wynn T., 1991, CAMB ARCHAEOL J, V1, P191, DOI [DOI 10.1017/S0959774300000354), 10.1017/S0959774300000354, DOI 10.1017/S0959774300000354]	101	464	486	2	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2001	291	5509					1748	1753		10.1126/science.1059487	http://dx.doi.org/10.1126/science.1059487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11249821				2022-12-28	WOS:000167320600049
J	Springer, MS; de Jong, WW				Springer, MS; de Jong, WW			Phylogenetics - Which mammalian supertree to bark up?	SCIENCE			English	Editorial Material							ORIGINS		Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; Univ Nijmegen, Dept Biochem, Nijmegen, Netherlands; Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1012 WX Amsterdam, Netherlands	University of California System; University of California Riverside; Radboud University Nijmegen; University of Amsterdam	Springer, MS (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.							Asher RJ, 1999, CLADISTICS, V15, P231, DOI 10.1111/j.1096-0031.1999.tb00266.x; Gatesy J, 1999, SYST BIOL, V48, P6, DOI 10.1080/106351599260409; Hedges SB, 2001, P NATL ACAD SCI USA, V98, P1, DOI 10.1073/pnas.98.1.1; Hutcheon JM, 1998, PHILOS T R SOC B, V353, P607, DOI 10.1098/rstb.1998.0229; Liu FGR, 2001, SCIENCE, V291, P1786, DOI 10.1126/science.1056346; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; Mouchaty SK, 2000, ZOOL SCR, V29, P307, DOI 10.1046/j.1463-6409.2000.00045.x; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Sanderson MJ, 1998, TRENDS ECOL EVOL, V13, P105, DOI 10.1016/S0169-5347(97)01242-1; Shoshani J, 1998, MOL PHYLOGENET EVOL, V9, P572, DOI 10.1006/mpev.1998.0520; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1	12	63	70	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2001	291	5509					1709	+		10.1126/science.1059434	http://dx.doi.org/10.1126/science.1059434			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11253193				2022-12-28	WOS:000167320600031
J	Hartmann, C; Tabin, CJ				Hartmann, C; Tabin, CJ			Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton	CELL			English	Article							REPLICATION-COMPETENT RETROVIRUSES; PROGRAMMED CELL-DEATH; TGF-BETA-SUPERFAMILY; CHICK LIMB BUD; CARTILAGE DIFFERENTIATION; VERTEBRATE LIMB; GENE-EXPRESSION; METATARSOPHALANGEAL JOINT; PATTERN-FORMATION; DIGIT DEVELOPMENT	The long bones of the vertebrate appendicular skeleton arise from initially continuous condensations of mesenchymal cells that subsequently segment and cavitate to form discrete elements separated by synovial joints, tittle is known, however, about the molecular mechanisms of joint formation. We present evidence that Wnt-14 plays a central role in initiating synovial joint formation in the chick limb. Wnt-14 is expressed in joint-forming regions prior to the segmentation of the cartilage elements, and local misexpression of Wnt-14 induces morphological and molecular changes characteristic of the first steps of joint formation. Induction of an ectopic joint-like region by Wnt-14 suppresses the formation of the immediately adjacent endogenous joint, potentially providing insight into the spacing of joints.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@rascal.med.harvard.edu		Hartmann, Christine/0000-0002-6854-8633				AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; ALLEN T. C., 1994, LAB METHODS HISTOTEC, P53; Arias AM, 1999, CURR OPIN GENET DEV, V9, P447, DOI 10.1016/S0959-437X(99)80068-9; Bachner D, 1999, MECH DEVELOP, V84, P121, DOI 10.1016/S0925-4773(99)00048-9; BALLARD KJ, 1968, J CELL SCI, V3, P245; Bergstein I, 1997, GENOMICS, V46, P450, DOI 10.1006/geno.1997.5041; Capdevila J, 1998, DEV BIOL, V197, P205, DOI 10.1006/dbio.1997.8824; CHANG SC, 1994, J BIOL CHEM, V269, P28227; Cox RT, 1998, CURR BIOL, V8, pR140, DOI 10.1016/S0960-9822(98)70081-8; CRAIG FM, 1987, DEVELOPMENT, V99, P383; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Dierick H, 1999, CURR TOP DEV BIOL, V43, P153, DOI 10.1016/S0070-2153(08)60381-6; EDWARDS JCW, 1994, J ANAT, V185, P355; Francis-West PH, 1999, DEVELOPMENT, V126, P1305; Francis-West PH, 1999, CELL TISSUE RES, V296, P111, DOI 10.1007/s004410051272; GAFFNEY E, 1994, LAB METHODS HISTOTEC, P149; Goff DJ, 1997, DEVELOPMENT, V124, P627; GRUNEBERG H, 1973, J EMBRYOL EXP MORPH, V30, P119; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Hall BK, 1995, INT J DEV BIOL, V39, P881; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Healy C, 1996, ANN NY ACAD SCI, V785, P261, DOI 10.1111/j.1749-6632.1996.tb56278.x; Hinchliffe J. R., 1980, DEV VERTEBRATE LIMB; HINCHLIFFE JR, 1994, DEVELOPMENT, P163; HOLDER N, 1977, J EMBRYOL EXP MORPH, V39, P115; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Hurle JM, 1996, ANAT EMBRYOL, V193, P355; Hurvitz JR, 1999, NAT GENET, V23, P94, DOI 10.1038/12699; IZPISUABELMONTE JC, 1992, DEV BIOL, V152, P26, DOI 10.1016/0012-1606(92)90153-8; Kawakami Y, 1999, DEV GROWTH DIFFER, V41, P29; Kimura S, 1996, J MORPHOL, V229, P337, DOI 10.1002/(SICI)1097-4687(199609)229:3<337::AID-JMOR8>3.0.CO;2-V; KOYAMA E, 1995, DEV DYNAM, V203, P152, DOI 10.1002/aja.1002030204; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; LANDAUER W, 1952, J HERED, V43, P293, DOI 10.1093/oxfordjournals.jhered.a106335; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; Merino R, 1999, DEV BIOL, V206, P33, DOI 10.1006/dbio.1998.9129; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; MITROVIC DR, 1977, AM J ANAT, V150, P333, DOI 10.1002/aja.1001500207; Mlodzik M, 1999, EMBO J, V18, P6873, DOI 10.1093/emboj/18.24.6873; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; MORI C, 1995, ANAT REC, V242, P103, DOI 10.1002/ar.1092420114; NAH HD, 1988, COLLAGEN REL RES, V8, P277; NALIN AM, 1995, DEV DYNAM, V203, P352, DOI 10.1002/aja.1002030307; OSTER GF, 1988, EVOLUTION, V42, P862, DOI 10.1111/j.1558-5646.1988.tb02508.x; Pathi S, 1999, DEV BIOL, V209, P239, DOI 10.1006/dbio.1998.9181; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; PITSILLIDES AA, 1995, J HISTOCHEM CYTOCHEM, V43, P263, DOI 10.1177/43.3.7868856; PITSILLIDES AA, 1999, BIOL SYNOVIAL JOINT, P41; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; ROS MA, 1995, ANAT EMBRYOL, V192, P483; Rudnicki JA, 1997, DEV BIOL, V185, P104, DOI 10.1006/dbio.1997.8536; Schweitzer R, 2000, MECH DEVELOP, V98, P171, DOI 10.1016/S0925-4773(00)00458-5; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; SHUBIN NH, 1986, EVOL BIOL, V20, P319; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Storm EE, 1996, DEVELOPMENT, V122, P3969; Stott NS, 1999, J CELL PHYSIOL, V180, P314, DOI 10.1002/(SICI)1097-4652(199909)180:3<314::AID-JCP2>3.3.CO;2-P; SWIDERSKI RE, 1992, DEVELOPMENT, V115, P169; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; TICKLE C, 1995, CURR OPIN GENET DEV, V5, P478, DOI 10.1016/0959-437X(95)90052-I; Wada N, 1999, INT J DEV BIOL, V43, P495; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537; WOLPERT L, 1990, J CELL SCI, P199; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xu LF, 2000, GENE DEV, V14, P585; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; ZAKANY J, 1993, NATURE, V362, P546, DOI 10.1038/362546a0; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	72	372	384	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2001	104	3					341	351		10.1016/S0092-8674(01)00222-7	http://dx.doi.org/10.1016/S0092-8674(01)00222-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239392	Bronze			2022-12-28	WOS:000167003100005
J	Thorpe, SJ; Fabre-Thorpe, M				Thorpe, SJ; Fabre-Thorpe, M			Perspectives: Neuroscience - Seeking categories in the brain	SCIENCE			English	Editorial Material							TEMPORAL VISUAL-CORTEX; RHESUS-MONKEYS; NEURONS; FACE; OBJECTS; IMAGES		Univ Toulouse 3, Ctr Rech Cerveau & Cognit, UMR 5549, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Thorpe, SJ (corresponding author), Univ Toulouse 3, Ctr Rech Cerveau & Cognit, UMR 5549, F-31062 Toulouse, France.	thorpe@cerco.ups-tlse.fr	Fabre-Thorpe, Michèle/B-2698-2008; THORPE, Simon J/A-5661-2008	THORPE, Simon J/0000-0003-4997-3367				Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Antal A, 2000, COGNITIVE BRAIN RES, V9, P117, DOI 10.1016/S0926-6410(99)00053-1; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Delorme A, 2000, VISION RES, V40, P2187, DOI 10.1016/S0042-6989(00)00083-3; Fabre-Thorpe M, 1998, NEUROREPORT, V9, P303, DOI 10.1097/00001756-199801260-00023; FABRETHORPE M, IN PRESS J COGN NEUR; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Jeffreys DA, 1996, VIS COGN, V3, P1, DOI 10.1080/713756729; JOHNSON JS, 2000, SOC NEUR ABSTR, V26, P952; KEYSERS C, IN PRESS J COGN NEUR; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; NOWAK LG, 1997, EXTRASTRIATE VISUAL, V12, P205; ORAM MW, 1992, J NEUROPHYSIOL, V68, P70, DOI 10.1152/jn.1992.68.1.70; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; ROLLS ET, 1979, BRAIN RES, V164, P121, DOI 10.1016/0006-8993(79)90010-6; ROLLS ET, 1977, BRAIN RES, V130, P229, DOI 10.1016/0006-8993(77)90272-4; SHEINBERG DL, IN PRESS J NEUROSCI; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Treisman AM, 1998, CURR OPIN NEUROBIOL, V8, P218, DOI 10.1016/S0959-4388(98)80143-8; VANRULLEN R, IN PRESS J COGN NEUR; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x	23	197	200	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2001	291	5502					260	+		10.1126/science.1058249	http://dx.doi.org/10.1126/science.1058249			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11253215				2022-12-28	WOS:000166352900032
J	Makishima, S; Komoriya, K; Yamaguchi, S; Aizawa, SI				Makishima, S; Komoriya, K; Yamaguchi, S; Aizawa, SI			Length of the flagellar hook and the capacity of the type III export apparatus	SCIENCE			English	Article							PROTEIN SECRETION SYSTEM; SALMONELLA-TYPHIMURIUM; SUPRAMOLECULAR STRUCTURE; MOTOR; FLIK; COMPLEX; MUTATIONS; COMPONENT; MACHINERY; ROTATION	Length determination in biology generally uses molecular rulers. The hook, a part of the flagellum of motile bacteria, has an invariant Length. Here, we examined hook length and found that it was determined not by molecular rulers but probably by the amount of subunit protein secreted by the flagellar export apparatus. The export apparatus shares common features with the type III virulence-factor secretion machinery and thus may be used more widely in Length determination of structures other than flagella.	Teikyo Univ, Dept Biosci, Utsunomiya, Tochigi 3208551, Japan; Utsunomiya Univ, Dept Appl Biochem, Utsunomiya, Tochigi 3218505, Japan; Meiji Univ, Tokyo 1680064, Japan	Teikyo University; Utsunomiya University; Meiji University	Aizawa, SI (corresponding author), Teikyo Univ, Dept Biosci, 1-1 Toyosatodai, Utsunomiya, Tochigi 3208551, Japan.			Aizawa, Shin-Ichi/0000-0002-9068-0825				Aizawa SI, 1996, MOL MICROBIOL, V19, P1, DOI 10.1046/j.1365-2958.1996.344874.x; FRANZ WM, 1994, CARDIOSCIENCE, V5, P235; HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; IRIKURA VM, 1993, J BACTERIOL, V175, P802, DOI 10.1128/JB.175.3.802-810.1993; JONES CJ, 1990, J MOL BIOL, V212, P377, DOI 10.1016/0022-2836(90)90132-6; KATADA MINORU, 1955, JOUR SHIMONOSEKI COLL FISH, V5, P1; KHAN IH, 1992, P NATL ACAD SCI USA, V89, P5956, DOI 10.1073/pnas.89.13.5956; Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x; Koroyasu S, 1998, BIOPHYS J, V74, P436, DOI 10.1016/S0006-3495(98)77801-4; KUBORI T, 1992, J MOL BIOL, V226, P433, DOI 10.1016/0022-2836(92)90958-M; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Kutsukake K, 1997, J BACTERIOL, V179, P1268, DOI 10.1128/jb.179.4.1268-1273.1997; Lloyd SA, 1999, NATURE, V400, P472, DOI 10.1038/22794; MACNAB RM, 1996, CELLULAR MOL BIOL, P123; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; Minamino T, 1999, MOL MICROBIOL, V34, P295, DOI 10.1046/j.1365-2958.1999.01597.x; Muramoto K, 1998, J MOL BIOL, V277, P871, DOI 10.1006/jmbi.1998.1659; Muramoto K, 1999, J BACTERIOL, V181, P5808, DOI 10.1128/JB.181.18.5808-5813.1999; OHNISHI K, 1994, J BACTERIOL, V176, P2272, DOI 10.1128/JB.176.8.2272-2281.1994; Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876; Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996; YAMAGUCHI S, 1986, J BACTERIOL, V168, P1172, DOI 10.1128/jb.168.3.1172-1179.1986; YAMAGUCHI S, 1986, J BACTERIOL, V166, P187, DOI 10.1128/jb.166.1.187-193.1986	25	81	83	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2411	2413		10.1126/science.1058366	http://dx.doi.org/10.1126/science.1058366			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264537				2022-12-28	WOS:000167618700056
J	Trewavas, A				Trewavas, A			Urban myths of organic farming	NATURE			English	Editorial Material									Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JH, Midlothian, Scotland	University of Edinburgh	Trewavas, A (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JH, Midlothian, Scotland.							ADDISCOTT TM, 1995, EUR J SOIL SCI, V46, P161, DOI 10.1111/j.1365-2389.1995.tb01823.x; AMES BN, 1990, P NATL ACAD SCI USA, V87, P7777, DOI 10.1073/pnas.87.19.7777; BERTILSSON G, 1992, P FERT SOC, V332; COGGON D, 1994, BRIT MED J, V308, P705, DOI 10.1136/bmj.308.6930.705; FOWLER SM, 1993, J AGR SCI, V120, P353, DOI 10.1017/S0021859600076516; *HOUS LORDS SEL CO, 1999, 16 HOUS LORDS SEL CO; Hovde CJ, 1999, APPL ENVIRON MICROB, V65, P3233; KAFFKA S, 1989, BIOL AGRIC HORTIC, V6, P89, DOI 10.1080/01448765.1989.9754508; Kirchmann H, 2000, EUR J AGRON, V12, P145, DOI 10.1016/S1161-0301(99)00053-2; Kline S. J, 1995, CONCEPTUAL FDN MULTI; MacKenzie D, 1999, NEW SCI, V162, P4; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; NOLTE C, 1994, BIOL AGRIC HORTIC, V10, P235, DOI 10.1080/01448765.1994.9754676; SCHUPHAN W, 1974, QUAL PLANT, V23, P333, DOI 10.1007/BF01095422; TSCHAPE H, 1995, EPIDEMIOL INFECT, V114, P441, DOI 10.1017/S0950268800052158; WARNE J, 1999, FARMERS WEEKLY, V130, P91; Woese K, 1997, J SCI FOOD AGR, V74, P281, DOI [10.1002/(SICI)1097-0010(199707)74:3&lt;281::AID-JSFA794&gt;3.0.CO;2-Z, 10.1002/(SICI)1097-0010(199707)74:3<281::AID-JSFA794>3.3.CO;2-Q]; Wood D, 1998, FOOD POLICY, V23, P371, DOI 10.1016/S0306-9192(98)00043-8; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	19	205	219	1	99	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					409	410		10.1038/35068639	http://dx.doi.org/10.1038/35068639			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260685	Bronze			2022-12-28	WOS:000167583800016
J	Dresser, R				Dresser, R			Ethical issues in embryonic stem cell research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Washington Univ, Sch Law, St Louis, MO 63130 USA; Washington Univ, Sch Med, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Dresser, R (corresponding author), Washington Univ, Sch Law, St Louis, MO 63130 USA.							Ethics Comm Am Soc Reprod Med, 2000, FERTIL STERIL, V74, P216; Juengst E, 2000, JAMA-J AM MED ASSOC, V284, P3180, DOI 10.1001/jama.284.24.3180; Lanza RP, 2000, JAMA-J AM MED ASSOC, V284, P3175, DOI 10.1001/jama.284.24.3175; Wade Nicholas, 1998, N Y Times Web, pA26	4	10	10	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1439	1440						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410VQ	11255409				2022-12-28	WOS:000167462100015
J	Murphy, AM				Murphy, AM			Searching for Margaret	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1413	1414		10.1001/jama.285.11.1413	http://dx.doi.org/10.1001/jama.285.11.1413			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410VQ	11255399				2022-12-28	WOS:000167462100001
J	Gage, BF; Fihn, SD; White, RH				Gage, BF; Fihn, SD; White, RH			Warfarin therapy for an octogenarian who has atrial fibrillation	ANNALS OF INTERNAL MEDICINE			English	Review							ORAL ANTICOAGULANT-THERAPY; MOLECULAR-WEIGHT HEPARIN; FIXED MINIDOSE WARFARIN; BLEEDING COMPLICATIONS; ANTITHROMBOTIC THERAPY; DOUBLE-BLIND; RISK-FACTORS; VITAMIN-K; OUTPATIENT ANTICOAGULATION; EXCESSIVE ANTICOAGULATION	In North America, atrial fibrillation is associated with at least 75 000 ischemic strokes each year. Most of these strokes occur in patients older than 75 years of age. The high incidence of stroke in very elderly persons reflects the increasing prevalence of atrial fibrillation that occurs with advanced age, the high incidence of stroke in elderly patients, and the failure of physicians to prescribe antithrombotic therapy in most of these patients. This failure is related to the increased risk for major hemorrhage with advanced age, obfuscating the decision to institute stroke prophylaxis with antithrombotic therapy. This case-based review describes the risk and benefits of prescribing antithrombotic therapy for a hypothetical 80-year-old man who has atrial fibrillation and hypertension, and it offers practical advice on managing warfarin therapy. After concluding that the benefits of warfarin outweigh its risks in this patient, we describe how to initiate warfarin therapy cautiously and how to monitor and dose the drug. We then review five recent randomized, controlled trials that document the increased risk for stroke when an international normalized ratio (INR) of less than 2.0 is targeted among patients with atrial fibrillation. Next, we make the case that cardioversion is not needed for this asymptomatic patient with chronic atrial fibrillation. Instead, we choose to leave the patient in atrial fibrillation and to central his ventricular rate with atenolol. Later, when the INR increases to 4.9, we advocate withholding one dose of warfarin and repeating the INR test. Finally, when the patient develops dental pain, we review the analgesic agents that are safe to take with warfarin and explain why warfarin therapy does not have to be interrupted during a subsequent dental extraction.	Washington Univ, Sch Med, Div Gen Med Sci, St Louis, MO 63110 USA; Univ Washington, Seattle, WA 98195 USA; Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; Univ Calif Davis, Sacramento, CA 95817 USA	Washington University (WUSTL); University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of California System; University of California Davis	Gage, BF (corresponding author), Washington Univ, Sch Med, Div Gen Med Sci, Campus Box 8005,660 S Euclid Ave, St Louis, MO 63110 USA.	bgage@im.wustl.edu	Fihn, Stephan/ABA-1040-2020	Gage, Brian/0000-0002-4727-8742	AHRQ HHS [R01 HS10133] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010133] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Anand SS, 1999, JAMA-J AM MED ASSOC, V282, P2058, DOI 10.1001/jama.282.21.2058; Anand SS, 1998, CIRCULATION, V98, P1064, DOI 10.1161/01.CIR.98.11.1064; Anderson DC, 1998, JAMA-J AM MED ASSOC, V279, P1273; Ansell JE, 1997, ANN PHARMACOTHER, V31, P604, DOI 10.1177/106002809703100516; ANTLITZ AM, 1969, CURR THER RES CLIN E, V11, P360; ANTLITZ AM, 1968, CURR THER RES CLIN E, V10, P501; ARONOW WS, 1994, DRUG AGING, V4, P184, DOI 10.2165/00002512-199404030-00002; Beirne OR, 1996, J ORAL MAXIL SURG, V54, P1115, DOI 10.1016/S0278-2391(96)90172-X; BENOLIEL R, 1986, ORAL SURG ORAL MED O, V62, P149, DOI 10.1016/0030-4220(86)90036-8; Berge E, 2000, LANCET, V355, P1205, DOI 10.1016/S0140-6736(00)02085-7; Beyth RJ, 1998, AM J MED, V105, P91, DOI 10.1016/S0002-9343(98)00198-3; Bhavnani M, 1998, BRIT J HAEMATOL, V102, P1110; Blackshear JL, 1996, LANCET, V348, P633; BOISSEL JP, 1982, NEW ENGL J MED, V307, P701; Brigden ML, 1998, AM J HEMATOL, V59, P22, DOI 10.1002/(SICI)1096-8652(199809)59:1<22::AID-AJH5>3.3.CO;2-J; BRITT RP, 1992, J CLIN PATHOL, V45, P1003, DOI 10.1136/jcp.45.11.1003; Chesebro JH, 1996, ARCH INTERN MED, V156, P409; COSGRIFF SW, 1956, ANN INTERN MED, V45, P14, DOI 10.7326/0003-4819-45-1-14; Crowther MA, 1997, ANN INTERN MED, V127, P333, DOI 10.7326/0003-4819-127-4-199708150-00019; Crowther MA, 1998, THROMB HAEMOSTASIS, V79, P1116; Crowther MA, 1999, ARCH INTERN MED, V159, P46, DOI 10.1001/archinte.159.1.46; Crowther MA, 2000, LANCET, V356, P1551, DOI 10.1016/S0140-6736(00)03125-1; DECLERCK D, 1992, J DENT RES, V71, P387, DOI 10.1177/00220345920710020701; DITTRICH HC, 1989, AM J CARDIOL, V63, P193, DOI 10.1016/0002-9149(89)90284-1; DOBRZANSKI S, 1983, J CLIN HOSP PHARM, V8, P75, DOI 10.1111/j.1365-2710.1983.tb00899.x; DUXBURY BM, 1986, ACTA HAEMATOL-BASEL, V76, P65, DOI 10.1159/000206023; Ezekowitz, 1999, J Cardiovasc Pharmacol Ther, V4, P3, DOI 10.1177/107424849900400102; Ezekowitz M, 1998, ARCH INTERN MED, V158, P1316; Fairweather RB, 1998, ARCH PATHOL LAB MED, V122, P768; FERGUSSON RJ, 1987, SCOT MED J, V32, P169, DOI 10.1177/003693308703200604; Fetrow CW, 1997, J CLIN PHARMACOL, V37, P751, DOI 10.1002/j.1552-4604.1997.tb04363.x; FIHN SD, 1994, J GEN INTERN MED, V9, P131, DOI 10.1007/BF02600026; Fihn SD, 1996, ANN INTERN MED, V124, P970, DOI 10.7326/0003-4819-124-11-199606010-00004; FIHN SD, 1993, ANN INTERN MED, V118, P511, DOI 10.7326/0003-4819-118-7-199304010-00005; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORFAR JC, 1979, BRIT HEART J, V42, P128; Furuya H, 1995, PHARMACOGENETICS, V5, P389, DOI 10.1097/00008571-199512000-00008; Fuster V, 1997, LANCET, V350, P389; GAGE BF, 1995, JAMA-J AM MED ASSOC, V274, P1839, DOI 10.1001/jama.274.23.1839; Gage BF, 2000, AM J MED, V109, P481, DOI 10.1016/S0002-9343(00)00545-3; Gage BF, 1998, STROKE, V29, P1083, DOI 10.1161/01.STR.29.6.1083; Gage BF, 2000, STROKE, V31, P822, DOI 10.1161/01.STR.31.4.822; Gage BF, 2001, STROKE, V32, P323; GARTEN S, 1971, BIOCHEM PHARMACOL, V20, P1661, DOI 10.1016/0006-2952(71)90294-2; Gerson LB, 2000, AM J GASTROENTEROL, V95, P1717; GLADMAN JRF, 1995, POSTGRAD MED J, V71, P153, DOI 10.1136/pgmj.71.833.153; GLOVER JJ, 1995, CHEST, V108, P987, DOI 10.1378/chest.108.4.987; Golzari H, 1996, ANN INTERN MED, V125, P311, DOI 10.7326/0003-4819-125-4-199608150-00010; Gullov AL, 1998, ARCH INTERN MED, V158, P1513, DOI 10.1001/archinte.158.14.1513; GURWITZ JH, 1992, ANN INTERN MED, V116, P901, DOI 10.7326/0003-4819-116-11-901; GURWITZ JH, 1988, ARCH INTERN MED, V148, P1733, DOI 10.1001/archinte.148.8.1733; Harrison L, 1997, ANN INTERN MED, V126, P133, DOI 10.7326/0003-4819-126-2-199701150-00006; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hart RG, 1998, ANN INTERN MED, V128, P408, DOI 10.7326/0003-4819-128-5-199803010-00012; Hellemons BSP, 1999, BMJ-BRIT MED J, V319, P958, DOI 10.1136/bmj.319.7215.958; Hirsh J, 1998, CHEST, V114, p445S, DOI 10.1378/chest.114.5_Supplement.445S; Horton JD, 1999, AM FAM PHYSICIAN, V59, P635; Huber KC, 1997, MAYO CLIN PROC, V72, P1103, DOI 10.4065/72.12.1103; Hull RD, 2000, ARCH INTERN MED, V160, P2199, DOI 10.1001/archinte.160.14.2199; Hylck EM, 2000, ARCH INTERN MED, V160, P1612, DOI 10.1001/archinte.160.11.1612; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802; Hylek EM, 1998, JAMA-J AM MED ASSOC, V279, P657, DOI 10.1001/jama.279.9.657; JAMES AH, 1992, J CLIN PATHOL, V45, P704, DOI 10.1136/jcp.45.8.704; Kearon C, 1997, NEW ENGL J MED, V336, P1506, DOI 10.1056/NEJM199705223362107; KOUDSTAAL PJ, 1995, NEW ENGL J MED, V333, P5; KUMAR S, 1989, THROMB HAEMOSTASIS, V62, P729; Laffort P, 2000, J AM COLL CARDIOL, V35, P739, DOI 10.1016/S0735-1097(99)00598-7; LANDEFELD CS, 1989, AM J MED, V87, P144; LANDEFELD CS, 1993, AM J MED, V95, P315, DOI 10.1016/0002-9343(93)90285-W; LAUNBJERG J, 1991, J INTERN MED, V229, P351, DOI 10.1111/j.1365-2796.1991.tb00358.x; Laupacis A, 1998, CHEST, V114, p579S, DOI 10.1378/chest.114.5_Supplement.579S; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Lousberg TR, 1998, ARCH INTERN MED, V158, P528, DOI 10.1001/archinte.158.5.528; MADURA JA, 1994, AM SURGEON, V60, P542; Makris M, 1997, THROMB HAEMOSTASIS, V77, P477; Man-Son-Hing M, 2000, MED DECIS MAKING, V20, P394, DOI 10.1177/0272989X0002000403; MATCHAR DB, 1994, ANN INTERN MED, V121, P54; MCCURDY SA, 1992, ARCH INTERN MED, V152, P589, DOI 10.1001/archinte.152.3.589; MCEVOY G, 2000, AM HOSP FORMULARY SE; Meade TW, 1998, LANCET, V351, P233; Michelson AD, 1998, CHEST, V114, p748S, DOI 10.1378/chest.114.5_Supplement.748S; Oates A, 1998, BRIT J CLIN PHARMACO, V46, P157, DOI 10.1046/j.1365-2125.1998.00755.x; PALARETI G, 1994, THROMB HAEMOSTASIS, V72, P222; Palareti G, 2000, ARCH INTERN MED, V160, P470, DOI 10.1001/archinte.160.4.470; PENGO V, 1993, BLOOD COAGUL FIBRIN, V4, P739, DOI 10.1097/00001721-199304050-00010; Pengo V, 1998, AM J CARDIOL, V82, P433, DOI 10.1016/S0002-9149(98)00357-9; Prystowsky EN, 1996, CIRCULATION, V93, P1262, DOI 10.1161/01.CIR.93.6.1262; ROSPOND RM, 1989, PHARMACOTHERAPY, V9, P207; ROUTLEDGE PA, 1979, EUR J CLIN PHARMACOL, V15, P319, DOI 10.1007/BF00558434; RYAN PJ, 1989, BRIT MED J, V299, P1207, DOI 10.1136/bmj.299.6709.1207; SCHIRGER A, 1959, P STAFF M MAYO CLIN, V34, P453; Segal JB, 2000, J FAM PRACTICE, V49, P47; Siegel JE, 1998, AM J CLIN PATHOL, V110, P184; SORANO GG, 1993, HAEMOSTASIS, V23, P77; Spandorfer JM, 1999, AM J CARDIOL, V84, P478, DOI 10.1016/S0002-9149(99)00341-0; Steward DJ, 1997, PHARMACOGENETICS, V7, P361, DOI 10.1097/00008571-199710000-00004; Tait RC, 1998, BRIT J HAEMATOL, V101, P450; TAKAHASHI H, 1965, CLIN PHARMACOL THER, V63, P519; Tiede DJ, 1998, MAYO CLIN PROC, V73, P665; TINKER JH, 1978, JAMA-J AM MED ASSOC, V239, P738, DOI 10.1001/jama.239.8.738; Triplett DA, 1998, MED CLIN N AM, V82, P601, DOI 10.1016/S0025-7125(05)70013-4; TURPIE AGG, 1993, NEW ENGL J MED, V329, P524, DOI 10.1056/NEJM199308193290802; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; VanGelder IC, 1996, ARCH INTERN MED, V156, P2585, DOI 10.1001/archinte.156.22.2585; Wahl MJ, 2000, J AM DENT ASSOC, V131, P77, DOI 10.14219/jada.archive.2000.0024; Weibert RT, 1997, ANN INTERN MED, V126, P959, DOI 10.7326/0003-4819-126-12-199706150-00005; WELLS PS, 1994, ANN INTERN MED, V121, P676, DOI 10.7326/0003-4819-121-9-199411010-00009; WHITE RH, 1987, J GEN INTERN MED, V2, P141, DOI 10.1007/BF02596140; WHITE RH, 1991, THER DRUG MONIT, V13, P46, DOI 10.1097/00007691-199101000-00006; White RH, 1996, ARCH INTERN MED, V156, P1197, DOI 10.1001/archinte.156.11.1197; WHITE RH, 1995, ANN INTERN MED, V122, P40, DOI 10.7326/0003-4819-122-1-199501010-00006; White RH, 1999, AM J MED, V107, P414, DOI 10.1016/S0002-9343(99)00267-3; Wong W, 1999, PHARMACOTHERAPY, V19, P1385, DOI 10.1592/phco.19.18.1385.30894; Wyse DG, 1997, AM J CARDIOL, V79, P1198; Yamaguchi T, 2000, STROKE, V31, P817, DOI 10.1161/01.STR.31.4.817	116	35	35	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					465	474		10.7326/0003-4819-134-6-200103200-00011	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00011			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409VF	11255522				2022-12-28	WOS:000167405800005
J	Leeson, CPM; Kattenhorn, M; Deanfield, JE; Lucas, A				Leeson, CPM; Kattenhorn, M; Deanfield, JE; Lucas, A			Duration of breast feeding and arterial distensibility in early adult life: population based study	BRITISH MEDICAL JOURNAL			English	Article							CHOLESTEROL; CHILDREN	Objectives To test the hypothesis that duration of breast feeding is related to changes in vascular function relevant to the development of cardiovascular disease. Design Population based observational study, Setting Cambridge. Participants 331 adults 171 women, 160 men) aged between 20 and 28 years, born in Cambridge Maternity Hospital. Main outcome measures Distensibility of brachial artery, type and duration of infant feeding, current lipid profile, and other cardiovascular. risk factors. Results The longer the period of breast feeding the less distensible the artery wall in early adult life, with no ses differences (regression coefficient = - 3.93 mum/month, 95% confidence interval - 7.29 to - 0.57, P = 0.02), However, in those breast fed for less than four months, arterial distensibility was not significantly reduced compared with an exclusively formula fed group. The vascular changes observed were not explained by alterations in plasma cholesterol concentration in adult life. Conclusions Breast feeding in infancy is related to reduced arterial function 20 years later. These data should not alter current recommendations in favour of bl east feeding, which has several benefits for infant health. Further work is needed, however, to explore the optimal duration of breast feeding in relation to cardiovascular outcomes.	Inst Child Hlth, MRC, Childhood Nutr Res Ctr, London WC1N 1EH, England; Great Ormond St Hosp Children, Vasc Physiol Unit, London WC1N 3JH, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Leeson, CPM (corresponding author), Inst Child Hlth, MRC, Childhood Nutr Res Ctr, 30 Guilford St, London WC1N 1EH, England.		Leeson, Paul/K-6964-2012; Deanfield, John E/C-5178-2008	Deanfield, John/0000-0001-8806-6052				CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; FALL CHD, 1992, BRIT MED J, V304, P801, DOI 10.1136/bmj.304.6830.801; Gartner LM, 1997, PEDIATRICS, V100, P1035, DOI 10.1542/peds.100.6.1035; HOEKS APG, 1990, ULTRASOUND MED BIOL, V16, P121, DOI 10.1016/0301-5629(90)90139-4; KARK JD, 1984, J EPIDEMIOL COMMUN H, V38, P218, DOI 10.1136/jech.38.3.218; Leeson CPM, 1997, CIRCULATION, V96, P2233; Leeson CPM, 2000, CIRCULATION, V101, P1533, DOI 10.1161/01.CIR.101.13.1533; Leeson P, 1997, HEART, V78, P22, DOI 10.1136/hrt.78.1.22; LUCAS A, 1991, CIBA F SYMP, V156, P38; MOTT GE, 1995, J LIPID RES, V36, P299; MOTT GE, 1991, CIBA FDN S CHILDHOOD, P128; *OFF POP CENS SURV, 1997, HLTH SURV ENGL 995; *OFF POP CENS SURV, 1986, OCC MORT DEC SUPPL 1; PHILLIPS DIW, 1993, ACTA ENDOCRINOL-COP, V129, P134, DOI 10.1530/acta.0.1290134; WONG WW, 1993, J LIPID RES, V34, P1403	15	87	87	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 17	2001	322	7287					643	647		10.1136/bmj.322.7287.643	http://dx.doi.org/10.1136/bmj.322.7287.643			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413QE	11250848	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000167622600023
J	Bibb, JA; Chen, JS; Taylor, JR; Svenningsson, P; Nishi, A; Snyder, GL; Yan, Z; Sagawa, ZK; Ouimet, CC; Nairn, AC; Nestler, EJ; Greengard, P				Bibb, JA; Chen, JS; Taylor, JR; Svenningsson, P; Nishi, A; Snyder, GL; Yan, Z; Sagawa, ZK; Ouimet, CC; Nairn, AC; Nestler, EJ; Greengard, P			Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5	NATURE			English	Article							MOLECULAR MECHANISMS; OPPOSITE MODULATION; CONDITIONED REWARD; LOCOMOTOR-ACTIVITY; NUCLEUS-ACCUMBENS; GENE-EXPRESSION; GLUR1 SUBUNIT; MUTANT MICE; DOPAMINE; PHOSPHORYLATION	Cocaine enhances dopamine-mediated neurotransmission by blocking dopamine re-uptake at axon terminals. Most dopamine-containing nerve terminals innervate medium spiny neurons in the striatum of the brain. Cocaine addiction is thought to stem, in part, from neural adaptations that act to maintain equilibrium by countering the effects of repeated drug administration(1,2). Chronic exposure to cocaine upregulates several transcription factors that alter gene expression and which could mediate such compensatory neural and behavioural changes(1-4). One such transcription factor is Delta FosB, a protein that persists in striatum long after the end of cocaine exposure(3,5). Here we identify cyclin-dependent kinase 5 (Cdk5) as a downstream target gene of Delta FosB by use of DNA array analysis of striatal material from inducible transgenic mice. Overexpression of Delta FosB, or chronic cocaine administration, raised levels of Cdk5 messenger RNA, protein, and activity in the striatum. Moreover, injection of Cdk5 inhibitors into the striatum potentiated behavioural effects of repeated cocaine administration. Our results suggest that changes in Cdk5 levels mediated by Delta FosB, and resulting alterations in signalling involving D1 dopamine receptors, contribute to adaptive changes in the brain related to cocaine addiction.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; Kurume Univ, Sch Med, Dept Physiol, Fukuoka 8300011, Japan; Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA	Rockefeller University; Yale University; Kurume University; State University System of Florida; Florida State University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bibb, JA (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10021 USA.		Svenningsson, Per JL/K-5210-2014	Nairn, Angus/0000-0002-7075-0195	NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NIDA NIH HHS [P01 DA010044] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Caporaso GL, 2000, NEUROPHARMACOLOGY, V39, P1637, DOI 10.1016/S0028-3908(99)00230-0; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen JS, 1998, MOL PHARMACOL, V54, P495, DOI 10.1124/mol.54.3.495; DREHER JK, 1989, BRAIN RES, V487, P267, DOI 10.1016/0006-8993(89)90831-7; DULUBOVA I, IN PRESS J NEUROCHEM; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hiroi N, 1999, EUR J NEUROSCI, V11, P1114, DOI 10.1046/j.1460-9568.1999.00570.x; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Horger BA, 1999, J NEUROSCI, V19, P4110; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; Nestler EJ, 1997, CURR OPIN NEUROBIOL, V7, P713, DOI 10.1016/S0959-4388(97)80094-3; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; OUIMET CC, 1995, NEUROPROTOCOLS, V6, P84; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Punch LJ, 1997, J NEUROSCI, V17, P8520; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; SNYDER GL, 1992, J NEUROSCI, V12, P3071, DOI 10.1523/JNEUROSCI.12-08-03071.1992; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Taylor JR, 1999, PSYCHOPHARMACOLOGY, V142, P31, DOI 10.1007/s002130050859; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; Zhang XF, 1998, J NEUROSCI, V18, P488; Zheng M, 1998, J NEUROBIOL, V35, P141, DOI 10.1002/(SICI)1097-4695(199805)35:2<141::AID-NEU2>3.0.CO;2-4	30	379	399	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					376	380		10.1038/35066591	http://dx.doi.org/10.1038/35066591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268215				2022-12-28	WOS:000167464100053
J	Pini, P				Pini, P			Help by and for medical editors	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Pini, P (corresponding author), Lancet, London WC1X 8RR, England.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					738	738		10.1016/S0140-6736(00)04182-9	http://dx.doi.org/10.1016/S0140-6736(00)04182-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253965				2022-12-28	WOS:000167400900009
J	Zhao, HQ; Reed, RR				Zhao, HQ; Reed, RR			X inactivation of the OCNC1 channel gene reveals a role for activity-dependent competition in the olfactory system	CELL			English	Article							UNILATERAL NARIS OCCLUSION; TRANSGENIC MICE; CELL-DYNAMICS; GERM-CELLS; EXPRESSION; MOUSE; BULB; RECEPTOR; EPITHELIUM; NEURONS	The organization of neuronal systems is often dependent on activity and competition between cells. In olfaction, the X-linked OCNC1 channel subunit is subject to random inactivation and is essential for odorant-evoked activity. Reporter-tagged OCNC1 mutant mice permit the visualization of OCNC1-deficient olfactory neurons and their projections. In heterozygous females, X inactivation creates a mosaic with two populations of genetically distinct neurons. OCNC1-deficient neurons are slowly and specifically depleted from the olfactory epithelium and display unusual patterns of projection to the olfactory bulb. Remarkably, this depletion is dependent on odorant exposure and is reversed by odorant deprivation. This suggests that odorants and the activity they evoke are critical for neuronal survival in a competitive environment and implicate evoked activity in the organization and maintenance of the olfactory system.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Reed, RR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, 725 N Wolfe St, Baltimore, MD 21205 USA.							Baker H, 1999, J NEUROSCI, V19, P9313; BAKER H, 1990, NEUROSCIENCE, V36, P761, DOI 10.1016/0306-4522(90)90018-Y; BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BRAUN RE, 1990, BIOL REPROD, V43, P684, DOI 10.1095/biolreprod43.4.684; Broillet MC, 1997, NEURON, V18, P951, DOI 10.1016/S0896-6273(00)80334-7; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; CUMMINGS DM, 1994, EXP NEUROL, V128, P124, DOI 10.1006/exnr.1994.1119; FARBMAN AI, 1988, J NEUROSCI, V8, P3290; FARBMAN AI, 1992, CELL BIOL OLFACTION; FAWCETT JW, 1984, P NATL ACAD SCI-BIOL, V81, P5589, DOI 10.1073/pnas.81.17.5589; FRAZIER LL, 1988, J COMP NEUROL, V269, P355, DOI 10.1002/cne.902690304; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Hendriks RW, 1996, EMBO J, V15, P4862, DOI 10.1002/j.1460-2075.1996.tb00867.x; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; MACKAYSIM A, 1991, J NEUROSCI, V11, P979; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MATTHEWS PM, 1995, NEUROMUSCULAR DISORD, V5, P209, DOI 10.1016/0960-8966(94)00057-G; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; OTTOSON D, 1971, HDB SENSORY PHYSL, P95; Parent A, 1998, J NEUROPHYSIOL, V79, P3295, DOI 10.1152/jn.1998.79.6.3295; REESE BE, 1995, P NATL ACAD SCI USA, V92, P2494, DOI 10.1073/pnas.92.7.2494; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Roskams AJI, 1996, J NEUROSCI, V16, P1294; Royal SJ, 1999, J NEUROSCI, V19, P9856; ROYET JP, 1988, J COMP NEUROL, V270, P559, DOI 10.1002/cne.902700409; Ruiz ML, 1996, J MOL CELL CARDIOL, V28, P1453, DOI 10.1006/jmcc.1996.0136; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	40	156	160	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2001	104	5					651	660		10.1016/S0092-8674(02)01107-8	http://dx.doi.org/10.1016/S0092-8674(02)01107-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257220	Bronze			2022-12-28	WOS:000167531100006
J	Hirsh, J; Bates, SM				Hirsh, J; Bates, SM			Clinical trials that have influenced the treatment of venous thromboembolism: A historical perspective	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-MOLECULAR-WEIGHT; DEEP-VEIN THROMBOSIS; VENA-CAVAL FILTER; CONTINUOUS INTRAVENOUS HEPARIN; ORAL ANTICOAGULANT-THERAPY; PARTIAL THROMBOPLASTIN TIME; LONG-TERM TREATMENT; UNFRACTIONATED HEPARIN; PULMONARY-EMBOLISM; STANDARD HEPARIN	In 1950, Barritt and Jordan performed the first randomized trial demonstrating the efficacy of anticoagulant therapy in the treatment of venous thromboembolism. Since then, important therapeutic advances have been made in the treatment of deep venous thrombosis and pulmonary embolism. This paper reviews the important clinical trials involving anticoagulant therapy and vena caval interruption. The studies are discussed from a historical perspective, and an attempt is made to analyze both the thought processes that prompted their design and the reasons why they changed practice.	Hamilton Civ Hosp Res ctr, Henderson Div, Hamilton, ON L8V 1C3, Canada; McMaster Univ, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University	Hirsh, J (corresponding author), Hamilton Civ Hosp Res ctr, Henderson Div, 711 Concess St, Hamilton, ON L8V 1C3, Canada.	jhirsh@thrombosis.hhscr.org						ACCP-NHLBI national conference on antithrombotic therapy, 1986, CHEST S, V89, p1S; Anand S, 1996, ARCH INTERN MED, V156, P1677, DOI 10.1001/archinte.156.15.1677; [Anonymous], 1997, COLL AM PATH COAG SU; BARRITT DW, 1960, LANCET, V1, P1309; BASU D, 1972, NEW ENGL J MED, V287, P324, DOI 10.1056/NEJM197208172870703; BECKER DM, 1992, ARCH INTERN MED, V152, P1985, DOI 10.1001/archinte.152.10.1985; Beyth RJ, 1998, AM J MED, V105, P91, DOI 10.1016/S0002-9343(98)00198-3; BRANDJES DPM, 1992, NEW ENGL J MED, V327, P1485, DOI 10.1056/NEJM199211193272103; BRATT G, 1985, THROMB HAEMOSTASIS, V54, P813; BRATT G, 1990, THROMB HAEMOSTASIS, V64, P506; BUSSEY HI, 1992, ARCH INTERN MED, V152, P278, DOI 10.1001/archinte.152.2.278; CADE JF, 1984, THROMB RES, V35, P613, DOI 10.1016/0049-3848(84)90265-2; Calligaro K D, 1991, Ann Vasc Surg, V5, P186, DOI 10.1007/BF02016754; CARTER CJ, 1982, BLOOD, V59, P1239; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Faivre R, 1987, J Mal Vasc, V12 Suppl B, P145; FENNERTY AG, 1987, CLIN LAB HAEMATOL, V9, P17; GALLUS A, 1986, LANCET, V2, P1293; GALLUS AS, 1976, JAMA-J AM MED ASSOC, V235, P1980, DOI 10.1001/jama.235.18.1980; Gould MK, 1999, ANN INTERN MED, V130, P800, DOI 10.7326/0003-4819-130-10-199905180-00003; GREENFIELD LJ, 1988, SURGERY, V104, P706; GREENFIELD LJ, 1989, ARCH SURG-CHICAGO, V124, P657; GREENFIELD LJ, 1981, ARCH SURG-CHICAGO, V116, P1451; GREENFIELD LJ, 1974, ANN SURG, V180, P461, DOI 10.1097/00000658-197410000-00011; HANDELAND GF, 1990, EUR J CLIN PHARMACOL, V39, P107, DOI 10.1007/BF00280041; Harrison L, 1998, ARCH INTERN MED, V158, P2001, DOI 10.1001/archinte.158.18.2001; HIRSH J, 1995, NEW ENGL J MED, V332, P1710, DOI 10.1056/NEJM199506223322510; HIRSH J, 1992, BLOOD, V79, P1; Hirsh J, 1998, CHEST, V114, p489S, DOI 10.1378/chest.114.5_Supplement.489S; HIRSH J, 1992, CHEST, V102, pS312, DOI 10.1378/chest.102.4.312S; Hirsh J, 1998, CHEST, V114, p445S, DOI 10.1378/chest.114.5_Supplement.445S; HIRSH J, 1988, THROMB HAEMOSTASIS, V59, P129; HOLMER E, 1981, BIOCHEM J, V193, P395, DOI 10.1042/bj1930395; HOLMGREN KAJ, 1985, ACTA MED SCAND, V218, P279; HOLMSTROM M, 1992, THROMB RES, V67, P49; HULL R, 1979, NEW ENGL J MED, V301, P855, DOI 10.1056/NEJM197910183011602; HULL R, 1982, NEW ENGL J MED, V306, P189, DOI 10.1056/NEJM198201283060401; HULL R, 1982, NEW ENGL J MED, V307, P1676, DOI 10.1056/NEJM198212303072704; HULL RD, 1990, NEW ENGL J MED, V322, P1260, DOI 10.1056/NEJM199005033221802; HULL RD, 1986, NEW ENGL J MED, V315, P1109, DOI 10.1056/NEJM198610303151801; HULL RD, 1992, NEW ENGL J MED, V326, P975, DOI 10.1056/NEJM199204093261502; HUNTER RB, 1960, LANCET, V2, P206; JONES TK, 1986, ANN THORAC SURG, V42, pS48, DOI 10.1016/S0003-4975(10)64643-7; JORDAN RE, 1980, J BIOL CHEM, V255, P81; KAKKAR VV, 1972, LANCET, V2, P101; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; KING DJ, 1984, ANN INTERN MED, V100, P535, DOI 10.7326/0003-4819-100-4-535; Koopman MMW, 1996, NEW ENGL J MED, V334, P682, DOI 10.1056/NEJM199603143341102; LAGERSTEDT CI, 1985, LANCET, V2, P515; LANE DA, 1984, BIOCHEM J, V218, P725, DOI 10.1042/bj2180725; Levine M, 1996, NEW ENGL J MED, V334, P677, DOI 10.1056/NEJM199603143341101; MAGNANT JG, 1992, J VASC SURG, V16, P701; MOBINUDDIN K, 1969, ARCH SURG-CHICAGO, V99, P711; MONREAL M, 1994, THROMB HAEMOSTASIS, V71, P7; O'Brien B, 1999, ARCH INTERN MED, V159, P2298, DOI 10.1001/archinte.159.19.2298; OCHSNER A, 1960, Postgrad Med, V27, P193; OSULLIVAN EF, 1972, MED J AUSTRALIA, V2, P1104, DOI 10.5694/j.1326-5377.1972.tb103752.x; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; PRANDONI P, 1992, LANCET, V339, P441, DOI 10.1016/0140-6736(92)91054-C; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; RASCHKE RA, 1993, ANN INTERN MED, V119, P874, DOI 10.7326/0003-4819-119-9-199311010-00002; SCHULMAN S, 1985, ACTA MED SCAND, V217, P547; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; SHAUGHNESSY SG, 1995, BLOOD, V86, P1368, DOI 10.1182/blood.V86.4.1368.bloodjournal8641368; Simonneau G, 1997, NEW ENGL J MED, V337, P663, DOI 10.1056/NEJM199709043371002; SUDLOW MF, 1992, LANCET, V340, P873; tenCate JW, 1997, NEW ENGL J MED, V337, P657; WARKENTIN TE, 1995, NEW ENGL J MED, V332, P1330, DOI 10.1056/NEJM199505183322003; Weitz JI, 1997, NEW ENGL J MED, V337, P688, DOI 10.1056/NEJM199709043371007; WESSLER S, 1959, CIRCULATION, V20, P864, DOI 10.1161/01.CIR.20.5.864; YOUNG E, 1993, THROMB HAEMOSTASIS, V70, P625; YOUNG E, 1992, THROMB HAEMOSTASIS, V67, P639; YOUNG E, 1996, THROMB HAEMOSTASIS, V71, P300	74	41	42	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2001	134	5					409	417		10.7326/0003-4819-134-5-200103060-00013	http://dx.doi.org/10.7326/0003-4819-134-5-200103060-00013			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405ZJ	11242501				2022-12-28	WOS:000167190200007
J	Cann, RL				Cann, RL			Genetic clues to dispersal in human populations: Retracing the past from the present	SCIENCE			English	Review							SINGLE-NUCLEOTIDE POLYMORPHISMS; POLYNESIAN ORIGINS; SEQUENCE VARIATION; EXPRESS-TRAIN; MITOCHONDRIAL; DNA; AFRICAN; HISTORY; LINEAGES; ISLAND	Ongoing debate about proper interpretation of DNA sequence polymorphisms and their ability to reconstruct human population history illustrates a important change in perspective that we have achieved in the past 20 years of population genetics. To what extent does the history of a Locus represent the history of a population? Tools originally developed for molecular systematics, where genetic Lineages have been separated by speciation events, are routinely applied to the analysis of variation within our species, with conflicting results. Because of automated technologies and linkage analysis, we are poised to harvest a wealth of information about our past, if we are successful in moving beyond a current polarization regarding models of human evolution. Rather than just suggesting that true resolution will only come by considering fossil or archaeological evidence, the realistic and appropriate application of genetic models for analysis of population structure is also necessary. Three examples from different dispersal events are highlighted here.	Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	University of Hawaii System	Cann, RL (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, 1960 EW Rd, Honolulu, HI 96822 USA.	rcann@hawaii.edu						Adcock GJ, 2001, P NATL ACAD SCI USA, V98, P537, DOI 10.1073/pnas.98.2.537; Antonovics J., 1998, SPATIAL ECOLOGY ROLE, P158; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Bellwood Peter, 1997, PREHISTORY INDOMALAY; BLUST R, 1997, 8 INT C AUSTR LING, P31; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; BONNICHSEN R, 1999, MAMMOTH TRUMPET, V14, P2; Brown J.H., 1995, MACROECOLOGY; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1969, AM J HUM GENET, V21, P252; COLBERT EH, 1992, EVOLUTION VERTEBRATE, P288; Cooper A, 2000, SCIENCE, V289, P1139; Darwin C., 1871, P475; DIAMOND JM, 1988, NATURE, V336, P307, DOI 10.1038/336307a0; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; Easton RD, 1996, AM J HUM GENET, V59, P213; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; Gagneux P, 1999, P NATL ACAD SCI USA, V96, P5077, DOI 10.1073/pnas.96.9.5077; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; GREEN RC, 1977, TARATAI PACIFIC ADVE, P220; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HANSKI I, 1997, METAPOPULATION BIOL; Harding RM, 1997, AM J HUM GENET, V60, P772; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Hutz MH, 1999, GENOMIC DIVERSITY, P23; HUXLEY TH, 1959, EVIDENCE MANS PLACE, P72; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; ISSAC G, 1972, MODELS ARCHAEOLOGY, P167; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kayser M, 2001, AM J HUM GENET, V68, P173, DOI 10.1086/316949; Kimura M., 1983, NEUTRAL THEORY MOL E; Kivisild T, 1999, GENOMIC DIVERSITY, P135; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LEWIS D, 1972, WE NAVIGATORS, P55; LIEINJO LE, 1976, ORIGIN AUSTR, P277; Lum JK, 2000, AM J PHYS ANTHROPOL, V113, P151; Lum JK, 1998, AM J HUM GENET, V63, P613, DOI 10.1086/301949; Mehdi SQ, 1999, GENOMIC DIVERSITY, P83; Merriwether DA, 1999, AM J PHYS ANTHROPOL, V110, P243, DOI 10.1002/(SICI)1096-8644(199911)110:3<243::AID-AJPA1>3.0.CO;2-M; Merriwether DA, 1999, GENOMIC DIVERSITY, P153; NEEL JV, 1977, HUM GENET, V37, P207, DOI 10.1007/BF00393584; NEI M, 1982, EVOL BIOL, V14, P1; Nielsen R, 1998, EVOLUTION, V52, P669, DOI 10.1111/j.1558-5646.1998.tb03692.x; O'Ryan C, 1998, ANIM CONSERV, V1, P85, DOI 10.1111/j.1469-1795.1998.tb00015.x; PARFIT M, 2000, NATL GEOGR, V198, P41; Pulliam H. Ronald, 1996, P45; QUINN J F, 1987, Conservation Biology, V1, P198, DOI 10.1111/j.1523-1739.1987.tb00033.x; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Richards M, 1998, AM J HUM GENET, V63, P1234, DOI 10.1086/302043; Rickards O, 1999, AM J HUM GENET, V65, P519, DOI 10.1086/302513; ROBERTS RG, 1994, ANTIQUITY, V68, P611, DOI 10.1017/S0003598X00047116; Ruhlen M., 1994, ORIGIN LANGUAGE; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; TERRELL J, 1988, ANTIQUITY, V62, P642, DOI 10.1017/S0003598X00075049; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; White TD, 2000, AM J PHYS ANTHROPOL, V113, P287, DOI 10.1002/1096-8644(200011)113:3<287::AID-AJPA1>3.0.CO;2-8; Wolpoff MH, 2000, AM J PHYS ANTHROPOL, V112, P129, DOI 10.1002/(SICI)1096-8644(200005)112:1<129::AID-AJPA11>3.0.CO;2-K; Zerjal T, 1999, GENOMIC DIVERSITY, P91	64	113	119	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2001	291	5509					1742	1748		10.1126/science.1058948	http://dx.doi.org/10.1126/science.1058948			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11249820				2022-12-28	WOS:000167320600048
J	Lachner, M; O'Carroll, N; Rea, S; Mechtler, K; Jenuwein, T				Lachner, M; O'Carroll, N; Rea, S; Mechtler, K; Jenuwein, T			Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins	NATURE			English	Article							CHROMO DOMAIN; IN-VITRO; HETEROCHROMATIN; DROSOPHILA; LOCALIZATION; ORGANIZATION; COMPONENT; INTERACTS; GENOME; YEAST	Distinct modifications of histone amino termini, such as acetylation, phosphorylation and methylation, have been proposed to underlie a chromatin-based regulatory mechanism(1,2) that modulates the accessibility of genetic information. In addition to histone modifications that facilitate gene activity, it is of similar importance to restrict inappropriate gene expression(3,4) if cellular and developmental programmes are to proceed unperturbed. Here we show that mammalian methyltransferases that selectively methylate histone H3 on lysine 9 (Suv39h HMTases)(5) generate a binding site for HP1 proteins-a family of heterochromatic adaptor molecules(6,7) implicated in both gene silencing and supra-nucleosomal chromatin structure. High-affinity in vitro recognition of a methylated histone H3 peptide by HP1 requires a functional chromo domain; thus, the HP1 chromo domain is a specific interaction motif for the methyl epitope on lysine 9 of histone H3. In vivo, heterochromatin association of HP1 proteins is lost in Suv39h double-null primary mouse fibroblasts but is restored after the re-introduction of a catalytically active SUV39H1 HMTase. Our data define a molecular mechanism through which the SUV39H-HP1 methylation system can contribute to the propagation of heterochromatic subdomains in native chromatin.	Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Jenuwein, T (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.		Mechtler, Karl/AAF-2717-2019	Mechtler, Karl/0000-0002-3392-9946; O'Carroll, Donal/0000-0002-8626-2217; Rea, Stephen/0000-0001-5797-5157				Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Breiling A, 1999, MOL CELL BIOL, V19, P8451; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Ekwall K, 1996, J CELL SCI, V109, P2637; Festenstein R, 1999, NAT GENET, V23, P457, DOI 10.1038/70579; Grosveld F, 1999, CURR OPIN GENET DEV, V9, P152, DOI 10.1016/S0959-437X(99)80023-9; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; PARO R, 1991, P NATL ACAD SCI USA, V88, P263, DOI 10.1073/pnas.88.1.263; Paro R., 1996, EPIGENETIC MECH GENE, P507; PIERCE J, 1992, DEVELOPMENT, V114, P921; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taddei A, 1999, J CELL BIOL, V147, P1153, DOI 10.1083/jcb.147.6.1153; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; WREGGETT KA, 1994, CYTOGENET CELL GENET, V66, P99, DOI 10.1159/000133676; Zhao T, 2000, J BIOL CHEM, V275, P28332	30	2086	2155	3	201	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					116	120		10.1038/35065132	http://dx.doi.org/10.1038/35065132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242053				2022-12-28	WOS:000167194300054
J	Reinhardt, RL; Khoruts, A; Merica, R; Zell, T; Jenkins, MK				Reinhardt, RL; Khoruts, A; Merica, R; Zell, T; Jenkins, MK			Visualizing the generation of memory CD4 T cells in the whole body	NATURE			English	Article							IN-VIVO; CLONAL EXPANSION; PERIPHERAL TOLERANCE; ANTIGEN-RECEPTOR; VIRAL-INFECTION; INDUCTION; IMMUNITY; TISSUE; LYMPHOCYTES; ACTIVATION	It is thought that immunity depends on naive CD4 T cells that proliferate in response to microbial antigens(1-4), differentiate into memory cells that produce anti-microbial lymphokines(5,6), and migrate to sites of infection(7,8). Here we use immunohistology to enumerate individual naive CD4 T cells, specific for a model antigen, in the whole bodies of adult mice. The cells resided exclusively in secondary lymphoid tissues, such as the spleen and lymph nodes, in mice that were not exposed to antigen. After injection of antigen alone into the blood, the T cells proliferated, migrated to the lungs, liver, gut and salivary glands, and then disappeared from these organs. If antigen was injected with the microbial product lipopolysaccharide, proliferation and migration were enhanced, and two populations of memory cells survived for months: one in the lymph nodes that produced the growth factor interleukin-2, and a larger one in the non-lymphoid tissues that produced the anti-microbial lymphokine interferon-gamma. These results show that antigen recognition in the context of infection generates memory cells that are specialized to proliferate in the secondary lymphoid tissues or to fight infection at the site of microbial entry.	Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Ctr Immunol, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jenkins, MK (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, MMC 334,420 Delaware St SE, Minneapolis, MN 55455 USA.		Jenkins, Marc K/G-1063-2012	Jenkins, Marc K/0000-0001-8009-7655				Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Alferink J, 1998, SCIENCE, V282, P1338, DOI 10.1126/science.282.5392.1338; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BELLINI G, 1990, INSULA, V45, P4; Bradley LM, 1996, CURR OPIN IMMUNOL, V8, P312, DOI 10.1016/S0952-7915(96)80118-X; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; CHILLER JM, 1971, SCIENCE, V171, P813, DOI 10.1126/science.171.3973.813; CHILLER JM, 1973, J EXP MED, V137, P740, DOI 10.1084/jem.137.3.740; DRESSER DW, 1961, NATURE, V191, P1169, DOI 10.1038/1911169a0; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Khoruts A, 1998, J EXP MED, V187, P225, DOI 10.1084/jem.187.2.225; Kim SK, 1999, J IMMUNOL, V163, P4125; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MACKAY CR, 1993, CURR OPIN IMMUNOL, V5, P423, DOI 10.1016/0952-7915(93)90063-X; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Merica R, 2000, J IMMUNOL, V164, P4551, DOI 10.4049/jimmunol.164.9.4551; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Pape KA, 1997, J IMMUNOL, V159, P591; Pape KA, 1997, IMMUNOL REV, V156, P67, DOI 10.1111/j.1600-065X.1997.tb00959.x; Pape KA, 1998, J IMMUNOL, V160, P4719; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SOUTHERN PJ, 1984, NATURE, V312, P555, DOI 10.1038/312555a0; VELLA AT, 1995, IMMUNITY, V2, P261, DOI 10.1016/1074-7613(95)90050-0; Westermann J, 1996, IMMUNOL TODAY, V17, P278, DOI 10.1016/0167-5699(96)80545-7	29	814	834	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					101	105		10.1038/35065111	http://dx.doi.org/10.1038/35065111			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242050				2022-12-28	WOS:000167194300051
J	Keating, MT; Sanguinetti, MC				Keating, MT; Sanguinetti, MC			Molecular and cellular mechanisms of cardiac arrhythmias	CELL			English	Review							LONG-QT SYNDROME; POTASSIUM CHANNEL GENE; LANGE-NIELSEN; HEART-DISEASE; K+-CHANNEL; FUNCTIONAL EXPRESSION; HERG; MUTATIONS; KVLQT1; SPECTRUM		Harvard Univ, Sch Med,Childrens Hosp, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA; Univ Utah, Hlth Sci Ctr, Dept Med,Eccles Program Human Mol Biol & Genet, Div Cardiol, Salt Lake City, UT 84112 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Keating, MT (corresponding author), Harvard Univ, Sch Med,Childrens Hosp, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA.	mkeating@genetics.med.harvard.edu	Sanguinetti, Michael/AAN-2615-2020					Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abildskov J. A., 1991, J CARDIOVASC ELECTR, V2, P355, DOI 10.1111/j.1540-8167.1991.tb01332.x; Ashcroft FM, 2000, ION CHANNELS DIS; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Brugada J, 1997, CIRCULATION, V96, P841; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Compton SJ, 1996, CIRCULATION, V94, P1018, DOI 10.1161/01.CIR.94.5.1018; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Duggal P, 1998, CIRCULATION, V97, P142, DOI 10.1161/01.CIR.97.2.142; Dumaine R, 1996, CIRC RES, V78, P916, DOI 10.1161/01.RES.78.5.916; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; Hoorntje T, 1999, CIRCULATION, V100, P1264, DOI 10.1161/01.CIR.100.12.1264; JERVELL A, 1957, AM HEART J, V54, P59, DOI 10.1016/0002-8703(57)90079-0; JIANG CA, 1994, NAT GENET, V8, P141, DOI 10.1038/ng1094-141; KANNEL WB, 1987, AM HEART J, V113, P799, DOI 10.1016/0002-8703(87)90722-8; KEATING M, 1991, SCIENCE, V252, P704, DOI 10.1126/science.1673802; KRISHNAN SC, 1991, CIRC RES, V69, P277, DOI 10.1161/01.RES.69.2.277; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lazzara R, 1997, J AM COLL CARDIOL, V29, P843; Lee MP, 1997, NAT GENET, V15, P181, DOI 10.1038/ng0297-181; Lees-Miller JP, 2000, MOL PHARMACOL, V57, P367; Li XD, 1997, J BIOL CHEM, V272, P705, DOI 10.1074/jbc.272.2.705; MARKS ML, 1995, J AM COLL CARDIOL, V25, P59, DOI 10.1016/0735-1097(94)00318-K; MARTINI B, 1989, AM HEART J, V118, P1203, DOI 10.1016/0002-8703(89)90011-2; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Mitcheson JS, 2000, J GEN PHYSIOL, V115, P229, DOI 10.1085/jgp.115.3.229; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; MORAIS J, 1998, CELL, V5, P649; MOSS AJ, 1995, CIRCULATION, V92, P2929, DOI 10.1161/01.CIR.92.10.2929; Moss Arthur J., 1997, American Journal of Cardiology, V79, P16, DOI 10.1016/S0002-9149(97)00116-1; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Priori SG, 2000, CIRCULATION, V102, pr49, DOI DOI 10.1161/01.CIR.102.8.E49; Roden DM, 1998, AM J CARDIOL, V82, p49I, DOI 10.1016/S0002-9149(98)00472-X; Roden DM, 1996, CIRCULATION, V94, P1996, DOI 10.1161/01.CIR.94.8.1996; ROMANO C, 1963, Clin Pediatr (Bologna), V45, P656; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; SCHOTT JJ, 1995, AM J HUM GENET, V57, P1114; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; SCHWARTZ PJ, 1993, CIRCULATION, V88, P782, DOI 10.1161/01.CIR.88.2.782; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Splawski I, 1997, NEW ENGL J MED, V336, P1562, DOI 10.1056/NEJM199705293362204; Tai KK, 1997, J BIOL CHEM, V272, P1654, DOI 10.1074/jbc.272.3.1654; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; VINCENT GM, 1992, NEW ENGL J MED, V327, P846, DOI 10.1056/NEJM199209173271204; WANG KW, 1995, NEURON, V14, P1303, DOI 10.1016/0896-6273(95)90277-5; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; WANG Q, 1995, HUM MOL GENET, V4, P1603, DOI 10.1093/hmg/4.9.1603; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wang Z, 1999, J CARDIOVASC ELECTR, V10, P817, DOI 10.1111/j.1540-8167.1999.tb00262.x; WARD O C, 1964, J Ir Med Assoc, V54, P103; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; WILLICH SN, 1987, AM J CARDIOL, V60, P801, DOI 10.1016/0002-9149(87)91027-7; Wollnik B, 1997, HUM MOL GENET, V6, P1943, DOI 10.1093/hmg/6.11.1943; Yang WP, 1997, P NATL ACAD SCI USA, V94, P4017, DOI 10.1073/pnas.94.8.4017; Yang WP, 1998, J BIOL CHEM, V273, P19419, DOI 10.1074/jbc.273.31.19419; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	71	732	771	2	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2001	104	4					569	580		10.1016/S0092-8674(01)00243-4	http://dx.doi.org/10.1016/S0092-8674(01)00243-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	405VP	11239413	Bronze			2022-12-28	WOS:000167181500011
J	Bertozzi, CR; Kiessling, LL				Bertozzi, CR; Kiessling, LL			Chemical glycobiology	SCIENCE			English	Review							SELECTIN-CARBOHYDRATE INTERACTIONS; ACYL SIDE-CHAIN; SIALYL-LEWIS-X; INHIBITORS; ACID; GLYCOPROTEIN; PROTEINS; BINDING; DESIGN; AFFINITY	Chemical tools have proven indispensable for studies in glycobiology. Synthetic oligosaccharides and glycoconjugates provide materials for correlating structure with function. Synthetic mimics of the complex assemblies found on cell surfaces can modulate cellular interactions and are under development as therapeutic agents, Small molecule inhibitors of carbohydrate biosynthetic and processing enzymes can block the assembly of specific oligosaccharide structures. Inhibitors of carbohydrate recognition and biosynthesis can reveal the biological functions of the carbohydrate epitope and its cognate receptors. Carbohydrate biosynthetic pathways are often amenable to interception with synthetic unnatural substrates, Such metabolic interference can block the expression of oligosaccharides or alter the structures of the sugars presented on cells. Collectively, these chemical approaches are contributing great insight into the myriad biological functions of oligosaccharides.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bertozzi, CR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.		Kiessling, Laura L/A-4074-2008; Kohler, Jennifer J./B-6589-2009	Kohler, Jennifer J./0000-0001-5373-3329; Kiessling, Laura/0000-0001-6829-1500				ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; [Anonymous], MODERN METHODS CARBO; Armstrong JI, 2000, ANGEW CHEM INT EDIT, V39, P1303, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1303::AID-ANIE1303>3.0.CO;2-0; Banteli R, 2000, HELV CHIM ACTA, V83, P2893, DOI 10.1002/1522-2675(20001108)83:11<2893::AID-HLCA2893>3.0.CO;2-G; Berecibar A, 1999, CHEM REV, V99, P779, DOI 10.1021/cr980033l; BERTOZZI CR, 1995, BIOCHEMISTRY-US, V34, P14271, DOI 10.1021/bi00044a001; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Burke SD, 2000, J AM CHEM SOC, V122, P4518, DOI 10.1021/ja000068e; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Collins BE, 2000, GLYCOBIOLOGY, V10, P11, DOI 10.1093/glycob/10.1.11; Cotton GJ, 1999, CHEM BIOL, V6, pR247, DOI 10.1016/S1074-5521(99)80109-4; Danishefsky SJ, 2000, ANGEW CHEM INT EDIT, V39, P836, DOI 10.1002/(SICI)1521-3773(20000303)39:5<836::AID-ANIE836>3.0.CO;2-I; DAVID S, 1991, ADV CARBOHYD CHEM BI, V49, P175, DOI 10.1016/S0065-2318(08)60183-3; Davis BG, 2000, J CHEM SOC PERK T 1, P2137, DOI 10.1039/a809774g; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dimick SM, 1999, J AM CHEM SOC, V121, P10286, DOI 10.1021/ja991729e; Douglas NL, 1998, J CHEM SOC PERK T 1, P51, DOI 10.1039/a705275h; Eason PD, 1999, BIOCHEMISTRY-US, V38, P5430, DOI 10.1021/bi982740e; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Fan EK, 2000, CURR OPIN STRUC BIOL, V10, P680, DOI 10.1016/S0959-440X(00)00152-4; Fan EK, 2000, J AM CHEM SOC, V122, P2663, DOI 10.1021/ja993388a; Flitsch SL, 2000, CURR OPIN CHEM BIOL, V4, P619, DOI 10.1016/S1367-5931(00)00152-6; Frechet J. M., 1980, POLYM SUPPORTED REAC, P407; Galustian C, 1997, BIOCHEM BIOPH RES CO, V240, P748, DOI 10.1006/bbrc.1997.7737; Ganem B, 1996, ACCOUNTS CHEM RES, V29, P340, DOI 10.1021/ar9502184; Geurtsen R, 1997, J ORG CHEM, V62, P8145, DOI 10.1021/jo971233k; Gildersleeve J, 1999, J AM CHEM SOC, V121, P6176, DOI 10.1021/ja990690a; Goebel WF, 1929, J EXP MED, V50, P521, DOI 10.1084/jem.50.4.521; GOON S, IN PRESS GLYCOCHEMIS; Gordon EJ, 1998, BIOORGAN MED CHEM, V6, P1293, DOI 10.1016/S0968-0896(98)00122-9; Gordon EJ, 1998, NATURE, V392, P30, DOI 10.1038/32073; Hang HC, 2001, J AM CHEM SOC, V123, P1242, DOI 10.1021/ja002962b; HEMMERICH S, 1995, J BIOL CHEM, V270, P12035, DOI 10.1074/jbc.270.20.12035; Herzner H, 2000, CHEM REV, V100, P4495, DOI 10.1021/cr990308c; HOLMGREN J, 1992, GASTROENTEROL CLIN N, V21, P283; Jenkins N, 1996, NAT BIOTECHNOL, V14, P975, DOI 10.1038/nbt0896-975; Jung G., 1999, COMBINATORIAL CHEM S; Kahne D, 1997, CURR OPIN CHEM BIOL, V1, P130, DOI 10.1016/S1367-5931(97)80119-6; KAYSER H, 1992, J BIOL CHEM, V267, P16934; Keppler OT, 1998, BIOCHEM BIOPH RES CO, V253, P437, DOI 10.1006/bbrc.1998.9650; KEPPLER OT, 1995, J BIOL CHEM, V270, P1308, DOI 10.1074/jbc.270.3.1308; KHAN SH, 1997, PREPARATIVE CARBOHYD; Kiessling LL, 1996, CHEM BIOL, V3, P71, DOI 10.1016/S1074-5521(96)90280-X; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Kim YJ, 1999, J AM CHEM SOC, V121, P5829, DOI 10.1021/ja9905391; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; Kitov PI, 2000, NATURE, V403, P669, DOI 10.1038/35001095; Koeller KM, 2000, CHEM REV, V100, P4465, DOI 10.1021/cr990297n; Koenigs W, 1901, BER DTSCH CHEM GES, V34, P957, DOI 10.1002/cber.190103401162; LASKY LA, 1995, ANNU REV BIOCHEM, V64, P113, DOI 10.1146/annurev.bi.64.070195.000553; Lee JH, 1999, J BIOL CHEM, V274, P21878, DOI 10.1074/jbc.274.31.21878; LEE YC, 1995, ACCOUNTS CHEM RES, V28, P321, DOI 10.1021/ar00056a001; Lemieux GA, 1999, J AM CHEM SOC, V121, P4278, DOI 10.1021/ja984228m; LEMIEUX RU, 1975, J AM CHEM SOC, V97, P4076, DOI 10.1021/ja00847a035; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; Liang R, 1996, SCIENCE, V274, P1520, DOI 10.1126/science.274.5292.1520; Liang R, 1997, P NATL ACAD SCI USA, V94, P10554, DOI 10.1073/pnas.94.20.10554; LUGEMWA FN, 1991, J BIOL CHEM, V266, P6674; Macmillan D, 2000, TETRAHEDRON, V56, P9515, DOI 10.1016/S0040-4020(00)00836-X; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Marcaurelle LA, 1999, CHEM-EUR J, V5, P1384, DOI 10.1002/(SICI)1521-3765(19990503)5:5<1384::AID-CHEM1384>3.3.CO;2-O; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MOOTOO DR, 1988, J AM CHEM SOC, V110, P5583, DOI 10.1021/ja00224a060; Mortell KH, 1996, J AM CHEM SOC, V118, P2297, DOI 10.1021/ja953574q; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Muller B, 1998, ANGEW CHEM INT EDIT, V37, P2893, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2893::AID-ANIE2893>3.0.CO;2-W; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Palcic MM, 1999, CURR OPIN BIOTECH, V10, P616, DOI 10.1016/S0958-1669(99)00044-0; PAULSEN H, 1982, ANGEW CHEM INT EDIT, V21, P155, DOI 10.1002/anie.198201553; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; Platt FM, 1997, SCIENCE, V276, P428, DOI 10.1126/science.276.5311.428; Pozsgay V, 1998, ANGEW CHEM INT EDIT, V37, P138, DOI 10.1002/(SICI)1521-3773(19980202)37:1/2<138::AID-ANIE138>3.0.CO;2-T; RAGHAVAN S, 1993, J AM CHEM SOC, V115, P1580, DOI 10.1021/ja00057a056; Rao JH, 1998, SCIENCE, V280, P708, DOI 10.1126/science.280.5364.708; Rosen SD, 1999, AM J PATHOL, V155, P1013, DOI 10.1016/S0002-9440(10)65201-7; Roy R, 1996, CURR OPIN STRUC BIOL, V6, P692, DOI 10.1016/S0959-440X(96)80037-6; Sames D, 1997, NATURE, V389, P587, DOI 10.1038/39292; Sanders WJ, 1999, J BIOL CHEM, V274, P5271, DOI 10.1074/jbc.274.9.5271; Sanders WJ, 1996, BIOCHEMISTRY-US, V35, P14862, DOI 10.1021/bi9613640; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Sears P, 1999, ANGEW CHEM INT EDIT, V38, P2301; Seeberger PH, 2000, CHEM REV, V100, P4349, DOI 10.1021/cr9903104; Shin Y, 1999, J AM CHEM SOC, V121, P11684, DOI 10.1021/ja992881j; Simanek EE, 1998, CHEM REV, V98, P833, DOI 10.1021/cr940226i; Sofia MJ, 1999, J MED CHEM, V42, P3193, DOI 10.1021/jm990212a; Tolbert TJ, 2000, J AM CHEM SOC, V122, P5421, DOI 10.1021/ja0000192; TOONE EJ, 1989, TETRAHEDRON, V45, P5365, DOI 10.1016/S0040-4020(01)89487-4; Tsai CY, 2000, TETRAHEDRON LETT, V41, P9499, DOI 10.1016/S0040-4039(00)01653-1; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Weatherman RV, 1996, BIOCHEMISTRY-US, V35, P3619, DOI 10.1021/bi951916z; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Wieser JR, 1996, FEBS LETT, V395, P170, DOI 10.1016/0014-5793(96)01029-0; YAMADA Y, 1994, BIOL REPROD, V50, P116; Yarema KJ, 1998, J BIOL CHEM, V273, P31168, DOI 10.1074/jbc.273.47.31168; Zhang ZY, 1999, J AM CHEM SOC, V121, P734, DOI 10.1021/ja982232s	98	1601	1651	25	563	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2001	291	5512					2357	2364		10.1126/science.1059820	http://dx.doi.org/10.1126/science.1059820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11269316				2022-12-28	WOS:000167618700043
J	Gough, D				Gough, D			Astronomy - The birth of asteroseismology	SCIENCE			English	Editorial Material							SOLAR OSCILLATIONS; ROTATION		Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England	University of Cambridge	Gough, D (corresponding author), Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England.	dou-glas@ast.cam.ac.uk						Bedding TR, 2001, ASTROPHYS J, V549, pL105, DOI 10.1086/319139; Chaplin WJ, 1998, MON NOT R ASTRON SOC, V298, pL7, DOI 10.1046/j.1365-8711.1998.01800.x; CLAVERIE A, 1979, NATURE, V282, P591, DOI 10.1038/282591a0; Frohlich C, 1997, SOL PHYS, V170, P1, DOI 10.1023/A:1004969622753; Gabriel AH, 1997, SOL PHYS, V175, P207, DOI 10.1023/A:1004911408285; GOUGH DO, 1990, SOL PHYS, V128, P143, DOI 10.1007/BF00154154; GREC G, 1980, NATURE, V288, P541, DOI 10.1038/288541a0; Houdek G, 1999, ASTRON ASTROPHYS, V351, P582; Kosovichev AG, 1997, SOL PHYS, V170, P43, DOI 10.1023/A:1004949311268; Martic M, 1999, ASTRON ASTROPHYS, V351, P993; NATHER RE, 1990, ASTROPHYS J, V361, P309, DOI 10.1086/169196; Schou J, 1998, ASTROPHYS J, V505, P390, DOI 10.1086/306146; WOLF, 1892, HDB ASTRON, V2, P549	13	12	12	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2001	291	5512					2325	+		10.1126/science.1060088	http://dx.doi.org/10.1126/science.1060088			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11269303				2022-12-28	WOS:000167618700029
J	Choy, EHS; Panayi, GS				Choy, EHS; Panayi, GS			Mechanisms of disease: Cytokine pathways and joint inflammation in rheumatoid arthritis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; INTERLEUKIN-1 RECEPTOR ANTAGONIST; COLLAGEN-INDUCED ARTHRITIS; ALPHA MONOCLONAL-ANTIBODY; INTERCELLULAR-ADHESION MOLECULE-1; FC FUSION PROTEIN; SYNOVIAL-FLUID; IL-1 RECEPTOR; CARTILAGE DEGRADATION; DOUBLE-BLIND		Kings Coll London, Guys Kings & St Thomas Hosp, Sch Med, Dept Rheumatol, London WC2R 2LS, England	University of London; King's College London	Choy, EHS (corresponding author), Kings Coll Hosp London, Dept Rheumatol, E Dulwich Grove, London SE22 8PT, England.							AREND WP, 1995, ARTHRITIS RHEUM, V38, P151, DOI 10.1002/art.1780380202; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blass S, 1999, ARTHRITIS RHEUM, V42, P2499, DOI 10.1002/1529-0131(199912)42:12<2499::AID-ANR1>3.0.CO;2-R; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO;2-U; BROCKHAUS M, 1990, P NATL ACAD SCI USA, V87, P3127, DOI 10.1073/pnas.87.8.3127; Butler DM, 1995, EUR CYTOKINE NETW, V6, P225; Campion GV, 1996, ARTHRITIS RHEUM, V39, P1092, DOI 10.1002/art.1780390704; CHIKANZA IC, 1995, J RHEUMATOL, V22, P600; CHIN JE, 1990, ARTHRITIS RHEUM, V33, P1776, DOI 10.1002/art.1780331204; CHOMARAT P, 1995, J IMMUNOL, V154, P1432; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; COPE AP, 1992, ARTHRITIS RHEUM, V35, P1160, DOI 10.1002/art.1780351008; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; DINARELLO CA, 1991, IMMUNOL TODAY, V12, P404, DOI 10.1016/0167-5699(91)90142-G; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; GHIVIZZANI SC, 1997, ARTHRITIS RHEUM, V40, P223; GIRASOLE G, 1994, J CLIN INVEST, V93, P1516, DOI 10.1172/JCI117130; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HAAKFRENDSCHO M, 1994, J IMMUNOL, V152, P1347; Hart PH, 1996, J IMMUNOL, V157, P3672; HAWORTH C, 1991, EUR J IMMUNOL, V21, P2575, DOI 10.1002/eji.1830211039; HOUSSIAU FA, 1995, CLIN RHEUMATOL, V14, P10, DOI 10.1007/BF02215851; ISLER P, 1993, EUR CYTOKINE NETW, V4, P15; Isomaki P, 1997, ANN MED, V29, P499, DOI 10.3109/07853899709007474; JASIN HE, 1991, J CLIN INVEST, V87, P1531, DOI 10.1172/JCI115164; Jiang YB, 1998, ARTHRITIS RHEUM, V41, pS50; Joosten LAB, 1996, ARTHRITIS RHEUM, V39, P797, DOI 10.1002/art.1780390513; KATSIKIS PD, 1994, J EXP MED, V179, P1517, DOI 10.1084/jem.179.5.1517; Kavanaugh AF, 1997, ARTHRITIS RHEUM, V40, P849, DOI 10.1002/art.1780400511; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; KOCH AE, 1995, J INVEST MED, V43, P28; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; LANCHBURY JS, 1992, CLIN EXP RHEUMATOL, V10, P301; Lovell DJ, 1999, ARTHRITIS RHEUM, V42, pS117; Lovell DJ, 2000, NEW ENGL J MED, V342, P763, DOI 10.1056/NEJM200003163421103; Lubberts E, 1999, J IMMUNOL, V163, P4546; MACNAUL KL, 1990, J BIOL CHEM, V265, P17238; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Maini R. N., 1997, Arthritis and Rheumatism, V40, pS224; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Makarov SS, 1996, P NATL ACAD SCI USA, V93, P402, DOI 10.1073/pnas.93.1.402; MCGEEHAN GM, 1994, NATURE, V370, P558, DOI 10.1038/370558a0; McIntosh E, 1996, BRIT J RHEUMATOL, V35, P781; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; MOHLER KM, 1993, J IMMUNOL, V151, P1548; MOORE AR, 1993, ANN RHEUM DIS, V52, P27, DOI 10.1136/ard.52.1.27; Moreland LM, 1999, ARTHRITIS RHEUM, V42, pS401; Moreland LW, 1999, ANN INTERN MED, V130, P478, DOI 10.7326/0003-4819-130-6-199903160-00004; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; NAWROTH PP, 1986, J EXP MED, V163, P1363, DOI 10.1084/jem.163.6.1363; Peschon JJ, 1998, J IMMUNOL, V160, P943; PETTIPHER ER, 1986, P NATL ACAD SCI USA, V83, P8749, DOI 10.1073/pnas.83.22.8749; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; PINCUS T, 1986, J RHEUMATOL, V13, P841; RANKIN ECC, 1995, BRIT J RHEUMATOL, V34, P334; SAXNE T, 1988, ARTHRITIS RHEUM, V31, P1041, DOI 10.1002/art.1780310816; SCOTT DL, 1987, LANCET, V1, P1108; SHINGU M, 1993, CLIN EXP IMMUNOL, V94, P145; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; SUGIYAMA E, 1995, J RHEUMATOL, V22, P2020; SVENSON M, 1995, EUR J IMMUNOL, V25, P2842, DOI 10.1002/eji.1830251020; Tak PP, 1996, ARTHRITIS RHEUM, V39, P1077, DOI 10.1002/art.1780390702; Takagi N, 1998, ARTHRITIS RHEUM, V41, P2117, DOI 10.1002/1529-0131(199812)41:12<2117::AID-ART6>3.3.CO;2-G; TARTAGLIA LA, 1993, J IMMUNOL, V151, P4637; TILDERS FJH, 1994, PSYCHONEUROENDOCRINO, V19, P209, DOI 10.1016/0306-4530(94)90010-8; van de Putte BA, 1999, ARTHRITIS RHEUM, V42, pS400; Van den Bosh F, 1998, ARTHRITIS RHEUM, V41, pS56; VAN SJ, 1990, ANNU REV IMMUNOL, V8, P253; VANROON JAG, 1995, ANN RHEUM DIS, V54, P836, DOI 10.1136/ard.54.10.836; vanRoon JAG, 1996, ARTHRITIS RHEUM, V39, P829, DOI 10.1002/art.1780390516; Verschueren PC, 1999, ARTHRITIS RHEUM, V42, pS197; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Whalen JD, 1999, J IMMUNOL, V162, P3625; WILLIAMS RO, 1992, P NATL ACAD SCI USA, V89, P9784, DOI 10.1073/pnas.89.20.9784; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0; WOOLEY PH, 1993, J IMMUNOL, V151, P6602; Yelin E, 1999, ARTHRITIS RHEUM, V42, P1209, DOI 10.1002/1529-0131(199906)42:6<1209::AID-ANR18>3.0.CO;2-M	79	1685	1815	6	196	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2001	344	12					907	916		10.1056/NEJM200103223441207	http://dx.doi.org/10.1056/NEJM200103223441207			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412PN	11259725				2022-12-28	WOS:000167563700007
J	Esplin, MS; Fausett, MB; Fraser, A; Kerber, R; Mineau, G; Carrillo, J; Varner, MW				Esplin, MS; Fausett, MB; Fraser, A; Kerber, R; Mineau, G; Carrillo, J; Varner, MW			Paternal and maternal components of the predisposition to preeclampsia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH FACTOR-II; GENE; BIRTH; ANGIOTENSINOGEN; POPULATION; ECLAMPSIA; MICE; IGF2; RISK	Background: There is an inherited maternal predisposition to preeclampsia. Whether there is a paternal component, however, is not known. Methods: We used records of the Utah Population Database to identify 298 men and 237 women born in Utah between 1947 and 1957 whose mothers had had preeclampsia during their pregnancy. For each man and woman in the study group, we identified two matched, unrelated control subjects who were not the products of pregnancies complicated by preeclampsia. We then identified 947 children of the 298 male study subjects and 830 children of the 237 female study subjects who had been born between 1970 and 1992. These children were matched to offspring of the control subjects (1973 offspring of the male control group and 1658 offspring of the female control group). Factors associated with preeclampsia were identified, and odds ratios were calculated with the use of stepwise logistic-regression analysis. Results: In the group of men whose mothers had had preeclampsia (the male study group), 2.7 percent of the offspring (26 of 947) were born of pregnancies complicated by preeclampsia, as compared with 1.3 percent of the offspring (26 of 1973) in the male control group. In the female study group, 4.7 percent of the pregnancies (39 of 830) were complicated by preeclampsia, as compared with 1.9 percent (32 of 1658) in the female control group. After adjustment for the offspring's year of birth, maternal parity, and the offspring's gestational age at delivery, the odds ratio for an adult whose mother had had preeclampsia having a child who was the product of a pregnancy complicated by preeclampsia was 2.1 (95 percent confidence interval, 1.0 to 4.3; P=0.04) in the male study group and 3.3 (95 percent confidence interval, 1.5 to 7.5; P=0.004) in the female study group. Conclusions: Both men and women who were the product of a pregnancy complicated by preeclampsia were significantly more likely than control men and women to have a child who was the product of a pregnancy complicated by preeclampsia. (N Engl J Med 2001;344:867-72.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Utah, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Oncol Serv, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Esplin, MS (corresponding author), Univ Utah, Sch Med, Dept Obstet & Gynecol, Rm 2B200,50 N Med Dr, Salt Lake City, UT 84132 USA.		Kerber, Richard/B-8038-2009; Varner, Michael/K-9890-2013	Varner, Michael/0000-0001-9455-3973				Adams MM, 1997, PAEDIATR PERINAT EP, V11, P78, DOI 10.1111/j.1365-3016.1997.tb00799.x; ARNGRIMSSON R, 1990, BRIT J OBSTET GYNAEC, V97, P762, DOI 10.1111/j.1471-0528.1990.tb02569.x; Cincotta RB, 1998, INT J GYNECOL OBSTET, V60, P23, DOI 10.1016/S0020-7292(97)00241-5; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Dekker GA, 1998, AM J OBSTET GYNECOL, V179, P1359, DOI 10.1016/S0002-9378(98)70160-7; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; LITSON WA, 1991, BRIT J OBSTET GYNAEC, V98, P1079; McDermott J, 1997, PAEDIATR PERINAT EP, V11, P105, DOI 10.1046/j.1365-3016.1997.d01-4.x; Mogren I, 1999, EPIDEMIOLOGY, V10, P518, DOI 10.1097/00001648-199909000-00009; O'Shaughnessy KM, 1999, HYPERTENSION, V33, P1338, DOI 10.1161/01.HYP.33.6.1338; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OHLSSON R, 1989, EMBO J, V8, P1993, DOI 10.1002/j.1460-2075.1989.tb03606.x; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; Porter TF, 1997, OBSTET GYNECOL, V90, P63, DOI 10.1016/S0029-7844(97)00215-9; SNELL LM, 1992, AM J PERINAT, V9, P219, DOI 10.1055/s-2007-999325; SUTHERLAND A, 1981, BRIT J OBSTET GYNAEC, V88, P785, DOI 10.1111/j.1471-0528.1981.tb01304.x; Takimoto E, 1996, SCIENCE, V274, P995, DOI 10.1126/science.274.5289.995; Varner MW, 1996, OBSTET GYNECOL, V87, P905, DOI 10.1016/0029-7844(96)00064-6; WARD K, 1993, NAT GENET, V4, P59, DOI 10.1038/ng0593-59	21	302	321	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2001	344	12					867	872		10.1056/NEJM200103223441201	http://dx.doi.org/10.1056/NEJM200103223441201			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412PN	11259719				2022-12-28	WOS:000167563700001
J	Kesteloot, H				Kesteloot, H			Queen Margrethe II and mortality in Danish women	LANCET			English	Article							CARDIOLOGY; SMOKING	All-cause mortality in women is declining in all western European countries, apart from in Danish women. Ail-cause mortality in Danish women, age-adjusted to 45-74 years was compared with all-cause mortality in women in Scotland and with the mean of the other countries of the European Union for 1970-96. The decline of all-cause mortality in Danish women stopped in 1978 whereas the decline continued in Scotland. In 1996, all-cause mortality was 48% higher in Denmark than that of the mean for the European Union countries. Many Danish women are smokers. Halting of the decline in mortality occurred about 5 years after the ascension to the throne of Denmark by Queen Margrethe II. The queen is very popular in Denmark and a known cigarette smoker. As a role model for women, the Queen's example could offer an explanation for the unusual mortality in Danish women.	Katholieke Univ Leuven, Sch Publ Hlth, Dept Epidemiol, B-3000 Louvain, Belgium	KU Leuven	Kesteloot, H (corresponding author), Katholieke Univ Leuven, Sch Publ Hlth, Dept Epidemiol, Kapucijnenvoer 35, B-3000 Louvain, Belgium.							Distefan JM, 1999, PREV MED, V28, P1, DOI 10.1006/pmed.1998.0409; Escamilla G, 2000, AM J PUBLIC HEALTH, V90, P412, DOI 10.2105/AJPH.90.3.412; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; KESTELOOT H, 1995, ACTA CARDIOL, V50, P343; Kesteloot H, 1993, Verh K Acad Geneeskd Belg, V55, P399; Kesteloot H. E. C., 1999, MEDICOGRAPHIA, V21, P95; RAYNER M, 2000, EUROPEAN CARDIOVASCU, P44; Sans S, 1997, EUR HEART J, V18, P1231; World Bank, 2022, WORLD BANK DEV IND	9	11	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 17	2001	357	9259					871	872		10.1016/S0140-6736(00)04202-1	http://dx.doi.org/10.1016/S0140-6736(00)04202-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265968				2022-12-28	WOS:000167586300035
J	Friis, EM; Pedersen, KR; Crane, PR				Friis, EM; Pedersen, KR; Crane, PR			Fossil evidence of water lilies (Nymphaeales) in the Early Cretaceous	NATURE			English	Article							ANGIOSPERM PHYLOGENY	Phylogenetic analyses have identified the water lilies (Nymphaeales: Cabombaceae and Nymphaeaceae), together with four other small groups of flowering plants (the 'ANITA clades': Amborellaceae, Illiciales, Trimeniaceae, Austrobaileyaceae), as the first diverging lineages from the main branch of the angiosperm phylogenetic tree(1-4), but evidence of these groups in the earliest phases of the angiosperm fossil record has remained elusive. Here we report the earliest unequivocal evidence, based on fossil floral structures and associated pollen, of fossil plants related to members of the ANITA clades. This extends the history of the water lilies (Nymphaeales) back to the Early Cretaceous (125-115 million years) and into the oldest fossil assemblages that contain unequivocal angiosperm stamens and carpels. This discovery adds to the growing congruence between results from molecular-based analyses of relationships among angiosperms and the palaeobotanical record. It is also consistent with previous observations that the flowers of early angiosperms were generally very small(5) compared with those of their living relatives.	Swedish Museum Nat Hist, Dept Palaeobot, SE-10405 Stockholm, Sweden; Aarhus Univ, Dept Geol, DK-8000 Aarhus C, Denmark; Royal Bot Gardens, Richmond TW9 3AB, Surrey, England	Swedish Museum of Natural History; Aarhus University; Royal Botanic Gardens, Kew	Friis, EM (corresponding author), Swedish Museum Nat Hist, Dept Palaeobot, Box 50007, SE-10405 Stockholm, Sweden.		Pedersen, Kaj Raunsgaard/L-4105-2013	Crane, Peter/0000-0003-4331-6948; Friis, Else Marie/0000-0001-7587-9687				BESSEY CE, 1915, ANN MISSOURI BOT GAR, V2, P109; Brenner Gilbert J., 1992, Palynology, V16, P137; Doyle J.A., 1976, ORIGIN EARLY EVOLUTI, P139; DOYLE JA, 1992, CRETACEOUS RES, V13, P337, DOI 10.1016/0195-6671(92)90039-S; DOYLE JA, 1977, PALYNOLOGY, V1, P43, DOI DOI 10.1080/01916122.1977.9989150; DRINNAN AN, 1994, PL SYST EVOL S, V8, P93; Endress PK, 2000, INT J PLANT SCI, V161, pS211, DOI 10.1086/317572; Friis EM, 1999, ANN MO BOT GARD, V86, P259, DOI 10.2307/2666179; Friis EM, 2000, INT J PLANT SCI, V161, pS169, DOI 10.1086/317570; Friis EM, 1997, EVOLUTION DIVERSIFIC, P121; FRIIS EM, 1994, PL SYST EVOL S, V8, P31; Frumin S, 1999, PLANT SYST EVOL, V216, P265, DOI 10.1007/BF01084403; Gandolfo M. A., 2000, MONOCOTS SYSTEMATICS, P44; HUGHES NF, 1990, REV PALAEOBOT PALYNO, V65, P145, DOI 10.1016/0034-6667(90)90065-Q; HUGHES NF, 1994, ENIGMA ANGIOSPERM OR; Kuzoff RK, 2000, TRENDS PLANT SCI, V5, P330, DOI 10.1016/S1360-1385(00)01685-X; Les DH, 1999, SYST BOT, V24, P28, DOI 10.2307/2419384; Magallon S, 1999, ANN MO BOT GARD, V86, P297, DOI 10.2307/2666180; Mohr BAR, 2000, INT J PLANT SCI, V161, pS155, DOI 10.1086/317580; Penny, 1986, SPEC PAP PALAEONTOL, V35, P121; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Qiu YL, 2000, INT J PLANT SCI, V161, pS3, DOI 10.1086/317584; REY J, 1972, SERVICOS GEOLOGICOS, V21, P1; Saporta GD., 1894, ACAD ROY SCI LISBONN, P112; Schneider E.L., 1993, FAMILIES GENERA VASC, P486, DOI DOI 10.1007/978-3-662-02899-5_57; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Takhtajan A, 1969, FLOWERING PLANTS ORI; Williamson PS, 1993, FAMILIES GENERA VASC, V2, P157, DOI DOI 10.1007/978-3-662-02899-5_16	28	173	180	2	42	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					357	360		10.1038/35066557	http://dx.doi.org/10.1038/35066557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268209				2022-12-28	WOS:000167464100047
J	Huang, YH; Park, YC; Rich, RL; Segal, D; Myszka, DG; Wu, H				Huang, YH; Park, YC; Rich, RL; Segal, D; Myszka, DG; Wu, H			Structural basis of caspase inhibition by XIAP: Differential roles of the linker versus the BIR domain	CELL			English	Article							APOPTOSIS PROTEIN XIAP; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; BACULOVIRAL-INHIBITOR; SURVIVIN REVEALS; NMR STRUCTURE; CELL-DEATH; IAP; COMPLEX; FAMILY	The inhibitor of apoptosis proteins (IAPs) represent the only endogenous caspase inhibitors and are characterized by the presence of baculoviral IAP repeats (BIRs). Here, we report the crystal structure of the complex between human caspase-7 and XIAP (BIR2 and the proceeding linker). The structure surprisingly reveals that the linker is the only contacting element for the caspase, while the BIR2 domain is invisible in the crystal. The linker interacts with and blocks the substrate groove of the caspase in a backward fashion, distinct from substrate recognition. Structural analyses suggest that the linker is the energetic and specificity determinant of the interaction. Further biochemical characterizations clearly establish that the linker harbors the major energetic determinant, while the BIR2 domain serves as a regulatory element for caspase binding and Smac neutralization.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, Program Physiol Biophys & Mol Med, New York, NY 10021 USA; Univ Utah, Sch Med, Ctr Biomol Interact Anal, Salt Lake City, UT 84132 USA	Cornell University; Cornell University; Utah System of Higher Education; University of Utah	Wu, H (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.							Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Blanchard H, 2000, J MOL BIOL, V302, P9, DOI 10.1006/jmbi.2000.4041; Blanchard H, 1999, STRUCTURE, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Hay BA, 2000, CELL DEATH DIFFER, V7, P1045, DOI 10.1038/sj.cdd.4400765; Hinds MG, 1999, NAT STRUCT BIOL, V6, P648; Holcik M, 2000, P NATL ACAD SCI USA, V97, P2286, DOI 10.1073/pnas.040469797; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LaLonde JM, 1998, J MED CHEM, V41, P4567, DOI 10.1021/jm980249f; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Mittl PRE, 1997, J BIOL CHEM, V272, P6539, DOI 10.1074/jbc.272.10.6539; Muchmore SW, 2000, MOL CELL, V6, P173, DOI 10.1016/S1097-2765(00)00018-6; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Myszka DG, 1999, MOL RECOGNIT, V12, P1; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Takahashi N, 1999, BIOCHEM BIOPH RES CO, V256, P449, DOI 10.1006/bbrc.1999.0252; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TONG L, 1993, J APPL CRYSTALLOGR, V26, P748, DOI 10.1107/S0021889893005631; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2	53	403	434	2	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2001	104	5					781	790		10.1016/S0092-8674(01)00273-2	http://dx.doi.org/10.1016/S0092-8674(01)00273-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257231	Bronze			2022-12-28	WOS:000167531100017
J	Chambers, JC; Fusi, L; Malik, IS; Haskard, DO; De Swiet, M; Kooner, JS				Chambers, JC; Fusi, L; Malik, IS; Haskard, DO; De Swiet, M; Kooner, JS			Association of maternal endothelial dysfunction with preeclampsia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTHY-YOUNG ADULTS; OXIDATIVE STRESS; NITRIC-OXIDE; ESSENTIAL-HYPERTENSION; DEPENDENT DILATATION; PASSIVE SMOKING; BLOOD-PRESSURE; RISK-FACTORS; IN-VIVO; WOMEN	Context Preeclampsia is believed to result from release of placental factors that damage maternal vascular endothelium. However, because most studies have been conducted during pregnancy, it has not been possible to separate maternal from placental mechanisms underlying endothelial dysfunction in preeclampsia. Objective To determine whether endothelial function is impaired in nonpregnant women with previous preeclampsia and whether endothelial dysfunction is mediated by oxidative stress. Design and Setting Case-control study conducted at 3 hospital maternity units in London, England, between July 1997 and June 2000. Participants A total of 113 women with previous preeclampsia (n=35 with recurrent episodes; n=78 with a single episode) and 48 women with previous uncomplicated pregnancies, all of whom were at least 3 months (median, 3 years) postpartum. Main Outcome Measures Brachial artery flow-mediated (endothelium-dependent) and glyceryl trinitrate-induced (endothelium-independent) dilatation were compared between previously preeclamptic women and controls. To investigate oxidative stress, these measurements were repeated after administration of ascorbic acid, 1 g intravenously, in 15 cases and 15 controls. Results Mean (SD) flow-mediated dilatation was lower in women with previous preeclampsia compared with controls (recurrent group, 0.9% [4.1 %]; single-episode group, 2.7% [3.5%]; and control group, 4.7% [4.3 % ]; P<.001). In contrast, glyceryl trinitrate-induced dilatation was similar in the 3 groups (recurrent, 19.5% [5.9%]; single-episode, 21.0% [8.0%]; and control, 21.0% [8.3%]; P=.65). Impaired flow-mediated dilatation in previously preeclamptic women was not accounted for by recognized vascular risk factors. Ascorbic acid administration increased flow-mediated dilatation in previously preeclamptic women (baseline, 2.6% [3.3%]; after administration, 5.6% [3.0%]; P=.001) but not in controls (baseline, 6.2% [3.3%]; after administration, 6.7% [5.0%]; P=.72). Conclusions Our results indicate that endothelial function is impaired in women with previous preeclampsia and is not explained by established maternal risk factors but is reversed by antioxidant ascorbic acid administration.	Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Natl Heart & Lung Inst, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Inst Obstet & Gynaecol, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Inst Reprod & Dev Biol, London W12 0NN, England	Imperial College London; Imperial College London; Imperial College London	Kooner, JS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Natl Heart & Lung Inst, Du Cane Rd, London W12 0NN, England.	j.kooner@ic.ac.uk						Caritis S, 1998, AM J OBSTET GYNECOL, V179, P946, DOI 10.1016/S0002-9378(98)70194-2; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P1468, DOI 10.1016/0735-1097(94)90141-4; Celermajer DS, 1996, NEW ENGL J MED, V334, P150, DOI 10.1056/NEJM199601183340303; Chambers JC, 1999, CIRCULATION, V99, P1156, DOI 10.1161/01.CIR.99.9.1156; Chambers JC, 2000, CIRCULATION, V102, P2479, DOI 10.1161/01.CIR.102.20.2479; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; Clarkson P, 1999, J AM COLL CARDIOL, V33, P1379, DOI 10.1016/S0735-1097(99)00036-4; Dekker GA, 1998, AM J OBSTET GYNECOL, V179, P1359, DOI 10.1016/S0002-9378(98)70160-7; Dupuis J, 1999, CIRCULATION, V99, P3227, DOI 10.1161/01.CIR.99.25.3227; Evans M, 2000, CIRCULATION, V101, P1773, DOI 10.1161/01.CIR.101.15.1773; FISKERSTRAND T, 1993, CLIN CHEM, V39, P263; Giugliano D, 1998, DIABETES CARE, V21, P631, DOI 10.2337/diacare.21.4.631; Hambrecht R, 2000, NEW ENGL J MED, V342, P454, DOI 10.1056/NEJM200002173420702; Hart CL, 1999, STROKE, V30, P1999, DOI 10.1161/01.STR.30.10.1999; Hingorani AD, 2000, CIRCULATION, V102, P994, DOI 10.1161/01.CIR.102.9.994; HOLCBERG G, 1995, AM J OBSTET GYNECOL, V173, P528; JOANNIDES R, 1995, CIRCULATION, V91, P1314, DOI 10.1161/01.CIR.91.5.1314; Kojda G, 1999, CARDIOVASC RES, V43, P562, DOI 10.1016/S0008-6363(99)00169-8; Matijevic R, 1999, BRIT J OBSTET GYNAEC, V106, P78, DOI 10.1111/j.1471-0528.1999.tb08089.x; Meeking DR, 1999, DIABETIC MED, V16, P841, DOI 10.1046/j.1464-5491.1999.00158.x; Meis PJ, 1998, AM J OBSTET GYNECOL, V178, P562, DOI 10.1016/S0002-9378(98)70439-9; Muiesan ML, 1999, HYPERTENSION, V33, P575, DOI 10.1161/01.HYP.33.1.575; Murphy S L, 2000, Natl Vital Stat Rep, V48, P1; Myatt L, 1996, HYPERTENSION, V28, P488, DOI 10.1161/01.HYP.28.3.488; POHL U, 1986, HYPERTENSION, V8, P37, DOI 10.1161/01.HYP.8.1.37; Raitakari OT, 1999, ANN INTERN MED, V130, P578, DOI 10.7326/0003-4819-130-7-199904060-00017; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Roberts JM, 1999, LANCET, V354, P788, DOI 10.1016/S0140-6736(99)80002-6; RODGERS GM, 1988, AM J OBSTET GYNECOL, V159, P908, DOI 10.1016/S0002-9378(88)80169-8; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SALVEMINI D, 1995, J CLIN INVEST, V96, P301, DOI 10.1172/JCI118035; Schiffrin EL, 2000, CIRCULATION, V101, P1653; Simons LA, 1998, ATHEROSCLEROSIS, V137, P197, DOI 10.1016/S0021-9150(97)00252-9; SORENSEN KE, 1995, BRIT HEART J, V74, P247; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; Virdis A, 2000, CIRCULATION, V101, P2258, DOI 10.1161/01.CIR.101.19.2258; Walker AB, 1999, DIABETES, V48, P1448, DOI 10.2337/diabetes.48.7.1448; Walsh SW, 1998, SEMIN REPROD ENDOCR, V16, P93, DOI 10.1055/s-2007-1016256; Woo KS, 1997, CIRCULATION, V96, P2542, DOI 10.1161/01.CIR.96.8.2542; Woo KS, 1999, J AM COLL CARDIOL, V34, P2002, DOI 10.1016/S0735-1097(99)00469-6	40	380	397	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2001	285	12					1607	1612		10.1001/jama.285.12.1607	http://dx.doi.org/10.1001/jama.285.12.1607			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413HH	11268269	Bronze			2022-12-28	WOS:000167606600028
J	Frank, DA; Augustyn, M; Knight, WG; Pell, T; Zuckerman, B				Frank, DA; Augustyn, M; Knight, WG; Pell, T; Zuckerman, B			Growth, development, and behavior in early childhood following prenatal cocaine exposure - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MATERNAL CIGARETTE-SMOKING; MOTHER-INFANT INTERACTION; LOW-BIRTH-WEIGHT; IN-UTERO; DRUG EXPOSURE; COGNITIVE-DEVELOPMENT; LANGUAGE-DEVELOPMENT; AROUSAL MODULATION; PRESCHOOL-CHILDREN; AGE-CHILDREN	Context Despite recent studies that failed to show catastrophic effects of prenatal cocaine exposure, popular attitudes and public policies still reflect the belief that cocaine is a uniquely dangerous teratogen. Objective To critically review outcomes in early childhood after prenatal cocaine exposure in 5 domains: physical growth; cognition; language skills; motor skills; and behavior, attention, affect, and neurophysiology. Data Sources Search of MEDLINE and Psychological Abstracts from 1984 to October 2000. Study Selection Studies selected for detailed review (1) were published in a peer-reviewed English-language journal; (2) included a corn parison group; (3) recruited samples prospectively in the perinatal period; (4) used masked assessment; and (5) did not include a substantial proportion of subjects exposed in utero to opiates, amphetamines, phencyclidine, or maternal human immunodeficiency virus infection. Data Extraction Thirty-six of 74 articles met criteria and were reviewed by 3 authors. Disagreements were resolved by consensus. Data Synthesis After controlling for confounders, there was no consistent negative association between prenatal cocaine exposure and physical growth, developmental test scores, or receptive or expressive language. Less optimal motor scores have been found up to age 7 months but not thereafter, and may reflect heavy tobacco exposure. No independent cocaine effects have been shown on standardized parent and teacher reports of child behavior scored by accepted criteria. Experimental paradigms and novel statistical manipulations of standard instruments suggest an association between prenatal cocaine exposure and decreased attentiveness and emotional expressivity, as well as differences on neurophysiologic and attentional/affecive findings. Conclusions Among children aged 6 years or younger, there is no convincing evidence that prenatal cocaine exposure is associated with developmental toxic effects that are different in severity, scope, or kind from the sequelae of multiple other risk factors. Many findings once thought to be specific effects of in utero cocaine exposure are correlated with other factors, including prenatal exposure to tobacco, marijuana, or alcohol, and the quality of the child's environment. Further replication is required of preliminary neurologic findings.	Boston Univ, Sch Med, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA	Boston University; Boston University	Frank, DA (corresponding author), Boston Med Ctr, Growth & Dev Programs, 820 Harrison Ave,FGH Bldg,3rd Floor, Boston, MA 02118 USA.	dafrank@bu.edu		Augustyn, Marilyn/0000-0001-9975-6067; Zuckerman, Barry/0000-0002-0044-2592	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006532] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA006532-14, R01 DA006532-11S1, R01 DA006532, R01 DA006532-13S2, DA 06532, R01 DA006532-13S1, R01 DA006532-12, R01 DA006532-13, R01 DA006532-11] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Adger H, 1999, PEDIATRICS, V103, P1083; ALESSANDRI SM, 1993, DEV PSYCHOL, V29, P989, DOI 10.1037/0012-1649.29.6.989; Alessandri SM, 1998, DEV PSYCHOL, V34, P565, DOI 10.1037/0012-1649.34.3.565; ANGELILLI ML, 1994, CLIN PEDIATR, V33, P514, DOI 10.1177/000992289403300901; [Anonymous], 1991, MANUAL CHILD BEHAV C; Arendt R, 1998, INFANT BEHAV DEV, V21, P627, DOI 10.1016/S0163-6383(98)90034-0; Arendt R, 1999, PEDIATRICS, V103, P86, DOI 10.1542/peds.103.1.86; AZUMA SD, 1993, PEDIATRICS, V92, P396; Bard KA, 2000, DEV PSYCHOBIOL, V36, P194, DOI 10.1002/(SICI)1098-2302(200004)36:3<194::AID-DEV3>3.0.CO;2-X; Barone D, 1997, J LIT RES, V29, P183, DOI 10.1080/10862969709547956; Behnke M, 1998, J PEDIATR-US, V132, P291, DOI 10.1016/S0022-3476(98)70447-0; Belcher HME, 1999, DEV MED CHILD NEUROL, V41, P240, DOI 10.1017/S0012162299000511; BELLINGER DC, 1995, NEUROTOXICOL TERATOL, V17, P201, DOI 10.1016/0892-0362(94)00081-N; Bender SL, 1995, J DEV BEHAV PEDIATR, V16, P418; Bendersky M, 1998, DEV PSYCHOL, V34, P555, DOI 10.1037/0012-1649.34.3.555; Betancourt L, 1999, J DEV BEHAV PEDIATR, V20, P418, DOI 10.1097/00004703-199912000-00003; Blackwell P, 1998, J APPL DEV PSYCHOL, V19, P235, DOI 10.1016/S0193-3973(99)80038-0; Blanchard Yvette, 1998, Physical and Occupational Therapy in Pediatrics, V18, P19, DOI 10.1300/J006v18n03_02; Bland-Stewart Linda M., 1998, Seminars in Speech and Language, V19, P167, DOI 10.1055/s-2008-1064043; BRAZDZIUNAS DM, 1994, PSYCHOSOC REHABIL, V17, P145; CHAPMAN JK, 2000, INFANT TODDLER INTER, V10, P19; CHASNOFF IJ, 1992, PEDIATRICS, V89, P284; CHIRIBOGA CA, 1995, PEDIATRICS, V96, P1070; CHIRIBOGA CA, 1996, PEDIATRICS, V98, P735; Coles CD, 1999, NEUROTOXICOL TERATOL, V21, P527, DOI 10.1016/S0892-0362(99)00023-9; Delaney-Black V, 1998, PEDIATRICS, V102, P945, DOI 10.1542/peds.102.4.945; Delaney-Black V, 2000, PEDIATRICS, V106, P782, DOI 10.1542/peds.106.4.782; DelaneyBlack V, 1996, PEDIATRICS, V98, P735; Dempsey DA, 2000, PEDIATRICS, V106, P79, DOI 10.1542/peds.106.1.79; EDMONDSON R, 1994, INFANT MENT HEALTH J, V15, P368, DOI 10.1002/1097-0355(199424)15:4<368::AID-IMHJ2280150406>3.0.CO;2-Q; ELLIOTT KT, 1991, J INSTRUCTIONAL PSYC, V18, P60; Espy KA, 1999, DEV NEUROPSYCHOL, V15, P447, DOI 10.1080/87565649909540761; Fares I, 1997, J Perinatol, V17, P179; Fetters L, 1996, PEDIATRICS, V98, P938; Fetters Linda, 1998, Physical and Occupational Therapy in Pediatrics, V18, P1, DOI 10.1300/J006v18n03_01; Franck EJ, 1996, CHILD WELFARE, V75, P19; FRANK DA, 1988, PEDIATRICS, V82, P888; Frank DA, 1998, ANN NY ACAD SCI, V846, P40, DOI 10.1111/j.1749-6632.1998.tb09725.x; Frank DA, 1999, PEDIATRICS, V104, P1101, DOI 10.1542/peds.104.5.1101; FRANK DA, 2000, CHILDREN ADDICTION R, P1; FREYER FJ, 1998, PROVIDENCE J B  0613, pA1; Fried PA, 2000, NEUROTOXICOL TERATOL, V22, P11, DOI 10.1016/S0892-0362(99)00046-X; Fried PA, 1998, NEUROTOXICOL TERATOL, V20, P293, DOI 10.1016/S0892-0362(97)00091-3; Goldschmidt L, 2000, NEUROTOXICOL TERATOL, V22, P325, DOI 10.1016/S0892-0362(00)00066-0; Gomez Laura, 1997, MISCONCEIVING MOTHER; GRAHAM K, 1992, CLIN INVEST MED, V15, P384; GREENHOUSE L, 2000, NY TIMES        1005, V5, pA26; GRIFFITH DR, 1994, J AM ACAD CHILD PSY, V33, P20, DOI 10.1097/00004583-199401000-00004; HAACK R, 1997, DRUG DEPENDENT MOTHE; Hans SL, 1992, MATERNAL SUBSTANCE A, P177; HARSHAM J, 1994, J AM DIET ASSOC, V94, P999, DOI 10.1016/0002-8223(94)92193-8; HARVEY JA, 1998, COCAINE EFFECTS DEV; HAWLEY TL, 1995, AM J ORTHOPSYCHIAT, V65, P364, DOI 10.1037/h0079693; Held JR, 1999, NEUROTOXICOL TERATOL, V21, P619, DOI 10.1016/S0892-0362(99)00032-X; HFFELFINGER A, 1997, J INT NEUROPSYCH SOC, V3, P237; HOFKOSH D, 1995, ARCH PEDIAT ADOL MED, V149, P665, DOI 10.1001/archpedi.1995.02170190075014; HOLZMAN C, 1994, EPIDEMIOL REV, V16, P315, DOI 10.1093/oxfordjournals.epirev.a036156; Horger E O 3rd, 1990, J S C Med Assoc, V86, P527; HOWARD J, 1995, NEUROTOXICOL TERATOL, V17, P403, DOI 10.1016/0892-0362(94)00077-Q; Hurt H, 1996, J DEV BEHAV PEDIATR, V17, P373, DOI 10.1097/00004703-199612000-00001; Hurt H, 1997, ARCH PEDIAT ADOL MED, V151, P1237, DOI 10.1001/archpedi.1997.02170490063011; Hurt H, 1997, J PEDIATR-US, V130, P310, DOI 10.1016/S0022-3476(97)70361-5; Hurt H, 1998, ARCH PEDIAT ADOL MED, V152, P993; HUSTON A, 1991, CHILD DEV, V65, P275; Jacobson, 1968, PYGMALION CLASSROOM; JACOBSON JL, 1994, ALCOHOL CLIN EXP RES, V18, P317, DOI 10.1111/j.1530-0277.1994.tb00020.x; Jacobson JL, 1996, DEV PSYCHOL, V32, P390; Jacobson SW, 1996, J PEDIATR-US, V129, P581, DOI 10.1016/S0022-3476(96)70124-5; Jacobson SW, 1999, DEV PSYCHOPATHOL, V11, P195, DOI 10.1017/S0954579499002011; Johnson HL, 1999, AM J ORTHOPSYCHIAT, V69, P448, DOI 10.1037/h0080393; Johnson JM, 1997, J COMMUN DISORD, V30, P45, DOI 10.1016/S0021-9924(96)00055-X; Karmel BZ, 1996, J PEDIATR PSYCHOL, V21, P821, DOI 10.1093/jpepsy/21.6.821; Kilbride H, 2000, J DEV BEHAV PEDIATR, V21, P19, DOI 10.1097/00004703-200002000-00004; Kuhn L, 2000, AM J EPIDEMIOL, V152, P112, DOI 10.1093/aje/152.2.112; Lassen K, 1998, ADDICT BEHAV, V23, P635, DOI 10.1016/S0306-4603(98)00022-7; Leech SL, 1999, NEUROTOXICOL TERATOL, V21, P109, DOI 10.1016/S0892-0362(98)00042-7; LEON DA, 1993, LANCET, V342, P479, DOI 10.1016/0140-6736(93)91599-H; Lester BM, 1998, SCIENCE, V282, P633, DOI 10.1126/science.282.5389.633; Lightwood JM, 1999, PEDIATRICS, V104, P1312, DOI 10.1542/peds.104.6.1312; LUTIGER B, 1991, TERATOLOGY, V44, P405, DOI 10.1002/tera.1420440407; Madison CL, 1998, J COMMUN DISORD, V31, P231, DOI 10.1016/S0021-9924(97)00091-9; MALAKOFF ME, 1994, AM J ADDICTION, V3, P346; Mayes LC, 1997, INFANT BEHAV DEV, V20, P489, DOI 10.1016/S0163-6383(97)90038-2; MAYES LC, 1995, PEDIATRICS, V95, P539; MENTIS M, 1995, J SPEECH HEAR RES, V38, P1303, DOI 10.1044/jshr.3806.1303; MIROCHNICK M, 1995, J PEDIATR-US, V126, P636, DOI 10.1016/S0022-3476(95)70367-5; MORRIS RS, 1993, ASSIST REPROD REV, V3, P211; Murphy S., 1999, PREGNANT WOMEN DRUGS; NELSON J, 1998, ETHICAL LEGAL ANAL 3; NULMAN I, 1994, CAN MED ASSOC J, V151, P1591; ONEILL AM, 1999, PEOPLE          0927, P145; OSTREA EM, 1992, PEDIATRICS, V89, P107; Ostrea EM, 1997, PEDIATRICS, V100, P79, DOI 10.1542/peds.100.1.79; PALTROW LYNN M., 1999, ALBANY LAW REV, V62, P999; Phelps L, 1997, PSYCHOL SCHOOLS, V34, P245, DOI 10.1002/(SICI)1520-6807(199707)34:3<245::AID-PITS7>3.0.CO;2-N; Phelps L, 1999, J PSYCHOEDUC ASSESS, V17, P343, DOI 10.1177/073428299901700404; RACINE A, 1993, JAMA-J AM MED ASSOC, V270, P1581, DOI 10.1001/jama.270.13.1581; Richardson GA, 1996, NEUROTOXICOL TERATOL, V18, P627, DOI 10.1016/S0892-0362(96)00121-3; RODNING C, 1990, DEV PSYCHOPATHOL, V1, P277; Rodning C., 1991, DEV PSYCHOPATHOL, V3, P351, DOI [DOI 10.1017/S0954579400007562, 10.1017/S0954579400007562]; Rosenthal R., 1966, EXPT EFFECTS BEHAV R; ROTHOLZ DA, 1995, ED TREATMENT CHILDRE, V18, P1; ROTZOLL BW, 2000, CHICAGO SUN TIM 0423, P12; Roumell N, 1997, INF MENTAL HLTH J, V18, P274, DOI 10.1002/(SICI)1097-0355(199723)18:3<274::AID-IMHJ4>3.3.CO;2-H; Scher MS, 2000, PEDIATRICS, V105, P39, DOI 10.1542/peds.105.1.39; Schlesselman JJ, 1982, CASE CONTROL STUDIES, P124; SCHNEIDER JW, 1992, NEUROTOXICOL TERATOL, V14, P97, DOI 10.1016/0892-0362(92)90057-H; Singer L, 1997, DEV PSYCHOPATHOL, V9, P473, DOI 10.1017/S0954579497001259; SINGER LT, 1994, J PEDIATR-US, V124, P765, DOI 10.1016/S0022-3476(05)81372-1; Slotkin TA, 1998, J PHARMACOL EXP THER, V285, P931; Stanger C, 1999, J AM ACAD CHILD PSY, V38, P421, DOI 10.1097/00004583-199904000-00015; Swanson MW, 1999, J DEV BEHAV PEDIATR, V20, P325, DOI 10.1097/00004703-199910000-00007; THURMAN SK, 1994, J EARLY INTERVENTION, V18, P119, DOI 10.1177/105381519401800201; Tronick EZ, 1996, PEDIATRICS, V98, P76; Van Beveren TT, 2000, AM J HUM BIOL, V12, P417; VANBAAR A, 1994, DEV MED CHILD NEUROL, V36, P1063; VANBAAR AL, 1989, ARCH DIS CHILD, V64, P241, DOI 10.1136/adc.64.2.241; VANBAAR AL, 1994, ACTA PAEDIATR, V83, P40; Wasserman GA, 1998, DRUG ALCOHOL DEPEN, V50, P203, DOI 10.1016/S0376-8716(98)00037-4; WEATHERS WT, 1993, PEDIATRICS, V91, P350; WEITZMAN M, 1992, PEDIATRICS, V90, P342; Werler MM, 1997, TERATOLOGY, V55, P382; WILL GF, 1999, BALTIMORE SUN   1101, pA15; Woods NS, 1998, J DEV BEHAV PEDIATR, V19, P283, DOI 10.1097/00004703-199808000-00007; [No title captured]	125	316	332	0	49	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2001	285	12					1613	1625		10.1001/jama.285.12.1613	http://dx.doi.org/10.1001/jama.285.12.1613			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	413HH	11268270	Green Accepted			2022-12-28	WOS:000167606600029
J	Lasaga, AC; Luttge, A				Lasaga, AC; Luttge, A			Variation of crystal dissolution rate based on a dissolution stepwave model	SCIENCE			English	Article							SCANNING FORCE MICROSCOPY; SOLUTION SATURATION STATE; REACTIVE SURFACE-AREA; WATER INTERFACE; ETCH PITS; REAL-TIME; RATE LAW; PH 8.8; KINETICS; CALCITE	A formulation based on defect-generated dissolution stepwaves of the variation of dissolution rate with the degree of undersaturation is validated by nearatomic-scale observations of surfaces, Monte Carte simulations, and experimental bulk dissolution rates. The dissolution stepwaves emanating from etch pits provide a train of steps similar to those of a spiral but with different behavior. Their role in accounting for the bulk dissolution rate of crystals provides a conceptual framework for mineral dissolution far from equilibrium. Furthermore, the Law extends research to conditions closer to equilibrium and predicts a nonlinear decrease in the rate of dissolution as equilibrium is approached, which has implications for understanding artificial and natural processes involving solid-fluid reactions.	Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA	Rice University; Yale University	Luttge, A (corresponding author), Rice Univ, Dept Earth Sci, Houston, TX 77005 USA.		Luttge, Andreas/A-2560-2011	Luttge, Andreas/0000-0002-5878-4026				Baxter EF, 2000, SCIENCE, V288, P1411, DOI 10.1126/science.288.5470.1411; BERNER RA, 1982, AM J SCI, V282, P1214, DOI 10.2475/ajs.282.8.1214; Blum A.E., 1987, AQUATIC SURFACE CHEM, P255; BLUM AE, 1990, GEOCHIM COSMOCHIM AC, V54, P283, DOI 10.1016/0016-7037(90)90318-F; BOSBACH D, 1994, GEOCHIM COSMOCHIM AC, V58, P843, DOI 10.1016/0016-7037(94)90509-6; BRANTLEY SL, 1986, GEOCHIM COSMOCHIM AC, V50, P2349, DOI 10.1016/0016-7037(86)90087-6; BURCH TE, 1993, CHEM GEOL, V105, P137, DOI 10.1016/0009-2541(93)90123-Z; CABRERA N, 1954, PHYS REV, V96, P1153, DOI 10.1103/PhysRev.96.1153; CABRERA N, 1956, PHILOS MAG, V1, P480; Cama J, 2000, GEOCHIM COSMOCHIM AC, V64, P2701, DOI 10.1016/S0016-7037(00)00378-1; CASEY WH, 1988, GEOCHIM COSMOCHIM AC, V52, P1545, DOI 10.1016/0016-7037(88)90224-4; CYGAN RT, 1989, CHEM GEOL, V78, P229, DOI 10.1016/0009-2541(89)90060-0; DOVE PM, 1993, GEOCHIM COSMOCHIM AC, V57, P705, DOI 10.1016/0016-7037(93)90381-6; Dove PM, 1996, CHEM GEOL, V127, P331, DOI 10.1016/0009-2541(95)00127-1; Drever JI, 1995, REV MINERAL, V31, P463; FRANK FC, 1951, ACTA CRYSTALLOGR, V4, P497, DOI 10.1107/S0365110X51001690; GILMER GH, 1980, SCIENCE, V208, P355, DOI 10.1126/science.208.4442.355; GILMER GH, 1976, J CRYST GROWTH, V35, P15; GRATZ AJ, 1993, GEOCHIM COSMOCHIM AC, V57, P965, DOI 10.1016/0016-7037(93)90033-S; GRATZ AJ, 1990, GEOCHIM COSMOCHIM AC, V54, P2911, DOI 10.1016/0016-7037(90)90109-X; HEINISCH HL, 1975, J GEOPHYS RES, V80, P1885, DOI 10.1029/JB080i014p01885; HELGESON HC, 1984, GEOCHIM COSMOCHIM AC, V48, P2405, DOI 10.1016/0016-7037(84)90294-1; HILLNER PE, 1992, GEOLOGY, V20, P359, DOI 10.1130/0091-7613(1992)020<0359:ASIOCG>2.3.CO;2; Jordan G, 1998, GEOCHIM COSMOCHIM AC, V62, P941, DOI 10.1016/S0016-7037(98)00030-1; Jordan G, 1999, GEOCHIM COSMOCHIM AC, V63, P3183, DOI 10.1016/S0016-7037(99)00225-2; LASAGA AC, 1986, GEOCHIM COSMOCHIM AC, V50, P2363, DOI 10.1016/0016-7037(86)90088-8; LASAGA AC, 1994, GEOCHIM COSMOCHIM AC, V58, P2361, DOI 10.1016/0016-7037(94)90016-7; LASAGA AC, 1983, 4TH INT S WAT ROCK I, P269; Liang Y, 1996, GEOCHIM COSMOCHIM AC, V60, P4883, DOI 10.1016/S0016-7037(96)00337-7; Luttge A, 1999, AM J SCI, V299, P652; LUTTGE A, UNPUB; MACINNIS IN, 1992, GEOCHIM COSMOCHIM AC, V56, P1113, DOI 10.1016/0016-7037(92)90049-O; McCoy JM, 1997, SURF SCI, V373, P288, DOI 10.1016/S0039-6028(96)01156-9; Mogollon JL, 1996, AM J SCI, V296, P729, DOI 10.2475/ajs.296.7.729; NAGY KL, 1992, GEOCHIM COSMOCHIM AC, V56, P3093, DOI 10.1016/0016-7037(92)90291-P; Ortoleva P., 1994, GEOCHEMICAL SELF ORG; Rufe E, 1999, SCIENCE, V285, P874, DOI 10.1126/science.285.5429.874; SATIO Y, 1998, STAT PHYSICS CRYSTAL; SCHOTT J, 1989, GEOCHIM COSMOCHIM AC, V53, P373, DOI 10.1016/0016-7037(89)90389-X; STIPP SLS, 1994, GEOCHIM COSMOCHIM AC, V58, P3023, DOI 10.1016/0016-7037(94)90176-7; Taylor AS, 2000, GEOCHIM COSMOCHIM AC, V64, P2389, DOI 10.1016/S0016-7037(00)00361-6; VANDERHOEK B, 1982, J CRYST GROWTH, V56, P621, DOI 10.1016/0022-0248(82)90045-8; White A.F., 1995, REV MINERALOGY, V31; Wood B.J., 1986, FLUID ROCK INTERACTI, P89, DOI DOI 10.1007/978-1-4612-4896-5_4; [No title captured]	45	354	361	2	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2400	2404		10.1126/science.1058173	http://dx.doi.org/10.1126/science.1058173			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264534				2022-12-28	WOS:000167618700053
J	Chambers, JQ; Higuchi, N; Tribuzy, ES; Trumbore, SE				Chambers, JQ; Higuchi, N; Tribuzy, ES; Trumbore, SE			Carbon sink for a century	NATURE			English	Article							TROPICAL FORESTS; RESPONSES; TREES		Univ Calif Irvine, Irvine, CA 92697 USA; Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; INPA, Biol Dynam Forest Fragments Project, BR-69011970 Manaus, Amazonas, Brazil; Inst Nacl de Pesquisas da Amazonia, BR-69011970 Manaus, Amazonas, Brazil	University of California System; University of California Irvine; National Center for Ecological Analysis & Synthesis; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Chambers, JQ (corresponding author), Univ Calif Irvine, Irvine, CA 92697 USA.	chambersjq@yahoo.com	Chambers, Jeffrey Q/J-9021-2014; Tribuzy, Edgard Siza/D-8200-2014; Chambers, Jeffrey Q/AAU-7097-2021; Higuchi, Niro/ABC-9134-2020; Trumbore, Susan/B-1948-2013; Higuchi, Niro/ABC-8890-2020; Higuchi, Niro/J-1287-2016	Chambers, Jeffrey Q/0000-0003-3983-7847; Higuchi, Niro/0000-0002-1203-4502; Higuchi, Niro/0000-0002-1203-4502; Siza Tribuzy, Edgard/0000-0002-6834-8535				Chambers JQ, 1998, NATURE, V391, P135, DOI 10.1038/34325; Chambers JQ, 2000, OECOLOGIA, V122, P380, DOI 10.1007/s004420050044; CHAMBERS JQ, IN PRESS FOR ECOL MA; CHAMBERS JQ, 1998, ROLE LARGE WOOD CARB; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Keeling RF, 1996, NATURE, V381, P218, DOI 10.1038/381218a0; Lloyd J, 1999, FUNCT ECOL, V13, P439, DOI 10.1046/j.1365-2435.1999.00350.x; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Norby RJ, 1999, PLANT CELL ENVIRON, V22, P683, DOI 10.1046/j.1365-3040.1999.00391.x; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; TRUMBORE SE, 1995, GLOBAL BIOGEOCHEM CY, V9, P515, DOI 10.1029/95GB02148	12	92	100	3	43	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 22	2001	410	6827					429	429		10.1038/35068624	http://dx.doi.org/10.1038/35068624			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260700	Bronze			2022-12-28	WOS:000167583800028
J	Ross, JJ; Shimmi, O; Vilmos, P; Petryk, A; Kim, H; Gaudenz, K; Hermanson, S; Ekker, SC; O'Connor, MB; Marsh, JL				Ross, JJ; Shimmi, O; Vilmos, P; Petryk, A; Kim, H; Gaudenz, K; Hermanson, S; Ekker, SC; O'Connor, MB; Marsh, JL			Twisted gastrulation is a conserved extracellular BMP antagonist	NATURE			English	Article							DORSAL-VENTRAL PATTERN; DROSOPHILA EMBRYO; ZEBRAFISH EMBRYO; SPEMANNS ORGANIZER; ACTIVITY GRADIENT; MOLECULAR NATURE; DPP ACTIVITY; PROTEIN; XENOPUS; GENES	Bone morphogenetic protein (BMP) signalling regulates embryonic dorsal-ventral cell fate decisions in flies, frogs and fish(1). BMP activity is controlled by several secreted factors including the antagonists chordin and short gastrulation (SOG)(2,3). Here we show that a second secreted protein, Twisted gastrulation (Tsg)(4), enhances the antagonistic activity of Sog/chordin. In Drosophila, visualization of BMP signalling using anti-phospho-Smad staining(5) shows that the tsg and sog loss-of-function phenotypes are very similar. In S2 cells and imaginal discs, TSG and SOG together make a more effective inhibitor of BMP signalling than either of them alone. Blocking Tsg function in zebrafish with morpholino oligonucleotides causes ventralization similar to that produced by chordin mutants. Co-injection of sub-inhibitory levels of morpholines directed against both Tsg and chordin synergistically enhances the penetrance of the ventralized phenotype. We show that Tsgs from different species are functionally equivalent, and conclude that Tsg is a conserved protein that functions with SOG/chordin to antagonize BMP signalling.	Univ Minnesota, Dept Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Dev & Cell Biol, Minneapolis, MN 55455 USA; Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; Univ Minnesota, Arnold & Mabel Beckman Ctr Transposon Res, Minneapolis, MN 55455 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Irvine	O'Connor, MB (corresponding author), Univ Minnesota, Dept Genet, Minneapolis, MN 55455 USA.		, 0000-0001-6341-9130/P-9094-2018; O'Connor, Michael B/C-9977-2014	, 0000-0001-6341-9130/0000-0001-6341-9130; O'Connor, Michael B/0000-0002-3067-5506; Ekker, Stephen/0000-0003-0726-4212; Vilmos, Peter/0000-0001-5692-8818				ARORA K, 1992, DEVELOPMENT, V114, P1003; Ashe HL, 2000, DEVELOPMENT, V127, P3305; Ashe HL, 1999, NATURE, V398, P427, DOI 10.1038/18892; Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; Dick A, 2000, DEVELOPMENT, V127, P343; FERGUSON EL, 1992, DEVELOPMENT, V114, P583; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Fisher S, 1997, DEVELOPMENT, V124, P1301; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Holley SA, 1997, BIOESSAYS, V19, P281, DOI 10.1002/bies.950190404; Holley SA, 1996, CELL, V86, P607, DOI 10.1016/S0092-8674(00)80134-8; Hukriede NA, 1999, P NATL ACAD SCI USA, V96, P9745, DOI 10.1073/pnas.96.17.9745; Jowett T, 1999, METHOD CELL BIOL, V59, P63; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; MASON ED, 1994, GENE DEV, V8, P1489, DOI 10.1101/gad.8.13.1489; Miller-Bertaglio V, 1999, DEV BIOL, V214, P72, DOI 10.1006/dbio.1999.9384; Mullins MC, 1996, DEVELOPMENT, V123, P81; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; RAY RP, 1991, DEVELOPMENT, V113, P35; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; SEGAL D, 1985, GENETICS, V109, P119; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; WHARTON KA, 1993, DEVELOPMENT, V117, P807; Yu K, 2000, DEVELOPMENT, V127, P2143	30	228	247	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					479	483		10.1038/35068578	http://dx.doi.org/10.1038/35068578			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260716	Green Published			2022-12-28	WOS:000167583800044
J	Lee, IM; Rexrode, KM; Cook, NR; Manson, JE; Buring, JE				Lee, IM; Rexrode, KM; Cook, NR; Manson, JE; Buring, JE			Physical activity and coronary heart disease in women - Is "no pain, no gain" passe?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONFATAL MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; RISK-FACTORS; POSTMENOPAUSAL WOMEN; OLDER ADULTS; MORTALITY; HEALTH; EXERCISE; MEN; WALKING	Context Physically active women have lower coronary heart disease (CHD) rates than inactive women. However, whether the association differs by intensity of activity or in women at high risk for CHD is unclear. Objective To examine the relation between physical activity, specifically investigating walking (a light-to-moderate activity depending on pace), and CHD among women, including those at high risk for CHD. Design, Setting, and Participants Cohort study of 39372 healthy female health professionals aged 45 years or older, enrolled throughout the United States between September 1992 and May 1995, with follow-up to March 1999. Recreational activities, including walking and stair climbing, were reported at study entry. Main Outcome Measure Correlation of CHD with energy expended on all activities, vigorous activities, and walking. Results A total of 244 cases of CHD occurred. Adjusting for potential confounders, the relative risks (RRs) of CHD for less than 200, 200-599, 600-1499, and 1500 or more kcal/wk expended on all activities were 1.00 (referent), 0.79 (95% confidence interval [CI], 0.56-1.12), 0.55 (95% CI, 0.37-0.82), and 0.75 (95% CI, 0.50-1.12), respectively (P for linear trend =.03). Vigorous activities were associated with lower risk (RR, 0.63; 95% CI, 0.38-1.04 comparing highest and lowest categories). Walking also predicted lower risk among women without vigorous activities. Among these women, the multivariate RRs for walking 1 to 59 min/wk, 1.0 to 1.5 h/wk, and 2 or more h/wk, compared with no regular walking, were 0.86 (95% CI, 0.57-1.29), 0.49 (95% CI, 0.28-0.86), and 0.48 (95% CI, 0.29-0.78), respectively. For walking paces of less than 3.2 km/h (2.0 mph), 3.2 to 4.7 km/h (2.0-2.9 mph), and 4.8 km/h (3.0 mph) or more, corn pared with no regular walking, RRs were 0.56 (95% CI, 0.32-0.97), 0.71 (95% CI, 0.47-1.05), and 0.52 (95% CI, 0.30-0.90), respectively. When analyzed simultaneously, time spent walking (P for linear trend =.01) but not walking pace (P for linear trend =.55) predicted lower risk. The inverse association between physical activity and CHD risk did not differ by weight or cholesterol levels (P for interaction =.95 and .71, respectively), but there were significant interactions by smoking and hypertension status. Physical activity was inversely related to risk in current smokers but not hypertensive women (P for interaction =.01 and .001, respectively). Conclusions These data indicate that even light-to-moderate activity is associated with lower CHD rates in women. At least 1 hour of walking per week predicted lower risk. The inverse association with physical activity was also present in women at high risk for CHD, including those who were overweight, had increased cholesterol levels, or were smokers.	Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Lee, IM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.		Lee, I-Min/ABD-5409-2021; Rexrode, Kathryn M/I-1177-2018	Rexrode, Kathryn/0000-0003-3387-8429	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER; NCI NIH HHS [CA-47988] Funding Source: Medline; NHLBI NIH HHS [HL-43851] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; *AM COLL SPORTS ME, 1985, GUID GRAD EX TEST EX; *AM HEART ASS, 1998, 1999 HEART STOK STAT; Bassett DR, 2000, MED SCI SPORT EXER, V32, P1018; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Blair SN, 1999, MED SCI SPORT EXER, V31, pS646, DOI 10.1097/00005768-199911001-00025; BRUNNER D, 1974, J CHRON DIS, V27, P217, DOI 10.1016/0021-9681(74)90047-2; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P30; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P27; CHANGCLAUDE J, 1993, INT J EPIDEMIOL, V22, P228, DOI 10.1093/ije/22.2.228; COX DR, 1972, J R STAT SOC B, V34, P187; Dorn JP, 1999, ANN EPIDEMIOL, V9, P366, DOI 10.1016/S1047-2797(99)00025-3; DUNCAN JJ, 1991, JAMA-J AM MED ASSOC, V266, P3295, DOI 10.1001/jama.266.23.3295; Folsom AR, 1997, MED SCI SPORT EXER, V29, P901, DOI 10.1097/00005768-199707000-00009; FRASER GE, 1992, CIRCULATION, V86, P406, DOI 10.1161/01.CIR.86.2.406; Haapanen N, 1997, INT J EPIDEMIOL, V26, P739, DOI 10.1093/ije/26.4.739; HAGBERG JM, 1989, AM J CARDIOL, V64, P348, DOI 10.1016/0002-9149(89)90533-X; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; KAPLAN GA, 1987, AM J PUBLIC HEALTH, V77, P307, DOI 10.2105/AJPH.77.3.307; Kushi LH, 1997, JAMA-J AM MED ASSOC, V277, P1287, DOI 10.1001/jama.277.16.1287; LaCroix AZ, 1996, J AM GERIATR SOC, V44, P113, DOI 10.1111/j.1532-5415.1996.tb02425.x; LAPIDUS L, 1986, BRIT HEART J, V55, P295, DOI 10.1136/hrt.55.3.295; LEE IM, 1995, JAMA-J AM MED ASSOC, V273, P1179, DOI 10.1001/jama.273.15.1179; Lee IM, 1996, RES Q EXERCISE SPORT, V67, P206, DOI 10.1080/02701367.1996.10607944; LEMAITRE RN, 1995, ARCH INTERN MED, V155, P2302, DOI 10.1001/archinte.155.21.2302; Lissner L, 1996, AM J EPIDEMIOL, V143, P54; MAGNUS K, 1979, AM J EPIDEMIOL, V110, P724, DOI 10.1093/oxfordjournals.aje.a112853; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; MARCEAU M, 1993, CIRCULATION, V88, P2803, DOI 10.1161/01.CIR.88.6.2803; MATSUSAKI M, 1992, CLIN EXP PHARMACOL P, V19, P471, DOI 10.1111/j.1440-1681.1992.tb00492.x; Mensink GBM, 1996, EPIDEMIOLOGY, V7, P391, DOI 10.1097/00001648-199607000-00009; OCONNOR GT, 1995, AM J EPIDEMIOL, V142, P1147, DOI 10.1093/oxfordjournals.aje.a117573; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; SALONEN JT, 1982, AM J EPIDEMIOL, V115, P525; SCRAGG R, 1987, AM J EPIDEMIOL, V126, P77, DOI 10.1093/oxfordjournals.aje.a114664; Sesso HD, 1999, AM J EPIDEMIOL, V150, P408; SHERMAN SE, 1994, AM HEART J, V128, P879, DOI 10.1016/0002-8703(94)90583-5; SIMONSICK EM, 1993, AM J PUBLIC HEALTH, V83, P1443, DOI 10.2105/AJPH.83.10.1443; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Weller I, 1998, EPIDEMIOLOGY, V9, P632, DOI 10.1097/00001648-199811000-00012; *WHO, 1971, ISCHAEMIC HEART DIS; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	45	361	366	0	19	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1447	1454		10.1001/jama.285.11.1447	http://dx.doi.org/10.1001/jama.285.11.1447			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410VQ	11255420				2022-12-28	WOS:000167462100026
J	Gress, F; Gottlieb, K; Sherman, S; Lehman, G				Gress, F; Gottlieb, K; Sherman, S; Lehman, G			Endoscopic ultrasonography - Guided fine-needle aspiration biopsy of suspected pancreatic cancer	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy/Digestive Diseases Week 1997	MAY 11-14, 1997	WASHINGTON, D.C.	Amer Soc Gastrointestinal Endoscopy			CARCINOMA; DIAGNOSIS	Background: In many institutions, computed tomography (CT) guided percutaneous fine-needle aspiration (FNA) has become the procedure of choice for biopsies of pancreatic mass lesions. This method of biopsy and others, such as endoscopic retrograde cholangiopancreatography (ERCP) cytology, are problematic because of a substantial false-negative rate. Objective: To investigate the yield of endoscopic ultrasonography-guided FNA biopsies in patients who had negative results on CT-guided biopsy or negative cytologic findings on ERCP sampling. Design: Prospective cohort study. Setting: Tertiary care university medical center. Patients: 102 patients (median age, 65 years; 58 men and 44 women) with suspected pancreatic cancer who fulfilled the above criteria were prospectively identified and underwent endoscopic ultrasonography-guided FNA biopsy. Measurements: The operating characteristics of endoscopic ultra; sonography-guided FNA for diagnosing pancreatic masses were determined. Surgical pathology or long-term follow-up (median, 24 months) was used to identify false-positive or false-negative results. Results: Median mass size was 3.5 cm x 2.7 cm. A median of 3.4 passes were performed. Cytologic results on endoscopic ultrasonography-guided FNA biopsy were positive in 57 patients, negative in 37, and inconclusive or nondiagnostic in 8. No false-positive results were observed. A diagnosis of pancreatic cancer was subsequently confirmed in 3 patients who had tested negative (false-negative results) and 1 of the 8 patients with nondiagnostic results. Of these 4 patients, 3 had cytologic evidence of chronic pancreatitis on endoscopic ultrasonography-guided FNA biopsy. The 95% CI for the likelihood ratio for a positive test result contained all values greater than or equal to 9.7. The likelihood ratio for a negative test result was 0.05 (CI, 0.02 to 0.15). The posterior probability of pancreatic cancer after a definitely positive result was at least 93.5% by a conservative lower 95% confidence limit; after a definitely negative test result, it was 6.9%. The prevalence of pancreatic cancer was 59.8% (61 of 102 patients). Self-limited complications occurred in 3 of the 102 patients (2.9% [CI, 0.6% to 8.4%]). Conclusion: Endoscopic ultrasonography-guided FNA biopsy may play a valuable role in the evaluation of a pancreatic mass when results on other biopsy methods are negative but pancreatic cancer is suspected.	SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA; Spokane Digest Dis Ctr, Spokane, WA USA; Indiana Univ, Med Ctr, Indianapolis, IN USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Indiana University System; Indiana University-Purdue University Indianapolis	Gress, F (corresponding author), Winthrop Univ Hosp, Div Gastroenterol & Hepatol, 222 Dtn Plaza N,Suite 429, Mineola, NY 11501 USA.			Gottlieb, Klaus/0000-0002-3747-2541				Ayar D, 1998, J THORAC IMAG, V13, P2, DOI 10.1097/00005382-199801000-00002; Bentz JS, 1998, DIAGN CYTOPATHOL, V18, P98, DOI 10.1002/(SICI)1097-0339(199802)18:2<98::AID-DC4>3.0.CO;2-P; BERGENFELDT M, 1988, ACTA CHIR SCAND, V154, P77; Bhutani MS, 1997, ENDOSCOPY, V29, P854, DOI 10.1055/s-2007-1004321; Bret P M, 1986, Diagn Cytopathol, V2, P221, DOI 10.1002/dc.2840020309; Carlucci M, 1989, HPB Surg, V1, P309, DOI 10.1155/1989/84039; CARLUCCI M, 1989, HPB SURG, V1, P315; CATURELLI E, 1985, DIAGN IMAG CLIN MED, V54, P88; Chang KJ, 1997, GASTROINTEST ENDOSC, V45, P387, DOI 10.1016/S0016-5107(97)70149-4; CHANG KJ, 1994, GASTROINTEST ENDOSC, V40, P694, DOI 10.1016/S0016-5107(94)70112-1; Di Stasi M, 1998, AM J GASTROENTEROL, V93, P1329; Gress FG, 1997, GASTROINTEST ENDOSC, V45, P243, DOI 10.1016/S0016-5107(97)70266-9; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; Lee J G, 1998, Gastrointest Endosc Clin N Am, V8, P221; Lerma E, 1996, ACTA CYTOL, V40, P683; Riker A, 1997, SURG ONCOL, V6, P157, DOI 10.1016/S0960-7404(97)00025-X; ROBINS DB, 1995, ACTA CYTOL, V39, P1; SACKETT DL, 1991, CLIN EPIDEMIOLOGY BA, P119; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; WOOLSON RF, 1987, STAT METHODS ANAL BI, P409; Yeaton P, 1998, CYTOMETRY, V32, P309, DOI 10.1002/(SICI)1097-0320(19980801)32:4<309::AID-CYTO8>3.0.CO;2-C	21	254	260	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					459	464		10.7326/0003-4819-134-6-200103200-00010	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	409VF	11255521				2022-12-28	WOS:000167405800004
J	Snow, V; Mottur-Pilson, C; Cooper, RJ; Hoffman, LR				Snow, V; Mottur-Pilson, C; Cooper, RJ; Hoffman, LR		Amer Coll Phys-Amer Soc Internal Med	Principles of appropriate antibiotic use for acute pharyngitis in adults	ANNALS OF INTERNAL MEDICINE			English	Article									Amer Coll Phys Amer Soc Internal Med, Customer Serv, Philadelphia, PA 19106 USA		Snow, V (corresponding author), Amer Coll Phys Amer Soc Internal Med, Customer Serv, 190 N Independence Mall W, Philadelphia, PA 19106 USA.				AHRQ HHS [F32 HS00134-01] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS000134] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)			0	134	146	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					506	508		10.7326/0003-4819-134-6-200103200-00018	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00018			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409VF	11255529				2022-12-28	WOS:000167405800012
J	Weinstein, MC; Goldie, SJ; Losina, E; Cohen, CJ; Baxter, JD; Zhang, H; Kimmel, AD; Freedberg, KA				Weinstein, MC; Goldie, SJ; Losina, E; Cohen, CJ; Baxter, JD; Zhang, H; Kimmel, AD; Freedberg, KA			Use of genotypic resistance testing to guide HIV therapy: Clinical impact and cost-effectiveness	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MYCOBACTERIUM-AVIUM COMPLEX; PROTEASE INHIBITOR THERAPY; DRUG-RESISTANCE; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; PLUS INDINAVIR; CELL COUNTS; ZIDOVUDINE; PROPHYLAXIS	Background: Genotypic sequencing for drug-resistant strains of HIV can guide the choice of antiretroviral therapy. Objective: To assess the cost-effectiveness of genotypic resistance testing for patients acquiring drug resistance through failed treatment (secondary resistance) and those infected with resistant virus (primary resistance). Design: Cost-effectiveness analysis with an HIV simulation model incorporating CD4 cell count and HIV RNA level as predictors of disease progression. Data Sources: Published randomized trials and data from the Multicenter AIDS Cohort Study, the national AIDS Cost and Services Utilization Survey, the Red Book, and an institutional cost-accounting system. Target Population: HIV-infected patients in the United States with baseline CD4 counts of 0.250 x 10(9) cells/L. Time Horizon: Lifetime. Perspective: societal. Interventions: Genotypic resistance testing and clinical judgment, compared with clinical judgment alone, in two contexts: after initial treatment failure (secondary resistance testing) and before initiation of antiretroviral therapy (primary resistance testing). Outcome Measures: Life expectancy, quality-adjusted life expectancy, and cost-effectiveness in dollars per quality-adjusted life-year (QALY) gained. Results of Base-Case Analysis: Secondary resistance testing increased life expectancy by 3 months, at a cost of $17 900 per QALY gained. The cost-effectiveness of primary resistance testing was $22 300 per QALY gained with a 20% prevalence of primary resistance but increased to $69 000 per QALY gained with 4% prevalence. Results of Sensitivity Analysis: The cost-effectiveness ratio for secondary resistance testing remained under $25 000 per QALY gained, even when effectiveness and cost of testing and antiretroviral therapy, quality-of-life weights, and discount rate were varied. Conclusions: Genotypic antiretroviral resistance testing following antiretroviral failure is cost-effective. Primary resistance testing also seems to be reasonably cost-effective and will become more so as the prevalence of primary resistance increases.	Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, Boston, MA 02115 USA; Boston Univ, Sch Publ Hlth, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Community Res Initiat New England, Brookline, MA USA; Univ Med & Dent New Jersey, Cooper Hosp, Camden, NJ 08103 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Camden, NJ 08103 USA	Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Harvard University; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Weinstein, MC (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, 718 Huntington Ave, Boston, MA 02115 USA.			Losina, ELENA/0000-0002-3424-0892	NIAID NIH HHS [R01 AI042006, R01-AI42006] Funding Source: Medline; PHS HHS [U64/CCU 114927] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042006] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1999, MMWR Recomm Rep, V48, P1; BALAGUERA HU, 2000, P 40 ANN INT C ANT A; Baxter JD, 2000, AIDS, V14, pF83, DOI 10.1097/00002030-200006160-00001; Bayoumi AM, 1998, AIDS, V12, P1503, DOI 10.1097/00002030-199812000-00013; Boden D, 1999, JAMA-J AM MED ASSOC, V282, P1135, DOI 10.1001/jama.282.12.1135; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; CAMERON DW, 2000, P 7 C RETR OPP INF J; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; COHEN C, 2000, ANTIVIR THER S, V5, P67; Cook J, 1999, AIDS RES HUM RETROV, V15, P499, DOI 10.1089/088922299311024; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; El-Sadr WM, 1999, CLIN INFECT DIS, V29, P775, DOI 10.1086/520433; El-Sadr WM, 2000, NEW ENGL J MED, V342, P1085, DOI 10.1056/NEJM200004133421503; Freedberg KA, 1998, JAMA-J AM MED ASSOC, V279, P130, DOI 10.1001/jama.279.2.130; FREEDBERG KA, IN PRESS N ENGL J ME; Gold MR, 1996, COST EFFECTIVENESS H; Gulick RM, 2000, ANN INTERN MED, V133, P35, DOI 10.7326/0003-4819-133-1-200007040-00007; Gulick RM, 1998, JAMA-J AM MED ASSOC, V280, P35, DOI 10.1001/jama.280.1.35; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Harrigan PR, 1999, AIDS, V13, P1863, DOI 10.1097/00002030-199910010-00008; Havlir DV, 2000, JAMA-J AM MED ASSOC, V283, P229, DOI 10.1001/jama.283.2.229; Havlir DV, 1996, NEW ENGL J MED, V335, P392, DOI 10.1056/NEJM199608083350604; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; HOLTGRAVE DR, 1995, MED DECIS MAKING, V15, P311, DOI 10.1177/0272989X9501500402; Levitz SM, 1998, NEW ENGL J MED, V338, P1074, DOI 10.1056/NEJM199804093381517; Little SJ, 1999, JAMA-J AM MED ASSOC, V282, P1142, DOI 10.1001/jama.282.12.1142; MAYNARD JL, 2000, ANTIVIR THER S, V5, P67; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; Moore RD, 2000, PHARMACOECONOMICS, V17, P325, DOI 10.2165/00019053-200017040-00002; *NAT TECHN INF SER, 1994, AIDS COST SERV UT SU; *NAT TECHN INF SER, 1995, MULT AIDS COH STUD M; NIGHTINGALE SD, 1993, NEW ENGL J MED, V329, P828, DOI 10.1056/NEJM199309163291202; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PATICK AK, 1998, ANTIVIR THER, V3, pS39; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Tsevat J, 1996, MED CARE, V34, P44, DOI 10.1097/00005650-199601000-00004; [U.S. Public Health Service (USPHS) Infectious Diseases Society of America (IDSA)], 1999, MMWR-MORBID MORTAL W, V48, p[1, 61]; US Bureau of the Census, 1998, STAT ABSTR US 1998; *US DEP HHS, 2000, HIV CLIN TRIALS, V1, P60; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Zolopa AR, 1999, ANN INTERN MED, V131, P813, DOI 10.7326/0003-4819-131-11-199912070-00003; 1998, DRUG TOPICS RED BOOK	47	184	188	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					440	450		10.7326/0003-4819-134-6-200103200-00008	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409VF	11255519				2022-12-28	WOS:000167405800002
J	Paulesu, E; Demonet, JF; Fazio, F; McCrory, E; Chanoine, V; Brunswick, N; Cappa, SF; Cossu, G; Habib, M; Frith, CD; Frith, U				Paulesu, E; Demonet, JF; Fazio, F; McCrory, E; Chanoine, V; Brunswick, N; Cappa, SF; Cossu, G; Habib, M; Frith, CD; Frith, U			Dyslexia: Cultural diversity and biological unity	SCIENCE			English	Article							DEVELOPMENTAL DYSLEXIA; WORD RECOGNITION; BRAIN; PET	The recognition of dyslexia as a neurodevelopmental disorder has been hampered by the belief that it is not a specific diagnostic entity because it has variable and culture-specific manifestations. In line with this belief, we found that Italian dyslexics, using a shallow orthography which facilitates reading, performed better on reading tasks than did English and French dyslexics, However, all dyslexics were equally impaired relative to their controls on reading and phonological tasks. Positron emission tomography scans during explicit and implicit reading showed the same reduced activity in a region of the Left hemisphere in dyslexics from all three countries, with the maximum peak in the middle temporal gyrus and additional peaks in the inferior and superior temporal gyri and middle occipital gyrus. We conclude that there is a universal neurocognitive basis for dyslexia and that differences in reading performance among dyslexics of different countries are due to different orthographies.	Univ Milan, Dept Psychol, Milan, Italy; Ist Sci San Raffaele, INB, CNR, Milan, Italy; Hop Purpan, INSERM, U455, Toulouse, France; Univ Milan, Neurosci & Biomed Technol Dept, Milan, Italy; UCL, Inst Cognit Neurosci, London, England; Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Univ Vita & Salute H San Raffaele, Dept Psychol, Milan, Italy; Univ Parma, Inst Human Physiol, I-43100 Parma, Italy; Inst Univ Geriatr, Ctr Rech, Montreal, PQ, Canada	University of Milan; University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Milan; University of London; University College London; University of London; University College London; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Parma	Paulesu, E (corresponding author), Univ Milan, Dept Psychol, Milan, Italy.	eraldo.paulesu@unimib.it	Frith, Uta/C-1757-2008; Cappa, Stefano/B-1874-2014; Frith, Chris D/A-2171-2009; Demonet, Jean-Francois/E-6725-2010; PAULESU, ERALDO/C-2737-2017	Frith, Uta/0000-0002-9063-4466; Cappa, Stefano/0000-0003-1003-3925; Frith, Chris D/0000-0002-8665-0690; Brunswick, Nicola/0000-0002-6652-5016; Chanoine, Valerie/0000-0002-3492-8160; PAULESU, ERALDO/0000-0002-9224-754X; Demonet, Jean-Francois/0000-0003-0100-6175				Brady S. A., 1991, PHONOLOGICAL PROCESS; COSSU G, 1995, READ WRIT, V7, P9, DOI 10.1007/BF01026945; Demonet JF, 1996, BRAIN LANG, V55, P352, DOI 10.1006/brln.1996.0109; Friston KJ, 1997, HUMAN BRAIN FUNCTION, P25; Frith U., 1998, SCI STUD READ, V2, P31, DOI [10.1207/s1532799xssr0201_2, DOI 10.1207/S1532799XSSR0201_2]; FROST R, 1987, J EXP PSYCHOL HUMAN, V13, P104, DOI 10.1037/0096-1523.13.1.104; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Landerl K, 1997, COGNITION, V63, P315, DOI 10.1016/S0010-0277(97)00005-X; Lepschy A. L., 1981, LINGUA ITALIANA; LINDGREN SD, 1985, CHILD DEV, V56, P1404, DOI 10.1111/j.1467-8624.1985.tb00206.x; Naidoo S., 1972, SPECIFIC DYSLEXIA; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Paulesu E, 1996, BRAIN, V119, P143, DOI 10.1093/brain/119.1.143; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 1996, P ROY SOC B-BIOL SCI, V263, P1501, DOI 10.1098/rspb.1996.0219; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; PRICE CJ, 1997, HUMAN BRAIN FUNCTION, P301; Rumsey JM, 1997, ARCH NEUROL-CHICAGO, V54, P562, DOI 10.1001/archneur.1997.00550170042013; Salmelin R, 1996, ANN NEUROL, V40, P157, DOI 10.1002/ana.410400206; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Smith SD, 1998, HUM BIOL, V70, P239; Snowling M., 2000, DYSLEXIA; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0	26	708	720	3	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2165	2167		10.1126/science.1057179	http://dx.doi.org/10.1126/science.1057179			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251124				2022-12-28	WOS:000167563800044
J	Umezawa, ES; Stolf, AMS; Corbett, CEP; Shikanai-Yasuda, MA				Umezawa, ES; Stolf, AMS; Corbett, CEP; Shikanai-Yasuda, MA			Chagas' disease	LANCET			English	Article							TRYPANOSOMA-CRUZI		Univ Sao Paulo, Fac Med, Inst Trop Med, BR-05403000 Sao Paulo, Brazil; Univ Sao Paulo, Fac Med, Dept Pathol, BR-05403000 Sao Paulo, Brazil; Univ Sao Paulo, Fac Med, Dept Infect & Parasit Dis, BR-05403000 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Umezawa, ES (corresponding author), Univ Sao Paulo, Fac Med, Inst Trop Med, BR-05403000 Sao Paulo, Brazil.		Shikanai Yasuda, Maria Aparecida/AAX-7693-2020; Shikanai-Yasuda, Maria A/C-4268-2012; Corbett, Carlos E P/R-7090-2018; ShikanaiYasuda, Maria A/A-9000-2013	Shikanai Yasuda, Maria Aparecida/0000-0003-3864-041X; ShikanaiYasuda, Maria A/0000-0003-3864-041X; Pereira Corbett, Carlos Eduardo/0000-0003-1587-3085				BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023; NOBUKO Y, 1997, CURR OPIN INFECT DIS, V10, P351; PRATA A, 1994, INFECT DIS CLIN N AM, V8, P61; Tarleton RL, 1999, PARASITOL TODAY, V15, P94, DOI 10.1016/S0169-4758(99)01398-8; Umezawa ES, 1996, J CLIN MICROBIOL, V34, P2143, DOI 10.1128/JCM.34.9.2143-2147.1996	5	53	55	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					797	799		10.1016/S0140-6736(00)04174-X	http://dx.doi.org/10.1016/S0140-6736(00)04174-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253987				2022-12-28	WOS:000167400900042
J	Baker, NE; Yu, SY				Baker, NE; Yu, SY			The EGF receptor defines domains of cell cycle progression and survival to regulate cell number in the developing Drosophila eye	CELL			English	Article							GENETIC MOSAICS; PRONEURAL GENE; DIVISION; DEATH; PROLIFERATION; EXPRESSION; HOMOLOG; PROTEIN; RETINA; ARREST	The number of cells in developing organs must be controlled spatially by extracellular signals. Our results show how cell number can be regulated by cell interactions controlling proliferation and survival in local neighborhoods in the case of the Drosophila compound eye. Intercellular signals act during the second mitotic wave, a cell cycle that generates a pool of uncommitted cells used for most ommatidial fates. We find that G1/S progression to start the cell cycle requires EGF receptor inactivity. EGF receptor activation is then required for progression from G2 to M phase of the same cells, and also prevents apoptosis. EGF receptor activation depends on short-range signals from five-cell preclusters of photoreceptor neurons not participating in the second mitotic wave. Through proliferation and survival control, such signals couple the total number of uncommitted cells being generated to the neural patterning of the retina.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Baker, NE (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047892] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47892] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker NE, 1996, CURR BIOL, V6, P1290, DOI 10.1016/S0960-9822(02)70715-X; BAKER NE, 1995, MECH DEVELOP, V49, P173, DOI 10.1016/0925-4773(94)00314-D; BAKER NE, 1992, DEV BIOL, V150, P381, DOI 10.1016/0012-1606(92)90250-K; BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Blanco MA, 2000, EMBO J, V19, P3945, DOI 10.1093/emboj/19.15.3945; Brown NL, 1996, DEV BIOL, V179, P65, DOI 10.1006/dbio.1996.0241; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; DENOOIJ JC, 1995, SCIENCE, V270, P983, DOI 10.1126/science.270.5238.983; Dickson Barry, 1993, P1327; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FOE VE, 1989, DEVELOPMENT, V107, P1; FREEMAN M, 1992, DEVELOPMENT, V116, P335; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Granderath S, 1999, CURR OPIN NEUROBIOL, V9, P531, DOI 10.1016/S0959-4388(99)00008-2; HAY BA, 1994, DEVELOPMENT, V120, P2121; HEBERLEIN U, 1993, DEV BIOL, V160, P51, DOI 10.1006/dbio.1993.1285; HORSCHT M, 1990, NEURON, V4, P697; Horsfield J, 1998, DEVELOPMENT, V125, P5069; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; KNOBLICH JA, 1993, EMBO J, V12, P65, DOI 10.1002/j.1460-2075.1993.tb05632.x; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; KRAMER H, 1991, NATURE, V352, P207, DOI 10.1038/352207a0; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Kunes S, 2000, CURR OPIN NEUROBIOL, V10, P58, DOI 10.1016/S0959-4388(99)00051-3; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Kylsten P, 1997, DEV BIOL, V192, P509, DOI 10.1006/dbio.1997.8770; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Milan M, 1996, P NATL ACAD SCI USA, V93, P11687, DOI 10.1073/pnas.93.21.11687; Miller DT, 1998, DEVELOPMENT, V125, P2327; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; PEIFER M, 1994, DEVELOPMENT, V120, P369; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Sawamoto K, 1998, CELL DEATH DIFFER, V5, P262, DOI 10.1038/sj.cdd.4400342; Srinivasan A, 1998, CELL DEATH DIFFER, V5, P1004, DOI 10.1038/sj.cdd.4400449; THOMAS BJ, 1994, CELL, V77, P1003, DOI 10.1016/0092-8674(94)90440-5; Tio M, 1997, DEVELOPMENT, V124, P343; TOMLINSON A, 1987, CELL, V51, P143, DOI 10.1016/0092-8674(87)90019-5; VINCENT JP, 1994, DEV BIOL, V164, P328, DOI 10.1006/dbio.1994.1203; WOLFF T, 1991, DEVELOPMENT, V113, P825; Wolff Tanya, 1993, P1277; XU T, 1993, DEVELOPMENT, V117, P1223	52	154	156	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2001	104	5					699	708		10.1016/S0092-8674(02)06076-2	http://dx.doi.org/10.1016/S0092-8674(02)06076-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257224	Bronze			2022-12-28	WOS:000167531100010
J	Milojkovic, D; Mufti, GJ				Milojkovic, D; Mufti, GJ			Extending the role of allogeneic stem-cell transplantation	LANCET			English	Editorial Material							BONE-MARROW TRANSPLANTATION; GRAFT-VERSUS-LEUKEMIA; THERAPY; CHEMOTHERAPY; MALIGNANCIES; BUSULFAN		Guys Kings & St Thomas Sch Med, Dept Haematol Med, London SE5 9RS, England	University of London; King's College London	Mufti, GJ (corresponding author), Guys Kings & St Thomas Sch Med, Dept Haematol Med, Kings Denmark Hill Campus, London SE5 9RS, England.							Carella AM, 2000, BONE MARROW TRANSPL, V25, P345, DOI 10.1038/sj.bmt.1702204; Carella AM, 1998, BRIT J HAEMATOL, V103, P565, DOI 10.1046/j.1365-2141.1998.01057.x; Childs R, 2000, NEW ENGL J MED, V343, P750, DOI 10.1056/NEJM200009143431101; Giralt S, 1997, BLOOD, V89, P4531, DOI 10.1182/blood.V89.12.4531; Hadzic N, 2000, NEW ENGL J MED, V342, P320, DOI 10.1056/NEJM200002033420504; HOROWITZ MM, 1990, BLOOD, V75, P555; Khouri IF, 1998, J CLIN ONCOL, V16, P2817, DOI 10.1200/JCO.1998.16.8.2817; Kirschbaum M, 1996, BLOOD, V88, P3827; KOLB HJ, 1995, BLOOD, V86, P2041, DOI 10.1182/blood.V86.5.2041.bloodjournal8652041; Kottaridis PD, 2000, BLOOD, V96, P2419; MCSWEENEY P, 1999, BLOOD S1, V94, pA1742; MICHAELLET M, 2000, HEMATOL J S1, V1, pA840; PARKER JE, 2000, HEMATOL J S1, V1, pA843; PETERSEN FB, 1989, BONE MARROW TRANSPL, V4, P617; Slattery JT, 1997, BLOOD, V89, P3055, DOI 10.1182/blood.V89.8.3055; Slavin S, 1998, BLOOD, V91, P756, DOI 10.1182/blood.V91.3.756.756_756_763	16	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					652	654		10.1016/S0140-6736(00)04150-7	http://dx.doi.org/10.1016/S0140-6736(00)04150-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247545				2022-12-28	WOS:000167282400004
J	Goldfine, H; Vance, DE				Goldfine, H; Vance, DE			Konrad E. Bloch (1912-2000) - Obituary	NATURE			English	Biographical-Item									Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Alberta, Dept Biochem, Heritage Med Res Ctr 328, Edmonton, AB T6G 2S2, Canada; Univ Alberta, CIHR Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada	University of Pennsylvania; University of Alberta; University of Alberta	Goldfine, H (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.		Goldfine, Howard/AAB-8097-2020						0	2	2	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					779	779		10.1038/35057430	http://dx.doi.org/10.1038/35057430			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11241981				2022-12-28	WOS:000166938800025
J	Hengartner, MO				Hengartner, MO			Apoptosis: Corralling the corpses	CELL			English	Review							PROGRAMMED CELL-DEATH; C-ELEGANS; CAENORHABDITIS-ELEGANS; PHAGOCYTOSIS; ENGULFMENT; PROMOTES; FUTURE		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Hengartner, MO (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		Hengartner, Michael O/A-7058-2008; Hengartner, Michael O/E-6235-2011	Hengartner, Michael/0000-0002-7584-596X				Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; ELLIS RE, 1991, GENETICS, V129, P79; Franc NC, 1999, CURR OPIN IMMUNOL, V11, P47, DOI 10.1016/S0952-7915(99)80009-0; Greaves DR, 1998, CURR OPIN LIPIDOL, V9, P425, DOI 10.1097/00041433-199810000-00006; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Marguet D, 1999, NAT CELL BIOL, V1, P454, DOI 10.1038/15690; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Smits E, 1999, CURR BIOL, V9, P1351, DOI 10.1016/S0960-9822(00)80062-7; Su HP, 2000, J BIOL CHEM, V275, P9542, DOI 10.1074/jbc.275.13.9542; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Young SG, 1999, NAT GENET, V22, P316, DOI 10.1038/11878; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	20	128	159	2	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2001	104	3					325	328		10.1016/S0092-8674(01)00219-7	http://dx.doi.org/10.1016/S0092-8674(01)00219-7			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239389	Green Accepted, Bronze			2022-12-28	WOS:000167003100002
J	Pennock, E; Buckley, K; Lundblad, V				Pennock, E; Buckley, K; Lundblad, V			Cdc13 delivers separate complexes to the telomere for end protection and replication	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNIT; YEAST TELOMERASE; RAD9 CHECKPOINT; RNA COMPONENT; EST GENES; MAINTENANCE; SENESCENCE; MUTANTS; PROTEIN	In Saccharomyces cerevisiae, the telomere binding protein Cdc13 mediates telomere replication by recruiting telomerase, and also performs an essential function in chromosome end protection. We show here that delivery of the Stn1 protein to the telomere, by fusing the DNA binding domain of Cdc13 (DBDCDC13) to Stn1, is sufficient to rescue the lethality of a cdc13 null strain and, hence, provide end protection. Telomere replication is still defective in this strain, but can be restored by delivering telomerase to the telomere as a DBDCDC13-telomerase fusion. These results establish Stn1 as the primary effector of chromosome end protection, whereas the principal function of Cdc13 is to provide a loading platform to recruit complexes that provide end protection and telomere replication.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine	Lundblad, V (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.				NIGMS NIH HHS [GM55867] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055867] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams AK, 1996, MOL CELL BIOL, V16, P4614; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; CARSON MJ, 1985, CELL, V42, P249, DOI 10.1016/S0092-8674(85)80120-3; CHANDRA A, 2001, IN PRESS GENES DEV; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Evans SK, 2000, J CELL SCI, V113, P3357; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Grandin N, 2000, MOL CELL BIOL, V20, P8397, DOI 10.1128/MCB.20.22.8397-8408.2000; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hughes TR, 2000, P NATL ACAD SCI USA, V97, P6457, DOI 10.1073/pnas.97.12.6457; Hughes TR, 2000, CURR BIOL, V10, P809, DOI 10.1016/S0960-9822(00)00562-5; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Lendvay TS, 1996, GENETICS, V144, P1399; Lingner J, 1997, P NATL ACAD SCI USA, V94, P11190, DOI 10.1073/pnas.94.21.11190; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Lundblad V, 2000, MUTAT RES-FUND MOL M, V451, P227, DOI 10.1016/S0027-5107(00)00052-X; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; McEachern MJ, 2000, P NATL ACAD SCI USA, V97, P11409, DOI 10.1073/pnas.210388397; Morris DK, 1997, CURR BIOL, V7, P969, DOI 10.1016/S0960-9822(06)00416-7; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Qi HY, 2000, GENE DEV, V14, P1777; Sandrock TM, 1997, GENETICS, V147, P1635; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; WEINERT TA, 1993, GENETICS, V134, P63; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V	34	345	350	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2001	104	3					387	396		10.1016/S0092-8674(01)00226-4	http://dx.doi.org/10.1016/S0092-8674(01)00226-4			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239396	Bronze			2022-12-28	WOS:000167003100009
J	Schar, P				Schar, P			Spontaneous DNA damage, genome instability, and cancer - When DNA replication escapes control	CELL			English	Review							RECOMBINATION		Univ Zurich, Inst Med Radiobiol, CH-8008 Zurich, Switzerland; Paul Scherrer Inst, CH-8008 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Schar, P (corresponding author), Univ Zurich, Inst Med Radiobiol, CH-8008 Zurich, Switzerland.		Schär, Primo/G-5967-2012	Schär, Primo/0000-0003-1843-6147				Brown EJ, 2000, GENE DEV, V14, P397; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Clarke DJ, 1999, CURR BIOL, V9, P365, DOI 10.1016/S0960-9822(99)80163-8; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; Frei C, 2000, J CELL SCI, V113, P2641; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Jiricny J, 1998, EMBO J, V17, P6427, DOI 10.1093/emboj/17.22.6427; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; LINDAHL T, 1992, ANNU REV BIOCHEM, V61, P251, DOI 10.1146/annurev.bi.61.070192.001343; MITELMAN F, 1994, CATALOG CHROMOSOME A; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Wang Y, 2000, GENE DEV, V14, P927	21	101	105	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2001	104	3					329	332		10.1016/S0092-8674(01)00220-3	http://dx.doi.org/10.1016/S0092-8674(01)00220-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239390	Bronze			2022-12-28	WOS:000167003100003
J	Lee, NLS; Yuen, KY; Kumana, CR				Lee, NLS; Yuen, KY; Kumana, CR			beta-lactam antibiotic and beta-lactamase inhibitor combinations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHARMACOKINETIC PROPERTIES; PIPERACILLIN-TAZOBACTAM; ANTIBACTERIAL ACTIVITY; AMPICILLIN-SULBACTAM; IN-VITRO; ENDOCARDITIS; PNEUMONIAE; EFFICACY		Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Kumana, CR (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Professorial Block 4-F,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.		Lee, Nelson/B-6418-2008; Yuen, Kwok Yung/C-4465-2009	Lee, Nelson/0000-0002-0783-6607; Yuen, Kwok-yung/0000-0002-2083-1552				AKYUREK N, 1997, BRIT J SURG, V84, P880; Backo M, 1999, ANTIMICROB AGENTS CH, V43, P2565, DOI 10.1128/AAC.43.10.2565; Bradley SJ, 1999, J ANTIMICROB CHEMOTH, V43, P261, DOI 10.1093/jac/43.2.261; Brun-Buisson C, 1998, CLIN INFECT DIS, V26, P346, DOI 10.1086/516294; Chaibi EB, 1999, J ANTIMICROB CHEMOTH, V43, P447, DOI 10.1093/jac/43.4.447; Corbella X, 1998, J ANTIMICROB CHEMOTH, V42, P793, DOI 10.1093/jac/42.6.793; Craig WA, 1997, DIAGN MICR INFEC DIS, V27, P49, DOI 10.1016/S0732-8893(97)00022-9; DAVEY PG, 1994, EUR J SURG S, V573, P67; de la Pena A, 1999, INT J CLIN PHARM TH, V37, P63; Goldstein FW, 1999, J ANTIMICROB CHEMOTH, V44, P141, DOI 10.1093/jac/44.2.141; Gould IM, 1999, J ANTIMICROB CHEMOTH, V43, P459, DOI 10.1093/jac/43.4.459; Jaccard C, 1998, ANTIMICROB AGENTS CH, V42, P2966, DOI 10.1128/AAC.42.11.2966; Kaye KS, 2000, ANTIMICROB AGENTS CH, V44, P1004, DOI 10.1128/AAC.44.4.1004-1009.2000; Lister PD, 1999, ANTIMICROB AGENTS CH, V43, P882, DOI 10.1128/AAC.43.4.882; Munoz P, 1996, INT J ANTIMICROB AG, V7, pS9, DOI 10.1016/0924-8579(96)00313-5; PARFITT K, 1999, MARTINDALE COMPLETE; PEFANIS A, 1993, ANTIMICROB AGENTS CH, V37, P507, DOI 10.1128/AAC.37.3.507; Pitts N E, 1989, APMIS Suppl, V5, P23; Prabhakaran K, 1999, INT J ANTIMICROB AG, V13, P133, DOI 10.1016/S0924-8579(99)00101-6; Quenzer RW, 1997, AM J MANAG C, V3, P1027; Rice LB, 1996, CLIN INFECT DIS, V23, P118, DOI 10.1093/clinids/23.1.118; Settle CD, 1998, ALIMENT PHARM THER, V12, P1217; SIROT D, 1995, J ANTIMICROB CHEMOTH, V36, P19, DOI 10.1093/jac/36.suppl_A.19; TODD PA, 1990, DRUGS, V39, P264, DOI 10.2165/00003495-199039020-00008; Virk A, 2000, MAYO CLIN PROC, V75, P200; Williams JD, 1997, CLIN INFECT DIS, V24, P494, DOI 10.1093/clinids/24.3.494; Wright AJ, 1999, MAYO CLIN PROC, V74, P290, DOI 10.4065/74.3.290	27	18	20	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2001	285	4					386	388		10.1001/jama.285.4.386	http://dx.doi.org/10.1001/jama.285.4.386			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394CG	11242403				2022-12-28	WOS:000166506000002
J	Sachs, CS				Sachs, CS			A 25-year-old woman with bipolar disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LOW SERUM LEVELS; LITHIUM; RECURRENCE; PLACEBO; MANIA; RISK; DEPRESSION; POPULATION; PREGNANCY; STANDARD		Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Massachusetts Gen Hosp, Harvard Bipolar Res Program, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Sachs, CS (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave,LY318, Boston, MA 02215 USA.							Altshuler LL, 1998, J CLIN PSYCHIAT, V59, P29; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Angst J, 1981, HDB BIOL PSYCHIAT 5, P225; BAUER MS, 1996, STRUCTURED GROUP PSY; Bowden CL, 2000, ARCH GEN PSYCHIAT, V57, P481, DOI 10.1001/archpsyc.57.5.481; BOWDEN CL, 1994, JAMA-J AM MED ASSOC, V271, P918, DOI 10.1001/jama.271.12.918; CALABRESE J, 1999, 12 ANN M EUR COLL NE; Calabrese JR, 1999, J CLIN PSYCHIAT, V60, P79, DOI 10.4088/JCP.v60n0203; Calabrese JR, 2000, J CLIN PSYCHIAT, V61, P841, DOI 10.4088/JCP.v61n1106; COHEN LS, 1989, PSYCHOSOMATICS, V30, P25, DOI 10.1016/S0033-3182(89)72314-8; COHEN LS, 1994, JAMA-J AM MED ASSOC, V271, P146, DOI 10.1001/jama.271.2.146; CORYELL W, 1989, PSYCHOL MED, V19, P129, DOI 10.1017/S0033291700011090; Coryell W, 1997, PSYCHOL MED, V27, P281, DOI 10.1017/S0033291796004461; FAVA GA, 1992, RES DESIGNS METHODS, P223; Frank E, 2000, BIOL PSYCHIAT, V48, P593, DOI 10.1016/S0006-3223(00)00969-0; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; Frank E., 1994, BEHAV THERAPIST, V17, P143; Frye MA, 2000, J CLIN PSYCHOPHARM, V20, P607, DOI 10.1097/00004714-200012000-00004; Gagne GG, 2000, AM J PSYCHIAT, V157, P1960, DOI 10.1176/appi.ajp.157.12.1960; GELENBERG AJ, 1989, NEW ENGL J MED, V321, P1489, DOI 10.1056/NEJM198911303212201; Ghaemi SN, 1999, J AFFECT DISORDERS, V52, P135, DOI 10.1016/S0165-0327(98)00076-7; Goodwin F, 1990, MANIC DEPRESSIVE ILL; GOODWIN GM, 1994, BRIT J PSYCHIAT, V164, P149, DOI 10.1192/bjp.164.2.149; Hantouche EG, 1998, J AFFECT DISORDERS, V50, P163, DOI 10.1016/S0165-0327(98)00112-8; HIRSHFELD DR, 1998, 106 ANN M AM PSYCH A; Jamison K R, 1986, Ann N Y Acad Sci, V487, P301, DOI 10.1111/j.1749-6632.1986.tb27909.x; KANAS N, 1993, INT J GROUP PSYCHOTH, V43, P321, DOI 10.1080/00207284.1993.11732596; KECK P, 2000, 40 ANN NCDEU M MAY 3; KELLER MB, 1992, ARCH GEN PSYCHIAT, V49, P371; Kessler RC, 1997, PSYCHOL MED, V27, P1079, DOI 10.1017/S0033291797005333; KESSLER RC, 1994, INT REV PSYCHIATR, V6, P8; Kraepelin E., 1921, MANIC DEPRESSIVE INS; LESSER AL, 1983, CAN J PSYCHIAT, V28, P362, DOI 10.1177/070674378302800506; LISH JD, 1994, J AFFECT DISORDERS, V31, P281, DOI 10.1016/0165-0327(94)90104-X; MAYO JA, 1979, AM J PSYCHIAT, V136, P1535; MIKLOWITZ DJ, 1988, ARCH GEN PSYCHIAT, V45, P225; Miklowitz DJ, 1996, J CLIN PSYCHOPHARM, V16, pS56, DOI 10.1097/00004714-199604001-00007; Muller-Oerlinghausen B, 2000, J CLIN PSYCHOPHARM, V20, P195, DOI 10.1097/00004714-200004000-00012; NEMEROFF CB, IN PRESS AM J PSYCHI; Nilsson A, 1999, J CLIN PSYCHIAT, V60, P85; OTTO M, 1999, COLLABORATIVE CARE W; Pande AC, 2000, BIPOLAR DISORD, V2, P249, DOI 10.1034/j.1399-5618.2000.20305.x; ROYBYRNE P, 1985, ACTA PSYCHIAT SCAND, V71, P1, DOI 10.1111/j.1600-0447.1985.tb10510.x; Sachs G, 1996, PSYCHIAT ANN, V26, pS454, DOI 10.3928/0048-5713-19960702-09; SACHS G, 1999, 38 ANN M AM COLL PSY; Sachs G S, 2000, Postgrad Med, VSpec No, P1; Sachs GS, 2000, BIOL PSYCHIAT, V48, P573, DOI 10.1016/S0006-3223(00)00991-4; SACHS GS, 1995, PSYCHIAT CLIN N AM, V2, P21; SACKEIM HA, 1990, J CLIN PSYCHOPHARM, V10, P96, DOI 10.1097/00004714-199004000-00004; Simon GE, 1999, PSYCHIATR SERV, V50, P1303, DOI 10.1176/ps.50.10.1303; Simpson SG, 1999, J CLIN PSYCHIAT, V60, P53; SUPPES T, 1991, ARCH GEN PSYCHIAT, V48, P1082; Tohen M, 1999, AM J PSYCHIAT, V156, P702; Tohen M, 2000, AM J PSYCHIAT, V157, P220, DOI 10.1176/appi.ajp.157.2.220; TOHEN M, 2000, 152 ANN M AM PSYCH A; van Gent E M, 1988, Acta Psychiatr Belg, V88, P405; VASILE RG, 1987, AM J PSYCHIAT, V144, P341; WILDGRUBE C, 1990, INT CLIN PSYCHOPHARM, V5, P89; Young LT, 2000, AM J PSYCHIAT, V157, P124, DOI 10.1176/ajp.157.1.124; ZAJECKA J, 2000, 39 ANN M AM COLL NEU; Zis A P, 1980, Psychopharmacol Bull, V16, P47	61	7	7	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2001	285	4					454	462		10.1001/jama.285.4.454	http://dx.doi.org/10.1001/jama.285.4.454			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	394CG	11242431				2022-12-28	WOS:000166506000034
J	Borbat, PP; Costa-Filho, AJ; Earle, KA; Moscicki, JK; Freed, JH				Borbat, PP; Costa-Filho, AJ; Earle, KA; Moscicki, JK; Freed, JH			Electron spin resonance in studies of membranes and proteins	SCIENCE			English	Review							CONFORMATIONAL-CHANGES; ESR; DYNAMICS; BACTERIORHODOPSIN; GRAMICIDIN; DIFFUSION; BILAYERS; FIELD	We provide a review of current electron spin resonance (ESR) techniques for studying basic molecular mechanisms in membranes and proteins by using nitroxide spin Labels. tn particular, nitroxide spin label studies with high-field/high-frequency ESR and two-dimensional Fourier transform ESR enable one to accurately determine distances in biomolecules, unravel the details of the complex dynamics in proteins. characterize the dynamic structure of membrane domains, and discriminate between bulk Lipids and boundary lipids that coat transmembrane peptides or proteins; these studies can also provide time resolution to studies of functional dynamics of proteins. We illustrate these capabilities with recent examples.	Cornell Univ, Baker Lab Chem & Chem Biol, Ithaca, NY 14853 USA; Jagiellonian Univ, Smoluchowski Inst Phys, PL-30059 Krakow, Poland	Cornell University; Jagiellonian University	Freed, JH (corresponding author), Cornell Univ, Baker Lab Chem & Chem Biol, Ithaca, NY 14853 USA.	jhf@ccmr.cornell.edu	Costa-Filho, Antonio J/D-3153-2012; Borbat, Petr P/A-8658-2014; Costa-Filho, Antonio José/AAZ-1808-2020; borbat, peter/B-1616-2016; Costa-Filho, Antonio/A-6329-2008	Costa-Filho, Antonio J/0000-0001-6730-8737; 				[Anonymous], 1976, SPIN LABELING THEORY, DOI DOI 10.1016/B978-0-12-092350-2.50008-4; Barnes JP, 1998, BIOPHYS J, V75, P2532, DOI 10.1016/S0006-3495(98)77698-2; Barnes JP, 1999, BIOPHYS J, V76, P3298, DOI 10.1016/S0006-3495(99)77482-5; Bennati M, 1999, J MAGN RESON, V139, P281, DOI 10.1006/jmre.1999.1769; Berliner L. J., 1976, SPIN LABELLING THEOR; BERLINER LJ, 1998, BIO MAGN RE, V14, P1; BERLINER LJ, 1989, SPIN LABELING THEORY, V8; BETH AH, 1989, SPIN LABELING THEORY, V1, P179; Borbat PP, 1997, J MAGN RESON, V127, P155, DOI 10.1006/jmre.1997.1201; Borbat PP, 1999, CHEM PHYS LETT, V313, P145, DOI 10.1016/S0009-2614(99)00972-0; BORBAT PP, 1999, 22 INT EPR S DENV CO; BORBAT PP, 2000, BIOL MAGNETIC RESOAN, V19; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Budil DE, 1996, J MAGN RESON SER A, V120, P155, DOI 10.1006/jmra.1996.0113; Budil DE, 2000, BIOPHYS J, V78, P430, DOI 10.1016/S0006-3495(00)76605-7; Budil DE, 1989, ADV EPR APPL BIOL BI, P307; EARLE KA, 1994, BIOPHYS J, V66, P1213, DOI 10.1016/S0006-3495(94)80905-1; Earle KA, 1997, J CHEM PHYS, V106, P9996, DOI 10.1063/1.474114; EARLE KA, 2000, AM PHYS SOC ABSTR, V45, P542; EATON GR, 2000, BIOL MAGNETIC RESONA, V19; Eaton SS, 1999, APPL MAGN RESON, V16, P159, DOI 10.1007/BF03161930; FREED JH, 1994, ANNU REV BIOPH BIOM, V23, P1, DOI 10.1146/annurev.bb.23.060194.000245; Ge MT, 1999, BIOPHYS J, V77, P925, DOI 10.1016/S0006-3495(99)76943-2; Ge MT, 1999, BIOPHYS J, V76, P264, DOI 10.1016/S0006-3495(99)77195-X; GRIFFITH OH, 1974, J MEMBRANE BIOL, V15, P159, DOI 10.1007/BF01870086; Grigoryants VM, 2000, BIOPHYS J, V78, P2702, DOI 10.1016/S0006-3495(00)76814-7; Hoff A. J., 1989, ADV EPR APPL BIOL BI, V1st; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hustedt EJ, 1997, BIOPHYS J, V72, P1861, DOI 10.1016/S0006-3495(97)78832-5; Kevan L., 1990, MODERN PULSED CONTIN; Lebedev Y.S., 1990, MODERN PULSED CONTIN, P365; Liang ZC, 1999, J PHYS CHEM B, V103, P6384, DOI 10.1021/jp9907746; Liang ZC, 2000, J PHYS CHEM B, V104, P5372, DOI 10.1021/jp994219f; MARSH D, 1989, SPIN LABELING THEORY, V1, P255; Mollaaghababa R, 2000, BIOCHEMISTRY-US, V39, P1120, DOI 10.1021/bi991963h; Patyal BR, 1997, BIOPHYS J, V73, P2201, DOI 10.1016/S0006-3495(97)78252-3; Pilar J, 2000, MACROMOLECULES, V33, P4438, DOI 10.1021/ma0002242; Prisner T. F., 1997, ADV MAGNETIC OPTICAL, V20, P245; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Schneider D. J., 1989, BIOL MAGN RESON, V8, P1; Steinhoff HJ, 1997, BIOPHYS J, V73, P3287, DOI 10.1016/S0006-3495(97)78353-X; Thorgeirsson TE, 1997, J MOL BIOL, V273, P951, DOI 10.1006/jmbi.1997.1362; [No title captured]; [No title captured]; [No title captured]	45	285	292	1	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2001	291	5502					266	269		10.1126/science.291.5502.266	http://dx.doi.org/10.1126/science.291.5502.266			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11253218				2022-12-28	WOS:000166352900035
J	Nakajima, K; Keyes, C; Kuroyanagi, T; Tatara, K				Nakajima, K; Keyes, C; Kuroyanagi, T; Tatara, K			Medical malpractice and legal resolution systems in Japan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Medical malpractice claims and dispute resolution systems have been examined in Western societies for their impact on the quality of: care and efficient compensation for injured patients. However, little is known about the Japanese malpractice environment because claim information has been closely guarded. Based on data from the Japanese Supreme Court, the Ministry of Health, Labor, and Welfare (formerly the Ministry of Health and Welfare), and the Japan Medical Association (JMA), which provides malpractice insurance to 43.5% of Japan's 250 000 physicians, we review Japanese malpractice liability systems and the frequency of claims during the last 30 years. Annual premiums for physician professional liability insurance are relatively low ($454-$491). Although the frequency of claims in Japan is lower than that reported in the United States, England, and Germany, the number of claims is increasing in Japan. According to publicly available data from the Japanese Supreme Court, the annual number of medical malpractice suits filed in district courts has increased from 102 in 1970 to 629 in 1998 (from 0.09 to 0.25 per 100 physicians). The proportion of awards greater than $89 300 increased from 13.6% in 1976 to 65.4% in 1987, Among JMA members, claims increased 31% from 1987 to 1999, but the frequency of claims has remained at approximately 0.3 per 100 JMA members. The JMA's professional liability program offers a nonbinding out-of-court review of claims that is faster and less expensive than judicial resolution (a few months with no attorney required vs 35 months and attorney fees), but is a poor means of deterrence or discipline. Since JMA data represent only 43.5% of Japanese physicians, generalizations cannot be made about all Japanese physicians and institutions. The lack of data on all claims hinders adequate evaluation of dispute resolution methods, development of appropriate risk management activities, and proactive education for Japanese physicians.	Osaka Univ, Grad Sch Med, Dept Social & Environm Hlth F2, Suita, Osaka 5650871, Japan; Harvard Med Inst, Risk Management Fdn, Boston, MA USA; Kaneko & Iwamatsu, Tokyo, Japan	Osaka University; Harvard University; Harvard Medical School	Nakajima, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Social & Environm Hlth F2, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.							*AM MED ASS, 1988, PROP ALT CIV JUST SY; ANNAS GJ, 1995, NEW ENGL J MED, V333, P527, DOI 10.1056/NEJM199508243330822; BRENNAN TA, 1995, J GEN INTERN MED, V10, P211, DOI 10.1007/BF02600257; *DAIN TOK BAR ASS, 1996, GUID ATT FEE SCHED, P6; FENN P, 1994, BRIT MED J, V309, P389, DOI 10.1136/bmj.309.6951.389; HAASHI M, 1998, CONT JUDICIAL SYSTEM, P1; HALEY JO, 1978, J JAPANESE STUDIES, V4, P359; HAMADA K, 1998, EMPLOYED PHYSICI JUN, P4; *HLTH WELF STAT AS, 1999, J HLTH WELFARE STAT, V46, P35; *IR STUD GROUP MED, 1993, MAN MED MALPR DISP, P244; *JAP FED BAR ASS, 1998, REG ATT 1998; *JAP MED ASS, 1999, ANN REP CLOS CIV SUI, P1; *JAP MED ASS, 1985, GUID UND JAP MED ASS, P1; *JAP MED ASS, 1998, ANN REP CLOS CIV SUI, P1; Japan Meteorological Agency, 1996, GUID UND PROF LIAB I, P1; JOHNSON WG, 1992, JAMA-J AM MED ASSOC, V267, P2487, DOI 10.1001/jama.267.18.2487; Jost TS, 1996, OHIO ST J DISP RESOL, V11, P81; KATO I, 1976, ISSUES MED MALPRACTI, P321; KAWASHIMA T, 1967, JAPANESE SENSE LAW, P139; KISAKI T, 1994, CLIN MAGAZINE, V4, P30; KUROYANAGI T, 1995, J JPN MED ASS, V113, P1874; KUROYANAGI T, 1998, RULE LAW, V111, P1; KUROYANAGI T, 2001, RULE LAW, V120, P65; Morlock LL, 1991, LAW CONTEMP PROBL, V54, P1; NAKAYAMA K, 1993, CRIMINAL CASES MED I, P2; NEALE G, 1993, BRIT MED J, V307, P1483, DOI 10.1136/bmj.307.6917.1483; *OS MED ASS, 1999, GUID UND MED PROF LI, P1; OSHIRO T, 2000, JPN MED J, V3982, P97; OSTERGARD N, 1997, FORUM, V18, P3; *PHYS LIAB JAP, 1975, ASIAN MED J, V18, P81; RAMSEYER JM, 1988, J JPN STUD, V14, P111, DOI 10.2307/132533; SHUZAIHAN I, 2000, MAINICH NEWPAPE 0818, P22; SHUZAIHAN I, 2000, MAINICH NEWPAPE 0817, P1; *STAT DEP MIN SECR, 1975, REP SURV MED CAR I 1, P26; *STAT DEP MIN SECR, 1982, REP SURV MED CAR I 1, P32; *STAT DEP MIN SECR, 1994, REP SURV MED CAR I 1, P42; *STAT DEP MIN SECR, 1974, REP SURV PHYS DENT P, P154; *STAT DEP MIN SECR, 1999, REP SURV PHYS DENT P, P154; *STAT DEP MIN SECR, 2000, REP SURV MED CAR I 1, P22; *STAT DEP MIN SECR, 1987, REP SURV MED CAR I 1, P110; *STAT DEP MIN SECR, 1996, REP SURV MED CAR I 1, P42; STRUCK D, 2000, WASHINGTON POST 1217, pA36; *TRAFF ACC JOINT C, 1997, STAND DAM CIV SUITS; WEILER PC, 1993, MEASURE MALPRACTICE, P61; *YAS FIR MAR CO LT, 1994, GUID UND PROF I LIAB, P1; *YAS FIR MAR CO LT, 1997, MED PROF LIAB INS PO, P1; 1999, J JPN MED ASS, V121, P1179; 1987, J JPN MED ASS, V97, P1392; 1986, J JPN MED ASS, V95, P1430; 1993, J JPN MED ASS, V109, P1301; 1997, J JPN MED ASS, V117, P1241; 1973, J JPN MED ASS, V69, P997; 1993, J JPN MED ASS, V109, P1220; 2000, J JPN MED ASS, V123, P1146; 2000, J JPN MED ASS, V123, P1267; 1976, J JPN MED ASS, V75, P885; 1990, J JPN MED ASS, V108, P1214; 2000, J JPN MED ASS, V123, P1175; 1998, J JPN MED ASS, V119, P1125; 1985, J JPN MED ASS, V93, P1504; 1977, J JPN MED ASS, V77, P885; 1982, J JPN MED ASS, V87, P926; 1981, J JPN MED ASS, V85, P1635; 1976, J JPN MED ASS, V75, P921; 1988, J JPN MED ASS, V99, P1347; 1981, J JPN MED ASS, V85, P1043; 1995, J JPN MED ASS, V113, P1232; 1981, J JPN MED ASS, V85, P1003; 1995, J JPN MED ASS, V113, P1155; 1986, J JPN MED ASS, V95, P1535; 1997, J JPN MED ASS, V117, P1271; 1975, J JPN MED ASS, V73, P1014; 1998, J JPN MED ASS, V99, P1448; 1999, J JPN MED ASS, V121, P1264; 1974, J JPN MED ASS, V71, P1119; 1998, J JPN MED ASS, V119, P1207; 1980, J JPN MED ASS, V83, P952; 1997, J JPN MED ASS, V117, P1362; 1974, J JPN MED ASS, V71, P1152; 1991, J JPN MED ASS, V105, P1264; 1991, J JPN MED ASS, V105, P1345	81	39	40	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2001	285	12					1632	1640		10.1001/jama.285.12.1632	http://dx.doi.org/10.1001/jama.285.12.1632			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	413HH	11268273				2022-12-28	WOS:000167606600032
J	Bracken, P; Thomas, P				Bracken, P; Thomas, P			Postpsychiatry: a new direction for mental health	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Bradford, Dept Appl Social Sci, Bradford BD7 1DP, W Yorkshire, England	University of Bradford	Bracken, P (corresponding author), Univ Bradford, Dept Appl Social Sci, Bradford BD7 1DP, W Yorkshire, England.	P.Bracken@bradford.ac.uk						[Anonymous], 1992, ETHNOPSYCHIATRY CULT; BEUMONT PJV, 1992, AUST NZ J PSYCHIAT, V26, P532, DOI 10.3109/00048679209072085; BRACKEN P, 1998, OPEN MIND, V89, P17; BRACKEN P, 1995, PHILOS PSYCHIAT PSYC, V2, P1; BRACKEN P, 1999, OPEN MIND, V95, P17; BRACKEN PJ, 1995, SOC SCI MED, V40, P1073, DOI 10.1016/0277-9536(94)00181-R; Bracken PJ, 1999, CURR OPIN PSYCHIATR, V12, P593, DOI 10.1097/00001504-199909000-00012; Clare A. W., 1976, PSYCHIAT DISSENT CON; *DEP HLTH, 1998, SAV LIV OUR HLTH NAT; *DEP HLTH, 1999, MOD STAND SERV MOD M; EASTMAN N, 1994, BRIT MED J, V308, P43, DOI 10.1136/bmj.308.6920.43; Ellenberger H., 1970, DISCOV UNCONSCIOUS; Foucault M, 1971, MADNESS CIVILIZATION; Fulford K. W. M., 1994, PHILOS PERSPECT, P211; Gordon Colin, 1990, HIST HUM SCI, V3, P3, DOI DOI 10.1177/095269519000300102; Gray JAM, 1999, LANCET, V354, P1550, DOI 10.1016/S0140-6736(98)08482-7; INGLEBY D, 1980, CRITICAL PSYCHIAT; Jaspers Karl, 1963, GEN PSYCHOPATHOLOGY; Kutchins H, 1999, MAKING US CRAZY; Leudar I., 2000, VOICES REASON VOICES; PHILLIPS J, 1996, PHILOS PSYCHIAT PSYC, V13, P61; Porter R., 1987, MIND FORGD MANACLES; RELTON P, 1999, ADVOCATE         MAY, P22; ROMME M, 1994, ACCEPTING VOICES; Rorty Richard, 1979, PHILOS MIRROR NATURE; SAMSON C, 1995, SOCIOL HEALTH ILL, V17, P245, DOI 10.1111/1467-9566.ep10933403; Sashidharan SP, 1999, BRIT MED J, V319, P254, DOI 10.1136/bmj.319.7204.254; Shepherd M., 1983, PSYCHOSOCIAL MATRIX; Szasz T.S., 1961, MYTH MENTAL ILLNESS; Thomas P., 1997, DIALECTICS SCHIZOPHR; Vygotsky L.S, 1978, MIND SOC DEV HIGHER, DOI DOI 10.2307/J.CTVJF9VZ4.11; ZIGMOND A, 1998, PSYCHIAT B, V22, P657	32	134	148	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2001	322	7288					724	727		10.1136/bmj.322.7288.724	http://dx.doi.org/10.1136/bmj.322.7288.724			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	416GB	11264215	Green Published			2022-12-28	WOS:000167771000030
J	Biron, D; Libros, P; Sagi, D; Mirelman, D; Moses, E				Biron, D; Libros, P; Sagi, D; Mirelman, D; Moses, E			Asexual reproduction - 'Midwives' assist dividing amoebae	NATURE			English	Article							DICTYOSTELIUM-DISCOIDEUM; ENTAMOEBA-HISTOLYTICA		Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Biron, D (corresponding author), Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel.	elisha.moses@weizmann.ac.il	MIRELMAN, DAVID/K-1596-2012					BAILEY GB, 1985, J PROTOZOOL, V32, P341; Fukui Y, 2000, MICROSC RES TECHNIQ, V49, P183, DOI 10.1002/(SICI)1097-0029(20000415)49:2<183::AID-JEMT11>3.3.CO;2-Y; Makioka A, 2000, PARASITOL RES, V86, P599, DOI 10.1007/PL00008536; MATO JM, 1975, P NATL ACAD SCI USA, V72, P4991, DOI 10.1073/pnas.72.12.4991; Moody-Haupt S, 2000, J MOL BIOL, V297, P409, DOI 10.1006/jmbi.2000.3577; SCHROEDER TE, 1990, ANN NY ACAD SCI, V582, P78; Weber I, 2000, CURR BIOL, V10, P501, DOI 10.1016/S0960-9822(00)00452-8	7	22	23	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2001	410	6827					430	430		10.1038/35068628	http://dx.doi.org/10.1038/35068628			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260701	Bronze			2022-12-28	WOS:000167583800029
J	Bolnick, DI				Bolnick, DI			Intraspecific competition favours niche width expansion in Drosophila melanogaster	NATURE			English	Article							SYMPATRIC SPECIATION; GENETIC-BASIS; TRADE-OFF; ENVIRONMENT; EVOLUTION; POLYMORPHISM; RESISTANCE; SELECTION	Ecologists have proposed that when interspecific competition is reduced, competition within a species becomes a potent evolutionary force leading to rapid diversification(1). This view reflects the observation that populations invading species-poor communities frequently evolve broader niches(2). Niche expansion can be associated with an increase in phenotypic variance(3,4) (known as character release(5)), with the evolution of polymorphisms(6-9), or with divergence into many species using distinct resources(10-13) (adaptive radiation). The relationship between intraspecific competition and diversification is known from theory(14,15), and has been used as the foundation for some models of speciation(16-20). However, there has been little empirical proof that niches evolve in response to intraspecific competition. To test this hypothesis, I introduced cadmium-intolerant Drosophila melanogaster populations to environments containing both cadmium-free and cadmium-laced resources. Here I show that populations experiencing high competition adapted to cadmium more rapidly than low competition populations. This provides experimental confirmation that competition in a population can drive niche expansion onto new resources for which competition is less severe.	Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Bolnick, DI (corresponding author), Univ Calif Davis, Ctr Populat Biol, Storer Hall, Davis, CA 95616 USA.	dibolnick@ucdavis.edu	Bolnick, Daniel I./G-4440-2015	Bolnick, Daniel I./0000-0003-3148-6296				Benkman CW, 1996, EVOL ECOL, V10, P119, DOI 10.1007/BF01239352; Coyne JA, 1997, EVOLUTION, V51, P643, DOI [10.2307/2411143, 10.1111/j.1558-5646.1997.tb03650.x]; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Doebeli M, 1996, J EVOLUTION BIOL, V9, P893, DOI 10.1046/j.1420-9101.1996.9060893.x; Drossel B, 2000, J THEOR BIOL, V204, P467, DOI 10.1006/jtbi.2000.2030; FEDER JL, 1995, OECOLOGIA, V101, P416, DOI 10.1007/BF00329420; Fisher, 1958, GENETICAL THEORY NAT; Fryer G, 1972, CICHLID FISHES GREAT; GIBBONS JRH, 1979, AM NAT, V114, P719, DOI 10.1086/283519; Gislason D, 1999, CAN J FISH AQUAT SCI, V56, P2229, DOI 10.1139/cjfas-56-12-2229; GRANT P R, 1972, Biological Journal of the Linnean Society, V4, P39, DOI 10.1111/j.1095-8312.1972.tb00690.x; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; Jones CD, 1998, GENETICS, V149, P1899; Kambysellis Michael P., 1997, P475; KNERER G, 1973, SCIENCE, V179, P1090, DOI 10.1126/science.179.4078.1090; Lack D., 1947, DARWINS FINCHES; LEROI AM, 1994, EVOLUTION, V48, P1244, DOI [10.2307/2410382, 10.1111/j.1558-5646.1994.tb05309.x]; LISTER BC, 1976, EVOLUTION, V30, P659, DOI 10.1111/j.1558-5646.1976.tb00947.x; MEYER A, 1990, BIOL J LINN SOC, V39, P279, DOI 10.1111/j.1095-8312.1990.tb00517.x; PROKOPY RJ, 1988, OECOLOGIA, V76, P138, DOI 10.1007/BF00379612; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Robinson BW, 2000, ADAPTIVE GENETIC VARIATION IN THE WILD, P65; ROSENZWEIG ML, 1978, BIOL J LINN SOC, V10, P275, DOI 10.1111/j.1095-8312.1978.tb00016.x; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; SCHLIEWEN UK, 1994, NATURE, V368, P629, DOI 10.1038/368629a0; Shirley MDF, 1999, EVOLUTION, V53, P826, DOI 10.1111/j.1558-5646.1999.tb05376.x; Simpson GG, 1954, MAJOR FEATURES EVOLU; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; WERNER TK, 1987, P NATL ACAD SCI USA, V84, P5506, DOI 10.1073/pnas.84.15.5506; WILSON DS, 1986, AM NAT, V127, P835, DOI 10.1086/284528	30	173	175	2	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2001	410	6827					463	466		10.1038/35068555	http://dx.doi.org/10.1038/35068555			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260712				2022-12-28	WOS:000167583800040
J	Ek, M; Engblom, D; Saha, S; Blomqvist, A; Jakobsson, PJ; Ericsson-Dahlstrand, A				Ek, M; Engblom, D; Saha, S; Blomqvist, A; Jakobsson, PJ; Ericsson-Dahlstrand, A			Inflammatory response - Pathway across the blood-brain barrier	NATURE			English	Article							PROSTAGLANDIN-E SYNTHASE; RAT-BRAIN; CYCLOOXYGENASE-2; INTERLEUKIN-1; MECHANISMS; NEURONS		Karolinska Inst, Dept Med, Rheumatol Unit, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Linkoping Univ, Dept Biomed & Surg, Div Cell Biol, S-58185 Linkoping, Sweden	Karolinska Institutet; Karolinska Institutet; Linkoping University	Ek, M (corresponding author), Karolinska Inst, Dept Med, Rheumatol Unit, S-17177 Stockholm, Sweden.		Jakobsson, Per-Johan/ABC-5594-2021; Blomqvist, Anders/K-3990-2019	Blomqvist, Anders/0000-0002-6928-4473				Ek M, 2000, J COMP NEUROL, V428, P5, DOI 10.1002/1096-9861(20001204)428:1<5::AID-CNE2>3.0.CO;2-M; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; ENGLOM D, 2000, NEUROSCI LETT, V281, P163; Ericsson A, 1997, J NEUROSCI, V17, P7166; ERICSSON A, 1994, J NEUROSCI, V14, P897; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; Thoren S, 2000, EUR J BIOCHEM, V267, P6428, DOI 10.1046/j.1432-1327.2000.01735.x; VANDAM AM, 1993, BRAIN RES, V613, P331, DOI 10.1016/0006-8993(93)90922-A; Zhang J, 1999, EUR J NEUROSCI, V11, P2651, DOI 10.1046/j.1460-9568.1999.00682.x	11	265	274	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					430	431		10.1038/35068632	http://dx.doi.org/10.1038/35068632			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260702				2022-12-28	WOS:000167583800030
J	Wang, ZY; Seto, H; Fujioka, S; Yoshida, S; Chory, J				Wang, ZY; Seto, H; Fujioka, S; Yoshida, S; Chory, J			BRI1 is a critical component of a plasma-membrane receptor for plant steroids	NATURE			English	Article							BRASSINOSTEROID SIGNAL-TRANSDUCTION; ARABIDOPSIS-THALIANA; KINASE; BRASSINOLIDE; GROWTH; BIOSYNTHESIS; HORMONE; ENCODES; ACTORS; GENE	Most multicellular organisms use steroids as signalling molecules for physiological and developmental regulation. Two different modes of steroid action have been described in animal systems: the well-studied gene regulation response mediated by nuclear receptors(1,2), and the rapid non-genomic responses mediated by proposed membrane-bound receptors(3,4). Plant genomes do not seem to encode members of the nuclear receptor superfamily(5). However, a transmembrane receptor kinase, brassinosteroid-insensitive1 (BRI1), has been implicated in brassinosteroid-responses(6,7). Here we show that BRI1 functions as a receptor of brassinolide, the most active brassinosteroid. The number of brassinolide-binding sites and the degree of response to brassinolide depend on the level of BRI1 protein. The brassinolide-binding activity co-immunoprecipitates with BRI1, and requires a functional BRI1 extracellular domain. Moreover, treatment of Arabidopsis seedlings with brassinolide induces autophosphorylation of BRI1, which, together with our binding studies, shows that BRI1 is a receptor kinase that transduces steroid signals across the plasma membrane.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; RIKEN, Inst Phys & Chem Res, Plant Funct Lab, Wako, Saitama 3510198, Japan	Howard Hughes Medical Institute; Salk Institute; Salk Institute; RIKEN	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu	Wang, Zhi-Yong/E-3810-2012	Wang, Zhi-Yong/0000-0003-4602-3390				Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Fujioka S, 1998, PHYTOCHEMISTRY, V49, P1841, DOI 10.1016/S0031-9422(98)00412-9; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Jinn TL, 2000, GENE DEV, V14, P108; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 1997, P NATL ACAD SCI USA, V94, P3554, DOI 10.1073/pnas.94.8.3554; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Luo WD, 1998, PHYTOCHEMISTRY, V49, P637, DOI 10.1016/S0031-9422(97)00881-9; MANDAVA NB, 1988, ANNU REV PLANT PHYS, V39, P23, DOI 10.1146/annurev.arplant.39.1.23; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Schmidt BMW, 2000, FRONT NEUROENDOCRIN, V21, P57, DOI 10.1006/frne.1999.0189; Schumacher K, 2000, CURR OPIN PLANT BIOL, V3, P79, DOI 10.1016/S1369-5266(99)00038-2; Seto H, 1998, TETRAHEDRON LETT, V39, P7525, DOI 10.1016/S0040-4039(98)01636-0; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Trotochaud AE, 2000, SCIENCE, V289, P613, DOI 10.1126/science.289.5479.613; Wang ZY, 2000, RECENT ADV PHYTOCHEM, V34, P409, DOI 10.1016/S0079-9920(00)80014-3; Wehling M, 1997, ANNU REV PHYSIOL, V59, P365, DOI 10.1146/annurev.physiol.59.1.365; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591	26	568	625	7	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					380	383		10.1038/35066597	http://dx.doi.org/10.1038/35066597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268216				2022-12-28	WOS:000167464100054
J	Dunn, RA; Toomey, DR; Detrick, RS; Wilcock, WSD				Dunn, RA; Toomey, DR; Detrick, RS; Wilcock, WSD			Continuous mantle melt supply beneath an overlapping spreading center on the East Pacific Rise	SCIENCE			English	Article							MID-OCEAN-RIDGE; MIDOCEAN RIDGES; SEAMARC-II; DISCONTINUITIES; SEGMENTATION; 9-DEGREES-03'N; CREST	Tomographic images of upper mantle velocity structure beneath an overlapping spreading center (OSC) on the East Pacific Rise indicate that this ridge axis discontinuity is underlain by a continuous region of Low P-wave velocities. The anomalous structure can be explained by an approximately 16-kilometer-wide region of high temperatures and melt fractions of a few percent by volume. Our results show that OSCs are not necessarily associated with a discontinuity in melt supply and that both OSC Limbs are supplied with melt from a mantle source Located beneath the OSC. We conclude that tectonic segmentation of the ridge by OSCs is not the direct result of magmatic segmentation at mantle depths.	Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Oregon; Brown University; Woods Hole Oceanographic Institution; University of Washington; University of Washington Seattle	Dunn, RA (corresponding author), Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA.		Dunn, Robert A/L-9892-2014	Dunn, Robert A/0000-0003-1434-5512; Toomey, Douglas/0000-0003-2873-4084; Wilcock, William/0000-0001-7224-7246				Barth GA, 1996, J GEOPHYS RES-SOL EA, V101, P17951, DOI 10.1029/96JB00814; BAZIN S, 2000, EOS S, V81, pF1346; CANALES JP, 1999, EOS T AGU S, V80, pF995; CARBOTTE S, 1992, J GEOPHYS RES-SOL EA, V97, P6959, DOI 10.1029/91JB03065; CARBOTTE SM, 1994, J GEOPHYS RES-SOL EA, V99, P13609, DOI 10.1029/93JB02971; CREAGER KC, 1982, J GEOPHYS RES, V87, P8379, DOI 10.1029/JB087iB10p08379; Dunn RA, 1997, NATURE, V388, P259, DOI 10.1038/40831; Dunn RA, 2000, J GEOPHYS RES-SOL EA, V105, P23537, DOI 10.1029/2000JB900210; erveny V., 1971, THEORY SEISMIC HEAD, DOI 10.3138/9781442652668; FAUL UH, 1994, GEOPHYS RES LETT, V21, P29, DOI 10.1029/93GL03051; Hansen TM, 1999, GEOPHYS RES LETT, V26, P2573, DOI 10.1029/1999GL900553; HAYMON RM, 1991, EARTH PLANET SC LETT, V104, P513, DOI 10.1016/0012-821X(91)90226-8; HESS HH, 1964, NATURE, V203, P629, DOI 10.1038/203629a0; Kent GM, 2000, NATURE, V406, P614, DOI 10.1038/35020543; KENT GM, 1993, J GEOPHYS RES-SOL EA, V98, P13971, DOI 10.1029/93JB00706; Lee SM, 1996, J GEOPHYS RES-SOL EA, V101, P22033, DOI 10.1029/96JB02114; Lee SM, 1995, THESIS MIT WOODS HOL; LONSDALE P, 1983, J GEOPHYS RES, V88, P9393, DOI 10.1029/JB088iB11p09393; LONSDALE P, 1989, J GEOPHYS RES-SOLID, V94, P713, DOI 10.1029/JB094iB01p00713; LONSDALE P, 1986, J GEOPHYS RES-SOLID, V91, P493, DOI 10.1029/JB091iB10p10493; MACDONALD KC, 1991, SCIENCE, V253, P986, DOI 10.1126/science.253.5023.986; MACDONALD KC, 1988, NATURE, V335, P217, DOI 10.1038/335217a0; MACDONALD KC, 1983, NATURE, V302, P55, DOI 10.1038/302055a0; MACDONALD KC, 1992, MAR GEOPHYS RES, V14, P299, DOI 10.1007/BF01203621; MACDONALD KC, 1986, J GEOPHYS RES-SOLID, V91, P501, DOI 10.1029/JB091iB10p10501; MADSEN JA, 1990, J GEOPHYS RES-SOLID, V95, P4967, DOI 10.1029/JB095iB04p04967; PHIPPSMORGAN J, 1993, J GEOPHYS RES, V98, P6283; SCHOUTEN H, 1985, NATURE, V317, P225, DOI 10.1038/317225a0; SEMPERE JC, 1986, TECTONICS, V5, P881, DOI 10.1029/TC005i006p00881; Singh SC, 1998, NATURE, V394, P874, DOI 10.1038/29740; SINTON JM, 1991, J GEOPHYS RES-SOLID, V96, P6133, DOI 10.1029/90JB02454; TOOMEY DR, 1990, NATURE, V347, P639, DOI 10.1038/347639a0; TOOMEY DR, 1994, J GEOPHYS RES-SOL EA, V99, P24135, DOI 10.1029/94JB01942; ZHANG SQ, 1995, NATURE, V375, P774, DOI 10.1038/375774a0	34	41	41	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1955	1958		10.1126/science.1057683	http://dx.doi.org/10.1126/science.1057683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239154				2022-12-28	WOS:000167401600044
J	Lundin, R				Lundin, R			Planetary science - Erosion by the solar wind	SCIENCE			English	Editorial Material							MARS; PLASMA; MAGNETOSPHERE		Swedish Inst Space Phys, S-98128 Kiruna, Sweden		Lundin, R (corresponding author), Swedish Inst Space Phys, S-98128 Kiruna, Sweden.							Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; CHAPPELL CR, 1987, J GEOPHYS RES, V92, P5896, DOI 10.1029/JA092iA06p05896; Kerr RA, 2000, SCIENCE, V289, P714, DOI 10.1126/science.289.5480.714; LUNDIN R, 1989, NATURE, V341, P609, DOI 10.1038/341609a0; PEREZDETEJADA H, 1987, J GEOPHYS RES, V92, P4713, DOI 10.1029/JA092iA05p04713; Seki K, 2001, SCIENCE, V291, P1939, DOI 10.1126/science.1058913	6	11	12	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1909	1909		10.1126/science.1059763	http://dx.doi.org/10.1126/science.1059763			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11245195				2022-12-28	WOS:000167401600030
J	Khaw, KT; Bingham, S; Welch, A; Luben, R; Wareham, N; Oakes, S; Day, N				Khaw, KT; Bingham, S; Welch, A; Luben, R; Wareham, N; Oakes, S; Day, N			Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study	LANCET			English	Article							CORONARY-HEART-DISEASE; VITAMIN-C STATUS; SUPPLEMENTATION; STROKE; DEATH; RISK	Background Ascorbic acid (vitamin C) might be protective for several chronic diseases. However. findings from prospective studies that relate ascorbic acid to cardiovascular disease or cancer are not consistent. We aimed to assess the relation between plasma ascorbic acid and subsequent mortality due to all causes, cardiovascular disease, ischaemic heart disease, and cancer. Methods We prospectively examined for 4 years the relation between plasma ascorbic acid concentrations and mortality due to all causes, and to cardiovascular disease, ischaemic heart disease, and cancer in 19 496 men and women aged 45-79 years. We recruited individuals by post using age-sex registers of general practices. Participants completed a health and lifestyle questionnaire and were examined at a clinic visit. They were followed-up for causes of death for about 4 years. Individuals were divided into sex-specific quintiles of plasma ascorbic acid. We used the Cox proportional hazard model to determine the effect of ascorbic acid and other risk factors on mortality. Findings Plasma ascorbic acid concentration was inversely related to mortality from all-causes, and from cardiovascular disease, and ischaemic heart disease in men and women. Risk of mortality in the top ascorbic acid quintile was about half the risk in the lowest quintile (p<0.0001). The relation with mortality was continuous through the whole distribution of ascorbic acid concentrations. 20 <mu>mol/L rise in plasma ascorbic acid concentration, equivalent to about 50 g per day increase in fruit and vegetable intake, was associated with about a 20% reduction in risk of all-cause mortality (p<0.0001), independent of age, systolic blood pressure, blood cholesterol, cigarette smoking habit, diabetes, and supplement use. Ascorbic acid was inversely related to cancer mortality in men but not women. Interpretation Small increases in fruit and vegetable intake of about one serving daily has encouraging prospects for possible prevention of disease.	Univ Cambridge, Sch Clin Med, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2QQ, England; MRC, Dunn Human Nutr Unit, Cambridge, England	University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Khaw, KT (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Clin Gerontol Unit, Box 251, Cambridge CB2 2QQ, England.	kk101@medschl.cam.ac.uk	Khaw, Kay-Tee/AAZ-3209-2021; Luben, Robert N/H-5519-2015; Welch, Ailsa Ann/A-4850-2008	Luben, Robert N/0000-0002-5088-6343; Welch, Ailsa Ann/0000-0002-6702-3704				Afridi N, 1996, J Cardiovasc Risk, V3, P358; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Bates CJ, 1991, DESIGN CONCEPTS NUTR, P192; BINGHAM SA, 1995, BRIT J NUTR, V73, P531, DOI 10.1079/BJN19950057; BLOT WJ, 1995, AM J CLIN NUTR, V62, P1424, DOI 10.1093/ajcn/62.6.1424S; COX DR, 1972, J R STAT SOC B, V34, P187; Day N, 1999, BRIT J CANCER, V80, P95; Duthie GG, 1999, BRIT MED BULL, V55, P568, DOI 10.1258/0007142991902637; ENSTROM JE, 1992, EPIDEMIOLOGY, V3, P194, DOI 10.1097/00001648-199205000-00003; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GALE CR, 1995, BRIT MED J, V310, P1563, DOI 10.1136/bmj.310.6994.1563; Gaziano J M, 1996, J Cardiovasc Risk, V3, P368; Hertog MGL, 1997, LANCET, V349, P699, DOI 10.1016/S0140-6736(05)60135-3; HUNT C, 1984, INT J VITAM NUTR RES, V54, P65; JIALAL I, 1990, ATHEROSCLEROSIS, V82, P185, DOI 10.1016/0021-9150(90)90039-L; KHAW KT, 1987, AM J EPIDEMIOL, V126, P1093, DOI 10.1093/oxfordjournals.aje.a114748; KHAW KT, 1987, NEW ENGL J MED, V316, P235, DOI 10.1056/NEJM198701293160502; Lonn EM, 1997, CAN J CARDIOL, V13, P957; Loria CM, 2000, AM J CLIN NUTR, V72, P139; MANTEL N, 1959, J NATL CANCER I, V22, P719; Ness A R, 1996, J Cardiovasc Risk, V3, P513, DOI 10.1097/00043798-199612000-00006; Ness AR, 1996, J HYPERTENS, V14, P503; Ness AR, 1996, EUR J CLIN NUTR, V50, P724; Rexrode K M, 1996, J Cardiovasc Risk, V3, P363; Sahyoun NR, 1996, AM J EPIDEMIOL, V144, P501, DOI 10.1093/oxfordjournals.aje.a008957; Sargeant LA, 2000, DIABETES CARE, V23, P726, DOI 10.2337/diacare.23.6.726; TunstallPedoe H, 1997, BRIT MED J, V315, P722, DOI 10.1136/bmj.315.7110.722; VUILLEUMIER JP, 1989, J MICRONUTR ANAL, V5, P25; WILSON T S, 1973, Age and Ageing, V2, P163, DOI 10.1093/ageing/2.3.163; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302	30	401	409	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2001	357	9257					657	663		10.1016/S0140-6736(00)04128-3	http://dx.doi.org/10.1016/S0140-6736(00)04128-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247548				2022-12-28	WOS:000167282400009
J	Parker, RA; Hartman, EE				Parker, RA; Hartman, EE			A 48-year-old man with recurrent sinusitis, 1 year later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Parker RA, 2000, JAMA-J AM MED ASSOC, V283, P2143, DOI 10.1001/jama.283.16.2143	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2001	285	4					462	462		10.1001/jama.285.4.462	http://dx.doi.org/10.1001/jama.285.4.462			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394CG	11242432				2022-12-28	WOS:000166506000035
J	Lobreglio, G; Valacca, A				Lobreglio, G; Valacca, A			Erythrophagocytosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Vito Fazzi Gen Hosp, I-73100 Lecce, Italy	Azienda Ospedaliera Vito Fazzi	Lobreglio, G (corresponding author), Vito Fazzi Gen Hosp, I-73100 Lecce, Italy.			Lobreglio, Giambattista/0000-0002-6850-4630					0	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2001	344	12					897	897		10.1056/NEJM200103223441205	http://dx.doi.org/10.1056/NEJM200103223441205			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412PN	11259723				2022-12-28	WOS:000167563700005
J	Russell-Jones, R				Russell-Jones, R			Shedding light on photopheresis	LANCET			English	Editorial Material							T-CELL LYMPHOMA; VERSUS-HOST-DISEASE; EXTRACORPOREAL PHOTOCHEMOTHERAPY; 8-METHOXYPSORALEN; INHIBITION; REJECTION; PEPTIDES		St Thomas Hosp, St Johns Inst Dermatol, Skin Tumour Unit, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Russell-Jones, R (corresponding author), St Thomas Hosp, St Johns Inst Dermatol, Skin Tumour Unit, London SE1 7EH, England.							Barr ML, 1998, NEW ENGL J MED, V339, P1744, DOI 10.1056/NEJM199812103392404; Berger CL, 1998, INT J CANCER, V76, P304, DOI 10.1002/(SICI)1097-0215(19980504)76:3<304::AID-IJC3>3.0.CO;2-Z; BERGER CL, 1990, J INVEST DERMATOL, V94, P52, DOI 10.1111/1523-1747.ep12873349; Bladon J, 1999, BRIT J HAEMATOL, V107, P707, DOI 10.1046/j.1365-2141.1999.01773.x; Child FJ, 1999, BONE MARROW TRANSPL, V23, P881, DOI 10.1038/sj.bmt.1701733; COSTANZONORDIN MR, 1992, TRANSPLANTATION, V53, P808, DOI 10.1097/00007890-199204000-00021; EDELSON R, 1987, NEW ENGL J MED, V316, P297, DOI 10.1056/NEJM198702053160603; ENOMOTO D, J AM ACAD DERMATOL, V41, P915; Fraser-Andrews E, 1998, ARCH DERMATOL, V134, P1001, DOI 10.1001/archderm.134.8.1001; Greinix HT, 2000, BLOOD, V96, P2426; Greinix HT, 1998, BLOOD, V92, P3098, DOI 10.1182/blood.V92.9.3098.421k32_3098_3104; Hanlon DJ, 1998, INT J CANCER, V78, P70, DOI 10.1002/(SICI)1097-0215(19980925)78:1<70::AID-IJC12>3.3.CO;2-3; HEALD P, 1992, J AM ACAD DERMATOL, V27, P427, DOI 10.1016/0190-9622(92)70212-X; KHAVARI PA, 1988, CLIN RES, V36, pA662; KNOBLER RM, 1993, J AM ACAD DERMATOL, V28, P580, DOI 10.1016/0190-9622(93)70077-7; LUDVIGSSON J, IN PRESS ARCH DIS CH; Mutis T, 1999, NAT MED, V5, P839, DOI 10.1038/10563; PEREZ M, 1989, J INVEST DERMATOL, V92, P669, DOI 10.1111/1523-1747.ep12696853; Photiou A, 2000, J INVEST DERMATOL, V115, P540; ROOK AH, 1992, ARCH DERMATOL, V128, P337, DOI 10.1001/archderm.128.3.337; Rook AH, 1999, J INVEST DERM SYMP P, V4, P85, DOI 10.1038/sj.jidsp.5640188; Rostami AM, 1999, MULT SCLER J, V5, P198, DOI 10.1191/135245899678846014; SONG PS, 1979, PHOTOCHEM PHOTOBIOL, V29, P1177, DOI 10.1111/j.1751-1097.1979.tb07838.x; THERAKOS, 1997, M TYN HALL UK OCT 11; ULLRICH SE, 1991, J INVEST DERMATOL, V96, P303; Wilson LD, 2000, J AM ACAD DERMATOL, V43, P54, DOI 10.1067/mjd.2000.105510	26	15	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2001	357	9259					820	821		10.1016/S0140-6736(00)04191-X	http://dx.doi.org/10.1016/S0140-6736(00)04191-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265946				2022-12-28	WOS:000167586300004
J	Chow, DC; He, XL; Snow, AL; Rose-John, S; Garcia, KC				Chow, DC; He, XL; Snow, AL; Rose-John, S; Garcia, KC			Structure of an extracellular gp130 cytokine receptor signaling complex	SCIENCE			English	Article							CRYSTAL-STRUCTURE; 2 DISTINCT; INTERLEUKIN-6; BINDING; IL-6; PROGRAM; REGION; RECOGNITION; TRANSDUCER; ACTIVATION	The activation of gp130, a shared signal-transducing receptor for a family of cytokines, is initiated by recognition of Ligand followed by oligomerization into a higher order signaling complex. Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human interleukin-6 (IL-6) that activates human gp130. In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral IL-6 and human gp130, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of gp130 and site III of viral IL-6, which is necessary for receptor activation. Unlike human IL-6 (which uses many hydrophilic residues), the viral cytokine Largely uses hydrophobic amino acids to contact gp 130, which enhances the complementarity of the viral IL-6-gp130 binding interfaces. The cross-reactivity of gp130 is apparently due to a chemical plasticity evident in the amphipathic gp130 cytokine-binding sites.	Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; Univ Kiel, Dept Biochem, D-24098 Kiel, Germany	Stanford University; Stanford University; University of Kiel	Garcia, KC (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Fairchild D319,299 Campus Dr, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Rose-John, Stefan/A-7998-2010	Rose-John, Stefan/0000-0002-7519-3279; Snow, Andrew/0000-0002-8728-6691	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048540] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI-48540-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Atwell S, 1997, SCIENCE, V278, P1125, DOI 10.1126/science.278.5340.1125; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Barton VA, 2000, J BIOL CHEM, V275, P36197, DOI 10.1074/jbc.M004648200; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; BRAKENHOFF JPJ, 1994, J BIOL CHEM, V269, P86; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHOW DC, UNPUB; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Deller MC, 2000, STRUCT FOLD DES, V8, P863, DOI 10.1016/S0969-2126(00)00176-3; Grotzinger J, 1997, PROTEINS, V27, P96; Hammacher A, 1998, J BIOL CHEM, V273, P22701, DOI 10.1074/jbc.273.35.22701; Hammacher A, 2000, BIOCHEM J, V345, P25, DOI 10.1042/0264-6021:3450025; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hoischen SH, 2000, EUR J BIOCHEM, V267, P3604, DOI 10.1046/j.1432-1327.2000.01389.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Horsten U, 1997, J BIOL CHEM, V272, P23748, DOI 10.1074/jbc.272.38.23748; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; INOUE M, 1995, P NATL ACAD SCI USA, V92, P8579, DOI 10.1073/pnas.92.19.8579; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurth I, 2000, J IMMUNOL, V164, P273, DOI 10.4049/jimmunol.164.1.273; Kurth I, 1999, J IMMUNOL, V162, P1480; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Molden J, 1997, J BIOL CHEM, V272, P19625, DOI 10.1074/jbc.272.31.19625; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Moritz RL, 1999, GROWTH FACTORS, V16, P265, DOI 10.3109/08977199909069145; PAONESSA G, 1995, EMBO J, V14, P1942, DOI 10.1002/j.1460-2075.1995.tb07186.x; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; SPRANG SR, 1993, CURR OPIN STRUC BIOL, V3, P815, DOI 10.1016/0959-440X(93)90144-A; Staunton D, 1998, PROTEIN ENG, V11, P1093, DOI 10.1093/protein/11.11.1093; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Ward LD, 1995, ANN NY ACAD SCI, V762, P471; Wells JA, 1996, ANNU REV BIOCHEM, V65, P609, DOI 10.1146/annurev.bi.65.070196.003141; Wilson IA, 1999, CURR OPIN STRUC BIOL, V9, P696, DOI 10.1016/S0959-440X(99)00032-9	53	207	225	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2001	291	5511					2150	2155		10.1126/science.1058308	http://dx.doi.org/10.1126/science.1058308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251120				2022-12-28	WOS:000167563800040
J	Kropman, MF; Bakker, HJ				Kropman, MF; Bakker, HJ			Dynamics of water molecules in aqueous solvation shells	SCIENCE			English	Article							HYDROGEN-BOND; LIQUID WATER; HYDRATION; ION; SPECTROSCOPY; TEMPERATURE; CLUSTERS	We report on the direct measurement of the dynamics of water molecules in the solvation shell of an ion in aqueous solution. The hydrogen-bond dynamics of water molecules solvating a Cl-. Br-, or I- anion is slow compared with neat liquid water, indicating that the aqueous solvation shells of these ions are rigid. This rigidity can play an important role in the overall dynamics of chemical reactions in aqueous solution. The experiments were performed with femtosecond midinfrared nonlinear spectroscopy, because this technique allows the spectral response of the water molecules in the solvation shell to be distinguished clearly from that of the other water molecules in the solution.	FOM, Inst AMOLF, NL-1098 SJ Amsterdam, Netherlands	AMOLF	Bakker, HJ (corresponding author), FOM, Inst AMOLF, Kruislaan 407, NL-1098 SJ Amsterdam, Netherlands.	bakker@amolf.nl						Ayotte P, 1999, J CHEM PHYS, V110, P7129, DOI 10.1063/1.478616; Cabarcos OM, 1999, J CHEM PHYS, V110, P5, DOI 10.1063/1.478075; Chandra A, 2000, PHYS REV LETT, V85, P768, DOI 10.1103/PhysRevLett.85.768; Choi JH, 1998, J PHYS CHEM A, V102, P503, DOI 10.1021/jp9729425; DANG LX, 1991, J AM CHEM SOC, V113, P2481, DOI 10.1021/ja00007a021; Gale GM, 1999, PHYS REV LETT, V82, P1068, DOI 10.1103/PhysRevLett.82.1068; HASHIMOTO K, 1994, CHEM PHYS LETT, V223, P423, DOI 10.1016/0009-2614(94)00489-7; JIMENEZ R, 1994, NATURE, V369, P471, DOI 10.1038/369471a0; Laenen R, 2000, PHYS REV LETT, V85, P50, DOI 10.1103/PhysRevLett.85.50; MIKENDA W, 1986, J MOL STRUCT, V147, P1, DOI 10.1016/0022-2860(86)87054-5; Mukamel S., 1995, PRINCIPLES NONLINEAR, V1st; Novak, 1974, STRUCT BOND, P177, DOI [10.1007/BFb0116438, DOI 10.1007/BFB0116438]; PESIHERBE G, 2000, CHEM PHYS, V258, P201; Ramaniah LM, 1998, J CHEM PHYS, V109, P6839, DOI 10.1063/1.477250; SMITH DE, 1994, J CHEM PHYS, V100, P3757, DOI 10.1063/1.466363; WALRAFEN GE, 1966, J CHEM PHYS, V44, P1546, DOI 10.1063/1.1726891; WALRAFEN GE, 1970, J CHEM PHYS, V52, P4176, DOI 10.1063/1.1673629; Weber JM, 2000, SCIENCE, V287, P2461, DOI 10.1126/science.287.5462.2461; Woutersen S, 1998, PHYS REV LETT, V81, P1106, DOI 10.1103/PhysRevLett.81.1106; Woutersen S, 1999, NATURE, V402, P507, DOI 10.1038/990058; Woutersen S, 1999, PHYS REV LETT, V83, P2077, DOI 10.1103/PhysRevLett.83.2077; Woutersen S, 1997, SCIENCE, V278, P658, DOI 10.1126/science.278.5338.658; ZHU SB, 1992, J CHEM PHYS, V97, P4336, DOI 10.1063/1.463903	23	403	412	4	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2001	291	5511					2118	2120		10.1126/science.1058190	http://dx.doi.org/10.1126/science.1058190			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251110				2022-12-28	WOS:000167563800030
J	Sabelis, MW; Janssen, A; Kant, MR				Sabelis, MW; Janssen, A; Kant, MR			Ecology - The enemy of my enemy is my ally	SCIENCE			English	Editorial Material							DEFENSES		Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	University of Amsterdam	Sabelis, MW (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.		Janssen, Arne/B-2657-2009	Janssen, Arne/0000-0001-5075-5303; Kant, Merijn/0000-0003-2524-8195				BRONSTEIN JL, 1994, Q REV BIOL, V69, P31, DOI 10.1086/418432; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Dicke M, 1998, EXP APPL ACAROL, V22, P311, DOI 10.1023/A:1024528507803; DRUKKER B, 1995, ENTOMOL EXP APPL, V77, P193, DOI 10.1007/BF02383034; Halitschke R, 2000, OECOLOGIA, V124, P408, DOI 10.1007/s004420000389; Janssen A, 1998, EXP APPL ACAROL, V22, P497, DOI 10.1023/A:1006089924336; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Sabelis M, 1999, INDUCED PLANT DEFENSES AGAINST PATHOGENS AND HERBIVORES, P269; Sabelis MW, 1999, HERBIVORES: BETWEEN PLANTS AND PREDATORS, P109; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420	10	47	58	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2104	2105		10.1126/science.1059939	http://dx.doi.org/10.1126/science.1059939			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11256409	Green Submitted			2022-12-28	WOS:000167563800025
J	Berger, E; Ball, S; Becker, KM; Clarke, M; Frail, DA; Fukuda, TA; Hoffman, IM; Mellon, R; Momjian, E; Murphy, NW; Teng, SH; Woodruff, T; Zauderer, BA; Zavala, RT				Berger, E; Ball, S; Becker, KM; Clarke, M; Frail, DA; Fukuda, TA; Hoffman, IM; Mellon, R; Momjian, E; Murphy, NW; Teng, SH; Woodruff, T; Zauderer, BA; Zavala, RT			Discovery of radio emission from the brown dwarf LP944-20	NATURE			English	Article							SOLAR-TYPE STARS; MAIN-SEQUENCE; CORONAE; FLARES; EQUIPARTITION; SUPERFLARES; LP-944-20; SEARCH	Brown dwarfs are not massive enough to sustain thermonuclear fusion of hydrogen at their centres, but are distinguished from gas-giant planets by their ability to burn deuterium(1). Brown dwarfs older than similar to 10 Myr are expected to possess short-lived magnetic fields(2) and to emit radio and X-rays only very weakly from their coronae. An X-ray flare was recently detected(3) on the brown dwarf LP944-20, whereas previous searches(4-7) for optical activity (and one X-ray search(1)) yielded negative results. Here we report the discovery of quiescent and flaring radio emission from LP944-20, with luminosities several orders of magnitude larger than predicted by the empirical relation(8,9) between the X-ray and radio luminosities that has been found for many types of stars. Interpreting the radio data within the context of synchrotron emission, we show that LP944-20 has an unusually weak magnetic field in comparison to active M-dwarf stars(10,11), which might explain the previous null optical(4-7) and X-ray(1) results, as well as the strength of the radio emissions compared to those at X-ray wavelengths.	CALTECH, Div Phys Math & Astron 105 24, Pasadena, CA 91125 USA; New Mexico Tech, Dept Phys, Socorro, NM 87801 USA; Oberlin Coll, Dept Phys, Oberlin, OH 44074 USA; Carleton Coll, Dept Phys, Northfield, MN 55057 USA; Natl Radio Astron Observ, Socorro, NM 87801 USA; Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; Penn State Univ, Dept Astron, Davey Lab 525, University Pk, PA 16802 USA; Univ Kentucky, Dept Phys & Astron, Lexington, KY 40506 USA; Amherst Coll, Dept Phys, Amherst, MA 01002 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA; Southwestern Univ, Dept Phys, Georgetown, TX 78626 USA; Agnes Scott Coll, Dept Phys & Astron, Decatur, GA 30030 USA; New Mexico State Univ, Dept Astron, Las Cruces, NM 88003 USA	California Institute of Technology; Oberlin College; Carleton College; National Radio Astronomy Observatory (NRAO); University of Denver; University of New Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Kentucky; Amherst College; University System of Maryland; University of Maryland College Park; New Mexico State University	Berger, E (corresponding author), CALTECH, Div Phys Math & Astron 105 24, Pasadena, CA 91125 USA.		Zavala, Robert/D-7821-2011	Zavala, Robert/0000-0002-9402-2870; Hoffman, Ian/0000-0001-6671-3482				Bastian TS, 1998, ANNU REV ASTRON ASTR, V36, P131, DOI 10.1146/annurev.astro.36.1.131; BENZ AO, 1994, ASTRON ASTROPHYS, V285, P621; BRUGGMANN G, 1990, ASTRON ASTROPHYS, V239, P347; BURBIDGE GR, 1957, ASTROPHYS J, V125, P1, DOI 10.1086/146279; DULK GA, 1982, ASTROPHYS J, V259, P350, DOI 10.1086/160171; DULK GA, 1987, LECTURE NOTES PHYSIC, V291, P72; DURNEY BR, 1993, SOL PHYS, V145, P207, DOI 10.1007/BF00690652; FLEMING TA, 1993, ASTROPHYS J, V410, P387, DOI 10.1086/172755; FLEMING TA, 1988, ASTROPHYS J, V331, P958, DOI 10.1086/166613; Fomalont E., 1981, NRAO NEWSL, V3, P3; Giampapa MS, 1996, ASTROPHYS J, V463, P707, DOI 10.1086/177284; Guedel M., 1993, APJ, V405, pL63; HAISCH B, 1991, ANNU REV ASTRON ASTR, V29, P275, DOI 10.1146/annurev.aa.29.090191.001423; Kirkpatrick JD, 1997, ASTRON J, V113, P1421, DOI 10.1086/118357; Krishnamurthi A, 1999, ASTRON J, V118, P1369, DOI 10.1086/301015; Neuhauser R, 1999, ASTRON ASTROPHYS, V343, P883; READHEAD ACS, 1994, ASTROPHYS J, V426, P51, DOI 10.1086/174038; Rubenstein EP, 2000, ASTROPHYS J, V529, P1031, DOI 10.1086/308326; Rutledge RE, 2000, ASTROPHYS J, V538, pL141, DOI 10.1086/312817; SAAR SH, 1985, ASTROPHYS J, V299, pL47, DOI 10.1086/184578; Schaefer BE, 2000, ASTROPHYS J, V529, P1026, DOI 10.1086/308325; SCOTT MA, 1977, MON NOT R ASTRON SOC, V180, P539, DOI 10.1093/mnras/180.4.539; SMITH EJ, 1975, SCIENCE, V188, P451, DOI 10.1126/science.188.4187.451; Sturrock PA, 1999, ASTROPHYS J, V521, P451, DOI 10.1086/307544; Tinney CG, 1999, MON NOT R ASTRON SOC, V304, P119, DOI 10.1046/j.1365-8711.1999.02297.x; Tinney CG, 1998, MON NOT R ASTRON SOC, V296, pL42, DOI 10.1046/j.1365-8711.1998.01642.x; Tinney CG, 1998, MON NOT R ASTRON SOC, V301, P1031, DOI 10.1046/j.1365-8711.1998.02079.x	28	152	152	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					338	340		10.1038/35066514	http://dx.doi.org/10.1038/35066514			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268202	Green Submitted			2022-12-28	WOS:000167464100040
J	Dainton, M				Dainton, M			Palaeoanthropology - Did our ancestors knuckle-walk?	NATURE			English	Article									Univ Liverpool, New Med Sch, Dept Human Anat & Cell Biol, Liverpool L69 3GE, Merseyside, England	University of Liverpool	Dainton, M (corresponding author), Univ Liverpool, New Med Sch, Dept Human Anat & Cell Biol, Ashton St, Liverpool L69 3GE, Merseyside, England.			Dainton, Michael/0000-0002-8784-3697				Collard M, 2000, NATURE, V404, P339, DOI 10.1038/35006181; Dainton M, 1999, J HUM EVOL, V36, P171, DOI 10.1006/jhev.1998.0265; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Jenkins F.A. Jr., 1975, P213; LAUDER GV, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P1; Richmond BG, 2000, NATURE, V404, P382, DOI 10.1038/35006045; Sarmiento E.E., 1995, Human Evolution, V10, P289, DOI 10.1007/BF02438967; SARMIENTO EE, 1988, INT J PRIMATOL, V9, P281, DOI 10.1007/BF02737381; TUTTLE R, 1972, NATURE, V236, P33, DOI 10.1038/236033a0; Tuttle R.H., 1975, P203; TUTTLE RH, 1967, AM J PHYS ANTHROPOL, V26, P171, DOI 10.1002/ajpa.1330260207; TUTTLE RH, 1969, J MORPHOL, V128, P309, DOI 10.1002/jmor.1051280304	12	26	26	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					324	325		10.1038/35066634	http://dx.doi.org/10.1038/35066634			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268197				2022-12-28	WOS:000167464100035
J	Ignes-Mullol, J; Schwartz, DK				Ignes-Mullol, J; Schwartz, DK			Shear-induced molecular precession in a hexatic Langmuir monolayer	NATURE			English	Article							BLODGETT-FILMS; CHANNEL FLOW; VELOCITY PROFILE; ORIENTATION; DEPENDENCE; ANISOTROPY; BEHAVIOR	Liquid crystalline behaviour is generally limited to a select group of specially designed bulk substances. By contrast, it is a common feature of simple molecular monolayers and other quasi-two-dimensional systems(1), which often possess a type of in-plane ordering that results from unbinding of dislocations-a 'hexatic' liquid crystalline phase. The flow of monolayers is closely related to molecular transport in biological membranes, affects foam and emulsion stability and is relevant to microfluidics research. For liquid crystalline phases, it is important to understand the coupling of the molecular orientation to the flow. Orientationally ordered (nematic) phases in bulk liquid crystals exhibit 'shear aligning' or 'tumbling' behaviour under shear, and are described quantitatively by Leslie-Ericksen theory(2). For hexatic monolayers, the effects of flow have been inferred from textures of Langmuir-Blodgett films(3-5) and directly observed at the macroscopic level(6-10). However, there is no accepted model of hexatic flow at the molecular level. Here we report observations of a hexatic Langmuir monolayer that reveal continuous, shear-induced molecular precession, interrupted by occasional jump discontinuities. Although superficially similar to tumbling in a bulk nematic phase, the kinematic details are quite different and provide a possible mechanism for domain coarsening and eventual molecular alignment in monolayers. We explain the precession and jumps within a quantitative framework that involves coupling of molecular orientation to the local molecular hexatic 'lattice', which is continuously deformed by shear.	Tulane Univ, Dept Chem, New Orleans, LA 70118 USA	Tulane University	Schwartz, DK (corresponding author), Univ Barcelona, Dept Quim Fis, Marti & Franques 1, E-08028 Barcelona, Spain.	daniel.schwartz@colorado.edu	Ignés-Mullol, Jordi/C-6233-2011; Schwartz, Daniel K/H-5153-2012	Ignés-Mullol, Jordi/0000-0001-7963-3799; Schwartz, Daniel K/0000-0001-5397-7200				BUBECK C, 1992, THIN SOLID FILMS, V210, P674, DOI 10.1016/0040-6090(92)90371-H; Chandrasekhar S., 1992, LIQ CRYST, DOI 10.1017/CBO9780511622496; Cuvillier N, 1999, J CHEM PHYS, V111, P6982, DOI 10.1063/1.479991; Edwards D.A., 1991, INTERFACIAL TRANSPOR; Friedenberg MC, 1996, LANGMUIR, V12, P1594, DOI 10.1021/la950574v; Ghaskadvi RS, 1997, LANGMUIR, V13, P5137, DOI 10.1021/la970036d; Ghaskadvi RS, 1999, J CHEM PHYS, V111, P3675, DOI 10.1063/1.479648; Ghaskadvi RS, 1996, PHYS REV E, V54, P1770, DOI 10.1103/PhysRevE.54.1770; HALPERIN BI, 1978, PHYS REV LETT, V41, P121, DOI 10.1103/PhysRevLett.41.121; Ignes-Mullol J, 2000, PHYS REV LETT, V85, P1476, DOI 10.1103/PhysRevLett.85.1476; Ikegami K, 1997, PHYS REV E, V56, P1987, DOI 10.1103/PhysRevE.56.1987; Ikegami K, 1998, THIN SOLID FILMS, V327, P24, DOI 10.1016/S0040-6090(98)00580-X; Ivanova A, 1999, LANGMUIR, V15, P4622, DOI 10.1021/la981742x; Ivanova AT, 2000, LANGMUIR, V16, P9433, DOI 10.1021/la000754r; Jeffery GB, 1922, P R SOC LOND A-CONTA, V102, P161, DOI 10.1098/rspa.1922.0078; Kaganer VM, 1999, REV MOD PHYS, V71, P779, DOI 10.1103/RevModPhys.71.779; Kurnaz ML, 1997, PHYS REV E, V56, P3378, DOI 10.1103/PhysRevE.56.3378; LEUTHE A, 1992, J PHYS D APPL PHYS, V25, P1786, DOI 10.1088/0022-3727/25/12/015; Maffettone PL, 1996, MACROMOLECULES, V29, P8473, DOI 10.1021/ma9603591; Maruyama T, 1998, J NON-NEWTON FLUID, V76, P233, DOI 10.1016/S0377-0257(97)00120-1; Maruyama T, 1998, LANGMUIR, V14, P1836, DOI 10.1021/la971047+; Maruyama T, 1996, SCIENCE, V274, P233, DOI 10.1126/science.274.5285.233; NELSON DR, 1980, PHYS REV B, V21, P5312, DOI 10.1103/PhysRevB.21.5312; PETERSON IR, 1984, THIN SOLID FILMS, V116, P357, DOI 10.1016/0040-6090(84)90116-0; SELINGER JV, 1993, PHYS REV LETT, V70, P1139, DOI 10.1103/PhysRevLett.70.1139	25	45	45	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2001	410	6826					348	351		10.1038/35066539	http://dx.doi.org/10.1038/35066539			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268206	Bronze			2022-12-28	WOS:000167464100044
J	Kleiman, FE; Manley, JL				Kleiman, FE; Manley, JL			The BARD1-CstF-50 interaction links mRNA 3 ' end formation to DNA damage and tumor suppression	CELL			English	Article							RNA-POLYMERASE-II; PRE-MESSENGER-RNA; B-CELL DIFFERENTIATION; POLYADENYLATION FACTOR; POLY(A) POLYMERASE; INDUCED UBIQUITINATION; TERMINAL DOMAIN; LARGE SUBUNIT; IN-VIVO; BRCA1	The mRNA polyadenylation factor CstF interacts with the BRCA1-associated protein BARD1, and this interaction represses the nuclear mRNA polyadenylation machinery in vitro. Given the suspected role of BRCA1/BARD1 in DNA repair, we tested whether inhibition of mRNA processing is linked to DNA damage. Strikingly, we found that 3' cleavage in extracts from cells treated with hydroxyurea or ultraviolet light was strongly, but transiently, inhibited. Although no changes were detected in CstF, BARD1, and BRCA1 protein levels, increased amounts of a CstF/BARD1/BRCA1 complex were detected. Supporting the physiological significance of these results, a previously identified tumor-associated germline mutation in BARD1 (Gln564His) reduced binding to CstF and abrogated inhibition of polyadenylation. Together these results indicate a link between mRNA 3' processing and DNA repair and tumor suppression.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Manley, JL (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	jlm2@columbia.edu		Manley, James/0000-0002-8341-1459	NIGMS NIH HHS [GM28983] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028983] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Ayi TC, 1998, ONCOGENE, V17, P2143, DOI 10.1038/sj.onc.1202123; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen Z, 2000, MOL CELL BIOL, V20, P5064, DOI 10.1128/MCB.20.14.5064-5076.2000; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; Colgan DF, 1996, NATURE, V384, P282, DOI 10.1038/384282a0; Colgan DF, 1998, EMBO J, V17, P1053, DOI 10.1093/emboj/17.4.1053; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; Hirose Y, 2000, GENE DEV, V14, P1415; Irminger-Finger I, 1998, J CELL BIOL, V143, P1329, DOI 10.1083/jcb.143.5.1329; Jin Y, 1997, P NATL ACAD SCI USA, V94, P12075, DOI 10.1073/pnas.94.22.12075; Kleiman FE, 1999, SCIENCE, V285, P1576, DOI 10.1126/science.285.5433.1576; Kumar A, 1995, LEUKEMIA RES, V19, P831, DOI 10.1016/0145-2126(95)00063-1; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Ljungman M, 1999, CARCINOGENESIS, V20, P395, DOI 10.1093/carcin/20.3.395; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; MACDONALD CC, 1994, MOL CELL BIOL, V14, P6647, DOI 10.1128/MCB.14.10.6647; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Meza JE, 1999, J BIOL CHEM, V274, P5659, DOI 10.1074/jbc.274.9.5659; Mitsui A, 1999, P NATL ACAD SCI USA, V96, P6054, DOI 10.1073/pnas.96.11.6054; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; Ruffner H, 1997, P NATL ACAD SCI USA, V94, P7138, DOI 10.1073/pnas.94.14.7138; Schwartz E, 1998, BIOCHEM BIOPH RES CO, V246, P217, DOI 10.1006/bbrc.1998.8601; Scorilas A, 1998, J EXP CLIN CANC RES, V17, P511; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 1996, SCIENCE, V272, P123, DOI 10.1126/science.272.5258.123; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; TAKAGAKI Y, 1990, GENE DEV, V4, P2112, DOI 10.1101/gad.4.12a.2112; TAKAGAKI Y, 1992, J BIOL CHEM, V267, P23471; TAKAGAKI Y, 1994, NATURE, V372, P471, DOI 10.1038/372471a0; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Thai TH, 1998, HUM MOL GENET, V7, P195, DOI 10.1093/hmg/7.2.195; Welcsh PL, 2000, TRENDS GENET, V16, P69, DOI 10.1016/S0168-9525(99)01930-7; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Yoshio TD, 1997, MOL CELL BIOL, V17, P3907, DOI 10.1128/MCB.17.7.3907; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhao WQ, 1998, MOL CELL BIOL, V18, P5010, DOI 10.1128/MCB.18.9.5010	53	167	173	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2001	104	5					743	753		10.1016/S0092-8674(02)07059-9	http://dx.doi.org/10.1016/S0092-8674(02)07059-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257228	Bronze			2022-12-28	WOS:000167531100014
J	Wierenga, KJJ; Hambleton, IR; Lewis, NA				Wierenga, KJJ; Hambleton, IR; Lewis, NA			Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study	LANCET			English	Article							NATURAL-HISTORY; CHILDREN; COHORT; MORTALITY; MANAGEMENT; DIAGNOSIS; LESSONS; ANEMIA; TRIAL; DEATH	Background Information about life expectancy of patients with homozygous sickle-cell disease is needed for research and patient counselling. Our aim was to study two Jamaican populations, one clinic-based and one birth cohort and, by careful consideration of data quality and statistical analysis, to identify ways to increase the chances of obtaining valid and generalisable results. Methods We investigated the survival experience of 3301 patients with homozygous sickle-cell disease attending the Jamaican sickle-cell clinic between Jan 1, 1987, and Dec 31, 1996. We applied and assessed a simulation technique for incorporating early life mortality using a birth cohort, and analysed the precision of this technique. Kaplan-Meier survival estimates are produced. Findings 290 of the 3301 patients died. Median survival calculated with the excess mortality rate simulation data was 53 years (95% CI 49.3-57.0) for men and 58.5 (55.1-67.5) for women. Interpretation Our simulation technique, with realistic assumptions based on empirical evidence, offers a new estimate of median survival for patients with homozygous sickle-cell disease. We present the precision of these survival estimates, which introduces an important level of uncertainty. The inherent biases of clinically ascertained populations of patients, and the assumptions underlying analysis techniques are crucial features of survival studies in sickle-cell disease, and can modify summary statistics substantially.	Univ W Indies, Res Inst Trop Med, Sickle Cell Unit, Kingston 7, Jamaica; Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton, Hants, England	University West Indies Mona Jamaica; University of Southampton	Wierenga, KJJ (corresponding author), Univ W Indies, Res Inst Trop Med, Sickle Cell Unit, Kingston 7, Jamaica.		Hambleton, Ian/AAP-3519-2020	Hambleton, Ian/0000-0002-5638-9794				Bowman AW, 1997, APPL SMOOTHING TECHN; BROOKMEYER R, 1987, BIOMETRICS, V43, P739, DOI 10.2307/2531529; CNAAN A, 1989, STAT MED, V8, P1255, DOI 10.1002/sim.4780081009; Corey M, 1996, PEDIATR PULM, V21, P149, DOI 10.1002/1099-0496(199603)21:3<149::AID-PPUL1950210302>3.0.CO;2-C; Efron B., 1994, MONOGRAPHS STAT APPL; EMOND AM, 1985, J PEDIATR-US, V107, P201, DOI 10.1016/S0022-3476(85)80125-6; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; Hendriks JCM, 1998, AIDS, V12, P1537, DOI 10.1097/00002030-199812000-00017; HOOVER DR, 1991, STAT MED, V10, P1993, DOI 10.1002/sim.4780101212; JOHN AB, 1984, BRIT MED J, V288, P1567, DOI 10.1136/bmj.288.6430.1567; Lee A, 1995, BRIT MED J, V311, P1600, DOI 10.1136/bmj.311.7020.1600; LEIKIN SL, 1989, PEDIATRICS, V84, P500; Magnus SA, 1999, ARCH DIS CHILD, V80, P537, DOI 10.1136/adc.80.6.537; METTERS J S, 1970, Journal of Obstetrics and Gynaecology of the British Commonwealth, V77, P935; MORGAN AG, 1981, BMJ-BRIT MED J, V282, P1181, DOI 10.1136/bmj.282.6271.1181; MORRIS J, 1991, BRIT J HAEMATOL, V77, P382, DOI 10.1111/j.1365-2141.1991.tb08588.x; *PAN AM HLTH ORG, 1994, SCI PUBL PAN AM HLTH, V549; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; POWARS D, 1989, PEDIATRICS, V83, P830; ROGERS DW, 1978, BRIT MED J, V1, P1515, DOI 10.1136/bmj.1.6126.1515; SERJEANT BE, 1974, CLIN CHEM, V20, P666; SERJEANT GR, 1981, BRIT J HAEMATOL, V48, P533, DOI 10.1111/j.1365-2141.1981.tb02750.x; SERJEANT GR, 1993, BLOOD REV, V7, P137, DOI 10.1016/0268-960X(93)90001-K; SERJEANT GR, 1986, BRIT J HAEMATOL, V64, P253, DOI 10.1111/j.1365-2141.1986.tb04117.x; SERJEANT GR, 1984, T ROY SOC TROP MED H, V78, P648, DOI 10.1016/0035-9203(84)90229-3; SERJEANT GR, 1968, BMJ-BRIT MED J, V3, P86, DOI 10.1136/bmj.3.5610.86; Serjeant GR., 1992, SICKLE CELL DIS; SIMON R, 1980, AM J EPIDEMIOL, V111, P444, DOI 10.1093/oxfordjournals.aje.a112920; Tsodikov A, 1998, STAT MED, V17, P1909, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1909::AID-SIM890>3.0.CO;2-0; VICHINSKY E, 1988, PEDIATRICS, V81, P749	31	127	133	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					680	683		10.1016/S0140-6736(00)04132-5	http://dx.doi.org/10.1016/S0140-6736(00)04132-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247552				2022-12-28	WOS:000167282400013
J	Cichowski, K; Jacks, T				Cichowski, K; Jacks, T			NF1 tumor suppressor gene function: Narrowing the GAP	CELL			English	Review							NEUROFIBROMATOSIS TYPE-1 GENE; NERVE SHEATH TUMORS; PROTEIN-KINASE-A; SCHWANN-CELLS; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; BENIGN NEUROFIBROMAS; HEMATOPOIETIC-CELLS; DROSOPHILA NF1; BONE-MARROW; MOUSE MODEL		Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Cichowski, K (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	kcichowski@rics.bwh.harvard.edu; tjacks@mit.edu						Atit RP, 1999, J INVEST DERMATOL, V112, P835, DOI 10.1046/j.1523-1747.1999.00609.x; BADER JL, 1986, ANN NY ACAD SCI, V486, P57; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; BENNINGTON JL, 1978, MAJOR PROBLEMS PATHO; Berner JM, 1999, GENE CHROMOSOME CANC, V26, P151, DOI 10.1002/(SICI)1098-2264(199910)26:2<151::AID-GCC7>3.0.CO;2-A; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; BOYER MJ, 1994, ONCOGENE, V9, P349; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; BUNGE MB, 1989, SCIENCE, V243, P229, DOI 10.1126/science.2492115; CARDESA A, 1989, CANCER-AM CANCER SOC, V63, P1737; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; COLMAN SD, 1995, NAT GENET, V11, P90, DOI 10.1038/ng0995-90; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; DeClue JE, 2000, J CLIN INVEST, V105, P1233, DOI 10.1172/JCI7610; Epstein JA, 2000, METH MOL B, V137, P459; ERIANDSON RA, 1991, ULTRASTRUCT PATHOL, V15, P335; FIALKOW PJ, 1971, NEW ENGL J MED, V284, P298, DOI 10.1056/NEJM197102112840604; Giordano MJ, 1996, J NEUROSCI RES, V43, P246; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Guha A, 1996, ONCOGENE, V12, P507; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; Gutmann DH, 1999, ONCOGENE, V18, P4450, DOI 10.1038/sj.onc.1202829; HAN JW, 1991, SCIENCE, V252, P576, DOI 10.1126/science.1902323; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HENKEMEYER M, 1995, NATURE, V377, P695, DOI 10.1038/377695a0; HIATT KK, 2000, IN PRESS J BIOL CHEM; Hughes S. M. H., 1994, NEUROFIBROMATOSES PA; Ingram DA, 2000, J EXP MED, V191, P181, DOI 10.1084/jem.191.1.181; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; JENSEN NA, 1993, P NATL ACAD SCI USA, V90, P3192, DOI 10.1073/pnas.90.8.3192; Jessen KR, 1998, MICROSC RES TECHNIQ, V41, P393, DOI 10.1002/(SICI)1097-0029(19980601)41:5<393::AID-JEMT6>3.0.CO;2-R; Kim HA, 1997, J NEUROSCI RES, V49, P236; Kim HA, 1997, MOL CELL BIOL, V17, P862, DOI 10.1128/MCB.17.2.862; Kioussi C, 1996, TRENDS GENET, V12, P84, DOI 10.1016/0168-9525(96)81411-9; Klesse LJ, 1998, J NEUROSCI, V18, P10420; Kluwe L, 1999, CANCER GENET CYTOGEN, V113, P65, DOI 10.1016/S0165-4608(99)00006-0; Kluwe L, 1999, GENE CHROMOSOME CANC, V24, P283, DOI 10.1002/(SICI)1098-2264(199903)24:3<283::AID-GCC15>3.0.CO;2-K; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kourea HP, 1999, AM J PATHOL, V155, P1855, DOI 10.1016/S0002-9440(10)65504-6; Lakkis MM, 1998, DEVELOPMENT, V125, P4359; Lau N, 2000, J NEUROPATH EXP NEUR, V59, P759, DOI 10.1093/jnen/59.9.759; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; LUONGO C, 1994, CANCER RES, V54, P5947; Mahgoub N, 1999, BLOOD, V94, P2469, DOI 10.1182/blood.V94.7.2469.419a01_2469_2476; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Mazarakis ND, 1996, GENES CELLS, V1, P125; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; Mulligan G, 1998, TRENDS GENET, V14, P223, DOI 10.1016/S0168-9525(98)01470-X; Nielsen GP, 1999, AM J PATHOL, V155, P1879, DOI 10.1016/S0002-9440(10)65507-1; NORDLUND ML, 1995, J NEUROPATH EXP NEUR, V54, P588, DOI 10.1097/00005072-199507000-00013; PELTONEN J, 1988, LAB INVEST, V59, P760; Rasmussen SA, 2000, GENE CHROMOSOME CANC, V28, P425, DOI 10.1002/1098-2264(200008)28:4<425::AID-GCC8>3.0.CO;2-E; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; ROSENBAUM T, 1995, DEVELOPMENT, V121, P3583; Sawada S, 1996, NAT GENET, V14, P110, DOI 10.1038/ng0996-110; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Serra E, 1997, AM J HUM GENET, V61, P512, DOI 10.1086/515504; Serra E, 2000, HUM MOL GENET, V9, P3055, DOI 10.1093/hmg/9.20.3055; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; SHEELA S, 1990, J CELL BIOL, V111, P645, DOI 10.1083/jcb.111.2.645; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; SKUSE GR, 1991, AM J HUM GENET, V49, P600; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; Upadhyaya MCDN, 1998, NEUROFIBROMATOSIS TY; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; VOGEL KS, 1995, CELL, V82, P733, DOI 10.1016/0092-8674(95)90470-0; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; WOODRUFF JM, 1996, SOFT TISSUE TUMORS I; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; XU W, 1992, GENE CHROMOSOME CANC, V4, P337, DOI 10.1002/gcc.2870040411	83	435	457	3	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2001	104	4					593	604		10.1016/S0092-8674(01)00245-8	http://dx.doi.org/10.1016/S0092-8674(01)00245-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	405VP	11239415	Bronze			2022-12-28	WOS:000167181500013
J	Li, YJ; Oslonovitch, J; Mazouz, N; Plenge, F; Krischer, K; Ertl, G				Li, YJ; Oslonovitch, J; Mazouz, N; Plenge, F; Krischer, K; Ertl, G			Turing-type patterns on electrode surfaces	SCIENCE			English	Article							ELECTROCHEMICAL SYSTEMS; MONOLAYERS	We report stationary, nonequilibrium potential and adsorbate patterns with an intrinsic wavelength that were observed in an electrochemical system with a specific type of current/electrode-potential (I-phi (DL)) characteristic. The patterns emerge owing to the interplay of a self-enhancing step in the reaction dynamics and a long-range inhibition by migration currents rather than by diffusion. Theoretical analysis revealed that this self-structuring of the electrode occurs in all electrochemical systems with an S-shaped I-phi (DL) characteristic in wide and well-accessible parameter ranges. This unusual pattern-forming instability in electrochemical systems has all the characteristics of the mechanism proposed by Turing in 1952 in the framework of an early theory of morphogenesis, Our finding might account for structure formation in certain biological systems that have gradients in the electric potential and may open new paths for fabricating patterned electrodes.	Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany	Max Planck Society; Fritz Haber Institute of the Max Planck Society	Krischer, K (corresponding author), Max Planck Gesell, Fritz Haber Inst, Faradayweg 4-6, D-14195 Berlin, Germany.		Krischer, Katharina/J-4731-2016					Bizzotto D, 1998, LANGMUIR, V14, P6269, DOI 10.1021/la980314o; Bizzotto D, 2000, J ELECTROANAL CHEM, V480, P233, DOI 10.1016/S0022-0728(99)00465-9; BUESSHERMAN C, 1994, PROG SURF SCI, V46, P335, DOI 10.1016/0079-6816(94)90015-9; CASTETS V, 1990, PHYS REV LETT, V64, P2953, DOI 10.1103/PhysRevLett.64.2953; EPSTEIN IR, 1992, PHYSICA A, V188, P26, DOI 10.1016/0378-4371(92)90249-P; FLATGEN G, 1995, SCIENCE, V269, P668, DOI 10.1126/science.269.5224.668; Hildebrand M, 1998, PHYS REV E, V58, P5483, DOI 10.1103/PhysRevE.58.5483; HUBERMAN BA, 1976, J CHEM PHYS, V65, P2013, DOI 10.1063/1.433272; Kapral R., 1995, CHEM WAVES PATTERNS; LENGYEL I, 1992, P NATL ACAD SCI USA, V89, P3977, DOI 10.1073/pnas.89.9.3977; Mazouz N, 1997, PHYS REV E, V55, P2260, DOI 10.1103/PhysRevE.55.2260; Mazouz N, 2000, J PHYS CHEM B, V104, P6081, DOI 10.1021/jp000203+; MIKHAILOV A, 1995, CHEM PHYS LETT, V238, P104, DOI 10.1016/0009-2614(95)00386-X; Murray J.D., 1990, MATH BIOL; Nicolis G., 1995, INTRO NONLINEAR SCI; OUYANG Q, 1991, NATURE, V352, P610, DOI 10.1038/352610a0; ROSS J, 1995, J PHYS CHEM-US, V99, P10417, DOI 10.1021/j100025a051; Rueda M, 1999, LANGMUIR, V15, P3672, DOI 10.1021/la981557j; STRIEGLER H, 1998, THESIS U ULM GERMANY; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; VERDASCA J, 1995, PHYS REV E, V52, pR4616, DOI 10.1103/PhysRevE.52.R4616	21	100	101	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2395	2398		10.1126/science.1057830	http://dx.doi.org/10.1126/science.1057830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264532				2022-12-28	WOS:000167618700051
J	Volkman, BF; Lipson, D; Wemmer, DE; Kern, D				Volkman, BF; Lipson, D; Wemmer, DE; Kern, D			Two-state allosteric behavior in a single-domain signaling protein	SCIENCE			English	Article							ENHANCER-BINDING PROTEIN; MODEL-FREE APPROACH; BACTERIAL CHEMOTAXIS; CHEMICAL-EXCHANGE; TIME-SCALE; RELAXATION; DYNAMICS; NTRC; NMR; CALMODULIN	Protein actions are usually discussed in terms of static structures, but function requires motion. We find a strong correlation between phosphorylation-driven activation of the signaling protein NtrC and microsecond time-scale backbone dynamics. Using nuclear magnetic resonance relaxation, we characterized the motions of NtrC in three functional states: unphosphorylated (inactive), phosphorylated (active), and a partially active mutant. These dynamics are indicative of exchange between inactive and active conformations. Both states are populated in unphosphorylated NtrC, and phosphorylation shifts the equilibrium toward the active species. These results support a dynamic population shift between two preexisting conformations as the underlying mechanism of activation.	Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; Univ Wisconsin, Dept Biochem, NMRFAM, Madison, WI 53706 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Brandeis University; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Volkman, BF (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.		Volkman, Brian F./ABE-7306-2020; Volkman, Brian F./ABE-7312-2020	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062117] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62117] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARAK R, 1992, BIOCHEMISTRY-US, V31, P1821, DOI 10.1021/bi00121a034; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Dill KA, 1999, PROTEIN SCI, V8, P1166, DOI 10.1110/ps.8.6.1166; Djordjevic S, 1998, J STRUCT BIOL, V124, P189, DOI 10.1006/jsbi.1998.4034; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Feher VA, 1999, NATURE, V400, P289, DOI 10.1038/22357; FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451; Ishima R, 1999, J BIOMOL NMR, V14, P369, DOI 10.1023/A:1008324025406; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Kumar S, 2000, PROTEIN SCI, V9, P10; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Malmendal A, 1999, J MOL BIOL, V293, P883, DOI 10.1006/jmbi.1999.3188; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Millet O, 2000, J AM CHEM SOC, V122, P2867, DOI 10.1021/ja993511y; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MOY FJ, 1994, BIOCHEMISTRY-US, V33, P10731, DOI 10.1021/bi00201a022; Nohaile M, 1997, J MOL BIOL, V273, P299, DOI 10.1006/jmbi.1997.1296; North AK, 1997, J MOL BIOL, V267, P17, DOI 10.1006/jmbi.1996.0838; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; Rombel I, 1998, COLD SPRING HARB SYM, V63, P157, DOI 10.1101/sqb.1998.63.157; SCHULAK JA, 1994, CLIN TRANSPLANT, V8, P211; Silversmith RE, 1999, TRENDS MICROBIOL, V7, P16, DOI 10.1016/S0966-842X(98)01409-7; Stock J.B., 1995, 2 COMPONENT SIGNAL T, P25; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; VOLZ K, 1993, BIOCHEMISTRY-US, V32, P11741, DOI 10.1021/bi00095a001; Wyman C, 1997, SCIENCE, V275, P1658, DOI 10.1126/science.275.5306.1658	29	523	526	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2429	2433		10.1126/science.291.5512.2429	http://dx.doi.org/10.1126/science.291.5512.2429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264542				2022-12-28	WOS:000167618700061
J	Gonzales, R; Bartlett, JC; Besser, RE; Hickner, JM; Hoffman, JR; Sande, MA				Gonzales, R; Bartlett, JC; Besser, RE; Hickner, JM; Hoffman, JR; Sande, MA			Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: Background	ANNALS OF INTERNAL MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; GENERAL-PRACTICE; DOUBLE-BLIND; COMMON-COLD; PURULENT SPUTUM; ILLNESSES; PHYSICIANS; COUGH	The following principles of appropriate antibiotic use for adults with nonspecific upper respiratory tract infections apply to immunocompetent adults without complicating comorbid conditions, such as chronic lung or heart disease. 1. The diagnosis of nonspecific upper respiratory tract infection or acute rhinopharyngitis should be used to denote an acute infection that is typically viral in origin and in which sinus, pharyngeal, and lower airway symptoms, although frequently present are not prominent 2. Antibiotic treatment of adults with nonspecific upper respiratory tract infection does not enhance illness resolution and is not recommended. Studies specifically testing the impact of antibiotic treatment on complications of nonspecific upper respiratory tract infections have not been performed in adults. Life-threatening complications of upper respiratory tract infection are rare. 3. Purulent secretions from the nares or throat (commonly observed in patients with uncomplicated upper respiratory tract infection) predict neither bacterial infection nor benefit from antibiotic treatment.	Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Johns Hopkins Univ, Baltimore, MD USA; Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Michigan State Univ, E Lansing, MI 48824 USA; Univ Utah, Salt Lake City, UT USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Johns Hopkins University; Centers for Disease Control & Prevention - USA; University of California System; University of California Los Angeles; Michigan State University; Utah System of Higher Education; University of Utah	Besser, RE (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, C-23,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	rbesser@cdc.gov						ARROLL B, 2000, COCHRANE DATABASE SY; CRONK GA, 1954, AM J MED, V16, P804, DOI 10.1016/0002-9343(54)90444-1; EVANS AS, 1967, MED CLIN N AM, V51, P803, DOI 10.1016/S0025-7125(16)33048-6; EVANS AS, 1957, NEW ENGL J MED, V256, P377, DOI 10.1056/NEJM195702282560901; GADOMSKI AM, 1993, PEDIATR INFECT DIS J, V12, P115, DOI 10.1097/00006454-199302000-00002; Gonzales R, 2001, ANN INTERN MED, V134, P479, DOI 10.7326/0003-4819-134-6-200103200-00013; Gonzales R, 1999, J GEN INTERN MED, V14, P151, DOI 10.1046/j.1525-1497.1999.00306.x; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; Gwaltney J M Jr, 1999, Can Respir J, V6 Suppl A, p46A; GWALTNEY JM, 1994, NEW ENGL J MED, V330, P25, DOI 10.1056/NEJM199401063300105; HEALD A, 1993, J GEN INTERN MED, V8, P667, DOI 10.1007/BF02598283; HEIKKINEN T, 1995, J PEDIATR-US, V126, P313, DOI 10.1016/S0022-3476(95)70569-4; HICKNER JM, 2001, ANN NTERN MED, V134, P489; HOAGLAND RJ, 1950, NEW ENGL J MED, V243, P773, DOI 10.1056/NEJM195011162432003; HOPESIMPSON RE, 1973, POSTGRAD MED J, V49, P763, DOI 10.1136/pgmj.49.577.763; HOWIE JGR, 1970, LANCET, V2, P1099; Kaiser L, 1996, LANCET, V347, P1507, DOI 10.1016/S0140-6736(96)90670-4; KAPIKIAN AZ, 1964, AM REV RESPIR DIS, V90, P175; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Mainous AG, 1997, LANCET, V350, P1077, DOI 10.1016/S0140-6736(05)70457-8; MARSHALL I, 2000, COCHRANE DATABASE SY; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; MELCHART D, 2000, COCHRANE DATABASE SY; MOGABGAB WJ, 1963, ANN INTERN MED, V59, P306, DOI 10.7326/0003-4819-59-3-306; POOLE PM, 1973, POSTGRAD MED J, V49, P778, DOI 10.1136/pgmj.49.577.778; Prasad AS, 2000, ANN INTERN MED, V133, P245, DOI 10.7326/0003-4819-133-4-200008150-00006; ROBERTSON AJ, 1952, LANCET, V262, P12; SCHAPPERT SM, 1999, VITAL HLTH STAT S 13, V143; SINGH M, 2000, COCHRANE DATABASE SY; STOTT NCH, 1976, BRIT MED J, V2, P556, DOI 10.1136/bmj.2.6035.556; TAVERNER D, 2000, COCHRANE DATABASE SY; VERHEIJ TJM, 1994, BRIT J GEN PRACT, V44, P400; WALSH BT, 1975, ARCH INTERN MED, V135, P1493, DOI 10.1001/archinte.135.11.1493; 1970, AM REV RESP DIS, V101, P119	34	89	99	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					490	494		10.7326/0003-4819-134-6-200103200-00015	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00015			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409VF	11255526				2022-12-28	WOS:000167405800009
J	Freedberg, KA; Losina, E; Weinstein, MC; Paltiel, AD; Cohen, CJ; Seage, GR; Craven, DE; Zhang, H; Kimmel, AD; Goldie, SJ				Freedberg, KA; Losina, E; Weinstein, MC; Paltiel, AD; Cohen, CJ; Seage, GR; Craven, DE; Zhang, H; Kimmel, AD; Goldie, SJ			The cost effectiveness of combination antiretroviral therapy for HIV disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PNEUMOCYSTIS-CARINII PNEUMONIA; IMMUNODEFICIENCY-VIRUS INFECTION; MYCOBACTERIUM-AVIUM COMPLEX; PLUS INDINAVIR; PROPHYLAXIS; ZIDOVUDINE; ADULTS; TRIAL; PREVENTION; LAMIVUDINE	Background: Combination antiretroviral therapy with a combination of three or more drugs has become the standard of care for patients with human immunodeficiency virus (HIV) infection in the United States. We estimated the clinical benefits and cost effectiveness of three-drug antiretroviral regimens. Methods: We developed a mathematical simulation model of HIV disease, using the CD4 cell count and HIV RNA level as predictors of the progression of disease. Outcome measures included life expectancy, life expectancy adjusted for the quality of life, lifetime direct medical costs, and cost effectiveness in dollars per quality-adjusted year of life gained. Clinical data were derived from major clinical trials, including the AIDS Clinical Trials Group 320 Study. Data on costs were based on the national AIDS Cost and Services Utilization Survey, with drug costs obtained from the Red Book. Results: For patients similar to those in the AIDS Clinical Trials Group 320 Study (mean CD4 cell count, 87 per cubic millimeter), life expectancy adjusted for the quality of life increased from 1.53 to 2.91 years, and per-person lifetime costs increased from $45,460 to $77,300 with three-drug therapy as compared with no therapy. The incremental cost per quality-adjusted year of life gained, as compared with no therapy, was $23,000. On the basis of additional data from other major studies, the cost-effectiveness ratio for three-drug therapy ranged from $13,000 to $23,000 per quality-adjusted year of life gained. The initial CD4 cell count and drug costs were the most important determinants of costs, clinical benefits, and cost effectiveness. Conclusions: Treatment of HIV infection with a combination of three antiretroviral drugs is a cost-effective use of resources. (N Engl J Med 2001;344:824-31.) Copyright (C) 2001 Massachusetts Medical Society.	Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, Boston, MA 02115 USA; Community Res Initiat New England, Boston, MA USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Boston Med Ctr, Dept Med, Boston, MA USA; Boston Univ, Sch Med, Boston, MA 02118 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Yale University; Boston Medical Center; Boston University	Freedberg, KA (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, 50 Staniford St,9th Fl, Boston, MA 02114 USA.			Losina, ELENA/0000-0002-3424-0892; Paltiel, A. David/0000-0002-4861-3290	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042006, R01AI058736] Funding Source: NIH RePORTER; NIAID NIH HHS [UO1 AI.8838, R01-AI42006, R01 AI042006] Funding Source: Medline; PHS HHS [U64/CCU 114927] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baxter JD, 2000, AIDS, V14, pF83, DOI 10.1097/00002030-200006160-00001; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; *BUR CENS, 1998, 1998 STAT ABSTR US; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Cook J, 1999, AIDS RES HUM RETROV, V15, P499, DOI 10.1089/088922299311024; Department of Health and Human Services, 2000, HIV CLIN TRIALS, V1, P60, DOI DOI 10.1310/HCT.2000.1.1.008; DOYLE A, 1999, NATL ADAP MONITORING; El-Sadr WM, 1999, CLIN INFECT DIS, V29, P775, DOI 10.1086/520433; Feinberg J, 1999, LANCET, V353, P1287, DOI 10.1016/S0140-6736(99)00123-3; FINKLER SA, 1982, ANN INTERN MED, V96, P102, DOI 10.7326/0003-4819-96-1-102; Freedberg KA, 1998, JAMA-J AM MED ASSOC, V279, P130, DOI 10.1001/jama.279.2.130; Freedberg KA, 1999, JAMA-J AM MED ASSOC, V281, P1989; Furrer H, 1999, NEW ENGL J MED, V340, P1301, DOI 10.1056/NEJM199904293401701; Gable CB, 1996, J ACQ IMMUN DEF SYND, V12, P413, DOI 10.1097/00042560-199608010-00013; Gold MR, 1996, COST EFFECTIVENESS H; GOLDMAN L, 1991, JAMA-J AM MED ASSOC, V265, P1145, DOI 10.1001/jama.265.9.1145; Gulick RM, 2000, ANN INTERN MED, V133, P35, DOI 10.7326/0003-4819-133-1-200007040-00007; Gulick RM, 1998, JAMA-J AM MED ASSOC, V280, P35, DOI 10.1001/jama.280.1.35; Hamel MB, 1997, ANN INTERN MED, V127, P195, DOI 10.7326/0003-4819-127-3-199708010-00003; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Havlir DV, 1996, NEW ENGL J MED, V335, P392, DOI 10.1056/NEJM199608083350604; Hayman JA, 1998, J CLIN ONCOL, V16, P1022, DOI 10.1200/JCO.1998.16.3.1022; Hellinger FJ, 2000, J ACQ IMMUN DEF SYND, V24, P182; Holtgrave DR, 1997, J ACQ IMMUN DEF SYND, V16, P54, DOI 10.1097/00042560-199709010-00009; HOLTGRAVE DR, 1995, MED DECIS MAKING, V15, P311, DOI 10.1177/0272989X9501500402; Keiser P, 1999, J ACQ IMMUN DEF SYND, V20, P28, DOI 10.1097/00042560-199901010-00004; LUBINSKI C, 1997, EXPANDING ELIGIBILIT; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; *MED EC, 1998, DRUG TOP RED BOOK; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; Moore RD, 2000, PHARMACOECONOMICS, V17, P325, DOI 10.2165/00019053-200017040-00002; Moore RD, 1996, PHARMACOECONOMICS, V10, P109, DOI 10.2165/00019053-199610020-00002; *NAT TECHN INF SER, 1994, AIDS COST SERV UT SU; *NAT TECHN INF SER, 1995, MULT AIDS COH STUD M; NIGHTINGALE SD, 1993, NEW ENGL J MED, V329, P828, DOI 10.1056/NEJM199309163291202; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; RUANE PJ, 1997, 4 C RET OPP INF WASH, P466; Schneider MME, 1999, LANCET, V353, P201, DOI 10.1016/S0140-6736(98)07204-3; Sendi PP, 1999, AIDS, V13, P1115, DOI 10.1097/00002030-199906180-00016; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Torres RA, 1997, NEW ENGL J MED, V336, P1531, DOI 10.1056/NEJM199705223362118; US Public Health Service and Infectious Diseases Society of America, 1999, MMWR-MORBID MORTAL W, V48, P1; Wright JC, 1998, NEW ENGL J MED, V339, P380, DOI 10.1056/NEJM199808063390606; [No title captured]	47	379	387	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2001	344	11					824	831		10.1056/NEJM200103153441108	http://dx.doi.org/10.1056/NEJM200103153441108			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410LA	11248160	Bronze			2022-12-28	WOS:000167440400008
J	Samatey, FA; Imada, K; Nagashima, S; Vonderviszt, F; Kumasaka, T; Yamamoto, M; Namba, K				Samatey, FA; Imada, K; Nagashima, S; Vonderviszt, F; Kumasaka, T; Yamamoto, M; Namba, K			Structure of the bacterial flagellar protofilament and implications for a switch for supercoiling	NATURE			English	Article							FILAMENT STRUCTURE; ANGSTROM RESOLUTION; TERMINAL REGIONS; SALMONELLA; PROTEIN; ROTATION; DOMAIN	The bacterial flagellar filament is a helical propeller constructed from 11 protofilaments of a single protein, flagellin. The filament switches between left- and right-handed supercoiled forms when bacteria switch their swimming mode between running and tumbling. Supercoiling is produced by two different packing interactions of flagellin called L and R. In switching from L to R, the intersubunit distance (similar to 52 Angstrom) along the protofilament decreases by 0.8 Angstrom. Changes in the number of L and R protofilaments govern supercoiling of the filament. Here we report the 2.0 Angstrom resolution crystal structure of a Salmonella flagellin fragment of relative molecular mass 41,300. The crystal contains pairs of antiparallel straight protofilaments with the R-type repeat. By simulated extension of the protofilament model, we have identified possible switch regions responsible for the bi-stable mechanical switch that generates the 0.8 Angstrom difference in repeat distance.	JST, ERATO, Proton NanoMachine Project, Kyoto 6190237, Japan; Univ Veszprem, Dept Phys, H-8201 Veszprem, Hungary; RIKEN, Harima Inst, Mikazuki, Hyogo 6795198, Japan; Matsushita Elect Ind Co Ltd, Adv Technol Res Labs, Kyoto 6190237, Japan	Japan Science & Technology Agency (JST); University of Pannonia; RIKEN; Panasonic	Namba, K (corresponding author), JST, ERATO, Proton NanoMachine Project, 3-4 Hikaridai, Kyoto 6190237, Japan.	keiichi@crl.mei.co.jp	Samatey, Fadel/A-3204-2012; Yamamoto, Masaki/B-7844-2015; Vonderviszt, Ferenc/GLR-5618-2022; Kumasaka, Takashi/D-7428-2018	Yamamoto, Masaki/0000-0002-1311-1768; Vonderviszt, Ferenc/0000-0002-6498-8172; Kumasaka, Takashi/0000-0001-9289-1557; Imada, Katsumi/0000-0003-1342-8885; Samatey, Fadel/0000-0002-0733-2863				Asakura S, 1970, Adv Biophys, V1, P99; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CALLADINE CR, 1976, J THEOR BIOL, V57, P469, DOI 10.1016/0022-5193(76)90016-3; CALLADINE CR, 1978, J MOL BIOL, V118, P457, DOI 10.1016/0022-2836(78)90285-1; CALLADINE CR, 1975, NATURE, V255, P121, DOI 10.1038/255121a0; Corpet F, 1998, NUCLEIC ACIDS RES, V26, P323, DOI 10.1093/nar/26.1.323; Honda S, 1999, J MOL BIOL, V293, P719, DOI 10.1006/jmbi.1999.3175; HOTANI H, 1982, J MOL BIOL, V156, P791, DOI 10.1016/0022-2836(82)90142-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAMIYA R, 1980, NATURE, V286, P628, DOI 10.1038/286628a0; KAMIYA R, 1976, J MOL BIOL, V106, P167, DOI 10.1016/0022-2836(76)90306-5; KAMIYA R, 1976, J MOL BIOL, V108, P513, DOI 10.1016/S0022-2836(76)80133-7; KAMIYA R, 1979, J MOL BIOL, V131, P725, DOI 10.1016/0022-2836(79)90199-2; KANTO S, 1991, J MOL BIOL, V219, P471, DOI 10.1016/0022-2836(91)90187-B; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUDO S, 1990, NATURE, V346, P677, DOI 10.1038/346677a0; LARSEN SH, 1974, NATURE, V249, P74, DOI 10.1038/249074a0; Leslie AGW, 1992, JNT CCP4 ESF EACMB N, V26; MACNAB RM, 1977, J MOL BIOL, V112, P1, DOI 10.1016/S0022-2836(77)80153-8; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MIMORI Y, 1995, J MOL BIOL, V249, P69, DOI 10.1006/jmbi.1995.0281; Mimori-Kiyosue Y, 1998, J MOL BIOL, V284, P521, DOI 10.1006/jmbi.1998.2184; MimoriKiyosue Y, 1997, J MOL BIOL, V270, P222, DOI 10.1006/jmbi.1997.1111; MimoriKiyosue Y, 1996, P NATL ACAD SCI USA, V93, P15108, DOI 10.1073/pnas.93.26.15108; MORGAN DG, 1995, J MOL BIOL, V249, P88, DOI 10.1006/jmbi.1995.0282; NAMBA K, 1989, NATURE, V342, P648, DOI 10.1038/342648a0; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; OBRIEN EJ, 1972, J MOL BIOL, V70, P133, DOI 10.1016/0022-2836(72)90168-4; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Ryu WS, 2000, NATURE, V403, P444, DOI 10.1038/35000233; Samatey FA, 2000, J STRUCT BIOL, V132, P106, DOI 10.1006/jsbi.2000.4312; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; SILVERMAN M, 1974, NATURE, V249, P73, DOI 10.1038/249073a0; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Ueki T, 1999, STRUCT FOLD DES, V7, pR183, DOI 10.1016/S0969-2126(99)80113-0; VONDERVISZT F, 1991, J MOL BIOL, V221, P1461, DOI 10.1016/0022-2836(91)90946-4; VONDERVISZT F, 1990, J MOL BIOL, V214, P97, DOI 10.1016/0022-2836(90)90149-G; Yamamoto M, 1998, J SYNCHROTRON RADIAT, V5, P222, DOI 10.1107/S0909049597014738; YAMASHITA I, 1995, J MOL BIOL, V253, P547, DOI 10.1006/jmbi.1995.0572; Yamashita I, 1998, NAT STRUCT BIOL, V5, P125; Yonekura K, 2000, SCIENCE, V290, P2148, DOI 10.1126/science.290.5499.2148; YOSHIOKA K, 1995, J BACTERIOL, V177, P1090, DOI 10.1128/jb.177.4.1090-1093.1995	46	369	395	3	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2001	410	6826					331	337		10.1038/35066504	http://dx.doi.org/10.1038/35066504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268201				2022-12-28	WOS:000167464100039
J	Sato, NK; Aso, N; Miyake, K; Shiina, R; Thalmeier, P; Varelogiannis, G; Geibel, C; Steglich, F; Fulde, P; Komatsubara, T				Sato, NK; Aso, N; Miyake, K; Shiina, R; Thalmeier, P; Varelogiannis, G; Geibel, C; Steglich, F; Fulde, P; Komatsubara, T			Strong coupling between local moments and superconducting 'heavy' electrons in UPd2Al3	NATURE			English	Article							FERMION SUPERCONDUCTIVITY; NEUTRON-SCATTERING; SPIN FLUCTUATIONS; T-C; COEXISTENCE; EXCITATIONS; MAGNETISM	The electronic structure of heavy-fermion compounds arises from the interaction of nearly localized 4f- or 5f-shell electrons (with atomic magnetic moments) with the free-electron-like itinerant conduction-band electrons. In actinide or rare-earth heavy-fermion materials, this interaction yields itinerant electrons having an effective mass about 100 times (or more) the bare electron mass. Moreover, the itinerant electrons in UPd2Al3 are found to be superconducting well below the magnetic ordering temperature(1,2) of this compound, whereas magnetism generally suppresses superconductivity in conventional metals. Here we report the detection of a dispersive excitation of the ordered f-electron moments, which shows a strong interaction with the heavy superconducting electrons. This 'magnetic exciton' is a localized excitation which moves through the lattice as a result of exchange forces between the magnetic moments. By combining this observation with previous tunnelling measurements on this material(3), we argue that these magnetic excitons may produce effective interactions between the itinerant electrons, and so be responsible for superconductivity in a manner analogous to the role played by phonons in conventional superconductors.	Nagoya Univ, Grad Sch Sci, Dept Phys, Nagoya, Aichi 4648602, Japan; Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany; Univ Tokyo, Inst Solid State Phys, Neutron Scattering Lab, Tokai, Ibaraki 3191106, Japan; Osaka Univ, Grad Sch Engn Sci, Dept Phys Sci, Toyonaka, Osaka 5608531, Japan; Max Planck Inst Phys Complex Syst, D-01187 Dresden, Germany; Fdn Res & Technol Hellas, Inst Elect Struct & Laser, Iraklion 71110, Greece; Tohoku Univ, Grad Sch Sci, Dept Phys, Sendai, Miyagi 9808578, Japan	Nagoya University; Max Planck Society; University of Tokyo; Osaka University; Max Planck Society; Foundation for Research & Technology - Hellas (FORTH); Tohoku University	Sato, NK (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Phys, Nagoya, Aichi 4648602, Japan.	kensho@edu3.phys.nagoya-u.ac.jp						Bernhoeft N, 2000, EUR PHYS J B, V13, P685, DOI 10.1007/s100510050086; Bernhoeft N, 1998, PHYS REV LETT, V81, P4244, DOI 10.1103/PhysRevLett.81.4244; BUYERS WJL, 1985, HDB PHYSICS CHEM ACT, V2, P239; CASPARY R, 1993, PHYS REV LETT, V71, P2146, DOI 10.1103/PhysRevLett.71.2146; Demler E, 1998, PHYS REV B, V58, P5719, DOI 10.1103/PhysRevB.58.5719; FEYERHERM R, 1994, PHYS REV LETT, V73, P1849, DOI 10.1103/PhysRevLett.73.1849; FONG HF, 1995, PHYS REV LETT, V75, P316, DOI 10.1103/PhysRevLett.75.316; GEIBEL C, 1991, Z PHYS B CON MAT, V84, P1, DOI 10.1007/BF01453750; GRAUEL A, 1992, PHYS REV B, V46, P5818, DOI 10.1103/PhysRevB.46.5818; Hayden S, 1999, PHYS WORLD, V12, P18; Jourdan M, 1999, NATURE, V398, P47, DOI 10.1038/17977; Knopfle K, 1996, J PHYS-CONDENS MAT, V8, P901, DOI 10.1088/0953-8984/8/7/014; Krimmel A, 1996, J PHYS-CONDENS MAT, V8, P1677, DOI 10.1088/0953-8984/8/11/012; KYOUGAKU M, 1993, J PHYS SOC JPN, V62, P4016; Mason TE, 1997, KONG DANSK VIDENSK, V45, P231; Metoki N, 1998, PHYS REV LETT, V80, P5417, DOI 10.1103/PhysRevLett.80.5417; SATO H, 1981, INT J BIOL MACROMOL, V3, P66, DOI 10.1016/0141-8130(81)90069-6; Sato N, 1997, J PHYS SOC JPN, V66, P1884, DOI 10.1143/JPSJ.66.1884; Sato N, 1998, J ALLOY COMPD, V271, P433, DOI 10.1016/S0925-8388(98)00105-4; Schenck A, 2000, EUR PHYS J B, V13, P245, DOI 10.1007/s100510050029; Takahashi T, 1996, J PHYS SOC JPN, V65, P156, DOI 10.1143/JPSJ.65.156; Varelogiannis G, 1997, Z PHYS B CON MAT, V104, P411, DOI 10.1007/s002570050469; Yaouanc A, 1998, PHYS REV B, V58, P8793, DOI 10.1103/PhysRevB.58.8793; Yotsuhashi S, 2001, J PHYS SOC JPN, V70, P186, DOI 10.1143/JPSJ.70.186; [No title captured]	25	271	273	3	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2001	410	6826					340	343		10.1038/35066519	http://dx.doi.org/10.1038/35066519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268203				2022-12-28	WOS:000167464100041
J	Wulf, G; Pool, S				Wulf, G; Pool, S			Waldenstrom's macroglobulinemia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Wulf, G (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.								0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2001	344	11					816	816		10.1056/NEJM200103153441106	http://dx.doi.org/10.1056/NEJM200103153441106			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410LA	11248158				2022-12-28	WOS:000167440400006
J	Imhof, A; Froehlich, M; Brenner, H; Boeing, H; Pepys, MB; Koenig, W				Imhof, A; Froehlich, M; Brenner, H; Boeing, H; Pepys, MB; Koenig, W			Effect of alcohol consumption on systemic markers of inflammation	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; ALL-CAUSE MORTALITY; ACUTE-PHASE RESPONSE; MYOCARDIAL-INFARCTION; RISK; ASSOCIATION; POPULATION; MEN; INTERLEUKIN-6	Background Epidemiological studies suggest that light to moderate alcohol intake is associated with lower all-cause mortality than abstention or heavy alcohol intake, primarily through reduced risk of coronary heart disease. The underlying mechanisms are incompletely understood. Methods We investigated the association between alcohol consumption (assessed by a 7-day food record) and concentrations of C-reactive protein ICRP), alpha1-globulins, alpha2-globulins, albumin, and transferrin, and leucocyte count in a sample of 2006 men and women aged 18-88 years participating in a national health survey carried out in former West Germany in 1987-88, Analyses were based on 781 men and 995 women with complete data. Findings Among men, alcohol consumption showed a U-shaped association with mean values of CRP (p for linear term 0.65, for quadratic term 0.048), alpha1-globulins (p=0.20, 0.0006). alpha2-globulins (p=0.82, 0.31), and leucocyte count (p=0.51, 0.26) even after adjustment for age, smoking, body-mass index, HDL and LDL cholesterol, history of hypertension, education, and income. There were inverted U-shaped associations between the negative acute-phase reactants albumin (p=0.41, 0.006) and transferrin (p=0.14, 0.28) and alcohol intake. In women, the associations were less strong for CRP (p=0.35, 0.31), leucocyte count (p=0.28, 0.15), and transferrin (p=0.86, 0.83). Concentrations of alpha1-globulins and alpha2-globulins were inversely related to alcohol consumption, and albumin showed a positive association with increasing alcohol intake in women. Interpretation Non-drinkers and heavy drinkers had higher CRP concentrations than moderate drinkers. In view of the robust association between markers of inflammation, especially CRP, and risk of coronary heart disease, an antiinflammatory action of alcohol could contribute to the link between moderate consumption and lower cardiovascular mortality.	Univ Ulm, Abt Innere Med Kardiol 2, Med Ctr, D-89081 Ulm, Germany; German Ctr Res Aging, Dept Epidemiol, Heidelberg, Germany; Univ Ulm, Dept Epidemiol, D-89081 Ulm, Germany; German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany; UCL Royal Free & Univ Coll Med Sch, Dept Med, London, England	Ulm University; Ulm University; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of London; University College London; UCL Medical School	Koenig, W (corresponding author), Univ Ulm, Abt Innere Med Kardiol 2, Med Ctr, Robert Koch Str 8, D-89081 Ulm, Germany.	wolfgang.koenig@medizin.uni-ulm.de	Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572				BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Boyle JJ, 1997, J PATHOL, V181, P93, DOI 10.1002/(SICI)1096-9896(199701)181:1<93::AID-PATH696>3.0.CO;2-H; Brenner H, 1997, INT J EPIDEMIOL, V26, P85, DOI 10.1093/ije/26.1.85; CASTELL JV, 1990, HEPATOLOGY, V12, P1179, DOI 10.1002/hep.1840120517; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DOLL R, 1994, BRIT MED J, V309, P911, DOI 10.1136/bmj.309.6959.911; Fuchs CS, 1997, NEW ENGL J MED, V336, P523; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; Gaziano JM, 2000, J AM COLL CARDIOL, V35, P96, DOI 10.1016/S0735-1097(99)00531-8; HESEKER H, 1994, EUR J CLIN NUTR, V48, P18; Hutchinson WL, 2000, CLIN CHEM, V46, P934; JACKSON R, 1991, BRIT MED J, V303, P211, DOI 10.1136/bmj.303.6796.211; Keil U, 1997, EPIDEMIOLOGY, V8, P150, DOI 10.1097/00001648-199703000-00005; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; MACLURE M, 1993, EPIDEMIOL REV, V15, P328, DOI 10.1093/oxfordjournals.epirev.a036124; McCarty MF, 1999, MED HYPOTHESES, V52, P465, DOI 10.1054/mehy.1997.0684; McClain CJ, 1999, SEMIN LIVER DIS, V19, P205, DOI 10.1055/s-2007-1007110; McElduff P, 1997, BRIT MED J, V314, P1159, DOI 10.1136/bmj.314.7088.1159; Mennen LI, 1999, ARTERIOSCL THROM VAS, V19, P887, DOI 10.1161/01.ATV.19.4.887; Muntwyler J, 1998, LANCET, V352, P1882, DOI 10.1016/S0140-6736(98)06351-X; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Romelsjo A, 1999, BRIT MED J, V319, P821, DOI 10.1136/bmj.319.7213.821; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shaper AG, 2000, HEART, V83, P394, DOI 10.1136/heart.83.4.394; SHAPER AG, 1988, LANCET, V2, P1267; White IR, 1999, J CLIN EPIDEMIOL, V52, P967, DOI 10.1016/S0895-4356(99)00076-1; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	29	399	407	0	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					763	767		10.1016/S0140-6736(00)04170-2	http://dx.doi.org/10.1016/S0140-6736(00)04170-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253971				2022-12-28	WOS:000167400900015
J	Lambalk, CB				Lambalk, CB			Is there a role for follicle-stimulating-hormone receptor in familial dizygotic twinning?	LANCET			English	Editorial Material							FSH		Vrije Univ Amsterdam, Med Ctr, Res Inst Endocrinol Reprod & Metab, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Lambalk, CB (corresponding author), Vrije Univ Amsterdam, Med Ctr, Res Inst Endocrinol Reprod & Metab, NL-1007 MB Amsterdam, Netherlands.	cb.lambalk@azvu.nl		Lambalk, Cornelis/0000-0003-3947-5129				Al-Hendy A, 2000, LANCET, V356, P914; Bergh T, 1999, LANCET, V354, P1579, DOI 10.1016/S0140-6736(99)04345-7; de Koning CH, 2000, HUM REPROD, V15, P1452, DOI 10.1093/humrep/15.7.1452; Derom C, 2001, LANCET, V357, P230, DOI 10.1016/S0140-6736(05)71330-1; Gromoll J, 2001, LANCET, V357, P230, DOI 10.1016/S0140-6736(05)71328-3; Lambalk CB, 1998, J CLIN ENDOCR METAB, V83, P481, DOI 10.1210/jc.83.2.481; Lambalk CB, 2000, STUD PROFERLIT, V9, P249; Lambalk CB, 1998, MOL CELL ENDOCRINOL, V145, P97, DOI 10.1016/S0303-7207(98)00175-0; Liao WX, 2001, LANCET, V357, P230, DOI 10.1016/S0140-6736(05)71329-5; Mayorga MP, 2000, J CLIN ENDOCR METAB, V85, P3365, DOI 10.1210/jc.85.9.3365; Montgomery GW, 2000, J CLIN ENDOCR METAB, V85, P3391, DOI 10.1210/jc.85.9.3391; SHERMAN BM, 1975, J CLIN INVEST, V55, P699, DOI 10.1172/JCI107979	12	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2001	357	9258					735	736		10.1016/S0140-6736(00)04178-7	http://dx.doi.org/10.1016/S0140-6736(00)04178-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253961				2022-12-28	WOS:000167400900005
J	Sharp, D				Sharp, D			Foot-and-mouth epidemic: the choices	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Sharp, D (corresponding author), Lancet, London WC1X 8RR, England.							BONNER J, 2001, FOOT MOUTHS RESURGEN; Kitching RP, 1998, J COMP PATHOL, V118, P89, DOI 10.1016/S0021-9975(98)80002-9; Sobrino F, 2001, VET RES, V32, P1, DOI 10.1051/vetres:2001106; WOODS A, 2001, TIMES           0301, P5	4	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					738	738		10.1016/S0140-6736(00)04181-7	http://dx.doi.org/10.1016/S0140-6736(00)04181-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253964				2022-12-28	WOS:000167400900008
J	Stanley, GD; Fautin, DG				Stanley, GD; Fautin, DG			Paleontology and evolution - The origins of modern corals	SCIENCE			English	Editorial Material							SCLERACTINIAN CORALS; REEFS		Univ Montana, Dept Geol, Missoula, MT 59812 USA; Univ Kansas, Museum Nat Hist, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA	University of Montana System; University of Montana; University of Kansas; University of Kansas	Stanley, GD (corresponding author), Univ Montana, Dept Geol, Missoula, MT 59812 USA.							Deng Z.-q., 1984, Acta Palaeontologica Sinica, V23, P489; Erwin D. H, 1993, GREAT PALEOZOIC CRIS; Ezaki Y, 1998, PALEOBIOLOGY, V24, P227; Ezaki Y, 2000, PALAEONTOLOGY, V43, P199, DOI 10.1111/1475-4983.00124; Fautin DG, 1992, P 7 INT COR REEF S, V2, P665; Fedorowski J, 1997, ACTA PALAEONTOL POL, V42, P446; Gattuso JP, 1999, AM ZOOL, V39, P160; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; MORYCOWA E, 1988, Acta Palaeontologica Polonica, V33, P91; OLIVER WA, 1980, PALEOBIOLOGY, V6, P146, DOI 10.1017/S0094837300006709; Oliver William A. Jr, 1996, Paleontological Society Papers, V1, P107; PETERSEN KW, 1979, BIOL SYSTEMATICS COL, P105; QI WT, 1984, PALEONTOGRAPHICA AM, V54, P187; Romano SL, 2000, B MAR SCI, V67, P1043; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; SANDBERG PA, 1983, NATURE, V305, P19, DOI 10.1038/305019a0; Scrutton Colin, 1999, Geology Today, V15, P184, DOI 10.1046/j.1365-2451.1999.1505005.x; Scrutton CT, 1997, P YORKS GEOL SOC, V51, P177, DOI 10.1144/pygs.51.3.177; STANLEY G D JR, 1988, Palaios, V3, P170; Veron J. E., 2000, CORALS WORLD, V1; Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568	21	89	91	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1913	1914		10.1126/science.1056632	http://dx.doi.org/10.1126/science.1056632			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11245198				2022-12-28	WOS:000167401600033
J	Varmus, H				Varmus, H			Public health - Proliferation of National Institutes of Health	SCIENCE			English	Editorial Material									Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; NIH, Bethesda, MD 20892 USA	Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA	Varmus, H (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.								0	6	6	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1903	+		10.1126/science.1059063	http://dx.doi.org/10.1126/science.1059063			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11245194				2022-12-28	WOS:000167401600027
J	Wolffe, AP; Hansen, JC				Wolffe, AP; Hansen, JC			Nuclear visions: Functional flexibility from structural instability	CELL			English	Review							HISTONE ACETYLATION; LIVING CELLS; SACCHAROMYCES-CEREVISIAE; CHROMATIN; DYNAMICS; PROTEIN; H1		Sangamo Biosci, Point Richmond Tech Ctr 2, Richmond, CA 94804 USA; Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78229 USA	Sangamo Therapeutics, Inc.; University of Texas System; University of Texas Health San Antonio	Wolffe, AP (corresponding author), Sangamo Biosci, Point Richmond Tech Ctr 2, 501 Canal Blvd,Suite A100, Richmond, CA 94804 USA.							Aragon-Alcaide L, 2000, NAT CELL BIOL, V2, P812, DOI 10.1038/35041055; Carruthers LM, 2000, J BIOL CHEM, V275, P37285, DOI 10.1074/jbc.M006801200; Dundr M, 2000, J CELL BIOL, V150, P433, DOI 10.1083/jcb.150.3.433; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; HAYES JJ, 2001, IN PRESS CURR OPIN G; Kourmouli N, 2000, EMBO J, V19, P6558, DOI 10.1093/emboj/19.23.6558; Lee HL, 1998, EMBO J, V17, P1454, DOI 10.1093/emboj/17.5.1454; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Wasser M, 2000, NAT CELL BIOL, V2, P268, DOI 10.1038/35010535; Waterborg JH, 2000, J BIOL CHEM, V275, P13007, DOI 10.1074/jbc.275.17.13007	14	47	47	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2001	104	5					631	634		10.1016/S0092-8674(02)01453-8	http://dx.doi.org/10.1016/S0092-8674(02)01453-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257215				2022-12-28	WOS:000167531100001
J	Zhang, HZ; Hackbarth, CJ; Chansky, KM; Chambers, HF				Zhang, HZ; Hackbarth, CJ; Chansky, KM; Chambers, HF			A proteolytic transmembrane signaling pathway and resistance to beta-lactams in staphylococci	SCIENCE			English	Article							BINDING PROTEIN 2A; METHICILLIN RESISTANCE; BACILLUS-LICHENIFORMIS; TRANSCRIPTION FACTOR; AUREUS; EXPRESSION; SEQUENCES; MEMBRANE; FAMILIES; GENE	beta -Lactamase and penicillin-binding protein Za mediate staphylococcal resistance to beta -lactam antibiotics, which are otherwise highly clinically effective. Production of these inducible proteins is regulated by a signal-transducing integral membrane protein and a transcriptional repressor. The signal transducer is a fusion protein with penicillin-binding and zinc metalloprotease domains. The signal for protein expression is transmitted by site-specific proteolytic cleavage of both the transducer, which autoactivates, and the repressor, which is inactivated, unblocking gene transcription. Compounds that disrupt this regulatory pathway could restore the activity of beta -lactam antibiotics against drug-resistant strains of staphylococci.	Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Infect Dis, San Francisco, CA 94110 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Chambers, HF (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Infect Dis, 1001 Potrero Ave, San Francisco, CA 94110 USA.	chipc@itsa.ucsf.edu			NIAID NIH HHS [AI46610, AI4005804] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046610, R29AI040058] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARCHER GL, 1994, ANTIMICROB AGENTS CH, V38, P447, DOI 10.1128/AAC.38.3.447; CHAMBERS HF, 1990, J INFECT DIS, V161, P1170, DOI 10.1093/infdis/161.6.1170; COHEN S, 1968, J BACTERIOL, V95, P1368, DOI 10.1128/JB.95.4.1368-1374.1968; DELENCASTRE H, 1994, J ANTIMICROB CHEMOTH, V33, P7, DOI 10.1093/jac/33.1.7; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Gregory PD, 1997, MOL MICROBIOL, V24, P1025, DOI 10.1046/j.1365-2958.1997.4051770.x; HACKBARTH CJ, 1993, ANTIMICROB AGENTS CH, V37, P1144, DOI 10.1128/AAC.37.5.1144; HACKBARTH CJ, 1994, ANTIMICROB AGENTS CH, V38, P2568, DOI 10.1128/AAC.38.11.2568; Hardt K, 1997, MOL MICROBIOL, V23, P935, DOI 10.1046/j.1365-2958.1997.2761642.x; Harlow E., 1988, ANTIBODIES LAB MANUA; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; HIRAMATSU K, 1995, MICROBIOL IMMUNOL, V39, P531, DOI 10.1111/j.1348-0421.1995.tb02239.x; HOFMEISTER AEM, 1995, CELL, V83, P219, DOI 10.1016/0092-8674(95)90163-9; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; JIANG WP, 1992, FEBS LETT, V312, P110, DOI 10.1016/0014-5793(92)80916-5; Kirby WMM, 1944, SCIENCE, V99, P452, DOI 10.1126/science.99.2579.452; KOBAYASHI T, 1987, J BACTERIOL, V169, P3873, DOI 10.1128/jb.169.9.3873-3878.1987; KREISWIRTH B, 1983, NATURE, V227, P680; KuwaharaArai K, 1996, ANTIMICROB AGENTS CH, V40, P2680, DOI 10.1128/AAC.40.12.2680; Marie-Claire C, 1998, J BIOL CHEM, V273, P5697, DOI 10.1074/jbc.273.10.5697; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; ROWLAND SJ, 1989, EMBO J, V8, P2761, DOI 10.1002/j.1460-2075.1989.tb08418.x; Sharma VK, 1998, J BACTERIOL, V180, P2160, DOI 10.1128/JB.180.8.2160-2166.1998; TESCH W, 1990, ANTIMICROB AGENTS CH, V34, P1703, DOI 10.1128/AAC.34.9.1703; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; VALLEJO AN, 1994, PCR METH APPL, V4, pS123	27	158	168	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2001	291	5510					1962	1965		10.1126/science.1055144	http://dx.doi.org/10.1126/science.1055144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239156				2022-12-28	WOS:000167401600046
J	Aitman, TJ				Aitman, TJ			CD36, insulin resistance, and coronary heart disease	LANCET			English	Editorial Material							OXIDIZED LDL; FATTY-ACID; PPAR-GAMMA; METABOLISM; MUTATION; MICE		Hammersmith Hosp, Imperial Coll Genet & Genom Res Inst, Mol Med Grp, MRC Clin Sci Ctr, London W12 0NN, England	Imperial College London	Aitman, TJ (corresponding author), Hammersmith Hosp, Imperial Coll Genet & Genom Res Inst, Mol Med Grp, MRC Clin Sci Ctr, London W12 0NN, England.	t.aitman@csc.mrc.ac.uk		Aitman, Timothy/0000-0002-7875-4502				Abumrad N, 1998, J LIPID RES, V39, P2309; Aitman TJ, 1997, ARTERIOSCL THROM VAS, V17, P748, DOI 10.1161/01.ATV.17.4.748; Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Curtis BR, 1996, TRANSFUSION, V36, P331, DOI 10.1046/j.1537-2995.1996.36496226147.x; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; NATHAN DM, 1997, LANCET S1, V350, P1; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; Savill J, 1998, NATURE, V392, P442, DOI 10.1038/33025; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5	18	27	28	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2001	357	9257					651	652		10.1016/S0140-6736(00)04149-0	http://dx.doi.org/10.1016/S0140-6736(00)04149-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247544				2022-12-28	WOS:000167282400003
J	Rousse, A; Rischel, C; Fourmaux, S; Uschmann, I; Sebban, S; Grillon, G; Balcou, P; Foster, E; Geindre, JP; Audebert, P; Gauthier, JC; Hulin, D				Rousse, A; Rischel, C; Fourmaux, S; Uschmann, I; Sebban, S; Grillon, G; Balcou, P; Foster, E; Geindre, JP; Audebert, P; Gauthier, JC; Hulin, D			Non-thermal melting in semiconductors measured at femtosecond resolution	NATURE			English	Article							X-RAY-DIFFRACTION; PHASE-TRANSFORMATIONS; STRUCTURAL DYNAMICS; LASER; SILICON; GAAS; TRANSITIONS; PICOSECOND; PULSES; INSB	Ultrafast time-resolved optical spectroscopy has revealed new classes of physical(1), chemical(2) and biological(3) reactions, in which directed, deterministic motions of atoms have a key role. This contrasts with the random, diffusive motion of atoms across activation barriers that typically determines kinetic rates on slower timescales. An example of these new processes is the ultrafast melting of semiconductors, which is believed to arise from a strong modification of the inter-atomic forces owing to laser-induced promotion of a large fraction (10% or more) of the valence electrons to the conduction band(1,4-12). The atoms immediately begin to move and rapidly gain sufficient kinetic energy to induce melting-much faster than the several picoseconds required to convert the electronic energy into thermal motions(13). Here we present measurements of the characteristic melting time of InSb with a recently developed technique of ultrafast time-resolved X-ray diffraction(14-19) that, in contrast to optical spectroscopy, provides a direct probe of the changing atomic structure. The data establish unambiguously a loss of long-range order up to 900 Angstrom inside the crystal, with time constants as short as 350 femtoseconds. This ability to obtain the quantitative structural characterization of non-thermal processes should rnd widespread application in the study of ultrafast dynamics in other physical, chemical and biological systems.	Ecole Polytech, ENSTA, Lab Opt Appl, CNRS,UMR 7639, F-91761 Palaiseau, France; Niels Bohr Inst, DK-2100 Copenhagen O, Denmark; Royal Vet & Agr Univ, Dept Math & Phys, DK-1871 Frederiksberg C, Denmark; Univ Jena, Inst Opt & Quantum Elect, Xray Opt Grp, D-07743 Jena, Germany; Univ Paris 07, CEA,Ecole Polytech, Lab Utilisat Lasers Intenses, CNRS,UMR 7605, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut Polytechnique de Paris; University of Copenhagen; Niels Bohr Institute; University of Copenhagen; Friedrich Schiller University of Jena; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; CEA; Institut Polytechnique de Paris; Universite Paris Cite	Rousse, A (corresponding author), Ecole Polytech, ENSTA, Lab Opt Appl, CNRS,UMR 7639, Chemin Huniere, F-91761 Palaiseau, France.		audebert, patrick/ABG-1351-2020; ROUSSE, Antoine/D-2712-2009; Balcou, Philippe/I-4624-2017	audebert, patrick/0000-0002-1330-3946; ROUSSE, Antoine/0000-0003-0885-9285; Balcou, Philippe/0000-0002-5546-6436				ASPNES DE, 1983, PHYS REV B, V27, P985, DOI 10.1103/PhysRevB.27.985; Chin AH, 1999, PHYS REV LETT, V83, P336, DOI 10.1103/PhysRevLett.83.336; Graves JS, 1998, PHYS REV B, V58, P13627, DOI 10.1103/PhysRevB.58.13627; HELLWEGE KH, 1991, LANDOLTBORNSTEIN S A, V17; Huang L, 1998, PHYS REV LETT, V80, P185, DOI 10.1103/PhysRevLett.80.185; Larsson J, 1998, APPL PHYS A-MATER, V66, P587, DOI 10.1007/s003390050719; LAUDE LD, 1983, NATO ASI SERIES, V69; Liebl U, 1999, NATURE, V401, P181, DOI 10.1038/43699; Lindenberg AM, 2000, PHYS REV LETT, V84, P111, DOI 10.1103/PhysRevLett.84.111; Phillpot S. R., 1989, Computers in Physics, V3, P20; PRONKO PP, 1995, J APPL PHYS, V78, P6233, DOI 10.1063/1.360570; Rischel C, 1997, NATURE, V390, P490, DOI 10.1038/37317; Rose-Petruck C, 1999, NATURE, V398, P310, DOI 10.1038/18631; SHANK CV, 1983, PHYS REV LETT, V50, P454, DOI 10.1103/PhysRevLett.50.454; SHANK CV, 1983, PHYS REV LETT, V51, P900, DOI 10.1103/PhysRevLett.51.900; Shumay IL, 1996, PHYS REV B, V53, P15878, DOI 10.1103/PhysRevB.53.15878; Siders CW, 1999, SCIENCE, V286, P1340, DOI 10.1126/science.286.5443.1340; Silvestrelli PL, 1996, PHYS REV LETT, V77, P3149, DOI 10.1103/PhysRevLett.77.3149; Sokolowski-Tinten K, 1998, PHYS REV LETT, V81, P224, DOI 10.1103/PhysRevLett.81.224; SOKOLOWSKITINTEN K, 1991, APPL PHYS A-MATER, V53, P227, DOI 10.1007/BF00324257; SOKOLOWSKITINTEN K, 1995, PHYS REV B, V51, P14186, DOI 10.1103/PhysRevB.51.14186; STAMPFLI P, 1995, APPL PHYS A-MATER, V60, P191, DOI 10.1007/BF01538245; THOMSEN C, 1986, PHYS REV B, V34, P4129, DOI 10.1103/PhysRevB.34.4129; VETELINO JF, 1972, PHYS REV B, V5, P2360, DOI 10.1103/PhysRevB.5.2360; Vos MH, 1999, BBA-BIOENERGETICS, V1411, P1, DOI 10.1016/S0005-2728(99)00035-3; WOOD RF, 1984, PULSED LASER PROCESS; YOFFA EJ, 1980, PHYS REV B, V21, P2415, DOI 10.1103/PhysRevB.21.2415; Zewail AH, 1996, J PHYS CHEM-US, V100, P12701, DOI 10.1021/jp960658s	28	577	586	3	155	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					65	68		10.1038/35065045	http://dx.doi.org/10.1038/35065045			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242040				2022-12-28	WOS:000167194300041
J	Glass, CK; Witztum, JL				Glass, CK; Witztum, JL			Atherosclerosis: The road ahead	CELL			English	Review							LOW-DENSITY-LIPOPROTEIN; LDL RECEPTOR-DEFICIENT; COLONY-STIMULATING FACTOR; FATTY STREAK FORMATION; SMOOTH-MUSCLE-CELLS; PPAR-GAMMA; GENE-EXPRESSION; TANGIER-DISEASE; CARDIOVASCULAR-DISEASE; ADHESION MOLECULE		Univ Calif San Diego, Specialized Ctr Res Mol Med & Atherosclerosis, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Endocrinol & Metab, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Glass, CK (corresponding author), Univ Calif San Diego, Specialized Ctr Res Mol Med & Atherosclerosis, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	cglass@ucsd.edu	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592				Accad M, 2000, J CLIN INVEST, V105, P711, DOI 10.1172/JCI9021; Behr-Roussel D, 2000, CIRCULATION, V102, P1033, DOI 10.1161/01.CIR.102.9.1033; Bennett MR, 1999, CARDIOVASC RES, V41, P361, DOI 10.1016/S0008-6363(98)00212-0; Benoit P, 1999, CIRCULATION, V99, P105, DOI 10.1161/01.CIR.99.1.105; BJORKHEM I, 1992, J LIPID RES, V33, P455; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Caligiuri G, 1999, P NATL ACAD SCI USA, V96, P6920, DOI 10.1073/pnas.96.12.6920; Carmeliet P, 2000, J CLIN INVEST, V105, P1519, DOI 10.1172/JCI10242; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Colles SM, 1996, J LIPID RES, V37, P2018; Collins RG, 2000, J EXP MED, V191, P189, DOI 10.1084/jem.191.1.189; Costet P, 2000, J BIOL CHEM, V275, P28240; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Dansky HM, 1997, P NATL ACAD SCI USA, V94, P4642, DOI 10.1073/pnas.94.9.4642; Dansky HM, 1999, ARTERIOSCL THROM VAS, V19, P1960, DOI 10.1161/01.ATV.19.8.1960; DAVIES MJ, 1993, BRIT HEART J, V69, P377; Detmers PA, 2000, J IMMUNOL, V165, P3430, DOI 10.4049/jimmunol.165.6.3430; Dong ZM, 1998, J CLIN INVEST, V102, P145, DOI 10.1172/JCI3001; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Fruchart JC, 1999, CURR OPIN LIPIDOL, V10, P245, DOI 10.1097/00041433-199906000-00007; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Glass CK, 2000, GENE DEV, V14, P121; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Gould AL, 1998, CIRCULATION, V97, P946; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Han KH, 1999, J LIPID RES, V40, P1053; Hansson GK, 1997, CURR OPIN LIPIDOL, V8, P301, DOI 10.1097/00041433-199710000-00009; Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100, DOI 10.1161/01.ATV.20.9.2100; Heinecke JW, 1998, ATHEROSCLEROSIS, V141, P1, DOI 10.1016/S0021-9150(98)00173-7; Hennekens CH, 1998, CIRCULATION, V97, P1095, DOI 10.1161/01.CIR.97.11.1095; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Horkko S, 2000, FREE RADICAL BIO MED, V28, P1771, DOI 10.1016/S0891-5849(00)00333-6; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; JHA P, 1995, ANN INTERN MED, V123, P860, DOI 10.7326/0003-4819-123-11-199512010-00009; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kirk EA, 2000, ARTERIOSCL THROM VAS, V20, P1529, DOI 10.1161/01.ATV.20.6.1529; Knowles JW, 2000, J CLIN INVEST, V105, P451, DOI 10.1172/JCI8376; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lee RT, 1997, ARTERIOSCL THROM VAS, V17, P1859, DOI 10.1161/01.ATV.17.10.1859; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Lutgens E, 1999, NAT MED, V5, P1313, DOI 10.1038/15271; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Mach F, 1998, ATHEROSCLEROSIS, V137, pS89, DOI 10.1016/S0021-9150(97)00309-2; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Moulton KS, 1999, CIRCULATION, V99, P1726, DOI 10.1161/01.CIR.99.13.1726; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Napoli C, 1997, J CLIN INVEST, V100, P2680, DOI 10.1172/JCI119813; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Okamoto H, 2000, NATURE, V406, P203, DOI 10.1038/35018119; Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847; Paulsson G, 2000, ARTERIOSCL THROM VAS, V20, P10, DOI 10.1161/01.ATV.20.1.10; Plump AS, 1999, ARTERIOSCL THROM VAS, V19, P1105, DOI 10.1161/01.ATV.19.4.1105; Qiao JH, 1997, AM J PATHOL, V150, P1687; Reckless J, 1997, CIRCULATION, V95, P1542; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; ROE EB, 2000, ADV INTERNAL MED, V45, P257; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; SCHWENKE DC, 1989, ARTERIOSCLEROSIS, V9, P895, DOI 10.1161/01.ATV.9.6.895; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Shiffman D, 2000, J BIOL CHEM, V275, P37324, DOI 10.1074/jbc.M004732200; Shih DM, 2000, J BIOL CHEM, V275, P17527, DOI 10.1074/jbc.M910376199; Shih PT, 1999, CIRC RES, V84, P345, DOI 10.1161/01.RES.84.3.345; Sjoland H, 2000, ARTERIOSCL THROM VAS, V20, P846, DOI 10.1161/01.ATV.20.3.846; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; SMITHIES O, 1995, P NATL ACAD SCI USA, V92, P5266, DOI 10.1073/pnas.92.12.5266; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Staels B, 1998, ATHEROSCLEROSIS, V137, pS19, DOI 10.1016/S0021-9150(97)00313-4; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Steinberg D, 1999, LIPOPROTEINS LIPOPRO; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tall AR, 2000, ARTERIOSCL THROM VAS, V20, P1185, DOI 10.1161/01.ATV.20.5.1185; Tangirala RK, 1999, CIRCULATION, V100, P1816, DOI 10.1161/01.CIR.100.17.1816; Thurberg BL, 1998, CURR OPIN LIPIDOL, V9, P387, DOI 10.1097/00041433-199810000-00002; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Voyiaziakis E, 1998, J LIPID RES, V39, P313; Wetterau JR, 1998, SCIENCE, V282, P751, DOI 10.1126/science.282.5389.751; Williams KJ, 1998, CURR OPIN LIPIDOL, V9, P471, DOI 10.1097/00041433-199810000-00012; Witztum J. L., 1995, CECIL TXB MED, P1090; Xiao Q, 1998, J CLIN INVEST, V101, P1184, DOI 10.1172/JCI1461; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; Yamada Y, 1998, CELL MOL LIFE SCI, V54, P628, DOI 10.1007/s000180050191; Young RA, 2000, CELL, V102, P9, DOI 10.1016/S0092-8674(00)00005-2; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302	104	2439	2577	4	218	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2001	104	4					503	516		10.1016/S0092-8674(01)00238-0	http://dx.doi.org/10.1016/S0092-8674(01)00238-0			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	405VP	11239408	Bronze			2022-12-28	WOS:000167181500006
J	Vasioukhin, V; Bauer, C; Degenstein, L; Wise, B; Fuchs, E				Vasioukhin, V; Bauer, C; Degenstein, L; Wise, B; Fuchs, E			Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin	CELL			English	Article							CELL-CELL ADHESION; E-CADHERIN; EPIDERMAL-KERATINOCYTES; RAS ACTIVATION; BETA-CATENIN; EXPRESSION; GROWTH; CANCER; KINASE; GENE	When surface epithelium was conditionally targeted for ablation of alpha -catenin, hair follicle development was blocked and epidermal morphogenesis was dramatically affected, with defects in adherens junction formation, intercellular adhesion, and epithelial polarity. Differentiation occurred, but epidermis displayed hyperproliferation, suprabasal mitoses, and multinucleated cells. In vitro, alpha -catenin null keratinocytes were poorly contact inhibited and grew rapidly. These differences were not dependent upon intercellular adhesion and were in marked contrast to keratinocytes conditionally null for another essential intercellular adhesion protein, desmoplakin (DP). KO keratinocytes exhibited sustained activation of the Ras-MAPK cascade due to aberrations in growth factor responses. Thus, remarkably, features of precancerous lesions often attributed to defects in cell cycle regulatory genes can be generated by compromising the function of alpha -catenin.	Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago	Fuchs, E (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, 5841 S Maryland Ave, Chicago, IL 60637 USA.		Fuchs, Elaine/G-1565-2016	Vasioukhin, Valeri/0000-0002-6730-0281	NIAMS NIH HHS [R01-AR27883] Funding Source: Medline; NIDCR NIH HHS [5P50 DE11921] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE011921] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Bagutti C, 1998, J PATHOL, V186, P8, DOI 10.1002/(SICI)1096-9896(199809)186:1<8::AID-PATH156>3.0.CO;2-H; Balmain A, 2000, CARCINOGENESIS, V21, P371, DOI 10.1093/carcin/21.3.371; Bullions LC, 1997, MOL CELL BIOL, V17, P4501, DOI 10.1128/MCB.17.8.4501; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Espada J, 1999, J CELL BIOL, V146, P967, DOI 10.1083/jcb.146.5.967; FREEDBERG IM, 1999, DERMATOLOGY GEN MED, V2; FREEDBERG IM, 1999, DERMATOLOGY GEN MED, V1; Gallicano GI, 1998, J CELL BIOL, V143, P2009, DOI 10.1083/jcb.143.7.2009; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hardy M.H., 1992, TRENDS GENET, V8, P159; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Higgins JMG, 1998, J CELL BIOL, V140, P197, DOI 10.1083/jcb.140.1.197; HIRAI Y, 1989, DEVELOPMENT, V105, P271; HODIVALA KJ, 1994, J CELL BIOL, V124, P589, DOI 10.1083/jcb.124.4.589; KINCH MS, 1995, J CELL BIOL, V130, P461, DOI 10.1083/jcb.130.2.461; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kofron M, 1997, DEVELOPMENT, V124, P1553; Kowalczyk AP, 1999, INT REV CYTOL, V185, P237; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Macpherson I, 1970, Adv Cancer Res, V13, P169, DOI 10.1016/S0065-230X(08)60166-9; MYERS MG, 1994, J BIOL CHEM, V269, P28783; NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; Ozawa M, 1998, J CELL BIOL, V142, P1605, DOI 10.1083/jcb.142.6.1605; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; SHIOZAKI H, 1994, AM J PATHOL, V144, P667; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; STOLER A, 1988, J CELL BIOL, V107, P427, DOI 10.1083/jcb.107.2.427; Sun TT, 1984, CANCER CELLS, V1, P169; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; von Schlippe M, 2000, J CELL SCI, V113, P425; Wang XJ, 2000, MOL CARCINOGEN, V27, P200, DOI 10.1002/(SICI)1098-2744(200003)27:3<200::AID-MC7>3.3.CO;2-0; Wang XM, 1997, P NATL ACAD SCI USA, V94, P219, DOI 10.1073/pnas.94.1.219; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Yap AS, 1998, CANCER INVEST, V16, P252, DOI 10.3109/07357909809039774; YONEMURA S, 1995, J CELL SCI, V108, P127; Yuspa SH, 1998, J DERMATOL SCI, V17, P1, DOI 10.1016/S0923-1811(97)00071-6	48	347	357	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 23	2001	104	4					605	617		10.1016/S0092-8674(01)00246-X	http://dx.doi.org/10.1016/S0092-8674(01)00246-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	405VP	11239416	Bronze			2022-12-28	WOS:000167181500014
J	Vidal, M				Vidal, M			A biological atlas of functional maps	CELL			English	Review							GENOMIC ANALYSIS; GENE-EXPRESSION; NETWORK; RNAI		Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Vidal, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	marc_vidal@defci.harvard.edu						Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; Hol WGJ, 2000, NAT STRUCT BIOL, V7, P964, DOI 10.1038/80744; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; LYNCH AS, 1995, NAT GENET, V11, P309, DOI 10.1038/ng1195-309; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Mohler WA, 1999, MOL BIOL CELL, V10, P3061, DOI 10.1091/mbc.10.10.3061; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92	24	151	160	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2001	104	3					333	339		10.1016/S0092-8674(01)00221-5	http://dx.doi.org/10.1016/S0092-8674(01)00221-5			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239391	Bronze			2022-12-28	WOS:000167003100004
J	Chavkin, W				Chavkin, W			Cocaine and pregnancy - Time to look at the evidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Columbia Sch Publ Hlth, New York, NY 10032 USA	Columbia University	Chavkin, W (corresponding author), Columbia Sch Publ Hlth, 60 Haven Ave,B-3, New York, NY 10032 USA.	jamwa@columbia.edu						CHAVKIN W, 1993, B NEW YORK ACAD MED, V70, P50; Frank DA, 2001, JAMA-J AM MED ASSOC, V285, P1613, DOI 10.1001/jama.285.12.1613; LINDNER CL, 2000, NY TIMES        1231, pM6; Marwick C, 1998, JAMA-J AM MED ASSOC, V279, P1149, DOI 10.1001/jama.279.15.1149; MAUER M, 1995, 9070; Mauer M., 1999, GENDER JUSTICE WOMEN; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; Paltrow L. M., 2000, YEAR 2000 OVERVIEW G; PEREZPENA R, 2001, NY TIMES        0427, pA1; Reinarman C, 1997, CRACK AM DEMON DRUGS	10	23	23	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2001	285	12					1626	1628		10.1001/jama.285.12.1626	http://dx.doi.org/10.1001/jama.285.12.1626			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413HH	11268271				2022-12-28	WOS:000167606600030
J	Robertson, MC; Gardner, MM; Devlin, N; McGee, R; Campbell, AJ				Robertson, MC; Gardner, MM; Devlin, N; McGee, R; Campbell, AJ			Effectiveness and economic evaluation of a nurse delivered home exercise programme to prevent falls. 2: Controlled trial in multiple centres	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED TRIAL; PEOPLE; WOMEN; OLDER	Objectives To assess the effectiveness of trained nurses based in general practices individually prescribing a home exercise programme to reduce falls and injuries in elderly people and to estimate the cost effectiveness of the programme. Design Controlled trial with one year's follow up. Setting 32 general practices in seven southern New Zealand centres. Participants 450 women and men aged 80 years and older. Intervention 330 participants received the exercise programme (exercise centres) and 120 received usual care (control centres); 87% (371 of 426) completed the trial. Main outcome measures Number of falls, number of injuries resulting from falls, costs of implementing the programme, and hospital costs as a result of falls. Results Falls were reduced by 30% in the exercise centres (incidence rate ratio 0.70, 95% confidence interval 0.59 to 0.84). The programme was equally effective in men and women. The programme cost $NZ418 (pound 121) (at 1998 prices) per person to deliver for one year or $NZ1519 (pound 441) per fall prevented. Fewer participants had falls resulting in injuries, but there was no difference in the number who had serious injuries and no difference in hospital costs resulting from falls in exercise centres compared with control centres. Conclusions An individually tailored exercise programme, delivered by trained nurses from within general practices, was effective in reducing falls in three different centres, This strategy should be combined with other successful interventions to form part of home programmes to prevent falls in elderly people.	Otago Med Sch, Dept Med & Surg Sci, Dunedin, New Zealand; Univ Otago, Dept Econ, Dunedin, New Zealand; Otago Med Sch, Dept Prevent & Social Med, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Robertson, MC (corresponding author), Otago Med Sch, Dept Med & Surg Sci, POB 913, Dunedin, New Zealand.		Robertson, Mary Clare/A-3964-2009	McGee, Rob/0000-0003-2429-6304				Campbell AJ, 1999, AGE AGEING, V28, P513, DOI 10.1093/ageing/28.6.513; CAMPBELL AJ, 1989, J GERONTOL, V44, pM112, DOI 10.1093/geronj/44.4.m112; Campbell AJ, 1999, J AM GERIATR SOC, V47, P850, DOI 10.1111/j.1532-5415.1999.tb03843.x; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; Cumming RG, 1999, J AM GERIATR SOC, V47, P1397, DOI 10.1111/j.1532-5415.1999.tb01556.x; Gardner MM, 2000, BRIT J SPORT MED, V34, P7, DOI 10.1136/bjsm.34.1.7; Haynes B, 1999, BRIT MED J, V319, P652, DOI 10.1136/bmj.319.7211.652; Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606; Robertson MC, 2001, BRIT MED J, V322, P697, DOI 10.1136/bmj.322.7288.697; *STAT, 1999, STAT STAT SOFTW; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301	11	180	184	0	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 24	2001	322	7288					701	704		10.1136/bmj.322.7288.701	http://dx.doi.org/10.1136/bmj.322.7288.701			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	416GB	11264207	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000167771000023
J	Denton, M; Marshall, C				Denton, M; Marshall, C			Laws of form revisited	NATURE			English	Article									Univ Otago, Dept Biochem, Dunedin 9001, New Zealand	University of Otago	Denton, M (corresponding author), Univ Otago, Dept Biochem, POB 56, Dunedin 9001, New Zealand.		Marshall, Craig J./C-6668-2009	Marshall, Craig J./0000-0003-4186-0368				CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Kirschner M, 2000, CELL, V100, P79, DOI 10.1016/S0092-8674(00)81685-2; LINDGARD P, 1996, PROTEIN FOLDS, P98; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0	5	59	60	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					417	417		10.1038/35068645	http://dx.doi.org/10.1038/35068645			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260691				2022-12-28	WOS:000167583800021
J	Selvaggi, SM				Selvaggi, SM			Implications of low diagnostic reproducibility of cervical cytologic and histologic diagnoses	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTERLABORATORY COMPARISON PROGRAM; CERVICOVAGINAL CYTOLOGY; SPECIMEN ADEQUACY; PARTICIPANTS; SMEARS; CELLS		Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA	Loyola University Chicago	Selvaggi, SM (corresponding author), Loyola Univ, Med Ctr, Dept Pathol, 2160 1st Ave, Maywood, IL 60153 USA.							Bishop JW, 1998, ACTA CYTOL, V42, P189, DOI 10.1159/000331545; Corkill M, 1997, ACTA CYTOL, V41, P39, DOI 10.1159/000332303; Crum CP, 1999, AM J CLIN PATHOL, V112, P384; Davey DD, 2000, ARCH PATHOL LAB MED, V124, P203; KOSS LG, 1989, JAMA-J AM MED ASSOC, V261, P737, DOI 10.1001/jama.261.5.737; KURMAN RJ, 1994, JAMA-J AM MED ASSOC, V271, P1866, DOI 10.1001/jama.271.23.1866; Kurman RJ, 1994, BETHESDA SYSTEM REPO; Lee KR, 1997, OBSTET GYNECOL, V90, P278, DOI 10.1016/S0029-7844(97)00228-7; PAPANICOLAOU GN, 1943, DIAGNOSIS UTERINE CA; REAGAN JW, 1953, CANCER, V6, P224, DOI 10.1002/1097-0142(195303)6:2<224::AID-CNCR2820060203>3.0.CO;2-H; Richart R M, 1973, Pathol Annu, V8, P301; ROS E, 1983, CITOLOGIA, V3, P9; RUBIO CA, 1977, OBSTET GYNECOL, V49, P576; Schiffman M, 2000, ACTA CYTOL, V44, P726, DOI 10.1159/000328554; SOLOMON D, 1989, JAMA-J AM MED ASSOC, V262, P931; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; VANDERGRAAF Y, 1987, J CLIN PATHOL, V40, P438, DOI 10.1136/jcp.40.4.438; Vassilakos P, 1999, ACTA CYTOL, V43, P65, DOI 10.1159/000330870; VOOIJS PG, 1985, ACTA CYTOL, V29, P32; Woodhouse SL, 1999, ARCH PATHOL LAB MED, V123, P1079	20	21	26	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1506	1508		10.1001/jama.285.11.1506	http://dx.doi.org/10.1001/jama.285.11.1506			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410VQ	11255428				2022-12-28	WOS:000167462100034
J	Morris, K				Morris, K			Growing pains of East Timor: health of an infant nation	LANCET			English	Article								In August, 1999, three-quarters of East Timorese adults voted to end more than two decades of an Indonesian administration never recognised by the United Nations. The ensuing spree of violence and destruction by militia backed by the Indonesian military meant the birth of the fledgling nation became a complex humanitarian disaster. 1 year on, progress was heartening: a transitional government, a judiciary, and tax systems were in place, and East Timer was a proud competitor in the Sydney Olympic games. Rebuilding a country from ground level has brought a golden opportunity for fresh approaches. However, reconstruction is also a slow, complex, and sometimes controversial process at the mercy of multiple agendas. The health sector has seen basic care restored, establishment of a much-needed public-health service, and planning for the future health system. An innovative partnership between WHO/Roll Back Malaria and Merlin for post-conflict research has provided data to guide malaria control. The story of progress from humanitarian emergency to national health plan epitomises the triumphs and challenges of this newest nations' first 18 months.			Morris, K (corresponding author), 6 Nimrod Rd, London SW16 6SY, England.	vital@dircon.co.uk						CARRETTE P, 2000, CLIN INFECT DIS, V30, P840; CLAUSEN L, 2000, TIME, V24, P44; *E TIM JOINT ASS M, 1999, REP JOINT ASS MISS E; *E TIM JOINT ASS M, 1999, HLTH ED BACKGR PAP; Ezard N, 2001, LANCET, V357, P149, DOI 10.1016/S0140-6736(05)71192-2; Fryauff DJ, 1998, T ROY SOC TROP MED H, V92, P82, DOI 10.1016/S0035-9203(98)90966-X; Morris K, 2000, LANCET, V356, P144, DOI 10.1016/S0140-6736(05)73160-3; MORRIS K, 2000, GUARDIAN        0710; Pribadi W., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P143; SOEPRAPTO W, 1995, LANCET, V346, P1304, DOI 10.1016/S0140-6736(95)91910-4; Stein D, 1999, LANCET, V354, P2075, DOI 10.1016/S0140-6736(99)10124-7; *UN DEV PROGR, 1999, CONC FRAM REC REC DE; *WORLD BANK, 1999, WORLD BANK E AS PAC; *WORLD BANK E AS P, 2000, E TIM HLTH SECT REH; 2000, LAO HAMUTUK B, V1, P4	15	14	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2001	357	9259					873	877		10.1016/S0140-6736(00)04203-3	http://dx.doi.org/10.1016/S0140-6736(00)04203-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265969				2022-12-28	WOS:000167586300036
J	Newschaffer, CJ; Topham, A; Herzberg, T; Weiner, S; Weinberg, DS				Newschaffer, CJ; Topham, A; Herzberg, T; Weiner, S; Weinberg, DS			Risk of colorectal cancer after breast cancer	LANCET			English	Article							HORMONE REPLACEMENT THERAPY; ADJUVANT TAMOXIFEN THERAPY; WOMEN; EPIDEMIOLOGY; SURVEILLANCE; ASSOCIATION; ESTROGEN; PROGRAM	Background History of breast cancer has been reported as a risk factor for colorectal cancer in women. In view of the ambiguous nature of existing evidence and the growing interest in targeted colorectal cancer prevention, we sought to quantify this risk. Methods We used the Surveillance Epidemiology and End Results (SEER) database to estimate risk of colorectal cancer after breast-cancer diagnosis in women with first incident breast cancer between 1974 and 1995. Observed colon and rectal cancer risk was compared with that expected in the general population. We stratified comparisons by age at breast-cancer diagnosis. stage of cancer, ethnic origin of patient, and follow-up time. Findings Overall, women with previous breast cancer were 5% less likely (95% CI 1-9) to develop colon and 13% less likely (6-19) to develop rectal cancer than women in the general population. Stratified analyses suggested that the risk reductions observed for colon and rectal cancer were most pronounced for women with breast cancer diagnosed after age 65 years, in white women, women with local stage breast cancer, and women diagnosed in the later study years (1990-94). Interpretations Breast cancer does not increase subsequent colorectal cancel risk, and reduced risk was seen for certain subgroups of women. Because no biologically plausible endogenous protective factor has been identified. we suggest that reduced risk could stem from an accumulation of exposures that increase breast-cancer frequency but protect against colorectal cancer.	Johns Hopkins Sch Med & Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Thomas Jefferson Univ, Jefferson Med Coll, Oncol Data Serv, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Div Gastroenterol & Hepatol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA	Johns Hopkins University; Jefferson University; Jefferson University; Jefferson University	Newschaffer, CJ (corresponding author), Johns Hopkins Sch Med & Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	cnewscha@jhsp.edu						Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Beral V, 1999, J Epidemiol Biostat, V4, P191; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; BRESLOW N, 1986, NATL CANC I MONOGR, V67, P149; Burnand B, 1999, ENDOSCOPY, V31, P673; Curtis RE, 1996, J NATL CANCER I, V88, P832, DOI 10.1093/jnci/88.12.832; Donovan JM, 1998, J WOMENS HEALTH, V7, P45, DOI 10.1089/jwh.1998.7.45; EISEN GM, 1994, J CLIN GASTROENTEROL, V19, P57, DOI 10.1097/00004836-199407000-00015; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Foulkes WD, 1996, J MED GENET, V33, P534, DOI 10.1136/jmg.33.7.534; Goodman SN, 1998, AM J EPIDEMIOL, V147, P807, DOI 10.1093/oxfordjournals.aje.a009531; Grodstein F, 1999, AM J MED, V106, P574, DOI 10.1016/S0002-9343(99)00063-7; Jednak MA, 1998, PRIMARY CARE, V25, P293, DOI 10.1016/S0095-4543(05)70065-8; Jordan V C, 1997, Oncology (Williston Park), V11, P7; Lin KM, 1999, DIS COLON RECTUM, V42, P1041, DOI 10.1007/BF02236700; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Nattinger AB, 1997, J CLIN EPIDEMIOL, V50, P939, DOI 10.1016/S0895-4356(97)00099-1; NEUGUT AI, 1991, CANCER, V68, P2069, DOI 10.1002/1097-0142(19911101)68:9<2069::AID-CNCR2820680938>3.0.CO;2-M; NEWELL GR, 1974, J NATL CANCER I, V53, P369, DOI 10.1093/jnci/53.2.369; PEARCE N, 1987, AM J EPIDEMIOL, V125, P1085, DOI 10.1093/oxfordjournals.aje.a114624; Platz EA, 1997, CANCER CAUSE CONTROL, V8, P894, DOI 10.1023/A:1018420513815; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; RUTQVIST LE, 1995, J NATL CANCER I, V87, P645, DOI 10.1093/jnci/87.9.645; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; SCHATZKIN A, 1998, CANCER, V62, P1451; SCHOEN RE, 1994, AM J GASTROENTEROL, V89, P835; Schottenfeld D, 1996, CANC EPIDEMIOLOGY PR, P813; Stoll BA, 1998, BRIT J SURG, V85, P1468; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; URY HK, 1985, AM J EPIDEMIOL, V122, P197, DOI 10.1093/oxfordjournals.aje.a114083; Whitlock EP, 1998, J WOMENS HEALTH, V7, P1017, DOI 10.1089/jwh.1998.7.1017	31	36	37	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2001	357	9259					837	840		10.1016/S0140-6736(00)04197-0	http://dx.doi.org/10.1016/S0140-6736(00)04197-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265952				2022-12-28	WOS:000167586300010
J	Sorensen, TIA; Echwald, SM				Sorensen, TIA; Echwald, SM			Obesity genes - Identifying single genes involved in polygenic inheritance is not easy	BRITISH MEDICAL JOURNAL			English	Editorial Material									Copenhagen Univ Hosp, Inst Prevent Med, Danish Epidemiol Sci Ctr, DK-1399 Copenhagen K, Denmark; Hagedorn Res Inst, Steno Diabet Ctr, DK-2820 Gentofte, Denmark	Aarhus University; University of Copenhagen; Novo Nordisk; Hagedorn Research Institute; Steno Diabetes Center	Sorensen, TIA (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Danish Epidemiol Sci Ctr, DK-1399 Copenhagen K, Denmark.							Chagnon YC, 2000, OBES RES, V8, P89, DOI 10.1038/oby.2000.12; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; Echwald SM, 1999, J INTERN MED, V245, P653, DOI 10.1046/j.1365-2796.1999.00494.x; Lin RCY, 1999, BMJ-BRIT MED J, V319, P1337, DOI 10.1136/bmj.319.7221.1337; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Nelson T L, 2000, Twin Res, V3, P43; Rosmond R, 2001, BRIT MED J, V322, P652, DOI 10.1136/bmj.322.7287.652; Sorensen T. I. A., 1994, GENETICS OBESITY, P49; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; World Health Organization,, 1998, WHO TECHN REP SER; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	11	15	15	1	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 17	2001	322	7287					630	631		10.1136/bmj.322.7287.630	http://dx.doi.org/10.1136/bmj.322.7287.630			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413QE	11250836	Green Published			2022-12-28	WOS:000167622600005
J	van Eijk, MEC; Avorn, J; Porsius, AJ; de Boer, A				van Eijk, MEC; Avorn, J; Porsius, AJ; de Boer, A			Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing	BRITISH MEDICAL JOURNAL			English	Article							EDUCATIONAL OUTREACH; DEPRESSION; PROGRAM; DRUGS; CARE	Objective To compare the effect of individual educational visits versus group visits using academic detailing to discuss prescribing of highly anticholinergic antidepressants in elderly people. Design Randomised controlled trial with three arms (individual visits, group visits, and a control arm). Setting Southwest Netherlands Participants 190 general practitioners and 37 pharmacists organised in 21 peer review groups were studied using a database covering all prescriptions to people covered by national health insurance in the area (about 240 000). Intervention,All general practitioners and pharmacists in both intervention arms were offered two educational visits. For physicians in groups randomised to the individual visit arm, 43 of 70 general practitioners participated; in the group visit intervention arm, five of seven groups (41 of 52 general practitioners) participated. Main outcome measures Numbers of elderly people (greater than or equal to 60 years) with new prescriptions of highly anticholinergic antidepressants and less anticholinergic antidepressants. Results An intention to treat analysis found a 26% reduction in the rate of starting highly anticholinergic antidepressants in elderly people (95% confidence interval - 4% to 48%) in the individual intervention ann and 45% (8% to 67'%) in the group intervention arm. The use of less anticholinergic antidepressants increased by 40% (6% to 83%) in the individual intervention arm and 29% (-7% to 79%) in the group intervention arm. Conclusions Both the individual and the group visits decreased the use of highly anticholinergic antidepressants and increased the use of less anticholinergic antidepressant In elderly people. These approaches are practical means to improve prescribing by continuing medical education.	Univ Utrecht, Fac Pharm, Utrecht Inst Pharmaceut Sci, Dept Pharmacoepidemiol & Pharmacotherapy, NL-3508 TB Utrecht, Netherlands; OZ Zorgverzekeringen, Breda, Netherlands; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Pharmacoepidemiol, Boston, MA 02115 USA	Utrecht University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	de Boer, A (corresponding author), Univ Utrecht, Fac Pharm, Utrecht Inst Pharmaceut Sci, Dept Pharmacoepidemiol & Pharmacotherapy, POB 80082, NL-3508 TB Utrecht, Netherlands.							Avorn J, 1998, NEW ENGL J MED, V339, P918, DOI 10.1056/NEJM199809243391311; AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; AVORN J, 1992, NEW ENGL J MED, V327, P168, DOI 10.1056/NEJM199207163270306; BEERS MH, 1991, ARCH INTERN MED, V151, P1825; BEERS MH, 1989, DRUGS, V37, P105, DOI 10.2165/00003495-198937010-00008; Braybrook S, 1996, J CLIN PHARM THER, V21, P247, DOI 10.1111/j.1365-2710.1996.tb01146.x; BREUREN MM, 1996, NEDERLANDS TIJDSCHRI, V51, P2586; CASSEL CK, 1997, GERIATRIC MED; DENIG P, 1993, SOC SCI MED, V36, P915, DOI 10.1016/0277-9536(93)90083-G; EDWARDS JG, 1995, BRIT MED J, V311, P887; EKEDAHL A, 1995, EUR J CLIN PHARMACOL, V47, P381; Granados A, 1997, INT J TECHNOL ASSESS, V13, P220, DOI 10.1017/S0266462300010370; Grol R, 1998, BRIT MED J, V317, P858, DOI 10.1136/bmj.317.7162.858; HAAIJERRUSKAMP FM, 1995, ESSENTIAL DRUGS MONI, V20, P20; Hartzema A. G., 1998, PHARMACOEPIDEMIOLOGY; KNEGTERING H, 1994, DRUG AGING, V5, P192, DOI 10.2165/00002512-199405030-00005; Maclure M, 1998, LANCET, V352, P943, DOI 10.1016/S0140-6736(97)11390-3; Marwijk HWJ, 1994, HUISARTS WET, V37, P482; MEERTENS R, 1988, SOCIALE PSYCHOL; Menting JEA, 1996, INT CLIN PSYCHOPHARM, V11, P165, DOI 10.1097/00004850-199609000-00003; MONANE M, 1993, ARCH INTERN MED, V153, P633, DOI 10.1001/archinte.153.5.633; Salzman C, 1997, INT CLIN PSYCHOPHARM, V12, pS37, DOI 10.1097/00004850-199712007-00007; SCLAR DA, 1994, CLIN THER, V16, P715; SCOTT DK, 1994, BRIT J CLIN PHARMACO, V37, P217, DOI 10.1111/j.1365-2125.1994.tb04265.x; Shaw ME, 1932, AM J PSYCHOL, V44, P491, DOI 10.2307/1415351; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Szecsenyi J, 1995, Z Arztl Fortbild (Jena), V89, P419; THOMSON MA, 1998, COCHRANE LIB; van Eijk MEC, 2000, J CLIN EPIDEMIOL, V53, P645, DOI 10.1016/S0895-4356(99)00194-8; VRIES CD, 1998, COLLABORATION HEALTH; WHITINGOKEEFE QE, 1984, MED CARE, V22, P1101, DOI 10.1097/00005650-198412000-00005; WILLCOX SM, 1994, JAMA-J AM MED ASSOC, V272, P292, DOI 10.1001/jama.272.4.292	32	70	73	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 17	2001	322	7287					654	657		10.1136/bmj.322.7287.654	http://dx.doi.org/10.1136/bmj.322.7287.654			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413QE	11250852	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000167622600027
J	Slamon, DJ; Leyland-Jones, B; Shak, S; Fuchs, H; Paton, V; Bajamonde, A; Fleming, T; Eiermann, W; Wolter, J; Pegram, M; Baselga, J; Norton, L				Slamon, DJ; Leyland-Jones, B; Shak, S; Fuchs, H; Paton, V; Bajamonde, A; Fleming, T; Eiermann, W; Wolter, J; Pegram, M; Baselga, J; Norton, L			Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; OVARIAN-CANCER; NEU ONCOGENE; PHASE-II; CELLS; THERAPY; PROTOONCOGENE; AMPLIFICATION; EXPRESSION; DISEASE	Background: The HER2 gene, which encodes the growth factor receptor HER2, is amplified and HER2 is overexpressed in 25 to 30 percent of breast cancers, increasing the aggressiveness of the tumor. Methods: We evaluated the efficacy and safety of trastuzumab, a recombinant monoclonal antibody against HER2, in women with metastatic breast cancer that overexpressed HER2. We randomly assigned 234 patients to receive standard chemotherapy alone and 235 patients to receive standard chemotherapy plus trastuzumab. Patients who had not previously received adjuvant (postoperative) therapy with an anthracycline were treated with doxorubicin (or epirubicin in the case of 36 women) and cyclophosphamide with (143 women) or without trastuzumab (138 women). Patients who had previously received adjuvant anthracycline were treated with paclitaxel alone (96 women) or paclitaxel with trastuzumab (92 women). Results: The addition of trastuzumab to chemotherapy was associated with a longer time to disease progression (median, 7.4 vs. 4.6 months; P<0.001), a higher rate of objective response (50 percent vs. 32 percent, P<0.001), a longer duration of response (median, 9.1 vs. 6.1 months; P<0.001), a lower rate of death at 1 year (22 percent vs. 33 percent, P=0.008), longer survival (median survival, 25.1 vs. 20.3 months; P=0.046), and a 20 percent reduction in the risk of death. The most important adverse event was cardiac dysfunction, which occurred in 27 percent of the group given an anthracycline, cyclophosphamide, and trastuzumab; 8 percent of the group given an anthracycline and cyclophosphamide alone; 13 percent of the group given paclitaxel and trastuzumab; and 1 percent of the group given paclitaxel alone. Although the cardiotoxicity was potentially severe and, in some cases, life-threatening, the symptoms generally improved with standard medical management. Conclusions: Trastuzumab increases the clinical benefit of first-line chemotherapy in metastatic breast cancer that overexpresses HER2. (N Engl J Med 2001;344:783-92.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Calif Los Angeles, Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; McGill Univ, Dept Oncol, Montreal, PQ, Canada; Genentech Inc, Med Affairs, S San Francisco, CA 94080 USA; IntraBiotics, Mt View, CA USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Frauenklin vom Roten Kreuz, Dept Obstet & Gynecol, Munich, Germany; Rush Presbyterian St Lukes Med Ctr, Dept Oncol, Chicago, IL 60612 USA; Hosp Gen Univ Vall Dhebron, Dept Oncol, Barcelona, Spain; Mem Sloan Kettering Canc Ctr, Dept Med Oncol, New York, NY 10021 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; McGill University; Roche Holding; Genentech; University of Washington; University of Washington Seattle; Rush University; Hospital Universitari Vall d'Hebron; Memorial Sloan Kettering Cancer Center	Slamon, DJ (corresponding author), Univ Calif Los Angeles, Sch Med, Div Hematol Oncol, 11-244 Factor Bldg,10833 Le Conte, Los Angeles, CA 90095 USA.		Mieszkowska, Magdalena/O-6753-2017; Wilson, Matthew H/K-3193-2013	Norton, Larry/0000-0003-3701-9250				AHERN RP, 1993, BRIT J CANCER, V67, P801, DOI 10.1038/bjc.1993.146; AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; Baselga J, 1999, CANCER RES, V59, P2020; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; CHAZIN VR, 1992, ONCOGENE, V7, P1859; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; Fossati R, 1998, J CLIN ONCOL, V16, P3439, DOI 10.1200/JCO.1998.16.10.3439; Greenberg PAC, 1996, J CLIN ONCOL, V14, P2197, DOI 10.1200/JCO.1996.14.8.2197; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hortobagyi GN, 1998, NEW ENGL J MED, V339, P974, DOI 10.1056/NEJM199810013391407; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; Konecny G., 1999, Breast Cancer Research and Treatment, V57, P114; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Pegram M, 1999, ONCOGENE, V18, P2241, DOI 10.1038/sj.onc.1202526; Pegram MD, 1998, J CLIN ONCOL, V16, P2659, DOI 10.1200/JCO.1998.16.8.2659; PIETRAS RJ, 1994, ONCOGENE, V9, P1829; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; Pietras RJ, 1998, ONCOGENE, V17, P2235, DOI 10.1038/sj.onc.1202132; Pietras RJ, 1999, CANCER RES, V59, P1347; PRESS MF, 1993, CANCER RES, V53, P4960; RAVDIN PM, 1995, GENE, V159, P19, DOI 10.1016/0378-1119(94)00866-Q; SESHADRI R, 1993, J CLIN ONCOL, V11, P1936, DOI 10.1200/JCO.1993.11.10.1936; SHEPARD HM, 1991, J CLIN IMMUNOL, V11, P117, DOI 10.1007/BF00918679; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SLEDGE GW, 1997, P AN M AM SOC CLIN, V16, P1; Smith G, 1996, SEMIN ONCOL, V23, P506; VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710	33	8199	8699	49	1260	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2001	344	11					783	792		10.1056/NEJM200103153441101	http://dx.doi.org/10.1056/NEJM200103153441101			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410LA	11248153				2022-12-28	WOS:000167440400001
J	Debenedetti, PG; Stillinger, FH				Debenedetti, PG; Stillinger, FH			Supercooled liquids and the glass transition	NATURE			English	Review							SPATIALLY HETEROGENEOUS DYNAMICS; POTENTIAL-ENERGY LANDSCAPE; LENNARD-JONES LIQUID; MODE-COUPLING THEORY; FORMING LIQUIDS; O-TERPHENYL; MECHANICAL INSTABILITIES; KINETIC INHOMOGENEITIES; CONFIGURATIONAL ENTROPY; INHERENT STRUCTURES	Glasses are disordered materials that lack the periodicity of crystals but behave mechanically like solids. The most common way of making a glass is by cooling a viscous liquid fast enough to avoid crystallization. Although this route to the vitreous state - supercooling - has been known for millennia, the molecular processes by which liquids acquire amorphous rigidity upon cooling are not fully understood. Here we discuss current theoretical knowledge of the manner in which intermolecular forces give rise to complex behaviour in supercooled liquids and glasses. An intriguing aspect of this behaviour is the apparent connection between dynamics and thermodynamics. The multidimensional potential energy surface as a function of particle coordinates (the energy landscape) offers a convenient viewpoint for the analysis and interpretation of supercooling and glass-formation phenomena. That much of this analysis is at present largely qualitative reflects the fact that precise computations of how viscous liquids sample their landscape have become possible only recently.	Princeton Univ, Dept Chem Engn, Princeton, NJ 08544 USA; Princeton Univ, Princeton Mat Inst, Princeton, NJ 08544 USA; Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA	Princeton University; Princeton University; Alcatel-Lucent; Lucent Technologies; AT&T	Debenedetti, PG (corresponding author), Princeton Univ, Dept Chem Engn, Princeton, NJ 08544 USA.	pdebene@princeton.edu	Debenedetti, Pablo/ABD-1497-2021	Debenedetti, Pablo/0000-0003-1881-1728				ABKEVICH VI, 1994, J CHEM PHYS, V101, P6052, DOI 10.1063/1.467320; ADAM G, 1965, J CHEM PHYS, V43, P139, DOI 10.1063/1.1696442; ANDERSON PW, 1995, SCIENCE, V268, P1154, DOI 10.1126/science.268.5214.1154; Angelani L, 2000, PHYS REV LETT, V85, P5356, DOI 10.1103/PhysRevLett.85.5356; Angell C.A., 1985, RELAXATION COMPLEX S, P1; Angell CA, 1997, PHYSICA D, V107, P122, DOI 10.1016/S0167-2789(97)00077-8; ANGELL CA, 1988, J NON-CRYST SOLIDS, V102, P205, DOI 10.1016/0022-3093(88)90133-0; ANGELL CA, 1991, J NON-CRYST SOLIDS, V131, P13, DOI 10.1016/0022-3093(91)90266-9; ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Angell CA, 2000, J APPL PHYS, V88, P3113, DOI 10.1063/1.1286035; Becker OM, 1997, J CHEM PHYS, V106, P1495, DOI 10.1063/1.473299; BENGTZELIUS U, 1984, J PHYS C SOLID STATE, V17, P5915, DOI 10.1088/0022-3719/17/33/005; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bohmer R, 1996, EUROPHYS LETT, V36, P55, DOI 10.1209/epl/i1996-00186-5; BRUNING R, 1992, PHYS REV B, V46, P11318, DOI 10.1103/PhysRevB.46.11318; Buchner S, 1999, PHYS REV E, V60, P6507, DOI 10.1103/PhysRevE.60.6507; CICERONE MT, 1995, J CHEM PHYS, V103, P5684, DOI 10.1063/1.470551; Cicerone MT, 1996, J CHEM PHYS, V104, P7210, DOI 10.1063/1.471433; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; Cummins HZ, 1996, PHYS REV E, V54, P5870, DOI 10.1103/PhysRevE.54.5870; Debenedetti P.G., 1996, METASTABLE LIQUIDS C; Debenedetti PG, 1999, J PHYS CHEM B, V103, P7390, DOI 10.1021/jp991384m; DEBENEDETTI PG, IN PRESS ADV CHEM EN; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Donati C, 1999, PHYS REV E, V60, P3107, DOI 10.1103/PhysRevE.60.3107; Ediger MD, 1996, J PHYS CHEM-US, V100, P13200, DOI 10.1021/jp953538d; Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FUJARA F, 1992, Z PHYS B CON MAT, V88, P195, DOI 10.1007/BF01323572; FUJIMORI H, 1995, SOLID STATE COMMUN, V94, P157, DOI 10.1016/0038-1098(94)00851-5; Fulcher GS, 1925, J AM CERAM SOC, V8, P339, DOI 10.1111/j.1151-2916.1925.tb16731.x; GESZTI T, 1983, J PHYS C SOLID STATE, V16, P5805, DOI 10.1088/0022-3719/16/30/010; GIBBS JH, 1958, J CHEM PHYS, V28, P373, DOI 10.1063/1.1744141; GOLDSTEIN M, 1969, J CHEM PHYS, V51, P3728, DOI 10.1063/1.1672587; Gotze W., 1995, Transport Theory and Statistical Physics, V24, P801, DOI 10.1080/00411459508203936; Gotze W, 1999, J PHYS-CONDENS MAT, V11, pA1, DOI 10.1088/0953-8984/11/10A/002; GOTZE W, 1992, REP PROG PHYS, V55, P241, DOI 10.1088/0034-4885/55/3/001; Green JL, 1999, J PHYS CHEM B, V103, P3991, DOI 10.1021/jp983927i; GREER AL, 1995, SCIENCE, V267, P1947, DOI 10.1126/science.267.5206.1947; Greer AL, 2000, NATURE, V404, P134, DOI 10.1038/35004689; GREET RJ, 1967, J CHEM PHYS, V46, P1243, DOI 10.1063/1.1840842; Hurley MM, 1996, J CHEM PHYS, V105, P10521, DOI 10.1063/1.472941; Ito K, 1999, NATURE, V398, P492, DOI 10.1038/19042; JENNISKENS P, 1994, SCIENCE, V265, P753, DOI 10.1126/science.11539186; JOHARI GP, 1973, J CHEM PHYS, V58, P1766, DOI 10.1063/1.1679421; JOHARI GP, 1970, J CHEM PHYS, V53, P2372, DOI 10.1063/1.1674335; JONSSON H, 1988, PHYS REV LETT, V60, P2295, DOI 10.1103/PhysRevLett.60.2295; KAUZMANN W, 1948, CHEM REV, V43, P219, DOI 10.1021/cr60135a002; Keyes T, 1997, J PHYS CHEM A, V101, P2921, DOI 10.1021/jp963706h; Keyes T, 1999, PHYS REV E, V59, P3207, DOI 10.1103/PhysRevE.59.3207; KIRKPATRICK TR, 1987, PHYS REV B, V36, P8552, DOI 10.1103/PhysRevB.36.8552; KIRKPATRICK TR, 1989, PHYS REV A, V40, P1045, DOI 10.1103/PhysRevA.40.1045; Kivelson D, 1996, PHYS REV E, V53, P751, DOI 10.1103/PhysRevE.53.751; KIVELSON D, 1995, PHYSICA A, V219, P27, DOI 10.1016/0378-4371(95)00140-3; Kivelson D, 1998, J CHEM PHYS, V109, P5481, DOI 10.1063/1.477166; Kivelson D, 1998, J NON-CRYST SOLIDS, V235, P86, DOI 10.1016/S0022-3093(98)00631-0; Klepeis JL, 1999, J COMPUT CHEM, V20, P1354, DOI 10.1002/(SICI)1096-987X(199910)20:13<1354::AID-JCC3>3.0.CO;2-N; Kob W, 1999, J PHYS-CONDENS MAT, V11, pR85, DOI 10.1088/0953-8984/11/10/003; KOB W, 1995, PHYS REV E, V51, P4626, DOI 10.1103/PhysRevE.51.4626; Kohlrausch R, 1854, ANN PHYS CHEM, V91, P179, DOI DOI 10.1002/ANDP.18541670203; Lacks DJ, 1998, PHYS REV LETT, V80, P5385, DOI 10.1103/PhysRevLett.80.5385; LAUGHLIN WT, 1972, J PHYS CHEM-US, V76, P2317, DOI 10.1021/j100660a023; Liu CZW, 1996, PHYS REV E, V53, P799, DOI 10.1103/PhysRevE.53.799; MACKENZIE JD, 1961, J AM CERAM SOC, V44, P598, DOI 10.1111/j.1151-2916.1961.tb11665.x; Malandro DL, 1999, J CHEM PHYS, V110, P4593, DOI 10.1063/1.478340; Malandro DL, 1997, J CHEM PHYS, V107, P5804, DOI 10.1063/1.474340; Malandro DL, 1998, PHYS REV LETT, V81, P5576, DOI 10.1103/PhysRevLett.81.5576; MELCUK AI, 1995, PHYS REV LETT, V75, P2522, DOI 10.1103/PhysRevLett.75.2522; Mezard M, 1999, PHYS REV LETT, V82, P747, DOI 10.1103/PhysRevLett.82.747; MOYNIHAN CT, 1976, ANN NY ACAD SCI, V279, P15, DOI 10.1111/j.1749-6632.1976.tb39688.x; Nienhaus GU, 1997, PHYSICA D, V107, P297, DOI 10.1016/S0167-2789(97)00097-3; Novikov VN, 1996, EUROPHYS LETT, V35, P289, DOI 10.1209/epl/i1996-00568-7; Perera DN, 1996, PHYS REV E, V54, P1652, DOI 10.1103/PhysRevE.54.1652; Perera DN, 1996, J CHEM PHYS, V104, P2369, DOI 10.1063/1.470932; Plotkin SS, 1996, PHYS REV E, V53, P6271, DOI 10.1103/PhysRevE.53.6271; PRIELMEIER FX, 1987, PHYS REV LETT, V59, P1128, DOI 10.1103/PhysRevLett.59.1128; Rastogi S, 1999, MACROMOLECULES, V32, P8897, DOI 10.1021/ma9912958; Richert R, 1998, J CHEM PHYS, V108, P9016, DOI 10.1063/1.476348; RICHERT R, 1994, DISORDER EFFECTS ON RELAXATIONAL PROCESSES, P1; ROSSLER E, 1994, J NON-CRYST SOLIDS, V172, P113, DOI 10.1016/0022-3093(94)90424-3; Russell EV, 2000, NATURE, V408, P695; Santen L, 2000, NATURE, V405, P550, DOI 10.1038/35014561; Sastry S, 1998, NATURE, V393, P554, DOI 10.1038/31146; Sastry S, 2001, NATURE, V409, P164, DOI 10.1038/35051524; SAVEN JG, 1994, J CHEM PHYS, V101, P11037, DOI 10.1063/1.467855; Scala A, 2000, NATURE, V406, P166, DOI 10.1038/35018034; Schulz M, 1998, PHYS REV B, V57, P11319, DOI 10.1103/PhysRevB.57.11319; Sciortino F, 1999, PHYS REV LETT, V83, P3214, DOI 10.1103/PhysRevLett.83.3214; Simon F, 1931, Z ANORG ALLG CHEM, V203, P219, DOI 10.1002/zaac.19312030120; Speedy RJ, 1999, J PHYS CHEM B, V103, P4060, DOI 10.1021/jp983830w; Stillinger FH, 1998, J PHYS CHEM B, V102, P2807, DOI 10.1021/jp973144h; STILLINGER FH, 1994, PHYS REV E, V50, P2064, DOI 10.1103/PhysRevE.50.2064; Stillinger FH, 1999, PHYS REV E, V59, P48, DOI 10.1103/PhysRevE.59.48; STILLINGER FH, 1995, SCIENCE, V267, P1935, DOI 10.1126/science.267.5206.1935; STILLINGER FH, 1988, J CHEM PHYS, V88, P7818, DOI 10.1063/1.454295; Stillinger FH, 1998, J CHEM PHYS, V109, P3983, DOI 10.1063/1.476997; Stillinger FH, 1999, J PHYS CHEM B, V103, P4052, DOI 10.1021/jp983831o; Tammann G., 1926, ANORG ALLG CHEM, V156, P245, DOI [10.1002/zaac.19261560121, DOI 10.1002/ZAAC.19261560121]; TARJUS G, 1995, J CHEM PHYS, V103, P3071, DOI 10.1063/1.470495; TURNBULL D, 1969, CONTEMP PHYS, V10, P473, DOI 10.1080/00107516908204405; Vogel H, 1921, PHYS Z, V22, P645; Wang CY, 1999, J PHYS CHEM B, V103, P4177, DOI 10.1021/jp984149x; Wang J, 1996, PHYS REV LETT, V76, P4861, DOI 10.1103/PhysRevLett.76.4861; Wilks J., 1967, PROPERTIES LIQUID SO; WILLIAMS G, 1970, T FARADAY SOC, V66, P80, DOI 10.1039/tf9706600080; WILLIAMS ML, 1955, J AM CHEM SOC, V77, P3701, DOI 10.1021/ja01619a008; Wolynes P. G., 1988, AIP C P, V180, P39, DOI [10.1063/1.37862, DOI 10.1063/1.37862]; Wolynes PG, 1997, J RES NATL INST STAN, V102, P187, DOI 10.6028/jres.102.014; [No title captured]	109	3425	3473	54	1252	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2001	410	6825					259	267		10.1038/35065704	http://dx.doi.org/10.1038/35065704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11258381				2022-12-28	WOS:000167320500060
J	Najman, Y; Pringle, M; Godin, L; Oliver, G				Najman, Y; Pringle, M; Godin, L; Oliver, G			Dating of the oldest continental sediments from the Himalayan foreland basin	NATURE			English	Article							EOCENE AGE; PAKISTAN; INDIA; EVOLUTION; COLLISION; HISTORY; ASIA; INITIATION; TECTONICS	A detailed knowledge of Himalayan development is important for our wider understanding of several global processes, ranging from models of plateau uplift to changes in oceanic chemistry and climate(1-4). Continental sediments 55 Myr old found in a foreland basin in Pakistan(5) are, by more than 20 Myr, the oldest deposits thought to have been eroded from the Himalayan metamorphic mountain belt. This constraint on when erosion began has influenced models of the timing and diachrony of the India-Eurasia collision(6-8), timing and mechanisms of exhumation(9,10) and uplift(11), as well as our general understanding of foreland basin dynamics(12). But the depositional age of these basin sediments was based on biostratigraphy from four intercalated marl units(5). Here we present dates of 257 detrital grains of white mica from this succession, using the Ar-40-(39) Ar method, and find that the largest concentration of ages are at 36-40 Myr. These dates are incompatible with the biostratigraphy unless the mineral ages have been reset, a possibility that we reject on the basis of a number of lines of evidence. A more detailed mapping of this formation suggests that the marl units are structurally intercalated with the continental sediments and accordingly that biostratigraphy cannot be used to date the clastic succession. The oldest continental foreland basin sediments containing metamorphic detritus eroded from the Himalaya orogeny therefore seem to be at least 15-20 Myr younger than previously believed, and models based on the older age must be re-evaluated.	Univ Calgary, Dept Geol & Geophys, Fold & Fault Res Project, Calgary, AB T2N 1N4, Canada; Scottish Univ Environm Res Ctr, E Kilbride G75 0QF, Lanark, Scotland; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Univ St Andrews, Sch Geog & Geosci, Crustal Geodynam Grp, St Andrews KY16 9ST, Fife, Scotland	University of Calgary; Scottish Universities Research & Reactor Center; University of Oxford; University of St Andrews	Najman, Y (corresponding author), Univ Calgary, Dept Geol & Geophys, Fold & Fault Res Project, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.		Najman, Yani/B-3027-2014; Pringle, Malcolm/ABD-5663-2020; Godin, Laurent/J-2578-2012; Godin, Laurent/N-4224-2019	Najman, Yani/0000-0003-1286-6509; 				BLENKINSOP TG, 1988, J METAMORPH GEOL, V6, P623, DOI 10.1111/j.1525-1314.1988.tb00444.x; BOSSART P, 1989, ECLOGAE GEOL HELV, V82, P133; BOSSART P, 1986, THESIS ETH ZURICH; Burbank D.W., 1996, TECTONIC EVOLUTION A, P149; BUTLER R, 1995, NATURE, V373, P20, DOI 10.1038/373020a0; Clauer N., 1998, LOW GRADE METAMORPHI, P202; CRITELLI S, 1994, SEDIMENT GEOL, V89, P265, DOI 10.1016/0037-0738(94)90097-3; DeCelles PG, 1998, TECTONICS, V17, P741, DOI 10.1029/98TC02598; GARZANTI E, 1987, GEODIN ACTA, V1, P297, DOI 10.1080/09853111.1987.11105147; Garzanti E, 1996, GEOL SOC AM BULL, V108, P631, DOI 10.1130/0016-7606(1996)108<0631:PAPEOT>2.3.CO;2; HOUSEMAN G, 1993, J GEOPHYS RES-SOL EA, V98, P12233, DOI 10.1029/93JB00443; KRISHNASWAMI S, 1992, EARTH PLANET SC LETT, V109, P2443; Kubler B., 1967, ETAGES TECTONIQUES C, P105; Najman YMR, 1997, GEOLOGY, V25, P535, DOI 10.1130/0091-7613(1997)025<0535:LAADOS>2.3.CO;2; Pivnik DA, 1996, GEOL SOC AM BULL, V108, P1295, DOI 10.1130/0016-7606(1996)108<1295:TTFTTT>2.3.CO;2; Richards JP, 1999, ECON GEOL BULL SOC, V94, P1231, DOI 10.2113/gsecongeo.94.8.1231; RICHTER FM, 1992, EARTH PLANET SC LETT, V109, P11, DOI 10.1016/0012-821X(92)90070-C; Rowley DB, 1996, EARTH PLANET SC LETT, V145, P1, DOI 10.1016/S0012-821X(96)00201-4; Rowley DB, 1998, J GEOL, V106, P229, DOI 10.1086/516018; RUDDIMAN WF, 1991, SCI AM, V3, P42; TRELOAR PJ, 1991, GEOL MAG, V128, P465, DOI 10.1017/S0016756800018628; TRELOAR PJ, 1999, TERRA NOSTRA, V2, P157; Uddin A, 1998, GEOL SOC AM BULL, V110, P497, DOI 10.1130/0016-7606(1998)110<0497:CHOTHB>2.3.CO;2; Weber K, 1972, NEUES JB MINER MONAT, V6, P267	24	114	124	1	20	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					194	197		10.1038/35065577	http://dx.doi.org/10.1038/35065577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242076	Green Accepted			2022-12-28	WOS:000167320500042
J	Cole, BE; Williams, JB; King, BT; Sherwin, MS; Stanley, CR				Cole, BE; Williams, JB; King, BT; Sherwin, MS; Stanley, CR			Coherent manipulation of semiconductor quantum bits with terahertz radiation	NATURE			English	Article							COMPUTATION; GAAS; DOTS	Quantum bits(1-5) (qubits) are the fundamental building blocks of quantum information processors, such as quantum computers(6). A qubit comprises a pair of well characterized quantum states that can in principle be manipulated quickly compared to the time it takes them to decohere by coupling to their environment(7). Much remains to be understood about the manipulation and decoherence of semiconductor qubits. Here we show that hydrogen-atom-like motional states of electrons bound to donor impurities in currently available semiconductors can serve as model qubits. We use intense pulses(8) of terahertz radiation to induce coherent, damped Rabi oscillations(9,10) in the population of two low-lying states of donor impurities in GaAs11-13. Our observations demonstrate that a quantum-confined extrinsic electron in a semiconductor can be coherently manipulated like an atomic electron, even while sharing space with similar to 10(5) atoms in its semiconductor host. We anticipate that this model system will be useful for measuring intrinsic decoherence processes, and for testing both simple and complex manipulations of semiconductor qubits.	Univ Calif Santa Barbara, Inst Quantum Engn Sci & Technol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; Univ Glasgow, Dept Elect & Elect Engn, Glasgow G12 8QQ, Lanark, Scotland	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Glasgow	Sherwin, MS (corresponding author), Univ Calif Santa Barbara, Inst Quantum Engn Sci & Technol, Santa Barbara, CA 93106 USA.		King, Benjamin Thomas/HHS-2747-2022; Sherwin, Mark S/Q-4762-2017	King, Benjamin Thomas/0000-0002-2404-4505; Sherwin, Mark S/0000-0002-3869-1893				BARRIE R, 1963, CAN J PHYS, V41, P1823, DOI 10.1139/p63-183; Bennett CH, 2000, NATURE, V404, P247, DOI 10.1038/35005001; BOCKELMANN U, 1994, PHYS REV B, V50, P17271, DOI 10.1103/PhysRevB.50.17271; Boyd R. W., 2003, NONLINEAR OPTICS; BURGHOORN J, 1994, SEMICOND SCI TECH, V9, P30, DOI 10.1088/0268-1242/9/1/006; CUNDIFF ST, 1994, PHYS REV LETT, V73, P1178, DOI 10.1103/PhysRevLett.73.1178; DIVINCENZO DP, 1995, SCIENCE, V270, P255, DOI 10.1126/science.270.5234.255; Hegmann FA, 1996, P SOC PHOTO-OPT INS, V2842, P90; Hegmann FA, 2000, APPL PHYS LETT, V76, P262, DOI 10.1063/1.125741; Imamoglu A, 1999, PHYS REV LETT, V83, P4204, DOI 10.1103/PhysRevLett.83.4204; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Klaassen TO, 1998, ATOMS AND MOLECULES IN STRONG EXTERNAL FIELDS, P291; KOHN W, 1957, SOLID STATE PHYS, V5, P257, DOI 10.1016/S0081-1947(08)60104-6; LARSEN DM, 1973, PHYS REV B, V8, P535, DOI 10.1103/PhysRevB.8.535; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; MCKNIGHT SW, 1987, INFRARED PHYS, V27, P327, DOI 10.1016/0020-0891(87)90074-1; NISHIKAWA K, 1963, CAN J PHYS, V41, P1135, DOI 10.1139/p63-116; PLANKEN PCM, 1995, PHYS REV B, V51, P9643, DOI 10.1103/PhysRevB.51.9643; Rabi II, 1937, PHYS REV, V51, P0652, DOI 10.1103/PhysRev.51.652; RAMIAN G, 1992, NUCL INSTRUM METH A, V318, P225, DOI 10.1016/0168-9002(92)91056-F; Schulzgen A, 1999, PHYS REV LETT, V82, P2346, DOI 10.1103/PhysRevLett.82.2346; Sherwin MS, 1999, PHYS REV A, V60, P3508, DOI 10.1103/PhysRevA.60.3508; STANLEY CR, 1991, APPL PHYS LETT, V58, P478, DOI 10.1063/1.104613; STANLEY CR, 1990, I PHYSICS C SERIES, V112, P67; STILLMAN GE, 1969, SOLID STATE COMMUN, V7, P921, DOI 10.1016/0038-1098(69)90543-2; VRIJEN R, 1999, QUANTPH9905096; Yu P. Y., 1999, FUNDAMENTALS SEMICON	27	216	227	0	50	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					60	63		10.1038/35065032	http://dx.doi.org/10.1038/35065032			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242038				2022-12-28	WOS:000167194300039
J	Sharon, E; Cohen, G; Fineberg, J				Sharon, E; Cohen, G; Fineberg, J			Propagating solitary waves along a rapidly moving crack front	NATURE			English	Article							DYNAMIC PLANAR CRACK; FRACTURE; PERTURBATION	A rapidly moving crack in a brittle material is often idealized(1) as a one-dimensional object with a singular tip, moving through a two-dimensional material. However, in real three-dimensional materials, tensile cracks form a planar surface whose edge is a rapidly moving one-dimensional singular front. The dynamics of these fronts under repetitive interaction(2-4) with material inhomogeneities (asperities) and the morphology(5-11) of the fracture surface that they create are not yet understood. Here we show that perturbations(12) to a crack front in a brittle material result in long-lived and highly localized waves, which we call 'front waves'. These waves exhibit a unique characteristic shape and propagate along the crack front at approximately(13-15) the Rayleigh wave speed (the speed of sound along a free surface). Following interaction, counter-propagating front waves retain both their shape and amplitude. They create characteristic traces along the fracture surface, providing cracks with both inertia and a new mode of dissipation. Front waves are intrinsically three-dimensional, and cannot exist in conventional two-dimensional theories of fracture(1). Because front waves can transport and distribute asperity-induced energy fluctuations throughout the crack front, they may help to explain how cracks remain a single coherent entity, despite repeated interactions with randomly dispersed asperities.	Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Fineberg, J (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.			Fineberg, Jay/0000-0002-8381-6675				Bahat D., 1991, TECTONOFRACTOGRAPHY; BEN-ZION Y, 1995, J MECH PHYS SOLIDS, V43, P1363, DOI 10.1016/0022-5096(95)00042-H; BOUCHAUD JP, 1993, PHYS REV LETT, V71, P2240, DOI 10.1103/PhysRevLett.71.2240; Daguier P, 1996, PHYS REV E, V53, P5637, DOI 10.1103/PhysRevE.53.5637; Daguier P, 1997, PHYS REV LETT, V78, P1062, DOI 10.1103/PhysRevLett.78.1062; Freund LB, 1990, DYNAMIC FRACTURE MEC, DOI [10.1017/oretCBO9780511546761-en, DOI 10.1017/ORETCBO9780511546761-EN]; HULL D, 1966, INT J FRACT MECH, V2, P468; Kulander BR, 1979, APPL FRACTOGRAPHY CO; MALOY KJ, 1992, PHYS REV LETT, V68, P213, DOI 10.1103/PhysRevLett.68.213; MANDELBROT BB, 1984, NATURE, V308, P721, DOI 10.1038/308721a0; Morrissey JW, 1998, J MECH PHYS SOLIDS, V46, P467, DOI 10.1016/S0022-5096(97)00072-0; Morrissey JW, 2000, J MECH PHYS SOLIDS, V48, P1229, DOI 10.1016/S0022-5096(99)00069-1; Movchan AB, 1998, INT J SOLIDS STRUCT, V35, P3419, DOI 10.1016/S0020-7683(97)00231-X; PERRIN G, 1994, J MECH PHYS SOLIDS, V42, P1047, DOI 10.1016/0022-5096(94)90083-3; Ramanathan S, 1997, PHYS REV LETT, V79, P877, DOI 10.1103/PhysRevLett.79.877; REMOISSENET M, 1996, WAVES CALLED SOLITON; RICE JR, 1994, J MECH PHYS SOLIDS, V42, P813, DOI 10.1016/0022-5096(94)90044-2; Sharon E, 1999, NATURE, V397, P333, DOI 10.1038/16891; Sharon E, 1996, PHYS REV B, V54, P7128, DOI 10.1103/PhysRevB.54.7128; Wallner H, 1939, Z PHYS, V114, P368, DOI 10.1007/BF01337002; Willis JR, 1997, J MECH PHYS SOLIDS, V45, P591, DOI 10.1016/S0022-5096(96)00102-0; WILLIS JR, 1995, J MECH PHYS SOLIDS, V43, P319, DOI 10.1016/0022-5096(94)00075-G	22	74	79	1	32	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					68	71		10.1038/35065051	http://dx.doi.org/10.1038/35065051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242041				2022-12-28	WOS:000167194300042
J	Saltiel, AR				Saltiel, AR			New perspectives into the molecular pathogenesis and treatment of Type 2 diabetes	CELL			English	Review							INCREASED INSULIN SENSITIVITY; ACTIVATED RECEPTOR-GAMMA; PROTEIN PHOSPHATASE 1; TNF-ALPHA; GLYCOGEN-SYNTHASE; GENE-EXPRESSION; PPAR-GAMMA; TYROSINE PHOSPHORYLATION; MICE LACKING; FATTY-ACIDS		Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Physiol, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Saltiel, AR (corresponding author), Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48109 USA.	saltiel@umich.edu	Saltiel, Alan/L-3632-2019	Saltiel, Alan/0000-0002-9726-9828				ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Berman HK, 1998, J BIOL CHEM, V273, P26421, DOI 10.1074/jbc.273.41.26421; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Brady MJ, 1997, J BIOL CHEM, V272, P29698, DOI 10.1074/jbc.272.47.29698; Brady MJ, 1998, J BIOL CHEM, V273, P14063, DOI 10.1074/jbc.273.23.14063; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Camp HS, 2000, DIABETES, V49, P539, DOI 10.2337/diabetes.49.4.539; Carpentier A, 1999, AM J PHYSIOL-ENDOC M, V276, pE1055, DOI 10.1152/ajpendo.1999.276.6.E1055; Cavaghan MK, 2000, J CLIN INVEST, V106, P329, DOI 10.1172/JCI10761; CHIANG SH, 2001, IN PRESS NATURE; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; Drake PG, 1998, MOL CELL BIOCHEM, V182, P79, DOI 10.1023/A:1006808100755; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Drucker DJ, 1999, TRENDS ENDOCRIN MET, V10, P153, DOI 10.1016/S1043-2760(98)00136-2; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Foretz M, 1999, MOL CELL BIOL, V19, P3760; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Glass CK, 2000, GENE DEV, V14, P121; Guilherme A, 2000, J BIOL CHEM, V275, P38151, DOI 10.1074/jbc.M003432200; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; HANSEN L, 1995, HUM MOL GENET, V4, P1313, DOI 10.1093/hmg/4.8.1313; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hattersley AT, 1998, DIABETIC MED, V15, P15, DOI 10.1002/(SICI)1096-9136(199801)15:1<15::AID-DIA562>3.0.CO;2-M; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Jiang T, 1998, J BIOL CHEM, V273, P11017, DOI 10.1074/jbc.273.18.11017; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928; KISSEBAH AH, 1994, PHYSIOL REV, V74, P761, DOI 10.1152/physrev.1994.74.4.761; Kjos SL, 1999, NEW ENGL J MED, V341, P1749, DOI 10.1056/NEJM199912023412307; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Krook A, 1997, J BIOL CHEM, V272, P30208, DOI 10.1074/jbc.272.48.30208; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lawrence JC, 1997, DIABETES, V46, P541, DOI 10.2337/diabetes.46.4.541; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Leiter EH, 1998, DIABETES, V47, P1287, DOI 10.2337/diabetes.47.8.1287; Mastick CC, 1997, J BIOL CHEM, V272, P20706, DOI 10.1074/jbc.272.33.20706; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Newgard CB, 2000, DIABETES, V49, P1967, DOI 10.2337/diabetes.49.12.1967; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Ofei F, 1996, DIABETES, V45, P881, DOI 10.2337/diabetes.45.7.881; Ohneda K, 2000, SEMIN CELL DEV BIOL, V11, P227, DOI 10.1006/scdb.2000.0171; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Peraldi P, 1998, MOL CELL BIOCHEM, V182, P169, DOI 10.1023/A:1006865715292; Permutt MA, 2000, TRENDS ENDOCRIN MET, V11, P383, DOI 10.1016/S1043-2760(00)00329-5; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Petersen KF, 1998, DIABETES, V47, P381, DOI 10.2337/diabetes.47.3.381; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; RANDLE PJ, 1963, LANCET, V1, P785; Rebrin K, 1996, J CLIN INVEST, V98, P741, DOI 10.1172/JCI118846; Ribon V, 1997, BIOCHEM J, V324, P839, DOI 10.1042/bj3240839; Ribon V, 1998, P NATL ACAD SCI USA, V95, P14751, DOI 10.1073/pnas.95.25.14751; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; SchmitzPeiffer C, 1997, DIABETES, V46, P169, DOI 10.2337/diabetes.46.2.169; Schreyer SA, 1998, J CLIN INVEST, V102, P402, DOI 10.1172/JCI2849; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Shah P, 2000, J CLIN ENDOCR METAB, V85, P4053, DOI 10.1210/jc.85.11.4053; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; Shen GQ, 1998, DIABETES CARE, V21, P1086, DOI 10.2337/diacare.21.7.1086; Shimabukuro M, 1997, P NATL ACAD SCI USA, V94, P4637, DOI 10.1073/pnas.94.9.4637; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; SHULMAN GI, 2000, J CLIN INVEST, V106, P171, DOI DOI 10.1172/JCI10583; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; STRACK AM, 1995, AM J PHYSIOL-REG I, V268, pR1209, DOI 10.1152/ajpregu.1995.268.5.R1209; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Taylor Simeon I., 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P419; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; TOKUYAMA Y, 1995, DIABETES, V44, P1447, DOI 10.2337/diabetes.44.12.1447; Unger RH, 1999, P NATL ACAD SCI USA, V96, P2327, DOI 10.1073/pnas.96.5.2327; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Wada T, 1999, ENDOCRINOLOGY, V140, P4585, DOI 10.1210/en.140.10.4585; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Xia J, 1998, DIABETES, V47, P1519, DOI 10.2337/diabetes.47.9.1519; Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974	103	546	583	0	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2001	104	4					517	529		10.1016/S0092-8674(01)00239-2	http://dx.doi.org/10.1016/S0092-8674(01)00239-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	405VP	11239409	Bronze			2022-12-28	WOS:000167181500007
J	Riordan, M; Rowson, PC; Wu, SL				Riordan, M; Rowson, PC; Wu, SL			Perspective: Particle physics - The search for the Higgs boson	SCIENCE			English	Editorial Material									Stanford Linear Accelerator Ctr, Stanford, CA 94309 USA; Univ Calif Santa Cruz, Dept Phys, Santa Cruz, CA 95064 USA; Univ Wisconsin, Madison, WI 53706 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California Santa Cruz; University of Wisconsin System; University of Wisconsin Madison	Riordan, M (corresponding author), Stanford Linear Accelerator Ctr, Stanford, CA 94309 USA.	michael@slac.stanford.edu		Wu, Sau Lan/0000-0001-5866-1504				ABE K, IN PRESS PHYS REV LE; Acciarri M, 2000, PHYS LETT B, V495, P18, DOI 10.1016/S0370-2693(00)01281-8; Barate R, 2000, PHYS LETT B, V495, P1, DOI 10.1016/S0370-2693(00)01269-7; ENGLERT F, 1964, PHYS REV LETT, V13, P321, DOI 10.1103/PhysRevLett.13.321; Gunion J. F., 1990, HIGGS HUNTERS GUIDE; GURALNIK GS, 1964, PHYS REV LETT, V13, P585, DOI 10.1103/PhysRevLett.13.585; GURTA A, 2000, 30 INT C HIGH EN PHY; HIGGS PW, 1964, PHYS LETT, V12, P132, DOI 10.1016/0031-9163(64)91136-9; HODDESON L, 1997, RISE STNADARD MODEL; IGOKEMENES P, 2000, LEP HIGGS WORK GROUP; *LEP EL WORK GROUP, 1995, CERNPPE95172 LEP EL; MIKENBERG G, 1996, 17 INT S LEPT PHOT I, P595	13	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2001	291	5502					259	260		10.1126/science.1057739	http://dx.doi.org/10.1126/science.1057739			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11253214				2022-12-28	WOS:000166352900031
J	Jarillo, JA; Capel, J; Tang, RH; Yang, HQ; Alonso, JM; Ecker, JR; Cashmore, AR				Jarillo, JA; Capel, J; Tang, RH; Yang, HQ; Alonso, JM; Ecker, JR; Cashmore, AR			An Arabidopsis circadian clock component interacts with both CRY1 and phyB	NATURE			English	Article							MOLECULAR-BASES; CONTROLLED GENE; RHYTHMS; NEUROSPORA; PROTEINS; DYSFUNCTION; ENCODES; TIME	Most organisms, from cyanobacteria to mammals, use circadian clocks to coordinate their activities with the natural 24-h light/dark cycle. The clock proteins of Drosophila and mammals exhibit striking homology but do not show similarity with clock proteins found so far from either cyanobacteria or Neurospora(1,2). Each of these organisms uses a transcriptionally regulated negative feedback loop in which the messenger RNA levels of the clock components cycle over a 24-h period. Proteins containing PAS domains are invariably found in at least one component of the characterized eukaryotic clocks(1). Here we describe ADAGIO1 (ADO1), a gene of Arabidopsis thaliana that encodes a protein containing a PAS domain. We found that a loss-of-function ado1 mutant is altered in both gene expression and cotyledon movement in circadian rhythmicity. Under constant white or blue light, the ado1 mutant exhibits a longer period than that of wild-type Arabidopsis seedlings, whereas under red light cotyledon movement and stem elongation are arrhythmic. Both yeast two-hybrid and in vitro binding studies show that there is a physical interaction between ADO1 and the photoreceptors CRY1 and phyB. We propose that ADO1 is an important component of the Arabidopsis circadian system.	Univ Penn, Inst Plant Sci, Dept Biol, Philadelphia, PA 19104 USA; Univ Almeria, Dept Biol Aplicata, Almeria 04120, Spain	University of Pennsylvania; Universidad de Almeria	Cashmore, AR (corresponding author), Univ Penn, Inst Plant Sci, Dept Biol, Philadelphia, PA 19104 USA.	cashmore@sas.upenn.edu	Ecker, Joseph R/B-9144-2008; Capel, Juan/M-3772-2018; Alonso, Jose M/K-6826-2014	Ecker, Joseph R/0000-0001-5799-5895; Capel, Juan/0000-0002-4327-0604; Alonso, Jose M/0000-0001-7087-1571; Jarillo, Jose Antonio/0000-0002-2963-7641; Tang, Ruhang/0000-0003-4918-3525				Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Ballario P, 1997, TRENDS MICROBIOL, V5, P458, DOI 10.1016/S0966-842X(97)01144-X; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; CARPENTER CD, 1994, PLANT PHYSIOL, V104, P1015, DOI 10.1104/pp.104.3.1015; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Jarillo JA., 1998, PLANT PHYSIOL, V117, P719; Kiyosue T, 2000, PLANT J, V23, P807, DOI 10.1046/j.1365-313x.2000.00850.x; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lakin-Thomas PL, 2000, TRENDS GENET, V16, P135, DOI 10.1016/S0168-9525(99)01945-9; Millar AJ, 1999, NEW PHYTOL, V141, P175, DOI 10.1046/j.1469-8137.1999.00349.x; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Ruf T, 1999, BIOL RHYTHM RES, V30, P178, DOI 10.1076/brhm.30.2.178.1422; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Somers DE, 1999, PLANT PHYSIOL, V121, P9, DOI 10.1104/pp.121.1.9; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6	29	159	188	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2001	410	6827					487	490		10.1038/35068589	http://dx.doi.org/10.1038/35068589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260718				2022-12-28	WOS:000167583800046
J	Bornman, PC; Beckingham, IJ				Bornman, PC; Beckingham, IJ			ABC of diseases of liver, pancreas, and biliary system - Chronic pancreatitis	BRITISH MEDICAL JOURNAL			English	Review									Univ Cape Town, ZA-7700 Rondebosch, South Africa; Queens Med Ctr, Dept Surg, Nottingham NG7 2UH, England	University of Cape Town; University of Nottingham	Bornman, PC (corresponding author), Univ Cape Town, ZA-7700 Rondebosch, South Africa.							Beckingham IJ, 1997, BRIT J SURG, V84, P1638, DOI 10.1002/bjs.1800841204; ECKHAUSER FE, 1995, HEPATOBIOLIARY PANCR, P395; MISIEWICZ JJ, 1994, DIS GUT PANCREAS, P441	3	23	24	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 17	2001	322	7287					660	663		10.1136/bmj.322.7287.660	http://dx.doi.org/10.1136/bmj.322.7287.660			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413QE	11250854	Green Published			2022-12-28	WOS:000167622600029
J	Elliott, MJ; Mallory, G; Khagani, A				Elliott, MJ; Mallory, G; Khagani, A			Transplantation from non-heart-beating donors	LANCET			English	Editorial Material									Great Ormond St Hosp Children, Dept Cardiothorac Surg, London WC1N 3JH, England; Great Ormond St Hosp Children, Dept Transplant Surg, London WC1N 3JH, England; Harefield Hosp, Dept Cardiothorac Surg, Herefield, Middx, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital	Elliott, MJ (corresponding author), Great Ormond St Hosp Children, Dept Cardiothorac Surg, Great Ormond St, London WC1N 3JH, England.		Elliott, Martin J/E-9229-2010	Elliott, Martin J/0000-0002-3913-9099				Fukushima N, 1998, ASAIO J, V44, pM525, DOI 10.1097/00002480-199809000-00041; Huddleston CB, 2000, J CARDIAC SURG, V15, P108, DOI 10.1111/j.1540-8191.2000.tb00450.x; Starnes VA, 1999, ANN THORAC SURG, V68, P2279, DOI 10.1016/S0003-4975(99)01155-8	3	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 17	2001	357	9259					819	820		10.1016/S0140-6736(00)04190-8	http://dx.doi.org/10.1016/S0140-6736(00)04190-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265945				2022-12-28	WOS:000167586300003
J	Tuomilehto, J; Jousilahti, P; Rastenyte, D; Moltchanov, V; Tanskanen, A; Pietinen, P; Nissinen, A				Tuomilehto, J; Jousilahti, P; Rastenyte, D; Moltchanov, V; Tanskanen, A; Pietinen, P; Nissinen, A			Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study	LANCET			English	Article							LOWER BLOOD-PRESSURE; DIETARY-SODIUM; OBSERVATIONAL DATA; RISK-FACTORS; SALT INTAKE; REDUCTION; DISEASE; POTASSIUM; STROKE	Background The evidence that high salt intake increases the risk of cardiovascular disease has been challenged. We aimed to find out whether salt intake, measured by 24 h urinary sodium excretion, is an independent risk factor for cardiovascular disease frequency and mortality, and all-cause mortality. Methods We prospectively followed 1173 Finnish men and 1263 women aged 25-64 years with complete data on 24 h urinary sodium excretion and cardiovascular risk factors. The endpoints were an incident coronary and stroke event. and death from coronary heart disease. cardiovascular disease, and any cause. Each endpoint was analysed separately with the Cox proportional hazards model. Findings The hazards ratios for coronary heart disease, cardiovascular disease, and all-cause mortality, associated with a 100 mmol increase in 24 h urinary sodium excretion, were 1.51 (95% CI 1.14-2.00), 1.45 (1.14-1.84), and 1.26 (1.06-1.50), respectively, in both men and women. The frequency of acute coronary events. but not acute stroke events, rose significantly with increasing sodium excretion. When analyses were done separately for each sex, the risk ratios were significant in men only. There was a significant interaction between sodium excretion and body mass index for cardiovascular and total mortality; sodium predicted mortality in men who were overweight. Correction for the regression dilution bias increased the hazards ratios markedly. Interpretation High sodium intake predicted mortality and risk of coronary heart disease, independent of other cardiovascular risk factors. including blood pressure. These results provide direct evidence of the harmful effects of high salt intake in the adult population.	Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FIN-00300 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; Kaunas Univ Med, Inst Cardiol, Kaunas, Lithuania; Univ Kuopio, Dept Psychiat, FIN-70211 Kuopio, Finland; Univ Kuopio, Dept Publ Hlth & Gen Practice, FIN-70211 Kuopio, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Lithuanian University of Health Sciences; University of Eastern Finland; University of Eastern Finland	Tuomilehto, J (corresponding author), Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Mannerheimintie 166, FIN-00300 Helsinki, Finland.	Jaakko.Tuomilehto@ktl.fi						ALDERMAN MH, 1995, HYPERTENSION, V25, P1144, DOI 10.1161/01.HYP.25.6.1144; Alderman MH, 1998, LANCET, V351, P781, DOI 10.1016/S0140-6736(97)09092-2; ALTSCHUL AM, 1981, INT J OBESITY, V5, P27; BEEVERS DG, 1989, J HUM HYPERTENS, V3, P279; DYER AR, 1994, HYPERTENSION, V23, P729, DOI 10.1161/01.HYP.23.6.729; ELLIOTT P, 1991, HYPERTENSION, V17, pI3, DOI 10.1161/01.HYP.17.1_Suppl.I3; Engelman K, 1998, LANCET, V351, P1508, DOI 10.1016/S0140-6736(05)78895-4; FROST CD, 1991, BRIT MED J, V302, P815, DOI 10.1136/bmj.302.6780.815; GARCIA G, 1997, HYPERTENSION, V29, P802; GLEIBERMANN L., 1973, Ecology of Food and Nutrition, V2, P143, DOI 10.1080/03670244.1973.9990329; He JA, 1999, JAMA-J AM MED ASSOC, V282, P2027, DOI 10.1001/jama.282.21.2027; IKEDA M, 1986, PREV MED, V15, P46, DOI 10.1016/0091-7435(86)90035-6; JACKSON FLC, 1991, HYPERTENSION, V17, pI129, DOI 10.1161/01.HYP.17.1_Suppl.I129; Jousilahti P, 1998, CIRCULATION, V97, P1087, DOI 10.1161/01.CIR.97.11.1087; Jousilahti P, 1996, CIRCULATION, V93, P1372, DOI 10.1161/01.CIR.93.7.1372; Karppanen H, 1998, LANCET, V351, P1509, DOI 10.1016/S0140-6736(05)78896-6; LAW MR, 1991, BMJ-BRIT MED J, V302, P811, DOI 10.1136/bmj.302.6780.811; LUFT FC, 1979, CIRCULATION, V60, P697, DOI 10.1161/01.CIR.60.3.697; MCCARRON DA, 1984, SCIENCE, V224, P1392, DOI 10.1126/science.6729459; Midgley JP, 1996, JAMA-J AM MED ASSOC, V275, P1590, DOI 10.1001/jama.275.20.1590; NISSINEN A, 1982, MAGNESIUM, V1, P232; PAJAK A, 1988, World Health Statistics Quarterly, V41, P115; PERRY IJ, 1992, J HUM HYPERTENS, V6, P23; PIETINEN P, 1982, ANN NUTR METAB, V26, P90, DOI 10.1159/000176550; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; ROCCHINI AP, 1989, NEW ENGL J MED, V321, P580, DOI 10.1056/NEJM198908313210905; TUOMILEHTO J, 1984, ANN CLIN RES, V16, P18; TUOMILEHTO J, 1981, ACTA CARDIOL, V36, P83; VARTIAINEN E, 1994, BMJ-BRIT MED J, V309, P23, DOI 10.1136/bmj.309.6946.23; VARTIAINEN E, 1995, BMJ-BRIT MED J, V310, P901, DOI 10.1136/bmj.310.6984.901; XIE JX, 1992, J HUM HYPERTENS, V6, P17; Yamori Y, 1994, Health Rep, V6, P22	32	415	429	1	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2001	357	9259					848	851		10.1016/S0140-6736(00)04199-4	http://dx.doi.org/10.1016/S0140-6736(00)04199-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265954				2022-12-28	WOS:000167586300012
J	Klein, ML				Klein, ML			Chemistry - Water on the move	SCIENCE			English	Editorial Material							INITIO MOLECULAR-DYNAMICS; SIMULATION; IONS		Univ Penn, Res Struct Matter Lab, Philadelphia, PA 19104 USA	University of Pennsylvania	Klein, ML (corresponding author), Univ Penn, Res Struct Matter Lab, Philadelphia, PA 19104 USA.							Bruge F, 1999, J AM CHEM SOC, V121, P10883, DOI 10.1021/ja990520y; Dellago C, 1998, J CHEM PHYS, V108, P1964, DOI 10.1063/1.475562; Geissler PL, 2001, SCIENCE, V291, P2121, DOI 10.1126/science.1056991; Hamm P, 1998, PHYS REV LETT, V81, P5326, DOI 10.1103/PhysRevLett.81.5326; Kropman MF, 2001, SCIENCE, V291, P2118, DOI 10.1126/science.1058190; LAASONEN K, 1994, J AM CHEM SOC, V116, P11620, DOI 10.1021/ja00104a073; Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579; Pasquarello A, 2001, SCIENCE, V291, P856, DOI 10.1126/science.291.5505.856; POWELL DH, 1988, FARADAY DISCUSS, P137; SOPER A, 2000, CHEM PHYS, V258; TUCKERMAN M, 1995, J PHYS CHEM-US, V99, P5749, DOI 10.1021/j100016a003; Yarne DA, 2000, CHEM PHYS, V258, P163, DOI 10.1016/S0301-0104(00)00114-2	13	29	32	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2106	2107		10.1126/science.1060087	http://dx.doi.org/10.1126/science.1060087			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11256411				2022-12-28	WOS:000167563800027
J	Lindley, D				Lindley, D			Questions of direction - Top-down versus bottom-up	NATURE			English	Article																			0	0	0	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					305	305		10.1038/35066643	http://dx.doi.org/10.1038/35066643			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268181	Bronze			2022-12-28	WOS:000167464100021
J	Smaglik, P				Smaglik, P			Pharmacogenetics initiative galvanizes public and private sectors	NATURE			English	Article																			0	3	3	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					393	394		10.1038/35066732	http://dx.doi.org/10.1038/35066732			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268220				2022-12-28	WOS:000167464100057
J	Mitch, WE; Price, SR				Mitch, WE; Price, SR			Transcription factors and muscle cachexia: is there a therapeutic target?	LANCET			English	Editorial Material							PROTEASOME PROTEOLYTIC PATHWAY; FACTOR-KAPPA-B; SKELETAL-MUSCLE; MESSENGER-RNA; PROTEIN-DEGRADATION; UBIQUITIN; GLUCOCORTICOIDS; ACTIVATION; MECHANISM; SEPSIS		Emory Univ, Sch Med, Div Renal, Atlanta, GA 30322 USA	Emory University	Mitch, WE (corresponding author), Emory Univ, Sch Med, Div Renal, Atlanta, GA 30322 USA.							Andersen JL, 2000, SCI AM, V283, P48, DOI 10.1038/scientificamerican0900-48; Baghdiguian S, 1999, NAT MED, V5, P503, DOI 10.1038/8385; Bertrand F, 1999, J BIOL CHEM, V274, P30596, DOI 10.1074/jbc.274.43.30596; Du J, 2000, J BIOL CHEM, V275, P19661, DOI 10.1074/jbc.M907258199; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Kaliman P, 1999, J BIOL CHEM, V274, P17437, DOI 10.1074/jbc.274.25.17437; Mansoor O, 1996, P NATL ACAD SCI USA, V93, P2714, DOI 10.1073/pnas.93.7.2714; MAY RC, 1986, J CLIN INVEST, V77, P614, DOI 10.1172/JCI112344; MEDINA R, 1995, BIOCHEM J, V307, P631, DOI 10.1042/bj3070631; MITCH WE, 1994, J CLIN INVEST, V93, P2127, DOI 10.1172/JCI117208; Mitch WE, 1999, AM J PHYSIOL-CELL PH, V276, pC1132, DOI 10.1152/ajpcell.1999.276.5.C1132; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Price SR, 1996, J CLIN INVEST, V98, P1703, DOI 10.1172/JCI118968; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Tiao G, 1997, J CLIN INVEST, V99, P163, DOI 10.1172/JCI119143; Tiao G, 1996, J CLIN INVEST, V97, P339, DOI 10.1172/JCI118421; WING SS, 1993, AM J PHYSIOL, V264, pE668, DOI 10.1152/ajpendo.1993.264.4.E668	17	34	36	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					734	735		10.1016/S0140-6736(00)04177-5	http://dx.doi.org/10.1016/S0140-6736(00)04177-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253960				2022-12-28	WOS:000167400900004
J	Malleret, G; Haditsch, U; Genoux, D; Jones, MW; Bliss, TVP; Vanhoose, AM; Weitlauf, C; Kandel, ER; Winder, DG; Mansuy, IM				Malleret, G; Haditsch, U; Genoux, D; Jones, MW; Bliss, TVP; Vanhoose, AM; Weitlauf, C; Kandel, ER; Winder, DG; Mansuy, IM			Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin	CELL			English	Article							DEPENDENT PROTEIN-KINASE; CAMP-RESPONSIVE ELEMENT; HIPPOCAMPAL CA1 REGION; MORRIS WATER MAZE; SYNAPTIC TRANSMISSION; PHOSPHATASE-ACTIVITY; EXPLORATORY ACTIVITY; ADENYLYL-CYCLASE; SPATIAL MEMORY; LTP	The threshold for hippocampal-dependent synaptic plasticity and memory storage is thought to be determined by the balance between protein phosphorylation and dephosphorylation mediated by the kinase PKA and the phosphatase calcineurin. To establish whether endogenous calcineurin acts as an inhibitory constraint in this balance, we examined the effect of genetically inhibiting calcineurin on plasticity and memory. Using the doxycycline-dependent rtTA system to express a calcineurin inhibitor reversibly in the mouse brain, we find that the transient reduction of calcineurin activity facilitates LTP in vitro and in vivo. This facilitation is PKA dependent and persists over several days in vivo. It is accompanied by enhanced learning and strengthened short- and long-term memory in several hippocampal-dependent spatial and nonspatial tasks. The LTP and memory improvements are reversed fully by suppression of transgene expression. These results demonstrate that endogenous calcineurin constrains LTP and memory.	ETH Honggerberg, Swiss Fed Inst Technol, Inst Cell Biol, CH-8093 Zurich, Switzerland; Natl Inst Med Res, Div Neurophysiol, London NW7 1AA, England; Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37232 USA; Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Bordeaux 1, Cognit Neurosci Lab, CNRS, Unite Mixte Rech 5807, F-33405 Talence, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; MRC National Institute for Medical Research; Vanderbilt University; Vanderbilt University; Columbia University; Howard Hughes Medical Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Mansuy, IM (corresponding author), ETH Honggerberg, Swiss Fed Inst Technol, Inst Cell Biol, CH-8093 Zurich, Switzerland.		Winder, Danny G./H-4857-2013; Mansuy, Isabelle M/N-3042-2015	Mansuy, Isabelle M/0000-0001-7785-5371; Jones, Matthew/0000-0001-5396-3108				Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; Allen PB, 2000, J NEUROSCI, V20, P3537, DOI 10.1523/JNEUROSCI.20-10-03537.2000; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BUHOT MC, 1995, HIPPOCAMPUS, V5, P198, DOI 10.1002/hipo.450050306; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Cassel JC, 1998, NEUROBIOL LEARN MEM, V69, P22, DOI 10.1006/nlme.1997.3807; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Day LB, 1999, BEHAV NEUROSCI, V113, P914, DOI 10.1037/0735-7044.113.5.914; Errington ML, 1997, NATURE, V387, P666, DOI 10.1038/42625; Floresco SB, 1997, J NEUROSCI, V17, P1880; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Huang Y Y, 1994, Learn Mem, V1, P74; Ikegami S, 2000, NEUROSCIENCE, V98, P637, DOI 10.1016/S0306-4522(00)00161-5; Ikegami Shiro, 1996, Molecular Brain Research, V41, P183, DOI 10.1016/0169-328X(96)00094-0; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Jerecic J, 1999, ANN NY ACAD SCI, V868, P27, DOI 10.1111/j.1749-6632.1999.tb11271.x; Kornhauser JM, 1997, NEURON, V18, P839, DOI 10.1016/S0896-6273(00)80322-0; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Makhinson M, 1999, J NEUROSCI, V19, P2500; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; Mansuy IM, 1998, NEURON, V21, P257, DOI 10.1016/S0896-6273(00)80533-4; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; OLTON DS, 1981, EXP BRAIN RES, V41, P380; Otmakhov N, 1997, J NEUROSCI, V17, P5357; Papatheodoropoulos C, 2000, NEUROSCI LETT, V286, P57, DOI 10.1016/S0304-3940(00)01084-3; PATERSON JM, 1995, BIOCHEM BIOPH RES CO, V214, P1000, DOI 10.1006/bbrc.1995.2385; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Vnek N, 1996, J NEUROSCI, V16, P2780; Wang JH, 1997, J NEUROSCI, V17, P4600; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Wolfer DP, 1998, NEWS PHYSIOL SCI, V13, P118, DOI 10.1152/physiologyonline.1998.13.3.118; Yakel JL, 1997, TRENDS PHARMACOL SCI, V18, P124, DOI 10.1016/S0165-6147(97)01046-8; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	53	361	376	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2001	104	5					675	686		10.1016/S0092-8674(01)00264-1	http://dx.doi.org/10.1016/S0092-8674(01)00264-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257222	Bronze			2022-12-28	WOS:000167531100008
J	Spahn, CMT; Kieft, JS; Grassucci, RA; Penczek, PA; Zhou, KH; Doudna, JA; Frank, J				Spahn, CMT; Kieft, JS; Grassucci, RA; Penczek, PA; Zhou, KH; Doudna, JA; Frank, J			Hepatitis C virus IRES RNA-induced changes in the conformation of the 40S ribosomal subunit	SCIENCE			English	Article							15 ANGSTROM RESOLUTION; COLI 70S RIBOSOME; CRYOELECTRON MICROSCOPY; ENTRY SITE; 3-DIMENSIONAL RECONSTRUCTION; TRANSLATION INITIATION; ELECTRON-MICROSCOPY; VISUALIZATION; LOCALIZATION; MODEL	Initiation of protein synthesis in eukaryotes requires recruitment of the 40S ribosomal subunit to the messenger RNA(mRNA). In most cases, this depends on recognition of a modified nucleotide cap on the 5' end of the mRNA. However, an alternate pathway uses a structured RNA element in the 5' untranslated region of the messenger or viral RNA called an internal ribosomal entry site (IRES). Here, we present a cryo-electron microscopy map of the hepatitis C virus (HCV) IRES bound to the 40S ribosomal subunit at about 20 Angstrom resolution. IRES binding induces a pronounced conformational change in the 40S subunit and closes the mRNA binding cleft, suggesting a mechanism for IRES-mediated positioning of mRNA in the ribosomal decoding center.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA; Wadsworth Ctr, Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA	Yale University; Howard Hughes Medical Institute; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Health Research Inc; Howard Hughes Medical Institute; Wadsworth Center	Doudna, JA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	doudna@csb.yale.edu; joachim@wadsworth.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029169, R01GM060635] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM60635, R37 GM29169] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1999, CURR OPIN STRUC BIOL, V9, P215, DOI 10.1016/S0959-440X(99)80031-1; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; Frank J, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P45; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Frank J, 2000, METHOD ENZYMOL, V317, P276; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Honda M, 1999, J VIROL, V73, P1165, DOI 10.1128/JVI.73.2.1165-1174.1999; JACKSON RJ, 1996, TRANSLATIONAL CONTRO, P71; Kieft JS, 1999, J MOL BIOL, V292, P513, DOI 10.1006/jmbi.1999.3095; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; KIEFT JS, UNPUB; Kolupaeva VG, 2000, J VIROL, V74, P6242, DOI 10.1128/JVI.74.14.6242-6250.2000; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; LUTSCH G, 1983, BIOMED BIOCHIM ACTA, V42, P705; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Merrick WC., 1996, TRANSLATION CONTROL, P31; Orlova EV, 1997, J MOL BIOL, V271, P417, DOI 10.1006/jmbi.1997.1182; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Rijnbrand RCA, 2000, CURR TOP MICROBIOL, V242, P85; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Sizova DV, 1998, J VIROL, V72, P4775, DOI 10.1128/JVI.72.6.4775-4782.1998; Spahn CMT, 2000, STRUCTURE, V8, P937, DOI 10.1016/S0969-2126(00)00185-4; SPAHN CMT, UNPUB; SRIVASTAVA S, 1995, J MOL BIOL, V245, P461, DOI 10.1006/jmbi.1994.0037; SRIVASTAVA S, 1992, J MOL BIOL, V226, P301, DOI 10.1016/0022-2836(92)90946-H; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WAGENKNECHT T, 1988, J MOL BIOL, V199, P137, DOI 10.1016/0022-2836(88)90384-1; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	41	413	427	3	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2001	291	5510					1959	1962		10.1126/science.1058409	http://dx.doi.org/10.1126/science.1058409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239155				2022-12-28	WOS:000167401600045
J	Ng, WL; Lourenco, MA; Gwilliam, RM; Ledain, S; Shao, G; Homewood, KP				Ng, WL; Lourenco, MA; Gwilliam, RM; Ledain, S; Shao, G; Homewood, KP			An efficient room-temperature silicon-based light-emitting diode	NATURE			English	Article							ELECTROLUMINESCENCE	There is an urgent requirement for an optical emitter that is compatible with standard, silicon-based ultra-large-scale integration (ULSI) technology(1). Bulk silicon has an indirect energy bandgap and is therefore highly inefficient as a light source, necessitating the use of other materials for the optical emitters. However, the introduction of these materials is usually incompatible with the strict processing requirements of existing ULSI technologies. Moreover, as the length scale of the devices decreases, electrons will spend increasingly more of their time in the connections between components; this interconnectivity problem could restrict further increases in computer chip processing power and speed in as little as five years. Many efforts have therefore been directed, with varying degrees of success, to engineering silicon-based materials that are efficient light emitters(2-7). Here, we describe the fabrication, using standard silicon processing techniques, of a silicon light-emitting diode (LED) that operates efficiently at room temperature. Boron is implanted into silicon both as a dopant to forma p-n junction, as well as a means of introducing dislocation loops. The dislocation loops introduce a local strain field, which modifies the band structure and provides spatial confinement of the charge carriers. It is this spatial confinement which allows room-temperature electroluminescence at the band-edge. This device strategy is highly compatible with ULSI technology, as boron ion implantation is already used as a standard method for the fabrication of silicon devices.	Univ Surrey, Sch Elect Engn Informat Technol & Math, Surrey GU2 7XH, England; Univ Surrey, Dept Mech & Mat Engn, Surrey GU2 7XH, England	University of Surrey; University of Surrey	Homewood, KP (corresponding author), Univ Surrey, Sch Elect Engn Informat Technol & Math, Surrey GU2 7XH, England.	k.homewood@eim.surrey.ac.uk	Shao, Guosheng/C-2143-2016	Shao, Guosheng/0000-0003-1498-7929; gwilliam, russell/0000-0002-1488-755X				FORCHEL A, 1998, TECHN ROADM OPT INT; Hirschman KD, 1996, NATURE, V384, P338, DOI 10.1038/384338a0; Hirth J. P., 1982, THEORY DISLOCATIONS, P63; KOMODA T, 1995, NUCL INSTRUM METH B, V96, P387, DOI 10.1016/0168-583X(94)00525-7; Leong D, 1997, NATURE, V387, P686, DOI 10.1038/42667; LU ZH, 1995, NATURE, V378, P258, DOI 10.1038/378258a0; Sveinbjornsson EO, 1996, APPL PHYS LETT, V69, P2686, DOI 10.1063/1.117678; TYBESKOV L, 1996, PHYS REV B, V54, pR8361; Vescan L, 1999, EUR MAT RES, V77, P485; ZHENG B, 1994, APPL PHYS LETT, V64, P2842, DOI 10.1063/1.111977	10	598	624	3	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2001	410	6825					192	194		10.1038/35065571	http://dx.doi.org/10.1038/35065571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242075				2022-12-28	WOS:000167320500041
J	Dasso, M				Dasso, M			Running on ran: Nuclear transport and the mitotic spindle	CELL			English	Review							MICROTUBULE; DYNAMICS; CYCLE		NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dasso, M (corresponding author), NICHD, Lab Gene Regulat & Dev, NIH, Bldg 18,Room 106,18 Lib Dr MSC-5431, Bethesda, MD 20892 USA.			Dasso, Mary/0000-0002-5410-1371	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001902] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001902] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Andersen SSL, 1999, BIOESSAYS, V21, P53, DOI 10.1002/(SICI)1521-1878(199901)21:1<53::AID-BIES7>3.0.CO;2-L; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dogterom M, 1996, J CELL BIOL, V133, P125, DOI 10.1083/jcb.133.1.125; Fleig U, 2000, J CELL BIOL, V151, P1101, DOI 10.1083/jcb.151.5.1101; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Guarguaglini G, 2000, CELL GROWTH DIFFER, V11, P455; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Kahana JA, 1999, J CELL BIOL, V146, P1205, DOI 10.1083/jcb.146.6.1205; KURIYAMA R, 1981, J CELL BIOL, V91, P822, DOI 10.1083/jcb.91.3.822; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Sazer S, 2000, J CELL SCI, V113, P1111; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429	19	143	146	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2001	104	3					321	324		10.1016/S0092-8674(01)00218-5	http://dx.doi.org/10.1016/S0092-8674(01)00218-5			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239388	Bronze			2022-12-28	WOS:000167003100001
J	Myles, PS; McLeod, ADM; Hunt, JO; Fletcher, H				Myles, PS; McLeod, ADM; Hunt, JO; Fletcher, H			Sex differences in speed of emergence and quality of recovery after anaesthesia: cohort study	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-ANESTHESIA; SURGERY		Alfred Hosp, Dept Anaesthesia & Pain Management, Prahran, Vic 3181, Australia	Florey Institute of Neuroscience & Mental Health	Myles, PS (corresponding author), Alfred Hosp, Dept Anaesthesia & Pain Management, Prahran, Vic 3181, Australia.		Myles, Paul/AAU-9524-2020	Myles, Paul/0000-0002-3324-5456; Hunt, Jennifer/0000-0002-3740-6851				FRYE CA, 1994, BRAIN RES, V643, P194, DOI 10.1016/0006-8993(94)90025-6; Gan TJ, 1999, ANESTHESIOLOGY, V90, P1283, DOI 10.1097/00000542-199905000-00010; Myles PS, 2000, ANESTH ANALG, V91, P1163, DOI 10.1097/00000539-200011000-00023; Myles PS, 1999, ANESTH ANALG, V88, P83, DOI 10.1097/00000539-199901000-00016; Myles PS, 2000, BRIT J ANAESTH, V84, P6, DOI 10.1093/oxfordjournals.bja.a013383	5	62	64	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 24	2001	322	7288					710	711		10.1136/bmj.322.7288.710	http://dx.doi.org/10.1136/bmj.322.7288.710			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416GB	11264210	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000167771000026
J	[Anonymous]				[Anonymous]			Science's response - Is a government archive the best option?	SCIENCE			English	Editorial Material																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2001	291	5512					2318	2319						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11269301				2022-12-28	WOS:000167618700025
J	Yin, L; Wu, L; Wesche, H; Arthur, CD; White, JM; Goeddel, DV; Schreiber, RD				Yin, L; Wu, L; Wesche, H; Arthur, CD; White, JM; Goeddel, DV; Schreiber, RD			Defective lymphotoxin-beta receptor-induced NF-kappa B transcriptional activity in NIK-deficient mice	SCIENCE			English	Article							KINASE COMPLEX; LIVER DEGENERATION; IKK-BETA; ACTIVATION; ALPHA; GENE; ALYMPHOPLASIA; INDUCTION; PROTEINS; MUTATION	The role of NF-kappaB-inducing kinase (NIK) in cytokine signaling remains controversial To identify the physiologic functions of NIK, we disrupted the NIK locus by gene targeting. Although NIK-/- mice displayed abnormalities in both lymphoid tissue development and antibody responses, NIK-/- cells manifested normal NF-kappaB DNA binding activity when treated with a variety of cytokines, including tumor necrosis factor (TNF), interleukin-1 (IL-1), and lymphotoxin-beta (LT beta). However, NIK was selectively required for gene transcription induced through ligation of LT beta receptor but not TNF receptors. These results reveal that NIK regulates the transcriptional activity of NF-kappaB in a receptor-restricted manner.	Washington Univ, Sch Med, Dept Pathol & Immunol, Ctr Immunol, St Louis, MO 63110 USA; Tularik Inc, S San Francisco, CA 94080 USA	Washington University (WUSTL)	Schreiber, RD (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Ctr Immunol, St Louis, MO 63110 USA.		Schreiber, Robert/Q-7550-2019; Schreiber, Robert D/A-1276-2013	Schreiber, Robert D/0000-0001-6311-0432; Schreiber, Robert/0000-0003-1590-2341; White, James Michael/0000-0001-5110-6567				Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Browning JL, 1997, J IMMUNOL, V159, P3288; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Garceau N, 2000, J EXP MED, V191, P381, DOI 10.1084/jem.191.2.381; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	23	337	349	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2162	2165		10.1126/science.1058453	http://dx.doi.org/10.1126/science.1058453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251123				2022-12-28	WOS:000167563800043
J	Schroeder, SA				Schroeder, SA			Prospects for expanding health insurance coverage.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; CARE; COMMUNITY; ACCESS		Robert Wood Johnson Fdn, Princeton, NJ 08543 USA	Robert Wood Johnson Foundation (RWJF)	Schroeder, SA (corresponding author), Robert Wood Johnson Fdn, Princeton, NJ 08543 USA.							*AM COLL PHYS AM S, 2000, NO HLTH INS ITS ENOU; *AM MED ASS, 2000, EXP HLTH INS AMA PRO; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; BLENDON R, 2000, COMMUNICATION   0814; Blumenthal D, 2001, NEW ENGL J MED, V344, P766, DOI 10.1056/NEJM200103083441012; *C BUDG OFF, 2000, INCR SMALL FIRM HLTH; Cunningham PJ, 1999, HEALTH SERV RES, V34, P255; Cunningham PJ, 1997, HEALTH AFFAIR, V16, P167, DOI 10.1377/hlthaff.16.4.167; Cunningham PJ, 1999, JAMA-J AM MED ASSOC, V282, P943; FEDER J, 2001, HLTH AFF MILLWOOD, V20, P227; Forrest CB, 2000, JAMA-J AM MED ASSOC, V284, P2077, DOI 10.1001/jama.284.16.2077; Gabel J, 2000, HEALTH AFFAIR, V19, P144, DOI 10.1377/hlthaff.19.5.144; Gore A, 2000, NEW ENGL J MED, V343, P1184, DOI 10.1056/NEJM200010193431611; Gruber J, 2000, HEALTH AFFAIR, V19, P72, DOI 10.1377/hlthaff.19.1.72; Grumbach K, 2000, JAMA-J AM MED ASSOC, V284, P2114, DOI 10.1001/jama.284.16.2114; HELMS WD, 1972, HLTH AFF MILLWOOD, V11, P7; Kahn CN, 2001, HEALTH AFFAIR, V20, P40, DOI 10.1377/hlthaff.20.1.40; *KAIS COMM MED UNI, 2001, PUBL KAIS COMM MED U, V2224; Kasper JD, 2000, MED CARE RES REV, V57, P298, DOI 10.1177/107755870005700302; Kronebusch K, 2001, HEALTH AFFAIR, V20, P97, DOI 10.1377/hlthaff.20.1.97; Lewin ME, 2000, AM HLTH CARE SAFETY; Long SH, 1999, HEALTH AFFAIR, V18, P105, DOI 10.1377/hlthaff.18.4.105; Marquis J., 2000, LOS ANGELES TIM 1125, pA16; MILLER WE, 1991, NATL ELECT STUDIES A; PARK MH, 2000, CTR STUDYING HLTH SY, V19; Pauly M, 2001, HEALTH AFFAIR, V20, P9, DOI 10.1377/hlthaff.20.1.9; Schroeder SA, 1996, NEW ENGL J MED, V334, P1130, DOI 10.1056/NEJM199604253341713; SHEILS J, HLTH COVERAGE 2000 C; SHEILS J, 2000, HLTH COVERAGE 2000 C; *URB I, 2000, SNAPSH AM FAM, V2; *US GEN ACC OFF, 1998, MED SAV ACC RES SURV	31	20	21	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2001	344	11					847	852		10.1056/NEJM200103153441113	http://dx.doi.org/10.1056/NEJM200103153441113			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410LA	11248165				2022-12-28	WOS:000167440400013
J	Cabrillac, D; Cock, JM; Dumas, C; Gaude, T				Cabrillac, D; Cock, JM; Dumas, C; Gaude, T			The S-locus receptor kinase is inhibited by thioredoxins and activated by pollen coat proteins	NATURE			English	Article							SELF-INCOMPATIBILITY; BRASSICA-OLERACEA; MALE DETERMINANT; DOMAIN; GLYCOPROTEINS; DIMERIZATION; ENVIRONMENT; STIGMA; GENE	The self-incompatibility response in Brassica allows recognition and rejection of self-pollen by the stigmatic papillae. The transmembrane S-locus receptor kinase (SRK), a member of the receptor-like kinase superfamily in plants, mediates recognition of self-pollen on the female side(1), whereas the S-locus cysteine-rich protein (SCR) is the male component of the self-incompatibility response(2). SCR is presumably located in the pollen coat, and is thought to be the SRK ligand(2,3). Although many receptorlike kinases have been isolated in plants, the mechanisms of signal transduction mediated by these molecules remain largely unknown. Here we show that SRK is phosphorylated in vivo within one hour of self-pollination. We also show that, in vitro, autophosphorylation of SRK is prevented by the stigma thioredoxin THL1 in the absence of a ligand. This inhibition is released in a haplotype-specific manner by the addition of pollen coat proteins. Our data indicate that SRK is inhibited by thioredoxins and activated by pollen coat proteins.	UCBL, Ecole Normale Super Lyon, INRA, CNRS,UMR 5667, F-69364 Lyon 07, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON)	Gaude, T (corresponding author), UCBL, Ecole Normale Super Lyon, INRA, CNRS,UMR 5667, 46 Allee Italie, F-69364 Lyon 07, France.			Cock, J. Mark/0000-0002-2650-0383; GAUDE, Thierry/0000-0002-0804-9445				Bower MS, 1996, PLANT CELL, V8, P1641, DOI 10.1105/tpc.8.9.1641; DELORME A, 1995, STUD PERCEPT ACTION, V3, P7; DICKINSON H, 1995, SEX PLANT REPROD, V8, P1, DOI 10.1007/BF00228756; DOUGHTY J, 1993, P NATL ACAD SCI USA, V90, P467, DOI 10.1073/pnas.90.2.467; FLANNERY AV, 1989, PROTEOLYTIC ENZYMES, P145; GAUDE T, 1993, PLANT CELL, V5, P75, DOI 10.1105/tpc.5.1.75; Giranton JL, 1995, PLANT J, V8, P827, DOI 10.1046/j.1365-313X.1995.8060827.x; Giranton JL, 2000, P NATL ACAD SCI USA, V97, P3759, DOI 10.1073/pnas.070025097; Gu TS, 1998, P NATL ACAD SCI USA, V95, P382, DOI 10.1073/pnas.95.1.382; Hashimoto S, 1999, BIOCHEM BIOPH RES CO, V258, P443, DOI 10.1006/bbrc.1999.0658; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; KANDASAMY MK, 1989, DEV BIOL, V134, P462, DOI 10.1016/0012-1606(89)90119-X; Meyer Y, 1999, TRENDS PLANT SCI, V4, P388, DOI 10.1016/S1360-1385(99)01475-2; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SARKER RH, 1988, P NATL ACAD SCI USA, V85, P4340, DOI 10.1073/pnas.85.12.4340; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; SPAARGAREN M, 1991, J BIOL CHEM, V266, P1733; Stephenson AG, 1997, PLANT J, V12, P1351, DOI 10.1046/j.1365-313x.1997.12061351.x; Stone SL, 1999, SCIENCE, V286, P1729, DOI 10.1126/science.286.5445.1729; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628	20	173	217	0	20	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					220	223		10.1038/35065626	http://dx.doi.org/10.1038/35065626			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242083	Green Submitted			2022-12-28	WOS:000167320500049
J	Jones, R; Higgs, R; de Angelis, C; Prideaux, D				Jones, R; Higgs, R; de Angelis, C; Prideaux, D			Changing face of medical curricula	LANCET			English	Article							LEARNING CURRICULA; PRIMARY-CARE; STUDENTS; REVALIDATION; EDUCATION; ACHIEVEMENT; ENVIRONMENT; EXPERIENCE; AUSTRALIA; DOCTORS	The changing role of medicine in society and the growing expectations patients have of their doctors means that the content and delivery of medical curricula also have to change. The focus of health care has shifted from episodic care of individuals In hospitals to promotion of health in the community, and from paternalism and anecdotal care to negotiated management based on evidence of effectiveness and safety. Medical training is becoming more student centred, with an emphasis on active learning rather than on the passive acquisition of knowledge, and on the assessment of clinical competence rather than on the ability to retain and recall unrelated facts. Rigid educational programmes are giving way to more adaptable and flexible ones, in which student feedback and patient participation have increasingly important roles. The implementation of sustained innovation in medical education continues to present challenges, especially in terms of providing institutional and individual incentives. However, a continuously evolving, high quality medical education system is needed to assure the continued delivery of high quality medicine.	GKT Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England; Johns Hopkins Med Sch, Baltimore, MD USA; Flinders Univ S Australia, Sch Med, Adelaide, SA 5001, Australia	University of London; King's College London; Johns Hopkins University; Johns Hopkins Medicine; Flinders University South Australia	Jones, R (corresponding author), GKT Sch Med, Dept Gen Practice & Primary Care, 5 Lambeth Walk, London SE11 6SP, England.							Abelmann WH, 1997, J INVEST MED, V45, P272; Bligh J, 2000, MED EDUC, V34, P487; Brotherton SE, 2000, JAMA-J AM MED ASSOC, V284, P1121, DOI 10.1001/jama.284.9.1121; Carey RM, 1996, ACAD MED, V71, P839, DOI 10.1097/00001888-199608000-00011; Colliver JA, 2000, ACAD MED, V75, P259, DOI 10.1097/00001888-200003000-00017; Dahle LO, 1997, MED EDUC, V31, P416, DOI 10.1046/j.1365-2923.1997.00690.x; Dauphinee WD, 1999, BMJ-BRIT MED J, V319, P1188, DOI 10.1136/bmj.319.7218.1188; du Boulay C, 2000, BRIT MED J, V320, P1490, DOI 10.1136/bmj.320.7248.1490; *GEN MED COUNC, 1993, TOM DOCT REC UND MED; Guthrie E, 1998, J ROY SOC MED, V91, P237, DOI 10.1177/014107689809100502; JONES R, IN PRESS BR J GEN PR; JONES R, 1995, ED GENERAL PRACTICE, V6, P218; Kaufman DM, 1998, ACAD MED, V73, P1211, DOI 10.1097/00001888-199811000-00022; Kinnersley P, 1999, BRIT J GEN PRACT, V49, P711; Larkins R, 1998, Med J Aust, V169, P653; Matson C C, 1999, Acad Med, V74, pS53, DOI 10.1097/00001888-199901000-00032; McManus IC, 1999, BRIT MED J, V319, P542, DOI 10.1136/bmj.319.7209.542; Murray E, 1997, MED EDUC, V31, P369, DOI 10.1046/j.1365-2923.1997.00678.x; Newble D, 1999, BRIT MED J, V319, P1185, DOI 10.1136/bmj.319.7218.1185; Norington M, 1997, Aust J Rural Health, V5, P204, DOI 10.1111/j.1440-1584.1997.tb00268.x; O'Neill PA, 2000, MED EDUC, V34, P222; Pettersen Helge Bjornstad, 1997, Tidsskrift for den Norske Laegeforening, V117, P2798; Prideaux D, 2000, MED EDUC, V34, P449, DOI 10.1046/j.1365-2923.2000.00568.x; Ross RH, 1998, ACAD MED, V73, P258, DOI 10.1097/00001888-199803000-00013; Scherger JE, 2000, ACAD MED, V75, P693, DOI 10.1097/00001888-200007000-00010; Schmidt HG, 1996, ACAD MED, V71, P658, DOI 10.1097/00001888-199606000-00021; SCHWARTZ P, 1990, JAMA-J AM MED ASSOC, V281, P96; Silverman M, 1997, CLIN INVEST MED, V20, P255; van den Hurk MM, 1999, MED EDUC, V33, P808, DOI 10.1046/j.1365-2923.1999.00403.x; 1999, MED CURRICULA EUROPE	30	182	200	0	24	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					699	703		10.1016/S0140-6736(00)04134-9	http://dx.doi.org/10.1016/S0140-6736(00)04134-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247568				2022-12-28	WOS:000167282400035
J	Champagne, P; Ogg, GS; King, AS; Knabenhans, C; Ellefsen, K; Nobile, M; Appay, V; Rizzardi, GP; Fleury, S; Lipp, M; Forster, R; Rowland-Jones, S; Sekaly, RP; McMichael, AJ; Pantaleo, G				Champagne, P; Ogg, GS; King, AS; Knabenhans, C; Ellefsen, K; Nobile, M; Appay, V; Rizzardi, GP; Fleury, S; Lipp, M; Forster, R; Rowland-Jones, S; Sekaly, RP; McMichael, AJ; Pantaleo, G			Skewed maturation of memory HIV-specific CD8 T lymphocytes	NATURE			English	Article							PRIMARY IMMUNE-RESPONSE; EFFECTOR; CELLS; INFECTION; EXPANSION; SUBSETS; USAGE; AIDS	Understanding the lineage differentiation of memory T cells is a central question in immunology. We investigated this issue by analysing the expression of the chemokine receptor CCR7, which defines distinct subsets of naive and memory T lymphocytes with different homing and effector capacities(1-3) and antiviral immune responses to HIV and cytomegalovirus. Ex vivo analysis of the expression of CD45RA and CCR7 antigens, together with in vitro analysis of the cell-division capacity of different memory CD8(+) T-cell populations, identified four subsets of HIV- and CMV-specific CD8(+) T lymphocytes, and indicated the following lineage differentiation pattern: CD45RA(+)CCR7(+) --> CD45RA(-) CCR7(+) --> CD45RA(-) CCR7(-) --> CD45RA(+) CCR7(-). Here we demonstrate through analysis of cell division (predominantly restricted to the CCR7(+) CD8(+) T-cell subsets) that the differentiation of antigen-specific CD8(+) T cells is a two-step process characterized initially by a phase of proliferation largely restricted to the CCR7(+) CD8(+) cell subsets, followed by a phase of functional maturation encompassing the CCR7(-) CD8(+) cell subsets. The distribution of these populations in HIV- and CMV-specific CD8(+) T cells showed that the HIV-specific cell pool was predominantly (70%) composed of pre-terminally differentiated CD45RA(-)CCR7(-) cells, whereas the CMV-specific cell pool consisted mainly (50%) of the terminally differentiated CD45RA(+) CCR7(-) cells. These results demonstrate a skewed maturation of HIV-specific memory CD8(+) T cells during HIV infection.	Univ Lausanne, CHU Vaudois, Dept Med, Div Immunol & Allergy,Lab AIDS Immunopathogenesis, CH-1011 Lausanne, Switzerland; Univ Lausanne, CHU Vaudois, Dept Med, Div Infect Dis,Lab AIDS Immunopathogenesis, CH-1011 Lausanne, Switzerland; Univ Montreal, Ctr Hosp, Ctr Rech, Immunol Lab, Montreal, PQ H2W 1T8, Canada; McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H3A 2T5, Canada; John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2T5, Canada; Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H2W 1T8, Canada	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universite de Montreal; McGill University; University of Oxford; Helmholtz Association; Max Delbruck Center for Molecular Medicine; McGill University; Universite de Montreal	Pantaleo, G (corresponding author), Univ Lausanne, CHU Vaudois, Dept Med, Div Immunol & Allergy,Lab AIDS Immunopathogenesis, CH-1011 Lausanne, Switzerland.	Giuseppe.Pantaleo@chuv.hospvd.ch	Pantaleo, Giuseppe/K-6163-2016; Förster, Reinhold/D-6770-2011; Appay, Victor/M-4830-2017; Lipp, Martin/G-2235-2010; Appay, Victor/AAM-7701-2021	Appay, Victor/0000-0001-5434-3963; Forster, Reinhold/0000-0001-6190-7923; Lipp, Martin/0000-0002-0087-2672; Ogg, Graham/0000-0002-3097-045X				Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Andersson J, 1998, AIDS, V12, pF123, DOI 10.1097/00002030-199811000-00004; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Fleury S, 2000, P NATL ACAD SCI USA, V97, P5393, DOI 10.1073/pnas.97.10.5393; Fleury S, 1998, NAT MED, V4, P794, DOI 10.1038/nm0798-794; GERDES J, 1984, J IMMUNOL, V133, P1710; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; JOHNSON RP, 1991, J IMMUNOL, V147, P1512; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0; MIEDEMA F, 1994, IMMUNOL REV, V140, P35, DOI 10.1111/j.1600-065X.1994.tb00864.x; MITCHISON NA, 1964, PROC R SOC SER B-BIO, V161, P275, DOI 10.1098/rspb.1964.0093; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; PANTALEO G, 1990, P NATL ACAD SCI USA, V87, P4818, DOI 10.1073/pnas.87.12.4818; PANTALEO G, 1990, J IMMUNOL, V144, P1696; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; Wolthers KC, 1996, SCIENCE, V274, P1543, DOI 10.1126/science.274.5292.1543; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173	26	851	870	0	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 1	2001	410	6824					106	111		10.1038/35065118	http://dx.doi.org/10.1038/35065118			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242051				2022-12-28	WOS:000167194300052
J	Muller, A; Homey, B; Soto, H; Ge, NF; Catron, D; Buchanan, ME; McClanahan, T; Murphy, E; Yuan, W; Wagner, SN; Barrera, JL; Mohar, A; Verastegui, E; Zlotnik, A				Muller, A; Homey, B; Soto, H; Ge, NF; Catron, D; Buchanan, ME; McClanahan, T; Murphy, E; Yuan, W; Wagner, SN; Barrera, JL; Mohar, A; Verastegui, E; Zlotnik, A			Involvement of chemokine receptors in breast cancer metastasis	NATURE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; SKIN-ASSOCIATED CHEMOKINE; CELL-DERIVED FACTOR-1; FACTOR-I; FUNCTIONAL-RESPONSE; TUMOR PROGRESSION; STROMAL CELLS; MICE LACKING; CXCR4; EXPRESSION	Breast cancer is characterized by a distinct metastatic pattern involving the regional lymph nodes, bone marrow, lung and liver. Tumour cell migration and metastasis share many similarities with leukocyte trafficking, which is critically regulated by chemokines and their receptors. Here we report that the chemokine receptors CXCR4 and CCR7 are highly expressed in human breast cancer cells, malignant breast tumours and metastases. Their respective ligands CXCL12/SDF-1 alpha and CCL21/6Ckine exhibit peak levels of expression in organs representing the first destinations of breast cancer metastasis. In breast cancer cells, signalling through CXCR4 or CCR7 mediates actin polymerization and pseudopodia formation, and subsequently induces chemotactic and invasive responses. In vivo, neutralizing the interactions of CXCL12/CXCR4 significantly impairs metastasis of breast cancer cells to regional lymph nodes and lung. Malignant melanoma, which has a similar metastatic pattern as breast cancer but also a high incidence of skin metastases, shows high expression levels of CCR10 in addition to CXCR4 and CCR7. Our findings indicate that chemokines and their receptors have a critical role in determining the metastatic destination of tumour cells.	DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, Palo Alto, CA 94304 USA; Univ Dusseldorf, Dept Radiat Oncol, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany; Univ Essen, Dept Dermatol, D-45147 Essen, Germany; Inst Nacl Cancerol, Mexico City 14000, DF, Mexico; Natl Autonomous Univ Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Duisburg Essen; Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico	Zlotnik, A (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, 901 Calif Ave, Palo Alto, CA 94304 USA.		Zlotnik, Albert/C-3791-2011	Wagner, Stephan/0000-0003-4941-7029				Arai J, 2000, EUR J HAEMATOL, V64, P323, DOI 10.1034/j.1600-0609.2000.90147.x; Beahrs O. H., 1992, MANUAL STAGING CANC, V4th; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; BRUCE J, 1970, LANCET, V1, P433; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Hedrick JA, 1997, J IMMUNOL, V159, P1589; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; HOLLON SD, 1991, J CONSULT CLIN PSYCH, V59, P88, DOI 10.1037/0022-006X.59.1.88; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; HOWARD TH, 1984, J CELL BIOL, V98, P1265, DOI 10.1083/jcb.98.4.1265; Hromas R, 1997, J IMMUNOL, V159, P2554; HUJANEN ES, 1985, CANCER RES, V45, P3517; Koshiba T, 2000, CLIN CANCER RES, V6, P3530; Luboshits G, 1999, CANCER RES, V59, P4681; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mohle R, 2000, BRIT J HAEMATOL, V110, P563, DOI 10.1046/j.1365-2141.2000.02157.x; Mohle R, 1999, LEUKEMIA, V13, P1954, DOI 10.1038/sj.leu.2401602; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; NICOLSON GL, 1993, CANCER METAST REV, V12, P325, DOI 10.1007/BF00665961; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; SAIKI I, 1990, CANCER RES, V50, P3631; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Vassileva G, 1999, J EXP MED, V190, P1183, DOI 10.1084/jem.190.8.1183; VERSCHUEREN H, 1994, J LEUKOCYTE BIOL, V55, P552, DOI 10.1002/jlb.55.4.552; Vicari AP, 2000, J IMMUNOL, V165, P1992, DOI 10.4049/jimmunol.165.4.1992; Wang JM, 1998, J IMMUNOL METHODS, V220, P1, DOI 10.1016/S0022-1759(98)00128-8; YEATMAN TJ, 1993, SEMIN SURG ONCOL, V9, P256; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	39	4144	4588	16	590	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					50	56		10.1038/35065016	http://dx.doi.org/10.1038/35065016			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242036				2022-12-28	WOS:000167194300037
J	Shen, YA; Buick, R; Canfield, DE				Shen, YA; Buick, R; Canfield, DE			Isotopic evidence for microbial sulphate reduction in the early Archaean era	NATURE			English	Article							SEDIMENTARY-ROCKS; WARRAWOONA GROUP; SULFUR; AUSTRALIA; SULFATE; CARBON; LIFE; RECORD	Sulphate-reducing microbes affect the modern sulphur cycle, and may be quite ancient(1,2), though when they evolved is uncertain. These organisms produce sulphide while oxidizing organic matter or hydrogen with sulphate(3). At sulphate concentrations greater than 1 mM, the sulphides are isotopically fractionated (depleted in S-34) by 10-40 parts per thousand compared to the sulphate, with fractionations decreasing to near 0 parts per thousand at lower concentrations(2,4-6). The isotope record of sedimentary sulphides shows large fractionations relative to seawater sulphate by 2.7 Gyr ago, indicating microbial sulphate reduction(7). In older rocks, however, much smaller fractionations are of equivocal origin, possibly biogenic but also possibly volcanogenic(2,8-10). Here we report microscopic sulphides in similar to3.47-Gyr-old barites from North Pole, Australia, with maximum fractionations of 21.1 parts per thousand, about a mean of 11.6 parts per thousand, clearly indicating microbial sulphate reduction. Our results extend the geological record of microbial sulphate reduction back more than 750 million years, and represent direct evidence of an early specific metabolic pathway-allowing time calibration of a deep node on the tree of life.	Odense Univ, SDU, Danish Ctr Earth Syst Sci, DK-5230 Odense M, Denmark; Odense Univ, SDU, Inst Biol, DK-5230 Odense, Denmark; Univ Sydney, Sch Geosci FO5, Sydney, NSW 2006, Australia	University of Southern Denmark; University of Southern Denmark; University of Sydney	Shen, YA (corresponding author), Odense Univ, SDU, Danish Ctr Earth Syst Sci, Campusvej 55, DK-5230 Odense M, Denmark.		Canfield, Don/C-1735-2012; Sontag, Philip T/G-3927-2011; Shen, Yanan/L-3724-2018	Canfield, Don/0000-0001-7602-8366; Buick, Roger/0000-0003-0139-1659; Shen, Yanan/0000-0001-8343-6763				[Anonymous], [No title captured]; BUICK R, 1990, SEDIMENTOLOGY, V37, P247, DOI 10.1111/j.1365-3091.1990.tb00958.x; BUICK R, 1995, NATURE, V375, P574, DOI 10.1038/375574a0; CAMERON EM, 1982, NATURE, V296, P145, DOI 10.1038/296145a0; CAMERON EM, 1987, ECON GEOL, V82, P1177, DOI 10.2113/gsecongeo.82.5.1177; Canfield DE, 1999, AM J SCI, V299, P697, DOI 10.2475/ajs.299.7-9.697; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; CANFIELD DE, 1986, CHEM GEOL, V54, P149, DOI 10.1016/0009-2541(86)90078-1; GOODWIN AM, 1976, ECON GEOL, V71, P870, DOI 10.2113/gsecongeo.71.5.870; GROVES DI, 1981, SCI AM, V245, P64, DOI 10.1038/scientificamerican1081-64; HARDIE LA, 1967, AM MINERAL, V52, P171; HARRISON AG, 1958, T FARADAY SOC, V54, P84, DOI 10.1039/tf9585400084; Hayes J.M., 1992, PROTEROZOIC BIOSPHER, P129; KAPLAN IR, 1964, J GEN MICROBIOL, V34, P195, DOI 10.1099/00221287-34-2-195; Knoll AH, 1999, SCIENCE, V285, P1025, DOI 10.1126/science.285.5430.1025; Knoll Andrew H., 1998, Paleontological Society Papers, V4, P212; LAMBERT IB, 1978, NATURE, V276, P808, DOI 10.1038/276808a0; Nijman W, 1998, PRECAMBRIAN RES, V88, P25, DOI 10.1016/S0301-9268(97)00062-4; OHMOTO H, 1993, SCIENCE, V262, P555, DOI 10.1126/science.11539502; Ohmoto H., 1997, GEOCHEMISTRY HYDROTH, P517; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Postgate JR, 1984, SULPHATE REDUCING BA, V2nd; RANKIN AH, 1978, MINERAL MAG, V42, P408, DOI 10.1180/minmag.1978.042.323.16; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; STETTER KO, 1996, EVOLUTION HYDROTHERM, P1; Wagner M, 1998, J BACTERIOL, V180, P2975, DOI 10.1128/JB.180.11.2975-2982.1998; WIDDEL F, 1988, BIOL ANAEROBIC MICRO, P496	30	427	455	5	166	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					77	81		10.1038/35065071	http://dx.doi.org/10.1038/35065071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242044				2022-12-28	WOS:000167194300045
J	Glickman, MS; Jacobs, WR				Glickman, MS; Jacobs, WR			Microbial pathogenesis of Mycobacterium tuberculosis: Dawn of a discipline	CELL			English	Review							PHENOLIC GLYCOLIPID-I; INTERFERON-GAMMA; MEDIATED ACTIVATION; MYCOLIC ACIDS; EXPRESSION; VIRULENCE; MACROPHAGES; PERSISTENCE; LIPOARABINOMANNAN; PHAGOSOMES		Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Howard Hughes Med Inst, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Div Infect Dis, Bronx, NY 10461 USA; Montefiore Med Ctr, Bronx, NY 10461 USA	Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Jacobs, WR (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Howard Hughes Med Inst, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	jacobsw@hhmi.org		Jacobs, William/0000-0003-3321-3080; Glickman, Michael S/0000-0001-7918-5164	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001534] Funding Source: NIH RePORTER; NIAID NIH HHS [AI27160, AI01534] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Altare F, 1998, CURR OPIN IMMUNOL, V10, P413, DOI 10.1016/S0952-7915(98)80114-3; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; BARCLAY R, 1989, BIOL MYOBACTERIA, P37; Bardarov S, 1997, P NATL ACAD SCI USA, V94, P10961, DOI 10.1073/pnas.94.20.10961; BARKSDALE L, 1977, BACTERIOL REV, V41, P217, DOI 10.1128/MMBR.41.1.217-372.1977; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Bentrup KHZ, 1999, J BACTERIOL, V181, P7161; Berthet FX, 1998, SCIENCE, V282, P759, DOI 10.1126/science.282.5389.759; BLOOM BR, 1994, TUBERCULOSIS PATHOGE; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; BROSCH R, 2000, MOL GENETICS MYCOBAC; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; CHATTERJEE D, 1992, INFECT IMMUN, V60, P1249, DOI 10.1128/IAI.60.3.1249-1253.1992; CLARK DP, 1996, ESCHERICHIA COLI SAL, P612; Clemens DL, 2000, INFECT IMMUN, V68, P2671, DOI 10.1128/IAI.68.5.2671-2684.2000; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; COHN DL, 1990, ANN INTERN MED, V112, P407, DOI 10.7326/0003-4819-76-3-112-6-407; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; Cossart P, 1996, SCIENCE, V271, P315, DOI 10.1126/science.271.5247.315; *COUNC EABMR, 1974, LANCET, V2, P237; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dannenberg Arthur M. Jr., 1994, P149; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fitzmaurice AM, 1998, J BIOL CHEM, V273, P8033, DOI 10.1074/jbc.273.14.8033; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Glickman MS, 2001, J BIOL CHEM, V276, P2228, DOI 10.1074/jbc.C000652200; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Hatfull GF, 2000, MOL GENETICS MYCOBAC; JACOBS WR, 1986, P NATL ACAD SCI USA, V83, P1926, DOI 10.1073/pnas.83.6.1926; JACOBS WR, 1987, NATURE, V327, P532, DOI 10.1038/327532a0; Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701; KAMEDA K, 1981, J BIOL CHEM, V256, P5702; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kramnik I, 2000, P NATL ACAD SCI USA, V97, P8560, DOI 10.1073/pnas.150227197; Kubica GP., 1984, MYCOBACTERIA SOURCEB; Li ZM, 1998, J INFECT DIS, V177, P1030, DOI 10.1086/515254; MCADAM RA, 1995, INFECT IMMUN, V63, P1004, DOI 10.1128/IAI.63.3.1004-1012.1995; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; McKinney JD, 1998, BIOMED RES REP, P51; McMurray David N., 1994, P135; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2; Ozeki Y, 1997, INFECT IMMUN, V65, P1793, DOI 10.1128/IAI.65.5.1793-1799.1997; Pavelka MS, 1999, J BACTERIOL, V181, P4780, DOI 10.1128/JB.181.16.4780-4789.1999; Pelicic V, 1996, MOL MICROBIOL, V20, P919, DOI 10.1111/j.1365-2958.1996.tb02533.x; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; PRASAD HK, 1987, J EXP MED, V165, P239, DOI 10.1084/jem.165.1.239; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; RATLEDGE C, 1982, BIOL MYCOBACTERIA, V1; REES RJ, 1961, BRIT J EXP PATHOL, V42, P83; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; SIBLEY LD, 1990, CLIN EXP IMMUNOL, V80, P141; SIBLEY LD, 1988, INFECT IMMUN, V56, P1232, DOI 10.1128/IAI.56.5.1232-1236.1988; SNAPPER SB, 1988, P NATL ACAD SCI USA, V85, P6987, DOI 10.1073/pnas.85.18.6987; SPARGO BJ, 1991, P NATL ACAD SCI USA, V88, P737, DOI 10.1073/pnas.88.3.737; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; SURVEILLANCE TWI, 1997, ANTITUBERCULOSIS DRU; VACHULA M, 1989, J IMMUNOL, V142, P1696; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982; WHEELER PR, 1988, J GEN MICROBIOL, V134, P2111; YOUNG RA, 1985, NATURE, V316, P450, DOI 10.1038/316450a0; YOUNG RA, 1985, P NATL ACAD SCI USA, V82, P2583, DOI 10.1073/pnas.82.9.2583	79	222	232	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2001	104	4					477	485		10.1016/S0092-8674(01)00236-7	http://dx.doi.org/10.1016/S0092-8674(01)00236-7			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	405VP	11239406	Bronze			2022-12-28	WOS:000167181500004
J	Myung, KJ; Datta, A; Kolodner, RD				Myung, KJ; Datta, A; Kolodner, RD			Suppression of spontaneous chromosomal rearrangements by S phase checkpoint functions in Saccharomyces cerevisiae	CELL			English	Article							STRAND BREAK REPAIR; COMPARATIVE GENOMIC HYBRIDIZATION; DNA-DAMAGE CHECKPOINTS; CELL-CYCLE CHECKPOINT; ATAXIA-TELANGIECTASIA; TELOMERE LENGTH; PROTEIN-KINASE; BUDDING YEAST; REPLICATION; GENE	Cancer cells show increased genome rearrangements, although it is unclear what defects cause these rearrangements. Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect. The rearrangements were primarily deletion of a portion of a chromosome arm along with TEL1-dependent addition of a new telomere. tell mutations increased the proportion of translocations observed, and in some cases showed synergistic interactions when combined with mutations that increased the genome rearrangement rate. These data suggest that one role of S phase checkpoint functions in normal cells is to suppress spontaneous genome rearrangements resulting from DNA replication errors.	Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu			NIGMS NIH HHS [GM26017] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026017, R01GM026017] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bashkirov VI, 2000, MOL CELL BIOL, V20, P4393, DOI 10.1128/MCB.20.12.4393-4404.2000; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Brown EJ, 2000, GENE DEV, V14, P397; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; CANNING S, 1989, P NATL ACAD SCI USA, V86, P5044, DOI 10.1073/pnas.86.13.5044; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chen C, 1999, MOL CELL BIOL, V19, P7801; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Clarke DJ, 1999, CURR BIOL, V9, P365, DOI 10.1016/S0960-9822(99)80163-8; Coleman WB, 1999, ANTICANCER RES, V19, P4645; Corda Y, 1999, NAT GENET, V21, P204, DOI 10.1038/5991; Craven RJ, 2000, MOL CELL BIOL, V20, P2378, DOI 10.1128/MCB.20.7.2378-2384.2000; Datta A, 2000, MOL CELL, V6, P593, DOI 10.1016/S1097-2765(00)00058-7; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Dong ZW, 1999, J BIOL CHEM, V274, P19513, DOI 10.1074/jbc.274.28.19513; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Fried LM, 1996, P NATL ACAD SCI USA, V93, P13825, DOI 10.1073/pnas.93.24.13825; Gardner R, 1999, EMBO J, V18, P3173, DOI 10.1093/emboj/18.11.3173; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; Gretarsdottir S, 1998, CANCER RES, V58, P859; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; Hermsen MAJA, 1996, HUM PATHOL, V27, P342, DOI 10.1016/S0046-8177(96)90106-9; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Ilyas M, 1999, EUR J CANCER, V35, P1986, DOI 10.1016/S0959-8049(99)00298-1; Jiricny J, 1998, EMBO J, V17, P6427, DOI 10.1093/emboj/17.22.6427; KATO R, 1994, NUCLEIC ACIDS RES, V22, P3104, DOI 10.1093/nar/22.15.3104; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Kohno T, 1996, DNA Res, V3, P421, DOI 10.1093/dnares/3.6.421; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; Lavin LF, 1999, INT J RADIAT BIOL, V75, P1201; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li GM, 1999, ONCOL RES, V11, P393; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Liu Y, 2000, MOL GEN GENET, V262, P1132, DOI 10.1007/PL00008656; LOEB LA, 1991, CANCER RES, V51, P3075; Longhese MP, 1996, MOL CELL BIOL, V16, P3235; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; McAinsh AD, 1999, CURR BIOL, V9, P963, DOI 10.1016/S0960-9822(99)80424-2; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Naiki T, 2000, MOL CELL BIOL, V20, P5888, DOI 10.1128/MCB.20.16.5888-5896.2000; NAVAS TA, 1995, CELL, V80, P29, DOI 10.1016/0092-8674(95)90448-4; Paciotti V, 2000, GENE DEV, V14, P2046; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; PONDER BAJ, 1995, GENETICS CANC 2 LOOK; Ritchie KB, 2000, GENETICS, V155, P475; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; ROBERTS BT, 1994, MOL CELL BIOL, V14, P8282, DOI 10.1128/MCB.14.12.8282; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sharan SK, 1998, J MAMMARY GLAND BIOL, V3, P413, DOI 10.1023/A:1018788132560; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; SINGH D, 1994, INDIAN J CHEM TECHN, V1, P266; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Sugimoto K, 1997, MOL CELL BIOL, V17, P5905, DOI 10.1128/MCB.17.10.5905; SUN Z, 1996, GENE DEV, V10, P295; Taylor SS, 1999, CURR BIOL, V9, pR562, DOI 10.1016/S0960-9822(99)80355-8; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tomlinson IPM, 1996, P NATL ACAD SCI USA, V93, P14800, DOI 10.1073/pnas.93.25.14800; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Vessey CJ, 2000, PROG NUCLEIC ACID RE, V63, P189, DOI 10.1016/S0079-6603(08)60723-0; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang H, 1999, P NATL ACAD SCI USA, V96, P3824, DOI 10.1073/pnas.96.7.3824; WANG YC, 1995, MOL CELL BIOL, V15, P6838; Weinert T, 1998, CURR OPIN GENET DEV, V8, P185, DOI 10.1016/S0959-437X(98)80140-8; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Yamamoto A, 1996, J CELL BIOL, V133, P85, DOI 10.1083/jcb.133.1.85; ZHANG JG, 1995, BRIT J HAEMATOL, V90, P138, DOI 10.1111/j.1365-2141.1995.tb03392.x; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	100	266	269	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2001	104	3					397	408		10.1016/S0092-8674(01)00227-6	http://dx.doi.org/10.1016/S0092-8674(01)00227-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239397	Bronze			2022-12-28	WOS:000167003100010
J	Collier, AC; Kalish, LA; Busch, MP; Gernsheimer, T; Assmann, SF; Lane, TA; Asmuth, DM; Lederman, MM; Murphy, EL; Kumar, P; Kelley, M; Flanigan, TP; McMahon, DK; Sacks, HS; Kennedy, MS; Holland, PV				Collier, AC; Kalish, LA; Busch, MP; Gernsheimer, T; Assmann, SF; Lane, TA; Asmuth, DM; Lederman, MM; Murphy, EL; Kumar, P; Kelley, M; Flanigan, TP; McMahon, DK; Sacks, HS; Kennedy, MS; Holland, PV		Viral Activation Transfusion Study	Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection - The viral activation transfusion study: A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MULTIPLE CYTOMEGALOVIRUS STRAINS; RECOMBINANT-HUMAN-ERYTHROPOIETIN; WHOLE-BLOOD; HIV-INFECTION; COMPONENTS; REDUCTION; TYPE-1; ALLOIMMUNIZATION; IMMUNOMODULATION; QUANTITATION	Context Allogeneic blood transfusions have immunomodulatory effects and have been associated with activation of human immunodeficiency virus (HIV) and cytomegalovirus (CMV) in vitro and of HIV in small pilot studies. Retrospective studies suggest that transfusions adversely affect the clinical course of HIV. Data in selected non-HIV-infected patients requiring blood transfusion have suggested clinical benefit with leukocyte-reduced red blood cells (RBCs). Objective To compare the effects of leukoreduced and unmodified RBC transfusions on survival, complications of acquired immunodeficiency syndrome, and relevant laboratory markers in HIV-infected patients. Design and Setting Double-blind randomized controlled trial conducted in 11 US academic medical centers from July 1995 through June 1999, with a median follow-up of 12 months (24 months in survivors). Patients A total of 531 persons infected with HIV and CMV, aged 14 years or older, who required transfusions for anemia; 259 received leukoreduced transfusions and 262 received unmodified transfusions (10 did not receive the planned transfusion). Main Outcome Measures Survival and change in plasma HIV RNA level 7 days after transfusion, compared by type of transfusion. Results At entry, the groups were similar in demographic, clinical, and relevant laboratory characteristics. A total of 3864 RBC units were transfused. Two hundred eighty-nine deaths occurred (151 with leukoreduced transfusion; 138 with unmodified transfusion); median survival was 13.0 and 20.5 months, respectively (relative hazard [RH], 1.20; 95% confidence interval [CI], 0.95-1.51; log-rank P = .12). Analyses adjusted for prognostic factors suggested possible worse survival with leukoreduction (RH, 1.35; 95% CI, 1.06-1.72). There was no difference in time to new opportunistic event/death or frequency of transfusion reactions. No changes in plasma HIV RNA level were seen in either group at days 7, 14, 21, or 28, even in patients not taking antiretroviral drugs. There were no differences in trends between groups in CMV DNA, CD4 cell counts, activated (CD38% or human leukocyte antigen-DR) CD8 cell counts, or plasma cytokine levels. Conclusions We found no evidence of HIV, CMV, or cytokine activation following blood transfusion in patients with advanced HIV infection, Leukoreduction provided no clinical benefit in these patients. These data demonstrate the importance of conducting controlled studies of effects of leukoreduction in different patient populations, since smaller studies in other patient populations have suggested leukoreduction may be beneficial.	Univ Washington, Sch Med, Seattle, WA USA; New England Res Inst, Watertown, MA 02172 USA; Blood Ctr Pacific, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Puget Sound Blood Ctr, Seattle, WA 98104 USA; Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; Univ Texas, Sch Med, Galveston, TX 77555 USA; Case Western Reserve Univ, Sch Med, Cleveland, OH USA; Georgetown Univ, Sch Med, Washington, DC USA; Univ N Carolina, Sch Med, Chapel Hill, NC USA; Brown Univ, Sch Med, Providence, RI 02912 USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; Mt Sinai Sch Med, New York, NY USA; Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; Sacramento Med Fdn Blood Ctr, Sacramento, CA USA	University of Washington; University of Washington Seattle; HealthCore, Inc; University of California System; University of California San Francisco; Puget Sound Blood Center; University of California System; University of California San Diego; University of Texas System; University of Texas Medical Branch Galveston; Case Western Reserve University; Georgetown University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Brown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Icahn School of Medicine at Mount Sinai; University System of Ohio; Ohio State University	Collier, AC (corresponding author), Univ Washington, Harborview Med Ctr, 325 9th Ave,Box 359929, Seattle, WA 98104 USA.	acollier@u.washington.edu		Asmuth, David/0000-0003-0916-7950	DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB057116, N01HB057115, N01HB057126, N01HB057117, N01HB057118, N01HB057123, N01HB057119, N01HB057124, N01HB057125, N01HB057120, N01HB057127, N01HB057121, N01HB057122] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000046] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00046] Funding Source: Medline; NHLBI NIH HHS [N01-HB-57127, N01-HB-57124, N01-HB-57118, N01-HB-57116, N01-HB-57115, N01-HB-57117, N01-HB-57122, N01-HB-57121, N01-HB-57125, N01-HB-57120, N01-HB-57119, N01-HB-57126, N01-HB-57123] Funding Source: Medline	DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		American Association of Blood Banks, 1998, AABB NEWS BRIEFS, V20, P16; AuBuchon JP, 1997, ANN INTERN MED, V127, P904, DOI 10.7326/0003-4819-127-10-199711150-00009; Baldanti F, 1998, ARCH VIROL, V143, P1701, DOI 10.1007/s007050050410; BLAJCHMAN MA, 1993, BLOOD, V81, P1880; Blajchman MA, 1999, TRANSFUSION, V39, P665, DOI 10.1046/j.1537-2995.1999.39070665.x; BLATT SP, 1993, JAMA-J AM MED ASSOC, V269, P622, DOI 10.1001/jama.269.5.622; BLUMBERG N, 1983, VOX SANG, V44, P212, DOI 10.1111/j.1423-0410.1983.tb01886.x; Bordin JO, 1999, TRANSFUSION, V39, P718, DOI 10.1046/j.1537-2995.1999.39070718.x; BORDIN JO, 1994, BLOOD, V84, P1703; BOWDEN RA, 1995, BLOOD, V86, P3598, DOI 10.1182/blood.V86.9.3598.bloodjournal8693598; BRANTLEY SG, 1988, TRANSFUSION, V28, P463, DOI 10.1046/j.1537-2995.1988.28588337338.x; BUSCH MP, 1992, BLOOD, V80, P2128; Busch MP, 1996, TRANSFUSION, V36, P854, DOI 10.1046/j.1537-2995.1996.361097017169.x; Carpenter C, 1998, ANN INTERN MED, V128, P1057, DOI 10.7326/0003-4819-128-12_Part_2-199806151-00002; *CDCP, 1993, MMWR-MORBID MORTAL W, V417, P1; CHEUNG KS, 1977, J INFECT DIS, V135, P841, DOI 10.1093/infdis/135.5.841; Chin-Yee I, 1998, TRANSFUSION MED, V8, P49; Coyle TE, 1997, MED CLIN N AM, V81, P449, DOI 10.1016/S0025-7125(05)70526-5; DEGRAANHENTZEN YCE, 1989, TRANSFUSION, V29, P757; Dzik S, 2000, TRANSFUS MED REV, V14, P34, DOI 10.1016/S0887-7963(00)80114-5; DZIK WH, 1994, TRANSFUSION, V34, P1007, DOI 10.1046/j.1537-2995.1994.341195065024.x; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; EIZURU Y, 1990, INTERVIROLOGY, V31, P355, DOI 10.1159/000150172; Fiebig E, 2000, TRANSFUSION, V40, P761, DOI 10.1046/j.1537-2995.2000.40070761.x; Fiebig EW, 1997, CYTOMETRY, V29, P340, DOI 10.1002/(SICI)1097-0320(19971201)29:4<340::AID-CYTO11>3.0.CO;2-U; Frabetti F, 1998, TRANSFUSION, V38, P1082, DOI 10.1046/j.1537-2995.1998.38111299056320.x; GATENBY PA, 1993, AM J REPROD IMMUNOL, V29, P88, DOI 10.1111/j.1600-0897.1993.tb00571.x; GEORGE CD, 1986, AM J SURG, V152, P329, DOI 10.1016/0002-9610(86)90269-2; GILBERT GL, 1989, LANCET, V1, P1228, DOI 10.1016/S0140-6736(89)92330-1; Groopman JE, 1997, SEMIN HEMATOL, V34, P27; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; HENRY DH, 1992, ANN INTERN MED, V117, P739, DOI 10.7326/0003-4819-117-9-739; HILLYER CD, 1994, TRANSFUSION, V34, P929, DOI 10.1046/j.1537-2995.1994.341095026982.x; Hillyer CD, 1999, TRANSFUS MED REV, V13, P1, DOI 10.1016/S0887-7963(99)80084-4; Houbiers JG, 1997, TRANSFUSION, V37, P126, DOI 10.1046/j.1537-2995.1997.37297203513.x; Hyllner M, 1997, TRANSFUSION, V37, P264, DOI 10.1046/j.1537-2995.1997.37397240207.x; Jacobsen N, 1996, VOX SANG, V70, P185; Jensen L S, 1998, Curr Opin Hematol, V5, P376, DOI 10.1097/00062752-199811000-00004; Jensen LS, 1996, LANCET, V348, P841, DOI 10.1016/S0140-6736(96)06168-5; KARNOFSK.DA, 1965, CANCER, V18, P1517, DOI 10.1002/1097-0142(196512)18:12<1517::AID-CNCR2820181202>3.0.CO;2-#; Kirkley SA, 1998, TRANSFUSION MED, V8, P195; KLEIN HG, 1996, CLIN PRACTICE TRANSF, P59; Kovacs JA, 1996, NEW ENGL J MED, V335, P1350, DOI 10.1056/NEJM199610313351803; Koval KJ, 1997, J ORTHOP TRAUMA, V11, P260, DOI 10.1097/00005131-199705000-00004; Kreuzer KA, 1997, ANN HEMATOL, V75, P179, DOI 10.1007/s002770050340; Kristiansson M, 1996, ACTA ANAESTH SCAND, V40, P496, DOI 10.1111/j.1399-6576.1996.tb04475.x; Larsson S, 1998, TRANSFUSION, V38, P271, DOI 10.1046/j.1537-2995.1998.38398222871.x; Lederman MM, 2000, AIDS, V14, P951, DOI 10.1097/00002030-200005260-00006; LEE TH, 1994, TRANSFUSION, V34, P986, DOI 10.1046/j.1537-2995.1994.341195065038.x; Lee TH, 1998, TRANSFUSION, V38, P262, DOI 10.1046/j.1537-2995.1998.38398222870.x; Long CM, 1998, J CLIN MICROBIOL, V36, P2434, DOI 10.1128/JCM.36.9.2434-2438.1998; McFarland J, 1997, NEW ENGL J MED, V337, P1861; MINCHEFF MS, 1993, VOX SANG, V65, P18, DOI 10.1111/j.1423-0410.1993.tb04519.x; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Moore RD, 1999, AIDS, V13, P1933, DOI 10.1097/00002030-199910010-00017; Moore RD, 1998, J ACQ IMMUN DEF SYND, V19, P29, DOI 10.1097/00042560-199809010-00004; Moore RD, 1999, CLIN INFECT DIS, V29, P44, DOI 10.1086/520178; Mudido PM, 1996, TRANSFUSION, V36, P860, DOI 10.1046/j.1537-2995.1996.361097017170.x; MULDER J, 1994, J CLIN MICROBIOL, V32, P292, DOI 10.1128/JCM.32.2.292-300.1994; Napier A, 1998, TRANSFUSION MED, V8, P59; OLDING LB, 1975, J EXP MED, V141, P561, DOI 10.1084/jem.141.3.561; OPELZ G, 1973, TRANSPLANT P, V5, P253; Opelz G, 1997, TRANSPLANTATION, V63, P964, DOI 10.1097/00007890-199704150-00010; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Patton LL, 1999, ORAL SURG ORAL MED O, V88, P561, DOI 10.1016/S1079-2104(99)70086-7; Pellegrin I, 1999, J CLIN MICROBIOL, V37, P3124, DOI 10.1128/JCM.37.10.3124-3132.1999; PETERS WR, 1989, DIS COLON RECTUM, V32, P749, DOI 10.1007/BF02562122; PHAIR JP, 1993, ARCH INTERN MED, V153, P2669, DOI 10.1001/archinte.153.23.2669; POPOVSKY MA, 1995, TRANSFUSION, V35, P612, DOI 10.1046/j.1537-2995.1995.35795357887.x; PRINCE HE, 1986, TRANSPLANTATION, V41, P235, DOI 10.1097/00007890-198602000-00019; SCHECHTER GP, 1972, NEW ENGL J MED, V287, P1169, DOI 10.1056/NEJM197212072872303; SLOAND E, 1994, TRANSFUSION, V34, P48, DOI 10.1046/j.1537-2995.1994.34194098603.x; SoderbergNaucler C, 1997, CELL, V91, P119, DOI 10.1016/S0092-8674(01)80014-3; SPECTOR SA, 1984, J INFECT DIS, V150, P953, DOI 10.1093/infdis/150.6.953; Sullivan PS, 1998, BLOOD, V91, P301, DOI 10.1182/blood.V91.1.301.301_301_308; VAMVAKAS E, 1993, TRANSFUSION, V33, P111, DOI 10.1046/j.1537-2995.1993.33293158041.x; Vamvakas EC, 1998, TRANSFUS MED REV, V12, P258, DOI 10.1016/S0887-7963(98)80002-3; Vamvakas EC, 1996, TRANSFUSION, V36, P175, DOI 10.1046/j.1537-2995.1996.36296181932.x; Vamvakas EC, 2000, TRANSFUS MED REV, V14, P137, DOI 10.1016/S0887-7963(00)80004-8; Wang YF, 1999, NAT MED, V5, P1004, DOI 10.1038/12440; Weisbach V, 1999, VOX SANG, V76, P100; WILLIAMS JG, 1989, LANCET, V2, P1524; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	83	71	72	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2001	285	12					1592	1601		10.1001/jama.285.12.1592	http://dx.doi.org/10.1001/jama.285.12.1592			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413HH	11268267	Bronze			2022-12-28	WOS:000167606600026
J	Gilsdorf, JR				Gilsdorf, JR			A simple song of gratitude	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2001	285	12					1555	1556		10.1001/jama.285.12.1555	http://dx.doi.org/10.1001/jama.285.12.1555			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413HH	11268244				2022-12-28	WOS:000167606600001
J	Andrews, GR				Andrews, GR			Care of older people - Promoting health and function in an ageing population	BRITISH MEDICAL JOURNAL			English	Article							PHYSICAL-ACTIVITY; LIFE-STYLE; RANDOMIZED TRIAL; COLLEGE ALUMNI; EXERCISE; MORBIDITY; MORTALITY; STRENGTH; DISEASE; MUSCLE		Flinders Univ S Australia, Ctr Aging Studies, Bedford Pk, SA 5042, Australia	Flinders University South Australia	Andrews, GR (corresponding author), Flinders Univ S Australia, Ctr Aging Studies, Sci Pk, Bedford Pk, SA 5042, Australia.							ABDELLAH FG, 1988, SURG GEN WORKSH HLTH; Andersen RE, 1999, JAMA-J AM MED ASSOC, V281, P335, DOI 10.1001/jama.281.4.335; BLAIR SN, 1985, PUBLIC HEALTH REP, V100, P172; *CAN MIN SUPPL SER, 1994, STRAT POP HLTH INV H; COOPER C, 1988, BRIT MED J, V297, P1443, DOI 10.1136/bmj.297.6661.1443; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; Dunn AL, 1999, JAMA-J AM MED ASSOC, V281, P327, DOI 10.1001/jama.281.4.327; FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; FRISCH RE, 1986, DIABETES, V35, P1101, DOI 10.2337/diabetes.35.10.1101; GINN J, 1997, RES OLDER PEOPLES HL; KOHL HW, 1988, SPORTS MED, V6, P222, DOI 10.2165/00007256-198806040-00004; Malbut-Shennan K, 1999, CORONARY ARTERY DIS, V10, P37; MANTON KG, 1982, MILBANK FUND Q, V60, P183, DOI 10.2307/3349767; Manton KG, 1997, P NATL ACAD SCI USA, V94, P2593, DOI 10.1073/pnas.94.6.2593; MCMURDO MET, 1993, AGE AGEING, V22, P11, DOI 10.1093/ageing/22.1.11; McMurdo MET, 1999, BRIT J SPORT MED, V33, P295, DOI 10.1136/bjsm.33.5.295; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; PAFFENBARGER RS, 1983, AM J EPIDEMIOL, V117, P245, DOI 10.1093/oxfordjournals.aje.a113537; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; POWELL KE, 1987, ANNU REV PUBL HEALTH, V8, P253, DOI 10.1146/annurev.publhealth.8.1.253; Richmond DE, 1996, NEW ZEAL MED J, V109, P122; *ROYAL COMM LONG T, 1999, ESP OLD AG LONG TERM; RUUSKANEN JM, 1995, AGE AGEING, V24, P292, DOI 10.1093/ageing/24.4.292; Sayer AA, 1998, AGE AGEING, V27, P579, DOI 10.1093/ageing/27.5.579; SPSS Inc, 2006, HLTH ED J, DOI DOI 10.1177/001789699705600102; TAYLOR CB, 1985, PUBLIC HEALTH REP, V100, P195; Vita AJ, 1998, NEW ENGL J MED, V338, P1035, DOI 10.1056/NEJM199804093381506; *WHO, 1998, WORLD HLTH REP LIF 2	29	54	54	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 24	2001	322	7288					728	729		10.1136/bmj.322.7288.728	http://dx.doi.org/10.1136/bmj.322.7288.728			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	416GB	11264216	Green Published			2022-12-28	WOS:000167771000031
J	Berman, DE; Dudai, Y				Berman, DE; Dudai, Y			Memory extinction, learning anew, and learning the new: Dissociations in the molecular machinery of learning in cortex	SCIENCE			English	Article							RAT INSULAR CORTEX; PROTEIN-SYNTHESIS; UNFAMILIAR TASTE; RECONSOLIDATION; CONSOLIDATION; ACTIVATION; RETRIEVAL; AMYGDALA	The rat insular cortex (IC) subserves the memory of conditioned taste aversion (CTA), in which a taste is associated with malaise. When the conditioned taste is unfamiliar, formation of Long-term CTA memory depends on muscarinic and beta -adrenergic receptors, mitogen-activated protein kinase (MAPK), and protein synthesis. We show that extinction of CTA memory is also dependent on protein synthesis and beta -adrenergic receptors in the IC, but independent of muscarinic receptors and MAPK. This resembles the molecular signature of the formation of Long-term memory of CTA to a familiar taste. Thus, memory extinction shares molecular mechanisms with Learning, but the mechanisms of learning anew differ from those of Learning the new.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Dudai, Y (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.							AGRANOFF BW, 1964, SCIENCE, V146, P952, DOI 10.1126/science.146.3646.952; Berman D.S., UNPUB; Berman DE, 1998, J NEUROSCI, V18, P10037; Berman DE, 2000, J NEUROSCI, V20, P7017, DOI 10.1523/JNEUROSCI.20-18-07017.2000; BOUTON ME, 1994, J EXP PSYCHOL-ANIM B, V20, P219, DOI 10.1037/0097-7403.20.3.219; BRAUD W G, 1973, Pharmacology Biochemistry and Behavior, V1, P651, DOI 10.1016/0091-3057(73)90028-2; Bures J, 1998, CONDITIONED TASTE AV; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; FALLS WA, 1992, J NEUROSCI, V12, P854; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; FLOOD JF, 1977, PHARMACOL BIOCHEM BE, V7, P71, DOI 10.1016/0091-3057(77)90013-2; Garcia J, 1966, PSYCHON SCI, V5, P121, DOI DOI 10.3758/BF03328311; MCCORMICK DA, 1982, BRAIN RES, V245, P239, DOI 10.1016/0006-8993(82)90806-X; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Naor C, 1996, BEHAV BRAIN RES, V79, P61, DOI 10.1016/0166-4328(95)00262-6; Pavlov I.P., 1927, CONDITIONED REFLEXES; PRADOALCALA RA, 1994, PHYSIOL BEHAV, V56, P27, DOI 10.1016/0031-9384(94)90257-7; Rescorla RA, 1996, Q J EXP PSYCHOL-B, V49, P245; Rosenblum K, 1997, J NEUROSCI, V17, P5129; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73	23	377	382	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2417	2419		10.1126/science.1058165	http://dx.doi.org/10.1126/science.1058165			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	413UH	11264539				2022-12-28	WOS:000167618700058
J	Topfer, K				Topfer, K			Climate change - Whither after The Hague?	SCIENCE			English	Article									UN Environm Program, Nairobi, Kenya	United Nations Environment Programme	Topfer, K (corresponding author), UN Environm Program, POB 30552, Nairobi, Kenya.							[Anonymous], 1998, HUM DEV REP 1998; *INT EN AG, 1998, EN STAT BAL OECD NON; *IPCC, 2001, SUMM POL MAK WORK GR; *PEW CTR GLOB CLIM, 2000, RED EM MAINT EC GROW; *UN FOOD AGR ORG, IN PRESS STAT WORLDS; United Nations, 1998, FRAM CONV CLIM CHANG; [No title captured]	7	1	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2095	2096		10.1126/science.1059490	http://dx.doi.org/10.1126/science.1059490			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11256405				2022-12-28	WOS:000167563800020
J	Jedema, FJ; Filip, AT; van Wees, BJ				Jedema, FJ; Filip, AT; van Wees, BJ			Electrical spin injection and accumulation at room temperature in an all-metal mesoscopic spin valve	NATURE			English	Article							GIANT MAGNETORESISTANCE; DIFFUSION LENGTH; MAGNETIC MULTILAYERS; TRANSPORT; SEMICONDUCTOR; PERMALLOY; CHARGE; SWITCH	Finding a means to generate, control and use spin-polarized currents represents an important challenge for spin-based electronics(1-3), or 'spintronics'. Spin currents and the associated phenomenon of spin accumulation can be realized by driving a current from a ferromagnetic electrode into a non-magnetic metal or semiconductor. This was first demonstrated over 15 years ago in a spin injection experiment(4) on a single crystal aluminium bar at temperatures below 77 K. Recent experiments(5-8) have demonstrated successful optical detection of spin injection in semiconductors, using either optical injection by circularly polarized light or electrical injection from a magnetic semiconductor. However, it has not been possible to achieve fully electrical spin injection and detection at room temperature. Here we report room-temperature electrical injection and detection of spin currents and observe spin accumulation in an all-metal lateral mesoscopic spin valve, where ferromagnetic electrodes are used to drive a spin-polarized current into crossed copper strips. We anticipate that larger signals should be obtainable by optimizing the choice of materials and device geometry.	Univ Groningen, Dept Appl Phys, NL-9747 AG Groningen, Netherlands; Univ Groningen, Ctr Mat Sci, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Jedema, FJ (corresponding author), Univ Groningen, Dept Appl Phys, Nijenborgh 4-13, NL-9747 AG Groningen, Netherlands.	jedema@phys.rug.nl	van, bart/U-1770-2017					AHSCROFT NW, 1976, SOLID STATE PHYSICS, V38, pCH2; Ansermet JP, 1998, J PHYS-CONDENS MAT, V10, P6027, DOI 10.1088/0953-8984/10/27/005; Brataas A, 2000, PHYS REV LETT, V84, P2481, DOI 10.1103/PhysRevLett.84.2481; CRANGLE J, 1977, MAGNETIC PROPERTIES, pCH6; Dubois S, 1999, PHYS REV B, V60, P477, DOI 10.1103/PhysRevB.60.477; Ebels U, 2000, PHYS REV LETT, V84, P983, DOI 10.1103/PhysRevLett.84.983; Fert A, 1996, PHYS REV B, V53, P6554, DOI 10.1103/PhysRevB.53.6554; Fiederling R, 1999, NATURE, V402, P787, DOI 10.1038/45502; Filip AT, 2000, PHYS REV B, V62, P9996, DOI 10.1103/PhysRevB.62.9996; Gijs MAM, 1997, ADV PHYS, V46, P285, DOI 10.1080/00018739700101518; Hershfield S, 1997, PHYS REV B, V56, P3296, DOI 10.1103/PhysRevB.56.3296; Huertas-Hernando D, 2000, PHYS REV B, V62, P5700, DOI 10.1103/PhysRevB.62.5700; JOHNSON M, 1993, SCIENCE, V260, P320, DOI 10.1126/science.260.5106.320; JOHNSON M, 1993, PHYS REV LETT, V70, P2142, DOI 10.1103/PhysRevLett.70.2142; JOHNSON M, 1985, PHYS REV LETT, V55, P1790, DOI 10.1103/PhysRevLett.55.1790; Katine JA, 2000, PHYS REV LETT, V84, P3149, DOI 10.1103/PhysRevLett.84.3149; Kikkawa JM, 1999, NATURE, V397, P139, DOI 10.1038/16420; Malajovich I, 2000, PHYS REV LETT, V84, P1015, DOI 10.1103/PhysRevLett.84.1015; MESERVEY R, 1994, PHYS REP, V238, P173, DOI 10.1016/0370-1573(94)90105-8; Ohno Y, 1999, NATURE, V402, P790, DOI 10.1038/45509; Prinz GA, 1998, SCIENCE, V282, P1660, DOI 10.1126/science.282.5394.1660; PRINZ GA, 1995, PHYS TODAY, V48, P58, DOI 10.1063/1.881459; Steenwyk SD, 1997, J MAGN MAGN MATER, V170, pL1, DOI 10.1016/S0304-8853(97)00061-9; VALET T, 1993, PHYS REV B, V48, P7099, DOI 10.1103/PhysRevB.48.7099; VANSON PC, 1987, PHYS REV LETT, V58, P2271, DOI 10.1103/PhysRevLett.58.2271; YANG Q, 1994, PHYS REV LETT, V72, P3274, DOI 10.1103/PhysRevLett.72.3274	26	983	994	10	255	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					345	348		10.1038/35066533	http://dx.doi.org/10.1038/35066533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268205	Green Published			2022-12-28	WOS:000167464100043
J	Becker, K; Southwick, K; Reardon, J; Berg, R; MacCormack, JN				Becker, K; Southwick, K; Reardon, J; Berg, R; MacCormack, JN			Histamine poisoning associated with eating tuna burgers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Histamine poisoning occurs when persons ingest fish in which bacteria have converted histidine to histamine, a process that usually can be controlled by storage at low temperatures. From 1994 to 1997, North Carolina averaged 2 cases annually; however, from July 1998 to February 1999, a total of 22 cases of histamine fish poisoning were reported. Objectives To examine the increase in histamine case reports, identify risk factors for poisoning, and develop recommendations for prevention. Design and Setting Case series evaluated in North Carolina from July 1998 to February 1999, Subjects Reported case-patients with 2 of the following symptoms within 2 hours of eating tuna: rash, facial flushing, vomiting, diarrhea, dyspnea, a tight feeling in the throat, headache, or a metallic or peppery taste in the mouth. Results Twenty cases occurred during 5 outbreaks, and there were 2 single occurrences. Of the 22 persons affected, 19 (86%) sought emergency medical care. All case-patients ate tuna: 18 ate tuna burgers, 2 ate salad containing tuna, and 2 ate filets, Tuna samples (available from 3 outbreaks) had histamine levels above the Food and Drug Administration regulatory level of 50 ppm (levels were between 213 and 3245 ppm). In 19 cases, the tuna used to prepare burgers or salads was frozen and thawed more than once before serving. Violations of recommended temperature controls were identified in 2 of the 5 restaurants, accounting for 14 (64%) cases. Conclusions Tuna burgers, a relatively new menu item in restaurants, were associated with an increase in histamine poisoning cases in North Carolina. Tuna ground for burgers can be susceptible to both temperature fluctuations and bacterial contamination.	Ctr Dis Control & Prevent, Raleigh, NC USA; N Carolina Dept Hlth & Human Serv, Raleigh, NC USA; N Carolina Dept Agr & Consumer Serv, Raleigh, NC USA; US FDA, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA)	Becker, K (corresponding author), US Dept HHS, Off Int & Refugee Hlth, 5600 Fishers Ln,Parklawn Bldg,Room 18-105, Rockville, MD 20857 USA.	kbecker@osophs.dhhs.gov						[Anonymous], 1995, FED REG, V60, P65096; BAGNIS R, 1970, B WORLD HEALTH ORGAN, V42, P69; *CDCP, 1989, MMWR-MORBID MORTAL W, V38, P140; *CDCP, 1980, MMWR-MORBID MORTAL W, V29, P106; *CDCP, 1985, 1982 FOODB DIS SURV; *CDCP, 1980, MMWR-MORBID MORTAL W, V29, P167; *CDCP, 1986, MMWR-MORBID MORTAL W, V35, P264; CHIN J, 2000, CONTROL COMMUNICABLE, P209; ETKIND P, 1987, JAMA-J AM MED ASSOC, V258, P3409, DOI 10.1001/jama.258.23.3409; *FDA, 1994, FDA PUBL; GILBERT RJ, 1980, BMJ-BRIT MED J, V281, P71; HUI JY, 1985, TOXICOL APPL PHARM, V81, P241, DOI 10.1016/0041-008X(85)90160-7; LOPEZSABATER EI, 1994, J FOOD PROTECT, V57, P318, DOI 10.4315/0362-028X-57.4.318; LopezSabater EI, 1996, J FOOD PROTECT, V59, P167, DOI 10.4315/0362-028X-59.2.167; Maher J. P., 2000, Morbidity and Mortality Weekly Report, V49, P398; MURRAY CK, 1982, J HYG-CAMBRIDGE, V88, P215, DOI 10.1017/S002217240007008X; ROGERS PR, 1993, LAB INFORMATION B, V3794; SENANAYAKE N, 1978, BRIT MED J, V2, P1127, DOI 10.1136/bmj.2.6145.1127-a; SMART DR, 1992, MED J AUSTRALIA, V157, P748; STRATTON JE, 1988, SEAFOOD SAFETY, P331; TAPPERO JW, 1995, JAMA-J AM MED ASSOC, V273, P1118, DOI 10.1001/jama.273.14.1118; Taylor S.L., 1986, SEAFOOD QUALITY DETE, P235; Taylor S.L., 1985, HISTAMINE POISONING; TAYLOR SL, 1986, CRC CR REV TOXICOL, V17, P91, DOI 10.3109/10408448609023767; TAYLOR SL, 1988, FOOD TECHNOL-CHICAGO, V42, P94; TAYLOR SL, 1989, J TOXICOL-CLIN TOXIC, V27, P225, DOI 10.3109/15563658908994420	26	78	86	3	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2001	285	10					1327	1330		10.1001/jama.285.10.1327	http://dx.doi.org/10.1001/jama.285.10.1327			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408QK	11255388				2022-12-28	WOS:000167339000025
J	Kern, KB; Halperin, HR; Field, J				Kern, KB; Halperin, HR; Field, J			New guidelines for cardiopulmonary resuscitation and emergency cardiac care - Changes in the management of cardiac arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMPRESSION-DECOMPRESSION RESUSCITATION; TRIAL		Amer Heart Assoc, Adv Cardiac Life Support Subcomm, Dallas, TX USA; Univ Arizona, Sarver Heart Ctr, Cardiol Sect, Coll Med, Tucson, AZ 85724 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Penn State Univ, Coll Med, Hershey, PA USA	University of Arizona; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kern, KB (corresponding author), Univ Arizona, Sarver Heart Ctr, Cardiol Sect, Coll Med, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	kernk@u.arizona.edu						[Anonymous], 1986, JAMA-J AM MED ASSOC, V255, P2905; [Anonymous], 1980, JAMA-J AM MED ASSOC, V244, P453; COHEN TJ, 1993, NEW ENGL J MED, V329, P1918, DOI 10.1056/NEJM199312233292603; HALPERIN HR, 1993, NEW ENGL J MED, V329, P762, DOI 10.1056/NEJM199309093291104; KERBER RE, 1992, JAMA-J AM MED ASSOC, V268, P2172; Kudenchuk PJ, 1999, NEW ENGL J MED, V341, P871, DOI 10.1056/NEJM199909163411203; Lindner KH, 1997, LANCET, V349, P535, DOI 10.1016/S0140-6736(97)80087-6; Plaisance P, 1997, CIRCULATION, V95, P955; Plaisance P, 1999, NEW ENGL J MED, V341, P569, DOI 10.1056/NEJM199908193410804; Plaisance P, 2000, CIRCULATION, V101, P989, DOI 10.1161/01.CIR.101.9.989; SACK JB, 1992, JAMA-J AM MED ASSOC, V267, P379; SACK JB, 1992, CIRCULATION, V86, P1692, DOI 10.1161/01.CIR.86.6.1692; SCHWAB TM, 1995, JAMA-J AM MED ASSOC, V273, P1261, DOI 10.1001/jama.273.16.1261; Standards for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiac Care (ECC), 1974, JAMA-J AM MED ASSOC, V227, P833; Stiell IG, 1996, JAMA-J AM MED ASSOC, V275, P1417, DOI 10.1001/jama.275.18.1417; TUCKER KJ, 1994, J AM COLL CARDIOL, V24, P201, DOI 10.1016/0735-1097(94)90564-9; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Willerson JT, 2000, CIRCULATION, V102, P1	18	18	19	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2001	285	10					1267	1269		10.1001/jama.285.10.1267	http://dx.doi.org/10.1001/jama.285.10.1267			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408QK	11255370				2022-12-28	WOS:000167339000002
J	Koelemay, MJW; Lijmer, JG; Stoker, J; Legemate, DA; Bossuyt, RMM				Koelemay, MJW; Lijmer, JG; Stoker, J; Legemate, DA; Bossuyt, RMM			Magnetic resonance angiography for the evaluation of lower extremity arterial disease - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TIME-OF-FLIGHT; ENHANCED MR-ANGIOGRAPHY; PERIPHERAL VASCULAR-DISEASE; DIGITAL-SUBTRACTION-ANGIOGRAPHY; OCCLUSIVE DISEASE; CONVENTIONAL ARTERIOGRAPHY; DIAGNOSTIC-TEST; PHASE-CONTRAST; PREOPERATIVE EVALUATION; RUNOFF VESSELS	Context Magnetic resonance angiography (MRA) is a rapidly evolving technique that has been reported to be accurate for assessment of lower extremity arterial disease. Objective To obtain the best available estimates of the diagnostic performance of MRA in patients with lower extremity arterial disease. Data Sources Studies published from January 1985 through May 2000 in English, German, or French, identified from the MEDLINE, EMBASE, and Current Contents databases, Study Selection Studies were included that allowed construction of 2 x 2 contingency tables for detection of stenosis greater than 50% or occlusion with MRA or arteriography in patients with claudication or critical ischemia. Data Extraction Two observers graded the following elements of study quality: consecutively enrolled patients, prospective study design, clear cut-off levels, blinded assessment, and clear description of MRA technique. Summary receiver operating characteristic analysis was performed to examine the influence of year of publication, all methodological criteria, arterial tract, number of subdivisions within arterial tracts, and MRA technique on diagnostic performance. Data Synthesis Of 3583 studies initially identified, 34 were included that evaluated MRA in 1090 patients (72% men; median age, 65 years). Magnetic resonance angiography was highly accurate for assessment of all lower extremity arteries. Three-dimensional gadolinium-enhanced (3-D Gd) MRA improved diagnostic performance compared with 2-D MRA (relative diagnostic odds ratio, 2.8 [95% confidence interval, 1.2-6.4]), adjusted for number of subdivisions within arterial tracts. The estimated points of equal sensitivity and specificity were 94% and 90% for 3-D Gd MRA and 2-D MRA, respectively. Conclusions Magnetic resonance angiography is highly accurate for assessment of the entire lower extremity for arterial disease. Three-dimensional Gd-enhanced MRA improves diagnostic performance compared with 2-D MRA.	Univ Amsterdam, Acad Med Ctr, Dept Vasc Surg, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Legemate, DA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Surg, G4-111,POB 22700, NL-1100 DE Amsterdam, Netherlands.	d.a.legemate@amc.uva.nl	Stoker, Jaap/AAH-7597-2019; Bossuyt, Patrick M./B-4557-2016	Stoker, Jaap/0000-0002-9822-3784; Bossuyt, Patrick M./0000-0003-4427-0128				ADAMIS MK, 1995, RADIOLOGY, V196, P689, DOI 10.1148/radiology.196.3.7644630; Altman D. G., 1995, PRACTICAL STAT MED R, P403; BAUM RA, 1995, JAMA-J AM MED ASSOC, V274, P875, DOI 10.1001/jama.274.11.875; BAUMGARTNER I, 1993, ROFO FORTSCHR RONTG, V159, P167, DOI 10.1055/s-2008-1032742; BRESLOW NE, 1980, STATISTICAL METHODS, V1, P142; Cambria RP, 1997, J VASC SURG, V25, P380, DOI 10.1016/S0741-5214(97)70360-4; CAMBRIA RP, 1993, J VASC SURG, V17, P1050, DOI 10.1016/0741-5214(93)90675-C; CARPENTER JP, 1992, J VASC SURG, V16, P807; Cortell ED, 1996, AM J ROENTGENOL, V167, P147, DOI 10.2214/ajr.167.1.8659360; CURRIE IC, 1995, EUR J VASC ENDOVASC, V9, P24, DOI 10.1016/S1078-5884(05)80220-5; Davis CP, 1997, AM J ROENTGENOL, V168, P1027, DOI 10.2214/ajr.168.4.9124109; deVries SO, 1996, ACAD RADIOL, V3, P361, DOI 10.1016/S1076-6332(96)80257-1; Eklof H, 1998, ACTA RADIOL, V39, P663, DOI 10.3109/02841859809175493; Glickerman DJ, 1996, AM J ROENTGENOL, V167, P445, DOI 10.2214/ajr.167.2.8686623; HALDANE JBS, 1956, ANN HUM GENET, V20, P309; Hany TF, 1997, RADIOLOGY, V204, P357, DOI 10.1148/radiology.204.2.9240520; HARTKAMP MJ, 1997, CRIT ISCHAEMIA, V6, P5; HERTZ SM, 1993, AM J SURG, V166, P112, DOI 10.1016/S0002-9610(05)81040-2; Ho KY, 1997, AM J ROENTGENOL, V169, P45, DOI 10.2214/ajr.169.1.9207499; Ho KYJAM, 1998, RADIOLOGY, V206, P683, DOI 10.1148/radiology.206.3.9494486; Ho KYJAM, 1998, RADIOLOGY, V206, P673, DOI 10.1148/radiology.206.3.9494485; Hoch JR, 1999, AM J SURG, V178, P166, DOI 10.1016/S0002-9610(99)00158-0; Hoch JR, 1996, J VASC SURG, V23, P792, DOI 10.1016/S0741-5214(96)70241-0; Huber TS, 1997, J VASC SURG, V26, P415, DOI 10.1016/S0741-5214(97)70034-X; IRWIG L, 1995, J CLIN EPIDEMIOL, V48, P119, DOI 10.1016/0895-4356(94)00099-C; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; Jones L, 1998, CLIN RADIOL, V53, P333, DOI 10.1016/S0009-9260(98)80003-2; Koelemay MJW, 1996, BRIT J SURG, V83, P404, DOI 10.1002/bjs.1800830336; Kohler T R, 1990, Ann Vasc Surg, V4, P280, DOI 10.1007/BF02009458; Laissy JP, 1998, JMRI-J MAGN RESON IM, V8, P1060, DOI 10.1002/jmri.1880080509; Lenhart M, 1999, ROFO-FORTSCHR RONTG, V171, P442, DOI 10.1055/s-1999-272; LITTENBERG B, 1993, MED DECIS MAKING, V13, P313, DOI 10.1177/0272989X9301300408; Lundin P, 2000, ACTA RADIOL, V41, P125, DOI 10.1080/028418500127345127; MASUI T, 1995, J COMPUT ASSIST TOMO, V19, P449, DOI 10.1097/00004728-199505000-00020; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; MCDERMOTT VG, 1995, CLIN RADIOL, V50, P741, DOI 10.1016/S0009-9260(05)83211-8; Meaney JFM, 1999, RADIOLOGY, V211, P59, DOI 10.1148/radiology.211.1.r99ap1859; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; MULLIGAN SA, 1991, RADIOLOGY, V178, P695, DOI 10.1148/radiology.178.3.1994405; Oberholzer K, 1999, ROFO-FORTSCHR RONTG, V171, P240, DOI 10.1055/s-1999-245; OWEN RS, 1993, RADIOLOGY, V187, P627, DOI 10.1148/radiology.187.3.8497607; OWEN RS, 1992, NEW ENGL J MED, V326, P1577, DOI 10.1056/NEJM199206113262428; Pell JP, 1997, EUR J VASC ENDOVASC, V13, P315, DOI 10.1016/S1078-5884(97)80104-9; Perrier E, 1998, J RADIOL, V79, P1493; Poon E, 1997, AM J ROENTGENOL, V169, P1139, DOI 10.2214/ajr.169.4.9308478; Quinn SF, 1997, JMRI-J MAGN RESON IM, V7, P197, DOI 10.1002/jmri.1880070130; Quinn SF, 1998, RADIOLOGY, V206, P693, DOI 10.1148/radiology.206.3.9494487; QUINN SF, 1993, RADIOLOGY, V189, P181, DOI 10.1148/radiology.189.1.8372190; Reimer P, 1998, ROFO-FORTSCHR RONTG, V168, P243, DOI 10.1055/s-2007-1015120; Rofsky NM, 1997, RADIOLOGY, V205, P163, DOI 10.1148/radiology.205.1.9314979; Ruehm SG, 2000, AM J ROENTGENOL, V174, P1127, DOI 10.2214/ajr.174.4.1741127; SCHIEBLER ML, 1992, INVEST RADIOL, V27, pS90, DOI 10.1097/00004424-199212002-00016; SIVANANTHAN UM, 1993, BRIT J RADIOL, V66, P1103, DOI 10.1259/0007-1285-66-792-1103; SNIDOW JJ, 1995, J VASC INTERV RADIOL, V6, P595, DOI 10.1016/S1051-0443(95)71143-5; SNIDOW JJ, 1995, RADIOLOGY, V196, P371, DOI 10.1148/radiology.196.2.7617847; Snidow JJ, 1996, RADIOLOGY, V198, P725, DOI 10.1148/radiology.198.3.8628861; Sostman HD, 1996, JMRI-J MAGN RESON IM, V6, P33, DOI 10.1002/jmri.1880060107; Steffens CJ, 1997, AM J ROENTGENOL, V169, P749, DOI 10.2214/ajr.169.3.9275891; Steffens JC, 1999, J COMPUT ASSIST TOMO, V23, P7, DOI 10.1097/00004728-199901000-00002; Sueyoshi E, 1999, RADIOLOGY, V210, P683, DOI 10.1148/radiology.210.3.r99fe22683; Sueyoshi E, 2000, ACTA RADIOL, V41, P133, DOI 10.1080/028418500127345136; Vosshenrich R, 1998, MAGN RESON IMAGING, V16, P887, DOI 10.1016/S0730-725X(98)00078-2; WESBEY GE, 1985, RADIOLOGY, V156, P733, DOI 10.1148/radiology.156.3.4023235; Winchester PA, 1998, J VASC INTERV RADIOL, V9, P891, DOI 10.1016/S1051-0443(98)70417-8; Winterer JT, 1999, J COMPUT ASSIST TOMO, V23, P583, DOI 10.1097/00004728-199907000-00019; Yamashita Y, 1998, JMRI-J MAGN RESON IM, V8, P1066, DOI 10.1002/jmri.1880080510; YOSHIKAWA K, 1994, BRIT J RADIOL, V67, P140, DOI 10.1259/0007-1285-67-794-140; YUCEL EK, 1993, RADIOLOGY, V187, P637, DOI 10.1148/radiology.187.3.8497608	68	153	161	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2001	285	10					1338	1345		10.1001/jama.285.10.1338	http://dx.doi.org/10.1001/jama.285.10.1338			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408QK	11255390				2022-12-28	WOS:000167339000027
J	Shinbrot, T; Muzzio, FJ				Shinbrot, T; Muzzio, FJ			Noise to order	NATURE			English	Review							VIBRATED GRANULAR LAYER; PATTERN-FORMATION; EXCITABLE MEDIA; BINARY-MIXTURES; HEART-MUSCLE; COLLOIDS; ENTROPY; PHASE; WAVES; DIFFUSION	Patterns in natural systems abound, from the stripes on a zebra to ripples in a riverbed. In many of these systems, the appearance of an ordered state is not unexpected as the outcome of an underlying ordered process. Thus crystal growth, honeycomb manufacture and floret evolution generate regular and predictable patterns. Intrinsically noisy and disordered processes such as thermal fluctuations or mechanically randomized scattering generate surprisingly similar patterns. Here we discuss some of the underlying mechanisms believed to be at the heart of these similarities.	Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Shinbrot, T (corresponding author), Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.	shinbrot@sol.rutgers.edu						Adams M, 1998, NATURE, V393, P349, DOI 10.1038/30700; ALDUSHIN AP, 1999, DIFFUSION DRIVEN COM; Aranson IS, 2000, PHYS REV LETT, V84, P3306, DOI 10.1103/PhysRevLett.84.3306; BAGNOLD RA, 1941, PHYSICS BLOWN SAND D; Ball P., 1999, SELF MADE TAPESTRY P; Barnsley M, 1993, FRACTALS EVERYWHERE; Bizon C, 1999, PHYS REV E, V60, P4340, DOI 10.1103/PhysRevE.60.4340; Bizon C, 1998, PHYS REV LETT, V80, P57, DOI 10.1103/PhysRevLett.80.57; Bowden N, 1997, SCIENCE, V276, P233, DOI 10.1126/science.276.5310.233; BRUSH SG, 1983, STAT PHYSICS ATOMIC, P86; CAVES CM, 1990, PHYS REV LETT, V65, P1387, DOI 10.1103/PhysRevLett.65.1387; CRAWFORD JD, 1993, NONLINEARITY, V6, P119, DOI 10.1088/0951-7715/6/2/001; Crocker JC, 1999, PHYS REV LETT, V82, P4352, DOI 10.1103/PhysRevLett.82.4352; Crocker JC, 1996, PHYS REV LETT, V77, P1897, DOI 10.1103/PhysRevLett.77.1897; Csahok Z, 2000, EUR PHYS J E, V3, P71, DOI 10.1007/s101890070043; DIJKSTRA M, 1994, PHYS REV LETT, V72, P298, DOI 10.1103/PhysRevLett.72.298; Dijkstra M, 1997, PHYS REV E, V56, P5594, DOI 10.1103/PhysRevE.56.5594; Dijkstra M, 1999, PHYS REV E, V59, P5744, DOI 10.1103/PhysRevE.59.5744; DING M, 1990, PHYS REV A, V42, P7025, DOI 10.1103/PhysRevA.42.7025; Dinsmore AD, 1996, NATURE, V383, P239, DOI 10.1038/383239a0; Dogic Z, 1997, PHYS REV LETT, V78, P2417, DOI 10.1103/PhysRevLett.78.2417; Duran J, 1998, PHYS REV LETT, V80, P3547, DOI 10.1103/PhysRevLett.80.3547; EDWARDS WS, 1994, J FLUID MECH, V278, P123, DOI 10.1017/S0022112094003642; Eggers J, 1999, PHYS REV E, V59, P4476, DOI 10.1103/PhysRevE.59.4476; Eggers J, 1999, PHYS REV LETT, V83, P5322, DOI 10.1103/PhysRevLett.83.5322; Einasto J, 1997, NATURE, V385, P139, DOI 10.1038/385139a0; FORREST SB, 1992, SCIENCE, V255, P1240, DOI 10.1126/science.255.5049.1240; GOLDHIRSCH I, 1993, PHYS REV LETT, V70, P1619, DOI 10.1103/PhysRevLett.70.1619; Golubitsky M., 1992, FEARFUL SYMMETRY IS; Gorman M, 1996, PHYS REV LETT, V76, P228, DOI 10.1103/PhysRevLett.76.228; GRAHAM MD, 1994, SCIENCE, V264, P80, DOI 10.1126/science.264.5155.80; Grier DG, 1998, NATURE, V393, P621, DOI 10.1038/31340; Grotzinger JP, 1996, NATURE, V383, P423, DOI 10.1038/383423a0; GUJRATI PD, IN PRESS PHYS REV E; Haim D, 1996, PHYS REV LETT, V77, P190, DOI 10.1103/PhysRevLett.77.190; HEANEY PJ, 1995, SCIENCE, V269, P1562, DOI 10.1126/science.269.5230.1562; HERZEL H, 1988, MATH MECH, V68, P11; HONG D, IN PRESS PHYS REV LE; Hosoi AE, 1996, J FLUID MECH, V328, P297, DOI 10.1017/S0022112096008737; JUNG P, 1995, PHYS REV LETT, V74, P2130, DOI 10.1103/PhysRevLett.74.2130; Kadar S, 1998, NATURE, V391, P770, DOI 10.1038/35814; Kestenbaum D, 1998, SCIENCE, V279, P1849, DOI 10.1126/science.279.5358.1849; Klausmeier CA, 1999, SCIENCE, V284, P1826, DOI 10.1126/science.284.5421.1826; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; KONIG A, IN PRESS PHYS REV E; Kudrolli A, 1998, PHYSICA D, V123, P99, DOI 10.1016/S0167-2789(98)00115-8; LEE KJ, 1993, SCIENCE, V261, P192, DOI 10.1126/science.261.5118.192; Lekkerkerker HNW, 1998, NATURE, V393, P305, DOI 10.1038/30599; LUDING S, 1994, PHYS REV E, V49, P1634, DOI 10.1103/PhysRevE.49.1634; Makse HA, 2000, EUR PHYS J E, V1, P127, DOI 10.1007/PL00014592; Metcalf TH, 1997, PHYSICA A, V236, P202, DOI 10.1016/S0378-4371(96)00370-6; Mueth DM, 1996, PHYS REV LETT, V77, P578, DOI 10.1103/PhysRevLett.77.578; Mullin T, 2000, PHYS REV LETT, V84, P4741, DOI 10.1103/PhysRevLett.84.4741; OLIVER S, 1995, NATURE, V378, P47, DOI 10.1038/378047a0; PEARSON JE, 1993, SCIENCE, V261, P189, DOI 10.1126/science.261.5118.189; PRAUSE BA, 1995, J PHYS-CONDENS MAT, V7, pL511, DOI 10.1088/0953-8984/7/40/001; REYNOLDS O, 1900, ACTION RAIN CALM SEA, P86; Sano O, 1999, J PHYS SOC JPN, V68, P1769, DOI 10.1143/JPSJ.68.1769; SCHLICHTING HJ, 1996, NATURWISSENSCHAFTEN, V49, P323; SELLWOOD JA, 1984, ASTROPHYS J, V282, P61, DOI 10.1086/162176; Sellwood JA, 2000, ASTROPHYS SPACE SCI, V272, P31, DOI 10.1023/A:1002668818252; Shinbrot T, 1997, NATURE, V389, P574, DOI 10.1038/39264; SHINBROT T, 1985, J ELECTROSTAT, V17, P113, DOI 10.1016/0304-3886(85)90014-2; Shinbrot T, 1999, J THEOR BIOL, V196, P455, DOI 10.1006/jtbi.1998.0843; Shinbrot T, 2000, GRANUL MATTER, V2, P65, DOI 10.1007/s100350050036; Shinbrot T, 2000, PHYS TODAY, V53, P25, DOI 10.1063/1.883018; Silber M, 2000, PHYSICA D, V143, P205, DOI 10.1016/S0167-2789(00)00102-0; Silber M, 1999, PHYS REV E, V59, P5446, DOI 10.1103/PhysRevE.59.5446; Silber M, 1998, PHYS REV LETT, V81, P2450, DOI 10.1103/PhysRevLett.81.2450; Sinai Y.G., 1970, USPEHI MAT NAUK, V25, P141, DOI 10.1070/RM1970v025n02ABEH003794; STROGATZ SH, 1994, NONLINEAR DYNAMICS C, P254; TOOMRE A, 1972, ASTROPHYS J, V178, P623, DOI 10.1086/151823; TSIMPLIS MN, 1992, J PHYS OCEANOGR, V22, P404, DOI 10.1175/1520-0485(1992)022<0404:TEORIC>2.0.CO;2; Tsimring LS, 1997, PHYS REV LETT, V79, P213, DOI 10.1103/PhysRevLett.79.213; Umbanhowar PB, 1996, NATURE, V382, P793, DOI 10.1038/382793a0; van Roij R, 1998, PHYSICA A, V261, P374, DOI 10.1016/S0378-4371(98)00429-4; vanBlaaderen A, 1997, NATURE, V385, P321, DOI 10.1038/385321a0; Venkataramani SC, 1998, PHYS REV LETT, V80, P3495, DOI 10.1103/PhysRevLett.80.3495; Vogel G, 1996, SCIENCE, V274, P343, DOI 10.1126/science.274.5286.343; WALKER J, 1975, FLYING CIRCUS PHYSIC, P14; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; WINFREE AT, 1994, SCIENCE, V266, P1003, DOI 10.1126/science.7973648; Winfree AT, 1997, INT J BIFURCAT CHAOS, V7, P487, DOI 10.1142/S0218127497000376; Wu KKS, 1999, NATURE, V397, P225, DOI 10.1038/16637	84	127	133	3	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2001	410	6825					251	258		10.1038/35065689	http://dx.doi.org/10.1038/35065689			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11258380				2022-12-28	WOS:000167320500059
J	Banerjee, SK				Banerjee, SK			Geophysics - When the compass stopped reversing its poles	SCIENCE			English	Editorial Material							EARTHS MAGNETIC-FIELD; GEOMAGNETIC REVERSALS; PALEOINTENSITY; FREQUENCY		Univ Minnesota, Sch Earth Sci, Inst Rock Magnetism, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Banerjee, SK (corresponding author), Univ Minnesota, Sch Earth Sci, Inst Rock Magnetism, Minneapolis, MN 55455 USA.	banerjee@umn.edu						[Anonymous], 1996, MAGNETIC FIELD EARTH; COX A, 1975, REV GEOPHYS, V13, P35, DOI 10.1029/RG013i003p00035; COX A, 1968, J GEOPHYS RES, V73, P3247, DOI 10.1029/JB073i010p03247; Glatzmaier GA, 1999, NATURE, V401, P885, DOI 10.1038/44776; Juarez MT, 1998, NATURE, V394, P878, DOI 10.1038/29746; Perrin M, 1997, J GEOMAGN GEOELECTR, V49, P601, DOI 10.5636/jgg.49.601; PICK T, 1993, J GEOPHYS RES-SOL EA, V98, P17949, DOI 10.1029/93JB01160; Selkin PA, 2000, PHILOS T R SOC A, V358, P1065, DOI 10.1098/rsta.2000.0574; Tarduno JA, 2001, SCIENCE, V291, P1779, DOI 10.1126/science.1057519	9	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2001	291	5509					1714	1715		10.1126/science.291.5509.1714	http://dx.doi.org/10.1126/science.291.5509.1714			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11253196				2022-12-28	WOS:000167320600034
J	Vukusic, P; Sambles, JR; Lawrence, CR; Wootton, RJ				Vukusic, P; Sambles, JR; Lawrence, CR; Wootton, RJ			Structural colour - Now you see it now you don't	NATURE			English	Article									Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England; DERA, Mech Sci Sector, Farnborough GU14 0LX, Hants, England; Univ Exeter, Sch Biol Sci, Exeter EX4 4PS, Devon, England	University of Exeter; University of Exeter	Vukusic, P (corresponding author), Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England.	p.vukusic@ex.ac.uk	Sambles, John Roy/X-8675-2019	SAMBLES, John/0000-0003-2721-0692	Biotechnology and Biological Sciences Research Council [JF16983] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		DEVRIES PJ, 1997, BUTTERFLIES COSTA RI, V2; GREENEWALT CH, 1960, J OPT SOC AM, V50, P1005, DOI 10.1364/JOSA.50.001005; Guinier A., 1963, XRAY DIFFRACTION; Land M F, 1972, Prog Biophys Mol Biol, V24, P75, DOI 10.1016/0079-6107(72)90004-1; Magnus D. B. E., 1958, Proceedings 10th International Congress of Entomology Montreal 1956, V2, P405; SILBERGLIED RE, 1984, S ROYAL ENTOMOLOGICA, V11, P207; SMART P, 1976, ENCY BUTTERFLY; Vukusic P, 1999, P ROY SOC B-BIOL SCI, V266, P1403, DOI 10.1098/rspb.1999.0794	8	122	132	7	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2001	410	6824					36	36		10.1038/35065161	http://dx.doi.org/10.1038/35065161			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242032	Bronze			2022-12-28	WOS:000167194300033
J	Nucifora, FC; Sasaki, M; Peters, MF; Huang, H; Cooper, JK; Yamada, M; Takahashi, H; Tsuji, S; Troncoso, J; Dawson, VL; Dawson, TM; Ross, CA				Nucifora, FC; Sasaki, M; Peters, MF; Huang, H; Cooper, JK; Yamada, M; Takahashi, H; Tsuji, S; Troncoso, J; Dawson, VL; Dawson, TM; Ross, CA			Interference by Huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity	SCIENCE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; CREB-BINDING PROTEIN; EXPANDED POLYGLUTAMINE; NEURODEGENERATIVE DISEASES; GLUTAMINE REPEATS; MUTANT HUNTINGTIN; TRANSGENIC MICE; PALLIDOLUYSIAN ATROPHY; MOUSE MODEL; IN-VIVO	Expanded polyglutamine repeats have been proposed to cause neuronal degeneration in Huntington's disease (HD) and related disorders, through abnormal interactions with other proteins containing short polyglutamine tracts such as the transcriptional coactivator CREB binding protein, CBP. We found that CBP was depleted from its normal nuclear Location and was present in polyglutamine aggregates in HD cell culture models, HD transgenic: mice, and human HD postmortem brain. Expanded polyglutamine repeats specifically interfere with CBP-activated gene transcription, and overexpression of CBP rescued polyglutamine-induced neuronal toxicity. Thus, polyglutamine-mediated interference with CBP-regulated gene transcription may constitute a genetic gain of function, underlying the pathogenesis of polyglutamine disorders.	Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neuropathol, Baltimore, MD 21205 USA; Niigata Univ, Brain Res Inst, Dept Pathol & Neurol, Niigata 9518585, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Niigata University	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA.		Dawson, Valina/Y-9757-2019; Ross, Christopher A/H-8395-2013; NUCIFORA, FREDERICK/X-2364-2019	Dawson, Valina/0000-0002-2915-3970; Cooper, Jillian/0000-0002-5850-563X	NINDS NIH HHS [NS34172, NS16375, NS37090, NS38144] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034172, P50NS016375, P01NS016375, R01NS038144, R01NS037090] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Gonzalez-Zulueta M, 1998, J NEUROSCI, V18, P2040; Gusella JF, 1996, ANNU REV MED, V47, P201; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; HO HN, 1989, GENE, V77, P51; HOUSMAN D, 1995, NAT GENET, V10, P3, DOI 10.1038/ng0595-3; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; IGARASHI S, 2000, SOC NEUR ABSTR, V382, P1030; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; Persichetti F, 1999, NEUROBIOL DIS, V6, P364, DOI 10.1006/nbdi.1999.0260; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; Peters MF, 1999, NEUROSCI LETT, V275, P129, DOI 10.1016/S0304-3940(99)00758-2; Preisinger E, 1999, PHILOS T ROY SOC B, V354, P1029, DOI 10.1098/rstb.1999.0455; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; RICHFIELD EK, 1995, ANN NEUROL, V37, P335, DOI 10.1002/ana.410370309; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; Ross CA, 1997, MEDICINE, V76, P305, DOI 10.1097/00005792-199709000-00001; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schilling G, 1999, NEURON, V24, P275, DOI 10.1016/S0896-6273(00)80839-9; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3	44	842	873	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2423	2428		10.1126/science.1056784	http://dx.doi.org/10.1126/science.1056784			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264541				2022-12-28	WOS:000167618700060
J	Bensaude-Vincent, B				Bensaude-Vincent, B			Chemical analysis	NATURE			English	Article									Univ Paris 10, Dept Philosophy, F-92001 Nanterre, France	Universite Paris Nanterre	Bensaude-Vincent, B (corresponding author), Univ Paris 10, Dept Philosophy, 200 Ave Republ, F-92001 Nanterre, France.		Rowland, Alan P/A-9793-2013	Rowland, Alan P/0000-0001-7499-8473					0	2	2	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					415	415		10.1038/35068642	http://dx.doi.org/10.1038/35068642			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260690	Bronze			2022-12-28	WOS:000167583800020
J	Li, QJ; Xu, ZF; Kress, WJ; Xia, YM; Zhang, L; Deng, XB; Gao, JY; Bai, ZL				Li, QJ; Xu, ZF; Kress, WJ; Xia, YM; Zhang, L; Deng, XB; Gao, JY; Bai, ZL			Pollination - Flexible style that encourages outcrossing	NATURE			English	Article									Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Mengla 666303, Yunnan, Peoples R China; Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA; Chinese Acad Sci, Kunming Inst Bot, Kunming 650204, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Li, QJ (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Mengla 666303, Yunnan, Peoples R China.							BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Cui X., 1996, P 2 S FAM ZING S CHI, P288; Darwin C, 1916, EFFECTS CROSS SELF F; HOLSINGER KE, 1991, TRENDS ECOL EVOL, V6, P307, DOI 10.1016/0169-5347(91)90033-T; LI QJ, IN PRESS ACTA BOT SI; Richards A.J, 1997, PLANT BREEDING SYSTE; SMITH R M, 1990, Edinburgh Journal of Botany, V47, P1; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; ZHANG JH, 1995, BIOL CONSERV, V73, P229, DOI 10.1016/0006-3207(94)00118-A	9	95	147	6	52	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					432	432		10.1038/35068635	http://dx.doi.org/10.1038/35068635			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260703	Bronze			2022-12-28	WOS:000167583800031
J	Samad, TA; Moore, KA; Sapirstein, A; Billet, S; Allchorne, A; Poole, S; Bonventre, JV; Woolf, CJ				Samad, TA; Moore, KA; Sapirstein, A; Billet, S; Allchorne, A; Poole, S; Bonventre, JV; Woolf, CJ			Interleukin-1 beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity	NATURE			English	Article							PROSTAGLANDIN E-2 RELEASE; RAT SPINAL-CORD; CYTOSOLIC PHOSPHOLIPASE A(2); ION CHANNELS; HYPERALGESIA; CELLS; CYCLOOXYGENASE-2; MICE; EXPRESSION; ALLODYNIA	Inflammation causes the induction of cyclooxygenase-2 (Cox-2)(1), leading to the release of prostanoids, which sensitize peripheral nociceptor terminals and produce localized pain hypersensitivity(2). Peripheral inflammation also generates pain hypersensitivity in neighbouring uninjured tissue (secondary hyperalgesia), because of increased neuronal excitability in the spinal cord (central sensitization)(3), and a syndrome comprising diffuse muscle and joint pain, fever, lethargy and anorexia(4). Here we show that Cox-2 may be involved in these central nervous system (CNS) responses, by finding a widespread induction of Cox-2 expression in spinal cord neurons and in other regions of the CNS, elevating prostaglandin E(2) (PGE(2)) levels in the cerebrospinal fluid. The major inducer of central Cox-2 upregulation is interleukin-1 beta in the CNS, and as basal phospholipase A(2) activity in the CNS does not change with peripheral inflammation, Cox-2 levels must regulate central prostanoid production. Intraspinal administration of an interleukin-converting enzyme or Cox-2 inhibitor decreases inflammation-induced central PGE(2) levels and mechanical hyperalgesia. Thus, preventing central prostanoid production by inhibiting the interleukin-1 beta -mediated induction of Cox-2 in neurons or by inhibiting central Cox-2 activity reduces centrally generated inflammatory pain hypersensitivity.	Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Med, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; UCL, Dept Anat, London WC1E 6BT, England; Natl Inst Biol Stand & Controls, S Mimms EN6 3QG, Herts, England	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of London; University College London; National Institute for Biological Standards & Control	Woolf, CJ (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA.	woolf.clifford@mgh.harvard.edu	Woolf, Clifford/A-9784-2010					Amaya F, 2000, MOL CELL NEUROSCI, V15, P331, DOI 10.1006/mcne.1999.0828; Beiche F, 1998, INFLAMM RES, V47, P482, DOI 10.1007/s000110050362; Beiche F, 1996, FEBS LETT, V390, P165, DOI 10.1016/0014-5793(96)00604-7; Bingham CO, 1999, J BIOL CHEM, V274, P31476, DOI 10.1074/jbc.274.44.31476; Cartmell T, 2000, J PHYSIOL-LONDON, V526, P653, DOI 10.1111/j.1469-7793.2000.00653.x; Curley J, 1996, ANESTHESIOLOGY, V84, P1401, DOI 10.1097/00000542-199606000-00017; Dantzer R, 1998, ANN NY ACAD SCI, V856, P132, DOI 10.1111/j.1749-6632.1998.tb08321.x; Dirig DM, 1997, EUR J PHARMACOL, V331, P155, DOI 10.1016/S0014-2999(97)01053-4; Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324; Hay CH, 1997, NEUROSCIENCE, V78, P843, DOI 10.1016/S0306-4522(96)00598-2; Hietaranta A, 1999, PANCREAS, V18, P385, DOI 10.1097/00006676-199905000-00009; Lashbrook JM, 1999, PAIN, V82, P65, DOI 10.1016/S0304-3959(99)00031-7; Levy R, 2000, ADV EXP MED BIOL, V479, P125; MAIER JAM, 1990, J BIOL CHEM, V265, P10805; MALMBERG AB, 1992, SCIENCE, V257, P1276, DOI 10.1126/science.1381521; McCleskey EW, 1999, ANNU REV PHYSIOL, V61, P835, DOI 10.1146/annurev.physiol.61.1.835; MINAMI T, 1994, BRIT J PHARMACOL, V112, P735, DOI 10.1111/j.1476-5381.1994.tb13139.x; Muth-Selbach US, 1999, ANESTHESIOLOGY, V91, P231, DOI 10.1097/00000542-199907000-00032; O'Banion MK, 1999, CRIT REV NEUROBIOL, V13, P45, DOI 10.1615/CritRevNeurobiol.v13.i1.30; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Sapirstein A, 1996, J BIOL CHEM, V271, P21505, DOI 10.1074/jbc.271.35.21505; Saunders MA, 1999, J PHARMACOL EXP THER, V288, P1101; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Southall MD, 1998, PAIN, V78, P39, DOI 10.1016/S0304-3959(98)00113-4; Swiergiel AH, 1997, BRAIN RES, V776, P96, DOI 10.1016/S0006-8993(97)01009-3; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; YAKSH TL, 1976, SCIENCE, V192, P1357, DOI 10.1126/science.1273597; Yamamoto T, 1998, NEUROREPORT, V9, P3869, DOI 10.1097/00001756-199812010-00019; Yao JH, 1999, AM J PHYSIOL-REG I, V277, pR1435, DOI 10.1152/ajpregu.1999.277.5.R1435	30	1014	1089	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					471	475		10.1038/35068566	http://dx.doi.org/10.1038/35068566			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260714				2022-12-28	WOS:000167583800042
J	Steen, S; Sjoberg, T; Pierre, L; Liao, QM; Eriksson, L; Algotsson, L				Steen, S; Sjoberg, T; Pierre, L; Liao, QM; Eriksson, L; Algotsson, L			Transplantation of lungs from a non-heart-beating donor	LANCET			English	Article							CRITICAL RESPIRATORY-FAILURE; VASCULAR FUNCTION; PRESERVATION; CADAVER; HYPOTHERMIA; PERFADEX; SAFE	Background In animals, we have previously done successful lung transplantations using organs from non-heart-beating donors. We have also developed an ex-vivo system of assessing the function of such organs before transplantation. The next stage was to try the technique in human beings. Bearing in mind the sensitive ethical issues involved, our first aim was to find out what procedures would be acceptable, and to use the results to guide a clinical lung transplantation from a non-heart-beating donor. Methods The ethical acceptability of the study was gauged from the results of a broad information programme directed at the general public in Sweden, and from discussions with professionals including doctors, nurses, hospital chaplains, and judges. The donor was a patient dying of acute myocardial infarction in a cardiac intensive-care unit after failed cardiopulmonary resuscitation. The next of kin gave permission to cool the lungs within the intact body, and intrapleural cooling was started 65 min after death. Blood samples were sent for virological testing and cross matching. The next of kin then had time to be alone with the deceased. After 3 h, the body was transported to the operating theatre and the heart-lung block removed. The lungs were assessed ex vivo, and the body was transported to the pathology department for necropsy. Results No contraindications to transplantation were found, and the right lung was transplanted successfully into a 54-year-old woman with chronic obstructive pulmonary disease. The donor lung showed excellent function only 5 min after reperfusion and ventilation, and during the first 5 months of follow-up, the function of the transplanted lung has been good. Interpretation About half the deaths in Sweden are caused by cardiac and cerebrovascular disease. This group could be a potential source of lung donors. When all hospitals and ambulance personnel in Sweden have received training in non-heart-beating lung donation, we hope that there will be enough donor lungs of good quality for all patients needing a lung transplant.	Univ Lund Hosp, Heart Lung Div, S-22185 Lund, Sweden	Lund University; Skane University Hospital	Steen, S (corresponding author), Univ Lund Hosp, Heart Lung Div, S-22185 Lund, Sweden.			pierre, leif/0000-0001-6464-505X				Bolys R, 1999, J HEART LUNG TRANSPL, V18, P582, DOI 10.1016/S1053-2498(98)00075-8; EGAN TM, 1991, ANN THORAC SURG, V52, P1113, DOI 10.1016/0003-4975(91)91290-C; Eriksson LT, 1998, ANN THORAC SURG, V65, P827, DOI 10.1016/S0003-4975(97)01388-X; INGEMANSSON R, 1995, ANN THORAC SURG, V60, P1210, DOI 10.1016/0003-4975(95)00548-Y; KOUL B, 1992, J THORAC CARDIOV SUR, V104, P579; Lindberg L, 1996, ANN THORAC SURG, V62, P1639, DOI 10.1016/S0003-4975(96)00744-8; STEEN S, 1994, ANN THORAC SURG, V58, P1657, DOI 10.1016/0003-4975(94)91654-3; Steen S, 1997, ANN THORAC SURG, V63, P345; STEEN S, 1994, ANN THORAC SURG, V57, P450, DOI 10.1016/0003-4975(94)91016-2; Steen S, 1996, PROGR APPL MICR, V22, P50; Van Raemdonck DEM, 1998, ANN SURG, V228, P788, DOI 10.1097/00000658-199812000-00010; WETTERBERG T, 1992, ACTA ANAESTH SCAND, V36, P490, DOI 10.1111/j.1399-6576.1992.tb03504.x; WETTERBERG T, 1991, INTENS CARE MED, V17, P73, DOI 10.1007/BF01691426; Wierup P, 1999, J HEART LUNG TRANSPL, V18, P133, DOI 10.1016/S1053-2498(98)00011-4; Wierup P, 2000, J HEART LUNG TRANSPL, V19, P270, DOI 10.1016/S1053-2498(99)00132-1	15	435	475	3	19	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 17	2001	357	9259					825	829		10.1016/S0140-6736(00)04195-7	http://dx.doi.org/10.1016/S0140-6736(00)04195-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265950				2022-12-28	WOS:000167586300008
J	Gupta, HK; Rao, NP; Rastogi, BK; Sarkar, D				Gupta, HK; Rao, NP; Rastogi, BK; Sarkar, D			Geology - The deadliest intraplate earthquake	SCIENCE			English	Editorial Material							INDIA		Natl Geophys Res Inst, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Geophysical Research Institute (NGRI)	Gupta, HK (corresponding author), Natl Geophys Res Inst, Hyderabad 500007, Andhra Pradesh, India.		Rastogi, Bal/AAF-3301-2020					Bhatia SC, 1999, ANN GEOFIS, V42, P1153; BISWAS SK, 1987, TECTONOPHYSICS, V135, P307, DOI 10.1016/0040-1951(87)90115-6; CHUNG WY, 1995, TECTONOPHYSICS, V242, P281, DOI 10.1016/0040-1951(94)00203-L; GSI, 2000, SEISM TECT ATL IND E; *IND STAND I, 1986, ISI PUBL; JOHNSTON AC, 1993, 10261 EPRI TR, pCH3; Kerr RA, 2001, SCIENCE, V291, P802, DOI 10.1126/science.291.5505.802	7	65	66	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2101	2102		10.1126/science.1060197	http://dx.doi.org/10.1126/science.1060197			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11256407				2022-12-28	WOS:000167563800023
J	Davidson, PU; Kost, J; Myers, GJ; Cox, C; Clarkson, TW; Shamlaye, CF				Davidson, PU; Kost, J; Myers, GJ; Cox, C; Clarkson, TW; Shamlaye, CF			Methylmercury and neurodevelopment: Reanalysis of the Seychelles Child Development Study outcomes at 66 months of age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							EXPOSURE		Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA	University of Rochester	Davidson, PU (corresponding author), Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA.		Myers, Gary J/I-4901-2013	Myers, Gary J/0000-0003-4317-015X				Davidson PW, 1998, JAMA-J AM MED ASSOC, V280, P701, DOI 10.1001/jama.280.8.701; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; National Research Council, 2000, TOX EFF METH	3	31	31	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2001	285	10					1291	1293		10.1001/jama.285.10.1291-a	http://dx.doi.org/10.1001/jama.285.10.1291-a			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408QK	11255383				2022-12-28	WOS:000167339000019
J	Frost, G; Dornhorst, A				Frost, G; Dornhorst, A			Starting the day the right way	LANCET			English	Editorial Material							BREAKFAST CONSUMPTION; GLYCEMIC-INDEX; TERM DIETARY; FAT		Hammersmith Hosp NHS Trust, Dept Nutr & Dietet, London W12 0HS, England; Univ London Imperial Coll Sci Technol & Med, Dept Metab Med, Div Invest Sci, London SW7 2AZ, England	Imperial College London; Imperial College London	Frost, G (corresponding author), Hammersmith Hosp NHS Trust, Dept Nutr & Dietet, London W12 0HS, England.							JENKINS DJA, 1978, BRIT MED J, V1, P1392, DOI 10.1136/bmj.1.6124.1392; JENKINS DJA, 1988, DIABETES CARE, V11, P149, DOI 10.2337/diacare.11.2.149; Martin A, 2000, BRIT J NUTR, V84, P337, DOI 10.1017/S0007114500001616; Ruxton CHS, 1997, BRIT J NUTR, V78, P199, DOI 10.1079/BJN19970140; STANTON JL, 1989, J AM COLL NUTR, V8, P567; Tsihlias EB, 2000, AM J CLIN NUTR, V72, P439; WOLEVER TMS, 1995, DIABETES CARE, V18, P962, DOI 10.2337/diacare.18.7.962	7	0	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					736	737		10.1016/S0140-6736(00)04179-9	http://dx.doi.org/10.1016/S0140-6736(00)04179-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253962				2022-12-28	WOS:000167400900006
J	Rodes, J; Bruguera, M				Rodes, J; Bruguera, M			The uses of error: latrogenic hepatitis	LANCET			English	Article									Hosp Clin & Prov Barcelona, Barcelona 08036, Spain	University of Barcelona; Hospital Clinic de Barcelona	Rodes, J (corresponding author), Hosp Clin & Prov Barcelona, Villarroel 170, Barcelona 08036, Spain.								0	4	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					791	791		10.1016/S0140-6736(00)04184-2	http://dx.doi.org/10.1016/S0140-6736(00)04184-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253985				2022-12-28	WOS:000167400900040
J	Riedl, SJ; Renatus, M; Schwarzenbacher, R; Zhou, Q; Sun, CH; Fesik, SW; Liddington, RC; Salvesen, GS				Riedl, SJ; Renatus, M; Schwarzenbacher, R; Zhou, Q; Sun, CH; Fesik, SW; Liddington, RC; Salvesen, GS			Structural basis for the inhibition of caspase-3 by XIAP	CELL			English	Article							CRYSTAL-STRUCTURE; CYTOCHROME-C; SURVIVIN REVEALS; NMR STRUCTURE; BIR DOMAIN; PROTEIN; APOPTOSIS; IAP; COMPLEX; BINDING	The molecular mechanism(s) that regulate apoptosis by caspase inhibition remain poorly understood. The main endogenous inhibitors are members of the IAP family and are exemplified by XIAP, which regulates the initiator caspase-9, and the executioner caspases-3 and -7. We report the crystal structure of the second BIR domain of XIAP (BIR2) in complex with caspase-3, at a resolution of 2.7 Angstrom, revealing the structural basis for inhibition. The inhibitor makes limited contacts through its BIR domain to the surface of the enzyme, and most contacts to caspase-3 originate from the N-terminal extension. This lies across the substrate binding cleft, but in reverse orientation compared to substrate binding. The mechanism of inhibition is due to a steric blockade prohibitive of substrate binding, and is distinct from the mechanism utilized by synthetic substrate analog inhibitors.	Burnham Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA; Abbott Labs, Div Pharmaceut Discovery, Abbott Pk, IL 60064 USA	Sanford Burnham Prebys Medical Discovery Institute; Abbott Laboratories	Salvesen, GS (corresponding author), Burnham Inst, Program Apoptosis & Cell Death Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gsalvesen@burnham.org			NIA NIH HHS [AG15402] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG015402] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanchard H, 1999, STRUCTURE, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Bode W, 1991, CURR OPIN STRUC BIOL, V1, P45, DOI 10.1016/0959-440X(91)90010-Q; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hinds MG, 1999, NAT STRUCT BIOL, V6, P648; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; KASOF GM, 2000, J BIOL CHEM, V9, P9; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mittl PRE, 1997, J BIOL CHEM, V272, P6539, DOI 10.1074/jbc.272.10.6539; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Muchmore SW, 2000, MOL CELL, V6, P173, DOI 10.1016/S1097-2765(00)00018-6; NAVAZZA J, 1994, ACTA CRYSTALLOGR A, V50; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATSTON PA, 1991, BIOCHEMISTRY-US, V30, P8876, DOI 10.1021/bi00100a022; READ RJ, 1986, PROTEINASE INHIBITOR, P301; Rotonda J, 1996, NAT STRUCT BIOL, V3, P619, DOI 10.1038/nsb0796-619; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Stennicke HR, 1999, METHODS, V17, P313, DOI 10.1006/meth.1999.0745; STUBBS MT, 1990, EMBO J, V9, P1939, DOI 10.1002/j.1460-2075.1990.tb08321.x; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; TURK D, 1992, WEITERENTWICKLUNG PR; Uren AG, 1998, TRENDS BIOCHEM SCI, V23, P159, DOI 10.1016/S0968-0004(98)01198-0; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Zheng TS, 1999, CELL DEATH DIFFER, V6, P1043, DOI 10.1038/sj.cdd.4400593; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w	60	598	643	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2001	104	5					791	800		10.1016/S0092-8674(02)02036-6	http://dx.doi.org/10.1016/S0092-8674(02)02036-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257232	Bronze			2022-12-28	WOS:000167531100018
J	Ohkusa, T; Fujiki, K; Takashimizu, I; Kumagai, J; Tanizawa, T; Eishi, Y; Yokoyama, T; Watanabe, M				Ohkusa, T; Fujiki, K; Takashimizu, I; Kumagai, J; Tanizawa, T; Eishi, Y; Yokoyama, T; Watanabe, M			Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated	ANNALS OF INTERNAL MEDICINE			English	Article							FOLLOW-UP; INFECTION; CANCER; MUCOSA; CLASSIFICATION; CURE	Background: Glandular atrophy and intestinal metaplasia are precancerous lesions; whether Helicobacter pylori eradication affects: these lesions is controversial. Objective: To determine whether H. pylori eradication is associated with improvement in glandular atrophy and intestinal metaplasia after at least 1 year. Design: Single-blind, uncontrolled prospective trial. Setting: Academic gastroenterology clinic in Japan. Patients: 163 consecutive patients with dyspepsia and H. pylori infection. Intervention: One-week course of a proton-pump inhibitor and antibiotic therapy. Measurements: Endoscopic examination with antral and corporal biopsy was done before treatment and at 1 to 3 and 12 to 15 months after treatment. Gastritis, atrophy, and metaplasia were graded according to the updated Sydney System. Results: In the 115 patients in whom H. pylori was eradicated, inflammation and mean neutrophil activity had decreased by 1 to 3 months, and both glandular atrophy in the corpus and intestinal metaplasia in the antrum had decreased by 12 to 15 months. Glandular atrophy in the corpus improved in 34 (89%) of 38 patients with atrophy before treatment, and intestinal metaplasia in the antrum improved in 28 (61%) of 46 patients who had metaplasia at baseline, In the 48 patients in whom eradication was unsuccessful, no significant histologic changes were observed. Conclusion: In the year after successful H. pylori eradication, precancerous lesions improved in most patients.	Tokyo Med & Dent Univ, Sch Med, Dept Gastroenterol & Hepatol, Bunkyo Ku, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU)	Ohkusa, T (corresponding author), Tokyo Med & Dent Univ, Sch Med, Dept Gastroenterol & Hepatol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	ohkusa.gast@tmd.ac.jp	大草, 敏史/HGD-2376-2022; Eishi, Yoshinobu/N-3602-2017	Eishi, Yoshinobu/0000-0002-0521-1670				Annibale B, 2000, ALIMENT PHARM THERAP, V14, P625; Ciok J, 1997, J Physiol Pharmacol, V48 Suppl 4, P115; CORREA P, 1988, AM J GASTROENTEROL, V83, P504; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; El-Omar EM, 2000, GASTROENTEROLOGY, V118, P22, DOI 10.1016/S0016-5085(00)70410-0; ENDO S, 1995, CANCER, V75, P2203, DOI 10.1002/1097-0142(19950501)75:9<2203::AID-CNCR2820750903>3.0.CO;2-6; Enomoto Y, 1999, GASTROENTEROLOGY, V116, pA156; Forbes GM, 1996, J GASTROEN HEPATOL, V11, P670, DOI 10.1111/j.1440-1746.1996.tb00312.x; GENTA RM, 1993, MODERN PATHOL, V6, P281; HEDEKER D, 1994, BIOMETRICS, V50, P933, DOI 10.2307/2533433; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; RUGGE M, 1991, HUM PATHOL, V22, P1002, DOI 10.1016/0046-8177(91)90008-D; Sung JJY, 2000, GASTROENTEROLOGY, V119, P7, DOI 10.1053/gast.2000.8550; Tepes B, 1999, J PATHOL, V188, P24, DOI 10.1002/(SICI)1096-9896(199905)188:1&lt;24::AID-PATH316&gt;3.0.CO;2-F; Tucci A, 1998, AM J GASTROENTEROL, V93, P1425, DOI 10.1111/j.1572-0241.1998.00454.x; Uemura N, 1997, CANCER EPIDEM BIOMAR, V6, P639; Valle J, 1996, SCAND J GASTROENTERO, V31, P546, DOI 10.3109/00365529609009126; vanderHulst RWM, 1997, GASTROENTEROLOGY, V113, P25, DOI 10.1016/S0016-5085(97)70076-3; WITTEMAN EM, 1995, J CLIN PATHOL, V48, P250, DOI 10.1136/jcp.48.3.250; Zerbib F, 2000, EUR J GASTROEN HEPAT, V12, P719, DOI 10.1097/00042737-200012070-00001	20	165	174	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2001	134	5					380	386		10.7326/0003-4819-134-5-200103060-00010	http://dx.doi.org/10.7326/0003-4819-134-5-200103060-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405ZJ	11242498				2022-12-28	WOS:000167190200004
J	Gregory, RL				Gregory, RL			Perceptions of knowledge	NATURE			English	Editorial Material									Univ Bristol, Dept Expt Psychol, Bristol BS8 1TN, Avon, England	University of Bristol	Gregory, RL (corresponding author), Univ Bristol, Dept Expt Psychol, Bristol BS8 1TN, Avon, England.							Gombrich Ernest, 1960, ART ILLUSION STUDY P; Gregory R. L., 1997, EYE BRAIN PSYCHOL SE	2	7	8	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					21	21		10.1038/35065174	http://dx.doi.org/10.1038/35065174			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242020				2022-12-28	WOS:000167194300022
J	Visscher, PM				Visscher, PM			A viable herd of genetically uniform cattle (vol 409, pg 303, 2001)	NATURE			English	Correction													Visscher, Peter/ABB-6151-2020	Visscher, Peter/0000-0002-2143-8760				Visscher PM, 2001, NATURE, V409, P303, DOI 10.1038/35053160	1	1	1	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					36	36		10.1038/35065164	http://dx.doi.org/10.1038/35065164			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242033	Bronze			2022-12-28	WOS:000167194300034
J	Liljedahl, M; Maeda, Y; Colanzi, A; Ayala, I; Van Lint, J; Malhotra, V				Liljedahl, M; Maeda, Y; Colanzi, A; Ayala, I; Van Lint, J; Malhotra, V			Protein kinase D regulates the fission of cell surface destined transport carriers from the trans-Golgi network	CELL			English	Article							PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; LIVING CELLS; BREFELDIN-A; C FAMILY; COMPARTMENT; ACTIVATION; COMPLEX; YEAST; STACK	When a kinase inactive form of Protein Kinase D (PKD-K618N) was expressed in HeLa cells, it localized to the trans-Golgi network (TGN) and caused extensive tubulation. Cargo that was destined for the plasma membrane was found in PKD-K618N-containing tubes but the tubes did not detach from the TGN. As a result, the transfer of cargo from TGN to the plasma membrane was inhibited. We have also demonstrated the formation and subsequent detachment of cargo-containing tubes from the TGN in cells stably expressing low levels of PKD-K618N. Our results suggest that PKD regulates the fission from the TGN of transport carriers that are en route to the cell surface.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Katholieke Univ Leuven, Fac Geneeskunde, Afdeling Biochem, B-3000 Louvain, Belgium	University of California System; University of California San Diego; KU Leuven	Malhotra, V (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.		Colanzi, Antonino/D-6821-2012; Van Lint, Johan/P-9073-2019; Ayala, Inmaculada/U-4565-2018; Malhotra, Vivek/O-9811-2014	Colanzi, Antonino/0000-0002-5643-0216; Ayala, Inmaculada/0000-0002-3329-1428; Malhotra, Vivek/0000-0001-6198-7943; Van Lint, Johan/0000-0002-0275-571X				Acharya U, 1998, CELL, V92, P183, DOI 10.1016/S0092-8674(00)80913-7; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Banting G, 1997, BBA-MOL CELL RES, V1355, P209, DOI 10.1016/S0167-4889(96)00146-2; COOPER MS, 1990, CELL, V61, P135, DOI 10.1016/0092-8674(90)90221-Y; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; Kuwana T, 1998, P NATL ACAD SCI USA, V95, P1056, DOI 10.1073/pnas.95.3.1056; Liljedahl M, 1998, IMMUNITY, V8, P233, DOI 10.1016/S1074-7613(00)80475-6; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Maier U, 2000, J BIOL CHEM, V275, P13746, DOI 10.1074/jbc.275.18.13746; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Nishikawa K, 1998, J BIOL CHEM, V273, P23126, DOI 10.1074/jbc.273.36.23126; ORCI L, 1989, CELL, V56, P357, DOI 10.1016/0092-8674(89)90239-0; ORCI L, 1993, NATURE, V362, P648, DOI 10.1038/362648a0; Polishchuk RS, 2000, J CELL BIOL, V148, P45, DOI 10.1083/jcb.148.1.45; Prestle J, 1996, J CELL BIOL, V134, P1401, DOI 10.1083/jcb.134.6.1401; SCHINDLER R, 1993, EUR J CELL BIOL, V61, P1; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; STURANY S, 2000, IN PRESS J BIOL CHEM; TAKIZAWA PA, 1993, CELL, V73, P1079, DOI 10.1016/0092-8674(93)90638-7; Toomre D, 1999, J CELL SCI, V112, P21; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Waldron RT, 1999, ELECTROPHORESIS, V20, P382, DOI 10.1002/(SICI)1522-2683(19990201)20:2<382::AID-ELPS382>3.0.CO;2-N; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	36	293	298	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2001	104	3					409	420		10.1016/S0092-8674(01)00228-8	http://dx.doi.org/10.1016/S0092-8674(01)00228-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239398	Bronze			2022-12-28	WOS:000167003100011
J	Dell, A; Morris, HR				Dell, A; Morris, HR			Glycoprotein structure determination mass spectrometry	SCIENCE			English	Review							FAST-ATOM-BOMBARDMENT; PRION PROTEIN; SERUM TRANSFERRIN; O-GLYCANS; LIQUID-CHROMATOGRAPHY; N-GLYCANS; GLYCOSYLATION; OLIGOSACCHARIDES; IONIZATION; PATIENT	The human genome encodes 30,000 to 40,000 proteins, and a major challenge is to understand how posttranslational events, such as glycosylation, affect the activities and functions of these proteins in health and disease. Glycosylated proteins are ubiquitous components of extracellular matrices and cellular surfaces where their oligosaccharide moieties are implicated in a wide range of cell-cell and cell-matrix recognition events. The power of ultrahigh-sensitivity mass spectrometric strategies for defining the primary structures of highly complex mixtures of glycoprotein glycoforms is set to revolutionize structural glycobiology in the coming postgenomic era.	Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2AY, England	Imperial College London	Dell, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2AY, England.	a.dell@ic.ac.uk						BARBER M, 1981, J CHEM SOC CHEM COMM, P325, DOI 10.1039/c39810000325; BIEMANN K, 1990, METHOD ENZYMOL, V193, P455, DOI 10.1016/0076-6879(90)93433-L; BURLINGAME AL, 1994, ANAL CHEM, V66, pR634; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Chance DL, 1996, CARBOHYD RES, V295, P157, DOI 10.1016/S0008-6215(96)90136-6; CHATTERJEE D, 1993, GLYCOBIOLOGY, V3, P497, DOI 10.1093/glycob/3.5.497; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Clark GF, 1996, HUM REPROD, V11, P467, DOI 10.1093/HUMREP/11.3.467; Coddeville B, 1998, GLYCOCONJUGATE J, V15, P265, DOI 10.1023/A:1006997012617; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Dawson J.H.J., 1989, RAPID COMMUN MASS SP, V3, P155, DOI [DOI 10.1002/RCM.1290030511, 10.1002/rcm.1290030511]; Dearmond S. J., 1998, Neurology, V50, P1271; Dell A, 1999, BBA-MOL BASIS DIS, V1455, P353, DOI 10.1016/S0925-4439(99)00064-2; DELL A, 1995, J BIOL CHEM, V270, P24116, DOI 10.1074/jbc.270.41.24116; DELL A, 1987, ADV CARBOHYD CHEM BI, V45, P19, DOI 10.1016/S0065-2318(08)60136-5; Easton RL, 2000, J BIOL CHEM, V275, P7731, DOI 10.1074/jbc.275.11.7731; Easton RL, 2000, J BIOL CHEM, V275, P21928, DOI 10.1074/jbc.M001534200; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; FENN JB, 1990, MASS SPECTROM REV, V9, P37, DOI 10.1002/mas.1280090103; GRINNELL BW, 1994, GLYCOBIOLOGY, V4, P221, DOI 10.1093/glycob/4.2.221; Harvey DJ, 2000, RAPID COMMUN MASS SP, V14, P2135, DOI 10.1002/1097-0231(20001130)14:22<2135::AID-RCM143>3.0.CO;2-#; Haslam SM, 1996, J BIOL CHEM, V271, P30561, DOI 10.1074/jbc.271.48.30561; Haslam SM, 1999, J BIOL CHEM, V274, P20953, DOI 10.1074/jbc.274.30.20953; Haslam SM, 2000, GLYCOBIOLOGY, V10, P223, DOI 10.1093/glycob/10.2.223; Hounsell EF, 1996, GLYCOCONJUGATE J, V13, P19, DOI 10.1007/BF01049675; HUNT DF, 1986, P NATL ACAD SCI USA, V83, P6233, DOI 10.1073/pnas.83.17.6233; Julkunen M, 1984, Arch Androl, V12 Suppl, P59; KARAS M, 1989, BIOMED ENVIRON MASS, V18, P841, DOI 10.1002/bms.1200180931; Khoo KH, 1997, GLYCOBIOLOGY, V7, P663, DOI 10.1093/glycob/7.5.663; KLEIN A, 1993, EUR J BIOCHEM, V211, P491, DOI 10.1111/j.1432-1033.1993.tb17575.x; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Mastrianni JA, 1999, NEW ENGL J MED, V340, P1630, DOI 10.1056/NEJM199905273402104; Morelle W, 2000, MOL BIOCHEM PARASIT, V109, P171, DOI 10.1016/S0166-6851(00)00241-3; Morris HR, 1996, J BIOL CHEM, V271, P32159, DOI 10.1074/jbc.271.50.32159; Morris HR, 1996, RAPID COMMUN MASS SP, V10, P889, DOI 10.1002/(SICI)1097-0231(19960610)10:8<889::AID-RCM615>3.0.CO;2-F; MORRIS HR, 1980, NATURE, V286, P447, DOI 10.1038/286447a0; MORRIS HR, 1978, J BIOL CHEM, V253, P5155; MORRIS HR, 1998, MASS SPECTROMETRY BI, V2, P53; Muller S, 1999, J BIOL CHEM, V274, P18165, DOI 10.1074/jbc.274.26.18165; PAPADIMITRIOU JT, 1997, IMMUNOL TODAY, V18, P105; Patankar MS, 1997, MOL HUM REPROD, V3, P501, DOI 10.1093/molehr/3.6.501; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Rosen SD, 1999, AM J PATHOL, V155, P1013, DOI 10.1016/S0002-9440(10)65201-7; Rudd PM, 1999, P NATL ACAD SCI USA, V96, P13044, DOI 10.1073/pnas.96.23.13044; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Scanlin TF, 1999, BBA-MOL BASIS DIS, V1455, P241, DOI 10.1016/S0925-4439(99)00059-9; SCHACHTER H, 1995, N COMP BIOC A, V29, P123; Shevchenko A, 2000, ANAL CHEM, V72, P2132, DOI 10.1021/ac9913659; Somerville RA, 1997, NATURE, V386, P564, DOI 10.1038/386564a0; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Stimson E, 1999, BIOCHEMISTRY-US, V38, P4885, DOI 10.1021/bi982330q; Sutton-Smith M, 2000, TETRAHEDRON-ASYMMETR, V11, P363, DOI 10.1016/S0957-4166(99)00581-9; TANG XJ, 1988, ANAL CHEM, V60, P1791, DOI 10.1021/ac00168a029; Teng-umnuay P, 1998, J BIOL CHEM, V273, P18242, DOI 10.1074/jbc.273.29.18242; Thomsson KA, 2000, ANAL CHEM, V72, P4543, DOI 10.1021/ac000631b; VANDERWEL H, UNPUB; VANHALBEEK H, 1994, GLYCOBIOLOGY, V4, P203, DOI 10.1093/glycob/4.2.203; WADA Y, 1992, BIOCHEM BIOPH RES CO, V189, P832, DOI 10.1016/0006-291X(92)92278-6; YAMASHITA K, 1993, J BIOCHEM-TOKYO, V114, P766, DOI 10.1093/oxfordjournals.jbchem.a124253	59	475	501	1	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2001	291	5512					2351	2356		10.1126/science.1058890	http://dx.doi.org/10.1126/science.1058890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11269315				2022-12-28	WOS:000167618700042
J	Rivkin, RB; Legendre, L				Rivkin, RB; Legendre, L			Biogenic carbon cycling in the upper ocean: Effects of microbial respiration	SCIENCE			English	Article							BACTERIAL PRODUCTION; PLANKTON COMMUNITY; AQUATIC SYSTEMS; GROWTH; TEMPERATURE; ZOOPLANKTON; EXCRETION; BALANCE; RATIO; RATES	Food-web processes are important controls of oceanic biogenic carbon flux and ocean-atmosphere carbon dioxide exchange. Two key controlling parameters are the growth efficiencies of the principal trophic components and the rate of carbon remineralization. We report that bacterial growth efficiency is an inverse function of temperature. This relationship permits bacterial respiration in the euphotic zone to be computed from temperature and bacterial production. Using the temperature-growth efficiency relationship, we show that bacterial respiration generally accounts for most community respiration. This implies that a Larger fraction of assimilated carbon is respired at Low than at high latitudes, so a greater proportion of production can be exported in polar than in tropical regions, Because bacterial production is also a function of temperature, it should be possible to compute euphotic zone heterotrophic respiration at Large scales using remotely sensed information.	Mem Univ Newfoundland, Ctr Ocean Sci, St Johns, NF A1C 5S7, Canada; Lab Oceanog Villefranche, F-06234 Villefranche Sur Mer, France	Memorial University Newfoundland; UDICE-French Research Universities; Sorbonne Universite	Rivkin, RB (corresponding author), Mem Univ Newfoundland, Ctr Ocean Sci, St Johns, NF A1C 5S7, Canada.							ANDERSON TR, 1992, J PLANKTON RES, V14, P1645, DOI 10.1093/plankt/14.12.1645; CARON DA, 1986, APPL ENVIRON MICROB, V52, P1340, DOI 10.1128/AEM.52.6.1340-1347.1986; CHOI JW, 1992, APPL ENVIRON MICROB, V58, P593, DOI 10.1128/AEM.58.2.593-599.1992; CHRISTIAN RR, 1974, CAN J MICROBIOL, V20, P1341, DOI 10.1139/m74-207; Del Giorgio P.A., 2000, MICROBIAL ECOLOGY OC, P289, DOI DOI 10.1146/ANNUREV.ECOLSYS.29.1.503; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; DUCKLOW HW, 1992, ADV MICROB ECOL, V12, P113; Ducklow HW, 1999, FEMS MICROBIOL ECOL, V30, P1, DOI 10.1111/j.1574-6941.1999.tb00630.x; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fourqurean JW, 1997, ESTUAR COAST SHELF S, V44, P493, DOI 10.1006/ecss.1996.0130; HERBERT RA, 1977, ARCH MICROBIOL, V113, P215, DOI 10.1007/BF00492028; JAHNKE RA, 1995, LIMNOL OCEANOGR, V40, P436, DOI 10.4319/lo.1995.40.2.0436; JENSEN LM, 1990, MAR ECOL PROG SER, V61, P75, DOI 10.3354/meps061075; LEFEVRE D, 1994, J EXP MAR BIOL ECOL, V184, P201, DOI 10.1016/0022-0981(94)90005-1; PAYNE WJ, 1978, ANNU REV MICROBIOL, V32, P155, DOI 10.1146/annurev.mi.32.100178.001103; RASSOULZADEGAN F, 1982, ANN I OCEANOGR PARIS, V58, P177; REID PC, 1988, PROTOZOA THEIR ROLE; SAMPOU P, 1994, MAR ECOL-PROG SER, V110, P240; Sarmiento JL, 1996, SCIENCE, V274, P1346, DOI 10.1126/science.274.5291.1346; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; SATHYENDRANATH S, 1991, NATURE, V353, P129, DOI 10.1038/353129a0; Sherr EB, 1996, AQUAT MICROB ECOL, V11, P91, DOI 10.3354/ame011091; Straile D, 1997, LIMNOL OCEANOGR, V42, P1375, DOI 10.4319/lo.1997.42.6.1375; VERITY PG, 1985, LIMNOL OCEANOGR, V30, P1268, DOI 10.4319/lo.1985.30.6.1268; Weiss R.F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2; WHITE PA, 1991, MICROBIAL ECOL, V21, P99, DOI 10.1007/BF02539147; Williams P.J.I.B., 2000, MICROBIAL ECOLOGY OC, P153; Williams PJL, 1998, NATURE, V394, P55; WILLIAMS PJL, 1983, HETEROTROPHIC ACTIVI, P375; WOODS J, 1993, J PLANKTON RES, V15, P1053, DOI 10.1093/plankt/15.9.1053	32	327	338	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2398	2400		10.1126/science.291.5512.2398	http://dx.doi.org/10.1126/science.291.5512.2398			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264533				2022-12-28	WOS:000167618700052
J	Roberts, RJ; Varmus, HE; Ashburner, M; Brown, PO; Eisen, MB; Khosla, C; Kirschner, M; Nusse, R; Scott, M; Wold, B				Roberts, RJ; Varmus, HE; Ashburner, M; Brown, PO; Eisen, MB; Khosla, C; Kirschner, M; Nusse, R; Scott, M; Wold, B			Information access - Building a "GenBank" of the published literature	SCIENCE			English	Editorial Material									New England Biolabs Inc, Beverly, MA 01915 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Univ Cambridge, Cambridge CB2 3EH, England; European Bioinformat Inst, Cambridge CB10 1SD, England; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	Memorial Sloan Kettering Cancer Center; University of Cambridge; European Molecular Biology Laboratory (EMBL); Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Harvard University; Harvard Medical School; California Institute of Technology	Roberts, RJ (corresponding author), New England Biolabs Inc, 32 Tozer Rd, Beverly, MA 01915 USA.			Eisen, Michael/0000-0002-7528-738X; Roberts, Richard/0000-0002-4348-0169					0	35	35	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2318	2319						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11269300				2022-12-28	WOS:000167618700024
J	Wang, CJ; Shim, M; Guyot-Sionnest, P				Wang, CJ; Shim, M; Guyot-Sionnest, P			Electrochromic nanocrystal quantum dots	SCIENCE			English	Article							FLAT-BAND POTENTIALS; SEMICONDUCTOR NANOCRYSTALS; ELECTRODES; POLYMER; FILMS	Incorporating nanocrystals into future electronic or optoelectronic devices will require a means of controlling charge-injection processes and an understanding of how the injected charges affect the properties of nanocrystals. We show that the optical properties of colloidal semiconductor nanocrystal quantum dots can be tuned by an electrochemical potential. The injection of electrons into the quantum-confined states of the nanocrystal Leads to an electrochromic response, including a strong, size-tunable, midinfrared absorption corresponding to an intraband transition, a bleach of the visible interband exciton transitions, and a quench of the narrow band-edge photoluminescence.	Univ Chicago, James Franck Inst, Chicago, IL 60637 USA	University of Chicago	Guyot-Sionnest, P (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.		Shim, Moonsub/A-7875-2009; Wang, Congjun/A-9608-2010	Shim, Moonsub/0000-0001-7781-1029; 				Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Ashoori RC, 1996, NATURE, V379, P413, DOI 10.1038/379413a0; COLVIN VL, 1994, NATURE, V370, P354, DOI 10.1038/370354a0; DABBOUSI BO, 1995, APPL PHYS LETT, V66, P1316, DOI 10.1063/1.113227; DIMITRIJEVIC NM, 1984, J PHYS CHEM-US, V88, P4278, DOI 10.1021/j150663a018; ENRIGHT B, 1994, J PHYS CHEM-US, V98, P6195, DOI 10.1021/j100075a023; Granqvist CG, 2000, SOL ENERG MAT SOL C, V60, P201, DOI 10.1016/S0927-0248(99)00088-4; Hines MA, 1998, J PHYS CHEM B, V102, P3655, DOI 10.1021/jp9810217; Hines MA, 1996, J PHYS CHEM-US, V100, P468, DOI 10.1021/jp9530562; HOYER P, 1994, CHEM PHYS LETT, V221, P379, DOI 10.1016/0009-2614(94)00287-8; KASTNER MA, 1993, PHYS TODAY, V46, P24, DOI 10.1063/1.881393; MEMMING R, 1994, TOP CURR CHEM, V169, P105; MICIC OI, 1994, J PHYS CHEM-US, V98, P4966, DOI 10.1021/j100070a004; MILLER RJD, 1995, SURFACE ELECT TRANSF, P44; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335; Nirmal M, 1999, ACCOUNTS CHEM RES, V32, P407, DOI 10.1021/ar9700320; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Shim M, 2000, NATURE, V407, P981, DOI 10.1038/35039577; SHIM M, IN PRESS J PHYS CH B; WITTRIG RE, 1995, J ELECTROANAL CHEM, V393, P75, DOI 10.1016/0022-0728(95)04069-Z; Yamase T, 1998, CHEM REV, V98, P307, DOI 10.1021/cr9604043; zum Felde U, 2000, J PHYS CHEM B, V104, P9388, DOI 10.1021/jp0010031	23	436	444	10	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2390	2392		10.1126/science.291.5512.2390	http://dx.doi.org/10.1126/science.291.5512.2390			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264530				2022-12-28	WOS:000167618700049
J	Alexandersen, P; Toussaint, A; Christiansen, C; Devogelaer, JP; Roux, C; Fechtenbaum, J; Gennari, C; Reginster, JY				Alexandersen, P; Toussaint, A; Christiansen, C; Devogelaer, JP; Roux, C; Fechtenbaum, J; Gennari, C; Reginster, JY		Ipriflavone Multicenter European F	Ipriflavone in the treatment of postmenopausal osteoporosis - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; WOMEN; MASS; FRACTURES; RISK	Context Data on the efficacy and safety of ipriflavone for prevention of postmenopausal bone loss are conflicting. Objectives To investigate the effect of oral ipriflavone on prevention of postmenopausal bone loss and to assess the safety profile of long-term treatment with ipriflavone in postmenopausal osteoporotic women. Design and Setting Prospective, randomized, double-blind, placebo-controlled, 4-year study conducted in 4 centers in Belgium, Denmark, and Italy from August 1994 to July 1998. Participants Four hundred seventy-four postmenopausal white women, aged 45 to 75 years, with bone mineral densities (BMDs) of less than 0.86 g/cm(2). Interventions Patients were randomly assigned to receive ipriflavone, 200 mg 3 times per day (n = 234), or placebo (n = 240); all received 500 mg/d of calcium. Main Outcome Measures Efficacy measures included spine, hip, and forearm BMD and biochemical markers of bone resorption (urinary hydroxyproline corrected for creatinine and urinary CrossLaps [Osteometer Biotech, Herlev, Denmark] corrected for creatinine), assessed every 6 months, Laboratory safety measures and adverse events were recorded every 3 months. Results Based on intent-to-treat analysis, after 36 months of treatment, the annual percentage change from baseline in BMD of the lumbar spine for ipriflavone vs placebo (0.1% [95% confidence interval {CI}, -7.9% to 8.1%] vs 0.8% [95% CI, -9.1% to 10.7%]; P =.14), or in any of the other sites measured, did not differ significantly between groups. The response in biochemical markers was also similar between groups (eg, for hydroxyproline corrected for creatinine, 20.13 mg/g [95% CI, 18.85-21.41 mg/g] vs 20.67 mg/g [95% CI, 19.41-21.92 mg/g]; P =.96); urinary CrossLaps corrected for creatinine, 268 mg/mol (95% CI, 249-288 mg/mol) vs 268 mg/mol (95% CI, 254-282 mg/mol); P =.81. The number of women with new vertebral fracture was identical or nearly so in the 2 groups at all time points. Lymphocyte concentrations decreased significantly (500/muL (0.5 x 10(9)/L]) in women treated with ipriflavone. Thirty-one women (13.2%) in the ipriflavone group developed subclinical lymphocytopenia, of whom 29 developed it during ipriflavone treatment. Of these, 15 (52%) of 29 had recovered spontaneously by 1 year and 22 (81 %) of 29 by 2 years. Conclusions Our data indicate that ipriflavone does not prevent bone loss or affect biochemical markers of bone metabolism. Additionally, ipriflavone induces lymphocytopenia in a significant number of women.	Ctr Clin & Basic Res, DK-2750 Ballerup, Denmark; CHU Brull, Bone Cartilage Metab Unit, Liege, Belgium; Catholic Univ Louvain, St Luc Univ Hosp, Rheumatol Unit, Brussels, Belgium; Hop Cochin, Ctr Evaluat Malad Osseuses, F-75674 Paris, France; Univ Paris 05, Dept Rheumatol, Paris, France; Univ Siena, Inst Internal Med, I-53100 Siena, Italy	Center Clinical & Basic Research; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Siena	Alexandersen, P (corresponding author), Ctr Clin & Basic Res, Ballerup Byvej 222, DK-2750 Ballerup, Denmark.							Acerbi D, 1998, EUR J DRUG METAB PH, V23, P172, DOI 10.1007/BF03189335; Adami S, 1997, OSTEOPOROSIS INT, V7, P119, DOI 10.1007/BF01623686; AGNUSDEI D, 1989, DRUG EXP CLIN RES, V15, P97; Agnusdei D, 1997, CALCIFIED TISSUE INT, V61, P142, DOI 10.1007/s002239900312; BENVENUTI S, 1991, J BONE MINER RES, V6, P987; BONDE M, 1995, J CLIN ENDOCR METAB, V80, P864, DOI 10.1210/jc.80.3.864; Bufalino L., 1997, CALCIFIED TISSUE INT, V61, P23; Castelino DJ, 1997, AUST NZ J MED, V27, P170, DOI 10.1111/j.1445-5994.1997.tb00934.x; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Gennari C, 1998, MENOPAUSE, V5, P9; GENNARI C, 1997, CALCIF TISSUE INT S1, V61, P519; Gergely P, 1999, DRUG SAFETY, V21, P91, DOI 10.2165/00002018-199921020-00003; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Meunier PJ, 1999, CLIN THER, V21, P1025, DOI 10.1016/S0149-2918(99)80022-8; MOSCARINI M, 1994, GYNECOL ENDOCRINOL, V8, P203, DOI 10.3109/09513599409072456; NOTOYA K, 1992, CALCIF TISSUE INT S1, V51, pS1; Ohta H, 1999, HORM RES, V51, P178, DOI 10.1159/000023354; PASSERI M, 1992, BONE MINER, V19, pS57, DOI 10.1016/0169-6009(92)90867-D; Reginster JY, 1997, CALCIFIED TISSUE INT, V61, pS28, DOI 10.1007/s002239900382; Tsuda M., 1986, J BONE MINER RES, V1, P206; YAMAZAKI I, 1986, LIFE SCI, V38, P951, DOI 10.1016/0024-3205(86)90265-1	23	135	144	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1482	1488		10.1001/jama.285.11.1482	http://dx.doi.org/10.1001/jama.285.11.1482			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410VQ	11255425				2022-12-28	WOS:000167462100031
J	Agarwala, S; Sanders, TA; Ragsdale, CW				Agarwala, S; Sanders, TA; Ragsdale, CW			Sonic hedgehog control of size and shape in midbrain pattern formation	SCIENCE			English	Article							FLOOR PLATE; MORPHOGEN GRADIENT; GENE-EXPRESSION; NEURAL-TUBE; INDUCTION; CHICK; SPECIFICATION; NOTOCHORD; HOMOLOG; LIMB	Little is known about how patterns of cell types are organized to form brain structures of appropriate size and shape. To study this process, we employed in vivo electroporation during midbrain development to create ectopic sources of Sonic: Hedgehog, a signaling molecule previously shown to specify different neuronal cell types in a concentration-dependent manner in vitro. We provide direct evidence that a Sonic Hedgehog source can control pattern at a distance in brain development and demonstrate that the sire, shape, and orientation of the cell populations produced depend on the geometry of the morphogen source. Thus, a single regulatory molecule can coordinate tissue size and shape with cell-type identity in brain development.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago	Ragsdale, CW (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.	cliff@drugs.bsd.uchicago.edu						BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Day SJ, 2000, DEVELOPMENT, V127, P2977; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Edgar BA, 1996, SCIENCE, V274, P1646, DOI 10.1126/science.274.5293.1646; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Grove EA, 1998, DEVELOPMENT, V125, P2315; GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; JOHNSON AD, 1995, DEV GENET, V17, P280, DOI 10.1002/dvg.1020170313; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; Le Douarin NM, 2000, CURR OPIN NEUROBIOL, V10, P23, DOI 10.1016/S0959-4388(99)00062-8; Lecuit T, 1998, DEVELOPMENT, V125, P4901; Marigo V, 1996, DEVELOPMENT, V122, P1225; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; Muramatsu T, 1997, BIOCHEM BIOPH RES CO, V233, P45, DOI 10.1006/bbrc.1997.6361; NIJHOUT HF, 1980, DEV BIOL, V80, P267, DOI 10.1016/0012-1606(80)90403-0; Placzek M, 2000, CURR OPIN NEUROBIOL, V10, P15, DOI 10.1016/S0959-4388(99)00060-4; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Sakamoto K, 1998, FEBS LETT, V426, P337, DOI 10.1016/S0014-5793(98)00369-X; SANDERS T, UNPUB; Watanabe Y, 2000, DEVELOPMENT, V127, P1131; Wolpert L, 1996, TRENDS GENET, V12, P359, DOI 10.1016/S0168-9525(96)80019-9; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	26	143	146	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2001	291	5511					2147	2150		10.1126/science.1058624	http://dx.doi.org/10.1126/science.1058624			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251119				2022-12-28	WOS:000167563800039
J	Kessler, A; Baldwin, IT				Kessler, A; Baldwin, IT			Defensive function of herbivore-induced plant volatile emissions in nature	SCIENCE			English	Article							SYSTEMIC PRODUCTION; ENEMIES	Herbivore attack is known to increase the emission of volatiles, which attract predators to herbivore-damaged plants in the laboratory and agricultural systems. We quantified volatile emissions from Nicotiana attenuata plants growing in natural populations during attack by three species of leaf-feeding herbivores and mimicked the release of five commonly emitted volatiles individually. Three compounds (cis-3-hexen-1-ol, Linalool, and cis-alpha -bergamotene) increased egg predation rates by a generalist predator; Linalool and the complete blend decreased Lepidopteran oviposition rates. As a consequence, a plant could reduce the number of herbivores by more than 90% by releasing volatiles. These results confirm that indirect defenses can operate in nature.	Max Planck Inst Chem Ecol, Dept Mol Ecol, D-07745 Jena, Germany	Max Planck Society	Baldwin, IT (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, D-07745 Jena, Germany.	baldwin@ice.mpg.de	Baldwin, Ian T/K-1809-2013; Kessler, Andre/C-7810-2014	Baldwin, Ian/0000-0001-5371-2974; Kessler, Andre/0000-0002-1797-7518				Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DICKE M, 1994, J PLANT PHYSIOL, V143, P465, DOI 10.1016/S0176-1617(11)81808-0; DICKE M, 1993, J CHEM ECOL, V19, P581, DOI 10.1007/BF00994327; Halitschke R, 2000, OECOLOGIA, V124, P408, DOI 10.1007/s004420000389; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Hawkins BA, 1999, OIKOS, V86, P493, DOI 10.2307/3546654; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; KESSLER A, UNPUB; Koch T, 1999, PLANT PHYSIOL, V121, P153, DOI 10.1104/pp.121.1.153; LOUGHRIN JH, 1995, J CHEM ECOL, V21, P1217, DOI 10.1007/BF02228321; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Pare PW, 1998, PHYTOCHEMISTRY, V47, P521, DOI 10.1016/S0031-9422(97)00442-1; Preston CA, 2000, ECOLOGY, V81, P293; Scutareanu P, 1997, J CHEM ECOL, V23, P2241, DOI 10.1023/B:JOEC.0000006671.53045.16; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; Turlings TCJ, 1998, PLANTA, V207, P146, DOI 10.1007/s004250050466; Turlings TCJ, 1998, ECOSCIENCE, V5, P321, DOI 10.1080/11956860.1998.11682472; van der Meijden E, 2000, OIKOS, V89, P202, DOI 10.1034/j.1600-0706.2000.890123.x; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041	21	1445	1615	19	735	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2001	291	5511					2141	2144		10.1126/science.291.5511.2141	http://dx.doi.org/10.1126/science.291.5511.2141			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251117				2022-12-28	WOS:000167563800037
J	Kienast, M; Steinke, S; Stattegger, K; Calvert, SE				Kienast, M; Steinke, S; Stattegger, K; Calvert, SE			Synchronous tropical South China Sea SST change and Greenland warming during deglaciation	SCIENCE			English	Article							LAST DEGLACIATION; SURFACE TEMPERATURES; EQUATORIAL PACIFIC; AMS FACILITY; ATLANTIC; OCEAN; CLIMATE; SYSTEM; U-37(K'); RECORDS	The tropical ocean plays a major role in global climate, It is therefore crucial to establish the precise phase between tropical and high-latitude climate variability during past abrupt climate events in order to gain insight into the mechanisms of global climate change. Here we present alkenone sea surface temperature (SST) records from the tropical South China Sea that show an abrupt temperature increase of at least 1 degreesC at the end of the Last glacial period. Within the recognized dating uncertainties, this SST increase is synchronous with the Bolling warming observed at 14.6 thousand years ago in the Greenland Ice Sheet Project 2 ice core.	Univ British Columbia, Vancouver, BC V6T 1Z4, Canada; Univ Kiel, Inst Geowissensch, Kiel, Germany	University of British Columbia; University of Kiel	Kienast, M (corresponding author), Univ British Columbia, Vancouver, BC V6T 1Z4, Canada.							ANDERSON DM, 1993, QUATERNARY SCI REV, V12, P465, DOI 10.1016/S0277-3791(05)80010-1; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Bard E, 1997, NATURE, V385, P707, DOI 10.1038/385707a0; Bard E, 1988, PALEOCEANOGRAPHY, V3, P635, DOI 10.1029/PA003i006p00635; BERGER AL, 1978, QUATERNARY RES, V9, P139, DOI 10.1016/0033-5894(78)90064-9; Cacho I, 1999, PALEOCEANOGRAPHY, V14, P698, DOI 10.1029/1999PA900044; Cayre O, 1999, QUATERNARY RES, V52, P337, DOI 10.1006/qres.1999.2083; Doose H, 1997, PALEOCEANOGRAPHY, V12, P615, DOI 10.1029/97PA00821; DUPLESSY JC, 1991, EARTH PLANET SC LETT, V103, P27, DOI 10.1016/0012-821X(91)90147-A; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; KIENAST SS, IN PRESS GEOPHYS RES; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; LYLE MW, 1992, NATURE, V355, P812, DOI 10.1038/355812a0; Meese DA, 1997, J GEOPHYS RES-OCEANS, V102, P26411, DOI 10.1029/97JC00269; Mix AC, 1996, SOUTH ATLANTIC, P503; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Nadeau MJ, 1997, NUCL INSTRUM METH B, V123, P22, DOI 10.1016/S0168-583X(96)00730-6; Nurnberg D, 2000, PALEOCEANOGRAPHY, V15, P124, DOI 10.1029/1999PA000370; Pelejero C, 1997, GEOCHIM COSMOCHIM AC, V61, P4789, DOI 10.1016/S0016-7037(97)00280-9; Pelejero C, 1999, PALEOCEANOGRAPHY, V14, P224, DOI 10.1029/1998PA900015; Ruhlemann C, 1999, NATURE, V402, P511, DOI 10.1038/990069; Schleicher M, 1998, RADIOCARBON, V40, P85; STATTEGGER K, 1997, 86 U KIEL GEOL PAL I; STEINKE S, IN PRESS QUATL RES; Stocker TF, 2000, QUATERNARY SCI REV, V19, P301, DOI 10.1016/S0277-3791(99)00067-0; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Villanueva J, 1997, J CHROMATOGR A, V757, P145, DOI 10.1016/S0021-9673(96)00669-3; Wang L, 1999, MAR GEOL, V156, P245, DOI 10.1016/S0025-3227(98)00182-0	28	177	205	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2132	2134		10.1126/science.1057131	http://dx.doi.org/10.1126/science.1057131			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251114				2022-12-28	WOS:000167563800034
J	Archer, GL; Bosilevac, JM				Archer, GL; Bosilevac, JM			Microbiology - Signaling antibiotic resistance in staphylococci	SCIENCE			English	Editorial Material							BETA-LACTAMASE SYNTHESIS; METHICILLIN RESISTANCE; SEQUENCES; AUREUS		Virginia Commonwealth Univ, Med Coll Virginia, Dept Med, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Immunol Microbiol, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Archer, GL (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Med, Richmond, VA 23298 USA.			Bosilevac, Joseph/0000-0002-0258-6581				ARCHER GL, 1994, ANTIMICROB AGENTS CH, V38, P447, DOI 10.1128/AAC.38.3.447; BOSILEVAC JM, UNPUB; BOYCE JM, 1997, STAPHYLOCOCCI HUMAN, P309, DOI DOI 10.1002/9781444308464.CH15; COHEN S, 1972, J BACTERIOL, V112, P682, DOI 10.1128/JB.112.2.682-689.1972; Fabret C, 1999, J BACTERIOL, V181, P1975, DOI 10.1128/JB.181.7.1975-1983.1999; Gregory PD, 1997, MOL MICROBIOL, V24, P1025, DOI 10.1046/j.1365-2958.1997.4051770.x; Hardt K, 1997, MOL MICROBIOL, V23, P935, DOI 10.1046/j.1365-2958.1997.2761642.x; Marie-Claire C, 1998, J BIOL CHEM, V273, P5697, DOI 10.1074/jbc.273.10.5697; MCKINNEY TT, UNPUB; Sharma VK, 1998, J BACTERIOL, V180, P2160, DOI 10.1128/JB.180.8.2160-2166.1998; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144	11	33	39	4	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1915	1916		10.1126/science.1059671	http://dx.doi.org/10.1126/science.1059671			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11245199				2022-12-28	WOS:000167401600034
J	Chai, JJ; Shiozaki, E; Srinivasula, SM; Wu, Q; Dataa, P; Alnemri, ES; Shi, YG				Chai, JJ; Shiozaki, E; Srinivasula, SM; Wu, Q; Dataa, P; Alnemri, ES; Shi, YG			Structural basis of caspase-7 inhibition by XIAP	CELL			English	Article							APOPTOSIS PROTEIN XIAP; 3-DIMENSIONAL STRUCTURE; BRAIN INJURY; CELL-DEATH; SMAC/DIABLO; ACTIVATION; ENZYME; SPECIFICITIES; BINDING; FAMILY	The inhibitor of apoptosis (IAP) proteins suppress cell death by inhibiting the catalytic activity of caspases. Here we present the crystal structure of caspase-7 in complex with a potent inhibitory fragment from XIAP at 2.45 Angstrom resolution. An 18-residue XIAP peptide binds the catalytic groove of caspase-7, making extensive contacts to the residues that are essential for its catalytic activity. Strikingly, despite a reversal of relative orientation, a subset of interactions between caspase-7 and XIAP closely resemble those between caspase-7 and its tetrapeptide inhibitor DEVD-CHO. Our biochemical and structural analyses reveal that the BIR domains are dispensable for the inhibition of caspase-3 and -7. This study provides a structural basis for the design of the next-generation caspase inhibitors.	Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Princeton University; Jefferson University	Shi, YG (corresponding author), Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Washington Rd, Princeton, NJ 08544 USA.	yshi@molbio.princeton.edu	Alnemri, Emad S/B-4526-2010	Chai, Jijie/0000-0001-7591-3873; Shi, Yigong/0000-0003-2030-168X				Blanchard H, 1999, STRUCTURE, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; Chinnaiyan AM, 1996, CURR BIOL, V6, P555; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P2737; GREEN DR, 1995, CURR OPIN IMMUNOL, V7, P694, DOI 10.1016/0952-7915(95)80079-4; Horvitz HR, 1999, CANCER RES, V59, p1701S; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Mittl PRE, 1997, J BIOL CHEM, V272, P6539, DOI 10.1074/jbc.272.10.6539; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Rodriguez I, 1996, J EXP MED, V184, P2067, DOI 10.1084/jem.184.5.2067; Rotonda J, 1996, NAT STRUCT BIOL, V3, P619, DOI 10.1038/nsb0796-619; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; SRINIVASULA SM, 2001, IN PRESS NATURE; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; SUN C, 2000, IN PRESS J BIOL CHEM; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	39	448	479	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2001	104	5					769	780		10.1016/S0092-8674(02)02034-2	http://dx.doi.org/10.1016/S0092-8674(02)02034-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257230	Bronze			2022-12-28	WOS:000167531100016
J	Kousteni, S; Bellido, T; Plotkin, LI; O'Brien, CA; Bodenner, DL; Han, L; Han, K; DiGregorio, GB; Katzenellenbogen, JA; Katzenellenbogen, BS; Roberson, PK; Weinstein, RS; Jilka, RL; Manolagas, SC				Kousteni, S; Bellido, T; Plotkin, LI; O'Brien, CA; Bodenner, DL; Han, L; Han, K; DiGregorio, GB; Katzenellenbogen, JA; Katzenellenbogen, BS; Roberson, PK; Weinstein, RS; Jilka, RL; Manolagas, SC			Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity	CELL			English	Article							HORMONE-BINDING DOMAIN; OSTEOBLAST APOPTOSIS; PEPTIDE ANTAGONISTS; C-SRC; PHOSPHORYLATION; MECHANISMS; OSTEOCYTE; LIGAND; ALPHA; CELLS	The relationship of the classical receptors and their transcriptional activity to nongenotropic effects of steroid hormones is unknown. We demonstrate herein a novel paradigm of sex steroid action on osteoblasts, osteocytes, embryonic fibroblasts, and HeLa cells involving activation of a Src/Shc/ERK signaling pathway and attenuating apoptosis. This action is mediated by the ligand binding domain and eliminated by nuclear targeting of the receptor protein; ER alpha, ER beta, or AR can transmit it with similar efficiency irrespective of whether the ligand is an estrogen or an androgen. This antiapoptotic action can be dissociated from the transcriptional activity of the receptor with synthetic ligands, providing proof of principle for the development of function-specific-as opposed to tissue-selective-and gender-neutral pharmacotherapeutics.	Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Div Endocrinol & Metab, Little Rock, AR 72205 USA; Cent Arkansas Vet Hlth Care Syst, Little Rock, AR 72205 USA; Univ Illinois, Dept Physiol, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Manolagas, SC (corresponding author), Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Div Endocrinol & Metab, Little Rock, AR 72205 USA.	manolagasstavros@uams.edu	O'Brien, Charles A./AAL-5078-2020; Plotkin, Lilian/H-7188-2019	Plotkin, Lilian/0000-0002-9537-4544	NIAMS NIH HHS [R01-AR43003] Funding Source: Medline; NIA NIH HHS [P01-AG13918] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BINDAL RD, 1987, J STEROID BIOCHEM, V28, P361, DOI 10.1016/0022-4731(87)91052-1; Chambliss KL, 2000, CIRC RES, V87, pE44, DOI 10.1161/01.RES.87.11.e44; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Ekena K, 1996, J BIOL CHEM, V271, P20053, DOI 10.1074/jbc.271.33.20053; ERIKSEN EF, 1988, SCIENCE, V241, P84, DOI 10.1126/science.3388021; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Hughes DE, 1996, NAT MED, V2, P1132, DOI 10.1038/nm1096-1132; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; Kameda T, 1997, J EXP MED, V186, P489, DOI 10.1084/jem.186.4.489; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Katzenellenbogen B S, 1979, Recent Prog Horm Res, V35, P259; Katzenellenbogen BS, 2000, RECENT PROG HORM RES, V55, P163; KATZENELLENBOGEN BS, 1978, MOL CELL ENDOCRINOL, V10, P103, DOI 10.1016/0303-7207(78)90063-1; KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427; KOMM BS, 1988, SCIENCE, V241, P81, DOI 10.1126/science.3164526; Kraus WL, 1997, J STEROID BIOCHEM, V63, P175, DOI 10.1016/S0960-0760(97)00089-7; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; LEGOFF P, 1994, J BIOL CHEM, V269, P4458; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MCEWEN BS, 1909, ENDOCR REV, V20, P279; McInerney EM, 1996, J BIOL CHEM, V271, P24172, DOI 10.1074/jbc.271.39.24172; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Nawaz Z, 1999, CANCER RES, V59, P372; Noble BS, 2000, MOL CELL ENDOCRINOL, V159, P7, DOI 10.1016/S0303-7207(99)00174-4; Norris JD, 1999, SCIENCE, V285, P744, DOI 10.1126/science.285.5428.744; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; OURSLER MJ, 1993, ANN MED, V25, P361, DOI 10.3109/07853899309147298; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; POTTRATZ ST, 1994, J CLIN INVEST, V93, P944, DOI 10.1172/JCI117100; RAYNAUD JP, 1978, CANCER RES, V38, P3044; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Schlegel A, 1999, J BIOL CHEM, V274, P33551, DOI 10.1074/jbc.274.47.33551; Schodin DJ, 1995, J BIOL CHEM, V270, P31163, DOI 10.1074/jbc.270.52.31163; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Solomon KR, 2000, J BONE MINER RES, V15, P2380, DOI 10.1359/jbmr.2000.15.12.2380; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; SZEDLACSEK SE, 1995, METHOD ENZYMOL, V249, P144; Vanderschueren D, 1998, BONE, V23, P391, DOI 10.1016/S8756-3282(98)00131-8; Walk SF, 1998, EUR J IMMUNOL, V28, P2265, DOI 10.1002/(SICI)1521-4141(199808)28:08<2265::AID-IMMU2265>3.0.CO;2-P; Watson CS, 1999, P SOC EXP BIOL MED, V220, P9, DOI 10.1046/j.1525-1373.1999.d01-2.x; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; WRENN CK, 1993, J BIOL CHEM, V268, P24089; Zhang ZY, 2000, J BIOL CHEM, V275, P37219, DOI 10.1074/jbc.M001818200	49	966	1041	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2001	104	5					719	730		10.1016/S0092-8674(01)00268-9	http://dx.doi.org/10.1016/S0092-8674(01)00268-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257226				2022-12-28	WOS:000167531100012
J	Schmitz, D; Mellor, J; Nicoll, RA				Schmitz, D; Mellor, J; Nicoll, RA			Presynaptic kainate receptor mediation of frequency facilitation at hippocampal mossy fiber synapses	SCIENCE			English	Article							SYNAPTIC TRANSMISSION; TRANSMITTER RELEASE; INHIBITION; ACTIVATION; CALCIUM; AMPA; ENHANCEMENT; DEPENDENCE; MODULATION; PLASTICITY	Inhibition of transmitter release by presynaptic receptors is widespread in the central nervous system and is typically mediated via metabotropic receptors; In contrast, very little is known about facilitatory receptors, and synaptic activation of a facilitatory autoreceptor has not been established. Here we show that activation of presynaptic kainate receptors can facilitate transmitter release from hippocampal mossy fiber synapses. Synaptic activation of these presumed ionotropic kainate receptors is very fast (<10 ms) and Lasts for seconds. Thus, these presynaptic kainate receptors contribute to the shortterm plasticity characteristics of mossy fiber synapses, which were previously thought to be an intrinsic property of the synapse.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.		MELLOR, Jack/B-4548-2019	MELLOR, Jack/0000-0002-7706-8105; Schmitz, Dietmar/0000-0003-2741-5241				Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Byrne JH, 1996, J NEUROSCI, V16, P425; Casado M, 2000, P NATL ACAD SCI USA, V97, P11593, DOI 10.1073/pnas.200354297; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; DELANEY K, 1991, J NEUROSCI, V11, P2631; DUDEL J, 1961, J PHYSIOL-LONDON, V155, P543, DOI 10.1113/jphysiol.1961.sp006646; Eccles, 2013, PHYSL SYNAPSES; EGEBJERG J, 1993, P NATL ACAD SCI USA, V90, P755, DOI 10.1073/pnas.90.2.755; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; Lerma J, 1997, NEURON, V19, P1155, DOI 10.1016/S0896-6273(00)80407-9; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; REGEHR WG, 1994, J NEUROSCI, V14, P523; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; SCHMITZ D, UNPUB; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	28	217	222	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1972	1976		10.1126/science.1057105	http://dx.doi.org/10.1126/science.1057105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239159				2022-12-28	WOS:000167401600049
J	Chien, P; Weissman, JS				Chien, P; Weissman, JS			Conformational diversity in a yeast prion dictates its seeding specificity	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; SUP35 PROTEIN; TRANSLATION TERMINATION; SPECIES BARRIER; RELEASE FACTOR; RODS CONTAIN; IN-VITRO; PROPAGATION; DETERMINANT; PSI(+)	A perplexing feature of prion-based inheritance is that prions composed of the same polypeptide can evoke different phenotypes (such as distribution of brain lesions), even when propagated in genetically identical hosts(1-3). The molecular basis of this strain diversity and the relationship between strains and barriers limiting transmission between species remain unclear. We have used the yeast prion phenomenon [PSI+](4) to investigate these issues and examine the role that conformational differences(1,2,5) may have in prion strains. We have made a chimaeric fusion between the prion domains of two species (Saccharomyces cerevisae and Candida albicans) of Sup35, the protein responsible for [PSI+](4,6). Here we report that this chimaera forms alternate prion strains in vivo when initiated by transient overexpression of different Sup35 species. Similarly, in vitro the purified chimaera, when seeded with different species of Sup35 fibres, establishes and propagates distinct amyloid conformations. These fibre conformations dictate amyloid seeding specificity: a chimaera seeded by S. cerevisiae fibres efficiently catalyses conversion of S. cerevisiae Sup35 but not of C. albicans Sup35, and vice versa. These and other considerations(1,2,5,7,8) argue that heritable prion strains result from self-propagating conformational differences within the prion protein itself. Moreover, these conformational differences seem to act in concert with the primary structure to determine a prion's propensity for transmission across a species barrier.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, Grad Grp Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, Grad Grp Biophys, San Francisco, CA 94143 USA.			Weissman, Jonathan/0000-0003-2445-670X				Appel TR, 1999, BIOL CHEM, V380, P1295, DOI 10.1515/BC.1999.165; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1996, GENETICS, V144, P1375; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Klein TR, 1998, BIOL CHEM, V379, P655, DOI 10.1515/bchm.1998.379.6.655; Kochneva-Pervukhova NV, 1998, EMBO J, V17, P5805, DOI 10.1093/emboj/17.19.5805; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TUITE MF, 1981, GENETICS, V98, P691; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182	30	128	130	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					223	227		10.1038/35065632	http://dx.doi.org/10.1038/35065632			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242084				2022-12-28	WOS:000167320500050
J	Stasch, JP; Becker, EM; Alonso-Alija, C; Apeler, H; Dembowsky, K; Feurer, A; Gerzer, R; Minuth, T; Perzborn, E; Pleiss, U; Schroder, H; Schroeder, W; Stahl, E; Steinke, W; Straub, A; Schramm, M				Stasch, JP; Becker, EM; Alonso-Alija, C; Apeler, H; Dembowsky, K; Feurer, A; Gerzer, R; Minuth, T; Perzborn, E; Pleiss, U; Schroder, H; Schroeder, W; Stahl, E; Steinke, W; Straub, A; Schramm, M			NO-independent regulatory site on soluble guanylate cyclase	NATURE			English	Article							NITRIC-OXIDE; NOBEL LECTURE; YC-1; 1H-<1,2,4>OXADIAZOLO<4,3-A>QUINOXALIN-1-ONE; ACTIVATION; EXPRESSION; INHIBITOR; DISCOVERY; CO	Nitric oxide (NO) is a widespread, potent, biological mediator that has many physiological and pathophysiological roles(1). Research in the field of NO appears to have followed a straightforward path, and the findings have been progressive: NO and cyclic GMP are involved in vasodilatation; glycerol trinitrate relaxes vascular smooth muscles by bioconversion to NO; mammalian cells synthesize NO; and last, NO mediates vasodilatation by stimulating the soluble guanylate cyclase (sGC), a heterodimeric (alpha/beta) haem protein that converts GTP to cGMP(2-4). Here we report the discovery of a regulatory site on sGC. Using photoaffinity labelling, we have identified the cysteine 238 and cysteine 243 region in the alpha (1)-subunit of sGC as the target for a new type of sGC stimulator. Moreover, we present a pyrazolopyridine, BAY 41-2272, that potently stimulates sGC through this site by a mechanism that is independent of NO. This results in antiplatelet activity, a strong decrease in blood pressure and an increase in survival in a low-NO rat model of hypertension, and as such may offer an approach for treating cardiovascular diseases.	Bayer AG, Pharma Res Ctr, D-42096 Wuppertal, Germany; Univ Halle Wittenberg, Sch Pharm, D-06099 Halle Saale, Germany; DLR, Inst Aerosp Med, D-51147 Cologne, Germany	Bayer AG; Martin Luther University Halle Wittenberg; Helmholtz Association; German Aerospace Centre (DLR)	Stasch, JP (corresponding author), Bayer AG, Pharma Res Ctr, Aprather Way 18A, D-42096 Wuppertal, Germany.	johannes-peter-stasch.js@bayer-ag.de						AHR HJ, 1994, XENOBIOT METAB DISPO, V9, P371; Becker EM, 1999, NITRIC OXIDE-BIOL CH, V3, P55, DOI 10.1006/niox.1999.0207; Becker EM, 2000, J CARDIOVASC PHARM, V35, P390, DOI 10.1097/00005344-200003000-00007; BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185; Brunner F, 1996, J PHARMACOL EXP THER, V277, P48; Friebe A, 1996, EMBO J, V15, P6863, DOI 10.1002/j.1460-2075.1996.tb01078.x; Friebe A, 1998, MOL PHARMACOL, V53, P123, DOI 10.1124/mol.53.1.123; Furchgott RF, 1999, ANGEW CHEM INT EDIT, V38, P1870, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1870::AID-ANIE1870>3.0.CO;2-8; Galle J, 1999, BRIT J PHARMACOL, V127, P195, DOI 10.1038/sj.bjp.0702495; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; HIRTHDIETRICH C, 1994, N-S ARCH PHARMACOL, V350, pR6; Hobbs AJ, 1997, TRENDS PHARMACOL SCI, V18, P484, DOI 10.1016/S0165-6147(97)01137-1; Hoenicka M, 1999, J MOL MED-JMM, V77, P14, DOI 10.1007/s001090050292; Ignarro LJ, 1999, ANGEW CHEM INT EDIT, V38, P1882, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1882::AID-ANIE1882>3.0.CO;2-V; Kharitonov VG, 1999, BIOCHEMISTRY-US, V38, P10699, DOI 10.1021/bi990277f; KO FN, 1994, BLOOD, V84, P4226, DOI 10.1182/blood.V84.12.4226.bloodjournal84124226; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MONCADA S, 1991, PHARMACOL REV, V43, P109; Mulsch A, 1997, BRIT J PHARMACOL, V120, P681, DOI 10.1038/sj.bjp.0700982; Murad F, 1999, ANGEW CHEM INT EDIT, V38, P1857, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1856::AID-ANIE1856>3.0.CO;2-D; NAKANE M, 1990, J BIOL CHEM, V265, P16841; Schrammel A, 1996, MOL PHARMACOL, V50, P1; STASCH JP, 1989, EUR J PHARMACOL, V174, P279, DOI 10.1016/0014-2999(89)90321-X; STRAUB A, 2000, Patent No. 200006568; WU CC, 1995, BRIT J PHARMACOL, V116, P1973, DOI 10.1111/j.1476-5381.1995.tb16400.x; Zabel U, 1998, BIOCHEM J, V335, P51, DOI 10.1042/bj3350051; Zhao Y, 1997, BIOCHEMISTRY-US, V36, P15959, DOI 10.1021/bi971825x; Zhao Y, 1998, BIOCHEMISTRY-US, V37, P4502, DOI 10.1021/bi972686m	28	444	468	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					212	215		10.1038/35065611	http://dx.doi.org/10.1038/35065611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242081				2022-12-28	WOS:000167320500047
J	Xu, X; Zhou, HH; Prum, RO				Xu, X; Zhou, HH; Prum, RO			Branched integumental structures in Sinornithosaurus and the origin of feathers	NATURE			English	Article							YIXIAN FORMATION; DINOSAUR	The evolutionary origin of feathers has long been obscured because no morphological antecedents were known to the earliest, structurally modern feathers of Archaeopteryx(1). It has been proposed that the filamentous integumental appendages on several theropod dinosaurs are primitive feathers(2-6); but the homology between these filamentous structures and feathers has been disputed(7-9), and two taxa with true feathers (Caudipteryx and Protarchaeopteryx) have been proposed to be flightless birds(8,10). Confirmation of the theropod origin of feathers requires documentation of unambiguously feather-like structures in a clearly non-avian theropod. Here we describe our observations of the filamentous integumental appendages of the basal dromaeosaurid dinosaur Sinornithosaurus millenii, which indicate that they are compound structures composed of multiple filaments. Furthermore, these appendages exhibit two types of branching structure that are unique to avian feathers: filaments joined in a basal tuft, and filaments joined at their bases in series along a central filament. Combined with the independent phylogenetic evidence supporting the theropod ancestry of birds(11-13), these observations strongly corroborate the hypothesis that the integumental appendages of Sinornithosaurus are homologous with avian feathers. The plesiomorphic feathers of Sinornithosaurus also conform to the predictions of an independent, developmental model of the evolutionary origin of feathers(14).	Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; Acad Sinica, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Univ Kansas, Museum Nat Hist, Lawrence, KS 66045 USA	University of Kansas; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Kansas	Prum, RO (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	prum@ukans.edu		Prum, Richard/0000-0002-4741-7132				Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Dalton R, 2000, NATURE, V406, P926, DOI 10.1038/35023316; DEBEER G, 1954, STUDY BASED BRIT MUS; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Gibbons A, 1997, SCIENCE, V278, P1229; GRAU VJ, 1994, BIOL PATOLOGIA CHINC; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Jones TD, 2000, SCIENCE, V288, P2202, DOI 10.1126/science.288.5474.2202; Jones TD, 2000, NATURE, V406, P716, DOI 10.1038/35021041; Lucas A., 1972, AVIAN ANATOMY INTEGU; Nowak RM, 1983, WALKERS MAMMALS WORL; Prum RO, 1999, J EXP ZOOL, V285, P291; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056	18	147	166	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2001	410	6825					200	204		10.1038/35065589	http://dx.doi.org/10.1038/35065589			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242078				2022-12-28	WOS:000167320500044
J	Spitz, F; Duboule, D				Spitz, F; Duboule, D			Development - The art of making a joint	SCIENCE			English	Editorial Material							MUTATIONS; MEMBERS; FAMILY; LIMB		Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland	University of Geneva	Spitz, F (corresponding author), Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland.			duboule, denis/0000-0001-9961-2960				Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Francis-West PH, 1999, CELL TISSUE RES, V296, P111, DOI 10.1007/s004410051272; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hinchliffe J. R., 1980, DEV VERTEBRATE LIMB; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; SHUBIN NH, 1986, EVOL BIOL, V20, P319; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Storm EE, 1996, DEVELOPMENT, V122, P3969; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537	10	14	14	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1713	1714		10.1126/science.1059665	http://dx.doi.org/10.1126/science.1059665			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11253195				2022-12-28	WOS:000167320600033
J	Lifton, RP; Gharavi, AG; Geller, DS				Lifton, RP; Gharavi, AG; Geller, DS			Molecular mechanisms of human hypertension	CELL			English	Review							EPITHELIAL SODIUM-CHANNEL; GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM; PSEUDOHYPOALDOSTERONISM TYPE-II; INFLUENCING BLOOD-PRESSURE; CONVERTING ENZYME LOCUS; LUNG LIQUID CLEARANCE; NITRIC-OXIDE SYNTHASE; LIDDLES-SYNDROME; BARTTERS-SYNDROME; BETA-SUBUNIT		Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Med, New Haven, CT USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New Haven, CT USA; Mt Sinai Sch Med, Dept Med, New York, NY USA	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University; Icahn School of Medicine at Mount Sinai	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06520 USA.				PHS HHS [K08] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; AMOR M, 1988, P NATL ACAD SCI USA, V85, P1600, DOI 10.1073/pnas.85.5.1600; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; August Phyllis, 1995, P2407; Bahring S, 1997, AM J HUM GENET, V60, P732; Baker EH, 1998, LANCET, V351, P1388, DOI 10.1016/S0140-6736(97)07306-6; Barker PM, 1998, J CLIN INVEST, V102, P1634, DOI 10.1172/JCI3971; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; BELLO CT, 1967, AM J MED SCI, V253, P194, DOI 10.1097/00000441-196702000-00007; BETTINELLI A, 1992, J PEDIATR-US, V120, P38, DOI 10.1016/S0022-3476(05)80594-3; BIRON P, 1976, CAN MED ASSOC J, V115, P773; BONGIOVANNI AM, 1963, NEW ENGL J MED, V268, P1283, DOI 10.1056/NEJM196306062682308; BOTEROVELEZ M, 1994, NEW ENGL J MED, V330, P178, DOI 10.1056/NEJM199401203300305; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Corvol P, 1999, HYPERTENSION, V33, P1324, DOI 10.1161/01.HYP.33.6.1324; CRUZ DN, 2001, IN PRESS HYPERTENSIO; Cvetkovic B, 2000, KIDNEY INT, V57, P863, DOI 10.1046/j.1523-1755.2000.057003863.x; Disse-Nicodeme S, 2000, AM J HUM GENET, V67, P302, DOI 10.1086/303020; FEINLEIB M, 1977, AM J EPIDEMIOL, V106, P284, DOI 10.1093/oxfordjournals.aje.a112464; Fornage M, 1998, CIRCULATION, V97, P1773, DOI 10.1161/01.CIR.97.18.1773; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; Gariepy CE, 2000, J CLIN INVEST, V105, P925, DOI 10.1172/JCI8609; Geller DS, 1998, NAT GENET, V19, P279, DOI 10.1038/966; Geller DS, 2000, SCIENCE, V289, P119, DOI 10.1126/science.289.5476.119; GORDON RD, 1994, CLIN EXP PHARMACOL P, V21, P315, DOI 10.1111/j.1440-1681.1994.tb02519.x; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; HANUKOGLU A, 1991, J CLIN ENDOCR METAB, V73, P936, DOI 10.1210/jcem-73-5-936; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; Hsueh WC, 2000, CIRCULATION, V101, P2810, DOI 10.1161/01.CIR.101.24.2810; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; HURLEY DM, 1991, J CLIN INVEST, V87, P680, DOI 10.1172/JCI115046; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; Inoue J, 1998, J CLIN ENDOCR METAB, V83, P2210, DOI 10.1210/jc.83.6.2210; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; JEUNEMAITRE X, 1992, NAT GENET, V1, P72, DOI 10.1038/ng0492-72; KAGIMOTO M, 1988, MOL ENDOCRINOL, V2, P564, DOI 10.1210/mend-2-6-564; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kerem E, 1999, NEW ENGL J MED, V341, P156, DOI 10.1056/NEJM199907153410304; KJELSBERG MO, 1982, JAMA-J AM MED ASSOC, V248, P1465; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; LIFTON RP, 1992, NAT GENET, V2, P66, DOI 10.1038/ng0992-66; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; LONGINI IM, 1984, AM J EPIDEMIOL, V120, P131, DOI 10.1093/oxfordjournals.aje.a113862; Luft FC, 2000, CURR OPIN NEPHROL HY, V9, P259, DOI 10.1097/00041552-200005000-00009; Mansfield TA, 1997, NAT GENET, V16, P202, DOI 10.1038/ng0697-202; MITSUUCHI Y, 1992, BIOCHEM BIOPH RES CO, V182, P974, DOI 10.1016/0006-291X(92)91827-D; Mosterd A, 1999, NEW ENGL J MED, V340, P1221, DOI 10.1056/NEJM199904223401601; MUNE T, 1995, NAT GENET, V10, P394, DOI 10.1038/ng0895-394; NEW MI, 1977, J CLIN ENDOCR METAB, V44, P924, DOI 10.1210/jcem-44-5-924; Niu TH, 1999, HYPERTENSION, V33, P698, DOI 10.1161/01.HYP.33.2.698; O'Donnell CJ, 1998, CIRCULATION, V97, P1766, DOI 10.1161/01.CIR.97.18.1766; Ohuchi T, 1999, AM J PHYSIOL-REG I, V276, pR1071, DOI 10.1152/ajpregu.1999.276.4.R1071; PASCOE L, 1992, P NATL ACAD SCI USA, V89, P4996, DOI 10.1073/pnas.89.11.4996; Plato CF, 2000, HYPERTENSION, V35, P319, DOI 10.1161/01.HYP.35.1.319; Rapp JP, 2000, PHYSIOL REV, V80, P135, DOI 10.1152/physrev.2000.80.1.135; RICE T, 1989, GENET EPIDEMIOL, V6, P571, DOI 10.1002/gepi.1370060503; RICH GM, 1992, ANN INTERN MED, V116, P813, DOI 10.7326/0003-4819-116-10-813; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; Schuster H, 1996, NAT GENET, V13, P98, DOI 10.1038/ng0596-98; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Spielman RS, 1996, AM J HUM GENET, V59, P983; Staessen JA, 1999, J HYPERTENS, V17, P9, DOI 10.1097/00004872-199917010-00003; STANTON JL, 1982, HYPERTENSION, V4, P135; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; STEWART PM, 1987, LANCET, V2, P821; Strautnieks SS, 1996, NAT GENET, V13, P248, DOI 10.1038/ng0696-248; SUTHERLAND DJ, 1966, CAN MED ASSOC J, V95, P1109; Takahashi N, 1999, J AM SOC NEPHROL, V10, P1598; ULICK S, 1979, J CLIN ENDOCR METAB, V49, P757, DOI 10.1210/jcem-49-5-757; US Renal Data System, 1999, USRDS 1999 ANN DAT R; WHITE PC, 1991, J CLIN INVEST, V87, P1664, DOI 10.1172/JCI115182	91	1239	1311	4	102	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 23	2001	104	4					545	556		10.1016/S0092-8674(01)00241-0	http://dx.doi.org/10.1016/S0092-8674(01)00241-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	405VP	11239411	Bronze			2022-12-28	WOS:000167181500009
J	Dennis, C; Gallagher, R; Campbell, P				Dennis, C; Gallagher, R; Campbell, P			Everyone's genome	NATURE			English	Editorial Material																			0	44	45	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					813	813						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11241983				2022-12-28	WOS:000166938800038
J	Olson, EN				Olson, EN			Development - The path to the heart and the road not taken	SCIENCE			English	Editorial Material							CARDIAC MYOGENESIS; INDUCTION; ENDODERM		Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.							FRASCH M, 1995, NATURE, V374, P464, DOI 10.1038/374464a0; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; NASCONE N, 1995, DEVELOPMENT, V121, P515; Polakis P, 2000, GENE DEV, V14, P1837; ROSENQUIST GLENN C., 1966, CARNEGIE INST WASH PUBL, V38, P111; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schultheiss TM, 1995, DEVELOPMENT, V121, P4203; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Tzahor E, 2001, GENE DEV, V15, P255, DOI 10.1101/gad.871501; WU XS, 1995, DEV BIOL, V169, P619, DOI 10.1006/dbio.1995.1174	11	39	40	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2327	2328		10.1126/science.1060063	http://dx.doi.org/10.1126/science.1060063			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11269304				2022-12-28	WOS:000167618700030
J	Orzel, C; Tuchman, AK; Fenselau, ML; Yasuda, M; Kasevich, MA				Orzel, C; Tuchman, AK; Fenselau, ML; Yasuda, M; Kasevich, MA			Squeezed states in a Bose-Einstein condensate	SCIENCE			English	Article							COLLECTIVE EXCITATIONS; COHERENCE; NUMBER; ATOMS; PHASE; NOISE	We report manipulation of the atom number statistics associated with Bose-Einstein condensed atoms confined in an array of weakly Linked mesoscopic traps. We used the interference of atoms released from the traps as a sensitive probe of these statistics. By controlling relative strengths of the tunneling rate between traps and atom-atom interactions within each trap, we observed trap states characterized by sub-Poissonian number fluctuations and adiabatic transitions between these number-squeeled states and coherent states of the atom field. The quantum states produced in this work may enable substantial gains in sensitivity for atom interference-based instruments as well as fundamental studies of quantum phase transitions.	Yale Univ, Dept Phys, New Haven, CT 06520 USA; Univ Tokyo, Bunkyo Ku, Tokyo 1138656, Japan	Yale University; University of Tokyo	Orzel, C (corresponding author), Yale Univ, Dept Phys, New Haven, CT 06520 USA.		Yasuda, Masami/L-9282-2018	Yasuda, Masami/0000-0001-6040-3176				Anderson BP, 1999, PHYS REV A, V59, pR938, DOI 10.1103/PhysRevA.59.R938; Anderson BP, 1998, SCIENCE, V282, P1686, DOI 10.1126/science.282.5394.1686; Anderson BP, 1999, P INT SCH PHYS, V140, P439; Baym G, 1996, PHYS REV LETT, V76, P6, DOI 10.1103/PhysRevLett.76.6; Berman P., 1997, ATOM INTERFEROMETRY; Bouyer P, 1997, PHYS REV A, V56, pR1083, DOI 10.1103/PhysRevA.56.R1083; Castin Y, 1997, PHYS REV A, V55, P4330, DOI 10.1103/PhysRevA.55.4330; CAVES CM, 1981, PHYS REV D, V23, P1693, DOI 10.1103/PhysRevD.23.1693; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; Hald J, 1999, PHYS REV LETT, V83, P1319, DOI 10.1103/PhysRevLett.83.1319; Ho TL, 2000, PHYS REV LETT, V84, P4031, DOI 10.1103/PhysRevLett.84.4031; Horak P, 1999, J PHYS B-AT MOL OPT, V32, P3421, DOI 10.1088/0953-4075/32/14/312; Imamoglu A, 1997, PHYS REV LETT, V78, P2511, DOI 10.1103/PhysRevLett.78.2511; Javanainen J, 1996, PHYS REV LETT, V76, P161, DOI 10.1103/PhysRevLett.76.161; Javanainen J, 1999, PHYS REV A, V60, P4902, DOI 10.1103/PhysRevA.60.4902; Javanainen J, 1999, PHYS REV A, V60, P2351, DOI 10.1103/PhysRevA.60.2351; Jin DS, 1996, PHYS REV LETT, V77, P420, DOI 10.1103/PhysRevLett.77.420; KITAGAWA M, 1993, PHYS REV A, V47, P5138, DOI 10.1103/PhysRevA.47.5138; Kuzmich A, 2000, PHYS REV LETT, V85, P1594, DOI 10.1103/PhysRevLett.85.1594; Mewes MO, 1996, PHYS REV LETT, V77, P988, DOI 10.1103/PhysRevLett.77.988; Pu H, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.023602; Sachdev S., 2000, QUANTUM PHASE TRANSI; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Spekkens RW, 1999, PHYS REV A, V59, P3868, DOI 10.1103/PhysRevA.59.3868; Walls D. F., 1994, QUANTUM OPT	27	741	751	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2001	291	5512					2386	2389		10.1126/science.1058149	http://dx.doi.org/10.1126/science.1058149			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264529				2022-12-28	WOS:000167618700048
J	Giri, S; White, CM; Dunn, AB; Felton, K; Freeman-Bosco, L; Reddy, P; Tsikouris, JP; Wilcox, HA; Kluger, J				Giri, S; White, CM; Dunn, AB; Felton, K; Freeman-Bosco, L; Reddy, P; Tsikouris, JP; Wilcox, HA; Kluger, J			Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial	LANCET			English	Article							RISK-FACTORS; CORONARY; STROKE; OUTCOMES; METAANALYSIS; PROPHYLAXIS; PREDICTOR; AGE	Background beta -blockers and amiodarone reduce the frequency of atrial fibrillation after open-heart surgery but the effectiveness of oral amiodarone in older patients already receiving beta -blockers is unknown. We have assessed the efficacy of oral amiodarone in preventing atrial fibrillation in patients aged 60 years or older undergoing open-heart surgery. Methods We did a randomised, double-blind placebo-controlled trial in which patients undergoing open-heart surgery (n=220, average age 73 years) received amiodarone (n=120) or placebo (n=100). Patients enrolled less than 5 days before surgery received 6 g of amiodarone or placebo over 6 days beginning on preoperative day 1. Patients enrolled at least 5 days before surgery received 7 g over 10 days beginning on preoperative day 5. Findings Patients on amiodarone had a lower frequency of any atrial fibrillation (22.5% vs 38.0%: p=0.01; absolute difference 15.5% [95% CI 3.4-27.6%]), and there were significant differences in favour of the active drug for symptomatic atrial fibrillation (4.2% vs 18.0%. p=0.001), cerebrovascular accident (1.7% vs 7.0%, p=0.04), and postoperative ventricular tachycardia (1.7% vs 7.0%, p=0.04). beta -blocker use (87.5% amiodarone vs 91.0% placebo), nausea (26.7% vs 16.0%), 30-day mortality (3.3% vs 4.0%), symptomatic bradycardia (7.5% vs 7.0%), and hypotension (14.2% vs 10.0%) were similar. Interpretation Oral amiodarone prophylaxis in combination with beta -blockers prevents atrial fibrillation and symptomatic fibrillation and reduces the risk of cerebrovascular accidents and ventricular tachycardia.	Hartford Hosp, Div Cardiol, Hartford, CT 06102 USA; Hartford Hosp, Div Drug Informat, Hartford, CT 06102 USA; Univ Connecticut, Sch Pharm, Storrs, CT USA; Univ Connecticut, Sch Med, Storrs, CT 06268 USA; Univ Connecticut, Sch Med, Farmington, CT USA; Univ Connecticut, Sch Pharm, Farmington, CT USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiol, Boston, MA 02115 USA	Hartford Hospital; Hartford Hospital; University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kluger, J (corresponding author), Hartford Hosp, Div Cardiol, Hartford, CT 06102 USA.	jkluger@harthosp.org						Alexander KP, 2000, J AM COLL CARDIOL, V35, P731, DOI 10.1016/S0735-1097(99)00606-3; ANDREWS TC, 1991, CIRCULATION, V84, P236; BUTLER J, 1993, BRIT HEART J, V70, P56; CRESWELL LL, 1993, ANN THORAC SURG, V56, P539, DOI 10.1016/0003-4975(93)90894-N; CROSBY LH, 1990, AM J CARDIOL, V66, P1520, DOI 10.1016/0002-9149(90)90550-K; Daoud EG, 1997, NEW ENGL J MED, V337, P1785, DOI 10.1056/NEJM199712183372501; DUSMAN RE, 1990, CIRCULATION, V82, P51, DOI 10.1161/01.CIR.82.1.51; FULLER JA, 1989, J THORAC CARDIOV SUR, V97, P821; Guarnieri T, 1999, J AM COLL CARDIOL, V34, P343, DOI 10.1016/S0735-1097(99)00212-0; HOHNLOSER SH, 1991, AM HEART J, V121, P89, DOI 10.1016/0002-8703(91)90960-P; JANSSEN J, 1986, ANGIOLOGY, V37, P601, DOI 10.1177/000331978603700807; Kalman JM, 1995, ANN THORAC SURG, V60, P1709, DOI 10.1016/0003-4975(95)00718-0; KOWEY PR, 1992, AM J CARDIOL, V69, P963, DOI 10.1016/0002-9149(92)90802-6; LEITCH JW, 1990, J THORAC CARDIOV SUR, V100, P338; LYNN GM, 1992, J THORAC CARDIOV SUR, V104, P1518, DOI 10.1016/S0022-5223(19)33878-4; Mathew JP, 1996, JAMA-J AM MED ASSOC, V276, P300, DOI 10.1001/jama.276.4.300; NEW MF, 1996, CIRCULATION S2, V93, P74; Parikka H, 1998, J CARDIOVASC PHARM, V31, P67, DOI 10.1097/00005344-199801000-00010; Rakowski H, 1999, AM HEART J, V138, P609, DOI 10.1016/S0002-8703(99)70171-7; RAO V, 1995, J CARDIAC SURG, V10, P468, DOI 10.1111/j.1540-8191.1995.tb00679.x; Redle JD, 1999, AM HEART J, V138, P144, DOI 10.1016/S0002-8703(99)70260-7; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; SALOMON NW, 1991, J THORAC CARDIOV SUR, V101, P209; SINGH BN, 1989, PROG CARDIOVASC DIS, V31, P249, DOI 10.1016/0033-0620(89)90033-9; SUTTORP MJ, 1991, AM J CARDIOL, V68, P1163, DOI 10.1016/0002-9149(91)90188-Q; TAYLOR GJ, 1987, AM J CARDIOL, V60, P905, DOI 10.1016/0002-9149(87)91045-9; Zhou L, 1998, J AM COLL CARDIOL, V31, P1672, DOI 10.1016/S0735-1097(98)00160-0; ZIPES DP, 1984, J AM COLL CARDIOL, V3, P1059, DOI 10.1016/S0735-1097(84)80367-8	28	148	156	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2001	357	9259					830	836		10.1016/S0140-6736(00)04196-9	http://dx.doi.org/10.1016/S0140-6736(00)04196-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265951				2022-12-28	WOS:000167586300009
J	Rosmond, R; Bouchard, C; Bjorntorp, P				Rosmond, R; Bouchard, C; Bjorntorp, P			Tsp509I polymorphism in exon 2 of the glucocorticoid receptor gene in relation to obesity and cortisol secretion: cohort study	BRITISH MEDICAL JOURNAL			English	Article							ABDOMINAL OBESITY		Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; Sahlgrens Univ Hosp, Dept Heart & Lung Dis, S-41345 Gothenburg, Sweden	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Sahlgrenska University Hospital	Rosmond, R (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.		Bouchard, Claude/A-7637-2009; Bouchard, Claude/AAE-2035-2019	Bouchard, Claude/0000-0002-0048-491X; 				Huizenga NATM, 1998, J CLIN ENDOCR METAB, V83, P144, DOI 10.1210/jc.83.1.144; Koper JW, 1997, HUM GENET, V99, P663, DOI 10.1007/s004390050425; Lin RCY, 1999, BMJ-BRIT MED J, V319, P1337, DOI 10.1136/bmj.319.7221.1337; Rosmond R, 2000, OBES RES, V8, P211, DOI 10.1038/oby.2000.24; Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853	5	61	62	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 17	2001	322	7287					652	653		10.1136/bmj.322.7287.652	http://dx.doi.org/10.1136/bmj.322.7287.652			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413QE	11250851	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000167622600026
J	Boyd, K				Boyd, K			Commentary: Early discontinuation violates Helsinki principles	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Edinburgh, Inst Med Eth Geriatr Med, Edinburgh EH3 9EW, Midlothian, Scotland	University of Edinburgh	Boyd, K (corresponding author), Univ Edinburgh, Inst Med Eth Geriatr Med, Edinburgh EH3 9EW, Midlothian, Scotland.							6World Medical Association, 2000, DECL HELS; Horton R, 2000, NEW YORK REV BOOKS, V47, P46; NAIRNE P, 1992, BMJ-BRIT MED J, V305, P699	3	15	16	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2001	322	7286					605	606						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411KU	11269247				2022-12-28	WOS:000167499900032
J	Oomen, CM; Ocke, MC; Feskens, EJM; van Erp-Baart, MAJ; Kok, FJ; Kromhout, D				Oomen, CM; Ocke, MC; Feskens, EJM; van Erp-Baart, MAJ; Kok, FJ; Kromhout, D			Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study	LANCET			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; HYDROGENATED SOYBEAN OIL; DIETARY-FAT; FISH-OIL; MEN; WOMEN; COUNTRIES; BUTTER; COHORT; EUROPE	Background Evidence on the relation between trans fatty acid intake and coronary heart disease is limited. We investigated this relation in a Dutch population with a fairly high trans fatty acid intake, including trans fatty acids from partly hydrogenated fish oils. Methods We prospectively studied 667 men of the Zutphen Elderly Study aged 64-84 years and free of coronary heart disease at baseline. We used dietary surveys to establish the participants' food consumption patterns. Information on risk factors and diet was obtained in 1985, 1990, and 1995. After 10 years of follow-up from 1985-95, there were 98 cases of fatal or non-fatal coronary heart disease. Findings Between 1985 and 1995, average trans fatty acid intake decreased from 43% to 1.9% of energy. After adjustment for age, body mass index, smoking, and dietary covariates, trans fatty acid intake at baseline was positively associated with the 10-year risk of coronary heart disease. The relative risk for a difference of 2% of energy in trans fatty acid intake at baseline was 1.28 (95% CI 1.01-1.61). Interpretation A high intake of trans fatty acids tall types of isomers) contributes to the risk of coronary heart disease. The substantial decrease in trans fatty acid intake, mainly due to industrial lowering of trans contents in Dutch edible fats, could therefore have had a large public-health impact.	Natl Inst Publ Hlth & Environm, Dept Chron Dis Epidemiol, NL-3720 BA Bilthoven, Netherlands; Natl Inst Publ Hlth & Environm, Div Publ Hlth Res, NL-3720 BA Bilthoven, Netherlands; Univ Wageningen & Res Ctr, Dept Human Nutr & Epidemiol, Wageningen, Netherlands; TNO Nutr & Food Res, Dept Nutr Epidemiol, Zeist, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Wageningen University & Research; Netherlands Organization Applied Science Research	Oomen, CM (corresponding author), Natl Inst Publ Hlth & Environm, Dept Chron Dis Epidemiol, POB 1, NL-3720 BA Bilthoven, Netherlands.		Feskens, Edith JM/A-3757-2012; Feskens, Edith/ABI-1446-2020; Robles-Sardin, Alma E/M-7714-2015; Kromhout, Daan/A-8566-2014	Feskens, Edith/0000-0001-5819-2488; Robles-Sardin, Alma E/0000-0003-2044-7793; 				ALMENDINGEN K, 1995, J LIPID RES, V36, P1370; Almendingen K, 1996, ARTERIOSCL THROM VAS, V16, P375, DOI 10.1161/01.ATV.16.3.375; ARO A, 1995, LANCET, V345, P273, DOI 10.1016/S0140-6736(95)90273-2; Aro A., 1998, Journal of Food Composition and Analysis, V11, P137, DOI 10.1006/jfca.1998.0569; Aro A, 1998, J AM OIL CHEM SOC, V75, P977, DOI 10.1007/s11746-998-0275-5; Aro A., 1998, Journal of Food Composition and Analysis, V11, P170, DOI 10.1006/jfca.1998.0572; Ascherio A, 1999, NEW ENGL J MED, V340, P1994, DOI 10.1056/NEJM199906243402511; Ascherio A, 1996, BMJ-BRIT MED J, V313, P84, DOI 10.1136/bmj.313.7049.84; ASCHERIO A, 1994, CIRCULATION, V89, P941; BLOEMBERG BPM, 1989, AM J EPIDEMIOL, V130, P1047, DOI 10.1093/oxfordjournals.aje.a115405; CASPERSEN CJ, 1991, AM J EPIDEMIOL, V133, P1078, DOI 10.1093/oxfordjournals.aje.a115821; Christiansen E, 1997, DIABETES CARE, V20, P881, DOI 10.2337/diacare.20.5.881; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hulshof KFAM, 1999, EUR J CLIN NUTR, V53, P143, DOI 10.1038/sj.ejcn.1600692; HULSHOF PJM, 1998, VOEDING, V5, P24; JUDD JT, 1994, AM J CLIN NUTR, V59, P861, DOI 10.1093/ajcn/59.4.861; KATAN MB, 1995, LANCET, V346, P1245, DOI 10.1016/S0140-6736(95)91858-2; Keys A, 1966, Acta Med Scand Suppl, V460, P1; KROMHOUT D, 1995, PREV MED, V24, P308, DOI 10.1006/pmed.1995.1049; Lichtenstein AH, 1999, NEW ENGL J MED, V340, P1933, DOI 10.1056/NEJM199906243402501; MENSINK RP, 1990, NEW ENGL J MED, V323, P439, DOI 10.1056/NEJM199008163230703; NESTEL PJ, 1992, AM J CLIN NUTR, V55, P46, DOI 10.1093/ajcn/55.1.46; OOMEN CM, 2000, 441110004 RIJKS VOLK; Pietinen P, 1997, AM J EPIDEMIOL, V145, P876, DOI 10.1093/oxfordjournals.aje.a009047; Rose G, 1968, CARDIOVASCULAR SURVE; SIEDEL J, 1981, J CLIN CHEM CLIN BIO, V19, P838; SUNDRAM K, 1997, J NUTR S, V127, P514; van de Vijver LPL, 2000, EUR J CLIN NUTR, V54, P126, DOI 10.1038/sj.ejcn.1600906; van Erp-Baart M.-A., 1998, Journal of Food Composition and Analysis, V11, P161, DOI 10.1006/jfca.1998.0571; van Poppel G., 1998, Journal of Food Composition and Analysis, V11, P112, DOI 10.1006/jfca.1998.0568; WARNICK GR, 1982, CLIN CHEM, V28, P1379; WILLETT WC, 1993, LANCET, V341, P581, DOI 10.1016/0140-6736(93)90350-P; WILLETT WC, 1994, AM J PUBLIC HEALTH, V84, P722, DOI 10.2105/AJPH.84.5.722; ZOCK PL, 1992, J LIPID RES, V33, P399	35	355	377	3	36	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					746	751		10.1016/S0140-6736(00)04166-0	http://dx.doi.org/10.1016/S0140-6736(00)04166-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253967				2022-12-28	WOS:000167400900011
J	Pederson, T				Pederson, T			Protein mobility within the nucleus - What are the right moves?	CELL			English	Review							LIVING HUMAN-CELLS; SPLICING FACTOR; RAPID EXCHANGE; CHROMATIN; STATE; GENE; RNA		Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Pederson, T (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.							BOISVERT FM, 2001, IN PRESS J CELL BIOL; CHEN D, 2001, IN PRESS J CELL BIOL; Daneholt B, 1999, CURR BIOL, V9, pR412, DOI 10.1016/S0960-9822(99)80256-5; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Kruhlak MJ, 2000, J CELL BIOL, V150, P41, DOI 10.1083/jcb.150.1.41; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Pederson T, 2000, NAT CELL BIOL, V2, pE73, DOI 10.1038/35010501; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043; Politz JC, 1999, CURR BIOL, V9, P285, DOI 10.1016/S0960-9822(99)80136-5; Snaar S, 2000, J CELL BIOL, V151, P653, DOI 10.1083/jcb.151.3.653; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896	17	80	81	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2001	104	5					635	638		10.1016/S0092-8674(02)01455-1	http://dx.doi.org/10.1016/S0092-8674(02)01455-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257216	Bronze			2022-12-28	WOS:000167531100002
J	Larbalestier, DC; Cooley, LD; Rikel, MO; Polyanskii, AA; Jiang, J; Patnaik, S; Cai, XY; Feldmann, DM; Gurevich, A; Squitieri, AA; Naus, MT; Eom, CB; Hellstrom, EE; Cava, RJ; Regan, KA; Rogado, N; Hayward, MA; He, T; Slusky, JS; Khalifah, P; Inumaru, K; Haas, M				Larbalestier, DC; Cooley, LD; Rikel, MO; Polyanskii, AA; Jiang, J; Patnaik, S; Cai, XY; Feldmann, DM; Gurevich, A; Squitieri, AA; Naus, MT; Eom, CB; Hellstrom, EE; Cava, RJ; Regan, KA; Rogado, N; Hayward, MA; He, T; Slusky, JS; Khalifah, P; Inumaru, K; Haas, M			Strongly linked current flow in polycrystalline forms of the superconductor MgB2	NATURE			English	Article							GRAIN-BOUNDARIES; BICRYSTALS	The discovery of superconductivity at 39 K in magnesium diboride(1), MgB2, raises many issues, a critical one being whether this material resembles a high-temperature copper oxide superconductor or a low-temperature metallic superconductor in terms of its behaviour in strong magnetic fields. Although the copper oxides exhibit very high transition temperatures, their in-field performance(2) is compromized by their large anisotropy, the result of which is to restrict high bulk current densities to a region much less than the full magnetic-field-temperature (H-T) space over which superconductivity is found. Moreover, the weak coupling across grain boundaries makes transport current densities in untextured polycrystalline samples low and strongly sensitive to magnetic field(3,4). Here we report that, despite the multiphase, untextured, microscale, subdivided nature of our MgB2 samples, supercurrents flow throughout the material without exhibiting strong sensitivity to weak magnetic fields(3). Our combined magnetization, magneto-optical, microscopy and X-ray investigations show that the supercurrent density is mostly determined by flux pinning, rather than by the grain boundary connectivity. Our results therefore suggest that this new superconductor class is not compromized by weak-link problems, a conclusion of significance for practical applications if higher temperature analogues of this compound can be discovered.	Univ Wisconsin, Ctr Appl Superconduct, Madison, WI 53706 USA; Univ Wisconsin, Dept Mat Sci & Engn, Madison, WI 53706 USA; Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Princeton Univ, Princeton Mat Inst, Princeton, NJ 08544 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Princeton University; Princeton University	Larbalestier, DC (corresponding author), Univ Wisconsin, Ctr Appl Superconduct, 1500 Engn Dr, Madison, WI 53706 USA.	larbales@engr.wisc.edu	Rikel, Mark/ABC-8142-2021; Cooley, Lance D/E-7377-2015; Eom, Chang-Beom/I-5567-2014; Cooley, Lance/N-4149-2019; Inumaru, Kei/J-9292-2015; Gurevich, Alex/A-4327-2008; Hayward, Michael/B-8005-2008; Cooley, Lance/AAE-5646-2021; Larbalestier, David/B-2277-2008; Jiang, Jianyi/F-2549-2017	Cooley, Lance D/0000-0003-3488-2980; Cooley, Lance/0000-0003-3488-2980; Gurevich, Alex/0000-0003-0759-8941; Hayward, Michael/0000-0002-6248-2063; Larbalestier, David/0000-0001-7098-7208; Jiang, Jianyi/0000-0002-1094-2013; Rikel, Mark/0000-0002-4537-0772; Khalifah, Peter/0000-0002-2216-0377; Hellstrom, Eric/0000-0001-8263-8662; Slusky, Joanna/0000-0003-0842-6340; Inumaru, Kei/0000-0001-6876-3854; Patnaik, Prof. Satyabrata/0000-0003-4984-9243				Bud'ko SL, 2001, PHYS REV LETT, V86, P1877, DOI 10.1103/PhysRevLett.86.1877; CAMPBELL AM, 1972, ADV PHYS, V21, P199, DOI 10.1080/00018737200101288; DEWHUGHES D, 1987, PHILOS MAG B, V55, P459, DOI 10.1080/13642818708217956; DIMOS D, 1990, PHYS REV B, V41, P4038, DOI 10.1103/PhysRevB.41.4038; FINNEMORE DK, IN PRESS PHYS REV LE; Heinig NF, 1999, PHYS REV B, V60, P1409, DOI 10.1103/PhysRevB.60.1409; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; SUENAGA M, 1991, PHYS REV LETT, V66, P1777, DOI 10.1103/PhysRevLett.66.1777; Yeshurun Y, 1996, REV MOD PHYS, V68, P911, DOI 10.1103/RevModPhys.68.911	10	813	850	5	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2001	410	6825					186	189		10.1038/35065559	http://dx.doi.org/10.1038/35065559			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242073	Green Submitted			2022-12-28	WOS:000167320500039
J	Leighton, PA; Mitchell, KJ; Goodrich, LV; Lu, XW; Pinson, K; Scherz, P; Skarnes, WC; Tessler-Lavigne, M				Leighton, PA; Mitchell, KJ; Goodrich, LV; Lu, XW; Pinson, K; Scherz, P; Skarnes, WC; Tessler-Lavigne, M			Defining brain wiring patterns and mechanisms through gene trapping in mice	NATURE			English	Article							TRANSMEMBRANE SEMAPHORIN; EMBRYONIC MOTOR; TYROSINE KINASE; GENOME-WIDE; EXPRESSION; MUTATIONS; RECEPTORS; CLONING; NEUROPILIN-2; DROSOPHILA	The search to understand the mechanisms regulating brain wiring has relied on biochemical purification approaches in vertebrates and genetic approaches in invertebrates to identify molecular cues and receptors for axon guidance. Here we describe a phenotype-based gene-trap screen in mice designed for the large-scale identification of genes controlling the formation of the trillions of connections in the mammalian brain. The method incorporates an axonal marker, which helps to identify cell-autonomous mechanisms in axon guidance, and has generated a resource of mouse lines with striking patterns of axonal labelling, which facilitates analysis of the normal wiring diagram of the brain. Studies of two of these mouse lines have identified an in vivo guidance function for a vertebrate transmembrane semaphorin, Sema6A, and have helped re-evaluate that of the Eph receptor EphA4.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Tessler-Lavigne, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	marctl@itsa.ucsf.edu		Mitchell, Kevin/0000-0002-3433-4530				Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Brennan J, 1999, METH MOL B, V97, P123, DOI 10.1385/1-59259-270-8:123; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Eckhardt F, 1997, MOL CELL NEUROSCI, V9, P409, DOI 10.1006/mcne.1997.0644; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kikuchi K, 1999, MOL CELL NEUROSCI, V13, P9, DOI 10.1006/mcne.1998.0732; Klostermann A, 2000, J BIOL CHEM, V275, P39647, DOI 10.1074/jbc.M006316200; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; MARTIN KA, 1995, NEURON, V14, P229, DOI 10.1016/0896-6273(95)90281-3; MITCHELL KJ, UNPUB NATURE GENET; Molnar Z, 1998, J NEUROSCI, V18, P5723; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MOUNTFORD PS, 1995, TRENDS GENET, V11, P179, DOI 10.1016/S0168-9525(00)89040-X; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Sagane K, 1999, GENE, V236, P79, DOI 10.1016/S0378-1119(99)00253-X; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; St Croix B, 2000, SCIENCE, V289, P1197; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Townley DJ, 1997, GENOME RES, V7, P293, DOI 10.1101/gr.7.3.293; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Xu XM, 2000, J NEUROSCI, V20, P2638; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Zhou L, 1997, MOL CELL NEUROSCI, V9, P26, DOI 10.1006/mcne.1997.0607	37	336	341	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2001	410	6825					174	179		10.1038/35065539	http://dx.doi.org/10.1038/35065539			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242070				2022-12-28	WOS:000167320500036
J	Marks, B; Stowell, MHB; Vallis, Y; Mills, IG; Gibson, A; Hopkins, CR; McMahon, HT				Marks, B; Stowell, MHB; Vallis, Y; Mills, IG; Gibson, A; Hopkins, CR; McMahon, HT			GTPase activity of dynamin and resulting conformation change are essential for endocytosis	NATURE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PLECKSTRIN HOMOLOGY DOMAIN; COATED VESICLE FORMATION; CRYSTAL-STRUCTURE; SH3 DOMAIN; AMPHIPHYSIN; RECEPTOR; BINDING; DROSOPHILA; MECHANISM	Dynamin is a large GTPase with a relative molecular mass of 96,000 (M-r 96K) that is involved in clathrin-mediated endocytosis and other vesicular trafficking processes(1,2). Although its function is apparently essential for scission of newly formed vesicles from the plasma membrane, the nature of dynamin's role in the scission process is still unclear(3,4). It has been proposed that dynamin is a regulator (similar to classical G proteins) of downstream effectors(5). Here we report the analysis of several point mutants of dynamin's GTPase effector (GED) and GTPase domains. We show that oligomerization and GTP binding alone, by dynamin, are not sufficient for endocytosis in vivo. Rather, efficient GTP hydrolysis and an associated conformational change are also required. These data argue that dynamin has a mechanochemical function in vesicle scission.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England	MRC Laboratory Molecular Biology; University of London; University College London	McMahon, HT (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	hmm@mrc-lmmb.cam.ac.uk	Mills, Ian/AAK-9292-2020	Mills, Ian/0000-0001-5347-5083; STOWELL, MICHAEL/0000-0001-7250-1419				Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; KOENIG JH, 1989, J NEUROSCI, V9, P3844; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Okamoto PM, 1999, J BIOL CHEM, V274, P10277, DOI 10.1074/jbc.274.15.10277; OTERO AD, 1990, BIOCHEM PHARMACOL, V39, P1399; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; Roos J, 1997, TRENDS CELL BIOL, V7, P257, DOI 10.1016/S0962-8924(97)01068-4; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wilson-Kubalek EM, 1998, P NATL ACAD SCI USA, V95, P8040, DOI 10.1073/pnas.95.14.8040	29	356	365	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2001	410	6825					231	235		10.1038/35065645	http://dx.doi.org/10.1038/35065645			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242086				2022-12-28	WOS:000167320500052
J	Oppenheimer, SJ; Richards, M				Oppenheimer, SJ; Richards, M			Polynesian origins - Slow boat to melanesia?	NATURE			English	Article									Univ Oxford Green Coll, Oxford OX2 6HG, England; Univ Huddersfield, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England	University of Oxford; University of Huddersfield	Oppenheimer, SJ (corresponding author), Univ Oxford Green Coll, Oxford OX2 6HG, England.							BAER AS, 1995, ASIAN PERSPECT, V34, P21; BELLWOOD P, 1997, PREHISTORY INDOMALAY, P119; Blust Robert, 1999, 8 INT C AUSTR LING, P31; Diamond JM, 2000, NATURE, V403, P709, DOI 10.1038/35001685; HANIHARA T, 1993, ANTHROPOL SCI, V101, P25, DOI 10.1537/ase.101.25; MEACHAM W, 1984, ASIAN PERSPECT, V26, P89; MELTON T, 1995, AM J HUM GENET, V57, P403; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; Richards M, 1998, AM J HUM GENET, V63, P1234, DOI 10.1086/302043; SERJEANTSON SW, 1989, COLONIZATION PACIFIC, P286; SOLHEIM WG, 1994, HIST HUMANITY, V1, P468; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; Terrell JE, 1997, ANTIQUITY, V71, P548, DOI 10.1017/S0003598X0008532X	13	67	69	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					166	167		10.1038/35065520	http://dx.doi.org/10.1038/35065520			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242066				2022-12-28	WOS:000167320500032
J	Kashiwaya, K; Ochiai, S; Sakai, H; Kawai, T				Kashiwaya, K; Ochiai, S; Sakai, H; Kawai, T			Orbit-related long-term climate cycles revealed in a 12-Myr continental record from Lake Baikal	NATURE			English	Article							CALIBRATION; SEDIMENTS; LOESS	Quaternary records of climate change from terrestrial sources, such as lake sediments(1,2) and aeolian sediments(3,4), in general agree well with marine records(5,6). But continuous records that cover more than the past one million years were essentially unavailable until recently, when the high-sedimentation-rate site of Lake Baikal was exploited(1,2,7,8). Because of its location in the middle latitudes, Lake Baikal is highly sensitive to insolation changes(9) and the entire lake remained uncovered by ice sheets throughout the Pleistocene epoch, making it a valuable archive for past climate. Here we examine long sediment cores from Lake Baikal that cover the past 12 million years. Our record reveals a gradual cooling of the Asian continental interior, with some fluctuations. Spectral analyses reveal periods of about 400 kyr, 600 kyr and 1,000 kyr, which may correspond to Milankovitch periods (reflecting orbital cycles). Our results indicate that changes in insolation were closely related to long-term environmental variations in the deep continental interior, over the past 12 million years.	Kanazawa Univ, Dept Earth Sci, Kanazawa, Ishikawa 9201192, Japan; Toyama Univ, Dept Earth Sci, Toyama 9308555, Japan; Natl Inst Environm Studies, Tsukuba, Ibaraki 3500044, Japan	Kanazawa University; University of Toyama; National Institute for Environmental Studies - Japan	Kashiwaya, K (corresponding author), Kanazawa Univ, Dept Earth Sci, Kanazawa, Ishikawa 9201192, Japan.							*BAIK DRILL PROJ L, 1997, EOS, V78, P597; BARRODALE I, 1980, GEOPHYSICS, V45, P420, DOI 10.1190/1.1441091; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Berger A., 1990, B CLASSE SCI, V1, P45, DOI [10.3406/barb.1990.38523, DOI 10.3406/BARB.1990.38523]; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Chambers J. M., 1983, GRAPHICAL METHODS DA, P395; Clemens SC, 1997, NATURE, V385, P801, DOI 10.1038/385801a0; Colman S, 1997, QUATERN INT, V37, P3; COLMAN SM, 1995, NATURE, V378, P769, DOI 10.1038/378769a0; Flower RJ, 1998, J PALEOLIMNOL, V20, P107, DOI 10.1023/A:1008047614619; Hayashi Y., 1981, J METEOR SOC JAPAN, V59, P620; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; KASHIWAYA K, 1991, GEOPHYS RES LETT, V18, P1245, DOI 10.1029/91GL01555; Kashiwaya K, 1998, GEOPHYS RES LETT, V25, P659, DOI 10.1029/98GL00240; Kashiwaya K, 1997, J PALEOLIMNOL, V18, P293, DOI 10.1023/A:1007991210384; KASHIWAYA K, 2001, LAKE BAIKAL; KASHIWAYA K, IN PRESS J PALEOLIMN; Kroon D., 1991, Proceedings of the Ocean Drilling Program Scientific Results, V117, P257, DOI 10.2973/odp.proc.sr.117.126.1991; KUKLA G, 1987, QUATERNARY SCI REV, V6, P191, DOI 10.1016/0277-3791(87)90004-7; LASKAR J, 1993, ASTRON ASTROPHYS, V270, P522; Lourens LJ, 1997, QUATERN INT, V40, P43, DOI 10.1016/S1040-6182(96)00060-2; MAASCH KA, 1988, CLIM DYNAM, V2, P133; MAHER BA, 1991, GEOLOGY, V19, P3, DOI 10.1130/0091-7613(1991)019<0003:MMROTC>2.3.CO;2; ORMSBY JF, 1961, J ACM, V8, P440, DOI 10.1145/321075.321087; PRELL WL, 1992, NATURE, V360, P647, DOI 10.1038/360647a0; Shackleton N.J., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P337, DOI 10.2973/odp.proc.sr.138.117.1995; SHACKLETON NJ, 1984, NATURE, V307, P620, DOI 10.1038/307620a0; SHACKLETON NJ, 1990, T ROY SOC EDIN-EARTH, V81, P251, DOI 10.1017/S0263593300020782; SHORT DA, 1991, QUATERNARY RES, V35, P157, DOI 10.1016/0033-5894(91)90064-C	30	96	108	2	28	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					71	74		10.1038/35065057	http://dx.doi.org/10.1038/35065057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242042				2022-12-28	WOS:000167194300043
J	Mackay, AL				Mackay, AL			Character-building - How do writing systems such as China's deal with the twenty-first century?	NATURE			English	Editorial Material									Univ London Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England	University of London; Birkbeck University London	Mackay, AL (corresponding author), Univ London Birkbeck Coll, Sch Crystallog, Malet St, London WC1E 7HX, England.								0	5	5	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					19	19		10.1038/35065171	http://dx.doi.org/10.1038/35065171			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242019	Bronze			2022-12-28	WOS:000167194300021
J	Schenk, PM; McKinnon, WB; Gwynn, D; Moore, JM				Schenk, PM; McKinnon, WB; Gwynn, D; Moore, JM			Flooding of Ganymede's bright terrains by low-viscosity water-ice lavas	NATURE			English	Article							GALILEAN SATELLITES; GROOVED TERRAIN; THERMAL EVOLUTION; STEREO IMAGES; STRATIGRAPHY; TOPOGRAPHY; VOLCANISM	Large regions of the jovian moon Ganymede have been resurfaced, but the means has been unclear(1,2). Suggestions have ranged from volcanic eruptions of liquid water(3-5) or solid ice(6) to tectonic deformation(7-9), but definitive high-resolution morphological evidence has been lacking. Here we report digital elevation models of parts of the surface of Ganymede, derived from stereo pairs combining data from the Voyager and Galileo spacecraft, which reveal bright, smooth terrains that lie at roughly constant elevations 100 to 1,000 metres below the surrounding rougher terrains. These topographic data, together with new images that show fine-scale embayment and burial of older features(10), indicate that the smooth terrains were formed by flooding of shallow structural troughs by low-viscosity water-ice lavas. The oldest and most deformed areas (the 'reticulate' terrains) in general have the highest relative elevations, whereas units of the most common resurfaced type-the grooved terrain-lie at elevations between those of the smooth and reticulate terrains. Bright terrain, which accounts for some two-thirds of the surface, probably results from a continuum of processes, including crustal rifting, shallow flooding and groove formation. Volcanism plays an integral role in these processes, and is consistent with partial melting of Ganymede's interior(11,12).	Lunar & Planetary Inst, Houston, TX 77058 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA; Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Los Angeles; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Schenk, PM (corresponding author), Lunar & Planetary Inst, 3303 NASA Rd 1, Houston, TX 77058 USA.							ALLISON ML, 1987, J GEOPHYS RES-SOLID, V92, P7865, DOI 10.1029/JB092iB08p07865; Belton MJS, 1996, SCIENCE, V274, P377, DOI 10.1126/science.274.5286.377; Collins GC, 1998, ICARUS, V135, P345, DOI 10.1006/icar.1998.5978; DOMBARD AJ, UNPUB ICARUS; Giese B, 1998, ICARUS, V135, P303, DOI 10.1006/icar.1998.5967; Head J. W, 1998, LUN PLAN SCI C CD RO, P1666; HEAD JW, 1992, GEOCHIM COSMOCHIM AC, V56, P2155, DOI 10.1016/0016-7037(92)90183-J; HEAD JW, 1997, LUN PLAN SCI C CD RO, V29, P535; Kay J. E, 1999, LUNAR PLANET SCI C, P1103; KIRK RL, 1987, ICARUS, V69, P91, DOI 10.1016/0019-1035(87)90009-1; LUCCHITTA BK, 1980, ICARUS, V44, P481, DOI 10.1016/0019-1035(80)90039-1; Moore JM, 1999, ICARUS, V140, P294, DOI 10.1006/icar.1999.6132; Pappalardo RT, 1998, ICARUS, V135, P276, DOI 10.1006/icar.1998.5966; PARMENTIER EM, 1982, NATURE, V295, P290, DOI 10.1038/295290a0; SCHENK PM, 1995, J GEOPHYS RES-PLANET, V100, P19009, DOI 10.1029/95JE01854; Schenk PM, 2000, J GEOPHYS RES-PLANET, V105, P24529, DOI 10.1029/1999JE001054; SCHENK PM, 1996, B AM ASTRON SOC, V28, P1074; Shoemaker E.M., 1982, SATELLITES JUPITER, P435; Showman AP, 1997, ICARUS, V127, P93, DOI 10.1006/icar.1996.5669; Showman AP, 1997, ICARUS, V129, P367, DOI 10.1006/icar.1997.5778; Squyres S. W., 1986, SATELLITES, P293; Zahnle K, 1998, ICARUS, V136, P202, DOI 10.1006/icar.1998.6015; [No title captured]	23	66	67	1	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					57	60		10.1038/35065027	http://dx.doi.org/10.1038/35065027			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242037				2022-12-28	WOS:000167194300038
J	Despres, JP; Lemieux, I; Prud'homme, D				Despres, JP; Lemieux, I; Prud'homme, D			Treatment of obesity: need to focus on high risk abdominally obese patients	BMJ-BRITISH MEDICAL JOURNAL			English	Review							VISCERAL ADIPOSE-TISSUE; WAIST CIRCUMFERENCE; BODY-FAT; CARDIOVASCULAR RISK; LIPOPROTEIN LEVELS; GLUCOSE-TOLERANCE; PARTICLE-SIZE; HEART-DISEASE; DENSE LDL; MEN		Laval Hosp Res Ctr, Quebec Heart Inst, Ste Foy, PQ G1V 4G5, Canada; CHUQ Res Ctr, Lipid Res Ctr, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Phys Act Sci Lab, Ste Foy, PQ G1K 7P4, Canada	Laval University; Laval University	Despres, JP (corresponding author), Laval Hosp Res Ctr, Quebec Heart Inst, Ste Foy, PQ G1V 4G5, Canada.	despres@crchul.ulaval.ca						BERGSTROM RW, 1990, DIABETES, V39, P104, DOI 10.2337/diabetes.39.1.104; Bray G. A., 1998, HDB OBESITY; CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; HAN TS, 1995, BRIT MED J, V311, P1401, DOI 10.1136/bmj.311.7017.1401; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; KISSEBAH AH, 1989, MED CLIN N AM, V73, P111, DOI 10.1016/S0025-7125(16)30695-2; Lamarche B, 1998, JAMA-J AM MED ASSOC, V279, P1955, DOI 10.1001/jama.279.24.1955; Lean MEJ, 1998, LANCET, V351, P853, DOI 10.1016/S0140-6736(97)10004-6; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Lemieux S, 1996, DIABETES CARE, V19, P983, DOI 10.2337/diacare.19.9.983; Lemieux S, 1996, AM J CLIN NUTR, V64, P685, DOI 10.1093/ajcn/64.5.685; Lemieux S, 1996, INT J OBESITY, V20, P618; MCNAMARA JR, 1992, ARTERIOSCLER THROMB, V12, P1284, DOI 10.1161/01.ATV.12.11.1284; *NAT HEART LUNG BL, 1998, CLIN GUID ID EV TREA, P1; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; POULIOT MC, 1992, DIABETES, V41, P826, DOI 10.2337/diabetes.41.7.826; POULIOT MC, 1990, INT J OBESITY, V14, P293; PYORALA K, 1987, Diabetes Metabolism Reviews, V3, P463; Sjostrom L, 1998, LANCET, V352, P167, DOI 10.1016/S0140-6736(97)11509-4; Tchernof A, 1996, DIABETES CARE, V19, P629, DOI 10.2337/diacare.19.6.629; TERRY RB, 1991, METABOLISM, V40, P733, DOI 10.1016/0026-0495(91)90093-C; VAGUE J, 1947, PRESSE MED, V55, P339; Williamson DF, 1999, JAMA-J AM MED ASSOC, V281, P278, DOI 10.1001/jama.281.3.278; World Health Organization, 1997, WORLD HLTH REP 1996, P1	26	513	538	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2001	322	7288					716	720		10.1136/bmj.322.7288.716	http://dx.doi.org/10.1136/bmj.322.7288.716			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416GB	11264213	Green Published			2022-12-28	WOS:000167771000028
J	Hicks, LK; Lin, Y; Robertson, DW; Robinson, DL; Woodrow, SI				Hicks, LK; Lin, Y; Robertson, DW; Robinson, DL; Woodrow, SI			Understanding the clinical dilemmas that shape medical students' ethical development: questionnaire survey and focus group study	BRITISH MEDICAL JOURNAL			English	Article							EDUCATION		Univ Toronto, Fac Med, Toronto, ON M5S 1A8, Canada; Univ Western Ontario, Fac Med, London, ON N6A 5B8, Canada	University of Toronto; Western University (University of Western Ontario)	Robertson, DW (corresponding author), 8 Clarence Sq, Toronto, ON M5V 1H1, Canada.			Hicks, Lisa/0000-0003-1858-7420				BISONETTE R, 1995, ACAD MED, V70, P1035; FEUDTNER C, 1994, ACAD MED, V69, P670, DOI 10.1097/00001888-199408000-00017; HAFFERTY FW, 1994, ACAD MED, V69, P861, DOI 10.1097/00001888-199411000-00001; StOnge J, 1997, CAN MED ASSOC J, V156, P1175; Swenson SL, 1996, ACAD MED, V71, P591, DOI 10.1097/00001888-199606000-00009	5	119	127	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 24	2001	322	7288					709	710		10.1136/bmj.322.7288.709	http://dx.doi.org/10.1136/bmj.322.7288.709			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416GB	11264209	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000167771000025
J	Liu, LM; Hausladen, A; Zeng, M; Que, L; Heitman, J; Stamler, JS				Liu, LM; Hausladen, A; Zeng, M; Que, L; Heitman, J; Stamler, JS			A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans	NATURE			English	Article							DEPENDENT FORMALDEHYDE DEHYDROGENASE; III ALCOHOL-DEHYDROGENASE; NITRIC-OXIDE; NITROSATIVE STRESS; GLUTATHIONE; NITROSOGLUTATHIONE; PROTEIN; FLAVOHEMOGLOBIN; QUANTIFICATION; IDENTIFICATION	Considerable evidence indicates that NO biology involves a family of NO-related molecules and that S-nitrosothiols (SNOs) are central to signal transduction and host defence(1-5). It is unknown, however, how cells switch off the signals or protect themselves from the SNOs produced for defence purposes. Here we have purified a single activity from Escherichia coli, Saccharomyces cerevisiae and mouse macrophages that metabolizes S-nitrosoglutathione (GSNO), and show that it is the glutathione-dependent formaldehyde dehydrogenase. Although the enzyme is highly specific for GSNO, it controls intracellular levels of both GSNO and S-nitrosylated proteins. Such 'GSNO reductase' activity is widely distributed in mammals. Deleting the reductase gene in yeast and mice abolishes the GSNO-consuming activity, and increases the cellular quantity of both GSNO and protein SNO. Furthermore, mutant yeast cells show increased susceptibility to a nitrosative challenge, whereas their resistance to oxidative stress is unimpaired. We conclude that GSNO reductase is evolutionarily conserved from bacteria to humans, is critical for SNO homeostasis, and protects against nitrosative stress.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Div Pulm, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Genet, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University; Duke University	Stamler, JS (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.		Heitman, Joseph/ABC-6006-2021	Stamler, Jonathan/0000-0002-6866-1572				Akaike T, 1997, J BIOCHEM-TOKYO, V122, P459; ASKEW SC, 1995, J CHEM SOC PERK T 2, P741, DOI 10.1039/p29950000741; Barber RD, 1998, BIOCHEMISTRY-US, V37, P530, DOI 10.1021/bi971463t; DeGroote MA, 1996, SCIENCE, V272, P414, DOI 10.1126/science.272.5260.414; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; Glover RE, 1999, NITRIC OXIDE-BIOL CH, V3, P439, DOI 10.1006/niox.1999.0256; GUTHEIL WG, 1992, BIOCHEMISTRY-US, V31, P475, DOI 10.1021/bi00117a025; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Hogg N, 1997, BIOCHEM J, V323, P477, DOI 10.1042/bj3230477; Hou YC, 1996, BIOCHEM BIOPH RES CO, V228, P88, DOI 10.1006/bbrc.1996.1620; Jensen DE, 1998, BIOCHEM J, V331, P659, DOI 10.1042/bj3310659; Kluge I, 1997, J NEUROCHEM, V69, P2599; KUWADA M, 1980, J BIOCHEM-TOKYO, V88, P859, DOI 10.1093/oxfordjournals.jbchem.a133040; Liu LM, 2000, P NATL ACAD SCI USA, V97, P4672, DOI 10.1073/pnas.090083597; Liu LM, 1999, P NATL ACAD SCI USA, V96, P6643, DOI 10.1073/pnas.96.12.6643; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Mayer B, 1998, J BIOL CHEM, V273, P3264, DOI 10.1074/jbc.273.6.3264; Minning DM, 1999, NATURE, V401, P497, DOI 10.1038/46822; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; RAS J, 1995, J BACTERIOL, V177, P247, DOI 10.1128/jb.177.1.247-251.1995; RIBEIRO JMC, 1993, SCIENCE, V260, P539, DOI 10.1126/science.8386393; Scorza G, 1997, FREE RADICAL BIO MED, V22, P633, DOI 10.1016/S0891-5849(96)00378-4; Shafqat J, 1996, P NATL ACAD SCI USA, V93, P5595, DOI 10.1073/pnas.93.11.5595; Shen SG, 1998, GENE, V216, P93, DOI 10.1016/S0378-1119(98)00315-1; Singh SP, 1996, P NATL ACAD SCI USA, V93, P14428, DOI 10.1073/pnas.93.25.14428; Trujillo M, 1998, J BIOL CHEM, V273, P7828, DOI 10.1074/jbc.273.14.7828; Uotila L., 1989, COENZYMES COFACTOR A, P517; WEHNER EP, 1993, MOL GEN GENET, V237, P351, DOI 10.1007/BF00279438	30	710	753	2	64	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					490	494		10.1038/35068596	http://dx.doi.org/10.1038/35068596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260719				2022-12-28	WOS:000167583800047
J	Solomon, SD; Glynn, RJ; Greaves, S; Ajani, U; Rouleau, JL; Menapace, F; Arnold, JMO; Hennekens, C; Pfeffer, MA				Solomon, SD; Glynn, RJ; Greaves, S; Ajani, U; Rouleau, JL; Menapace, F; Arnold, JMO; Hennekens, C; Pfeffer, MA			Recovery of ventricular function after myocardial infarction in the reperfusion era: The healing and early afterload reducing therapy study	ANNALS OF INTERNAL MEDICINE			English	Article							CONVERTING-ENZYME-INHIBITION; CORONARY-ARTERY REPERFUSION; CREATINE-KINASE; SIZE; DETERMINANT; DYSFUNCTION; PREDICTORS; PROGNOSIS; CAPTOPRIL; SURVIVAL	Background: Patients with reduced left ventricular function and ventricular enlargement after myocardial infarction are at significantly greater risk for congestive heart failure and death. Nevertheless, recovery of ventricular function occurs in a significant proportion of patients after myocardial infarction, and modern reperfusion strategies have been associated with increased recovery of function. Objective: To determine the extent and predictors of recovery of ventricular function after anterior Q-wave myocardial infarction in the reperfusion era. Design: subgroup analysis of the Healing and Early Afterload Reducing Therapy study. Setting: 35 medical centers in the United States and Canada. Patients: 352 patients with Q-wave anterior myocardial infarction. Intervention: Placebo for 14 days, followed by full-dose (10 mg) ramipril until day 90; low-dose (0.625 mg) ramipril for 90 days; or full-dose ramipril for 90 days. All patients underwent reperfusion therapy. Measurements: Echocardiography was performed on day 1 (before randomization), day 14, and day 90 after myocardial infarction. Left ventricular volume and ejection fraction were measured and wall-motion analyses were performed at all three time points in 249 patients and at baseline in an additional 12 patients who died during follow-up. Echocardiographic and nonechocardiographic predictors of ventricular recovery were examined. Results: By day 90, 55 of 252 (22%) patients who had abnormal ejection fraction and wall-motion abnormalities on day 1 demonstrated complete recovery of function (ejection fraction in the normal range and infarct segment length of 0%), and an additional 36% (91 of 252 patients) demonstrated partial recovery of function. At 90 days, 53% (132 of 249) of patients had greater than 5% improvement in ejection fraction, whereas only 16% (39 of 249) had a decrease in ejection fraction of more than 5%. The majority of functional improvement occurred by day 14 after infarction. Of various clinical and echocardiographic measures obtained on day 1, peak creatine kinase level was the strongest independent predictor of subsequent recovery of ventricular function in multivariate analysis. Each 100-unit increase in peak creatine kinase was associated with a 4.3% decreased odds of recovery (P < 0.001) after adjustment for ejection fraction on day 1, extent of akinesis or dyskinesis, treatment regimen, Killip class, age, and sex. Conclusion: Significant myocardial stunning with subsequent improvement of ventricular function occurred in the majority of patients after Q-wave anterior myocardial infarction. A lower peak level of creatine kinase, an estimate of the extent of necrosis, is independently predictive of recovery of function. Early functional assessment (day 1 after acute myocardial infarction) had limited ability to predict recovery of ventricular function.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA; Toronto Gen Hosp, Toronto, ON, Canada; London Sci Ctr, London, England; Geisinger Med Clin, Danville, PA USA; Green Lane Hosp, Auckland 3, New Zealand; Univ Miami, Boca Raton, FL USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Geisinger Medical Center	Solomon, SD (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	ssolomon@rics.bwh.harvard.edu	Arnold, Malcolm/G-2869-2011; Solomon, Scott/I-5789-2013					BLANKE H, 1984, J AM COLL CARDIOL, V3, P675, DOI 10.1016/S0735-1097(84)80242-9; BOLLI R, 1992, CIRCULATION, V86, P1671, DOI 10.1161/01.CIR.86.6.1671; CHRISTIAN TF, 1990, J AM COLL CARDIOL, V16, P1632, DOI 10.1016/0735-1097(90)90313-E; Dissmann R, 1998, AM HEART J, V135, P1, DOI 10.1016/S0002-8703(98)70335-7; FIORETTI P, 1985, EUR HEART J, V6, P473, DOI 10.1093/oxfordjournals.eurheartj.a061892; GAUDRON P, 1993, CIRCULATION, V87, P755, DOI 10.1161/01.CIR.87.3.755; ITO H, 1993, CIRCULATION, V87, P355, DOI 10.1161/01.CIR.87.2.355; Kadowaki K, 1992, Kokyu To Junkan, V40, P59; MARINO P, 1992, AM HEART J, V123, P1157, DOI 10.1016/0002-8703(92)91016-T; MOSS AJ, 1983, NEW ENGL J MED, V309, P331, DOI 10.1056/nejm198308113090602; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; PFEFFER MA, 1988, NEW ENGL J MED, V319, P80, DOI 10.1056/NEJM198807143190204; Pfeffer MA, 1997, CIRCULATION, V95, P2643, DOI 10.1161/01.CIR.95.12.2643; ROBERTS R, 1983, CIRCULATION, V68, P83; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; RYAN W, 1981, AM HEART J, V101, P162, DOI 10.1016/0002-8703(81)90660-8; SANZ G, 1982, NEW ENGL J MED, V306, P1065, DOI 10.1056/NEJM198205063061801; SCHOFER J, 1993, EUR HEART J, V14, P958, DOI 10.1093/eurheartj/14.7.958; SERRUYS PW, 1986, J AM COLL CARDIOL, V7, P729, DOI 10.1016/S0735-1097(86)80330-8; SHARPE N, 1991, LANCET, V337, P872, DOI 10.1016/0140-6736(91)90202-Z; SHEEHAN FH, 1988, J AM COLL CARDIOL, V12, P289, DOI 10.1016/0735-1097(88)90397-X; SHELL WE, 1973, J CLIN INVEST, V52, P2579, DOI 10.1172/JCI107450; SUTTON MS, 1994, CIRCULATION, V89, P68, DOI 10.1161/01.CIR.89.1.68; TAMAKI S, 1983, J AM COLL CARDIOL, V2, P1031, DOI 10.1016/S0735-1097(83)80326-X; VATNER SF, 1978, J CLIN INVEST, V61, P1048, DOI 10.1172/JCI109004; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44	26	160	171	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					451	458		10.7326/0003-4819-134-6-200103200-00009	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409VF	11255520				2022-12-28	WOS:000167405800003
J	Kagawa, T; Sakai, T; Suetsugu, N; Oikawa, K; Ishiguro, S; Kato, T; Tabata, S; Okada, K; Wada, M				Kagawa, T; Sakai, T; Suetsugu, N; Oikawa, K; Ishiguro, S; Kato, T; Tabata, S; Okada, K; Wada, M			Arabidopsis NPL1: A phototropin homolog controlling the chloroplast high-light avoidance response	SCIENCE			English	Article							BLUE-LIGHT; PROTEIN-KINASE; NPH1; ADIANTUM	Chloroplasts relocate their positions in a cell in response to the intensity of incident Light, moving to the side wall of the cell to avoid strong Light, but gathering at the front face under weak Light to maximize Light interception. Here, Arabidopsis thaliana mutants defective in the avoidance response were isolated, and the mutated gene was identified as NPL1 (NPH-Like 1), a homolog of NPH1 (nonphototropic hypocotyl 1), a blue Light receptor used in phototropism. Hence, NPL1 is Likely a blue Light receptor regulating the avoidance response under strong light.	Natl Inst Basic Biol, Div Biol Regulat & Photobiol, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Corp, PRESTO, Unit Proc & Combined Circuit, Kawaguchi, Saitama 3320012, Japan; RIKEN, Plant Sci Ctr, Kyoto 6068502, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan; Kazusa DNA Res Inst, Chiba 2920812, Japan; Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST); RIKEN; Tokyo Metropolitan University; Kazusa DNA Research Institute; Kyoto University	Wada, M (corresponding author), Natl Inst Basic Biol, Div Biol Regulat & Photobiol, Okazaki, Aichi 4448585, Japan.	wada-masamitsu@c.metro-u.ac.jp	Sakai, Tatsuya/A-8909-2010; Ishiguro, Sumie/AAH-2592-2019; Suetsugu, Noriyuki/AAB-5274-2019; ISHIGURO, Sumie/I-6903-2014	Sakai, Tatsuya/0000-0002-1589-6247; Ishiguro, Sumie/0000-0002-6160-7434; Suetsugu, Noriyuki/0000-0002-3328-3313; Oikawa, Kazusato/0000-0002-1033-9089				Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Casal JJ, 2000, PHOTOCHEM PHOTOBIOL, V71, P1, DOI 10.1562/0031-8655(2000)071&lt;0001:PCPPII&gt;2.0.CO;2; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HAUPT W, 1959, PLANTA, V53, P484, DOI 10.1007/BF01900644; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; JARILLO JA, 2000, PLANT PHYSIOL, V117, P719; Kagawa T, 2000, PLANT CELL PHYSIOL, V41, P84, DOI 10.1093/pcp/41.1.84; KASAHARA M, COMMUNICATION; Motchoulski A, 1999, SCIENCE, V286, P961, DOI 10.1126/science.286.5441.961; Nozue K, 1998, P NATL ACAD SCI USA, V95, P15826, DOI 10.1073/pnas.95.26.15826; Sakai T, 2000, PLANT CELL, V12, P225, DOI 10.1105/tpc.12.2.225; Sakai T., UNPUB; SENN G, 1908, GESTALTS LAGEVERANDR; YATSUHASHI H, 1985, PLANTA, V165, P43, DOI 10.1007/BF00392210; Zurzycki J., 1980, The blue light syndrome [Senger, H. (Editor)]., P50	16	508	549	3	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2001	291	5511					2138	2141		10.1126/science.291.5511.2138	http://dx.doi.org/10.1126/science.291.5511.2138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251116				2022-12-28	WOS:000167563800036
J	van Weel, C				van Weel, C			Examination of context of medicine	LANCET			English	Editorial Material							BREAST-CANCER		Univ Med Ctr St Radboud, Dept Gen Practice, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	van Weel, C (corresponding author), Univ Med Ctr St Radboud, Dept Gen Practice, NL-6500 HB Nijmegen, Netherlands.		van Weel, Chris/D-4375-2009	van Weel, Chris/0000-0003-3653-4701				FREDRIKSON M, 1993, BRAIN BEHAV IMMUN, V7, P79, DOI 10.1006/brbi.1993.1008; FREEMAN GK, 1984, FAM PRACT, V1, P124; HJORTDAHL P, 1992, FAM PRACT, V9, P3, DOI 10.1093/fampra/9.1.3; Kirsch I., 1997, PLACEBO EFFECT INTER; PETTINGALE KW, 1981, J PSYCHOSOM RES, V25, P453, DOI 10.1016/0022-3999(81)90071-4; PINKUS T, 1997, J MIND BODY HLTH, V13, P3; Starfield B, 1994, LANCET, V344, P129; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; van Weel C, 1999, LANCET, V353, P916, DOI 10.1016/S0140-6736(98)08024-6; van Weel C, 2000, J FAM PRACTICE, V49, P938; VANDULMEN AM, 2000, CONTEXTWERKING GENEE; vanWeel C, 1996, LANCET, V348, P1431, DOI 10.1016/S0140-6736(96)08116-0	12	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					733	734		10.1016/S0140-6736(00)04176-3	http://dx.doi.org/10.1016/S0140-6736(00)04176-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253959				2022-12-28	WOS:000167400900003
J	Ward, JPT; Gordon, J; Field, MJ; Lehmann, HP				Ward, JPT; Gordon, J; Field, MJ; Lehmann, HP			Communication and information technology in medical education	LANCET			English	Article							WORLD-WIDE-WEB; VIRTUAL-REALITY; STUDENTS; HEALTH	The past few years have seen rapid advances in communication and information technology (C&IT), and the pervasion of the worldwide web into everyday life has important implications for education. Most medical schools provide extensive computer networks for their students, and these are increasingly becoming a central component of the learning and teaching environment. Such advances bring new opportunities and challenges to medical education, and are having an impact on the way that we teach and on the way that students learn, and on the very design and delivery of the curriculum. The plethora of information available on the web is overwhelming, and both students and staff need to be taught how to manage it effectively. Medical schools must develop clear strategies to address the Issues raised by these technologies. We describe how medical schools are rising to this challenge, look at some of the ways in which communication and information technology can be used to enhance the learning and teaching environment, and discuss the potential impact of future developments on medical education.	Guys Hosp, Dept Resp Med & Allergy, London SE1 9RT, England; Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Guy's & St Thomas' NHS Foundation Trust; University of Sydney; Johns Hopkins University	Ward, JPT (corresponding author), Guys Hosp, Dept Resp Med & Allergy, 5th Floor,Thomas Guy House, London SE1 9RT, England.	jeremy.ward@kcl.ac.uk	Tao, Youyou/D-2367-2014; Ward, Jeremy PT/E-4704-2010	Ward, Jeremy PT/0000-0001-7037-4268; Field, Michael/0000-0003-1310-5074; Lehmann, Harold/0000-0002-7698-219X				Barnes S Z, 1997, Biomed Sci Instrum, V33, P19; Carlile S, 1998, MED J AUSTRALIA, V168, P340, DOI 10.5694/j.1326-5377.1998.tb138963.x; CRILEY JM, 2000, PHYSL ORIGINS HEART; Devitt P, 1998, AUST NZ J SURG, V68, P284, DOI 10.1111/j.1445-2197.1998.tb02084.x; Fresnel A, 1998, MED INFORM, V23, P253, DOI 10.3109/14639239809001406; Friedman CP, 1999, ACAD MED, V74, P130; Friedman RB, 1996, ACAD MED, V71, P979, DOI 10.1097/00001888-199609000-00013; Gallagher AG, 1999, ENDOSCOPY, V31, P310; Hagdrup NA, 1999, MED EDUC, V33, P537, DOI 10.1046/j.1365-2923.1999.00350.x; HANCOCK L, 1996, PHYSICIANS GUIDE INT; HERRINGTON J, 1999, AECT NAT CONV HOUST; Hoffman H, 1997, ACAD MED, V72, P1076, DOI 10.1097/00001888-199712000-00018; KEAR K, 1999, SEFT DOCUMENT, V23, P145; Kreiter CD, 1999, ACAD MED, V74, P1125, DOI 10.1097/00001888-199910000-00016; Land SM, 2000, THEORETICAL FOUNDATIONS OF LEARNING ENVIRONMENTS, P1; Lee J., 1999, ACTIVE LEARNING, V10, P4; LEHMANN HP, 1998, MED INFORMATICS ED T; McGee JB, 1998, ST HEAL T, V52, P732; MYERS H, 2000, CLIN COMPETENCY EXAM; ORSINIJONES M, 1999, ACTIVE LEARNING, V10, P32; PETERSON NS, 2000, LIFE SCI ED COMP, V11, P12; Prystowsky JB, 1999, AM J SURG, V177, P171, DOI 10.1016/S0002-9610(98)00328-6; Pychyl TA, 1999, TEACH PSYCHOL, V26, P138, DOI 10.1207/s15328023top2602_16; Ryan M, 2000, BRIT J BIOMED SCI, V57, P28; Sackett D. L., 1997, EVIDENCE BASED MED P; Turchin A, 1999, J AM MED INFORM ASSN, P627; van Bemmel JH, 1999, M D COMPUT, V16, P21; WAUGH RA, 1995, ARCH INTERN MED, V155, P197, DOI 10.1001/archinte.155.2.197; YOLTON RL, 2000, J AM OPTOM ASSOC, V71, P20	29	164	173	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2001	357	9258					792	796		10.1016/S0140-6736(00)04173-8	http://dx.doi.org/10.1016/S0140-6736(00)04173-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253986				2022-12-28	WOS:000167400900041
J	Chang, LF; Karin, M				Chang, LF; Karin, M			Mammalian MAP kinase signalling cascades	NATURE			English	Article							CD4(+) T-CELLS; C-JUN; INDUCED APOPTOSIS; PROTEIN-KINASES; LYMPHOCYTE DEVELOPMENT; ACTIVATION; JNK; ERK; DIFFERENTIATION; TRANSCRIPTION	Mitogen-activated protein kinases (MAPKs) are important signal transducing enzymes, unique to eukaryotes, that are involved in many facets of cellular regulation. Initial research concentrated on defining the components and organization of MAPK signalling cascades, but recent studies have begun to shed light on the physiological functions of these cascades in the control of gene expression, cell proliferation and programmed cell death.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.							Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Chen CY, 2000, GENE DEV, V14, P1236; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Ganiatsas S, 1998, P NATL ACAD SCI USA, V95, P6881, DOI 10.1073/pnas.95.12.6881; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Graves LM, 2000, NATURE, V403, P328, DOI 10.1038/35002111; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; GUTKIND SJ, 2000, REGULATION MITOGEN A; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Nishina H, 1997, J EXP MED, V186, P941, DOI 10.1084/jem.186.6.941; Paget WJ, 1999, SOZ PRAVENTIV MED, V44, P1, DOI 10.1007/BF01624804; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Swat W, 1998, IMMUNITY, V8, P625, DOI 10.1016/S1074-7613(00)80567-1; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Treinies I, 1999, MOL CELL BIOL, V19, P321; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; WINZEN R, 1999, EMBO J, V19, P6742; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu X, 1997, P NATL ACAD SCI USA, V94, P12655, DOI 10.1073/pnas.94.23.12655; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911	52	4141	4376	25	520	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					37	40		10.1038/35065000	http://dx.doi.org/10.1038/35065000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242034				2022-12-28	WOS:000167194300035
J	Rowland-Jones, S; Pinheiro, S; Kaul, R				Rowland-Jones, S; Pinheiro, S; Kaul, R			New insights into host factors in HIV-1 pathogenesis	CELL			English	Review							T-LYMPHOCYTES; INFECTION; POLYMORPHISM; CD8(+); PROGRESSION; AIDS; HLA		John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, Oxford OX3 9DS, England	University of Oxford	Rowland-Jones, S (corresponding author), John Radcliffe Hosp, Inst Mol Med, Human Immunol Unit, Oxford OX3 9DS, England.	sarah.rowland-jones@ndm.ox.ac.uk		Kaul, Rupert/0000-0002-1586-4093				Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; D'Souza MP, 2000, JAMA-J AM MED ASSOC, V284, P215, DOI 10.1001/jama.284.2.215; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Hellerstein M, 1999, NAT MED, V5, P83, DOI 10.1038/4772; John GC, 2000, J VIROL, V74, P5736, DOI 10.1128/JVI.74.12.5736-5739.2000; Lin CL, 2000, J EXP MED, V192, P587, DOI 10.1084/jem.192.4.587; Liu HL, 1999, P NATL ACAD SCI USA, V96, P4581, DOI 10.1073/pnas.96.8.4581; MacDonald KS, 2000, J INFECT DIS, V181, P1581, DOI 10.1086/315472; Malim MH, 2001, CELL, V104, P469, DOI 10.1016/S0092-8674(01)00234-3; McDermott DH, 2000, AIDS, V14, P2671, DOI 10.1097/00002030-200012010-00006; MONTANER LJ, 2000, MOD TRENDS IMMUNOL, V22, P92; O'Brien SJ, 2000, IMMUNOL REV, V177, P99, DOI 10.1034/j.1600-065X.2000.17710.x; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467	20	48	49	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2001	104	4					473	476		10.1016/S0092-8674(01)00235-5	http://dx.doi.org/10.1016/S0092-8674(01)00235-5			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	405VP	11239405	Bronze			2022-12-28	WOS:000167181500003
J	Sun, Y; Nadal-Vicens, M; Misono, S; Lin, MZ; Zubiaga, A; Hua, XX; Fan, GP; Greenberg, ME				Sun, Y; Nadal-Vicens, M; Misono, S; Lin, MZ; Zubiaga, A; Hua, XX; Fan, GP; Greenberg, ME			Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; HELIX TRANSCRIPTION FACTORS; MAMMALIAN ACHAETE-SCUTE; ZONE PROGENITOR CELLS; CREST STEM-CELLS; NEURONAL DIFFERENTIATION; DETERMINATION GENES; FATE DETERMINATION; VENTRICULAR ZONE; CEREBRAL-CORTEX	The mechanisms by which neural stem cells give rise to neurons, astrocytes, or oligodendrocytes are beginning to be elucidated. However, it is not known how the specification of one cell lineage results in the suppression of alternative fates. We find that in addition to inducing neurogenesis, the bHLH transcription factor neurogenin (Ngn1) inhibits the differentiation of neural stem cells into astrocytes. While Ngn1 promotes neurogenesis by functioning as a transcriptional activator, Ngn1 inhibits astrocyte differentiation by sequestering the CBP-Smad1 transcription complex away from astrocyte differentiation genes, and by inhibiting the activation of STAT transcription factors that are necessary for gliogenesis. Thus, two distinct mechanisms are involved in the activation and suppression of gene expression during cell-fate specification by neurogenin.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Univ Basque Country, Fac Ciencias, Dept Genet, E-48080 Bilbao, Spain; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Basque Country; Massachusetts Institute of Technology (MIT); Whitehead Institute	Greenberg, ME (corresponding author), Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	greenberg@a1.tch.harvard.edu	Albertini, David/AAD-3856-2021; zubiaga, ana/S-3457-2019	Albertini, David/0000-0001-6536-2828; zubiaga, ana/0000-0002-2132-9708; Misono, Stephanie/0000-0001-9000-6323; Fan, Guoping/0000-0001-5235-6410; Lin, Michael/0000-0002-0492-1961	NCI NIH HHS [R01 CA43855] Funding Source: Medline; NICHD NIH HHS [NIHP30-HD18655] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA043855] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON DJ, 1993, J NEUROBIOL, V24, P185, DOI 10.1002/neu.480240206; Bayer S.A., 1991, NEOCORTICAL DEV; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; BONNI A, 1993, SCIENCE, V262, P1575, DOI 10.1126/science.7504325; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Cau E, 1997, DEVELOPMENT, V124, P1611; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 2000, GENE DEV, V14, P67; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Goodman RH, 2000, GENE DEV, V14, P1553; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kageyama R, 1997, INT J BIOCHEM CELL B, V29, P1389, DOI 10.1016/S1357-2725(97)89968-2; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Koyano-Nakagawa N, 1999, MOL CELL NEUROSCI, V14, P327, DOI 10.1006/mcne.1999.0783; LEHMING N, 1994, NATURE, V371, P175, DOI 10.1038/371175a0; Li WW, 1998, J NEUROSCI, V18, P8853; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Ma QF, 1997, J NEUROSCI, V17, P3644; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; NIETO M, 2001, IN PRESS NEURON, V29; Park JK, 1999, J NEUROSCI, V19, P10383; PEYTON M, 1994, J BIOL CHEM, V269, P25936; PRICE J, 1988, DEVELOPMENT, V104, P473; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rajan P, 1998, J NEUROSCI, V18, P3620; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; STAHL N, 1994, J NEUROBIOL, V25, P1454, DOI 10.1002/neu.480251111; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	51	618	663	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 9	2001	104	3					365	376		10.1016/S0092-8674(01)00224-0	http://dx.doi.org/10.1016/S0092-8674(01)00224-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239394	Bronze			2022-12-28	WOS:000167003100007
J	Glick, SN				Glick, SN			Cost-effectiveness of colorectal cancer screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Med Coll Penn & Hahnemann Univ, Dept Radiol, Philadelphia, PA USA	Drexel University	Glick, SN (corresponding author), Med Coll Penn & Hahnemann Univ, Dept Radiol, Philadelphia, PA USA.							Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; Glick S, 2000, AM J ROENTGENOL, V174, P1529, DOI 10.2214/ajr.174.6.1741529; Glick S, 1998, AM J ROENTGENOL, V170, P629, DOI 10.2214/ajr.170.3.9490943; Wagner JL, 1996, PREVENTION EARLY DET, P321	4	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2001	285	4					407	408						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394CG	11242413				2022-12-28	WOS:000166506000016
J	Buck, M; Rosen, MK				Buck, M; Rosen, MK			Structural biology - Flipping a switch	SCIENCE			English	Editorial Material							DYNAMICS; DOMAIN; NMR		Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Buck, M (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 1275 York Ave, New York, NY 10021 USA.		Buck, Matthias/B-2106-2017	Buck, Matthias/0000-0002-2958-0403				Cannon WR, 1996, NAT STRUCT BIOL, V3, P821, DOI 10.1038/nsb1096-821; DOBSON CM, 1993, CURR BIOL, V3, P530, DOI 10.1016/0960-9822(93)90049-T; Feher VA, 1999, NATURE, V400, P289, DOI 10.1038/22357; Hajdu J, 2000, NAT STRUCT BIOL, V7, P1006, DOI 10.1038/80911; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; Malmendal A, 1999, J MOL BIOL, V293, P883, DOI 10.1006/jmbi.1999.3188; MOY FJ, 1994, BIOCHEMISTRY-US, V33, P10731, DOI 10.1021/bi00201a022; Nohaile M, 1997, J MOL BIOL, V273, P299, DOI 10.1006/jmbi.1997.1296; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; Rao JH, 1998, SCIENCE, V280, P708, DOI 10.1126/science.280.5364.708; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	13	12	14	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2329	2330		10.1126/science.1060383	http://dx.doi.org/10.1126/science.1060383			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11269305				2022-12-28	WOS:000167618700031
J	Margulies, L; Winther, G; Poulsen, HF				Margulies, L; Winther, G; Poulsen, HF			In situ measurement of grain rotation during deformation of polycrystals	SCIENCE			English	Article								Texture evolution governs many of the physical, chemical, and mechanical properties of polycrystalline materials, but texture models have only been tested on the macroscopic Level, which makes it hard to distinguish between approaches that are conceptually very different. Here, we present a universal method for providing data on the underlying structural dynamics at the grain and subgrain Level. The method is based on diffraction with focused hard x-rays, First results relate to the tensile deformation of pure aluminum. Experimental grain rotations are inconsistent with the classical Taylor and Sachs models.	Riso Natl Lab, Mat Res Dept, DK-4000 Roskilde, Denmark; European Synchrotron Radiat Facil, F-38043 Grenoble, France	Technical University of Denmark; European Synchrotron Radiation Facility (ESRF)	Poulsen, HF (corresponding author), Riso Natl Lab, Mat Res Dept, DK-4000 Roskilde, Denmark.		Winther, Grethe/D-5146-2014; Poulsen, Henning F/A-4131-2012	Winther, Grethe/0000-0002-4178-3449; Poulsen, Henning F/0000-0001-7876-4113				Barrett CS, 1940, T AM I MIN MET ENG, V137, P112; HANSEN N, 1977, ACTA METALL MATER, V25, P863, DOI 10.1016/0001-6160(77)90171-7; Huang X., COMMUNICATION; HUTCHINSON JW, 1970, PROC R SOC LON SER-A, V319, P247, DOI 10.1098/rspa.1970.0177; Jensen DJ, 2000, MATER RES SOC SYMP P, V590, P227, DOI 10.1557/PROC-590-227; JENSEN DJ, 2000, P 21 RIS INT S MAT S, P103; Kocks U.F., 1998, TEXTURE ANISOTROPY P; KRONER E, 1961, ACTA METALL MATER, V9, P155, DOI 10.1016/0001-6160(61)90060-8; Nielsen SF, 2000, J SYNCHROTRON RADIAT, V7, P103, DOI 10.1107/S0909049500000625; NIELSEN SF, 2000, P 21 RIS INT S MAT S, P473; PANCHANADEESWARAN S, 1994, MATER SCI FORUM, V157-, P1277, DOI 10.4028/www.scientific.net/MSF.157-162.1277; Poulsen HF, 1997, J SYNCHROTRON RADIAT, V4, P147, DOI 10.1107/S0909049597002021; Sachs G, 1928, Z VER DTSCH ING, V72, P734; Taylor GI, 1938, J I MET, V62, P307	15	296	302	7	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2392	2394		10.1126/science.1057956	http://dx.doi.org/10.1126/science.1057956			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264531				2022-12-28	WOS:000167618700050
J	Masopust, D; Vezys, V; Marzo, AL; Lefrancois, L				Masopust, D; Vezys, V; Marzo, AL; Lefrancois, L			Preferential localization of effector memory cells in nonlymphoid tissue	SCIENCE			English	Article							CD8 T-CELLS; VIRUS-INFECTION; INFLUENZA PNEUMONIA; BACTERIAL-INFECTION; ANTIGEN; LYMPHOCYTES; MICE; VISUALIZATION; MECHANISMS	Many intracellular pathogens infect a broad range of host tissues, but the importance of T cells for immunity in these sites is unclear because most of our understanding of antimicrobial T cell responses comes from analyses of lymphoid tissue. Here, we show that in response to viral or bacterial infection, antigen-specific CD8 T cells migrated to nonlymphoid tissues and were present as Long-Lived memory cells. Strikingly, CD8 memory T cells isolated from nonlymphoid tissues exhibited effector Levels of Lytic activity directly ex vivo, in contrast to their splenic counterparts. These results point to the existence of a population of extralymphoid effector memory T cells poised for immediate response to infection.	Univ Connecticut, Ctr Hlth, Dept Med, Div Immunol, Farmington, CT 06030 USA	University of Connecticut	Lefrancois, L (corresponding author), Univ Connecticut, Ctr Hlth, Dept Med, Div Immunol, Farmington, CT 06030 USA.		masopust, david/B-5027-2008; Vezys, Vaiva/N-3144-2013	Marzo, amanda/0000-0002-5839-0430	NIAID NIH HHS [T32-AI07080, AI41576] Funding Source: Medline; NIDDK NIH HHS [DK45260] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041576, T32AI007080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045260] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Belz GT, 1998, P NATL ACAD SCI USA, V95, P13812, DOI 10.1073/pnas.95.23.13812; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Busch DH, 1998, J EXP MED, V188, P61, DOI 10.1084/jem.188.1.61; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Cho BK, 1999, P NATL ACAD SCI USA, V96, P2976, DOI 10.1073/pnas.96.6.2976; Dobber R, 1992, Dev Immunol, V2, P141, DOI 10.1155/1992/57057; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; Kim SK, 1999, J IMMUNOL, V163, P4125; Kundig TM, 1996, IMMUNOL REV, V150, P63, DOI 10.1111/j.1600-065X.1996.tb00696.x; Kundig TM, 1996, P NATL ACAD SCI USA, V93, P9716, DOI 10.1073/pnas.93.18.9716; Masopust D, 2001, J IMMUNOL, V166, P2348, DOI 10.4049/jimmunol.166.4.2348; Masopust D., UNPUB; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; PUDDINGTON L, 1986, J VIROL, V60, P708, DOI 10.1128/JVI.60.2.708-717.1986; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Selin LK, 1997, J IMMUNOL, V158, P5366; Slifka MK, 1997, BLOOD, V90, P2103, DOI 10.1182/blood.V90.5.2103; Usherwood EJ, 1999, J VIROL, V73, P7278, DOI 10.1128/JVI.73.9.7278-7286.1999; VANBLEEK GM, 1990, NATURE, V348, P213; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; WAGNER RR, 1987, RHABDOVIRUSES; YEWDELL JW, 1986, J EXP MED, V163, P1529, DOI 10.1084/jem.163.6.1529; Zimmermann C, 1996, J EXP MED, V183, P1367, DOI 10.1084/jem.183.4.1367	31	1484	1523	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2413	2417		10.1126/science.1058867	http://dx.doi.org/10.1126/science.1058867			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264538				2022-12-28	WOS:000167618700057
J	Horwitz, ME; Barrett, AJ; Brown, MR; Carter, CS; Childs, R; Gallin, JI; Gress, RE; Holland, SM; Linton, GF; Miller, JA; Leitman, SF; Read, EJ; Schermerhorn, J; Malech, HL				Horwitz, ME; Barrett, AJ; Brown, MR; Carter, CS; Childs, R; Gallin, JI; Gress, RE; Holland, SM; Linton, GF; Miller, JA; Leitman, SF; Read, EJ; Schermerhorn, J; Malech, HL			Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW TRANSPLANTATION; MIXED ALLOGENEIC CHIMERAS; DONOR LYMPHOCYTE INFUSION; VERSUS-HOST DISEASE; FLUDARABINE MONOPHOSPHATE; THALASSEMIC PATIENTS; PULMONARY TOXICITY; SINGLE-CENTER; GRAFT; RECONSTITUTION	Background: The treatment of chronic granulomatous disease with conventional allogeneic hematopoietic stem-cell transplantation carries a high risk of serious complications and death. We investigated the feasibility of stem-cell transplantation without ablation of the recipient's bone marrow. Methods: Ten patients, five children and five adults, with chronic granulomatous disease underwent peripheral-blood stem-cell transplantation from an HLA-identical sibling. We used a nonmyeloablative conditioning regimen consisting of cyclophosphamide, fludarabine, and antithymocyte globulin. The allograft was depleted of T cells to reduce the risk of severe graft-versus-host disease. Donor lymphocytes were administered at intervals of 30 days or more after the transplantation to facilitate engraftment. Results: After a median follow-up of 17 months (range, 8 to 26), the proportion of donor neutrophils in the circulation in 8 of the 10 patients was 33 to 100 percent, a level that can be expected to provide normal host defense; in 6 the proportion was 100 percent. In two patients, graft rejection occurred. Acute graft-versus-host disease (grade II, III, or IV) developed in three of the four adult patients with engraftment, one of whom subsequently had chronic graft-versus-host disease. None of the five children had grade II, III, or IV acute graft-versus-host disease. During the follow-up period, four serious infections occurred among the patients who had engraftment. Three of the 10 recipients died. Preexisting granulomatous lesions resolved in the patients in whom transplantation was successful. Conclusions: Nonmyeloablative conditioning followed by a T-cell-depleted hematopoietic stem-cell allograft is a feasible option for patients with chronic granulomatous disease, recurrent life-threatening infections, and an HLA-identical family donor. (N Engl J Med 2001;344:881-8.) Copyright (C) 2001 Massachusetts Medical Society.	NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; NHLBI, NIH, Bethesda, MD 20892 USA; NIH, Dept Clin Pathol, Bethesda, MD 20892 USA; NIH, Dept Transfus Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA	Horwitz, ME (corresponding author), NIAID, Host Def Lab, NIH, Bldg 10,Room 11N117,MC 1886, Bethesda, MD 20892 USA.			Malech, Harry/0000-0001-5874-5775	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL002342, ZIAHL002342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000615, Z01AI000615] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aker M, 1998, J PEDIAT HEMATOL ONC, V20, P145, DOI 10.1097/00043426-199803000-00011; Akioka S, 1998, BONE MARROW TRANSPL, V22, P609, DOI 10.1038/sj.bmt.1701394; Andreani M, 2000, BONE MARROW TRANSPL, V25, P401, DOI 10.1038/sj.bmt.1702151; Barrett AJ, 1998, BONE MARROW TRANSPL, V21, P543, DOI 10.1038/sj.bmt.1701131; Calvino MC, 1996, EUR J PEDIATR, V155, P877; Childs R, 1999, BLOOD, V94, P3234, DOI 10.1182/blood.V94.9.3234.421k16_3234_3241; Childs R, 2000, NEW ENGL J MED, V343, P750, DOI 10.1056/NEJM200009143431101; DIBARTOLOMEO P, 1989, BONE MARROW TRANSPL, V4, P695; EISNER MD, 1995, BONE MARROW TRANSPL, V15, P663; EZEKOWITZ RAB, 1991, NEW ENGL J MED, V324, P509, DOI 10.1056/NEJM199102213240801; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; HADDAD E, 1995, BLOOD, V85, P3328, DOI 10.1182/blood.V85.11.3328.bloodjournal85113328; HILL RS, 1986, BLOOD, V67, P811; Ho CML, 1996, BONE MARROW TRANSPL, V18, P213; HURST PG, 1987, INVEST NEW DRUG, V5, P207; ILDSTAD ST, 1986, J IMMUNOL, V136, P28; ILDSTAD ST, 1985, J EXP MED, V162, P231, DOI 10.1084/jem.162.1.231; KAMANI N, 1988, J PEDIATR-US, V113, P697, DOI 10.1016/S0022-3476(88)80382-2; KAMANI N, 1984, J PEDIATR-US, V105, P42, DOI 10.1016/S0022-3476(84)80354-6; KANE GC, 1992, RESP MED, V86, P261, DOI 10.1016/S0954-6111(06)80066-1; KEEVER CA, 1989, BLOOD, V73, P1340; Khouri IF, 1998, J CLIN ONCOL, V16, P2817, DOI 10.1200/JCO.1998.16.8.2817; KLEIN C, 1995, BLOOD, V85, P580; KLEMPNER MS, 1998, INFECT DIS, P41; LUCARELLI G, 1990, NEW ENGL J MED, V322, P417, DOI 10.1056/NEJM199002153220701; Lucarelli G, 1999, BLOOD, V93, P1164, DOI 10.1182/blood.V93.4.1164.404k18_1164_1167; MARANINCHI D, 1987, LANCET, V2, P175; MARGOLIS DM, 1990, J INFECT DIS, V162, P723, DOI 10.1093/infdis/162.3.723; MARMONT AM, 1991, BLOOD, V78, P2120, DOI 10.1182/blood.V78.8.2120.bloodjournal7882120; MARTIN PJ, 1993, J EXP MED, V178, P703, DOI 10.1084/jem.178.2.703; Nagler A, 1999, BONE MARROW TRANSPL, V24, P339, DOI 10.1038/sj.bmt.1701903; Ozsahin H, 1996, J PEDIATR-US, V129, P238, DOI 10.1016/S0022-3476(96)70248-2; Ozsahin H, 1998, BLOOD, V92, P2719, DOI 10.1182/blood.V92.8.2719.420k02_2719_2724; Pelot M R, 1999, Biol Blood Marrow Transplant, V5, P133, DOI 10.1053/bbmt.1999.v5.pm10392959; RAPPEPORT JM, 1982, J PEDIATR-US, V101, P952, DOI 10.1016/S0022-3476(82)80017-6; Slavin S, 1998, BLOOD, V91, P756, DOI 10.1182/blood.V91.3.756.756_756_763; SYKES M, 1988, J IMMUNOL, V140, P2903; SYKES M, 1988, J EXP MED, V168, P2391, DOI 10.1084/jem.168.6.2391; Thiede C, 1999, BONE MARROW TRANSPL, V23, P1055, DOI 10.1038/sj.bmt.1701779; THOMAS C, 1995, BLOOD, V86, P1629, DOI 10.1182/blood.V86.4.1629.bloodjournal8641629; Vermylen C, 1998, BONE MARROW TRANSPL, V22, P1, DOI 10.1038/sj.bmt.1701291; VOWELLS SJ, 1995, J IMMUNOL METHODS, V178, P89, DOI 10.1016/0022-1759(94)00247-T; Vowells SJ, 1996, J PEDIATR-US, V128, P104, DOI 10.1016/S0022-3476(96)70437-7; Walters MC, 1996, NEW ENGL J MED, V335, P369, DOI 10.1056/NEJM199608083350601; WEENING RS, 1983, J PEDIATR-US, V103, P127, DOI 10.1016/S0022-3476(83)80798-7; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003	46	205	211	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2001	344	12					881	888		10.1056/NEJM200103223441203	http://dx.doi.org/10.1056/NEJM200103223441203			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412PN	11259721				2022-12-28	WOS:000167563700003
J	Sutton, MD; Briggs, DEG; Siveter, DJ; Siveter, DJ				Sutton, MD; Briggs, DEG; Siveter, DJ; Siveter, DJ			An exceptionally preserved vermiform mollusc from the Silurian of England	NATURE			English	Article							PHYLOGENY; GOTLAND; SWEDEN	Studies of the origin and radiation of the molluscs have yet to resolve many issues regarding their nearest relatives, phylogeny and ancestral characters(1-11). The Polyplacophora (chitons) and the Aplacophora are widely interpreted as the most primitive extant molluscs(2,3,9,10), but Lower Palaeozoic fossils of the former lack soft parts, and the latter were hitherto unrecognized as fossils. The Herefordshire Lagerstatte(12) is a Silurian (about 425 Myr BP) deposit that preserves a marine biota in remarkable three-dimensional detail. The external surface of even non-biomineralized cuticle was preserved by entombment in volcanic ash, subsequent incorporation into concretions, and infilling of the fossils with sparry calcite(13). Here we describe, from this deposit, a complete vermiform mollusc, which we interpret as a plated aplacophoran. Serial grinding at intervals of tens of micrometres, combined with computer-based reconstruction methods, renders the fossils in the round(14).	Univ Oxford, Dept Earth Sci, Oxford OX1 3PS, England; Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; Univ Museum Nat Hist, Oxford OX1 3PW, England	University of Oxford; University of Leicester; University of Oxford	Siveter, DJ (corresponding author), Univ Oxford, Dept Earth Sci, S Parks Rd, Oxford OX1 3PS, England.	derek.siveter@earth.ox.ac.uk	Sutton, Mark/A-4189-2010					BENGTSON S, 1992, LETHAIA, V25, P401, DOI 10.1111/j.1502-3931.1992.tb01644.x; Briggs DEG, 1996, NATURE, V382, P248, DOI 10.1038/382248a0; Cherns L, 1998, PALAEONTOLOGY, V41, P939; Cherns L, 1998, PALAEONTOLOGY, V41, P545; Lindberg David R., 1996, P67; MORRIS SC, 1995, PHILOS T ROY SOC B, V347, P305, DOI 10.1098/rstb.1995.0029; Orr PJ, 2000, J GEOL SOC LONDON, V157, P173, DOI 10.1144/jgs.157.1.173; OVANOV DL, 1996, ORIGIN EVOLUTIONARY, P59; PEEL JS, 1991, GRONLANDS GEOLOGISKE, V161, P1; Rosenberg G, 1997, J MOLLUS STUD, V63, P301, DOI 10.1093/mollus/63.3.301; RUNNEGAR B., 1985, MOLLUSCA, V10, DOI DOI 10.1016/B978-0-12-751408-6.50008-4; Runnegar Bruce, 1996, P77; Scheltema Amelie H., 1996, P53; SUTTON MD, IN PRESS PALEONTOL E; VONSALVINIPLAWE.L, 1996, ORIGIN EVOLUTIONARY, P29; Wingstrand K.G., 1985, Galathea Report, V16, P7; Winnepenninckx B, 1996, MOL BIOL EVOL, V13, P1306, DOI 10.1093/oxfordjournals.molbev.a025577	17	64	69	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					461	463		10.1038/35068549	http://dx.doi.org/10.1038/35068549			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260711				2022-12-28	WOS:000167583800039
J	Snow, V; Mottur-Pilson, C; Gonzales, R				Snow, V; Mottur-Pilson, C; Gonzales, R		Amer Coll Phys-Amer Soc Internal Med	Principles of appropriate antibiotic use for treatment of acute bronchitis in adults	ANNALS OF INTERNAL MEDICINE			English	Article									Amer Coll Phys Amer Soc Internal Med, Customer Serv, Philadelphia, PA 19106 USA		Snow, V (corresponding author), Amer Coll Phys Amer Soc Internal Med, Customer Serv, 190 N Independence Mall W, Philadelphia, PA 19106 USA.							Irwin RS, 1998, CHEST, V114, p133S, DOI 10.1378/chest.114.2_Supplement.133S	1	83	89	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					518	520		10.7326/0003-4819-134-6-200103200-00020	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00020			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409VF	11255531				2022-12-28	WOS:000167405800014
J	Holmes-Rovner, M; Llewellyn-Thomas, H; Entwistle, V; Coulter, A; O'Connor, A; Rovner, DR				Holmes-Rovner, M; Llewellyn-Thomas, H; Entwistle, V; Coulter, A; O'Connor, A; Rovner, DR			Patient choice modules for summaries of clinical effectiveness: a proposal	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DECISION AIDS		Michigan State Univ, Coll Human Med, E Lansing, MI 48823 USA; Dartmouth Coll, Sch Med, Dept Community & Family Med, Hanover, NH 03755 USA; Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; Picker Inst Europe, Oxford OX1 1RX, England; Univ Ottawa, Loeb Res Inst, Ottawa, ON K1H 8M5, Canada; Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1H 8M5, Canada	Michigan State University; Michigan State University College of Human Medicine; Dartmouth College; University of Aberdeen; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Holmes-Rovner, M (corresponding author), Michigan State Univ, Coll Human Med, Dept Med, Clin Ctr B213, E Lansing, MI 48824 USA.	mholmes@msu.edu	Coulter, Angela/N-6998-2019; Entwistle, Vikki Ann/I-9266-2019	Coulter, Angela/0000-0002-6308-8375; Entwistle, Vikki Ann/0000-0002-0856-4025				Charles C, 1999, SOC SCI MED, V49, P651, DOI 10.1016/S0277-9536(99)00145-8; Coulter A, 1997, J Health Serv Res Policy, V2, P112; Coulter A, 1999, BRIT MED J, V318, P318, DOI 10.1136/bmj.318.7179.318; COULTER A, 1998, INFORMING PATIENTS A; DETSKY AS, IN PRESS J GEN INTER; Entwistle Vikki A., 2000, Health Expect, V3, P77, DOI 10.1046/j.1369-6513.2000.00087.x; General Medical Council, 1999, SEEK PAT CONS ETH CO; Gray JAM, 1999, BRIT MED J, V319, P1476, DOI 10.1136/bmj.319.7223.1476; HOLMES M, IN PRESS EVIDENCE BA; Holmes-Rovner Margaret, 2000, Health Expect, V3, P182, DOI 10.1046/j.1369-6513.2000.00093.x; Hope T., 1996, EVIDENCE BASED PATIE; Kasper J F, 1992, QRB Qual Rev Bull, V18, P183; Molenaar S, 2000, MED DECIS MAKING, V20, P112, DOI 10.1177/0272989X0002000114; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; OCONNOR AM, 1999, MONOGR NCI, P67; Rogers A, 1998, BRIT MED J, V316, P1816, DOI 10.1136/bmj.316.7147.1816; Sox HC, 1988, MED DECISION MAKING	17	68	68	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2001	322	7287					664	667		10.1136/bmj.322.7287.664	http://dx.doi.org/10.1136/bmj.322.7287.664			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413QE	11250855	Green Published			2022-12-28	WOS:000167622600030
J	Harries, JE; Brindley, HE; Sagoo, PJ; Bantges, RJ				Harries, JE; Brindley, HE; Sagoo, PJ; Bantges, RJ			Increases in greenhouse forcing inferred from the outgoing longwave radiation spectra of the Earth in 1970 and 1997	NATURE			English	Article							ATMOSPHERIC FLUXES; CLIMATE MODELS; COOLING RATES; WATER-VAPOR; TRENDS; FEEDBACK; OZONE	The evolution of the Earth's climate has been extensively studied(1,2), and a strong link between increases in surface temperatures and greenhouse gases has been established(3,4). But this relationship is complicated by several feedback processes-most importantly the hydrological cycle-that are not well understood(5-7). Changes in the Earth's greenhouse effect can be detected from variations in the spectrum of outgoing longwave radiation(8-10), which is a measure of how the Earth cools to space and carries the imprint of the gases that are responsible for the greenhouse effect(11-13). Here we analyse the difference between the spectra of the outgoing longwave radiation of the Earth as measured by orbiting spacecraft in 1970 and 1997. We rnd differences in the spectra that point to long-term changes in atmospheric CH4, CO2 and O-3 as well as CFC-11 and CFC-12. Our results provide direct experimental evidence for a significant increase in the Earth's greenhouse effect that is consistent with concerns over radiative forcing of climate.	Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Space & Atmospher Phys Grp, London SW7 2BW, England	Imperial College London	Harries, JE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Space & Atmospher Phys Grp, London SW7 2BW, England.			Brindley, Helen/0000-0002-7859-9207				ACKERMAN SA, 1990, MON WEATHER REV, V118, P2377, DOI 10.1175/1520-0493(1990)118<2377:TOFICC>2.0.CO;2; Bantges RJ, 1999, J QUANT SPECTROSC RA, V63, P487, DOI 10.1016/S0022-4073(99)00034-5; BERK A, 1989, AFGLTR880177; CESS RD, 1989, SCIENCE, V245, P513, DOI 10.1126/science.245.4917.513; Chamberlain J., 1979, PRINCIPLES INTERFERO; CLOUGH SA, 1995, J GEOPHYS RES-ATMOS, V100, P16519, DOI 10.1029/95JD01386; CLOUGH SA, 1992, J GEOPHYS RES-ATMOS, V97, P15761, DOI 10.1029/92JD01419; Goody R, 1998, B AM METEOROL SOC, V79, P2541, DOI 10.1175/1520-0477(1998)079<2541:TCMAA>2.0.CO;2; GOODY R, 1995, EARTH OBSERV REMOTE, V13, P713; HANEL RA, 1971, APPL OPTICS, V10, P1376, DOI 10.1364/AO.10.001376; HANEL RA, 1972, J GEOPHYS RES, V77, P2629, DOI 10.1029/JC077i015p02629; Harries JE, 1998, GEOPHYS RES LETT, V25, P3975, DOI 10.1029/1998GL900056; HOUGHTON J, 1995, CLIMATTE CHANGE 1995; Houghton J.T., 1990, CLIMATE CHANGE IPCC; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kobayashi H., 1999, INTERFEROMETRIC MONI; LINDZEN RS, 1990, B AM METEOROL SOC, V71, P288, DOI 10.1175/1520-0477(1990)071<0288:SCCGW>2.0.CO;2; MITCHELL JFB, 1995, NATURE, V376, P501, DOI 10.1038/376501a0; Olivier J.G.J., 1996, 771060002 RIVM; OLIVIER JG, 1996, R96119 TNO MEP; OORT AH, 1993, J CLIMATE, V6, P292, DOI 10.1175/1520-0442(1993)006<0292:UATTOT>2.0.CO;2; Randel WJ, 1999, GEOPHYS RES LETT, V26, P3089, DOI 10.1029/1999GL900615; RIND D, 1991, NATURE, V349, P500, DOI 10.1038/349500a0; SHETTLE EP, 1990, ATMOSPHERIC PROPAGAT; Slingo A, 1997, Q J ROY METEOR SOC, V123, P293, DOI 10.1002/qj.49712353803; STRABALA KI, 1994, J APPL METEOROL, V33, P212, DOI 10.1175/1520-0450(1994)033<0212:CPIFD>2.0.CO;2; Tett SFB, 1999, NATURE, V399, P569, DOI 10.1038/21164; *WORLD MET ORG, 1999, SCI ASS OZ DEPL 1998, pCH4	28	112	117	3	45	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					355	357		10.1038/35066553	http://dx.doi.org/10.1038/35066553			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268208				2022-12-28	WOS:000167464100046
J	Lincoln, T				Lincoln, T			Animal behaviour - Greensleaves	NATURE			English	Editorial Material																		Cholewa E, 2001, BIOL J LINN SOC, V72, P179, DOI [10.1111/j.1095-8312.2001.tb01310.x, 10.1006/bijl.2000.0493]	1	0	0	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					318	318		10.1038/35066669	http://dx.doi.org/10.1038/35066669			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268190	Bronze			2022-12-28	WOS:000167464100029
J	Sackeim, HA; Haskett, RF; Mulsant, BH; Thase, ME; Mann, JJ; Pettinati, HM; Greenberg, RM; Crowe, RR; Cooper, TB; Prudic, J				Sackeim, HA; Haskett, RF; Mulsant, BH; Thase, ME; Mann, JJ; Pettinati, HM; Greenberg, RM; Crowe, RR; Cooper, TB; Prudic, J			Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEROTONIN REUPTAKE INHIBITORS; MAJOR DEPRESSION; MEDICATION RESISTANCE; ELECTRODE PLACEMENT; CLINICAL-RESPONSE; DRUG-THERAPY; LITHIUM; ECT; IMIPRAMINE; PAROXETINE	Context Electroconvulsive therapy (ECT) is highly effective for treatment of major depression, but naturalistic studies show a high rate of relapse after discontinuation of ECT. Objective To determine the efficacy of continuation pharmacotherapy with nortriptyline hydrochloride or combination nortriptyline and lithium carbonate in preventing post-ECT relapse, Design Randomized double-blind, placebo-controlled trial conducted from 1993 to 1998, stratified by medication resistance or presence of psychotic depression in the index episode. Setting Two university-based hospitals and 1 private psychiatric hospital. Patients Of 290 patients with unipolar major depression recruited through clinical referral who completed an open ECT treatment phase, 159 patients met remitter criteria; 84 remitting patients were eligible and agreed to participate in the continuation study. Interventions Patients were randomly assigned to receive continuation treatment for 24 weeks with placebo (n = 29), nortriptyline (target steady-state level, 75-125 ng/mL) (n = 27), or combination nortriptyline and lithium (target steady-state level, 0.5-0.9 mEq/L) (n = 28). Main Outcome Measure Relapse of major depressive episode, compared among the 3 continuation groups. Results Nortriptyline-lithium combination therapy had a marked advantage in time to relapse, superior to both placebo and nortriptyline alone. Over the 24-week trial, the relapse rate for placebo was 84% (95% confidence interval [CI], 70%-99%); for nortriptyline, 60% (95% CI, 41%-79%); and for nortriptyline-lithium, 39% (95% CI, 19%-59%). All but 1 instance of relapse with nortriptyline-lithium occurred within 5 weeks of ECT termination, while relapse continued throughout treatment with placebo or nortriptyline alone. Medication-resistant patients, female patients, and those with more severe depressive symptoms following ECT had more rapid relapse. Conclusions Our study indicates that without active treatment, virtually all remitted patients relapse within 6 months of stopping ECT. Monotherapy with nortriptyline has limited efficacy. The combination of nortriptyline and lithium is more effective, but the relapse rate is still high, particularly during the first month of continuation therapy.	New York State Psychiat Inst & Hosp, Dept Biol Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Dept Neurosci, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Dept Anat Psychopharmacol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Radiol, New York, NY 10032 USA; Univ Pittsburgh, Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15213 USA; Carrier Fdn, Belle Mead, NJ USA; Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; St Francis Hosp, Dept Psychiat, Jersey City, NJ USA	New York State Psychiatry Institute; New York State Psychiatry Institute; New York State Psychiatry Institute; Columbia University; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa	Sackeim, HA (corresponding author), New York State Psychiat Inst & Hosp, Dept Biol Psychiat, 1051 Riverside Dr, New York, NY 10032 USA.	has1@columbia.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R10MH057009, R37MH035636, R01MH047709, P30MH052247, R01MH047739] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABOUSALEH MT, 1987, AM J PSYCHIAT, V144, P1247; ABOUSALEH MT, 1988, CONVULSIVE THER, V4, P263; ABRAMS R, 1997, ELECTROCONVULSIVE TH; *AM PSYCH ASS COMM, 1990, PRACT EL THER REC TR; American Psychiatric Association Committee on Electroconvulsive Therapy, 2001, PRACT EL THER REC TR; Andersen B, 1990, J AFFECT DISORDERS, V18, P289; ANDERSON IM, 1986, PSYCHOPHARMACOLOGY, V89, P131; ANDERSON IM, 1994, J PSYCHOPHARMACOL, V8, P238, DOI 10.1177/026988119400800407; [Anonymous], 1994, Am J Psychiatry, V151, P1; ARONSON TA, 1987, CONVULSIVE THER, V3, P251; Baldessarini RJ, 1996, J CLIN PSYCHIAT, V57, P441, DOI 10.4088/JCP.v57n1001; BLACK DW, 1991, EUR ARCH PSY CLIN N, V241, P41, DOI 10.1007/BF02193753; Bruijn JA, 1998, J CLIN PSYCHIAT, V59, P657, DOI 10.4088/JCP.v59n1203; COOPER TB, 1976, AM J PSYCHIAT, V133, P440; COOPER TB, 1978, AM J PSYCHIAT, V135, P333; COOPER TB, 1979, LITHIUM CONTROVERSIE, P346; COPPEN A, 1981, BRIT J PSYCHIAT, V139, P284, DOI 10.1192/bjp.139.4.284; COX DR, 1972, J R STAT SOC B, V34, P187; d'Elia G, 1970, Acta Psychiatr Scand Suppl, V215, P1; DEMONTIGNY C, 1983, ARCH GEN PSYCHIAT, V40, P1327; DINAN TG, 1989, ACTA PSYCHIAT SCAND, V80, P97, DOI 10.1111/j.1600-0447.1989.tb01306.x; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; ERNST C, 1992, EUR ARCH PSY CLIN N, V241, P222, DOI 10.1007/BF02190257; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; Flint AJ, 1998, AM J PSYCHIAT, V155, P178; Flint AJ, 1996, J AFFECT DISORDERS, V36, P95, DOI 10.1016/0165-0327(95)00063-1; Flint AJ, 1997, BRIT J PSYCHIAT, V170, P268, DOI 10.1192/bjp.170.3.268; GRUNHAUS L, 1994, BIOL PSYCHIAT, V36, P214, DOI 10.1016/0006-3223(94)90602-5; Guy W., 1976, US DHEW PUBLICATION; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; HENINGER GR, 1983, ARCH GEN PSYCHIAT, V40, P1335; Hyman SE, 1996, AM J PSYCHIAT, V153, P151; IMALAH NW, 1966, NEUROPSYCHOPHARMACOL, V4, P438; JOFFE RT, 1993, ARCH GEN PSYCHIAT, V50, P387; Kalbfleisch JD, 1980, SURVIVAL MODELS DATA; KANTOR D, 1986, CAN J PSYCHIAT, V31, P416, DOI 10.1177/070674378603100506; KARLINSKY H, 1984, J AM GERIATR SOC, V32, P183, DOI 10.1111/j.1532-5415.1984.tb01999.x; KAY DWK, 1970, BRIT J PSYCHIAT, V117, P667, DOI 10.1192/bjp.117.541.667; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Lauritzen L, 1996, ACTA PSYCHIAT SCAND, V94, P241, DOI 10.1111/j.1600-0447.1996.tb09856.x; Lemstra A, 1996, Ned Tijdschr Geneeskd, V140, P260; MALCOLM K, 1991, Journal of Psychopharmacology, V5, P255, DOI 10.1177/026988119100500313; McCall WV, 2000, ARCH GEN PSYCHIAT, V57, P438, DOI 10.1001/archpsyc.57.5.438; *MED RES COUNC, 1965, BMJ-BRIT MED J, V1, P881; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Mulsant BH, 1997, AM J PSYCHIAT, V154, P559; OLeary DA, 1996, BRIT J PSYCHIAT, V169, P423, DOI 10.1192/bjp.169.4.423; PRIEN RF, 1986, AM J PSYCHIAT, V143, P18; Prien Robert F., 1995, P1067; PRUDIC J, 1990, PSYCHIAT RES, V31, P287, DOI 10.1016/0165-1781(90)90098-P; Prudic J, 1996, AM J PSYCHIAT, V153, P985; REIMHERR FW, 1984, PSYCHOPHARMACOL BULL, V20, P70; Reynolds CF, 1996, AM J PSYCHIAT, V153, P1418; ROOSE SP, 1994, AM J PSYCHIAT, V151, P1735; Royal College of Psychiatrists. Special Committee on ECT (2nd) FC, 1995, ECT HDB 2 REP ROYAL; SACKEIM H, 1987, ARCH GEN PSYCHIAT, V44, P355; SACKEIM HA, 1994, PSYCHOPHARMACOL BULL, V30, P501; SACKEIM HA, 1993, NEW ENGL J MED, V328, P839, DOI 10.1056/NEJM199303253281204; SACKEIM HA, 1990, J CLIN PSYCHOPHARM, V10, P96, DOI 10.1097/00004714-199004000-00004; Sackeim HA, 2000, ARCH GEN PSYCHIAT, V57, P425, DOI 10.1001/archpsyc.57.5.425; Sackeim Harold A., 1995, P1123; SACKHEIM HA, 1990, REV PSYCHIATRY, V9, P91; Sareen J, 2000, J ECT, V16, P43, DOI 10.1097/00124509-200003000-00006; SARGANT W, 1964, INTRO PHYSICAL METHO; SARGEANT JK, 1990, ARCH GEN PSYCHIAT, V47, P519; SEAGER CP, 1962, J MENT SCI, V108, P704, DOI 10.1192/bjp.108.456.704; SHAPIRA B, 1995, CONVULSIVE THER, V11, P80; Simpson HB, 1997, ARCH GEN PSYCHIAT, V54, P633; Spiker Duane G., 1985, Convuls Ther, V1, P167; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; *STEER COMM AM PSY, 1996, J CLIN PSYCHIAT S12A, V57, P3; SUPPES T, 1991, ARCH GEN PSYCHIAT, V48, P1082; THASE ME, 1989, J CLIN PSYCHIAT, V50, P413; THOMPSON JW, 1994, AM J PSYCHIAT, V151, P1657; TIGNOL J, 1992, INT CLIN PSYCHOPHARM, V7, P91, DOI 10.1097/00004850-199207020-00005; ZIMMERMAN M, 1986, AM J PSYCHIAT, V143, P1030	76	470	478	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2001	285	10					1299	1307		10.1001/jama.285.10.1299	http://dx.doi.org/10.1001/jama.285.10.1299			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	408QK	11255384				2022-12-28	WOS:000167339000021
J	Drayna, D; Manichaikul, A; de Lange, M; Snieder, H; Spector, T				Drayna, D; Manichaikul, A; de Lange, M; Snieder, H; Spector, T			Genetic correlates of musical pitch recognition in humans	SCIENCE			English	Article							ABSOLUTE PITCH; TWIN; TRAITS	We used a twin study to investigate the genetic and environmental contributions to differences in musical pitch perception abilities in humans. We administered a Distorted Tunes Test (DTT), which requires subjects to judge whether simple popular melodies contain notes with incorrect pitch, to 136 monozygotic twin pairs and 148 dizygotic twin pairs. The correlation of DTT scores between twins was estimated at 0.67 for monozygotic pairs and 0.44 for dizygotic pairs. Genetic model-fitting, techniques supported an additive genetic model, with heritability; estimated at 0.71 to 0.80, depending on how subjects were categorized, and with no effect of shared environment. DTT scores were only weakly correlated with measures of peripheral hearing. This suggests that variation in musical pitch recognition is primarily due to highly heritable differences in auditory functions not tested by conventional audiologic methods.	Natl Inst Deafness & Other Commun Disorders, NIH, Rockville, MD 20850 USA; St Thomas Hosp, Twin Res & Genet Epidemiol Unit, London SE1 7EH, England	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Guy's & St Thomas' NHS Foundation Trust	Drayna, D (corresponding author), Med Coll Georgia, Georgia Prevent Inst, Bldg HS-1640, Augusta, GA 30912 USA.		Manichaikul, Ani/B-7726-2009; Spector, Tim D/F-6533-2012		NIDCD NIH HHS [Z01-DC-00043-03] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000043, Z01DC000046] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Bataille V, 2000, JNCI-J NATL CANCER I, V92, P457, DOI 10.1093/jnci/92.6.457; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; de Lange M, 2001, LANCET, V357, P101, DOI 10.1016/S0140-6736(00)03541-8; Drayna D, 1998, NAT GENET, V18, P96, DOI 10.1038/ng0298-96; Fry DB, 1948, SPEECH, P1; GERGESEN PK, 1999, AM J HUM GENET, V65, P911; Hammond CJ, 2000, NEW ENGL J MED, V342, P1786, DOI 10.1056/NEJM200006153422404; HARTMAN WM, 1997, SIGNALS SOUND SENSAT, P117; Houtsma Adrianus J. M., 1995, P267, DOI 10.1016/B978-012505626-7/50010-8; KALMUS H, 1980, ANN HUM GENET, V43, P369, DOI 10.1111/j.1469-1809.1980.tb01571.x; KOIKE KJ, 1994, OTOLARYNG HEAD NECK, V111, P625, DOI 10.1016/S0194-5998(94)70531-3; LEVITIN DJ, 1994, PERCEPT PSYCHOPHYS, V56, P414, DOI 10.3758/BF03206733; MacGregor AJ, 2000, TRENDS GENET, V16, P131, DOI 10.1016/S0168-9525(99)01946-0; MOORE BCJ, 1993, SPRINGER HDB AUDITOR, P56; Neale MC, 1992, METHODOLOGY GENETIC; PROFITA J, 1988, AM J MED GENET, V29, P763, DOI 10.1002/ajmg.1320290405; Snieder H, 2000, HYPERTENSION, V35, P574, DOI 10.1161/01.HYP.35.2.574; Spector TD, 1996, BRIT MED J, V312, P940; SPECTOR TD, 2000, ADV TWIN SIBPAIR ANA; *STAT CORP, 1997, STAT STAT SOFTW REL; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; Witte JS, 1999, GENET EPIDEMIOL, V16, P290, DOI 10.1002/(SICI)1098-2272(1999)16:3<290::AID-GEPI5>3.0.CO;2-8	23	203	211	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1969	1972		10.1126/science.291.5510.1969	http://dx.doi.org/10.1126/science.291.5510.1969			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239158	Green Submitted			2022-12-28	WOS:000167401600048
J	Reid, DT				Reid, DT			Laser physics - Toward attosecond pulses	SCIENCE			English	Editorial Material							TI-SAPPHIRE LASER; DISPERSION		Heriot Watt Univ, Dept Phys, Ultrafast Opt Grp, Edinburgh EH14 4AS, Midlothian, Scotland	Heriot Watt University	Reid, DT (corresponding author), Heriot Watt Univ, Dept Phys, Ultrafast Opt Grp, Edinburgh EH14 4AS, Midlothian, Scotland.		Reid, Derryck T/O-6073-2015	Reid, Derryck T/0000-0002-0385-4939				CHRISTOV IP, 1994, OPT LETT, V19, P1465, DOI 10.1364/OL.19.001465; CURLEY PF, 1993, OPT LETT, V18, P54, DOI 10.1364/OL.18.000054; Drescher M, 2001, SCIENCE, V291, P1923, DOI 10.1126/science.1058561; HUANG CP, 1992, OPT LETT, V17, P1289, DOI 10.1364/OL.17.001289; Jung ID, 1997, OPT LETT, V22, P1009, DOI 10.1364/OL.22.001009; STINGL A, 1995, OPT LETT, V20, P602, DOI 10.1364/OL.20.000602; Sutter DH, 1999, OPT LETT, V24, P631, DOI 10.1364/OL.24.000631; Xu L, 1996, OPT LETT, V21, P1259, DOI 10.1364/OL.21.001259	8	2	2	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1911	+		10.1126/science.1059499	http://dx.doi.org/10.1126/science.1059499			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11245197				2022-12-28	WOS:000167401600032
J	Volchkov, VE; Volchkova, VA; Muhlberger, E; Kolesnikova, LV; Weik, M; Dolnik, O; Klenk, HD				Volchkov, VE; Volchkova, VA; Muhlberger, E; Kolesnikova, LV; Weik, M; Dolnik, O; Klenk, HD			Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity	SCIENCE			English	Article							MARBURG-VIRUS; MESSENGER-RNA; GLYCOPROTEIN; REPLICATION; REGION; DOMAIN; TRANSCRIPTION; CONTAINS; PROTEIN; CDNA	To study the mechanisms underlying the high pathogenicity of Ebola virus, we have established a system that allows the recovery of infectious virus from cloned cDNA and thus permits genetic manipulation. We created a mutant in which the editing site of the gene encoding envelope glycoprotein (CP) was eliminated. This mutant no longer expressed the nonstructural glycoprotein sGP, Synthesis of CP increased, but most of it accumulated in the endoplasmic reticulum as immature precursor. The mutant was significantly more cytotoxic than wild-type virus, indicating that cytotoxicity caused by CP is down-regulated by the virus through transcriptional RNA editing and expression of sGP.	Univ Marburg, Inst Virol, D-35037 Marburg, Germany; Univ Lyon 1, Filovirus Lab, F-69365 Lyon 07, France	Philipps University Marburg; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Volchkov, VE (corresponding author), Univ Marburg, Inst Virol, Robert Koch Str 17, D-35037 Marburg, Germany.	viktor.volchkov@ens-lyon.fr	Muhlberger, Elke/AAD-6924-2019; Volchkov, Viktor/M-7846-2014	Volchkov, Viktor/0000-0001-7896-8706; Muhlberger, Elke/0000-0003-3547-9376; Valentina A, Volchkova/0000-0003-4028-782X				Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; BUKREYEV AA, 1993, FEBS LETT, V323, P183, DOI 10.1016/0014-5793(93)81476-G; Chan SY, 2000, J GEN VIROL, V81, P2155, DOI 10.1099/0022-1317-81-9-2155; Feldmann H, 1999, CURR TOP MICROBIOL, V235, P1; Ito H, 1999, J VIROL, V73, P8907, DOI 10.1128/JVI.73.10.8907-8912.1999; Muhlberger E, 1998, J VIROL, V72, P8756; Muhlberger E, 1999, J VIROL, V73, P2333; PATTNAIK AK, 1992, CELL, V69, P1011, DOI 10.1016/0092-8674(92)90619-N; PERROTTA AT, 1991, NATURE, V350, P434, DOI 10.1038/350434a0; Peters C.J., 1996, FIELDS VIROLOGY, P1161; Sanchez A, 1999, J INFECT DIS, V179, pS164, DOI 10.1086/514282; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; VIDAL S, 1990, EMBO J, V9, P2017, DOI 10.1002/j.1460-2075.1990.tb08330.x; Volchkov VE, 2000, VIROLOGY, V277, P147, DOI 10.1006/viro.2000.0572; VOLCHKOV VE, 1992, FEBS LETT, V305, P181, DOI 10.1016/0014-5793(92)80662-Z; Volchkov VE, 1999, J GEN VIROL, V80, P355, DOI 10.1099/0022-1317-80-2-355; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; WILL C, 1993, J VIROL, V67, P1203, DOI 10.1128/JVI.67.3.1203-1210.1993; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654	21	226	263	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2001	291	5510					1965	1969		10.1126/science.1057269	http://dx.doi.org/10.1126/science.1057269			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239157				2022-12-28	WOS:000167401600047
J	Yoder, J; Pham, C; Iizuka, YM; Kanagawa, O; Liu, SK; McGlade, J; Cheng, AM				Yoder, J; Pham, C; Iizuka, YM; Kanagawa, O; Liu, SK; McGlade, J; Cheng, AM			Requirement for the SLP-76 adaptor CADS in T cell development	SCIENCE			English	Article							THYMOCYTE DEVELOPMENT; PROTEIN SLP-76; RECEPTOR; LAT; ACTIVATION; MICE; BETA; DELETION; KINASES; PATHWAY	GADS is an adaptor protein implicated in CD3 signaling because of its ability to link SLP-76 to LAT. A GADS-deficient mouse was generated by gene targeting, and the function of GADS in T cell development and activation was examined. GADS(-) CD4(-)CD8(-) thymocytes exhibited a severe block in proliferation but still differentiated into mature T cells. GADS(-) thymocytes failed to respond to CD3 cross-linking in vivo and were-impaired in positive and negative selection. Immunoprecipitation experiments revealed that the association between SLP-76 and LAT was uncoupled in GADS(-) thymocytes. These observations indicate that CADS is a critical adaptor for CD3 signaling.	Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Med Sci Training Program, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Cheng, AM (corresponding author), Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA.	acheng@im.wustl.edu		Liu, Stanley/0000-0001-6851-0857				Asada H, 1999, J EXP MED, V189, P1383, DOI 10.1084/jem.189.9.1383; Bourette RP, 1998, EMBO J, V17, P7273, DOI 10.1093/emboj/17.24.7273; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Chan AC, 1996, CURR OPIN IMMUNOL, V8, P394, DOI 10.1016/S0952-7915(96)80130-0; Clements JL, 1999, J CLIN INVEST, V103, P19, DOI 10.1172/JCI5317; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Law CL, 1999, J EXP MED, V189, P1243, DOI 10.1084/jem.189.8.1243; LEVELT CN, 1993, J EXP MED, V177, P707, DOI 10.1084/jem.177.3.707; Liu SK, 1998, ONCOGENE, V17, P3073, DOI 10.1038/sj.onc.1202337; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Rodewald HR, 1998, ADV IMMUNOL, V69, P1, DOI 10.1016/S0065-2776(08)60606-9; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	26	122	125	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2001	291	5510					1987	1991		10.1126/science.1057176	http://dx.doi.org/10.1126/science.1057176			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239162				2022-12-28	WOS:000167401600052
J	Schon, JH; Dodabalapur, A; Bao, Z; Kloc, C; Schenker, O; Batlogg, B				Schon, JH; Dodabalapur, A; Bao, Z; Kloc, C; Schenker, O; Batlogg, B			RETRACTED: Gate-induced superconductivity in a solution-processed organic polymer film (Retracted article. See vol 422 pg 92 2003)	NATURE			English	Article; Retracted Publication							CHARGE-TRANSPORT; REGIOREGULAR POLY(3-HEXYLTHIOPHENE); MOBILITY	The electrical and optical properties of conjugated polymers have received considerable attention in the context of potentially low-cost replacements for conventional metals and inorganic semiconductors. Charge transport in these organic materials has been characterized in both the doped-metallic and the semiconducting state(1-4), but superconductivity has not hitherto been observed in these polymers. Here we report a distinct metal-insulator transition and metallic levels of conductivity in a polymer field-effect transistor. The active material is solution-cast regioregular poly(3-hexylthiophene), which forms relatively well ordered films owing to self-organization, and which yields a high charge carrier mobility (0.05-0.1 cm(2) V-1 s(-1)) at room temperature. At temperatures below similar to2.35 K with sheet carrier densities exceeding 2.5 x 10(14) cm(-2), the polythiophene film becomes superconducting. The appearance of superconductivity seems to be closely related to the self-assembly properties of the polymer, as the introduction of additional disorder is found to suppress superconductivity. Our findings therefore demonstrate the feasibility of tuning the electrical properties of conjugated polymers over the largest range possible-from insulating to superconducting.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; Univ Konstanz, Dept Phys, D-78457 Constance, Germany; ETH Honggerberg, Solid State Phys Lab, CH-8093 Zurich, Switzerland	Alcatel-Lucent; Lucent Technologies; AT&T; University of Konstanz; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schon, JH (corresponding author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.	hendrik@lucent.com	Bao, Zhenan/AAC-5044-2019; Dodabalapur, Ananth/H-3043-2012; Kloc, Christian/A-2255-2011	Bao, Zhenan/0000-0002-0972-1715; 				Ahlskog M, 1998, PHYS STATUS SOLIDI B, V205, P305, DOI 10.1002/(SICI)1521-3951(199801)205:1<305::AID-PSSB305>3.0.CO;2-B; Ahn CH, 1999, SCIENCE, V284, P1152, DOI 10.1126/science.284.5417.1152; Aleshin A, 1997, SYNTHETIC MET, V90, P61, DOI 10.1016/S0379-6779(97)81227-1; Bao Z, 1996, APPL PHYS LETT, V69, P4108, DOI 10.1063/1.117834; CHIANG CK, 1977, PHYS REV LETT, V39, P1098, DOI 10.1103/PhysRevLett.39.1098; Crone B, 2000, NATURE, V403, P521, DOI 10.1038/35000530; Dodabalapur A, 1998, APPL PHYS LETT, V73, P142, DOI 10.1063/1.121736; Gunnarsson O, 1997, REV MOD PHYS, V69, P575, DOI 10.1103/RevModPhys.69.575; Horowitz G, 2000, ADV MATER, V12, P1046, DOI 10.1002/1521-4095(200007)12:14<1046::AID-ADMA1046>3.0.CO;2-W; Ishiguro T., 1998, ORGANIC SUPERCONDUCT, V2nd; Kim JH, 1997, SYNTHETIC MET, V84, P71, DOI 10.1016/S0379-6779(96)03841-6; Knupfer M, 1999, PHYS REV LETT, V83, P1443, DOI 10.1103/PhysRevLett.83.1443; Kobashi M, 1998, MACROMOLECULES, V31, P7273, DOI 10.1021/ma980632u; Lovinger AJ, 1998, CHEM MATER, V10, P3275, DOI 10.1021/cm980402u; MARK JE, 1996, PHYSICAL PROPERTIES; MASUBUCHI S, 1995, SYNTHETIC MET, V74, P151, DOI 10.1016/0379-6779(95)03356-4; MCCULLOUGH RD, 1993, J AM CHEM SOC, V115, P4910, DOI 10.1021/ja00064a070; Mooij JE, 1999, SCIENCE, V285, P1036, DOI 10.1126/science.285.5430.1036; Nalwa H.S, 1997, HDB ORGANIC CONDUCTI, V1st ed.; Osterbacka R, 2000, SCIENCE, V287, P839, DOI 10.1126/science.287.5454.839; Schon JH, 2000, NATURE, V408, P549, DOI 10.1038/35046008; Schon JH, 2000, NATURE, V406, P702, DOI 10.1038/35021011; Schon JH, 2000, SCIENCE, V288, P656, DOI 10.1126/science.288.5466.656; Schon JH, 2000, SYNTHETIC MET, V115, P75, DOI 10.1016/S0379-6779(00)00348-9; Schon JH, 2000, PHYS STATUS SOLIDI B, V221, pR4, DOI 10.1002/1521-3951(200009)221:1<R4::AID-PSSB99994>3.0.CO;2-R; SCHON JH, 2000, NATURE, V287, P1022; Simanek E., 1994, INHOMOGENEOUS SUPERC; Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359; Sirringhaus H, 1998, SCIENCE, V280, P1741, DOI 10.1126/science.280.5370.1741; SKOTHEIM TA, 1996, HDB CONJUGATED POLYM; VERTHAMER NR, 1966, PHYS REV, V147, P295	31	141	146	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2001	410	6825					189	192		10.1038/35065565	http://dx.doi.org/10.1038/35065565			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242074				2022-12-28	WOS:000167320500040
J	Chaturvedi, N				Chaturvedi, N		ACE Inhibitors in Diab Nephro	Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data	ANNALS OF INTERNAL MEDICINE			English	Article							IDDM PATIENTS; GLOMERULAR STRUCTURE; NEPHROPATHY; PROGRESSION; CAPTOPRIL; LISINOPRIL; PREVENTION	Purpose: To determine whether response of albumin excretion rate, to angiotensin-converting enzyme (ACE) inhibitors has a threshold in patients with type 1 diabetes mellitus and microalbuminuria and to examine treatment effect according to covariates. Data Sources: Studies were identified by searching MEDLINE and related bibliographies. Study Selection: selected studies included at least 10 normotensive patients with type 1 diabetes mellitus and microalbuminuria, had a placebo or nonintervention group, and included at least 1 year of follow-up. Data Extraction: Raw data were obtained for 698 patients from the 12 identified trials. Analysis of treatment effect at 2 years was restricted to trials with at least 2 years of follow-up (646 patients from 10 trials). Data Synthesis: In patients receiving ACE inhibitors, progression to macroalbuminuria was reduced (odds ratio, 0.38 [95% Cl, 0.25 to 0.57]) and the odds ratio for regression to normoalbuminuria was 3.07 (Cl, 2.15 to 4.44). At 2 years, albumin excretion rate was 50.5% (Cl, 29.2% to 65.5%) lower in treated patients than in those receiving placebo (P < 0.001). Estimated treatment effect varied by baseline albumin excretion rate (74.1% and 17.8% in patients with a rate of 200 <mu>g/min and 20 mug/min, respectively [P = 0.04]) but not by patient subgroup. Adjustment for change in blood pressure attenuated the treatment difference in albumin excretion rate at 2 years to 45.1% (Cl, 18.6% to 63.1%; P < 0.001). Conclusions: In normotensive patients with type 1 diabetes mellitus and microalbuminuria, ACE inhibitors significantly reduced progression to macroalbuminuria and increased chances of regression. Beneficial effects were weaker at the lowest levels of microalbuminuria but did not differ according to other baseline risk factors. Changes in blood pressure cannot entirely explain the antiproteinuric effect of ACE inhibitors.	Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; Univ Birmingham, Birmingham B15 2TT, W Midlands, England; S Cleveland Hosp, Middlesbrough, Cleveland, England; Univ Warwick, Coventry CV4 7AL, W Midlands, England; Kings Coll London, London WC2R 2LS, England; Linkoping Univ Hosp, S-58185 Linkoping, Sweden; Univ Padua & Sassari, Padua, Italy; Natl Res Ctr Study Aging, Padua, Italy; Hop Broussais, F-75674 Paris, France; Steno Diabet Ctr, Copenhagen, Denmark; Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; Joslin Diabet Ctr, Boston, MA 02215 USA	Imperial College London; University of Birmingham; University of Warwick; University of London; King's College London; Linkoping University; University of Padua; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Steno Diabetes Center; Aarhus University; Harvard University; Joslin Diabetes Center, Inc.	Chaturvedi, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, Norfolk Pl, London W2 1PG, England.	n.chaturvedi@ic.ac.uk		Marre, Michel/0000-0002-3071-1837; Hardy, Rebecca/0000-0001-9949-0799				BARNES LA, IN PRESS DIABETES; Bojestig M., 1997, Diabetologia, V40, pA544; Chalmers J, 1999, J HYPERTENS, V17, P151; Chaturvedi N, 1997, LANCET, V349, P1787, DOI 10.1016/S0140-6736(96)10244-0; CHAVERS BM, 1989, NEW ENGL J MED, V320, P966, DOI 10.1056/NEJM198904133201503; Cooper ME, 1998, LANCET, V352, P213, DOI 10.1016/S0140-6736(98)01346-4; Cordonnier DJ, 1999, J AM SOC NEPHROL, V10, P1253; Crepaldi G, 1998, DIABETES CARE, V21, P104, DOI 10.2337/diacare.21.1.104; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DOYLE AE, 1991, BRIT MED J, V302, P210; Ebbehoj E, 1998, DIABETOLOGIA, V41, pA5; FIORETTO P, 1995, KIDNEY INT, V48, P1929, DOI 10.1038/ki.1995.493; FIORETTO P, 1994, DIABETES, V43, P1358, DOI 10.2337/diabetes.43.11.1358; Goldstein H, 2000, J ROY STAT SOC C-APP, V49, P399, DOI 10.1111/1467-9876.00200; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; KASISKE BL, 1993, ANN INTERN MED, V118, P129, DOI 10.7326/0003-4819-118-2-199301150-00009; LAFFEL LMB, 1995, AM J MED, V99, P497, DOI 10.1016/S0002-9343(99)80226-5; MARRE M, 1988, BMJ-BRIT MED J, V297, P1092, DOI 10.1136/bmj.297.6656.1092; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; MATHIESEN ER, 1991, BMJ-BRIT MED J, V303, P81, DOI 10.1136/bmj.303.6794.81; Nankervis A, 1998, METABOLISM, V47, P12, DOI 10.1016/S0026-0495(98)90364-X; O'Hare JP, 2000, DIABETES CARE, V23, P1823, DOI 10.2337/diacare.23.12.1823; ODONNELL MJ, 1993, J HUM HYPERTENS, V7, P327; RASBASH J, 1996, MLN COMMAND REFERENC; Rudberg S, 1999, DIABETOLOGIA, V42, P589, DOI 10.1007/s001250051199; Senn S, 2000, STAT MED, V19, P861, DOI 10.1002/(SICI)1097-0258(20000330)19:6<861::AID-SIM407>3.0.CO;2-F; STEPHENSON JM, 1994, J DIABETES COMPLICAT, V8, P166, DOI 10.1016/1056-8727(94)90035-3; Striker GE, 1996, NEPHROL DIAL TRANSPL, V11, P58; VANHOUWELINGEN HC, 1993, STAT MED, V12, P2273, DOI 10.1002/sim.4780122405; VIBERTI G, 1994, JAMA-J AM MED ASSOC, V271, P275, DOI 10.1001/jama.271.4.275; WALKER JD, 1992, KIDNEY INT, V41, P741, DOI 10.1038/ki.1992.116; WHITEHEAD A, 1991, STAT MED, V10, P1665, DOI 10.1002/sim.4780101105; [No title captured]	33	297	300	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2001	134	5					370	379		10.7326/0003-4819-134-5-200103060-00009	http://dx.doi.org/10.7326/0003-4819-134-5-200103060-00009			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405ZJ	11242497				2022-12-28	WOS:000167190200003
J	Spiegelman, BM; Flier, JS				Spiegelman, BM; Flier, JS			Obesity and the regulation of energy balance	CELL			English	Review							MITOCHONDRIAL UNCOUPLING PROTEIN; MELANIN-CONCENTRATING HORMONE; NUCLEAR RESPIRATORY FACTORS; LEPTIN GENE-EXPRESSION; ADIPOSE-TISSUE; BODY-WEIGHT; NEUROPEPTIDE-Y; FOOD-INTAKE; PPAR-GAMMA; MICE		Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu; jflier@caregroup.harvard.edu	Flier, jeffrey/AAG-6223-2019					Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; BILLINGTON CJ, 1994, AM J PHYSIOL, V266, pR1765, DOI 10.1152/ajpregu.1994.266.6.R1765; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; BJORBAEK C, 2000, IN PRESS J BIOL CHEM; Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; Boss O, 1999, BIOCHEM BIOPH RES CO, V261, P870, DOI 10.1006/bbrc.1999.1145; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brown MS, 1998, NUTR REV, V56, pS1; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; CASSARDDOULCIER AM, 1993, MOL ENDOCRINOL, V7, P497, DOI 10.1210/me.7.4.497; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Cone RD, 1999, TRENDS ENDOCRIN MET, V10, P211, DOI 10.1016/S1043-2760(99)00153-8; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emond M, 1999, AM J PHYSIOL-REG I, V276, pR1545, DOI 10.1152/ajpregu.1999.276.5.R1545; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Flier JS, 2000, J CLIN INVEST, V105, P859, DOI 10.1172/JCI9725; Flint A, 1998, J CLIN INVEST, V101, P515, DOI 10.1172/JCI990; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gehlert DR, 1999, NEUROPEPTIDES, V33, P329, DOI 10.1054/npep.1999.0057; Gloaguen I, 1997, P NATL ACAD SCI USA, V94, P6456, DOI 10.1073/pnas.94.12.6456; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; Graham M, 1997, NAT GENET, V17, P273, DOI 10.1038/ng1197-273; Gugneja S, 1996, MOL CELL BIOL, V16, P5708; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kozak LP, 2000, ANNU REV NUTR, V20, P339, DOI 10.1146/annurev.nutr.20.1.339; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; LEE Y, 2000, IN PRESS J BIOL CHEM; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lowell BB, 1997, ANNU REV MED, V48, P307; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; Mantzoros CS, 2000, J CLIN ENDOCR METAB, V85, P4000, DOI 10.1210/jc.85.11.4000; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Moran TH, 2000, NUTRITION, V16, P858, DOI 10.1016/S0899-9007(00)00419-6; Neel JV, 1999, NUTR REV, V57, pS2, DOI 10.1111/j.1753-4887.1999.tb01782.x; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; RAVUSSIN E, 1995, METABOLISM, V44, P12, DOI 10.1016/0026-0495(95)90312-7; RICQUIER D, 2000, J PHYSL, V1, P3; Rosen ED, 2000, GENE DEV, V14, P1293; ROSS SR, 1993, GENE DEV, V7, P1318, DOI 10.1101/gad.7.7b.1318; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sears IB, 1996, MOL CELL BIOL, V16, P3410; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SIMONSEN L, 1992, AM J PHYSIOL, V263, pE850, DOI 10.1152/ajpendo.1992.263.5.E850; Smith GP, 2000, NUTRITION, V16, P814, DOI 10.1016/S0899-9007(00)00457-3; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; STANLEY BG, 1986, PEPTIDES, V7, P1189; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Troiano RP, 1999, INT J OBESITY, V23, pS22, DOI 10.1038/sj.ijo.0800855; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	100	1774	1844	5	227	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2001	104	4					531	543		10.1016/S0092-8674(01)00240-9	http://dx.doi.org/10.1016/S0092-8674(01)00240-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	405VP	11239410	Bronze			2022-12-28	WOS:000167181500008
J	Heidelbach, F				Heidelbach, F			Materials science - Watching grains deform	SCIENCE			English	Editorial Material									Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany	University of Bayreuth	Heidelbach, F (corresponding author), Univ Bayreuth, Bayer Geoinst, POB 101251, D-95440 Bayreuth, Germany.							ADAMS BL, 1993, METALL TRANS A, V24, P819, DOI 10.1007/BF02656503; BERGER A, 1988, PROG MATER SCI, V32, P1, DOI 10.1016/0079-6425(88)90009-6; Kocks U. F., 1998, TEXTURE ANISOTROPY; Margulies L, 2001, SCIENCE, V291, P2392, DOI 10.1126/science.1057956; MOLINARI A, 1987, ACTA METALL MATER, V35, P2983, DOI 10.1016/0001-6160(87)90297-5; Sachs G., 1928, VDIZ, V12, P134; Taylor GI, 1938, J I MET, V62, P307; WRIGHT SI, 1993, MATER SCI FORUM, V157, P1313	8	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2330	2331		10.1126/science.1060345	http://dx.doi.org/10.1126/science.1060345			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11269306				2022-12-28	WOS:000167618700032
J	Pearce, JA; Leat, PT; Barker, PF; Millar, IL				Pearce, JA; Leat, PT; Barker, PF; Millar, IL			Geochemical tracing of Pacific-to-Atlantic upper-mantle flow through the Drake passage	NATURE			English	Article							AUSTRALIAN-ANTARCTIC DISCORDANCE; EAST-SCOTIA RIDGE; CHILE RIDGE; BASALTS; ISOTOPE; PLUME; OCEAN; CONVECTION; ELEMENT; ORIGIN	The Earth's convecting upper mantle can be viewed as comprising three main reservoirs, beneath the Pacific, Atlantic and Indian oceans. Because of the uneven global distribution and migration of ridges and subduction zones, the surface area of the Pacific reservoir is at present contracting at about 0.6 km(2) yr(-1), while the Atlantic and Indian reservoirs are growing at about 0.45 km(2) yr(-1) and 0.15 km(2) yr(-1), respectively(1,2). Garfunkel(1) and others have argued that there must accordingly be net mantle flow from the Pacific to the Atlantic and Indian reservoirs (in order to maintain mass balance), and Alvarez(2) further predicted that this flow should be restricted to the few parts of the Pacific rim (here termed 'gateways') where there are no continental roots or subduction zones that might act as barriers to shallow mantle flow. The main Pacific gateways are, according to Alvarez(2,3), the southeast Indian Ocean, the Caribbean Sea and the Drake passage. Here we report geochemical data which confirm that there has been some outflow of Pacific mantle into the Drake passage-but probably in response to regional tectonic constraints, rather than global mass-balance requirements. We also show that a mantle domain boundary, equivalent to the Australian-Antarctic discordance, must lie between the Drake passage and the east Scotia Sea.	Cardiff Univ, Dept Earth Sci, Cardiff CF10 3YE, S Glam, Wales; British Antarctic Survey, Cambridge CB3 0ET, England	Cardiff University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Pearce, JA (corresponding author), Cardiff Univ, Dept Earth Sci, Cardiff CF10 3YE, S Glam, Wales.		Pearce, Julian A/C-5807-2009; Millar, Ian L/F-1541-2010	Pearce, Julian A/0000-0002-1206-148X; 				ALVAREZ W, 1990, TECTONICS, V9, P1213, DOI 10.1029/TC009i005p01213; ALVAREZ W, 1982, J GEOPHYS RES, V87, P6697, DOI 10.1029/JB087iB08p06697; Bach W, 1996, EARTH PLANET SC LETT, V142, P223, DOI 10.1016/0012-821X(96)00095-7; BACH W, 1994, CONTRIB MINERAL PETR, V116, P365, DOI 10.1007/BF00310905; Barker P.F., 1995, BACKARC BASINS TECTO, P281, DOI [DOI 10.1007/978-1-4615-1843-3_, 10.1007/978-1-4615-1843-3_7]; BARKER PF, 1977, MAR GEOL, V25, P15, DOI 10.1016/0025-3227(77)90045-7; Castillo PR, 1998, EARTH PLANET SC LETT, V154, P109, DOI 10.1016/S0012-821X(97)00172-6; Christie DM, 1998, NATURE, V394, P637, DOI 10.1038/29226; Douglass J, 1999, J GEOPHYS RES-SOL EA, V104, P2941, DOI 10.1029/98JB02642; DVORKIN J, 1993, TECTONOPHYSICS, V227, P63, DOI 10.1016/0040-1951(93)90087-Z; FERGUSON EM, 1993, NATURE, V366, P330, DOI 10.1038/366330a0; GARFUNKEL Z, 1975, J GEOPHYS RES, V80, P4425, DOI 10.1029/JB080i032p04425; HELFFRICH G, 1999, J C ABS, V4, P844; KLEIN EM, 1995, NATURE, V374, P52, DOI 10.1038/374052a0; KLEIN EM, 1988, NATURE, V333, P623, DOI 10.1038/333623a0; Kurz MD, 1998, GEOCHIM COSMOCHIM AC, V62, P841, DOI 10.1016/S0016-7037(97)00383-9; Leat PT, 2000, J PETROL, V41, P845, DOI 10.1093/petrology/41.6.845; LEROEX AP, 1985, CONTRIB MINERAL PETR, V90, P367, DOI 10.1007/BF00384715; Livermore R, 1997, EARTH PLANET SC LETT, V150, P261, DOI 10.1016/S0012-821X(97)00074-5; MAHONEY J, 1992, J GEOPHYS RES-SOL EA, V97, P19771, DOI 10.1029/92JB01424; MAHONEY JJ, 1994, EARTH PLANET SC LETT, V121, P173, DOI 10.1016/0012-821X(94)90039-6; MORGAN JP, 1995, J GEOPHYS RES-SOL EA, V100, P12753, DOI 10.1029/95JB00041; Morgan JP, 1999, EARTH PLANET SC LETT, V170, P215, DOI 10.1016/S0012-821X(99)00114-4; PYLE DG, 1995, J GEOPHYS RES-SOL EA, V100, P22261, DOI 10.1029/95JB01424; RUSSO RM, 1994, SCIENCE, V263, P1105, DOI 10.1126/science.263.5150.1105; Russo RM, 1996, PHYS EARTH PLANET IN, V95, P251, DOI 10.1016/0031-9201(95)03128-6; Saunders A. D., 1982, ANTARCT GEOSCI, P213; SLEEP NH, 1990, J GEOPHYS RES-SOLID, V95, P6715, DOI 10.1029/JB095iB05p06715; Vlastelic I, 1999, NATURE, V399, P345, DOI 10.1038/20664; WOODHOUSE JH, 1984, J GEOPHYS RES, V89, P5953, DOI 10.1029/JB089iB07p05953	30	68	71	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					457	461		10.1038/35068542	http://dx.doi.org/10.1038/35068542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260710				2022-12-28	WOS:000167583800038
J	Scott, IC; Blitz, IL; Pappano, WN; Maas, SA; Cho, KWY; Greenspan, DS				Scott, IC; Blitz, IL; Pappano, WN; Maas, SA; Cho, KWY; Greenspan, DS			Homologues of Twisted gastrulation are extracellular cofactors in antagonism of BMP signalling	NATURE			English	Article							BONE MORPHOGENETIC PROTEIN-1; DROSOPHILA EMBRYO; GROWTH-FACTOR; ACTIVITY GRADIENT; FAMILY MEMBER; CHORDIN; BINDING; XENOPUS; GENES; SOG	Twisted gastrulation (TSG) is involved in specifying the dorsal-most cell fate in Drosophila embryos(1), but its mechanism of action is poorly understood. TSG has been proposed to modify the action of Short gastrulation (SOG), thereby increasing signalling by the bone morphogenetic protein (BMP) Decapentaplegic. SOG, an inhibitor of BMP signalling, is in turn inactivated by the protease Tolloid(2,3). Here we identify Tsg gene products from human, mouse, Xenopus, zebrafish and chick. Expression patterns in mouse and Xenopus embryos are consistent with in vivo interactions between Tsg, BMPs and the vertebrate SOG orthologue, chordin. We show that Tsg binds both the vertebrate Decapentaplegic orthologue BMP4 and chordin, and that these interactions have multiple effects. Tsg increases chordin's binding of BMP4, potentiates chordin's ability to induce secondary axes in Xenopus embryos, and enhances chordin cleavage by vertebrate tolloid-related proteases at a site poorly used in Tsg's absence; also, the presence of Tsg enhances the secondary axis-inducing activity of two products of chordin cleavage. We conclude that Tsg acts as a cofactor in chordin's antagonism of BMP signalling.	Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, Madison, WI 53706 USA; Univ Wisconsin, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Irvine; University of California System; University of California Irvine	Greenspan, DS (corresponding author), Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, 1300 Univ Ave, Madison, WI 53706 USA.			Pappano, William/0000-0003-2848-2219; Greenspan, Daniel/0000-0001-8096-7446				ARORA K, 1992, DEVELOPMENT, V114, P1003; ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Blitz IL, 2000, DEV BIOL, V223, P120, DOI 10.1006/dbio.2000.9740; Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; CHO KWY, 1991, CELL, V67, P111; FERGUSON EL, 1992, DEVELOPMENT, V114, P583; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; Furuta Y, 1997, DEVELOPMENT, V124, P2203; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; Holley SA, 1996, CELL, V86, P607, DOI 10.1016/S0092-8674(00)80134-8; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Larrain J, 2000, DEVELOPMENT, V127, P821; Lee SB, 1997, J BIOL CHEM, V272, P19059, DOI 10.1074/jbc.272.30.19059; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; MASON ED, 1994, GENE DEV, V8, P1489, DOI 10.1101/gad.8.13.1489; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Pappano WN, 1998, GENOMICS, V52, P236, DOI 10.1006/geno.1998.5474; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; TAKAHARA K, 1994, J BIOL CHEM, V269, P32572; WHARTON KA, 1993, DEVELOPMENT, V117, P807; Yu K, 2000, DEVELOPMENT, V127, P2143; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069; ZUSMAN SB, 1988, DEV BIOL, V129, P417, DOI 10.1016/0012-1606(88)90389-2	27	152	170	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					475	478		10.1038/35068572	http://dx.doi.org/10.1038/35068572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260715				2022-12-28	WOS:000167583800043
J	Snow, V; Mottur-Pilson, C; Gonzales, R				Snow, V; Mottur-Pilson, C; Gonzales, R		Amer Coll Phys-Amer Soc Internal Med	Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults	ANNALS OF INTERNAL MEDICINE			English	Article									Amer Coll Phys Amer Soc Internal Med, Customer Serv, Philadelphia, PA 19106 USA		Snow, V (corresponding author), Amer Coll Phys Amer Soc Internal Med, Customer Serv, 190 N Independence Mall W, Philadelphia, PA 19106 USA.								0	68	76	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					487	489		10.7326/0003-4819-134-6-200103200-00014	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00014			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409VF	11255525				2022-12-28	WOS:000167405800008
J	Goldstein, LSB				Goldstein, LSB			Transduction - When worlds collide - Trafficking in JNK	SCIENCE			English	Editorial Material							ALZHEIMERS-DISEASE; SCAFFOLD PROTEINS; AXONAL-TRANSPORT; RECEPTOR; KINASE; MEMBRANE; BINDING; COMPLEX; SIGNAL; MOTOR		Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego	Goldstein, LSB (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.							Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; Ito M, 1999, MOL CELL BIOL, V19, P7539; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Yasuda J, 1999, MOL CELL BIOL, V19, P7245	17	31	32	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2102	2103		10.1126/science.1059766	http://dx.doi.org/10.1126/science.1059766			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11256408				2022-12-28	WOS:000167563800024
J	Wu, K; Leighton, JA				Wu, K; Leighton, JA			Paclitaxel and cell division.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Mayo Clin, Jacksonville, FL 32216 USA; Mayo Clin Scottsdale, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Wu, K (corresponding author), Mayo Clin, Jacksonville, FL 32216 USA.								0	4	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2001	344	11					815	815		10.1056/NEJM200103153441105	http://dx.doi.org/10.1056/NEJM200103153441105			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410LA	11248157				2022-12-28	WOS:000167440400005
J	Rodriguez, I; Kilborn, MJ; Liu, XK; Pezzullo, JC; Woosley, RL				Rodriguez, I; Kilborn, MJ; Liu, XK; Pezzullo, JC; Woosley, RL			Drug-induced QT prolongation in women during the menstrual cycle	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VENTRICULAR REPOLARIZATION; ATRIAL-FLUTTER; DE-POINTES; GENDER; IBUTILIDE; INTERVAL; SEX; RISK; FIBRILLATION; DIFFERENCE	Context Women have a higher incidence of torsades de pointes than men, but it is not known if the risk of drug-induced torsades de pointes varies during the menstrual cycle, Objectives To determine if the degree of QT prolongation in response to ibutilide varies with the menstrual cycle phase and to compare QT prolongation between women and men. Design and Setting Cohort study of men and women who received the same intervention conducted between November 1998 and November 2000 at a general clinical research center of a university hospital. Participants A volunteer sample of 58 healthy adults (38 men and 20 women) aged 21 to 40 years. Intervention A low dose of ibutilide (0.003 mg/kg), infused intravenously for 10 minutes. Subjects were monitored for 120 minutes. Women received the intervention on 3 separate occasions to correspond with menstrual cycle phases, which were verified by using hormonal assays. Main Outcome Measure QT interval, recorded from electrocardiogram at timed intervals during and after ibutilide infusion and standardized for variations in heart rate (QTc), Results Maximum (mean [SD]) millisecond increase in QTc after ibutilide infusion was greater for women during menses (63 [13]) and the ovulatory phase (59 [17]) compared with women during the luteal phase (53 [14]) and compared with men (46 [16]; P = .002 vs menses and P = .007 vs ovulation), Progesterone (r = -0.40) and progesterone-to-estradiol ratio (r = -0.41), but not estradiol (r = 0.14) or testosterone (r = 0.09), were inversely correlated with ibutilide-induced QT prolongation. Conclusions Menstrual cycle and sex differences exist in QTc responses to ibutilide, with the greatest increase in QTc corresponding to the first half of the menstrual cycle.	Georgetown Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Washington, DC 20007 USA; Georgetown Univ, Med Ctr, Dept Pharmacol, Washington, DC 20007 USA	Georgetown University; Georgetown University	Woosley, RL (corresponding author), Georgetown Univ, Med Ctr, Dept Med, Div Clin Pharmacol, 3900 Reservoir Rd NW,Med Dent Bldg,Room SE 402, Washington, DC 20007 USA.		Woosley, Raymond/AAE-4874-2020	Woosley, Raymond/0000-0002-2588-328X; Liu, Xiaoke/0000-0003-4782-0957	NCRR NIH HHS [1 M01-RR13297] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR013297] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Benton RE, 2000, CLIN PHARMACOL THER, V67, P413, DOI 10.1067/mcp.2000.105761; Burke JH, 1996, AM J MED, V100, P537, DOI 10.1016/S0002-9343(96)00018-6; Burke JH, 1997, AM J CARDIOL, V79, P178, DOI 10.1016/S0002-9149(96)00707-2; Drici MD, 1998, JAMA-J AM MED ASSOC, V280, P1774, DOI 10.1001/jama.280.20.1774; Drici MD, 1996, CIRCULATION, V94, P1471, DOI 10.1161/01.CIR.94.6.1471; Foster RH, 1997, DRUGS, V54, P312, DOI 10.2165/00003495-199754020-00010; Fridericia LS, 1920, ACTA MED SCAND, V53, P489; Hara M, 1998, J PHARMACOL EXP THER, V285, P1068; Kowey P R, 1996, Am J Cardiol, V78, P46, DOI 10.1016/S0002-9149(96)00566-8; Lee KS, 1998, J PHARMACOL EXP THER, V286, P9; Lehmann MH, 1996, CIRCULATION, V94, P2535, DOI 10.1161/01.CIR.94.10.2535; Liu XK, 1998, J PHARMACOL EXP THER, V285, P672; MAKKAR RR, 1993, JAMA-J AM MED ASSOC, V270, P2590, DOI 10.1001/jama.270.21.2590; Naccarelli G V, 1996, Am J Cardiol, V78, P12, DOI 10.1016/S0002-9149(96)00560-7; Rashba EJ, 1998, CIRCULATION, V97, P451; RAUTAHARJU PM, 1992, CAN J CARDIOL, V8, P690; SALE ME, 1994, CLIN PHARMACOL THER, V56, P295, DOI 10.1038/clpt.1994.140; Stambler BS, 1996, CIRCULATION, V94, P1613, DOI 10.1161/01.CIR.94.7.1613; StrambaBadiale M, 1997, EUR HEART J, V18, P1000; Waldegger S, 1996, N-S ARCH PHARMACOL, V354, P698, DOI 10.1007/BF00166894; YANG T, 1995, CIRCULATION, V91, P1799, DOI 10.1161/01.CIR.91.6.1799	22	212	220	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2001	285	10					1322	1326		10.1001/jama.285.10.1322	http://dx.doi.org/10.1001/jama.285.10.1322			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408QK	11255387	Bronze			2022-12-28	WOS:000167339000024
J	Slevogt, H; Schiller, R; Wesselmann, H; Suttorp, N				Slevogt, H; Schiller, R; Wesselmann, H; Suttorp, N			Ascending cellulitis after an insect bite	LANCET			English	Article							NOCARDIOSIS		Humboldt Univ, Charite, Dept Med Infect Dis, D-13353 Berlin, Germany; Humboldt Univ, Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Slevogt, H (corresponding author), Humboldt Univ, Charite, Dept Med Infect Dis, Augustenburger Pl 1, D-13353 Berlin, Germany.			Suttorp, Norbert/0000-0002-3958-1151				BOIRON P, 1992, EUR J CLIN MICROBIOL, V11, P709, DOI 10.1007/BF01989975; Hornef MW, 2000, DERMATOLOGY, V200, P78, DOI 10.1159/000018325; Lerner PI, 1996, CLIN INFECT DIS, V22, P891, DOI 10.1093/clinids/22.6.891; SMEGO RA, 1984, REV INFECT DIS, V6, P164; TSUBOI R, 1986, ARCH DERMATOL, V122, P1183, DOI 10.1001/archderm.122.10.1183	5	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					768	768		10.1016/S0140-6736(00)04171-4	http://dx.doi.org/10.1016/S0140-6736(00)04171-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253972				2022-12-28	WOS:000167400900016
J	Tahirov, TH; Inoue-Bungo, T; Morii, H; Fujikawa, A; Sasaki, M; Kimura, K; Shiina, M; Sato, K; Kumasaka, T; Yamamoto, M; Ishii, S; Ogata, K				Tahirov, TH; Inoue-Bungo, T; Morii, H; Fujikawa, A; Sasaki, M; Kimura, K; Shiina, M; Sato, K; Kumasaka, T; Yamamoto, M; Ishii, S; Ogata, K			Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBF beta	CELL			English	Article							CORE-BINDING-FACTOR; TRANSCRIPTION FACTOR PEBP2; ACUTE MYELOID-LEUKEMIA; CLEIDOCRANIAL DYSPLASIA; CRYSTAL-STRUCTURE; POINT MUTATIONS; AML1/PEBP2-ALPHA-B GENE; FUNCTIONAL DOMAINS; CYSTEINE RESIDUES; ALPHA-SUBUNIT	The core binding factor (CBF) heterodimeric transcription factors comprised of AML/CBFA/PEBPSalpha/Runx and CBF beta /PEBP2 beta subunits are essential for differentiation of hematopoietic and bone cells, and their mutation is intimately related to the development of acute leukemias and cleidocranial dysplasia. Here, we present the crystal structures of the AML1/Runx-1/CBF alpha (Runt domain)-CBF beta (core domain)-C/EBP beta (b-Zip)-DNA, AML1/Runx-1/CBF alpha (Runt domain)-C/EBP beta (bZip)-DNA, and AML1/Runx-1/CBF alpha (Runt domain)DNA complexes. The hydrogen bonding network formed among CBF alpha (Runt domain) and CBF beta, and CBF alpha (Runt domain) and DNA revealed the allosteric regulation mechanism of CBF alpha (Runt domain)-DNA binding by CBF beta. The point mutations of CBF alpha related to the aforementioned diseases were also mapped and their effect on DNA binding is discussed.	Yokohama City Univ, Sch Med, Kanagawa Acad Sci & Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Sch Med, Dept Biol Struct, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Sch Med, Dept Urol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Sch Med, Dept Pathol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Sch Med, Dept Biochem, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Natl Inst Biosci & Human Technol, Prot Folding Grp, Tsukuba, Ibaraki 3058566, Japan; RIKEN, Harima Inst SPring 8, Biocrystallog Technol Div, Sayo, Hyogo 6795148, Japan; RIKEN, Harima Inst SPring 8, Struct Biophys Lab, Sayo, Hyogo 6795148, Japan; JST, Res Project, CREST, Tsukuba, Ibaraki 3050074, Japan; RIKEN, Tsukuba Inst, Genet Mol Lab, Tsukuba, Ibaraki 3050074, Japan	Kanagawa Academy Science & Technology; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; National Institute of Advanced Industrial Science & Technology (AIST); RIKEN; RIKEN; Japan Science & Technology Agency (JST); RIKEN	Ogata, K (corresponding author), Yokohama City Univ, Sch Med, Kanagawa Acad Sci & Technol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.		Yamamoto, Masaki/B-7844-2015; Ishii, Shunsuke/A-5271-2016; Kumasaka, Takashi/D-7428-2018	Yamamoto, Masaki/0000-0002-1311-1768; Ishii, Shunsuke/0000-0002-6530-2478; Kumasaka, Takashi/0000-0001-9289-1557; Tahirov, Tahir/0000-0002-1238-0069				Akamatsu Y, 1997, GENE, V185, P111, DOI 10.1016/S0378-1119(96)00644-0; Akamatsu Y, 1997, J BIOL CHEM, V272, P14497, DOI 10.1074/jbc.272.23.14497; Barton K, 2000, BIOESSAYS, V22, P214, DOI 10.1002/(SICI)1521-1878(200003)22:3<214::AID-BIES2>3.0.CO;2-I; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Berardi MJ, 1999, STRUCT FOLD DES, V7, P1247, DOI 10.1016/S0969-2126(00)80058-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Chen YQ, 1998, NAT STRUCT BIOL, V5, P67, DOI 10.1038/nsb0198-67; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Cleary ML, 1999, NAT GENET, V23, P134, DOI 10.1038/13761; Cramer P, 1997, EMBO J, V16, P7078, DOI 10.1093/emboj/16.23.7078; Crute BE, 1996, J BIOL CHEM, V271, P26251, DOI 10.1074/jbc.271.42.26251; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Goger M, 1999, NAT STRUCT BIOL, V6, P620; Gu TL, 2000, MOL CELL BIOL, V20, P91, DOI 10.1128/MCB.20.1.91-103.2000; Hollstein M, 1996, NUCLEIC ACIDS RES, V24, P141, DOI 10.1093/nar/24.1.141; Huang XM, 1999, NAT STRUCT BIOL, V6, P624; Imai Y, 2000, BLOOD, V96, P3154, DOI 10.1182/blood.V96.9.3154.h8003154_3154_3160; Ito Y, 1999, GENES CELLS, V4, P685, DOI 10.1046/j.1365-2443.1999.00298.x; KAGOSHIMA H, 1993, TRENDS GENET, V9, P338, DOI 10.1016/0168-9525(93)90026-E; Kagoshima H, 1996, J BIOL CHEM, V271, P33074, DOI 10.1074/jbc.271.51.33074; KAMACHI Y, 1990, J VIROL, V64, P4808, DOI 10.1128/JVI.64.10.4808-4819.1990; Komori T, 1998, CURR OPIN GENET DEV, V8, P494, DOI 10.1016/S0959-437X(98)80123-8; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; LENNY N, 1995, ONCOGENE, V11, P1761; Li LH, 1999, DEVELOPMENT, V126, P3313; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Lutterbach B, 2000, GENE, V245, P223, DOI 10.1016/S0378-1119(00)00014-7; MELNIKOVA IN, 1993, J VIROL, V67, P2408, DOI 10.1128/JVI.67.4.2408-2411.1993; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Nagata T, 1999, NAT STRUCT BIOL, V6, P615; OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Perez-Alvarado GC, 2000, FEBS LETT, V470, P125, DOI 10.1016/S0014-5793(00)01296-5; Petrovick HS, 1998, MOL CELL BIOL, V18, P3915, DOI 10.1128/MCB.18.7.3915; Preudhomme C, 2000, BLOOD, V96, P2862, DOI 10.1182/blood.V96.8.2862.h8002862_2862_2869; Quack I, 1999, AM J HUM GENET, V65, P1268, DOI 10.1086/302622; RAINWATER R, 1995, MOL CELL BIOL, V15, P3892; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Speck NA, 1995, CRIT REV EUKAR GENE, V5, P337, DOI 10.1615/CritRevEukarGeneExpr.v5.i3-4.60; SPECK NA, 1999, CANCER RES, V59, P1789; TAHIROV TH, 2001, IN PRESS ACTA CRYSTA; Tang YY, 2000, J BIOL CHEM, V275, P39579, DOI 10.1074/jbc.M007350200; Tang YY, 2000, FEBS LETT, V470, P167, DOI 10.1016/S0014-5793(00)01312-0; Warren AJ, 2000, EMBO J, V19, P3004, DOI 10.1093/emboj/19.12.3004; Werner MH, 1999, NAT MED, V5, P1356, DOI 10.1038/70920; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; Zhang YW, 2000, GENE, V244, P21, DOI 10.1016/S0378-1119(99)00558-2; Zhou G, 1999, HUM MOL GENET, V8, P2311, DOI 10.1093/hmg/8.12.2311; Zhou P, 1998, CELL, V92, P687, DOI 10.1016/S0092-8674(00)81136-8	57	256	267	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2001	104	5					755	767		10.1016/S0092-8674(01)00271-9	http://dx.doi.org/10.1016/S0092-8674(01)00271-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257229	Bronze			2022-12-28	WOS:000167531100015
J	Tissenbaum, HA; Guarente, L				Tissenbaum, HA; Guarente, L			Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans	NATURE			English	Article							FAMILY-MEMBER; PROTEIN SIR2; C-ELEGANS; LONGEVITY; DIAPAUSE; AGE-1; DAF-2; REPRODUCTION; MUTATION; PATHWAY	In Caenorhabditis elegans, mutations that reduce the activity of an insulin-like receptor (daf-2)(1) or a phosphatidylinositol-3-OH kinase (age-1)(2) favour entry into the dauer state during larval development(3) and extend lifespan in adults(3-6). Downregulation of this pathway activates a forkhead transcription factor (daf-16)(7,8), which may regulate targets that promote dauer formation in larvae and stress resistance and longevity in adults(9). In yeast, the SIR2 gene determines the lifespan of mother cells, and adding an extra copy of SIR2 extends lifespan(10). Sir2 mediates chromatin silencing through a histone deacetylase activity that depends on NAD (nicotinamide adenine dinucleotide) as a cofactor(11-13). We have surveyed the lifespan of C. elegans strains containing duplications of chromosomal regions. Here we report that a duplication containing sir-2.1-the C. elegans gene most homologous to yeast SIR2-confers a lifespan that is extended by up to 50%. Genetic analysis indicates that the sir-2.1 transgene functions upstream of daf-16 in the insulin-like signalling pathway. Our findings suggest that Sir2 proteins may couple longevity to nutrient availability in many eukaryotic organisms.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@MIT.edu						Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; BRENNER S, 1974, GENETICS, V77, P71; DORMAN JB, 1995, GENETICS, V141, P1399; FRIEDMAN DB, 1988, GENETICS, V118, P75; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gems D, 1998, GENETICS, V150, P129; HEDGECOCK EM, 1995, GENETICS, V141, P989; HERMAN RK, 1979, DEV BIOL, V49, P200; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; LARSEN PL, 1995, GENETICS, V139, P1567; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; RIDDLE DL, 1997, ELEGANS, V2, P739; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Tissenbaum HA, 1998, GENETICS, V148, P703	27	1478	1575	4	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2001	410	6825					227	230		10.1038/35065638	http://dx.doi.org/10.1038/35065638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242085				2022-12-28	WOS:000167320500051
J	Feldman, AM; Li, YY; McTiernan, CF				Feldman, AM; Li, YY; McTiernan, CF			Matrix metalloproteinases in pathophysiology and treatment of heart failure	LANCET			English	Editorial Material							TISSUE INHIBITORS; COLLAGEN; EXPRESSION; DISEASE; MICE		Univ Penn, Med Ctr Hlth Syst, Cardiovasc Inst, Pittsburgh, PA 15213 USA	University of Pennsylvania	Feldman, AM (corresponding author), Univ Penn, Med Ctr Hlth Syst, Cardiovasc Inst, Pittsburgh, PA 15213 USA.							BORG TK, 1981, FED PROC, V40, P2037; DOLLERY CM, 1995, CIRC RES, V77, P863, DOI 10.1161/01.RES.77.5.863; GunjaSmith Z, 1996, AM J PATHOL, V148, P1639; HAMERMAN D, 1993, JOINT CARTILAGE DEGR, P529; Holmgren Emil, 1907, Archiv fuer Mikroskopische Anatomie Bonn, V71, DOI 10.1007/BF02979915; Li YY, 2000, CARDIOVASC RES, V46, P214, DOI 10.1016/S0008-6363(00)00003-1; Li YY, 2000, P NATL ACAD SCI USA, V97, P12746, DOI 10.1073/pnas.97.23.12746; Li YY, 1998, CIRCULATION, V98, P1728, DOI 10.1161/01.CIR.98.17.1728; Rohde LE, 1999, CIRCULATION, V99, P3063, DOI 10.1161/01.CIR.99.23.3063; Spinale FG, 2000, CARDIOVASC RES, V46, P225, DOI 10.1016/S0008-6363(99)00431-9; Spinale FG, 2000, CIRCULATION, V102, P1944, DOI 10.1161/01.CIR.102.16.1944; Spinale FG, 1998, CIRC RES, V82, P482, DOI 10.1161/01.RES.82.4.482; Spinale FG, 1999, CIRC RES, V85, P364, DOI 10.1161/01.RES.85.4.364; Thomas CV, 1998, CIRCULATION, V97, P1708, DOI 10.1161/01.CIR.97.17.1708; WEBER KT, 1988, AM HEART J, V116, P1641, DOI 10.1016/0002-8703(88)90763-6; WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4	16	32	37	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					654	655		10.1016/S0140-6736(00)04151-9	http://dx.doi.org/10.1016/S0140-6736(00)04151-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247546				2022-12-28	WOS:000167282400005
J	Spiegel, PB; Salama, P				Spiegel, PB; Salama, P			Emergencies in developed countries: are aid organisations ready to adapt?	LANCET			English	Editorial Material									Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Serv, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Spiegel, PB (corresponding author), Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Serv, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA.		Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				BURKHOLDER BT, 2000, FORC MIGR MORT P WAS; *STEER COMM HUM RE, 1998, SPHER HUM CHART MIN	2	13	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					714	714		10.1016/S0140-6736(00)04143-X	http://dx.doi.org/10.1016/S0140-6736(00)04143-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247574				2022-12-28	WOS:000167282400041
J	Woo, PCY; Wong, SSY; Lum, PNL; Hui, WT; Yuen, KY				Woo, PCY; Wong, SSY; Lum, PNL; Hui, WT; Yuen, KY			Cell-wall-deficient bacteria and culture-negative febrile episodes in bone-marrow-transplant recipients	LANCET			English	Article							RISK-FACTORS; INFECTION	Background Although about 75-80% of neutropenic fevers are thought to be caused by infections, a causal organism can be confirmed microbiologically or suspected clinically in only 30-50%, and even fewer of these cases (16%) have a documented bacteraemia. The cause of neutropenic fever in the remaining cases remains elusive. We investigate the role of cell-wall-deficient bacteria in bone-marrow transplantation (BMT). Methods Blood cultures were obtained from bone-marrow-transplant recipients and were inoculated into an aerobic bottle with resin, an anaerobic bottle, and a bottle to isolate cell-wall deficient bacteria. When growth was detected in the blood-culture bottle for cell-wall-deficient bacteria, 20 muL of the broth was subcultured and the isolate identified by standard biochemical methods. The microbiological findings were correlated with the clinical characteristics of the patients. Findings From the 86 BMT recipients enrolled into the study, 798 sets of blood cultures were sent for laboratory analysis. 55 blood cultures were positive in the aerobic bottle, and the same isolates were also detected in 52 blood-culture bottles for cell-wall-deficient forms. For 20 sets of blood cultures, the isolates were detected only in the bottle for cell-wall-deficient forms. Blood for 13 (65%) of these 20 sets were sampled in the pre-engraftment neutropenic period, three (15%) during conditioning when the absolute neutrophil count was above 0.5x10(9)/L, and four (20%) in the post-engraftment period. 17 (85%) of the isolates were gram positive: four (20%) were Staphylococcus spp and ten (50%) were Bacillus spp. Antibiotic treatment was successful in 19 (95%) of 20 episodes. Interpretation Bacteraemia due to cell-wall-deficient forms causes a significant proportion of so-called culture-negative febrile episodes in BMT recipients.	Univ Hong Kong, Dept Microbiol, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Yuen, KY (corresponding author), Univ Hong Kong, Dept Microbiol, Queen Mary Hosp, Pathol Bldg,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.		Wong, Samson/C-4446-2009; Yuen, Kwok Yung/C-4465-2009; Woo, Patrick Chiu Yat/C-4449-2009	Woo, Patrick Chiu Yat/0000-0001-9401-1832; Yuen, Kwok-yung/0000-0002-2083-1552				Baron E.J., 1999, MANUAL CLIN MICROBIO, V7th; BOW EJ, 1998, J ANTIMICROB CHEMO S, V41, pD1; DePauw BE, 1996, ANN HEMATOL, V72, P273; Dienes L, 1940, P SOC EXP BIOL MED, V44, P470; Dienes L, 1939, J INFECT DIS, V65, P24, DOI 10.1093/infdis/65.1.24; DIENTES L, 1970, ROLE MYCOPLASMAS L F, P185; GOODRICH JM, 1991, J INFECT DIS, V164, P731, DOI 10.1093/infdis/164.4.731; HOLLER GJ, 1968, MICROBIAL PROTOPLAST, P352; MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301; NIMO LN, 1969, APPL MICROBIOL, V18, P535; PATTERSON SK, 1982, CELL WALL DEFICIENT, P1; PIZZO PA, 1993, NEW ENGL J MED, V328, P1323; ROBERTS RICHARD B., 1968, P230; SABLE CA, 1994, CLIN INFECT DIS, V18, P273, DOI 10.1093/clinids/18.3.273; WEIBULL C, 1953, J BACTERIOL, V66, P688, DOI 10.1128/JB.66.6.688-695.1953; Wong SSY, 2000, DIAGN MICR INFEC DIS, V36, P261, DOI 10.1016/S0732-8893(99)00141-8; Woo PCY, 1998, CLIN INFECT DIS, V27, P382, DOI 10.1086/514659; Yuen KY, 1998, BONE MARROW TRANSPL, V21, P1137, DOI 10.1038/sj.bmt.1701246; Yuen KY, 1998, DIAGN MICR INFEC DIS, V30, P75, DOI 10.1016/S0732-8893(97)00213-7	19	43	47	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					675	679		10.1016/S0140-6736(00)04131-3	http://dx.doi.org/10.1016/S0140-6736(00)04131-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247551				2022-12-28	WOS:000167282400012
J	Merscher, S; Funke, B; Epstein, JA; Heyer, J; Puech, A; Lu, MM; Xavier, RJ; Demay, MB; Russell, RG; Factor, S; Tokooya, K; Jore, BS; Lopez, M; Pandita, RK; Lia, M; Carrion, D; Xu, H; Schorle, H; Kobler, JB; Scambler, P; Wynshaw-Boris, A; Skoultchi, AI; Morrow, BE; Kucherlapati, R				Merscher, S; Funke, B; Epstein, JA; Heyer, J; Puech, A; Lu, MM; Xavier, RJ; Demay, MB; Russell, RG; Factor, S; Tokooya, K; Jore, BS; Lopez, M; Pandita, RK; Lia, M; Carrion, D; Xu, H; Schorle, H; Kobler, JB; Scambler, P; Wynshaw-Boris, A; Skoultchi, AI; Morrow, BE; Kucherlapati, R			TBX1 is responsible for cardiovascular defects in Velo-Cardio-Facial/DiGeorge syndrome	CELL			English	Article							CONGENITAL HEART-DISEASE; DIGEORGE-SYNDROME REGION; HOLT-ORAM-SYNDROME; NEURAL CREST CELLS; FACIAL-SYNDROME; 22Q11 DELETIONS; MOLECULAR DEFINITION; MICE DEFICIENT; GENE; MUTATIONS	Velo-cardio-facial syndrome (VCFS)/DiGeorge syndrome (DGS) is a human disorder characterized by a number of phenotypic features including cardiovascular defects. Most VCFS/DGS patients are hemizygous for a 1.5-3.0 Mb region of 22q11. To investigate the etiology of this disorder, we used a cre-loxP strategy to generate mice that are hemizygous for a 1.5 Mb deletion corresponding to that on 22q11. These mice exhibit significant perinatal lethality and have conotruncal and parathyroid defects. The conotruncal defects can be partially rescued by a human BAC containing the TBX1 gene. Mice heterozygous for a null mutation in Tbx1 develop conotruncal defects. These results together with the expression patterns of Tbx1 suggest a major role for this gene in the molecular etiology of VCFS/DGS.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Univ Penn, Div Cardiovasc, Philadelphia, PA 19104 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Univ London, Coll Med, Inst Child Hlth, London, England; Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Forschungszentrum Karlsruhe, Inst Genet & Toxikol, D-76133 Karlsruhe, Germany; Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med,Dept Otol & Laryngol, HP Mosher Laryngol Res Lab, Boston, MA 02114 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; University of California System; University of California San Diego; University of London; University College London; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Helmholtz Association; Karlsruhe Institute of Technology; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Morrow, BE (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Schorle, Hubert/M-5001-2016; Toyooka, Kazuhito/AAQ-6928-2020; Kucherlapati, Raju/ABC-8807-2021; Toyooka, Kazuhito/AAH-7175-2019; Scambler, Peter/AAZ-6026-2020; PUECH, Anne/A-7470-2013; Schorle, Hubert/S-1713-2019; Scambler, Peter J/C-4998-2008	Schorle, Hubert/0000-0001-8272-0076; Toyooka, Kazuhito/0000-0002-0173-0430; Toyooka, Kazuhito/0000-0002-0173-0430; Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628; Epstein, Jonathan/0000-0001-8637-4465; Morrow, Bernice/0000-0002-8076-4726; Merscher, Sandra/0000-0002-4757-7494	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD034980] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061475, R01HL062974] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL61475, HL 62974] Funding Source: Medline; NICHD NIH HHS [HD34980] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; BOCKMAN DE, 1984, SCIENCE, V223, P498, DOI 10.1126/science.6606851; BOCKMAN DE, 1987, AM J ANAT, V180, P332; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chieffo C, 1997, GENOMICS, V43, P267, DOI 10.1006/geno.1997.4829; CONLEY ME, 1979, J PEDIATR-US, V94, P883, DOI 10.1016/S0022-3476(79)80207-3; Creazzo TL, 1998, ANNU REV PHYSIOL, V60, P267, DOI 10.1146/annurev.physiol.60.1.267; DiGeorge A, 1965, J PEDIAT, V67, P907, DOI [DOI 10.1016/S0022-3476(65)81796-6, 10.1016/S0022-3476(65)82145-X]; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Epstein JA, 2000, PEDIATR RES, V48, P717, DOI 10.1203/00006450-200012000-00003; FINLEY JP, 1977, CAN MED ASSOC J, V116, P635; FUNKE B, 2001, IN PRESS GENOMICS; GOLDBERG R, 1993, AM J MED GENET, V45, P313, DOI 10.1002/ajmg.1320450307; Kimber WL, 1999, HUM MOL GENET, V8, P2229, DOI 10.1093/hmg/8.12.2229; KIRBY ML, 1990, CIRCULATION, V82, P332, DOI 10.1161/01.CIR.82.2.332; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; LEDOUARIN N, 1981, NEURAL CREST; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Li QY, 1997, NAT GENET, V15, P21; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Maldonado-Saldivia J, 2000, MECH DEVELOP, V96, P121, DOI 10.1016/S0925-4773(00)00370-1; McKie JM, 1997, HUM GENET, V101, P6, DOI 10.1007/s004390050576; MORROW B, 1995, AM J HUM GENET, V56, P1391; Puech A, 2000, P NATL ACAD SCI USA, V97, P10090, DOI 10.1073/pnas.97.18.10090; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Scuccimarri R, 1998, J PEDIATR ENDOCR MET, V11, P273; SHPRINTZEN R J, 1985, American Journal of Human Genetics, V37, pA77; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; Sucov HM, 1998, ANNU REV PHYSIOL, V60, P287, DOI 10.1146/annurev.physiol.60.1.287; VANMIEROP LHS, 1986, AM J CARDIOL, V58, P133, DOI 10.1016/0002-9149(86)90256-0; Ware J, 2000, P NATL ACAD SCI USA, V97, P2803, DOI 10.1073/pnas.050582097; YAGI M, 1994, J BIOL CHEM, V269, P17424	36	688	698	0	26	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 23	2001	104	4					619	629		10.1016/S0092-8674(01)00247-1	http://dx.doi.org/10.1016/S0092-8674(01)00247-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	405VP	11239417	Bronze			2022-12-28	WOS:000167181500015
J	Vickers, NJ; Christensen, TA; Baker, TC; Hildebrand, JG				Vickers, NJ; Christensen, TA; Baker, TC; Hildebrand, JG			Odour-plume dynamics influence the brain's olfactory code	NATURE			English	Article							OSCILLATING NEURAL ASSEMBLIES; ODORS; REPRESENTATIONS; INFORMATION; NETWORK; MOTHS; RESPONSES; GLOMERULI	The neural computations used to represent olfactory information in the brain have long been investigated(1-3). Recent studies in the insect antennal lobe suggest that precise temporal and/or spatial patterns of activity underlie the recognition and discrimination of different odours(3-7), and that these patterns may be strengthened by associative learning(8,9). It remains unknown, however, whether these activity patterns persist when odour intensity varies rapidly and unpredictably, as often occurs in nature(10,11). Here we show that with naturally intermittent odour stimulation, spike patterns recorded from moth antennal-lobe output neurons varied predictably with the fine-scale temporal dynamics and intensity of the odour. These data support the hypothesis that olfactory circuits compensate for contextual variations in the stimulus pattern with high temporal precision. The timing of output neuron activity is constantly modulated to reflect ongoing changes in stimulus intensity and dynamics that occur on a millisecond timescale.	Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA; Iowa State Univ, Dept Entomol, Ames, IA 50011 USA	University of Arizona; Iowa State University	Vickers, NJ (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.			Vickers, Neil/0000-0002-0378-8724				Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; Baker TC, 1997, INSECT PHEROMONE RESEARCH, P248; Buracas GT, 1999, TRENDS NEUROSCI, V22, P303, DOI 10.1016/S0166-2236(98)01376-9; CHRISTENSEN TA, 1995, J COMP PHYSIOL A, V177, P545, DOI 10.1007/BF00207184; Christensen TA, 1996, J NEUROBIOL, V30, P82, DOI 10.1002/(SICI)1097-4695(199605)30:1<82::AID-NEU8>3.0.CO;2-C; Christensen TA, 1998, J NEUROSCI, V18, P5999; Christensen TA, 2000, NAT NEUROSCI, V3, P927, DOI 10.1038/78840; CHRISTENSEN TA, 2001, NEUROBIOLOGY TAST SM, V2, P201; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; GELPERIN A, 1990, NATURE, V345, P437, DOI 10.1038/345437a0; Hansson Bill S., 1999, P125; Heinbockel T, 1998, J COMP PHYSIOL A, V182, P703, DOI 10.1007/s003590050215; Hildebrand JG, 1996, J COMP PHYSIOL A, V178, P5, DOI 10.1007/BF00189586; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; King JR, 2000, J NEUROSCI, V20, P2391; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, J NEUROSCI, V16, P3837; LEI H, 2000, SOC NEUR ABSTR, V26, P1208; Murlis J, 1997, INSECT PHEROMONE RESEARCH, P221; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Vickers NJ, 1998, J COMP NEUROL, V400, P35; VICKERS NJ, 1994, P NATL ACAD SCI USA, V91, P5756, DOI 10.1073/pnas.91.13.5756; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0	23	185	192	0	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					466	470		10.1038/35068559	http://dx.doi.org/10.1038/35068559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260713				2022-12-28	WOS:000167583800041
J	Stoler, MH; Schiffman, M				Stoler, MH; Schiffman, M		Atypical Squamous Cells Undetermin	Interobserver reproducibility of cervical cytologic and histologic interpretations - Realistic estimates from the ASCUS-LSIL triage study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATYPICAL GLANDULAR CELLS; HISTOPATHOLOGICAL DIAGNOSIS; UNDETERMINED SIGNIFICANCE; OBSERVER VARIATION; BIOPSY SPECIMENS; VARIABILITY; AGREEMENT; ABNORMALITIES; DYSPLASIA; CRITERIA	Context Despite a critical presumption of reliability, standards of interpathologist agreement have not been well defined for interpretation of cervical pathology specimens. Objective To determine the reproducibility of cytologic, colposcopic histologic, and loop electrosurgical excision procedure (LEEP) histologic cervical specimen interpretations among multiple well-trained observers. Design and Setting The Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion (ASCUS-LSIL) Triage Study (ALTS), an ongoing US multicenter clinical trial. Subjects From women enrolled in ALTS during 1996-1998, 4948 monolayer cytologic slides, 2237 colposcopic biopsies, and 535 LEEP specimens were interpreted by 7 clinical center and 4 Pathology Quality Control Group (QC) pathologists. Main Outcome Measures kappa Values calculated for comparison of the original clinical center interpretation and the first QC reviewer's masked interpretation of specimens. Results For all 3 specimen types, the clinical center pathologists rendered significantly more severe interpretations than did reviewing QC pathologists. The reproducibility of monolayer cytologic interpretations was moderate (kappa =0.46; 95% confidence interval [CI], 0.44-0.48) and equivalent to the reproducibility of punch biopsy histopathologic interpretations (kappa =0.46; 95% CI, 0.43-0.49) and LEEP histopathologic interpretations (kappa =0.49; 95% CI, 0.44-0.55), The lack of reproducibility of histopathology was most evident for less severe interpretations. Conclusions Interpretive variability is substantial for all types of cervical specimens. Histopathology of cervical biopsies is not more reproducible than monolayer cytology, and even the interpretation of LEEP results is variable. Given the degree of irreproducibility that exists among well-trained pathologists, realistic performance expectations should guide use of their interpretations.	Univ Virginia Hlth Syst, Div Surg Pathol & Cytopathol, Charlottesville, VA 22908 USA; NCI, Bethesda, MD 20892 USA	University of Virginia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stoler, MH (corresponding author), Univ Virginia Hlth Syst, Div Surg Pathol & Cytopathol, Box 800214, Charlottesville, VA 22908 USA.		Schiffman, Mark/B-9766-2015		DIVISION OF CANCER PREVENTION AND CONTROL [N01CN055157, N01CN055155, N01CN055153, N01CN055105, N01CN055154, N01CN055156, N01CN055159] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01CP010124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER; NCI NIH HHS [CN55159, CN55155, CN55154, CN55153, CN15518, CN55156, CN55105, CN55157] Funding Source: Medline	DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		COCKER J, 1968, J CLIN PATHOL, V21, P67, DOI 10.1136/jcp.21.1.67; CONFORTINI M, 1993, ACTA CYTOL, V37, P49; CREAGH T, 1995, J CLIN PATHOL, V48, P9; Crum CP, 1999, AM J CLIN PATHOL, V112, P384; DEVET HCW, 1992, J CLIN EPIDEMIOL, V45, P785, DOI 10.1016/0895-4356(92)90056-S; DEVET HCW, 1990, J CLIN EPIDEMIOL, V43, P1395, DOI 10.1016/0895-4356(90)90107-Z; DEVET HCW, 1995, J CLIN EPIDEMIOL, V48, P869, DOI 10.1016/0895-4356(94)00225-F; EVANS DMD, 1974, J CLIN PATHOL, V27, P945, DOI 10.1136/jcp.27.12.945; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Ferris D G, 1998, J Low Genit Tract Dis, V2, P195, DOI 10.1097/00128360-199810000-00003; Fleiss JL, 1981, STAT METHODS RATES P, P218; GENEST DR, 1993, HUM PATHOL, V24, P730, DOI 10.1016/0046-8177(93)90009-6; HORN PL, 1985, ACTA CYTOL, V29, P692; ISMAIL SM, 1989, BRIT MED J, V298, P707, DOI 10.1136/bmj.298.6675.707; KLINKHAMER PJJM, 1988, ACTA CYTOL, V32, P794; LAMBOURNE A, 1973, J CLIN PATHOL, V26, P564, DOI 10.1136/jcp.26.8.564; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; McCluggage WG, 1996, J CLIN PATHOL, V49, P833, DOI 10.1136/jcp.49.10.833; Raab SS, 1997, AM J CLIN PATHOL, V107, P299, DOI 10.1093/ajcp/107.3.299; Raab SS, 1998, AM J CLIN PATHOL, V110, P653, DOI 10.1093/ajcp/110.5.653; RINGSTED J, 1978, ACTA PATH MICRO IM A, V86, P273; ROBERTSON AJ, 1989, J CLIN PATHOL, V42, P231, DOI 10.1136/jcp.42.3.231; Schiffman M, 2000, ACTA CYTOL, V44, P726, DOI 10.1159/000328554; SELLORS JW, 1990, OBSTET GYNECOL, V76, P1005; SEYBOLT JF, 1971, AM J OBSTET GYNECOL, V109, P1089, DOI 10.1016/0002-9378(71)90297-3; SHERMAN ME, 1994, AM J CLIN PATHOL, V102, P182, DOI 10.1093/ajcp/102.2.182; Sherman ME, 1999, MODERN PATHOL, V12, P335; SIEGLER EE, 1956, CANCER, V9, P463, DOI 10.1002/1097-0142(195605/06)9:3<463::AID-CNCR2820090306>3.0.CO;2-8; Stoler MH, 2000, MODERN PATHOL, V13, P275, DOI 10.1038/modpathol.3880048; Stoler MH, 1999, CANCER CYTOPATHOL, V87, P45, DOI 10.1002/(SICI)1097-0142(19990425)87:2<45::AID-CNCR1>3.0.CO;2-J; YOBS AR, 1987, ACTA CYTOL, V31, P900; YOUNG NA, 1994, DIAGN CYTOPATHOL, V11, P352, DOI 10.1002/dc.2840110408	32	767	807	1	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1500	1505		10.1001/jama.285.11.1500	http://dx.doi.org/10.1001/jama.285.11.1500			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410VQ	11255427	Bronze			2022-12-28	WOS:000167462100033
J	Prins, JB; Bleijenberg, G; Bazelmans, E; Elving, LD; de Boo, TM; Severens, JL; van der Wilt, GJ; Spinhoven, P; van der Meer, JWM				Prins, JB; Bleijenberg, G; Bazelmans, E; Elving, LD; de Boo, TM; Severens, JL; van der Wilt, GJ; Spinhoven, P; van der Meer, JWM			Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial	LANCET			English	Article							KARNOFSKY PERFORMANCE STATUS; MULTIPLE-SCLEROSIS; VALIDITY; IMPACT	Background Cognitive behaviour therapy (CBT) seems a promising treatment for chronic fatigue syndrome (CFS), but the applicability of this treatment outside specialised settings has been questioned. We compared CBT with guided support groups and the natural course in a randomised trial at three centres. Methods Of 476 patients diagnosed with CFS, 278 were eligible and willing to take part. 93 were randomly assigned CBT (administered by 13 therapists recently trained in this technique for CFS), 94 were assigned the support-group approach, and 91 the control natural course. Multidimensional assessments were done at baseline, 8 months, and 14 months. The primary outcome variables were fatigue severity (on the checklist individual strength) and functional impairment (on the sickness impact profile) at 8 and 14 months. Data were analysed by intention to treat. Findings 241 patients had complete data (83 CBT, 80 support groups, 78 natural course) at 8 months. At 14 months CBT was significantly more effective than both control conditions for fatigue severity (CBT vs support groups 5.8 [2.2-9.4]; CBT vs natural course 5.6 [2.1-9.0]) and for functional impairment (CBT vs support groups 263 [38-488]. CBT vs natural course 222 [3-441]). Support groups were not more effective for CFS patients than the natural course. Among the CBT group. clinically significant improvement was seen in fatigue severity for 20 of 58 (35%), in Karnofsky performance status for 28 of 57 (49%), and self-rated improvement for 29 of 58 (50%). Prognostic factors for outcome after CBT were a higher sense of control predicting more improvement, and a passive activity pattern and focusing on bodily symptoms predicting less improvement. Interpretation CBT was more effective than guided support groups and the natural course in a multicentre trial with many therapists. Our study showed a lower proportion of patients with improvement than CBT trials with a few highly skilled therapists.	Univ Med Ctr Nijmegen, Dept Med Psychol, NL-6500 HB Nijmegen, Netherlands; Univ Med Ctr, Dept Internal Med, Nijmegen, Netherlands; Univ Med Ctr, Dept Med Stat, Nijmegen, Netherlands; Univ Med Ctr, Dept Med Technol Assessment, Nijmegen, Netherlands; Leiden Univ, Dept Psychol & Psychiat, NL-2300 RA Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University - Excl LUMC	Prins, JB (corresponding author), Univ Med Ctr Nijmegen, Dept Med Psychol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.prins@cksmps.azn.nl	Prins, Judith B/C-8522-2013; van der Wilt, G.J./H-8120-2014; Bazelmans, Ellen/AAM-1820-2021; van der Meer, Jos W.M./C-8521-2013	van der Wilt, G.J./0000-0002-5856-762X; van der Meer, Jos W.M./0000-0001-5120-3690				BARLOW JH, 1993, PATIENT EDUC COUNS, V20, P153, DOI 10.1016/0738-3991(93)90129-K; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Beurskens AJHM, 2000, OCCUP ENVIRON MED, V57, P353, DOI 10.1136/oem.57.5.353; BONNER D, 1994, J NEUROL NEUROSUR PS, V57, P617, DOI 10.1136/jnnp.57.5.617; BUTLER S, 1991, J NEUROL NEUROSUR PS, V54, P153, DOI 10.1136/jnnp.54.2.153; Deale A, 1997, AM J PSYCHIAT, V154, P408; DEBRUIN AF, 1992, TIJDSCHRIFT SOCIALE, V70, P160; Ettema J, 1986, SCL 90 HANDLEIDING B; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Jacobs H M, 1990, Ned Tijdschr Geneeskd, V134, P1950; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kendall PC, 1999, J CONSULT CLIN PSYCH, V67, P285, DOI 10.1037/0022-006X.67.3.285; Little R. J. A., 1987, STAT ANAL MISSING DA; Myers C, 1999, QUAL LIFE RES, V8, P9, DOI 10.1023/A:1026459027453; ODELL MW, 1995, J ACQ IMMUN DEF SYND, V10, P350; Prins JB, 1999, J BEHAV THER EXP PSY, V30, P325, DOI 10.1016/S0005-7916(99)00032-4; Reid S, 2000, BMJ-BRIT MED J, V320, P292, DOI 10.1136/bmj.320.7230.292; SCHAAFSMA J, 1994, QUAL LIFE RES, V3, P413, DOI 10.1007/BF00435393; Schulz KF, 1996, LANCET, V348, P596, DOI 10.1016/S0140-6736(96)01201-9; Sharpe M, 1996, BRIT MED J, V312, P22, DOI 10.1136/bmj.312.7022.22; Subramaniam V, 1999, J PAIN SYMPTOM MANAG, V17, P376, DOI 10.1016/S0885-3924(99)00012-3; van der Werf SP, 2000, J PSYCHOSOM RES, V49, P373, DOI 10.1016/S0022-3999(00)00197-5; VanDulmen AM, 1997, PSYCHOL MED, V27, P725, DOI 10.1017/S0033291796003777; Vercoulen J. H, 1999, GEDRAGSTHERAPIE, V32, P31; Vercoulen JHMM, 1997, J PSYCHIAT RES, V31, P661, DOI 10.1016/S0022-3956(97)00039-3; Vercoulen JHMM, 1998, J PSYCHOSOM RES, V45, P507, DOI 10.1016/S0022-3999(98)00023-3; Vercoulen JHMM, 1996, LANCET, V347, P858, DOI 10.1016/S0140-6736(96)91345-8; Vercoulen JHMM, 1996, ARCH NEUROL-CHICAGO, V53, P642, DOI 10.1001/archneur.1996.00550070080014; Vercoulen JHMM, 1996, J NEUROL NEUROSUR PS, V60, P489, DOI 10.1136/jnnp.60.5.489; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Wessely S, 1998, CHRONIC FATIGUE ITS; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	33	361	364	0	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2001	357	9259					841	847		10.1016/S0140-6736(00)04198-2	http://dx.doi.org/10.1016/S0140-6736(00)04198-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	412ZW	11265953				2022-12-28	WOS:000167586300011
J	Rajendran, R				Rajendran, R			A lump in the mouth	LANCET			English	Editorial Material									Coll Med, Dept Oral Pathol, Trivandrum 695011, Kerala, India		Rajendran, R (corresponding author), Coll Med, Dept Oral Pathol, Dent Wing, Trivandrum 695011, Kerala, India.							Bakilana P B, 1985, Odontostomatol Trop, V8, P133; EBERHARD ML, 1991, CLIN LAB MED, V11, P977, DOI 10.1016/S0272-2712(18)30531-6; OTTESEN E A, 1989, American Journal of Tropical Medicine and Hygiene, V41, P9; Sasa M., 1976, HUMAN FILARIASIS GLO, P1	4	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 17	2001	357	9259					852	852		10.1016/S0140-6736(00)04200-8	http://dx.doi.org/10.1016/S0140-6736(00)04200-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265955				2022-12-28	WOS:000167586300013
J	Cahn, RW				Cahn, RW			Genesis by definition	NATURE			English	Article									Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England	University of Cambridge	Cahn, RW (corresponding author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.							CAHN RW, 2001, COMING MAT SCI; Ziman J., 2000, REAL SCI; Ziman John, 1996, SCI STUD, V9, P67	3	2	2	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					307	307		10.1038/35066646	http://dx.doi.org/10.1038/35066646			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268182	Bronze			2022-12-28	WOS:000167464100022
J	Koch, A; Melbye, M; Sorensen, P; Homoe, P; Madsen, HO; Molbak, K; Hansen, CH; Andersen, LH; Hahn, GW; Garred, P				Koch, A; Melbye, M; Sorensen, P; Homoe, P; Madsen, HO; Molbak, K; Hansen, CH; Andersen, LH; Hahn, GW; Garred, P			Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROTEIN GENE; SERINE-PROTEASE; OTITIS-MEDIA; ASSOCIATION; CHILDREN; MUTATIONS; SUSCEPTIBILITY; POPULATIONS; COMPLEMENT; ADULTS	Context Hospital-based studies have found that increased susceptibility to certain infections is associated with low serum levels of mannose-binding lectin (MBL) due to MBL variant alleles, However, the contribution of MBL insufficiency to incidence of common childhood infections at a population level is unknown, Objective To investigate the effect of MBL insufficiency on risk for acute respiratory tract infection (ARI) in unselected children younger than 2 years. Design and Setting Population-based, prospective, cohort study conducted in Sisimiut, Greenland, Participants Two hundred fifty-two children younger than 2 years who were followed up weekly between August 1996 and August 1998 for morbidity surveillance. Main Outcome Measure Risk of ARI, based on medical history and clinical examination, compared by MBL genotype, determined from blood samples based on presence of structural and promoter alleles. Results A 2.08-fold (95% confidence interval [CI], 1.41-3.06) increased relative risk (RR) of ARI was found in MBL-insufficient children (n = 13) compared with MBL sufficient children (n = 239; P < .001), The risk association was largely restricted to children aged 6 to 17 months (RR, 2.92; 95% CI, 1.78-4.79) while less effect (RR, 1.47; 95% CI, 0.45-4.82) and no effect (RR, 1.00; 95% CI, 0.42-2.37) was shown among children aged 0 to 5 months and 18 to 23 months, respectively, Conclusion These data suggest that genetic factors such as MBL insufficiency play an important role in host defense, particularly during the vulnerable period of childhood from age 6 through 17 months, when the adaptive immune system is immature.	Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; Natl Univ Hosp, Rigshosp, Dept Otolaryngol Head & Neck Surg, Copenhagen, Denmark; Natl Univ Hosp, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark	Statens Serum Institut; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Koch, A (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen, Denmark.		Madsen, Hans O/Q-2035-2015; Hahn, Gitte/AAN-4967-2020	Madsen, Hans O/0000-0001-5551-4787; Koch, Anders/0000-0001-9205-1048; Molbak, Kare/0000-0002-3100-4990; melbye, mads/0000-0001-8264-6785; Garred, Peter/0000-0002-2876-8586; Sorensen, Per Soelberg/0000-0002-2818-3780; Homoe, Preben/0000-0003-2877-3518				BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; DENNY FW, 1986, REV INFECT DIS, V8, P527; Diggle PJ, 1994, ANAL LONGITUDINAL DA; EZEKOWITZ R A B, 1991, Current Biology, V1, P60; Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1; Garred P, 1999, ARTHRITIS RHEUM, V42, P2145, DOI 10.1002/1529-0131(199910)42:10<2145::AID-ANR15>3.0.CO;2-#; Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861; GARRED P, 1993, CLIN EXP IMMUNOL, V94, P99; GARRED P, 1994, EUR J IMMUNOGENET, V21, P125, DOI 10.1111/j.1744-313X.1994.tb00183.x; Garred P, 2000, J RHEUMATOL, V27, P26; GARRED P, 1995, LANCET, V346, P94; Garred P, 1996, COLLECTINS INNATE IM, P139; *GENMOD PROC, 1996, SAS STAT SOFTW CHANG, P21; GRAHAM NMH, 1990, EPIDEMIOL REV, V12, P149, DOI 10.1093/oxfordjournals.epirev.a036050; HARTSHORN KL, 1993, J CLIN INVEST, V91, P1414, DOI 10.1172/JCI116345; Homoe P, 1999, SCAND J INFECT DIS, V31, P363, DOI 10.1080/00365549950163798; Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709; Madsen HO, 1998, J IMMUNOL, V161, P3169; MADSEN HO, 1995, J IMMUNOL, V155, P3013; MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Nepomuceno RR, 1997, IMMUNITY, V6, P119, DOI 10.1016/S1074-7613(00)80419-7; SASTRY K, 1989, J EXP MED, V170, P1175, DOI 10.1084/jem.170.4.1175; SELWYN BJ, 1990, REV INFECT DIS, V12, P870; SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9; SUMMERFIELD JA, 1995, LANCET, V345, P886, DOI 10.1016/S0140-6736(95)90009-8; Summerfield JA, 1997, BRIT MED J, V314, P1229, DOI 10.1136/bmj.314.7089.1229; SUPER M, 1989, LANCET, V2, P1236; TAYLOR ME, 1989, BIOCHEM J, V262, P763, DOI 10.1042/bj2620763; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Turner M W, 1991, Clin Exp Allergy, V21 Suppl 1, P182, DOI 10.1111/j.1365-2222.1991.tb01725.x; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; TURNER MW, 1994, BIOCHEM SOC T, V22, P88, DOI 10.1042/bst0220088	33	349	363	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2001	285	10					1316	1321		10.1001/jama.285.10.1316	http://dx.doi.org/10.1001/jama.285.10.1316			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408QK	11255386	Bronze			2022-12-28	WOS:000167339000023
J	Hargreaves, S				Hargreaves, S			Rape as a war crime: putting policy into practice	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Hargreaves, S (corresponding author), Lancet, London WC1X 8RR, England.			Hargreaves, Sally/0000-0003-2974-4348				Bruderlein C, 1999, BRIT MED J, V319, P430, DOI 10.1136/bmj.319.7207.430; MYDANS S, 2001, NY TIMES        0301; 2001, LANCET, V357, P302	3	13	13	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					737	737		10.1016/S0140-6736(00)04180-5	http://dx.doi.org/10.1016/S0140-6736(00)04180-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253963				2022-12-28	WOS:000167400900007
J	Glass, L				Glass, L			Synchronization and rhythmic processes in physiology	NATURE			English	Review							PERIOD-DOUBLING BIFURCATIONS; LOW-DIMENSIONAL CHAOS; PHASE-LOCKING; HEART-RATE; MECHANICAL VENTILATION; EPILEPTIC SEIZURES; DYNAMICS; MODEL; NOISE; INFORMATION	Complex bodily rhythms are ubiquitous in living organisms. These rhythms arise from stochastic, nonlinear biological mechanisms interacting with a fluctuating environment. Disease often leads to alterations from normal to pathological rhythm. Fundamental questions concerning the dynamics of these rhythmic processes abound. For example, what is the origin of physiological rhythms? How do the rhythms interact with each other and the external environment? Can we decode the fluctuations in physiological rhythms to better diagnose human disease? And can we develop better methods to control pathological rhythms? Mathematical and physical techniques combined with physiological and medical studies are addressing these questions and are transforming our understanding of the rhythms of life.	McGill Univ, Dept Physiol, Ctr Nonlinear Dynam Physiol & Med, Montreal, PQ H3G 1Y6, Canada	McGill University	Glass, L (corresponding author), McGill Univ, Dept Physiol, Ctr Nonlinear Dynam Physiol & Med, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.		Glass, Leon/C-5732-2008					Achermann P, 1999, J BIOL RHYTHM, V14, P460, DOI 10.1177/074873099129001028; BABLOYANTZ A, 1986, P NATL ACAD SCI USA, V83, P3513, DOI 10.1073/pnas.83.10.3513; Bak P., 1996, NATURE WORKS SCI SEL; Bassingthwaighte J. B., 1994, FRACTAL PHYSL; Beuter A, 1998, NEUROTOXICOL TERATOL, V20, P581, DOI 10.1016/S0892-0362(98)00021-X; Butera RJ, 1999, J NEUROPHYSIOL, V82, P398, DOI 10.1152/jn.1999.82.1.398; Camm AJ, 1996, CIRCULATION, V93, P1043; Christini DJ, 2001, HDB BIOL PHYS, V4, P205; Collins JJ, 1996, J NEUROPHYSIOL, V76, P642, DOI 10.1152/jn.1996.76.1.642; Collins JJ, 1997, PHYS REV E, V56, P923, DOI 10.1103/PhysRevE.56.923; Colquhoun David, 1995, P397; Costa M, 1999, J CARDIOVASC ELECTR, V10, P1350, DOI 10.1111/j.1540-8167.1999.tb00190.x; DAAN S, 1984, PSYCHOPHARMACOL BULL, V20, P566; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; De Vries G, 1998, B MATH BIOL, V60, P1167, DOI 10.1006/bulm.1998.0057; DEFELICE LJ, 1993, J STAT PHYS, V70, P339, DOI 10.1007/BF01053972; DEFELICE LJ, 1983, SINGLE CHANNEL RECOR, P323; Ditto WL, 2000, INT J BIFURCAT CHAOS, V10, P593, DOI 10.1142/S0218127400000402; DOUGLASS JK, 1993, NATURE, V365, P337, DOI 10.1038/365337a0; Edwards R, 2000, J CLIN NEUROPHYSIOL, V17, P87, DOI 10.1097/00004691-200001000-00009; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; GARFINKEL A, 1992, SCIENCE, V257, P1230, DOI 10.1126/science.1519060; Gerr F, 2000, NEUROTOXICOLOGY, V21, P753; GLASS L, 1979, J MATH BIOL, V7, P339, DOI 10.1007/BF00275153; Glass L, 1988, CLOCKS CHAOS RHYTHMS; Glass L, 1991, CHAOS, V1, P13, DOI 10.1063/1.165810; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Golubitsky M, 1999, NATURE, V401, P693, DOI 10.1038/44416; GRAVES C, 1986, AM J PHYSIOL, V250, pR902, DOI 10.1152/ajpregu.1986.250.5.R902; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Greenwood PE, 2000, PHYS REV LETT, V84, P4773, DOI 10.1103/PhysRevLett.84.4773; GUEVARA MR, 1982, J MATH BIOL, V14, P1, DOI 10.1007/BF02154750; GUEVARA MR, 1981, SCIENCE, V214, P1350, DOI 10.1126/science.7313693; GUEVARA MR, 1995, CHAOS, V5, P174, DOI 10.1063/1.166065; Haurie C, 1998, BLOOD, V92, P2629, DOI 10.1182/blood.V92.8.2629.420a35_2629_2640; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; Hausdorff JM, 2000, J APPL PHYSIOL, V88, P2045, DOI 10.1152/jappl.2000.88.6.2045; Hegger R, 1999, CHAOS, V9, P413, DOI 10.1063/1.166424; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huikuri HV, 2000, CIRCULATION, V101, P47, DOI 10.1161/01.CIR.101.1.47; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; JANSEN BH, 1993, NONLINEAR DYNAMICAL; Jewett ME, 1998, J THEOR BIOL, V192, P455, DOI 10.1006/jtbi.1998.0667; KANTERS JK, 1994, J CARDIOVASC ELECTR, V5, P591, DOI 10.1111/j.1540-8167.1994.tb01300.x; Kaplan DT, 1996, PHYS REV LETT, V76, P4074, DOI 10.1103/PhysRevLett.76.4074; Keener J., 1998, MATH PHYSL; KEENER JP, 1981, SIAM J APPL MATH, V41, P503, DOI 10.1137/0141042; Kiloh LG, 1981, CLIN ELECTROENCEPHAL; Klingenheben T, 2000, LANCET, V356, P651, DOI 10.1016/S0140-6736(00)02609-X; KOBAYASHI M, 1982, IEEE T BIO-MED ENG, V29, P456, DOI 10.1109/TBME.1982.324972; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Lehnertz K, 1998, PHYS REV LETT, V80, P5019, DOI 10.1103/PhysRevLett.80.5019; Leloup JC, 1998, J BIOL RHYTHM, V13, P70, DOI 10.1177/074873098128999934; LIPSITZ LA, 1995, CHAOS, V5, P102, DOI 10.1063/1.166091; LIPSITZ LA, 1995, BRIT HEART J, V74, P390; LONGTIN A, 1991, PHYS REV LETT, V67, P656, DOI 10.1103/PhysRevLett.67.656; LONGTIN A, 1995, CHAOS, V5, P209, DOI 10.1063/1.166140; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; Martinerie J, 1998, NAT MED, V4, P1173, DOI 10.1038/2667; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; Mormont MC, 1997, INT J CANCER, V70, P241, DOI 10.1002/(SICI)1097-0215(19970117)70:2<241::AID-IJC16>3.0.CO;2-L; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Paydarfar D, 1997, MED HYPOTHESES, V49, P19, DOI 10.1016/S0306-9877(97)90246-2; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; PEREZ R, 1982, PHYS LETT A, V90, P441, DOI 10.1016/0375-9601(82)90391-7; PETRILLO GA, 1984, AM J PHYSIOL, V246, pR311, DOI 10.1152/ajpregu.1984.246.3.R311; POOL R, 1989, SCIENCE, V243, P604, DOI 10.1126/science.2916117; Poon CS, 1997, NATURE, V389, P492, DOI 10.1038/39043; PRANK K, 1995, CHAOS, V5, P76, DOI 10.1063/1.166089; Prank K, 1996, BIOPHYS J, V70, P2540, DOI 10.1016/S0006-3495(96)79825-9; Rabinovich MI, 1998, NEUROSCIENCE, V87, P5, DOI 10.1016/S0306-4522(98)00091-8; Richardson KA, 1998, CHAOS, V8, P599, DOI 10.1063/1.166341; Roach D, 1998, AM J PHYSIOL-HEART C, V274, pH1465, DOI 10.1152/ajpheart.1998.274.5.H1465; ROSENBAUM DS, 1994, NEW ENGL J MED, V330, P235, DOI 10.1056/NEJM199401273300402; RUELLE D, 1994, PHYS TODAY, V47, P24, DOI 10.1063/1.881395; Schafer C, 1998, NATURE, V392, P239, DOI 10.1038/32567; Schiff SJ, 1998, NAT MED, V4, P1117, DOI 10.1038/2610; SCHIFF SJ, 1994, NATURE, V370, P615, DOI 10.1038/370615a0; Shinbrot T, 1995, ADV PHYS, V44, P73, DOI 10.1080/00018739500101506; Simon PM, 2000, J APPL PHYSIOL, V89, P760, DOI 10.1152/jappl.2000.89.2.760; Simonotto E, 1997, PHYS REV LETT, V78, P1186, DOI 10.1103/PhysRevLett.78.1186; SKARDA CA, 1987, BEHAV BRAIN SCI, V10, P161, DOI 10.1017/S0140525X00047336; SKINNER JE, 1993, AM HEART J, V125, P731, DOI 10.1016/0002-8703(93)90165-6; STROGATZ SH, 1986, LECT NOTES BIOMATHEM, V69; Suki B, 1998, NATURE, V393, P127, DOI 10.1038/30130; TAKAHASHI N, 1990, PHYSICA D, V43, P318, DOI 10.1016/0167-2789(90)90140-K; Turcott RG, 1996, ANN BIOMED ENG, V24, P269, DOI 10.1007/BF02667355; Veldman RG, 1999, EUR J ENDOCRINOL, V140, P192, DOI 10.1530/eje.0.1400192; Wiggins S., 1990, INTRO APPL NONLINEAR; WILDERS R, 1993, BIOPHYS J, V65, P2601, DOI 10.1016/S0006-3495(93)81289-X; Winfree AT., 1980, GEOMETRY BIOL TIME; [No title captured]	92	939	968	7	153	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 8	2001	410	6825					277	284		10.1038/35065745	http://dx.doi.org/10.1038/35065745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11258383				2022-12-28	WOS:000167320500062
J	Schmidt, OG; Eberl, K				Schmidt, OG; Eberl, K			Nanotechnology - Thin solid films roll up into nanotubes	NATURE			English	Article							CARBON NANOTUBE		Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany	Max Planck Society	Schmidt, OG (corresponding author), Max Planck Inst Festkorperforsch, Heisenbergstr 1, D-70569 Stuttgart, Germany.		Schmidt, Oliver G/W-4877-2019					Prinz VY, 2000, PHYSICA E, V6, P828, DOI 10.1016/S1386-9477(99)00249-0; Rueckes T, 2000, SCIENCE, V289, P94, DOI 10.1126/science.289.5476.94; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954	3	886	947	2	230	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					168	168		10.1038/35065525	http://dx.doi.org/10.1038/35065525			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242068	Bronze			2022-12-28	WOS:000167320500034
J	Laine, L; Schoenfeld, P; Fennerty, MB				Laine, L; Schoenfeld, P; Fennerty, MB			Therapy for Helicobacter pylori in patients with nonulcer dyspepsia - A meta-analysis of randomized, controlled trials	ANNALS OF INTERNAL MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; FUNCTIONAL DYSPEPSIA; LONG-TERM; POSITIVE PATIENTS; IMPROVE SYMPTOMS; FOLLOW-UP; ERADICATION; BENEFIT; MANAGEMENT	Purpose: To assess the effect of eradication therapy for Helicobacter pylori on symptoms of nonulcer dyspepsia. Data Sources: Duplicate searches of bibliographic databases, reviews of proceedings of annual gastroenterology and H. pylori meetings from 1995 to 1999, reviews of reference lists, and contact with primary investigators and pharmaceutical manufacturers. Study Selection: Included studies 1) examined patients with nonulcer dyspepsia and H, pylori infection; 2) used combination therapy for H. pylori and a control therapy without efficacy against H, pylori; 3) were randomized, controlled trials; 4) lasted for at least 1 month after the end of therapy; and 5) assessed symptoms of nonulcer dyspepsia. Ten studies were included. Data Extraction: Independent, duplicate data extraction of the methodologic quality, population, intervention, study design, duration, and outcome of the trials. Data Synthesis: The odds ratio (OR) for treatment success in nonulcer dyspepsia with H. pylori eradication therapy compared with control therapy was 1.29 (95% Cl, 0.89 to 1.89; P = 0.18). However, significant heterogeneity (P = 0.04) calls the validity of aggregating the data into question. Heterogeneity resolved with the exclusion of one study (OR, 1.07 [Cl, 0.83 to 1.37]; P > 0.2). For predefined analysis of trials that used a specifically stated definition of dyspepsia (that is, upper abdominal pain or discomfort), the OR was 1.04 (Cl, 0.80 to 1.35) without heterogeneity. For treatment that resulted in cure rather than persistent infection, the OR was 1.17 (Cl, 0.87 to 1.59) without heterogeneity. Conclusion: This meta-analysis provides little support for the use of H. pylori eradication therapy in patients with nonulcer dyspepsia.	Univ So Calif, Sch Med, Los Angeles, CA 90089 USA; Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; An Arbor Vet Affiars Med Ctr, Ann Arbor, MI USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA	University of Southern California; University of Michigan System; University of Michigan; Oregon Health & Science University	Laine, L (corresponding author), Univ So Calif, Sch Med, Los Angeles, CA 90089 USA.							Blum AL, 1998, NEW ENGL J MED, V339, P1875, DOI 10.1056/NEJM199812243392602; David J, 1996, GASTROENTEROLOGY, V110, pA91; Dhali GK, 1999, J GASTROEN HEPATOL, V14, P523, DOI 10.1046/j.1440-1746.1999.01909.x; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; GLUPCZYNSKI Y, 1988, AM J GASTROENTEROL, V83, P365; Greenberg PD, 1999, ARCH INTERN MED, V159, P2283, DOI 10.1001/archinte.159.19.2283; Heaney A, 1999, GUT, V45, P186, DOI 10.1136/gut.45.2.186; Hsu PI, 1999, GASTROENTEROLOGY, V116, pA191; Jaakkimainen RL, 1999, BMJ-BRIT MED J, V319, P1040, DOI 10.1136/bmj.319.7216.1040; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Koelz HR, 1998, GASTROENTEROLOGY, V114, pA182, DOI 10.1016/S0016-5085(98)80741-5; Lassen AT, 1998, GASTROENTEROLOGY, V114, pA196, DOI 10.1016/S0016-5085(98)80796-8; MCCARTHY C, 1995, DIGEST DIS SCI, V40, P114, DOI 10.1007/BF02063953; McColl K, 1998, NEW ENGL J MED, V339, P1869, DOI 10.1056/NEJM199812243392601; McColl KEL, 2000, NEW ENGL J MED, V342, P589; MCNULTY CAM, 1986, BRIT MED J, V293, P645, DOI 10.1136/bmj.293.6548.645; Mitty RD, 1997, GASTROENTEROLOGY, V112, pA221; Passos MCF, 1998, GUT, V43, pA81; Sheu BS, 1996, AM J GASTROENTEROL, V91, P441; TALLEY NJ, 1994, GASTROENTEROLOGY, V106, P1174, DOI 10.1016/0016-5085(94)90007-8; Talley NJ, 1999, GUT, V45, P37; Talley NJ, 1999, BMJ-BRIT MED J, V318, P833, DOI 10.1136/bmj.318.7187.833; Talley NJ, 1999, NEW ENGL J MED, V341, P1106, DOI 10.1056/NEJM199910073411502; TALLEY NJ, 1991, ALIMENT PHARM THERAP, V5, P145; Talley NJ, 1998, GASTROENTEROLOGY, V114, P582, DOI 10.1016/S0016-5085(98)70542-6; VAIRA D, 1992, ITAL J GASTROENTEROL, V24, P400; VANZANTEN SV, 1995, GASTROENTEROLOGY, V108, pA250	27	198	210	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2001	134	5					361	369		10.7326/0003-4819-134-5-200103060-00008	http://dx.doi.org/10.7326/0003-4819-134-5-200103060-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405ZJ	11242496				2022-12-28	WOS:000167190200002
J	Kahana, JA; Cleveland, DW				Kahana, JA; Cleveland, DW			Cell cycle - Some importin news about spindle assembly	SCIENCE			English	Editorial Material							XENOPUS EGG EXTRACTS; GTP-BOUND RAN; MITOTIC SPINDLE; MICROTUBULE ASTERS; ORGANIZATION; NUMA		Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Kahana, JA (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.		Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682				Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; COMPTON DA, 1993, J CELL BIOL, V120, P947, DOI 10.1083/jcb.120.4.947; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Guarguaglini G, 2000, CELL GROWTH DIFFER, V11, P455; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Zhang CM, 1999, J CELL SCI, V112, P2453	14	27	28	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1718	1719		10.1126/science.1059765	http://dx.doi.org/10.1126/science.1059765			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11253198				2022-12-28	WOS:000167320600036
J	Lin, CLG; Orlov, I; Ruggiero, AM; Dykes-Hoberg, M; Lee, A; Jackson, M; Rothstein, JD				Lin, CLG; Orlov, I; Ruggiero, AM; Dykes-Hoberg, M; Lee, A; Jackson, M; Rothstein, JD			Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18	NATURE			English	Article							CELL-SURFACE EXPRESSION; SYNAPTIC LOCALIZATION; SUBTYPE; ACTIVATION; ASTROCYTES; KIDNEY	Excitatory amino-acid carrier 1 (EAAC1) is a high-affinity Na+-dependent L-glutamate/D, L-aspartate cell-membrane transport protein 1. It is expressed in brain as well as several non-nervous tissues. In brain, EAAC1 is the primary neuronal glutamate transporter(2,3). It has a polarized distribution in cells and mainly functions perisynaptically to transport glutamate from the extracellular environment(2-4). In the kidney it is involved in renal acidic amino-acid re-absorption and amino-acid metabolism(5-7). Here we describe the identification and characterization of an EAAC1-associated protein, GTRAP3-18. Like EAAC1, GTRAP3-18 is expressed in numerous tissues(8,9). It localizes to the cell membrane and cytoplasm, and specifically interacts with carboxy-terminal intracellular domain of EAAC1. Increasing the expression of GTRAP3-18 in cells reduces EAAC1-mediated glutamate transport by lowering substrate affinity. The expression of GTRAP3-18 can be upregulated by retinoic acid, which results in a specific reduction of EAAC1-mediated glutamate transport. These studies show that glutamate transport proteins can be regulated potently and that GTRAP can modulate the transport functions ascribed to EAAC1. GTRAP3-18 may be important in regulating the metabolic function of EAAC1.	Johns Hopkins Univ, Dept Neurol & Neurosci, Baltimore, MD 21287 USA	Johns Hopkins University	Rothstein, JD (corresponding author), Johns Hopkins Univ, Dept Neurol & Neurosci, Meyer 6-109,600 N Wolfe St, Baltimore, MD 21287 USA.		rothstein, jeffrey d/C-9470-2013; Lin, Chien-liang G/E-3513-2011					Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Conti F, 1998, CEREB CORTEX, V8, P108, DOI 10.1093/cercor/8.2.108; Davis KE, 1998, J NEUROSCI, V18, P2475; Diamond JS, 1997, J NEUROSCI, V17, P4672; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; He Y, 2000, J COMP NEUROL, V418, P255; Hediger MA, 1999, AM J PHYSIOL-RENAL, V277, pF487, DOI 10.1152/ajprenal.1999.277.4.F487; Hediger MA, 1999, AM J PHYSIOL-RENAL, V277, pF477, DOI 10.1152/ajprenal.1999.277.4.F477; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Lin CLG, 1998, MOL BRAIN RES, V63, P174, DOI 10.1016/S0169-328X(98)00256-3; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Robinson MB, 1998, NEUROCHEM INT, V33, P479, DOI 10.1016/S0197-0186(98)00055-2; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; SEPKUTY JP, 1997, SOC NEUR ABSTR, V23, P1484; Shayakul C, 1997, AM J PHYSIOL-RENAL, V273, pF1023, DOI 10.1152/ajprenal.1997.273.6.F1023; Sims KD, 2000, J BIOL CHEM, V275, P5228, DOI 10.1074/jbc.275.7.5228	19	180	194	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					84	88		10.1038/35065084	http://dx.doi.org/10.1038/35065084			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242046				2022-12-28	WOS:000167194300047
J	Martin, SL; Mackie, L; Kupper, LL; Buescher, P; Moracco, KE				Martin, SL; Mackie, L; Kupper, LL; Buescher, P; Moracco, KE			Physical abuse of women before, during, and after pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VIOLENCE; MOTHERS; IDENTIFICATION; POSTPARTUM; RISK	Context Clinicians who care for new mothers and infants need information concerning postpartum physical abuse of women as a foundation on which to develop appropriate clinical screening and intervention procedures. However, no previous population-based studies have been conducted of postpartum physical abuse. Objectives To examine patterns of physical abuse before. during, and after pregnancy in a representative statewide sample of North Carolina women. Design, Setting, and Participants Survey of participants in the North Carolina Pregnancy Risk Assessment Monitoring System (NC PRAMS). Of the 3542 women invited to participate in NC PRAMS between July 1, 1997, and December 31, 1998, 75% (n=2648) responded. Main Outcome Measures Prevalence of physical abuse during the 12 months before pregnancy, during pregnancy, and after infant delivery; injuries and medical interventions resulting from postpartum abuse; and patterns of abuse over time in relation to sociodemographic characteristics and use of well-baby care. Results The prevalence of abuse before pregnancy was 6.9% (95% confidence interval [CI], 5.6%-8.2%) compared with 6.1% (95% CI, 4.8%-7.4%) during pregnancy and 3.2% (95% CI, 2.3%-4.1%) during a mean postpartum period of 3.6 months. Abuse during a previous period was strongly predictive of later abuse, Most women who were abused after pregnancy (77%) were injured, but only 23% received medical treatment for their injuries. Virtually all abused and nonabused women used well-baby care; private physicians were the most common source of care. The mean number of well-baby care visits did not differ significantly by maternal patterns of abuse. Conclusion Since well-baby care use is similar for abused and nonabused mothers, pediatric practices may be important settings for screening women for violence.	Univ N Carolina, Sch Publ Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Hlth Behav & Hlth Educ, Chapel Hill, NC 27599 USA; Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; State Ctr Hlth Stat, Raleigh, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Martin, SL (corresponding author), Univ N Carolina, Sch Publ Hlth, Dept Maternal & Child Hlth, CB 7400, Chapel Hill, NC 27599 USA.	sandra_martin@unc.edu			PHS HHS [R49/CCR402444-15] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AM COLL OBST GYN, 1989, ACOG TECHN B, V124; [Anonymous], 2000, INTIMATE PARTNER VIO; Bays JA, 1998, PEDIATRICS, V101, P1091; BELSKY J, 1983, J MARRIAGE FAM, V45, P567, DOI 10.2307/351661; *BUR JUST STAT, 2001, CRIM VICT US 1998 ST; Clark KA, 2000, ARCH FAM MED, V9, P1093, DOI 10.1001/archfami.9.10.1093; Council on Scientific Affairs American Medical Association, 1992, JAMA-J AM MED ASSOC, V267, P3184, DOI DOI 10.1001/JAMA.1992.03480230076032; GAZMARARIAN JA, 1995, OBSTET GYNECOL, V85, P1031, DOI 10.1016/0029-7844(95)00057-X; Gazmararian JA, 1996, JAMA-J AM MED ASSOC, V275, P1915, DOI 10.1001/jama.275.24.1915; GELLES RJ, 1988, J MARRIAGE FAM, V50, P841, DOI 10.2307/352652; GIELEN AC, 1994, SOC SCI MED, V39, P781, DOI 10.1016/0277-9536(94)90039-6; Hedin LW, 2000, EUR J OBSTET GYN R B, V89, P41; HELTON AS, 1987, AM J PUBLIC HEALTH, V77, P1337, DOI 10.2105/AJPH.77.10.1337; Kerker BD, 2000, ARCH PEDIAT ADOL MED, V154, P457, DOI 10.1001/archpedi.154.5.457; Martin SL, 1996, AM J PUBLIC HEALTH, V86, P991, DOI 10.2105/AJPH.86.7.991; MCFARLANE J, 1992, JAMA-J AM MED ASSOC, V267, P3176, DOI 10.1001/jama.267.23.3176; MILLER BC, 1980, FAM RELAT, V29, P459, DOI 10.2307/584459; Shah BV, 1996, SUDAAN USERS MANUAL; Spivak H, 1999, PEDIATRICS, V103, P173; STEWART DE, 1993, CAN MED ASSOC J, V149, P1257; STEWART DE, 1994, CAN MED ASSOC J, V151, P1601; Tjaden P, 2000, EXTENT NATURE CONSEQ; Tjaden Patricia., 1998, PREVALENCE INCIDENCE; Wright RJ, 2000, ARCH PEDIAT ADOL MED, V154, P431, DOI 10.1001/archpedi.154.5.431; Wright RJ, 1997, PEDIATRICS, V99, P186, DOI 10.1542/peds.99.2.186	25	226	230	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2001	285	12					1581	1584		10.1001/jama.285.12.1581	http://dx.doi.org/10.1001/jama.285.12.1581			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	413HH	11268265	Bronze			2022-12-28	WOS:000167606600024
J	Mackay, CR; von Andrian, UH				Mackay, CR; von Andrian, UH			Immunology - Memory T cells - Local heroes in the struggle for immunity	SCIENCE			English	Editorial Material							NAIVE		Garvan Inst Med Res, Arthrit & Asthma Program, Darlinghurst, NSW 2010, Australia; Harvard Univ, Sch Med, Ctr Blood Res, Dept Pathol, Boston, MA 02115 USA	Garvan Institute of Medical Research; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Mackay, CR (corresponding author), Garvan Inst Med Res, Arthrit & Asthma Program, Darlinghurst, NSW 2010, Australia.		Mackay, Charles R/A-9673-2008; von Andrian, Ulrich H/A-5775-2008	Mackay, Charles R/0000-0002-6338-7340; 				BRADLEY LM, 1994, J EXP MED, V180, P2401, DOI 10.1084/jem.180.6.2401; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407	8	35	37	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2323	2324		10.1126/science.1059984	http://dx.doi.org/10.1126/science.1059984			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11269302				2022-12-28	WOS:000167618700028
J	Leakey, MG; Spoor, F; Brown, FH; Gathogo, PN; Kiarie, C; Leakey, LN; McDougall, I				Leakey, MG; Spoor, F; Brown, FH; Gathogo, PN; Kiarie, C; Leakey, LN; McDougall, I			New hominin genus from eastern Africa shows diverse middle Pliocene lineages	NATURE			English	Article							AUSTRALOPITHECUS-AFARENSIS; HADAR FORMATION; SOUTH-AFRICA; FOSSIL HOMINIDS; TURKANA BASIN; LAKE TURKANA; KOOBI FORA; ETHIOPIA; KENYA; SKULL	Most interpretations of early hominin phylogeny recognize a single early to middle Pliocene ancestral lineage, best represented by Australopithecus afarensis, which gave rise to a radiation of taxa in the late Pliocene. Here we report on new fossils discovered west of Lake Turkana, Kenya, which differ markedly from those of contemporary A. afarensis, indicating that hominin taxonomic diversity extended back, well into the middle Pliocene. A 3.5 Myr-old cranium, showing a unique combination of derived facial and primitive neurocranial features, is assigned to a new genus of hominin. These findings point to an early diet-driven adaptive radiation, provide new insight on the association of hominin craniodental features, and have implications for our understanding of Plio-Pleistocene hominin phylogeny.	Natl Museums Kenya, Div Palaeontol, Nairobi, Kenya; UCL, Dept Anat & Dev Biol, London WC1E 6JJ, England; Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia	University of London; University College London; Utah System of Higher Education; University of Utah; Australian National University	Leakey, MG (corresponding author), Natl Museums Kenya, Div Palaeontol, POB 40658, Nairobi, Kenya.	meave@swiftkenya.com	Spoor, Fred/C-1718-2008	Leakey, Louise/0000-0003-3420-6341				Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; BILSBOROUGH A, 1988, AM J PHYS ANTHROPOL, V76, P61, DOI 10.1002/ajpa.1330760107; BROWN B, IN PRESS J HUM EVOL; BROWN FH, 1978, GEOPHYS J ROY ASTR S, V54, P519, DOI 10.1111/j.1365-246X.1978.tb05492.x; Brunet M, 1996, CR ACAD SCI II A, V322, P907; DEMENOCAL PB, 1999, HOMINID EVOLUTION CL, V1, P23; ECK GG, 1993, THEROPITHECUS, P15, DOI 10.1017/CBO9780511565540.003; Feibel C.S., 1991, P321; FEIBEL CS, 1989, AM J PHYS ANTHROPOL, V78, P595, DOI 10.1002/ajpa.1330780412; GRINE FE, 1994, J HUM EVOL, V26, P57, DOI 10.1006/jhev.1994.1004; HAILEAB B, 1995, GEOCHEMISTRY GEOCHRO; Harris J.M., 1987, P524; HARRIS M, 1988, CONT SCI NAT HIST MU, V399, P1; Harrison Terry, 1993, P345; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P373, DOI 10.1002/ajpa.1330570402; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P545, DOI 10.1002/ajpa.1330570406; Keyser AW, 2000, S AFR J SCI, V96, P189; Kimbel W.H., 1988, P259; KIMBEL WH, 1988, J HUM EVOL, V17, P647, DOI 10.1016/0047-2484(88)90022-X; KIMBEL WH, 1984, AM J PHYS ANTHROPOL, V64, P337, DOI 10.1002/ajpa.1330640403; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; LEAKEY M.D., 1987, LAETOLI PLIOCENE SIT; Leakey MG, 1998, NATURE, V393, P62, DOI 10.1038/29972; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; Lockwood CA, 1999, J HUM EVOL, V36, P637, DOI 10.1006/jhev.1999.0299; Lockwood CA, 2000, J HUM EVOL, V39, P23, DOI 10.1006/jhev.2000.0401; McCollum MA, 1999, SCIENCE, V284, P301, DOI 10.1126/science.284.5412.301; MCDOUGALL I, 1985, GEOL SOC AM BULL, V96, P159, DOI 10.1130/0016-7606(1985)96<159:KAADOT>2.0.CO;2; MCDOUGALL I, 1992, GEOPHYS RES LETT, V19, P2349, DOI 10.1029/92GL02714; Moggi-Cecchi J, 1998, AM J PHYS ANTHROPOL, V106, P425, DOI 10.1002/(SICI)1096-8644(199808)106:4<425::AID-AJPA2>3.0.CO;2-I; Rak Y., 1983, AUSTRALOPITHECINE FA, DOI [10.1016/B978-0-12-576280-9.50006-7, DOI 10.1016/B978-0-12-576280-9.50006-7]; ROBINSON J. T., 1956, TRANSVAAL MUS MEM, V9, P1; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Strait DS, 1997, J HUM EVOL, V32, P17, DOI 10.1006/jhev.1996.0097; Suwa G, 1997, NATURE, V389, P489, DOI 10.1038/39037; Tobias P.V., 1991, OLDUVAI GORGE, V4; WALKER A, 1986, NATURE, V322, P517, DOI 10.1038/322517a0; WALTER RC, 1993, J HUM EVOL, V25, P229, DOI 10.1006/jhev.1993.1046; Ward C, 1999, EVOL ANTHROPOL, V7, P197, DOI 10.1002/(SICI)1520-6505(1999)7:6<197::AID-EVAN4>3.0.CO;2-T; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WHITE TD, 1977, AM J PHYS ANTHROPOL, V46, P197, DOI 10.1002/ajpa.1330460203; White TD, 2000, AM J PHYS ANTHROPOL, V111, P45, DOI 10.1002/(SICI)1096-8644(200001)111:1<45::AID-AJPA4>3.0.CO;2-I; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B., 1991, HOMINID CRANIAL REMA, V4; WOOD B, 2000, HOMO EVOL ANTHR, V8, P195	48	210	222	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2001	410	6827					433	440		10.1038/35068500	http://dx.doi.org/10.1038/35068500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260704				2022-12-28	WOS:000167583800032
J	Snow, V; Mottur-Pilson, C; Hickner, JM				Snow, V; Mottur-Pilson, C; Hickner, JM		Amer Coll Phys-Amer Soc Internal Med	Principles of appropriate antibiotic use for acute sinusitis in adults	ANNALS OF INTERNAL MEDICINE			English	Article									Amer Coll Phys Amer Soc Internal Med, Customer Serv, Philadelphia, PA 19106 USA		Snow, V (corresponding author), Amer Coll Phys Amer Soc Internal Med, Customer Serv, 190 N Independence Mall W, Philadelphia, PA 19106 USA.								0	103	107	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					495	497		10.7326/0003-4819-134-6-200103200-00016	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00016			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409VF	11255527				2022-12-28	WOS:000167405800010
J	Villeneuve, AM				Villeneuve, AM			Development - How to stimulate your partner	SCIENCE			English	Editorial Material							MAJOR SPERM PROTEIN; CAENORHABDITIS-ELEGANS; MSP		Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Villeneuve, AM (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.							Bullock TL, 1996, J MOL BIOL, V263, P284, DOI 10.1006/jmbi.1996.0575; Italiano JE, 1996, CELL, V84, P105, DOI 10.1016/S0092-8674(00)80997-6; KLASS MR, 1981, DEV BIOL, V84, P299, DOI 10.1016/0012-1606(81)90398-5; L'Hernault SW, 1997, C ELEGANS, P271; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Roberts TM, 2000, J CELL BIOL, V149, P7, DOI 10.1083/jcb.149.1.7; SCHEDL T, 1997, C ELEGANS, V2, P241; WARD S, 1988, J MOL BIOL, V199, P1, DOI 10.1016/0022-2836(88)90374-9	9	2	3	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2099	+		10.1126/science.1060125	http://dx.doi.org/10.1126/science.1060125			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11256406				2022-12-28	WOS:000167563800022
J	Hansen, JL; van Hecke, M; Haaning, A; Ellegaard, C; Andersen, KH; Bohr, T; Sams, T				Hansen, JL; van Hecke, M; Haaning, A; Ellegaard, C; Andersen, KH; Bohr, T; Sams, T			Pattern formation - Instabilities in sand ripples	NATURE			English	Article							WATER		Niels Bohr Inst, DK-2100 Copenhagen, Denmark; Danish Def Res Estab, DK-2100 Copenhagen, Denmark; Danish Tech Univ, ISVA, DK-2800 Lyngby, Denmark; Danish Tech Univ, Inst Phys, DK-2800 Lyngby, Denmark	University of Copenhagen; Niels Bohr Institute; Technical University of Denmark; Technical University of Denmark	Hansen, JL (corresponding author), Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.		Sams, Thomas/A-9781-2014; Bohr, Tomas/A-6106-2011	Sams, Thomas/0000-0002-6316-2539; Bohr, Tomas/0000-0003-3620-7276; Andersen, Ken Haste/0000-0002-8478-3430; van Hecke, Martin/0000-0002-9550-6607; Hansen, Jonas Lundbek/0000-0002-9124-0274				ANDERSEN KH, 1999, THESIS N BOHR I COPE; BAGNOLD RA, 1946, PROC R SOC LON SER-A, V187, P1, DOI 10.1098/rspa.1946.0062; BAGNOLDD RA, 1941, PHYSICS BLOWN SAND D; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Drazin P.G., 1982, HYDRODYNAMIC STABILI; Scherer MA, 1999, PHYS FLUIDS, V11, P58, DOI 10.1063/1.869902; Stegner A, 1999, PHYS REV E, V60, pR3487, DOI 10.1103/PhysRevE.60.R3487	7	67	67	0	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					324	324						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268196				2022-12-28	WOS:000167464100034
J	McJunkin, JE; de los Reyes, EC; Irazuzta, JE; Caceres, MJ; Khan, RR; Minnich, LL; Fu, KD; Lovett, GD; Tsai, T; Thompson, A				McJunkin, JE; de los Reyes, EC; Irazuzta, JE; Caceres, MJ; Khan, RR; Minnich, LL; Fu, KD; Lovett, GD; Tsai, T; Thompson, A			La crosse encephalitis in children.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYMERASE-CHAIN-REACTION; CENTRAL-NERVOUS-SYSTEM; SEVERE HEAD-INJURY; BACTERIAL-MENINGITIS; INTRACRANIAL-PRESSURE; INAPPROPRIATE SECRETION; BRAIN; HYPOTHERMIA; DIAGNOSIS; VIRUS	Background: La Crosse encephalitis is a mosquito-borne disease that can be mistaken for herpes simplex encephalitis. It has been reported in 28 states but may be underrecognized. Methods: We investigated the manifestations and clinical course of La Crosse encephalitis in 127 patients hospitalized from 1987 through 1996. The diagnosis was established by serologic testing for IgM and IgG antibodies to La Crosse virus. Data were collected by chart review. Results: Most of the patients were school-aged children (mean [+/-SD] age, 7.8+/-3.5 years; range, 0.5 to 15.0). Symptoms included headache, fever, and vomiting (each in 70 percent or more of the patients), seizures (in 46 percent), and disorientation (in 42 percent). Thirteen percent had aseptic meningitis. Hyponatremia developed in 21 percent, and there were signs of increased intracranial pressure in 13 percent. Six patients, including three with cerebral herniation, underwent intracranial-pressure monitoring. The 13 patients (11 percent) whose condition deteriorated in the hospital had decreases in serum sodium levels (P=0.007) and increases in body temperature (P=0.003) at the time of deterioration. At admission, these patients more often had a history of vomiting (P=0.047) and a score of 12 or lower on the Glasgow Coma Scale (P=0.02) than the others; a trend toward a greater prevalence of seizures at admission was also evident in this group (P=0.07). All the patients survived, but 15 of them (12 percent) had neurologic deficits at discharge. Follow-up assessments, performed in 28 children, suggested an increase in cognitive and behavioral deficits 10 to 18 months after the episode of encephalitis. Conclusions: La Crosse virus infection should be considered in children who present with aseptic meningitis or encephalitis. Hyponatremia and increasing body temperature may be related to clinical deterioration. (N Engl J Med 2001;344:801-7.) Copyright (C) 2001 Massachusetts Medical Society.	W Virginia Univ, Robert C Byrd Hlth Sci Ctr, Charleston Div, Charleston, WV 25304 USA; Charleston Area Med Ctr, Charleston, WV USA; Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA	West Virginia University; Centers for Disease Control & Prevention - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McJunkin, JE (corresponding author), W Virginia Univ, Dept Pediat, POB 9214, Morgantown, WV 26506 USA.	jmcjunkin@hsc.wvu.edu	de los Reyes, Emily C/AAP-3836-2020					Achenbach T. M., 1991, CHILD BEHAV CHECKLIS; *AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P82; ASHLEY R, 1995, 10 POST SESS PAN AM; BALFOUR HH, 1973, PEDIATRICS, V52, P680; CAMPBELL WP, 1995, J VIROL METHODS, V53, P55, DOI 10.1016/0166-0934(94)00176-H; CASSIDY LF, 1989, ANTIMICROB AGENTS CH, V33, P2009, DOI 10.1128/AAC.33.11.2009; Chun R W, 1983, Prog Clin Biol Res, V123, P193; CHUN RWM, 1968, NEUROLOGY, V18, P369; *COMM HOSP CAR SEC, 1999, PEDIATRICS, V103, P840; Conners C.K., 1997, CONNERS RATING SCALE; CRAMBLETT HG, 1966, J AMER MED ASSOC, V198, P108, DOI 10.1001/jama.198.2.108; DUCK SC, 1988, J PEDIATR-US, V113, P10, DOI 10.1016/S0022-3476(88)80521-3; FISHMAN RA, 1975, NEW ENGL J MED, V293, P706, DOI 10.1056/NEJM197510022931407; Floret D, 1999, ARCH PEDIATRIE, V6, P199, DOI 10.1016/S0929-693X(99)80209-7; GRABOW JD, 1969, NEUROLOGY, V19, P394, DOI 10.1212/WNL.19.4.394; Grimstad P. R., 1988, The arboviruses: epidemiology and ecology. Volume II., P99; Gundersen C B, 1983, Prog Clin Biol Res, V123, P169; HARRIS GD, 1988, J PEDIATR-US, V113, P65, DOI 10.1016/S0022-3476(88)80529-8; HAYNES RE, 1969, J AMER MED ASSOC, V208, P1657, DOI 10.1001/jama.208.9.1657; HILTY MD, 1972, AM J DIS CHILD, V124, P530, DOI 10.1001/archpedi.1972.02110160068006; Huang C, 1999, CLIN INFECT DIS, V28, P1294, DOI 10.1086/514789; Huang C, 1999, NEW ENGL J MED, V340, P483, DOI 10.1056/NEJM199902113400616; Irazuzta JE, 2000, BRAIN RES, V881, P88, DOI 10.1016/S0006-8993(00)02894-8; JANSSEN R, 1984, LAB INVEST, V50, P447; JOHNSON KP, 1968, J NEUROPATH EXP NEUR, V27, P390, DOI 10.1097/00005072-196807000-00003; KAPLAN SL, 1978, J PEDIATR-US, V92, P758, DOI 10.1016/S0022-3476(78)80144-9; Kappus K D, 1983, Prog Clin Biol Res, V123, P31; KATSUMURA H, 1995, ACTA NEUROCHIR, V135, P62, DOI 10.1007/BF02307416; MACK K, 1996, 12 M PAN AM SOC CLIN; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MATTHEWS CG, 1968, NEUROLOGY, V18, P1023, DOI 10.1212/WNL.18.10.1023; MCGILLICUDDY JE, 1985, CHEST, V87, P85, DOI 10.1378/chest.87.1.85; McJunkin JE, 1998, INFECT DIS CLIN N AM, V12, P83, DOI 10.1016/S0891-5520(05)70410-4; McJunkin JE, 1997, PEDIATRICS, V99, P261, DOI 10.1542/peds.99.2.261; MCJUNKIN JE, 1998, TXB PEDIAT INFECT DI, V2, P2150; MUNOZ SJ, 1993, TRANSPLANTATION, V55, P1071, DOI 10.1097/00007890-199305000-00025; Nara I, 1998, ACT NEUR S, V71, P22; PANTUWATANA S, 1974, AM J TROP MED HYG, V23, P246; PATWARI AK, 1995, ANN TROP PAEDIATR, V15, P179, DOI 10.1080/02724936.1995.11747769; Rauf SJ, 1999, INFECT DIS CLIN N AM, V13, P647, DOI 10.1016/S0891-5520(05)70099-4; RIE HE, 1973, AM J DIS CHILD, V125, P824, DOI 10.1001/archpedi.1973.04160060036007; ROGERS MC, 1996, TXB PEDIAT INTENSIVE, P657; Rust RS, 1999, J CHILD NEUROL, V14, P1, DOI 10.1177/088307389901400101; SATTLER JM, 1992, ASSESSMENT CHILDREN, P1152; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; SILBERMAN AW, 1986, CANCER, V57, P1401, DOI 10.1002/1097-0142(19860401)57:7<1401::AID-CNCR2820570727>3.0.CO;2-2; SNODGRASS SM, 1989, J CLIN NEUROPHYSIOL, V6, P159, DOI 10.1097/00004691-198904000-00003; Sormunen P, 1999, J PEDIATR-US, V134, P725, DOI 10.1016/S0022-3476(99)70288-X; THOMPSON WH, 1965, AM J EPIDEMIOL, V81, P230, DOI 10.1093/oxfordjournals.aje.a120511; THOMPSON WH, 1965, AM J EPIDEMIOL, V81, P245, DOI 10.1093/oxfordjournals.aje.a120512; TROST HA, 1992, ACTA NEUROCHIR, V116, P33, DOI 10.1007/BF01541250; WATTS DM, 1975, ANN NY ACAD SCI, V266, P135, DOI 10.1111/j.1749-6632.1975.tb35094.x; Wechsler D., 1991, WISC 3 WECHSLER INTE; WOODRUFF BA, 1992, AM J EPIDEMIOL, V136, P320, DOI 10.1093/oxfordjournals.aje.a116497; 1988, MMWR MORB MORTAL WKL, V37, P79	55	160	167	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2001	344	11					801	807		10.1056/NEJM200103153441103	http://dx.doi.org/10.1056/NEJM200103153441103			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410LA	11248155				2022-12-28	WOS:000167440400003
J	Shors, TJ; Miesegaes, G; Beylin, A; Zhao, MR; Rydel, T; Gould, E				Shors, TJ; Miesegaes, G; Beylin, A; Zhao, MR; Rydel, T; Gould, E			Neurogenesis in the adult is involved in the formation of trace memories	NATURE			English	Article							NICTITATING-MEMBRANE RESPONSE; HIPPOCAMPAL-NEURONS; DENTATE GYRUS; RAT NEOCORTEX; BRAIN; MIGRATION; PROLIFERATION; AWARENESS; CELLS	The vertebrate brain continues to produce new neurons throughout life(1-12). In the rat hippocampus, several thousand are produced each day, many of which die within weeks(13). Associative learning can enhance their survival(13,14); however, until now it was unknown whether new neurons are involved in memory formation. Here we show that a substantial reduction in the number of newly generated neurons in the adult rat impairs hippocampal-dependent trace conditioning, a task in which an animal must associate stimuli that are separated in time(15). A similar reduction did not affect learning when the same stimuli are not separated in time, a task that is hippocampal-independent(16,17). The reduction in neurogenesis did not induce death of mature hippocampal neurons or permanently alter neurophysiological properties of the CA1 region, such as long-term potentiation. Moreover, recovery of cell production was associated with the ability to acquire trace memories. These results indicate that newly generated neurons in the adult are not only affected by the formation of a hippocampal-dependent memory(13), but also participate in it.	Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Princeton University	Shors, TJ (corresponding author), Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA.							ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; BARNEA A, 1994, P NATL ACAD SCI USA, V91, P11217, DOI 10.1073/pnas.91.23.11217; BERGER TW, 1983, BEHAV BRAIN RES, V8, P49, DOI 10.1016/0166-4328(83)90171-7; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; JOHNSTON MV, 1979, BRAIN RES, V170, P135, DOI 10.1016/0006-8993(79)90946-6; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; LaBar KS, 1998, HIPPOCAMPUS, V8, P620, DOI 10.1002/(SICI)1098-1063(1998)8:6<620::AID-HIPO4>3.0.CO;2-6; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LOPEZGARCIA C, 1988, BRAIN RES, V471, P167; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; MINGER SL, 1992, EXP NEUROL, V117, P124, DOI 10.1016/0014-4886(92)90121-6; NOTTEBOHM F, 1989, SCI AM, V260, P74, DOI 10.1038/scientificamerican0289-74; Quinn CC, 1999, J NEUROBIOL, V41, P158, DOI 10.1002/(SICI)1097-4695(199910)41:1<158::AID-NEU19>3.0.CO;2-0; SCHMALTZ LW, 1972, J COMP PHYSIOL PSYCH, V79, P328, DOI 10.1037/h0032531; Shors TJ, 2000, BEHAV BRAIN RES, V110, P39, DOI 10.1016/S0166-4328(99)00183-7; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Wagner JP, 1999, J NEUROSCI, V19, P6006, DOI 10.1523/JNEUROSCI.19-14-06006.1999; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; WEISS C, 1990, BEHAV NEUROSCI, V104, P243; WOOD KA, 1995, J NEUROSCI, V15, P5851	30	1576	1650	2	117	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					372	376		10.1038/35066584	http://dx.doi.org/10.1038/35066584			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268214				2022-12-28	WOS:000167464100052
J	Toner, GC; Stockler, MR; Boyer, MJ; Jones, M; Thomson, DB; Harvey, VJ; Olver, IN; Dhillon, H; McMullen, A; Gebski, VJ; Levi, JA; Simes, RJ				Toner, GC; Stockler, MR; Boyer, MJ; Jones, M; Thomson, DB; Harvey, VJ; Olver, IN; Dhillon, H; McMullen, A; Gebski, VJ; Levi, JA; Simes, RJ		Australian New Zealand Germ Cell T	Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial	LANCET			English	Article							TESTICULAR CANCER; COMBINATION CHEMOTHERAPY; CLINICAL-TRIALS; POOR RISK; BLEOMYCIN; TUMORS; ETOPOSIDE; CISPLATIN; THERAPY; CARCINOMA	Background Most patients with metastatic germ-cell tumours are cured with chemotherapy. However, the optimum chemotherapy regimen is uncertain, and there is variation in international practice. We did a multicentre randomised trial to compare two standard chemotherapy regimens for men with good-prognosis germ-cell tumours. Methods Good prognosis was defined by modified Memorial Sloan-Kettering criteria. The first regimen (regimen A) was based on treatment recommendations from Indiana University and comprised three cycles of 20 mg/m(2) cisplatin on days 1-5, 100 mg/m(2) etoposide on days 1-5, and 30 kU bleomycin on days 1, 8, and 15, repeated every 21 days. The second regimen (regimen B) was based on the control regimen of a published randomised clinical trial and comprised four cycles of 100 mg/m(2) cisplatin on day 1, 120 mg/m(2) etoposide on days 1-3, and 30 kU bleomycin on day 1, repeated every 21 days. The primary outcome measure was overall survival. Analysis was by intention to treat. Findings 166 patients were randomised, 83 to each regimen. The trial was stopped when the second planned interim analysis met predefined stopping rules. The median follow-up was 33 months, Overall survival was substantially better with regimen A (three vs 13 deaths, hazard ratio 0.22 [95% CI 0.06-0.77], p=0.008). This difference was due to deaths from cancer tone vs nine), and not deaths from treatment (two vs two) and remained significant after adjustment for other prognostic factors (0.25 [0.07-0.88], p=0.03). Interpretation In men with good-prognosis germ-cell tumours, the regimen developed at Indiana University is superior to the alternative regimen studied in this trial. The lower total dose and dose-intensity of bleomycin and the lower dose-intensity of etoposide in regimen B could be responsible for the worse outcome.	Peter MacCallum Canc Inst, Med Oncol Unit, E Melbourne, Vic 3002, Australia; Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; Princess Alexandra Hosp, Med Oncol Unit, Brisbane, Qld 4102, Australia; Sydney Canc Ctr, Med Oncol Unit, Sydney, NSW, Australia; Auckland Hosp, Clin Oncol Unit, Auckland, New Zealand; Royal Adelaide Hosp, Med Oncol Unit, Adelaide, SA 5000, Australia; Royal N Shore Hosp, Med Oncol Unit, Sydney, NSW, Australia	Peter Maccallum Cancer Center; University of Sydney; University of Sydney; Auckland City Hospital; Royal Adelaide Hospital; Royal North Shore Hospital; University of Sydney	Toner, GC (corresponding author), Peter MacCallum Canc Inst, Med Oncol Unit, St Andrews Pl, E Melbourne, Vic 3002, Australia.		Dhillon, Haryana M/G-8503-2011; Thomson, Damien B/F-9076-2013; Stockler, Martin R/N-3859-2016; Olver, Ian/I-1518-2015; Toner, Guy C/G-1738-2011	Dhillon, Haryana M/0000-0003-4039-5169; Stockler, Martin R/0000-0003-3793-8724; Olver, Ian/0000-0001-5478-1576; Toner, Guy/0000-0001-9873-3592; Boyer, Michael/0000-0002-0452-2987				BAJORIN D, 1988, J CLIN ONCOL, V6, P786, DOI 10.1200/JCO.1988.6.5.786; BAJORIN DF, 1991, CANCER, V67, P28, DOI 10.1002/1097-0142(19910101)67:1<28::AID-CNCR2820670106>3.0.CO;2-3; BAJORIN DF, 1991, UROL INT, V46, P298, DOI 10.1159/000282155; Bajorin DF, 1997, J CLIN ONCOL, V15, P1717, DOI 10.1200/JCO.1997.15.5.1717; BOSL GJ, 1988, J CLIN ONCOL, V6, P1231, DOI 10.1200/JCO.1988.6.8.1231; CULINE S, 1999, P AM SOC CLIN ONCOL, V18, pA1188; deWit R, 1997, J CLIN ONCOL, V15, P1837, DOI 10.1200/JCO.1997.15.5.1837; DEWIT R, 2000, P AM SOC CLIN ONCOL, V19, pA1281; DEWIT R, 1999, P AM SOC CLIN ONCOL, V18, pA1187; EINHORN LH, 1989, J CLIN ONCOL, V7, P387, DOI 10.1200/JCO.1989.7.3.387; EINHORN LH, 1981, CANCER RES, V41, P3275; EINHORN LH, 1981, NEW ENGL J MED, V305, P727, DOI 10.1056/NEJM198109243051303; Horwich A, 1997, J CLIN ONCOL, V15, P1844, DOI 10.1200/JCO.1997.15.5.1844; HUGHES MD, 1988, STAT MED, V7, P1231, DOI 10.1002/sim.4780071204; LEVI JA, 1993, J CLIN ONCOL, V11, P1300, DOI 10.1200/JCO.1993.11.7.1300; McKiernan JM, 1999, J UROLOGY, V162, P361, DOI 10.1016/S0022-5347(05)68560-6; Mead GM, 1997, J CLIN ONCOL, V15, P594; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; PECKHAM MJ, 1981, BRIT J UROL, V53, P162, DOI 10.1111/j.1464-410X.1981.tb03160.x; PECKHAM MJ, 1983, BRIT J CANCER, V47, P613, DOI 10.1038/bjc.1983.99; Saxman SB, 1998, J CLIN ONCOL, V16, P702, DOI 10.1200/JCO.1998.16.2.702; SIGNORINI DF, 1993, STAT MED, V12, P2343, DOI 10.1002/sim.4780122410; Silva ID, 1999, INT J CANCER, V83, P630; SLEVIN ML, 1989, J CLIN ONCOL, V7, P1333, DOI 10.1200/JCO.1989.7.9.1333; TONER GC, 1991, CANCER-AM CANCER SOC, V67, P2049, DOI 10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H; WILLIAMS SD, 1987, NEW ENGL J MED, V316, P1435, DOI 10.1056/NEJM198706043162302	26	75	76	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					739	745		10.1016/S0140-6736(00)04165-9	http://dx.doi.org/10.1016/S0140-6736(00)04165-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253966				2022-12-28	WOS:000167400900010
J	Levashina, EA; Moita, LF; Blandin, S; Vriend, G; Lagueux, M; Kafatos, FC				Levashina, EA; Moita, LF; Blandin, S; Vriend, G; Lagueux, M; Kafatos, FC			Conserved role of a complement-like protein in phagocytosis revealed by dsRNA knockout in cultured cells of the mosquito, Anopheles gambiae	CELL			English	Article							ESCHERICHIA-COLI; IMMUNE-RESPONSES; INNATE IMMUNITY; EXPRESSION; DROSOPHILA; MODEL; TRANSFORMATION; GENES; C3	We characterize a novel hemocyte-specific acute phase glycoprotein from the malaria vector, Anopheles gambiae. It shows substantial structural and functional similarities, including the highly conserved thioester motif, to both a central component of mammalian complement system, factor C3, and to a pan-protease inhibitor, alpha (2)-macroglobulin. Most importantly, this protein serves as a complement-like opsonin and promotes phagocytosis of some Gram-negative bacteria in a mosquito hemocyte-like cell line. Chemical inactivation by methylamine and depletion by double-stranded RNA knockout demonstrate that this function is dependent on the internal thioester bond. This evidence of a complement-like function in a protostome animal adds substantially to the accumulating evidence of a common ancestry of immune defenses in insects and vertebrates.	European Mol Biol Lab, D-69117 Heidelberg, Germany; IBMC, CNRS, UPR 9022, F-67084 Strasbourg, France	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kafatos, FC (corresponding author), European Mol Biol Lab, 1 Meyerhofstr, D-69117 Heidelberg, Germany.	kafatos@embl-heidelberg.de	Moita, Luis/HCI-2793-2022; Vriend, Gert/D-6730-2011; Moita, Luis F./L-1296-2013; Vriend, G./H-8112-2014; Blandin, Stephanie/I-2786-2016; Blandin, Stephanie/ABH-2267-2021	Moita, Luis/0000-0003-0707-315X; Moita, Luis F./0000-0003-0707-315X; Blandin, Stephanie/0000-0003-4566-1200; Blandin, Stephanie/0000-0003-4566-1200; Levashina, Elena/0000-0003-4605-906X	NIAID NIH HHS [1PO1 AI44220] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Al-Sharif WZ, 1998, J IMMUNOL, V160, P2983; ARAUJOJORGE TC, 1990, PARASITOL RES, V76, P545, DOI 10.1007/BF00932558; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; ARMSTRONG PB, 1987, BIOCHEM J, V248, P703, DOI 10.1042/bj2480703; Barillas-Mury C, 2000, INSECT BIOCHEM MOLEC, V30, P429, DOI 10.1016/S0965-1748(00)00018-7; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Bosher JM, 2000, NAT CELL BIOL, V2, pE31, DOI 10.1038/35000102; Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096; Catteruccia F, 2000, P NATL ACAD SCI USA, V97, P2157, DOI 10.1073/pnas.040568397; CHINEA G, 1995, PROTEINS, V23, P415, DOI 10.1002/prot.340230315; Danielli A, 2000, P NATL ACAD SCI USA, V97, P7136, DOI 10.1073/pnas.97.13.7136; Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619; Dimopoulos G, 2001, CURR OPIN IMMUNOL, V13, P79, DOI 10.1016/S0952-7915(00)00186-2; Dodds AW, 1998, IMMUNOL REV, V166, P15; DREVETS DA, 1991, J IMMUNOL METHODS, V142, P31, DOI 10.1016/0022-1759(91)90289-R; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; FRORATH B, 1992, BIOTECHNIQUES, V12, P558; Gorman MJ, 2000, GENE, V251, P9, DOI 10.1016/S0378-1119(00)00181-5; Gorman MJ, 1998, J INSECT PHYSIOL, V44, P947, DOI 10.1016/S0022-1910(98)00056-0; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Harlow E., 1988, ANTIBODIES LAB MANUA; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; HOFFMANN JA, 1966, C R ACAD SCI HEBD D, V262, P1471; HOWARD JB, 1980, J BIOL CHEM, V255, P7082; Kopacek P, 2000, EUR J BIOCHEM, V267, P465, DOI 10.1046/j.1432-1327.2000.01020.x; Lagueux M, 2000, P NATL ACAD SCI USA, V97, P11427, DOI 10.1073/pnas.97.21.11427; Lowenberger CA, 1999, EXP PARASITOL, V91, P59, DOI 10.1006/expr.1999.4350; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nonaka M, 1999, DEV COMP IMMUNOL, V23, P421, DOI 10.1016/S0145-305X(99)00021-X; Nonaka M, 2000, CURR TOP MICROBIOL, V248, P37; Oduol F, 2000, P NATL ACAD SCI USA, V97, P11397, DOI 10.1073/pnas.180060997; Richman AM, 1997, EMBO J, V16, P6114, DOI 10.1093/emboj/16.20.6114; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019; Salam T A, 1993, Ann Vasc Surg, V7, P21, DOI 10.1007/BF02042655; Schneider D, 2000, SCIENCE, V288, P2376, DOI 10.1126/science.288.5475.2376; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; VOLANAKIS JE, 1995, ANNU REV IMMUNOL, V13, P277, DOI 10.1146/annurev.immunol.13.1.277; Volanakis JE, 1998, HUMAN COMPLEMENT SYS, V20, P9, DOI DOI 10.1201/B14212-3; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WIGGLESWORTH VB, 1970, J RETICULOENDOTH SOC, V7, P208	43	409	434	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2001	104	5					709	718		10.1016/S0092-8674(01)00267-7	http://dx.doi.org/10.1016/S0092-8674(01)00267-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257225	Bronze			2022-12-28	WOS:000167531100011
J	Peacock, JA; Cole, S; Norberg, P; Baugh, CM; Bland-Hawthorn, J; Bridges, T; Cannon, RD; Colless, M; Collins, C; Couch, W; Dalton, G; Deeley, K; De Propris, R; Driver, SP; Efstathiou, G; Ellis, RS; Frenk, CS; Glazebrook, K; Jackson, C; Lahav, O; Lewis, I; Lumsden, S; Maddox, S; Percival, WJ; Peterson, BA; Price, I; Sutherland, W; Taylor, K				Peacock, JA; Cole, S; Norberg, P; Baugh, CM; Bland-Hawthorn, J; Bridges, T; Cannon, RD; Colless, M; Collins, C; Couch, W; Dalton, G; Deeley, K; De Propris, R; Driver, SP; Efstathiou, G; Ellis, RS; Frenk, CS; Glazebrook, K; Jackson, C; Lahav, O; Lewis, I; Lumsden, S; Maddox, S; Percival, WJ; Peterson, BA; Price, I; Sutherland, W; Taylor, K			A measurement of the cosmological mass density from clustering in the 2dF Galaxy Redshift Survey	NATURE			English	Article							LARGE-SCALE BIAS; POWER-SPECTRUM; SPACE DISTORTIONS; UNIVERSE; LUMINOSITY; EVOLUTION; CONSTANT; SAMPLE	The large-scale structure in the distribution of galaxies is thought to arise from the gravitational instability of small fluctuations in the initial density field of the Universe. A key test of this hypothesis is that forming superclusters of galaxies should generate a systematic infall of other galaxies. This would be evident in the pattern of recessional velocities, causing an anisotropy in the inferred spatial clustering of galaxies. Here we report a precise measurement of this clustering, using the redshifts of more than 141,000 galaxies from the two-degree-field (2dF) galaxy redshift survey. We determine the parameter beta = Ohm (0.6)/b = 0.43 +/- 0.07, where Vis the total mass-density parameter of the Universe and b is a measure of the 'bias' of the luminous galaxies in the survey. (Bias is the difference between the clustering of visible galaxies and of the total mass, most of which is dark.) Combined with the anisotropy of the cosmic microwave background, our results favour a low-density Universe with Ohm approximate to 0.3.	Univ Edinburgh, Royal Observ, Inst Astron, Edinburgh EH9 3HJ, Midlothian, Scotland; Univ Durham, Dept Phys, Durham DH1 3LE, England; Anglo Australian Observ, Epping, NSW 2121, Australia; Australian Natl Univ, Res Sch Astron & Astrophys, Weston, ACT 2611, Australia; Liverpool John Moores Univ, Astrophys Res Inst, Birkenhead L14 1LD, Merseyside, England; Univ New S Wales, Dept Astrophys, Sydney, NSW 2052, Australia; Univ Oxford, Dept Phys, Oxford OX3 RH, England; Univ St Andrews, Sch Phys & Astron, St Andrews KY6 9SS, Fife, Scotland; Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; CALTECH, Dept Astron, Pasadena, CA 91125 USA; Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; Univ Leeds, Dept Phys, Leeds LS2 9JT, W Yorkshire, England; Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England	University of Edinburgh; Durham University; Australian National University; Liverpool John Moores University; University of New South Wales Sydney; University of Oxford; University of St Andrews; University of Cambridge; California Institute of Technology; Johns Hopkins University; University of Leeds; University of Nottingham	Peacock, JA (corresponding author), Univ Edinburgh, Royal Observ, Inst Astron, Blackford Hill, Edinburgh EH9 3HJ, Midlothian, Scotland.		Frenk, Carlos/Z-3084-2019; Baugh, Carlton/A-8482-2012; Glazebrook, Karl/N-3488-2015; bland-hawthorn, joss/ABE-7646-2020; Colless, Matthew/G-3495-2011; Baugh, Carlton/P-7605-2019; Driver, Simon P/H-9115-2014	Baugh, Carlton/0000-0002-9935-9755; Glazebrook, Karl/0000-0002-3254-9044; bland-hawthorn, joss/0000-0001-7516-4016; Colless, Matthew/0000-0001-9552-8075; Driver, Simon P/0000-0001-9491-7327; Lumsden, Stuart/0000-0001-5748-5166; Sutherland, William/0000-0002-6498-0437; Peacock, John/0000-0002-1168-8299; Maddox, Stephen/0000-0001-5549-195X				Ballinger WE, 1996, MON NOT R ASTRON SOC, V282, P877, DOI 10.1093/mnras/282.3.877; BAUGH CM, 1994, MON NOT R ASTRON SOC, V267, P323, DOI 10.1093/mnras/267.2.323; BEAN AJ, 1983, MON NOT R ASTRON SOC, V205, P605, DOI 10.1093/mnras/205.3.605; Benoist C, 1996, ASTROPHYS J, V472, P452, DOI 10.1086/178078; Benson AJ, 2000, MON NOT R ASTRON SOC, V311, P793, DOI 10.1046/j.1365-8711.2000.03101.x; Carlberg RG, 2000, ASTROPHYS J, V542, P57, DOI 10.1086/309503; Cole S, 1998, MON NOT R ASTRON SOC, V300, P945, DOI 10.1046/j.1365-8711.1998.01936.x; Colless M, 1999, PHILOS T R SOC A, V357, P105, DOI 10.1098/rsta.1999.0317; DAVIS M, 1983, ASTROPHYS J, V267, P465, DOI 10.1086/160884; Dekel A, 1999, ASTROPHYS J, V520, P24, DOI 10.1086/307428; DELAPPARENT V, 1986, ASTROPHYS J, V302, pL1, DOI 10.1086/184625; FELDMAN HA, 1994, ASTROPHYS J, V426, P23, DOI 10.1086/174036; Folkes S, 1999, MON NOT R ASTRON SOC, V308, P459, DOI 10.1046/j.1365-8711.1999.02721.x; FREEDMAN WL, FINAL RESULTS HUBBLE; Hamilton AJS, 2000, MON NOT R ASTRON SOC, V317, pL23, DOI 10.1046/j.1365-8711.2000.03888.x; HAMILTON AJS, 1993, ASTROPHYS J, V417, P19, DOI 10.1086/173288; HAMILTON AJS, 1998, EVOLVING UNIVERSE, V185, P231; Hatton S, 1998, MON NOT R ASTRON SOC, V296, P10, DOI 10.1046/j.1365-8711.1998.01269.x; Hubble E, 1934, ASTROPHYS J, V79, P8, DOI 10.1086/143517; JAFFE A, COSMOLOGY MAXIMA 1 B; Jenkins A, 1998, ASTROPHYS J, V499, P20, DOI 10.1086/305615; Jing YP, 1998, ASTROPHYS J, V494, P1, DOI 10.1086/305209; KAISER N, 1986, MON NOT R ASTRON SOC, V219, P785, DOI 10.1093/mnras/219.4.785; KAISER N, 1987, MON NOT R ASTRON SOC, V227, P1; Kauffmann G, 1997, MON NOT R ASTRON SOC, V286, P795, DOI 10.1093/mnras/286.4.795; KIRSHNER RP, 1981, ASTROPHYS J, V248, pL57, DOI 10.1086/183623; LANDY SD, 1993, ASTROPHYS J, V412, P64, DOI 10.1086/172900; LOVEDAY J, 1995, ASTROPHYS J, V442, P457, DOI 10.1086/175453; Maddox SJ, 1996, MON NOT R ASTRON SOC, V283, P1227, DOI 10.1093/mnras/283.4.1227; Meiksin A, 1999, MON NOT R ASTRON SOC, V308, P1179, DOI 10.1046/j.1365-8711.1999.02825.x; Mould JR, 2000, ASTROPHYS J, V529, P786, DOI 10.1086/308304; OUTRAM PJ, IN PRESS MON NOT R A; PEACOCK JA, 1996, MNRAS, V280, P19; Pen UL, 1998, ASTROPHYS J, V504, P601, DOI 10.1086/306098; SAUNDERS W, 1991, NATURE, V349, P32, DOI 10.1038/349032a0; Scoccimarro R, 1999, ASTROPHYS J, V527, P1, DOI 10.1086/308059; Shectman SA, 1996, ASTROPHYS J, V470, P172, DOI 10.1086/177858; STRAUSS MA, 1995, PHYS REP, V261, P271, DOI 10.1016/0370-1573(95)00013-7; Szalay AS, 1998, ASTROPHYS J, V498, pL1, DOI 10.1086/311293; TAYLOR AN, IN PRESS MON NOT R A; Taylor K, 1997, P SOC PHOTO-OPT INS, V2871, P145, DOI 10.1117/12.269033; Verde L, 1998, MON NOT R ASTRON SOC, V300, P747, DOI 10.1046/j.1365-8711.1998.01937.x	43	554	559	1	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					169	173		10.1038/35065528	http://dx.doi.org/10.1038/35065528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242069	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000167320500035
J	Zhu, M; Yu, XB; Ahlberg, PE				Zhu, M; Yu, XB; Ahlberg, PE			A primitive sarcopterygian fish with an eyestalk	NATURE			English	Article							FOSSIL FISH; PALEONTOLOGY; COELACANTH; TETRAPODS	The discovery of two Early Devonian osteichthyan (bony fish) fossils(1-4) has challenged established ideas about the origin of osteichthyans and their divergence into actinopterygians (teleosts and their relatives) and sarcopterygians (tetrapods, coelacanths, lungfishes and related groups)(5-7). Psarolepis from China(1,2,8,9) and an unnamed braincase from Australia(3) combine derived sarcopterygian and actinopterygian characters with primitive features previously restricted to non-osteichthyans, suggesting that early osteichthyan evolution may have involved substantial parallellism between sarcopterygians and actinopterygians. But interpretation of these fossils has been hampered by poor phylogenetic resolution(1,3). Here we describe a basal sarcopterygian fish, Achoania gen, et sp. nov., that fills the morphological gap between Psarolepis and higher sarcoptergyians. We also report the presence of eyestalk attachments in both Achoania and Psarolepis, showing that this supposedly non-osteichthyan feature occurs in basal sarcopterygians as well as the actinoptergyian-like Australian braincase(3).	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Kean Univ, Dept Biol Sci, Union, NJ 07083 USA; Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Natural History Museum London	Zhu, M (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.		Ahlberg, Per/E-8086-2013; min, zhu/AAL-6712-2021; Yu, Xiaobo/G-7160-2011; Zhu, Min/E-8728-2012	Yu, Xiaobo/0000-0001-9600-7888; Zhu, Min/0000-0002-4786-0898; Ahlberg, Per/0000-0001-9054-2900				AHLBERG PE, 1991, ZOOL J LINN SOC-LOND, V103, P241, DOI 10.1111/j.1096-3642.1991.tb00905.x; Ahlberg PE, 1999, NATURE, V397, P564, DOI 10.1038/17484; Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; Chang M.-M., 1982, THESIS STOCKHOLM U; Chang Mee-Mann, 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P235; Chang MM, 2000, NATURE, V403, P152, DOI 10.1038/35003093; Cloutier Richard, 1996, P227; Husken T.-C., 1997, Acta Universitatis Carolinae Geologica, V40, P445, DOI 10.1016/B978-012670950-6/50018-7; Forey PL, 2000, J VERTEBR PALEONTOL, V20, P243, DOI 10.1671/0272-4634(2000)020[0243:ANCFTM]2.0.CO;2; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Goujet D. F., 1984, POISSONS PLACODERMS; Janvier P., 1996, EARLY VERTEBRATES; Janvier Philippe, 1999, Geodiversitas, V21, P33; JESSEN H L, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V167, P180; LONG JA, 1993, PALAEOZOIC VERTEBRAT; MAISEY JG, IN PRESS MAJOR EVENT, pCH16; Min Z, 1997, LETHAIA, V30, P293; ROSEN D E, 1981, Bulletin of the American Museum of Natural History, V167, P159; SCHULTZE HP, IN PRESS MAJOR EVENT, pCH18; Swofford D., 1998, PAUP PHYLOGENETIC AN; Yu XB, 1998, J VERTEBR PALEONTOL, V18, P261, DOI 10.1080/02724634.1998.10011055; Zardoya R, 1998, MOL BIOL EVOL, V15, P506, DOI 10.1093/oxfordjournals.molbev.a025950; Zardoya R, 1996, P NATL ACAD SCI USA, V93, P5449, DOI 10.1073/pnas.93.11.5449; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594	24	84	92	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2001	410	6824					81	84		10.1038/35065078	http://dx.doi.org/10.1038/35065078			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242045				2022-12-28	WOS:000167194300046
J	Tamblyn, R; Laprise, R; Hanley, JA; Abrahamowicz, M; Scott, S; Mayo, N; Hurley, J; Grad, R; Latimer, E; Perreault, R; McLeod, P; Huang, A; Larochelle, P; Mallet, L				Tamblyn, R; Laprise, R; Hanley, JA; Abrahamowicz, M; Scott, S; Mayo, N; Hurley, J; Grad, R; Latimer, E; Perreault, R; McLeod, P; Huang, A; Larochelle, P; Mallet, L			Adverse events associated with prescription drug cost-sharing among poor and elderly persons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH MAINTENANCE ORGANIZATION; LONGITUDINAL DATA-ANALYSIS; ATTRIBUTABLE FRACTION; PRIMARY-CARE; MEDICAID; THERAPY; PAYMENT; IMPACT; VALIDATION; POPULATION	Context Rising costs of medications and inequities in access have sparked calls for drug policy reform in the United States and Canada. Control of drug expenditures by prescription cost-sharing for elderly persons and poor persons is a contentious issue because little is known about the health impact in these subgroups. Objectives To determine (1) the impact of introducing prescription drug cost-sharing on use of essential and less essential drugs among elderly persons and welfare recipients and (2) rates of emergency department (ED) visits and serious adverse events associated with reductions in drug use before and after policy implementation. Design and Setting Interrupted time-series analysis of data from 32 months before and 17 months after introduction of a prescription coinsurance and deductible cost-sharing policy in Quebec in 1996, Separate 10-month prepolicy control and post-policy cohort studies were conducted to estimate the impact of the drug reform on adverse events. Participants A random sample of 93 950 elderly persons and 55 333 adult welfare medication recipients. Main Outcome Measures Mean daily number of essential and less essential drugs used per month, ED visits, and serious adverse events (hospitalization, nursing home admission, and mortality) before and after policy introduction. Results After cost-sharing was introduced, use of essential drugs decreased by 9.12% (95% confidence interval [CI], 8.7%-9.6%) in elderly persons and by 14.42% (95% CI, 13.3%-15.6%) in welfare recipients; use of less essential drugs decreased by 15.14% (95% CI, 14.4%-15.9%) and 22.39% (95% CI, 20.9%-23.9%), respectively. The rate (per 10000 person-months) of serious adverse events associated with reductions in use of essential drugs increased from 5.8 in the prepolicy control cohort to 12.6 in the postpolicy cohort in elderly persons (a net increase of 6.8 [95% CI, 5.6-8.0]) and from 14.7 to 27.6 in welfare recipients (a net increase of 12.9 [95% CI, 10.2-15.5]). Emergency department visit rates related to reductions in the use of essential drugs also increased by 14.2 (95% CI, 8.5-19.9) per 10000 person-months in elderly persons (prepolicy control cohort, 32.9; postpolicy cohort, 47.1) and by 54.2 (95% CI, 33.5-74.8) among welfare recipients (prepolicy control cohort, 69.6; postpolicy cohort, 123.8). These increases were primarily due to an increase in the proportion of recipients who reduced their use of essential drugs. Reductions in the use of less essential drugs were not associated with an increase in risk of adverse events or ED visits. Conclusions In our study, increased cost-sharing for prescription drugs in elderly persons and welfare recipients was followed by reductions in use of essential drugs and a higher rate of serious adverse events and ED visits associated with these reductions.	McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada	McGill University; McGill University	Tamblyn, R (corresponding author), McGill Univ, Ctr Hlth, Dept Med, Royal Victoria Hosp Site,Ross Pavil,Room 4-12,687, Montreal, PQ H3A 1A1, Canada.		mallet, louise/AAA-4088-2020; Tamblyn, Robyn/L-6010-2016	mallet, louise/0000-0002-3151-8991; Latimer, Eric/0000-0002-4485-1056; Abrahamowicz, Michal/0000-0002-3172-3952				BACOVSKY RA, 1998, C NAT APPR PHARM JAN; BLOOM BS, 1985, MED CARE, V23, P872, DOI 10.1097/00005650-198507000-00004; BROOK RH, 1983, NEW ENGL J MED, V309, P1426, DOI 10.1056/NEJM198312083092305; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DEMERS M, 1994, COUT SERVICES MED DU, P39; DEYO RA, 1993, J CLIN EPIDEMIOL, V46, P1081, DOI 10.1016/0895-4356(93)90104-9; Efron B., 1994, MONOGRAPHS STAT APPL; Goetghebeur E, 1998, STAT MED, V17, P341, DOI 10.1002/(SICI)1097-0258(19980215)17:3<341::AID-SIM766>3.0.CO;2-X; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Grymonpre RE, 1998, ANN PHARMACOTHER, V32, P749, DOI 10.1345/aph.17423; HARRIS BL, 1990, MED CARE, V28, P907, DOI 10.1097/00005650-199010000-00005; HURLEY J, 1991, CAN PUBLIC POL, V17, P473, DOI 10.2307/3551708; HUTTIN C, 1994, HEALTH POLICY, V27, P53, DOI 10.1016/0168-8510(94)90157-0; INUI TS, 1980, MED CARE, V18, P986, DOI 10.1097/00005650-198010000-00002; Johnson RE, 1997, MED CARE, V35, P1119, DOI 10.1097/00005650-199711000-00004; Lau HS, 1997, J CLIN EPIDEMIOL, V50, P619, DOI 10.1016/S0895-4356(97)00040-1; LEIBOWITZ A, 1985, SOC SCI MED, V21, P1063, DOI 10.1016/0277-9536(85)90161-3; Levy R A, 1992, Pharmacoeconomics, V2, P219, DOI 10.2165/00019053-199202030-00005; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lohr KathleenN., 1986, USE MED CARE RAND HL; LURIE N, 1986, NEW ENGL J MED, V314, P1266, DOI 10.1056/NEJM198605083141934; Martin BC, 1996, MED CARE, V34, P686, DOI 10.1097/00005650-199607000-00003; Martin M, 1996, CAN MED ASSOC J, V154, P1264; *MIN PUBL WORKS GO, 1997, CAN HLTH ACT BUILD L; MORGENSTERN H, 1998, MODERN EPIDEMIOLOGY, P459; NELSON AA, 1984, MED CARE, V22, P724, DOI 10.1097/00005650-198408000-00004; Newhouse JP, 1993, FREE ALL LESSONS RAN; OBRIEN B, 1989, J HEALTH ECON, V8, P109, DOI 10.1016/0167-6296(89)90011-8; Reeder C E, 1993, Pharmacoeconomics, V4, P92, DOI 10.2165/00019053-199304020-00004; REEDER CE, 1985, INQUIRY-J HEALTH CAR, V22, P396; Rockhill B, 1998, AM J EPIDEMIOL, V147, P826, DOI 10.1093/oxfordjournals.aje.a009535; RYAN M, 1991, SOC SCI MED, V33, P681, DOI 10.1016/0277-9536(91)90022-5; Simon GE, 1996, AM J PSYCHIAT, V153, P331; SIMON GE, 1994, AM J PSYCHIAT, V151, P908; SMITH DG, 1993, INQUIRY-J HEALTH CAR, V30, P189; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; SOUMERAI SB, 1993, MILBANK Q, V71, P217, DOI 10.2307/3350399; SOUMERAI SB, 1994, NEW ENGL J MED, V331, P650, DOI 10.1056/NEJM199409083311006; Soumerai SB, 1999, NEW ENGL J MED, V340, P722, DOI 10.1056/NEJM199903043400909; SOUMERAI SB, 1987, NEW ENGL J MED, V317, P550, DOI 10.1056/NEJM198708273170906; SOUMERAI SB, 1989, MILBANK Q, V67, P268, DOI 10.2307/3350142; TAMBLYN R, 1995, J CLIN EPIDEMIOL, V48, P999, DOI 10.1016/0895-4356(94)00234-H; Tamblyn R, 2000, J CLIN EPIDEMIOL, V53, P183, DOI 10.1016/S0895-4356(99)00136-5; Tamblyn R, 1998, ENCY BIOSTATISTICS, P1235; WARD MM, 1993, J CLIN EPIDEMIOL, V46, P645, DOI 10.1016/0895-4356(93)90038-3; *WHO, 1999, WHO DRUG INFORMATION, V13, P249; Wilkins R, 1993, Health Rep, V5, P157; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; [No title captured]	49	600	607	0	34	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2001	285	4					421	429		10.1001/jama.285.4.421	http://dx.doi.org/10.1001/jama.285.4.421			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	394CG	11242426	Green Published, Bronze			2022-12-28	WOS:000166506000029
J	Wehner, R				Wehner, R			Perspectives: Ecology - Bird navigation - Computing orthodromes	SCIENCE			English	Editorial Material							ORIENTATION		Univ Zurich, Dept Zool, CH-8057 Zurich, Switzerland	University of Zurich	Wehner, R (corresponding author), Univ Zurich, Dept Zool, CH-8057 Zurich, Switzerland.							Able KP, 1996, J EXP BIOL, V199, P3; ALERSTAM T, 1991, J THEOR BIOL, V152, P191, DOI 10.1016/S0022-5193(05)80452-7; Alerstam T, 2001, SCIENCE, V291, P300, DOI 10.1126/science.291.5502.300; ENS BJ, 1990, ARDEA, V78, P1; Helbig AJ, 1996, J EXP BIOL, V199, P49; Mouritsen H, 1998, ANIM BEHAV, V56, P899, DOI 10.1006/anbe.1998.0826; Thorup Kasper, 2000, Animal Behaviour Forum, V60, pF3; Weindler P, 1996, NATURE, V383, P158, DOI 10.1038/383158a0; Williams T. C., 1978, ANIMAL MIGRATION NAV, P239; Wiltschko R., 1995, TIEROSYCHOL	10	5	5	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					264	265		10.1126/science.1058147	http://dx.doi.org/10.1126/science.1058147			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11253217				2022-12-28	WOS:000166352900034
J	Pillai, S; Catellani, C				Pillai, S; Catellani, C			A woman experiencing difficulty with breastfeeding	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Miro Ctr Integrat Med, Evanston, IL USA		Pillai, S (corresponding author), Miro Ctr Integrat Med, Evanston, IL USA.							Lawrence RA, 2001, JAMA-J AM MED ASSOC, V285, P73, DOI 10.1001/jama.285.1.73; LOCKIE A, 1989, FAMILY GUIDE HOMEOPA, P430; LOCKIE A, 1995, COMPLETE GUIDE HOMEO, P140	3	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2001	285	12					1576	1576						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413HH	11268259				2022-12-28	WOS:000167606600018
J	Robins, SJ; Collins, D; Wittes, JT; Papademetriou, V; Deedwania, PC; Schaefer, EJ; McNamara, JR; Kashyap, ML; Hershman, JM; Wexler, LF; Rubins, HB				Robins, SJ; Collins, D; Wittes, JT; Papademetriou, V; Deedwania, PC; Schaefer, EJ; McNamara, JR; Kashyap, ML; Hershman, JM; Wexler, LF; Rubins, HB		VA-HIT Study Grp	Relation of gemfibrozil treatment and lipid levels with major coronary events - VA-HIT: A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; ARTERY-DISEASE; HEART-DISEASE; SECONDARY PREVENTION; BASE-LINE; REFERENCE INTERVALS; HDL-CHOLESTEROL; RISK-FACTORS; MEN	Context A low plasma level of high-density lipoprotein cholesterol (HDL-C) is a major risk factor for coronary heart disease (CHD). A secondary prevention study, the Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT), demonstrated that CHD events were significantly reduced during a median follow-up of 5.1 years by treating patients with the fibric acid derivative gemfibrozil when the predominant lipid abnormality was low HDL-C. Objective To determine if the reduction in major CHD events with gemfibrozil in VA-HIT could be attributed to changes in major plasma lipid levels. Design Multicenter, randomized, double-blind, placebo-controlled trial conducted from September 1991 to August 1998. Setting The Department of Veterans Affairs Cooperative Studies Program, in which 20 VA medical centers were participating sites. Participants A total of 2531 men with a history of CHD who had low HDL-C levels (mean, 32 mg/dL [0.83 mmol/L] ) and low low-density lipoprotein cholesterol (LDL-C) levels (mean, 111 mg/dL [2.88 mmol/L]). Intervention Participants were randomly assigned to receive gemfibrozil, 1200 mg/d (n =1264), or matching placebo (n = 1267). Main Outcome Measure Relation of lipid levels at baseline and averaged during the first 18 months of gemfibrozil treatment with the combined incidence of nonfatal myocardial infarction and CHD death. Results Concentrations of HDL-C were inversely related to CHD events. Multivariable Cox proportional hazards analysis showed that CHD events were reduced by 11% with gemfibrozil for every 5-mg/dL (0.13-mmol/L) increase in HDL-C (P = .02). Events were reduced even further with gemfibrozil beyond that explained by increases in HDL-C values, particularly in the second through fourth quintiles of HDL-C values during treatment. During gemfibrozil treatment, only the increase in HDL-C significantly predicted a lower risk of CHD events; by multivariable analysis, neither triglyceride nor LDL-C levels at baseline or during the trial predicted CHD events. Conclusions Concentrations of HDL-C achieved with gemfibrozil treatment predicted a significant reduction in CHD events in patients with low HDL-C levels, However, the change in HDL-C levels only partially explained the beneficial effect of gemfibrozil.	Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; VAMC, Cooperat Studies Program Coordinating Ctr, West Haven, CT USA; Stat Collaborat, Washington, DC USA; Tufts Univ, Sch Med, Lipid Res Lab, Boston, MA 02111 USA; Vet Affairs Med Ctr, Dept Med, Washington, DC 20422 USA; Vet Affairs Med Ctr, Dept Med, Fresno, CA USA; Vet Affairs Med Ctr, Dept Med, Long Beach, CA USA; Vet Affairs Med Ctr, Dept Med, Los Angeles, CA USA; Vet Affairs Med Ctr, Dept Med, Cincinnati, OH 45267 USA; Vet Affairs Med Ctr, Dept Med, Minneapolis, MN 55417 USA	Boston University; Tufts University; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Robins, SJ (corresponding author), Boston Univ, Sch Med, Sect Endocrinol Nutr & Diabet, Evans 204,88 E Newton St, Boston, MA 02118 USA.	sjrobins@bu.edu		Robins, Sander/0000-0002-3735-8415; Papademetriou, Vasilios/0000-0002-2882-2757; Kashyap, Moti/0000-0002-0052-8302; bloomfield, hanna/0000-0002-0756-7064				[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; Ballantyne CM, 1999, CIRCULATION, V99, P736, DOI 10.1161/01.CIR.99.6.736; BLANKENHORN DH, 1990, CIRCULATION, V81, P470, DOI 10.1161/01.CIR.81.2.470; BROWN G, 1990, NEW ENGL J MED, V323, P1289, DOI 10.1056/NEJM199011083231901; CABEZAS MC, 1993, EUR J CLIN INVEST, V23, P122, DOI 10.1111/j.1365-2362.1993.tb00751.x; CARLSON LA, 1988, ACTA MED SCAND, V223, P405; Contois JH, 1996, CLIN CHEM, V42, P515; Contois JH, 1996, CLIN CHEM, V42, P507; COX DR, 1972, J R STAT SOC B, V34, P187; FIELDING CJ, 1989, HIGH DENSITY LIPOPRO, V2, P149; FRANCESCHINI G, 1995, ATHEROSCLEROSIS, V114, P61, DOI 10.1016/0021-9150(94)05465-U; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fruchart JC, 1999, CURR OPIN LIPIDOL, V10, P245, DOI 10.1097/00041433-199906000-00007; GENEST J, 1992, J AM COLL CARDIOL, V19, P792, DOI 10.1016/0735-1097(92)90520-W; Goldbourt U, 1997, ARTERIOSCL THROM VAS, V17, P107, DOI 10.1161/01.ATV.17.1.107; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; KANNEL WB, 1995, AM J CARDIOL, V76, pC69, DOI 10.1016/S0002-9149(99)80474-3; Lamarche B, 1996, ATHEROSCLEROSIS, V119, P235, DOI 10.1016/0021-9150(95)05653-X; MACK WJ, 1996, THROMB VASC BIOL, V16, P697; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; MANTTARI M, 1990, ATHEROSCLEROSIS, V81, P11, DOI 10.1016/0021-9150(90)90054-M; MCNAMARA JR, 1994, CLIN CHEM, V40, P233; MCNAMARA JR, 1987, CLIN CHIM ACTA, V166, P1, DOI 10.1016/0009-8981(87)90188-4; MILLER GJ, 1975, LANCET, V1, P16; NGUYEN T, 1989, CLIN CHEM, V35, P1086; OLIVER M F, 1978, British Heart Journal, V40, P1069, DOI 10.1136/hrt.40.10.1069; PONSIN G, 1994, BIOCHEM MED METAB B, V52, P58, DOI 10.1006/bmmb.1994.1034; Research Committee of the Scottish Society of Physicians, 1971, BMJ-BRIT MED J, V4, P775; Rubins HB, 1996, AM J CARDIOL, V78, P572, DOI 10.1016/S0002-9149(96)00369-4; RUBINS HB, 1995, AM J CARDIOL, V75, P1196, DOI 10.1016/S0002-9149(99)80761-9; RUBINS HB, 1993, AM J CARDIOL, V71, P45, DOI 10.1016/0002-9149(93)90708-K; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Ruotolo G, 1998, J AM COLL CARDIOL, V32, P1648, DOI 10.1016/S0735-1097(98)00442-2; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SAKU K, 1985, J CLIN INVEST, V75, P1702, DOI 10.1172/JCI111879; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Sehayek Ephraim, 1994, Current Opinion in Lipidology, V5, P350, DOI 10.1097/00041433-199410000-00006; SORISKY A, 1987, ATHEROSCLEROSIS, V67, P181, DOI 10.1016/0021-9150(87)90278-4; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; Syvanne M, 1998, CIRCULATION, V98, P1993, DOI 10.1161/01.CIR.98.19.1993; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; WATTS GF, 1993, METABOLISM, V42, P1461, DOI 10.1016/0026-0495(93)90199-X; 1971, BMJ, V4, P767	46	695	720	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2001	285	12					1585	1591		10.1001/jama.285.12.1585	http://dx.doi.org/10.1001/jama.285.12.1585			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413HH	11268266	Bronze			2022-12-28	WOS:000167606600025
J	Berardini, TZ; Bollman, K; Sun, H; Poethig, RS				Berardini, TZ; Bollman, K; Sun, H; Poethig, RS			Regulation of vegetative phase change in Arabidopsis thaliana by cyclophilin 40	SCIENCE			English	Article							TETRATRICOPEPTIDE REPEAT DOMAIN; GENE FAMILY; PROTEIN; HSP90; BINDING; CYP-40; IMMUNOPHILINS; THERMOTOLERANCE; COMPONENT; IDENTITY	During its development, a plant shoot progresses from a juvenile to an adult phase of vegetative growth and from a reproductively incompetent to a reproductively competent state. In Arabidopsis, Loss-of-function mutations in SQUINT (SQN) reduced the number of juvenile Leaves and had subtle effects on inflorescence morphology but had no effect on flowering time or on reproductive competence. SQN encodes the Arabidopsis homolog of cyclophilin 40 (CyP40), a protein found in association with the Hsp90 chaperone complex in yeast, mammals, and plants. Thus, in Arabidopsis, CyP40 is specifically required for the vegetative but not the reproductive maturation of the shoot.	Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	Poethig, RS (corresponding author), Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA.	spoethig@sas.upenn.edu	Poethig, R. Scott/J-7009-2015	Poethig, R. Scott/0000-0001-6592-5862; Berardini, Tanya/0000-0002-3837-8864	NIGMS NIH HHS [R01-GM1893-04] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allsopp A, 1967, Adv Morphog, V6, P127; BRINK RA, 1962, Q REV BIOL, V37, P1, DOI 10.1086/403567; Carrello A, 1999, J BIOL CHEM, V274, P2682, DOI 10.1074/jbc.274.5.2682; Chien JC, 1996, PLANT PHYSIOL, V111, P1321, DOI 10.1104/pp.111.4.1321; Chou IT, 1997, PLANT MOL BIOL, V35, P873, DOI 10.1023/A:1005930024796; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; Duina AA, 1998, J BIOL CHEM, V273, P10819, DOI 10.1074/jbc.273.18.10819; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Goebel K, 1900, ORGANOGRAPHY PLANT 1; Hackett W., 1993, MICROPROPAGATION WOO, P93, DOI DOI 10.1007/978-94-015-8116-5_6; Kerstetter RA, 1998, ANNU REV CELL DEV BI, V14, P373, DOI 10.1146/annurev.cellbio.14.1.373; KIEFFER LJ, 1993, J BIOL CHEM, V268, P12303; Milioni D, 1997, PLANT MOL BIOL, V35, P955, DOI 10.1023/A:1005874521528; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; OwensGrillo JK, 1996, BIOCHEMISTRY-US, V35, P15249, DOI 10.1021/bi9615349; OWENSGRILLO JK, 1995, J BIOL CHEM, V270, P20479, DOI 10.1074/jbc.270.35.20479; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; POETHIG RS, 1990, SCIENCE, V250, P923, DOI 10.1126/science.250.4983.923; Prandl R, 1998, MOL GEN GENET, V258, P269, DOI 10.1007/s004380050731; Pratt WB, 1999, CELL SIGNAL, V11, P839, DOI 10.1016/S0898-6568(99)00064-9; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; Ratajczak T, 1996, J BIOL CHEM, V271, P2961, DOI 10.1074/jbc.271.6.2961; RATAJCZAK T, 1993, J BIOL CHEM, V268, P13187; ROBBELEN GERHARD, 1957, BER DEUTSCH BOT GES, V70, P39; SCHIRMER EC, 1994, PLANT CELL, V6, P1899, DOI 10.1105/tpc.6.12.1899; Telfer A, 1998, DEVELOPMENT, V125, P1889; Telfer A, 1997, DEVELOPMENT, V124, P645; Tsukaya H, 2000, PLANTA, V210, P536, DOI 10.1007/s004250050042; Vittorioso P, 1998, MOL CELL BIOL, V18, P3034, DOI 10.1128/MCB.18.5.3034; WEIGEL D, 1995, NATURE, V377, P495, DOI 10.1038/377495a0; Weisman R, 1996, EMBO J, V15, P447, DOI 10.1002/j.1460-2075.1996.tb00377.x	33	130	141	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2001	291	5512					2405	2407		10.1126/science.1057144	http://dx.doi.org/10.1126/science.1057144			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264535				2022-12-28	WOS:000167618700054
J	Xu, GZ; Cirilli, M; Huang, YH; Rich, RL; Myszka, DG; Wu, H				Xu, GZ; Cirilli, M; Huang, YH; Rich, RL; Myszka, DG; Wu, H			Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex	NATURE			English	Article							BACULOVIRUS P35 PROTEIN; CELL-DEATH; APOPTOSIS; SITE; EXPRESSION; DROSOPHILA; CLEAVAGE; SUITE; GENE	Apoptosis is a highly regulated process that is crucial for normal development and homeostasis of multicellular organisms(1,2). The p35 protein from baculoviruses effectively prevents apoptosis by its broad-spectrum caspase inhibition(3-7). Here we report the crystal structure of p35 in complex with human caspase-8 at 3.0 Angstrom resolution, and biochemical and mutagenesis studies based on the structural information. The structure reveals that the caspase is inhibited in the active site through a covalent thioester linkage to p35, which we confirmed by gel electrophoresis, hydroxylamine treatment and mass spectrometry experiments. The p35 protein undergoes dramatic conformational changes on cleavage by the caspase. The repositioning of the amino terminus of p35 into the active site of the caspase eliminates solvent accessibility of the catalytic dyad. This may be crucial for preventing hydrolysis of the thioester intermediate, which is supported by the abrogation of inhibitory activity through mutations at the N terminus of p35. The p35 protein also makes conserved contacts with the caspase outside the active-site region, providing the molecular basis for the broad-spectrum inhibitory activity of this protein. We demonstrate a new molecular mechanism of caspase inhibition, as well as protease inhibition in general.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, Program Physiol Biophys & Mol Med, New York, NY 10021 USA; CNR, Ist Strutturist Chim Giordano Giacomello, Monterotondo Stn, Italy; Univ Utah, Sch Med, Ctr Biomol Interact Anal, Salt Lake City, UT 84132 USA	Cornell University; Cornell University; Consiglio Nazionale delle Ricerche (CNR); Utah System of Higher Education; University of Utah	Wu, H (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.							BEIDLER DR, 1995, J BIOL CHEM, V270, P16526, DOI 10.1074/jbc.270.28.16526; Bertin J, 1996, J VIROL, V70, P6251, DOI 10.1128/JVI.70.9.6251-6259.1996; Blanchard H, 1999, STRUCTURE, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; BRUICE TC, 1966, BIOORGANIC MECH; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; Fisher AJ, 1999, EMBO J, V18, P2031, DOI 10.1093/emboj/18.8.2031; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hisahara S, 2000, EMBO J, V19, P341, DOI 10.1093/emboj/19.3.341; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Myszka DG, 1999, MOL RECOGNIT, V12, P1; OWEN WG, 1976, THROMB HAEMOSTASIS, V35, P87, DOI 10.1055/s-0038-1647914; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; Robertson NM, 1997, CANCER RES, V57, P43; Sambrook J., 1989, MOL CLONING; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Stennicke HR, 1999, CELL DEATH DIFFER, V6, P1054, DOI 10.1038/sj.cdd.4400599; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TONG L, 1993, J APPL CRYSTALLOGR, V26, P748, DOI 10.1107/S0021889893005631; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; WRIGHT HT, 1995, PROTEINS, V22, P210, DOI 10.1002/prot.340220303; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w; Zoog SJ, 1999, J BIOL CHEM, V274, P25995, DOI 10.1074/jbc.274.37.25995	30	146	154	1	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					494	497		10.1038/35068604	http://dx.doi.org/10.1038/35068604			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260720				2022-12-28	WOS:000167583800048
J	Ickovics, JR; Hamburger, ME; Vlahov, D; Schoenbaum, EE; Schuman, P; Boland, RJ; Moore, J				Ickovics, JR; Hamburger, ME; Vlahov, D; Schoenbaum, EE; Schuman, P; Boland, RJ; Moore, J		HIV Epidemiology Res Study Grp	Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women - Longitudinal analysis from the HIV epidemiology research study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLACEBO-CONTROLLED TRIAL; MAJOR DEPRESSION; LYMPHOCYTE SUBSETS; HOMOSEXUAL MEN; UNITED-STATES; INFECTED MEN; ANTIDEPRESSANT TREATMENT; MYOCARDIAL-INFARCTION; SERVICES UTILIZATION	Context The impact of depression on morbidity and mortality among women with human immunodeficiency virus (HIV) has not been examined despite the fact that women with HIV have substantially higher rates of depression than their male counterparts. Objective To determine the association of depressive symptoms with HIV-related mortality and decline in CD4 lymphocyte counts among women with HIV. Design The HIV Epidemiologic Research Study, a prospective, longitudinal cohort study conducted from April 1993 through January 1995, with follow-up through March 2000. Setting Four academic medical centers in Baltimore, Md; Bronx, NY; Providence, RI; and Detroit, Mich. Participants A total of 765 HIV-seropositive women aged 16 to 55 years. Main Outcome Measures HIV-related mortality and CD4 cell count slope decline over a maximum of 7 years, compared among women with limited or no depressive symptoms, intermittent depressive symptoms, or chronic depressive symptoms, as measured using the self-report Center for Epidemiologic Studies Depression Scale. Results In multivariate analyses controlling for clinical, treatment, and other factors, women with chronic depressive symptoms were 2 times more likely to die than women with limited or no depressive symptoms (relative risk [RR], 2.0; 95% confidence interval [CI], 1.0-3,8). Among women with CD4 cell counts of less than 200 x 10(6)/L, HIV-related mortality rates were 54% for those with chronic depressive symptoms (RR, 4.3; 95 % CI, 1.6-11.6) and 48% for those with intermittent depressive symptoms (RR, 3.5; 95% CI, 1.1-10.5) compared with 21% for those with limited or no depressive symptoms. Chronic depressive symptoms were also associated with significantly greater decline in CD4 cell counts after controlling for other variables in the model, especially among women with baseline CD4 cell counts of less than 500 x 10(6)/L and baseline viral load greater than 10000 copies/mul. Conclusions Our results indicate that depressive symptoms among women with HIV are associated with HIV disease progression, controlling for clinical, substance use, and sociodemographic characteristics. These results highlight the importance of adequate diagnosis and treatment of depression among women with HIV, Further research is needed to determine if treatment of depression can not only enhance the mental health of women with HIV but also impede disease progression and mortality.	Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA; Ctr Dis Control & Prevent, Epidemiol Branch, Div HIV AIDS Prevent, Atlanta, GA USA; New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY USA; Montefiore Med Ctr, Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10467 USA; Wayne State Univ, Dept Med, Div Infect Dis, Detroit, MI 48202 USA; Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA	Yale University; Yale University; Centers for Disease Control & Prevention - USA; New York Academy of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Wayne State University; Brown University	Ickovics, JR (corresponding author), Yale Univ, Dept Epidemiol & Publ Hlth, POB 208034,60 Coll St,Suite 415, New Haven, CT 06520 USA.			Schoenbaum, Ellie/0000-0002-0878-284X	CSP VA [U64/CU506831, U64/CU200714, U64/CU106795, U64/CU306802] Funding Source: Medline	CSP VA		[Anonymous], [No title captured], DOI DOI 10.1023/A:1022359307814; ATKINSON JH, 1988, ARCH GEN PSYCHIAT, V45, P859; Boland R, 1997, AM J PSYCHIAT, V154, P1632, DOI 10.1176/ajp.154.11.1632-a; BRESLAU N, 1985, PSYCHIAT RES, V15, P219, DOI 10.1016/0165-1781(85)90079-4; BRUCE ML, 1994, AM J PSYCHIAT, V151, P716; BURACK JH, 1993, JAMA-J AM MED ASSOC, V270, P2568, DOI 10.1001/jama.270.21.2568; Cohen Jacob, 1975, APPL MULTIPLE REGRES; COHEN S, 1996, ANNU REV PSYCHOL, V47, P114; CRAIG TJ, 1976, AM J PSYCHIAT, V133, P1426; EATON WW, 1981, AM J EPIDEMIOL, V114, P28; Elliott AJ, 1998, AM J PSYCHIAT, V155, P367; Fernandez DM, 1997, CELL MOL BIOL, V43, P1115; Ferrando SJ, 1997, GEN HOSP PSYCHIAT, V19, P89, DOI 10.1016/S0163-8343(96)00172-7; Ferrando SJ, 1999, J CLIN PSYCHIAT, V60, P741; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; FRASURESMITH N, 1995, CIRCULATION, V91, P999, DOI 10.1161/01.CIR.91.4.999; GILL D, 2000, COCHRANE LIB UPDATE; GIORGI JV, 1990, CLIN IMMUNOL IMMUNOP, V55, P173, DOI 10.1016/0090-1229(90)90096-9; Gordillo V, 1999, AIDS, V13, P1763, DOI 10.1097/00002030-199909100-00021; Havlir DV, 1996, ANN INTERN MED, V124, P984, DOI 10.7326/0003-4819-124-11-199606010-00006; HERBERT TB, 1993, PSYCHOL BULL, V113, P472, DOI 10.1037/0033-2909.113.3.472; Herrmann C, 1998, PSYCHOSOM MED, V60, P570, DOI 10.1097/00006842-199809000-00011; ICKOVICS JR, 2000, HDB HLTH PSYCHOL, P821; KALICHMAN SC, 1995, J PERS ASSESS, V64, P86, DOI 10.1207/s15327752jpa6401_5; Kaplan MS, 1997, AM J ORTHOPSYCHIAT, V67, P80, DOI 10.1037/h0080213; KEMENY ME, 1994, HEALTH PSYCHOL, V13, P14, DOI 10.1037/0278-6133.13.1.14; KLERMAN GL, 1989, ARCH GEN PSYCHIAT, V46, P856; Leserman J, 1999, PSYCHOSOM MED, V61, P397, DOI 10.1097/00006842-199905000-00021; Leserman J, 1997, ARCH GEN PSYCHIAT, V54, P279; LIPSITZ JD, 1994, AM J PSYCHIAT, V151, P1662; Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P295; LYKETSOS CG, 1993, JAMA-J AM MED ASSOC, V270, P2563, DOI 10.1001/jama.270.21.2563; MARKOWITZ JC, 1994, AIDS, V8, P403, DOI 10.1097/00002030-199404000-00001; Markowitz JC, 1998, ARCH GEN PSYCHIAT, V55, P452, DOI 10.1001/archpsyc.55.5.452; Mayne TJ, 1996, ARCH INTERN MED, V156, P2233, DOI 10.1001/archinte.156.19.2233; MCEWEN BS, 1998, NEW ENGL J MED, V38, P670; Miller GE, 1999, PSYCHOSOM MED, V61, P850, DOI 10.1097/00006842-199911000-00021; Moore J, 1999, AIDS, V13, P2459, DOI 10.1097/00002030-199912030-00018; MYERS JK, 1980, AM J PSYCHIAT, V137, P1081; PageShafer K, 1996, ANN EPIDEMIOL, V6, P420, DOI 10.1016/S1047-2797(96)00064-6; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Patterson TL, 1996, ANN BEHAV MED, V18, P30, DOI 10.1007/BF02903937; PERKINS DO, 1994, AM J PSYCHIAT, V151, P233; PERRY S, 1990, AM J PSYCHIAT, V147, P89; PERRY S, 1992, ARCH GEN PSYCHIAT, V49, P396; PERRY S, 1993, JAMA-J AM MED ASSOC, V270, P2609, DOI 10.1001/jama.270.21.2609; RABKIN JG, 1991, ARCH GEN PSYCHIAT, V48, P111; Rabkin JG, 1997, AM J PSYCHIAT, V154, P231, DOI 10.1176/ajp.154.2.231; Rabkin JG, 1999, AM J PSYCHIAT, V156, P101, DOI 10.1176/ajp.156.1.101; Rabkin JG, 1997, AIDS, V11, P507, DOI 10.1097/00002030-199704000-00015; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; REICHLIN S, 1993, NEW ENGL J MED, V329, P1246; ROBERTS G, 1984, SENSOR ACTUATOR, V4, P131; ROBERTS RE, 1983, AM J PSYCHIAT, V140, P41; ROVNER BW, 1991, JAMA-J AM MED ASSOC, V265, P993, DOI 10.1001/jama.265.8.993; Sambamoorthi U, 2000, J GEN INTERN MED, V15, P311, DOI 10.1046/j.1525-1497.2000.06219.x; Schulz R, 2000, ARCH INTERN MED, V160, P1761, DOI 10.1001/archinte.160.12.1761; Semple SJ, 1996, WOMEN HEALTH, V24, P17, DOI 10.1300/J013v24n02_02; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Smith DK, 1997, AM J EPIDEMIOL, V146, P459, DOI 10.1093/oxfordjournals.aje.a009299; SMITH DK, 1996, WOMEN AIDS COPING CA, P185; WILLIAMS JBW, 1991, ARCH GEN PSYCHIAT, V48, P124; Wulsin LR, 1999, PSYCHOSOM MED, V61, P6, DOI 10.1097/00006842-199901000-00003; Zheng DY, 1997, ANN EPIDEMIOL, V7, P213, DOI 10.1016/S1047-2797(97)00014-8; Zisook S, 1998, J CLIN PSYCHIAT, V59, P217, DOI 10.4088/JCP.v59n0502; Zorrilla EP, 1996, AM J PSYCHIAT, V153, P626	66	665	678	1	42	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1466	1474		10.1001/jama.285.11.1466	http://dx.doi.org/10.1001/jama.285.11.1466			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410VQ	11255423	Bronze			2022-12-28	WOS:000167462100029
J	Navas-Nacher, EL; Colangelo, L; Beam, C; Greenland, P				Navas-Nacher, EL; Colangelo, L; Beam, C; Greenland, P			Risk factors for coronary heart disease in men 18 to 39 years of age	ANNALS OF INTERNAL MEDICINE			English	Article							CHOLESTEROL SCREENING GUIDELINES; FOLLOW-UP; SERUM-CHOLESTEROL; BLOOD-PRESSURE; ATHEROSCLEROSIS; MORTALITY; ADULTS; ASSOCIATION; PRAVASTATIN; CONSENSUS	Background: Few studies have evaluated the long-term predictive capacity of risk factors for death from coronary heart disease in men younger than 40 years of age. Objective: To assess the predictive capacity and discriminatory ability of major coronary risk factors in predicting death from coronary heart disease in young men. Design: Prospective cohort study with 20 years of follow-up. Setting: 84 companies in the Chicago area that participated in the Chicago Heart Association Detection Project in Industry (1967-1973). Participants: 11 016 men 18 to 39 years of age (mean age, 29.7 years) at baseline were the primary focus of this report; 8955 men 40 to 59 years of age at baseline served as a reference group. Measurements: The main end point was death from coronary heart disease. Results: All major risk factors-age, serum cholesterol level, systolic blood pressure, and cigarette smoking-were significantly associated with death from coronary heart disease over 20 years in young men. Relative risks for the major risk factors were of generally similar magnitude in young and middle-aged men. Receiver-operating characteristic curves for the best predictive model yielded an area under the curve of 0.82, indicating that standard risk factors were highly predictive of long-term outcome in young men. Conclusions: Major coronary disease risk factors, many of which are modifiable, are strong contributors to prediction of future risk, even in young men. These data may help in formulating appropriate strategies to identify young men at heightened risk for death from coronary heart disease in later adulthood.	Northwestern Univ, Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA	Northwestern University; Medical College of Wisconsin	Greenland, P (corresponding author), Northwestern Univ, Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.		Greenland, Philip/ABD-5528-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021010] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		American Heart Association, 1999, HEART STROK STAT UPD; ANDERSON KM, 1987, JAMA-J AM MED ASSOC, V257, P2176, DOI 10.1001/jama.257.16.2176; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; BYINGTON RP, 1995, CIRCULATION, V92, P2419, DOI 10.1161/01.CIR.92.9.2419; Cleeman JI, 1997, CIRCULATION, V95, P1646; DAVIS CE, 1990, JAMA-J AM MED ASSOC, V264, P3044, DOI 10.1001/jama.264.23.3044; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; ENOS WF, 1953, JAMA-J AM MED ASSOC, V152, P1090, DOI 10.1001/jama.1953.03690120006002; Garber AM, 1996, ANN INTERN MED, V124, P515, DOI 10.7326/0003-4819-124-5-199603010-00013; Garber AM, 1997, CIRCULATION, V95, P1642; GROVER SA, 1995, JAMA-J AM MED ASSOC, V274, P801, DOI 10.1001/jama.274.10.801; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; HAWK PB, 1954, PRACTICAL PHYSL CHEM, P564; Hoffman WS, 1937, J BIOL CHEM, V120, P51; *JOINT NAT COMM PR, 1997, NAT HEART LUNG BLOOD; JUDSON JJ, 1971, J AMER MED ASSOC, V216, P1185; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; Krauss RM, 1996, CIRCULATION, V94, P1795, DOI 10.1161/01.CIR.94.7.1795; LaRosa JC, 1997, CIRCULATION, V95, P1651; LEVINE JB, 1964, CLIN CHIM ACTA, V10, P381, DOI 10.1016/0009-8981(64)90073-7; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MCGILL HC, 1990, JAMA-J AM MED ASSOC, V264, P3018; McGill HC, 2000, CIRCULATION, V102, P374; *NAT CTR HLTH STAT, 1967, INT CLASS DIS, P49; PEDERSEN TR, 1994, LANCET, V344, P1383; *POOL PROJ RES GRO, 1978, J CHRON DIS, V31, P201, DOI DOI 10.1016/0021-9681(78)90073-5; PRINEAS RJ, 1983, HYPERTENSION, V5, P160; Ridker PM, 1999, ANN INTERN MED, V130, P933, DOI 10.7326/0003-4819-130-11-199906010-00018; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; STAMLER J, 1993, CARDIOLOGY, V82, P191, DOI 10.1159/000175868; STAMLER J, 1975, J CHRON DIS, V28, P499, DOI 10.1016/0021-9681(75)90059-4; Therneau T. M., 2013, MODELING SURVIVAL DA, DOI 10.1007/978-1-4757-3294-8; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; ZWEIG MH, 1993, CLIN CHEM, V39, P561	34	88	94	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					433	439		10.7326/0003-4819-134-6-200103200-00007	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409VF	11255518				2022-12-28	WOS:000167405800001
J	Kumar, JP; Moses, K				Kumar, JP; Moses, K			EGF receptor and notch signaling act upstream of Eyeless/Pax6 to control eye specification	CELL			English	Article							CELL-FATE; TYROSINE KINASE; HOMEOBOX GENE; ABSENT GENE; WILD-TYPE; DROSOPHILA; PROTEIN; DIFFERENTIATION; WINGLESS; HOMOLOG	The Drosophila compound eye is specified by the concerted action of seven nuclear factors that include Eyeless/Pax6. These factors have been called "master control" proteins because loss-of-function mutants lack eyes and ectopic expression can direct ectopic eye development. However, inactivation of these genes does not cause the presumptive eye to change identity. Surprisingly, we find that several of these eye specification genes are not coexpressed in the same embryonic cells-or even in the presumptive eye. We demonstrate that the EGF Receptor and Notch signaling pathways have homeotic functions that are genetically upstream of the eye specification genes, and show that specification occurs much later than previously thought-not during embryonic development but in the second larval stage.	Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	Emory University	Moses, K (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, 1648 Pierce Dr, Atlanta, GA 30322 USA.	kmoses@cellbio.emory.edu			NATIONAL EYE INSTITUTE [R01EY012537, F32EY006763] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY006763, 5 F32 EY06763, R01 EY-12537] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alifragis P, 1997, P NATL ACAD SCI USA, V94, P13099, DOI 10.1073/pnas.94.24.13099; Apidianakis Y, 1999, MECH DEVELOP, V86, P39, DOI 10.1016/S0925-4773(99)00099-4; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Aza-Blanc P, 1999, TRENDS GENET, V15, P458, DOI 10.1016/S0168-9525(99)01869-7; Baker CVH, 2000, DEVELOPMENT, V127, P3045; Baker NE, 2000, BIOESSAYS, V22, P264, DOI 10.1002/(SICI)1521-1878(200003)22:3<264::AID-BIES8>3.0.CO;2-M; Baonza A, 2000, P NATL ACAD SCI USA, V97, P7331, DOI 10.1073/pnas.97.13.7331; Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Bhat KM, 2000, DEVELOPMENT, V127, P655; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; Blair SS, 1999, CURR BIOL, V9, pR356, DOI 10.1016/S0960-9822(99)80226-7; Bonini NM, 1998, DEV BIOL, V196, P42, DOI 10.1006/dbio.1997.8845; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Boube M, 1997, GENETICS, V146, P619; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Boyle M, 1997, DEVELOPMENT, V124, P971; Brennan K, 1997, GENETICS, V147, P177; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; CLIFFORD RJ, 1989, GENETICS, V123, P771; Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8; Dickson BJ, 1998, CURR BIOL, V8, pR90, DOI 10.1016/S0960-9822(98)70054-5; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; Dong PDS, 2000, DEVELOPMENT, V127, P209; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; FREEMAN M, 1994, DEVELOPMENT, V120, P2297; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Gehring WJ., 1998, MASTER CONTROL GENES; Giebel B, 1997, P NATL ACAD SCI USA, V94, P6250, DOI 10.1073/pnas.94.12.6250; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; GROSSNIKLAUS U, 1992, GENE DEV, V6, P1030, DOI 10.1101/gad.6.6.1030; Hadorn E, 1978, GENETICS BIOL DROS C, V2c, P555; HAYASHI S, 1993, DEVELOPMENT, V118, P105; Hayashi T, 1998, DEV BIOL, V200, P131, DOI 10.1006/dbio.1998.8959; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; Heberlein U, 2000, Results Probl Cell Differ, V31, P37; Helms W, 1999, DEV BIOL, V215, P358, DOI 10.1006/dbio.1999.9477; Hidalgo A, 1996, TRENDS GENET, V12, P1, DOI 10.1016/0168-9525(96)81373-4; Huppert SS, 1997, DEVELOPMENT, V124, P3283; Ito K, 1997, DEVELOPMENT, V124, P761; Jones NA, 1998, DEVELOPMENT, V125, P4163; Karim FD, 1998, DEVELOPMENT, V125, P1; KASSIS JA, 1990, GENE DEV, V4, P433, DOI 10.1101/gad.4.3.433; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Kramer S, 1999, DEVELOPMENT, V126, P2515; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Kumar J P, 2000, Results Probl Cell Differ, V31, P93; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Kurata S, 2000, P NATL ACAD SCI USA, V97, P2117, DOI 10.1073/pnas.040556497; Lawrence PA, 1995, DEVELOPMENT, V121, P4303; Lee T, 1996, GENE DEV, V10, P2912, DOI 10.1101/gad.10.22.2912; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Li W, 1997, DEVELOPMENT, V124, P4163; Manning L, 1999, DEVELOPMENT, V126, P2063; MARDON G, 1994, DEVELOPMENT, V120, P3473; Martin-Blanco E, 1998, INT J DEV BIOL, V42, P363; Maurel-Zaffran C, 2000, DEVELOPMENT, V127, P1007; Michelson AM, 1998, DEVELOPMENT, V125, P4379; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nilson LA, 1999, CURR TOP DEV BIOL, V44, P203; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; POSTLETHWAIT JH, 1971, DEV BIOL, V24, P477, DOI 10.1016/0012-1606(71)90061-3; Price JV, 1997, GENETICS, V147, P1139; Queenan AM, 1997, DEVELOPMENT, V124, P3871; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; REICHMANFRIED M, 1994, GENE DEV, V8, P428, DOI 10.1101/gad.8.4.428; Riechmann V, 1997, DEVELOPMENT, V124, P2915; Royet J, 1997, DEVELOPMENT, V124, P4793; Royet J, 1996, DEVELOPMENT, V122, P1849; Sawamoto K, 1996, NEUROSCI RES, V26, P205, DOI 10.1016/S0168-0102(96)01110-8; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; Scholz H, 1997, MECH DEVELOP, V64, P137; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; Seimiya M, 2000, DEVELOPMENT, V127, P1879; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; TATA F, 1995, MECH DEVELOP, V51, P305, DOI 10.1016/0925-4773(95)00377-0; Tio M, 1997, DEVELOPMENT, V124, P343; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; Treisman JE, 1999, BIOESSAYS, V21, P843, DOI 10.1002/(SICI)1521-1878(199910)21:10<843::AID-BIES6>3.3.CO;2-A; Treisman JE, 1998, CURR TOP DEV BIOL, V39, P119, DOI 10.1016/S0070-2153(08)60454-8; WIESCHAUS E, 1974, THESIS YALE U NEW HA, P1; YOUNOSSIHARTENSTEIN A, 1993, ROUX ARCH DEV BIOL, V203, P60, DOI 10.1007/BF00539891; zur Lage P, 1999, DEVELOPMENT, V126, P3149	92	171	175	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2001	104	5					687	697		10.1016/S0092-8674(01)00265-3	http://dx.doi.org/10.1016/S0092-8674(01)00265-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257223	Bronze			2022-12-28	WOS:000167531100009
J	Santiago, JR; Nolledo, MS; Kinzler, W; Santiago, TV				Santiago, JR; Nolledo, MS; Kinzler, W; Santiago, TV			Sleep and sleep disorders in pregnancy	ANNALS OF INTERNAL MEDICINE			English	Review							PERIODIC LEG MOVEMENTS; MIDDLE-AGED MEN; APNEA SYNDROME; FEMALE RATS; PROLACTIN SECRETION; MYOMETRIAL ACTIVITY; GROWTH-RETARDATION; CIRCADIAN-RHYTHMS; HEART-FAILURE; REM-SLEEP	Sleep problems are common in pregnant women. This review examines sleep in normal pregnancy; discusses the physiologic bases for alterations in sleep, including hormonal and mechanical factors; and correlates these factors with changes in sleep of pregnant women, as determined subjectively by surveys and objectively by polysomnographic studies. The changes in respiratory physiology during pregnancy, the possible predisposition of the pregnant woman to sleep-disordered breathing because of these changes, and results of published studies of sleep-disordered breathing in pregnancy are discussed. Finally, the effect of pregnancy on other sleep disorders and the management of these sleep disorders during pregnancy are outlined, including changes in management necessitated by this state. The paucity of available data and the need for further studies of incidence and outcomes of sleep disorders in the pregnant woman are emphasized.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Robert Wood Johnson Univ Hosp, Comprehens Sleep Disorders Ctr, New Brunswick, NJ 08903 USA; Univ New Brunswick, St Peters Hosp, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Santiago, JR (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Robert Wood Johnson Univ Hosp, Comprehens Sleep Disorders Ctr, 1 Robert Wood Johnson Pl, New Brunswick, NJ 08903 USA.	santiate@umdnj.edu						AHMED M, 1994, SLEEP, V17, P527, DOI 10.1093/sleep/17.6.527; ALDRICH MS, 1990, NEW ENGL J MED, V323, P389; *AM SLEEP DIS ASS, 1997, INT CLASS SLEEP DIS, P297; AMBROGETTI A, 1991, AUST NZ J MED, V21, P863, DOI 10.1111/j.1445-5994.1991.tb01408.x; ANG CK, 1969, BRIT MED J, V4, P201, DOI 10.1136/bmj.4.5677.201; AWE RJ, 1979, OBSTET GYNECOL, V53, P182; BALDWIN GR, 1977, AM J OBSTET GYNECOL, V127, P235, DOI 10.1016/0002-9378(77)90460-4; BERLIN RM, 1988, SLEEP, V11, P298, DOI 10.1093/sleep/11.3.298; Bernstein I, 1996, OBSTET NORMAL PROBLE, P863; BEVAN DR, 1974, BMJ-BRIT MED J, V1, P13, DOI 10.1136/bmj.1.5896.13; BILLIARD M, 1994, SLEEP, V17, pS107, DOI 10.1093/sleep/17.suppl_8.S107; BLOCK AJ, 1979, NEW ENGL J MED, V300, P513, DOI 10.1056/NEJM197903083001001; BORN J, 1989, J CLIN ENDOCR METAB, V68, P904, DOI 10.1210/jcem-68-5-904; BOURNE T, 1995, BRIT J ANAESTH, V75, P678, DOI 10.1093/bja/75.6.678; BOYAR RM, 1975, J CLIN ENDOCR METAB, V40, P1117, DOI 10.1210/jcem-40-6-1117; BRANCHEY M, 1971, PHYSIOL BEHAV, V6, P743, DOI 10.1016/0031-9384(71)90267-8; Branchey M, 1968, Acta Neurol Psychiatr Belg, V68, P453; BRANCHEY M, 1970, PHYSIOL BEHAV, V5, P365, DOI 10.1016/0031-9384(70)90112-5; BRIGGS GG, 1998, DRUGS PREGNANCY LACT; BROUGHTON RJ, 1968, SCIENCE, V159, P1070, DOI 10.1126/science.159.3819.1070; BROWNELL LG, 1986, AM REV RESPIR DIS, V133, P38, DOI 10.1164/arrd.1986.133.1.38; BRUNNER DP, 1994, SLEEP, V17, P576, DOI 10.1093/sleep/17.7.576; Buysse DJ, 1997, SLEEP, V20, P542, DOI 10.1093/sleep/20.7.542; CARSKADON MA, 2000, PRINCIPLES PRACTICE, P15; CASSONE VM, 1992, J BIOL RHYTHM, V7, P27, DOI 10.1177/074873049200700103; CHAO A, 1990, J REPROD MED, V35, P678; CHARBONNEAU M, 1991, AM REV RESPIR DIS, V144, P461, DOI 10.1164/ajrccm/144.2.461; CHERNIACK NS, 1973, NEW ENGL J MED, V288, P952, DOI 10.1056/NEJM197305032881810; CHERNIACK NS, 1981, NEW ENGL J MED, V305, P325; COLVIN GB, 1969, EXP NEUROL, V25, P616, DOI 10.1016/0014-4886(69)90104-6; COLVIN GERALD B., 1968, BRAIN RES, V7, P173, DOI 10.1016/0006-8993(68)90095-4; CONTI M, 1988, EUR J ANAESTH, V5, P151; CONTRERAS G, 1991, AM REV RESPIR DIS, V144, P837, DOI 10.1164/ajrccm/144.4.837; COUSINS L, 1983, AM J OBSTET GYNECOL, V145, P411, DOI 10.1016/0002-9378(83)90309-5; CROCKER BD, 1990, AM REV RESPIR DIS, V142, P14, DOI 10.1164/ajrccm/142.1.14; DIJK DJ, 1989, AM J PHYSIOL, V256, pR106, DOI 10.1152/ajpregu.1989.256.1.R106; DRIVER HS, 1992, SLEEP, V15, P449, DOI 10.1093/sleep/15.5.449; Edwards N, 2000, AM J RESP CRIT CARE, V162, P252, DOI 10.1164/ajrccm.162.1.9905006; EKHOLM EMK, 1992, AM J OBSTET GYNECOL, V167, P1262, DOI 10.1016/S0002-9378(11)91698-6; ELKUS R, 1992, CLIN CHEST MED, V13, P555; ERIKSSON L, 1989, GYNECOL OBSTET INVES, V27, P78, DOI 10.1159/000293623; Fang JD, 1996, BRAIN RES, V734, P275, DOI 10.1016/0006-8993(96)00652-X; FEINSILVER SH, 1992, CLIN CHEST MED, V13, P637; FEWELL JE, 1995, AM J PHYSIOL-HEART C, V268, pH1734, DOI 10.1152/ajpheart.1995.268.4.H1734; FIGUEROA JP, 1990, AM J OBSTET GYNECOL, V163, P648, DOI 10.1016/0002-9378(90)91217-Z; FLETCHER EC, 1995, AM J MED, V98, P118, DOI 10.1016/S0002-9343(99)80395-7; Franklin KA, 2000, CHEST, V117, P137, DOI 10.1378/chest.117.1.137; Friess E, 1997, AM J PHYSIOL-ENDOC M, V272, pE885, DOI 10.1152/ajpendo.1997.272.5.E885; FUCHS AR, 1992, AM J OBSTET GYNECOL, V167, P1559, DOI 10.1016/0002-9378(92)91739-W; GOLBE LI, 1994, NEUROL CLIN, V12, P497, DOI 10.1016/S0733-8619(18)30083-5; GOLD AR, 1986, AM REV RESPIR DIS, V134, P925, DOI 10.1164/arrd.1986.134.5.925; GORDON M, 1970, AM J OBSTET GYNECOL, V106, P421, DOI 10.1016/0002-9378(70)90371-6; GUILLEMINAULT C, 1993, SLEEP, V16, pS137, DOI 10.1093/sleep/16.suppl_8.S137; HASTIE SJ, 1989, AUST NZ J OBSTET GYN, V29, P365, DOI 10.1111/j.1479-828X.1989.tb01768.x; HENING WA, 1986, NEUROLOGY, V36, P1363, DOI 10.1212/WNL.36.10.1363; HERITAGE AS, 1980, SCIENCE, V207, P1377, DOI 10.1126/science.7355296; HERTZ G, 1992, SLEEP, V15, P246, DOI 10.1093/sleep/15.3.246; HILL LM, 1984, MAYO CLIN PROC, V59, P707, DOI 10.1016/S0025-6196(12)62060-6; HILL LM, 1984, MAYO CLIN PROC, V59, P755, DOI 10.1016/S0025-6196(12)65586-4; HIRST JJ, 1996, J CLIN ENDOCR METAB, V73, P804; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; JACOBS GD, 1993, BEHAV THER, V24, P159, DOI 10.1016/S0005-7894(05)80261-8; Javaheri S, 1999, NEW ENGL J MED, V341, P949, DOI 10.1056/NEJM199909233411304; JOELCOHEN SJ, 1978, EUR J OBSTET GYN R B, V8, P77, DOI 10.1016/0028-2243(78)90131-4; JONES BE, 2000, PRINCIPLES PRACTICE, P134; KAPAS L, 1994, AM J PHYSIOL, V266, pR151, DOI 10.1152/ajpregu.1994.266.1.R151; KARACAN I, 1968, AM J OBSTET GYNECOL, V101, P579, DOI 10.1016/0002-9378(68)90293-7; KARACAN I, 1969, BRIT J PSYCHIAT, V115, P929, DOI 10.1192/bjp.115.525.929; KIMOFF RJ, 1994, AM J RESP CRIT CARE, V149, P707, DOI 10.1164/ajrccm.149.3.8118640; Kimura M, 1996, AM J PHYSIOL-REG I, V271, pR1063, DOI 10.1152/ajpregu.1996.271.4.R1063; KIVELA A, 1989, J CLIN ENDOCR METAB, V69, P1065, DOI 10.1210/jcem-69-5-1065; KNUTTGEN HG, 1974, J APPL PHYSIOL, V36, P549, DOI 10.1152/jappl.1974.36.5.549; KOWALL J, 1989, OBSTET GYNECOL, V74, P453; KRIPKE DF, 1979, ARCH GEN PSYCHIAT, V36, P103; Lancel M, 1996, AM J PHYSIOL-ENDOC M, V271, pE763, DOI 10.1152/ajpendo.1996.271.4.E763; Lee KA, 2000, OBSTET GYNECOL, V95, P14, DOI 10.1016/S0029-7844(99)00486-X; Lefcourt L A, 1996, Obstet Gynecol Surv, V51, P503, DOI 10.1097/00006254-199608000-00024; Lewis DF, 1998, SOUTHERN MED J, V91, P761, DOI 10.1097/00007611-199808000-00013; LITTLE BC, 1974, J NERV MENT DIS, V159, P256, DOI 10.1097/00005053-197410000-00004; Littner MR, 1996, CHEST, V109, P859, DOI 10.1378/chest.109.4.859; LIU JH, 1988, J CLIN ENDOCR METAB, V66, P839; Loube DI, 1996, CHEST, V109, P885, DOI 10.1378/chest.109.4.885; Manber R, 1999, SLEEP, V22, P540; MARTIN RJ, 1982, AM REV RESPIR DIS, V125, P175; MCGINTY DJ, 1968, SCIENCE, V160, P1253, DOI 10.1126/science.160.3833.1253; MERRYMAN W, 1954, J CLIN ENDOCR METAB, V14, P1567, DOI 10.1210/jcem-14-12-1567; MITLER MM, 1994, SLEEP, V17, P352; MITLER MM, 1994, SLEEP, V17, pS103, DOI 10.1093/sleep/17.suppl_8.S103; MONTPLAISIR J, 1992, SLEEP, V15, P391, DOI 10.1093/sleep/15.5.391; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; *NAT COMM SLEEP DI, 1993, WAK AM NAT SLEEP AL, V1, P10; Nikkola E, 1996, AM J OBSTET GYNECOL, V174, P1622, DOI 10.1016/S0002-9378(96)70618-X; OBAL F, 1989, BRAIN RES, V490, P292, DOI 10.1016/0006-8993(89)90246-1; PARISI RA, 1988, AM REV RESPIR DIS, V138, P610, DOI 10.1164/ajrccm/138.3.610; PIETERS T, 1995, EUR RESPIR J, V8, P1424, DOI 10.1183/09031936.95.08081424; Popovic RM, 1998, J APPL PHYSIOL, V84, P1055, DOI 10.1152/jappl.1998.84.3.1055; PROWSE CM, 1965, ANESTHESIOLOGY, V26, P381, DOI 10.1097/00000542-196507000-00003; REDLINE S, 1994, AM J RESP CRIT CARE, V149, P722, DOI 10.1164/ajrccm.149.3.8118642; REDMAN CWG, 1988, LANCET, V1, P809; REMMERS JE, 1978, J APPL PHYSIOL, V44, P931, DOI 10.1152/jappl.1978.44.6.931; ROBERTS JM, 1989, MATERNAL FETAL MED P, P783; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; SACHAR EJ, 1976, PHARMAKOPSYCH NEURO, V9, P11, DOI 10.1055/s-0028-1094472; SANTIAGO TV, 1986, BREATHING DISORDERS, P197; SCHARF SM, 1990, SLEEP, V13, P344; SCHOENFELD A, 1989, MED HYPOTHESES, V30, P51, DOI 10.1016/0306-9877(89)90125-4; Schorr S J, 1998, J Perinatol, V18, P427; SCHWEIGER MS, 1972, AM J OBSTET GYNECOL, V114, P879, DOI 10.1016/0002-9378(72)90091-9; SERONFERRE M, 1993, ENDOCR REV, V14, P594, DOI 10.1210/er.14.5.594; SHERER DM, 1991, AM J OBSTET GYNECOL, V165, P1300; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; SHOUSE MN, 1992, BRAIN RES, V571, P50, DOI 10.1016/0006-8993(92)90508-7; SMELLIE W, 1778, TREATISE THEORY PRAC, V3; SNYDER S, 1986, AM J PSYCHIAT, V143, P391; SPIEGEL K, 1994, SLEEP, V17, P20, DOI 10.1093/sleep/17.1.20; STOOHS R, 1992, J APPL PHYSIOL, V72, P583, DOI 10.1152/jappl.1992.72.2.583; STRADLING JR, 1991, THORAX, V46, P85, DOI 10.1136/thx.46.2.85; STROHL KP, 1986, AM REV RESPIR DIS, V134, P555; SULLIVAN CE, 1981, LANCET, V1, P862; SUZUKI S, 1994, J PSYCHOSOM OBST GYN, V15, P19, DOI 10.3109/01674829409025625; SUZUKI S, 1993, J PINEAL RES, V15, P191, DOI 10.1111/j.1600-079X.1993.tb00904.x; Taibah K, 1998, J LARYNGOL OTOL, V112, P1189, DOI 10.1017/S0022215100142811; TEJANI NA, 1982, OBSTET GYNECOL, V59, P329; TOTH P, 1994, BRAIN RES, V654, P181, DOI 10.1016/0006-8993(94)90478-2; TURTON P, 1980, NURSING LOND, V20, P863; VANCAUTER E, 1990, HORM RES, V34, P45, DOI 10.1159/000181794; WEBB WB, 1973, SLEEP DREAMS INTRO G, P8; WEINBERGER SE, 1980, AM REV RESPIR DIS, V121, P559, DOI 10.1164/arrd.1980.121.3.559; WETTERBERG L, 1979, LANCET, V2, P1361; WHEATLEY JR, 1993, SLEEP, V16, pS87, DOI 10.1093/sleep/16.suppl_8.S87; YELLON SM, 1987, AM J PHYSIOL, V252, pE799, DOI 10.1152/ajpendo.1987.252.6.E799; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; ZARAZAGA IA, 1996, REPROD NUTR DEV, V36, P105; ZEMDEGS IZ, 1988, ENDOCRINOLOGY, V123, P284, DOI 10.1210/endo-123-1-284; 1886, GENUINE WORKS HIPPOC, P242; 1996, SLEEP, V17, P348	137	125	133	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2001	134	5					396	408		10.7326/0003-4819-134-5-200103060-00012	http://dx.doi.org/10.7326/0003-4819-134-5-200103060-00012			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405ZJ	11242500				2022-12-28	WOS:000167190200006
J	Fletcher, RH				Fletcher, RH			The uses of error: Missed opportunities	LANCET			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School	Fletcher, RH (corresponding author), Harvard Univ, Sch Med, 126 Brookline Ave, Boston, MA 02215 USA.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					703	703		10.1016/S0140-6736(05)71468-9	http://dx.doi.org/10.1016/S0140-6736(05)71468-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247569				2022-12-28	WOS:000167282400036
J	Stumpf, MPH; Goldstein, DB				Stumpf, MPH; Goldstein, DB			Genealogical and evolutionary inference with the human Y chromosome	SCIENCE			English	Review							SHORT TANDEM REPEATS; STATISTICAL PROPERTIES; MICROSATELLITE LOCI; MUTATION PROCESSES; SEQUENCE VARIATION; POPULATION; ORIGINS; ASIA; DISTRIBUTIONS; DIVERSITY	Population genetics has emerged as a powerful tool for unraveling human history. In addition to the study of mitochondrial and autosomal DNA, attention has recently focused on Y-chromosome variation. Ambiguities and inaccuracies in data analysis, however, pose an important obstacle to further development of the field. Here we review the methods available for genealogical inference using Y-chromosome data. Approaches can be divided into those that do and those that do not use an explicit population model in genealogical inference. We describe the strengths and weaknesses of these model-based and model-free approaches, as well as difficulties associated with the mutation process that affect both methods. In the case of genealogical inference using microsatellite Loci, we use coalescent simulations to show that relatively simple generalizations of the mutation process can greatly increase the accuracy of genealogical inference. Because model-free and model-based approaches have different biases and Limitations, we conclude that there is considerable benefit in the continued use of both types of approaches.	UCL, Dept Biol, London NW1 2HE, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of London; University College London; University of Oxford	Goldstein, DB (corresponding author), UCL, Dept Biol, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	d.goldstein@ucl.ac.uk	Goldstein, David/AAY-8125-2020					Bosch E, 1999, AM J HUM GENET, V65, P1623, DOI 10.1086/302676; Capelli C, 2001, AM J HUM GENET, V68, P432, DOI 10.1086/318205; Cox DR, 1974, THEORETICAL STAT; de Knijff P, 2000, AM J HUM GENET, V67, P1055; Donnelly P, 1996, CIBA F SYMP, V197, P25; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; FELSENSTEIN J, 1992, GENET RES, V59, P139, DOI 10.1017/S0016672300030354; GARZA JC, 1995, MOL BIOL EVOL, V12, P594; Goldstein DB, 1999, AM J HUM GENET, V64, P1071, DOI 10.1086/302313; Goldstein DB, 1996, MOL BIOL EVOL, V13, P1213, DOI 10.1093/oxfordjournals.molbev.a025686; Goldstein DB, 1999, BIOESSAYS, V21, P148, DOI 10.1002/(SICI)1521-1878(199902)21:2<148::AID-BIES8>3.0.CO;2-5; Goldstein DB, 1997, J HERED, V88, P335, DOI 10.1093/oxfordjournals.jhered.a023114; GOLDSTEIN DB, 1995, GENETICS, V139, P463; GOLDSTEIN DB, IN PRESS GENETICS; GRIFFITHS RC, 1994, THEOR POPUL BIOL, V46, P131, DOI 10.1006/tpbi.1994.1023; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Harr B, 2000, GENETICS, V155, P1213; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Hill EW, 2000, NATURE, V404, P351, DOI 10.1038/35006158; Hurles ME, 1999, AM J HUM GENET, V65, P1437, DOI 10.1086/302617; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; KIMURA M, 1969, P NATL ACAD SCI USA, V63, P1181, DOI 10.1073/pnas.63.4.1181; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; Malaspina P, 1998, AM J HUM GENET, V63, P847, DOI 10.1086/301999; MORAN PAP, 1975, THEOR POPUL BIOL, V8, P318, DOI 10.1016/0040-5809(75)90049-0; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Perez-Lezaun A, 1999, AM J HUM GENET, V65, P208, DOI 10.1086/302451; Poloni ES, 1997, AM J HUM GENET, V61, P1015, DOI 10.1086/301602; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Reich DE, 1999, MOL BIOL EVOL, V16, P453, DOI 10.1093/oxfordjournals.molbev.a026127; Ruiz-Linares A, 1999, P NATL ACAD SCI USA, V96, P6312, DOI 10.1073/pnas.96.11.6312; Seielstad M, 2000, AM J HUM GENET, V67, P1062; Seielstad M, 1999, GENOME RES, V9, P558; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; SLATKIN M, 1995, GENETICS, V139, P457; STUMPF MPH, UNPUB; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Tavare S, 1997, GENETICS, V145, P505; Thomas MG, 2000, AM J HUM GENET, V66, P674, DOI 10.1086/302749; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; THORNSON R, 2000, P NATL ACAD SCI USA, V97, P7360; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wilson IJ, 1998, GENETICS, V150, P499; WILSON J, IN PRESS P NATL ACAD	46	67	76	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2001	291	5509					1738	1742		10.1126/science.291.5509.1738	http://dx.doi.org/10.1126/science.291.5509.1738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11249819				2022-12-28	WOS:000167320600047
J	Seidman, JG; Seidman, C				Seidman, JG; Seidman, C			The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms	CELL			English	Review							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; CARDIAC TROPONIN-T; HEAVY-CHAIN GENE; SMOOTH-MUSCLE MYOSIN; ENCODING LAMIN A/C; DILATED CARDIOMYOPATHY; MOUSE MODEL; PROTEIN; HEART; ACTIN		Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet & Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Seidman, JG (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet & Med, Boston, MA 02115 USA.	seidman@rascal.med.harvard.edu; cseidman@rascal.med.harvard.edu						Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Badorff C, 1999, NAT MED, V5, P320, DOI 10.1038/6543; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; BOZKURT B, 2000, CARDIOVASCULAR MED, P1034; CARRIER L, 1993, NAT GENET, V4, P311, DOI 10.1038/ng0793-311; Chen J, 1999, J CLIN INVEST, V103, P1483, DOI 10.1172/JCI7297; Cohn JN, 1997, CIRCULATION, V95, P766; CORAVAZQUEZ R, 1999, CELL, V97, P543; Cuda G, 1997, J MUSCLE RES CELL M, V18, P275, DOI 10.1023/A:1018613907574; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Fatkin D, 1999, J CLIN INVEST, V103, P147, DOI 10.1172/JCI4631; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Fatkin D, 2000, J CLIN INVEST, V106, P1351, DOI 10.1172/JCI11093; FATKIN D, 2000, CARDIOVASCULAR MED, P1055; Filatov VL, 1999, BIOCHEMISTRY-MOSCOW+, V64, P969; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; GREVE G, 1994, HUM MOL GENET, V3, P2073; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Ho CY, 2000, CIRCULATION, V102, P1950, DOI 10.1161/01.CIR.102.16.1950; Ito N, 1997, J CLIN INVEST, V99, P125, DOI 10.1172/JCI119123; Jaaskelainen P, 1998, J AM COLL CARDIOL, V32, P1709, DOI 10.1016/S0735-1097(98)00448-3; JARCHO JA, 1989, NEW ENGL J MED, V321, P1372, DOI 10.1056/NEJM198911163212005; KAMISAGO M, 2000, IN PRESS N ENGL J ME; Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379; Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461; Mackrill JJ, 1999, BIOCHEM J, V337, P345, DOI 10.1042/0264-6021:3370345; Marian AJ, 1999, J CLIN INVEST, V104, P1683, DOI 10.1172/JCI7956; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; McConnell BK, 1999, J CLIN INVEST, V104, P1235, DOI 10.1172/JCI7377; Mestroni L, 1999, J AM COLL CARDIOL, V34, P181, DOI 10.1016/S0735-1097(99)00172-2; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Mogensen J, 1999, J CLIN INVEST, V103, pR39, DOI 10.1172/JCI6460; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Nigro V, 1997, HUM MOL GENET, V6, P601, DOI 10.1093/hmg/6.4.601; NISHI H, 1994, BIOCHEM BIOPH RES CO, V200, P549, DOI 10.1006/bbrc.1994.1483; Oberst L, 1998, J CLIN INVEST, V102, P1498, DOI 10.1172/JCI4088; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; OrtizLopez R, 1997, CIRCULATION, V95, P2434, DOI 10.1161/01.CIR.95.10.2434; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1995, P NATL ACAD SCI USA, V92, P3864, DOI 10.1073/pnas.92.9.3864; Rust EM, 1999, J CLIN INVEST, V103, P1459, DOI 10.1172/JCI6377; Satoh M, 1999, BIOCHEM BIOPH RES CO, V262, P411, DOI 10.1006/bbrc.1999.1221; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schonberger J, 2000, CIRCULATION, V101, P1812, DOI 10.1161/01.CIR.101.15.1812; SCHRODER RR, 1993, NATURE, V364, P171, DOI 10.1038/364171a0; SEIDMAN CE, 2000, METABOLIC MOL BASES, P5433; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Tardiff JC, 1998, J CLIN INVEST, V101, P2800, DOI 10.1172/JCI2389; THIERFELDER L, 1993, P NATL ACAD SCI USA, V90, P6270, DOI 10.1073/pnas.90.13.6270; Towbin JA, 1999, NAT MED, V5, P266, DOI 10.1038/6474; Tyska MJ, 2000, CIRC RES, V86, P737, DOI 10.1161/01.RES.86.7.737; WATKINS H, 1993, NAT GENET, V3, P333, DOI 10.1038/ng0493-333; Watkins H, 1996, J CLIN INVEST, V98, P2456, DOI 10.1172/JCI119063; WATKINS H, 1992, J CLIN INVEST, V90, P1666, DOI 10.1172/JCI116038; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Yang QL, 1998, J CLIN INVEST, V102, P1292, DOI 10.1172/JCI3880; Zolk O, 1998, CARDIOVASC RES, V39, P242, DOI 10.1016/S0008-6363(98)00081-9	65	769	808	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2001	104	4					557	567		10.1016/S0092-8674(01)00242-2	http://dx.doi.org/10.1016/S0092-8674(01)00242-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	405VP	11239412	Bronze			2022-12-28	WOS:000167181500010
J	Barton, ES; Forrest, JC; Connolly, JL; Chappell, JD; Liu, Y; Schnell, FJ; Nusrat, A; Parkos, CA; Dermody, TS				Barton, ES; Forrest, JC; Connolly, JL; Chappell, JD; Liu, Y; Schnell, FJ; Nusrat, A; Parkos, CA; Dermody, TS			Junction adhesion molecule is a receptor for reovirus	CELL			English	Article							NF-KAPPA-B; CENTRAL-NERVOUS-SYSTEM; ATTACHMENT PROTEIN SIGMA-1; CELL-SURFACE RECEPTOR; TRANSCRIPTIONAL ACTIVITY; NEUTROPHIL MIGRATION; FUNCTIONAL DOMAINS; MAMMALIAN REOVIRUS; TYPE-3 REOVIRUS; APOPTOSIS	Virus attachment to cells plays an essential role in Viral tropism and disease. Reovirus serotypes 1 and 3 differ in the capacity to target distinct cell types in the murine nervous system and in the efficiency to induce apoptosis. The binding of viral attachment protein ol to unidentified receptors controls these phenotypes. We used expression cloning to identify junction adhesion molecule (JAM), an integral tight junction protein, as a reovirus receptor. JAM binds directly to al and permits reovirus infection of nonpermissive cells. Ligation of JAM is required for reovirus-induced activation of NF-KB and apoptosis. Thus, reovirus interaction with cell-surface receptors is a critical determinant of both cell-type specific tropism and virus-induced intracellular signaling events that culminate in cell death.	Vanderbilt Univ, Dept Microbiol, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Immunol, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Pediat, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Elizabeth B Lamb Ctr Pediat Res, Sch Med, Nashville, TN 37232 USA; Emory Univ, Sch Med, Dept Pathol & Lab Med, Div Gastrointestinal Pathol, Atlanta, GA 30322 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Emory University	Dermody, TS (corresponding author), Vanderbilt Univ, Dept Microbiol, Sch Med, Nashville, TN 37232 USA.		Nusrat, Asma/B-3887-2009; Parkos, Charles a/B-3896-2009		NATIONAL CANCER INSTITUTE [T32CA009385, P30CA068485] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL054229, R01HL054229, R01HL060540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038296, R01AI038296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, F32DK010013] Funding Source: NIH RePORTER; NCI NIH HHS [CA68485, T32 CA09385] Funding Source: Medline; NHLBI NIH HHS [HL60540, HL54229] Funding Source: Medline; NIAID NIH HHS [AI38296] Funding Source: Medline; NIDDK NIH HHS [DK20593, DK10013] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AakuSaraste E, 1996, DEV BIOL, V180, P664, DOI 10.1006/dbio.1996.0336; Anrather J, 1999, J BIOL CHEM, V274, P13594, DOI 10.1074/jbc.274.19.13594; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; Baer GS, 1997, J VIROL, V71, P4921, DOI 10.1128/JVI.71.7.4921-4928.1997; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Barton ES, 2001, J BIOL CHEM, V276, P2200, DOI 10.1074/jbc.M004680200; Bazzoni G, 1999, TRENDS CARDIOVAS MED, V9, P147, DOI 10.1016/S1050-1738(99)00022-5; Bazzoni G, 2000, J BIOL CHEM, V275, P20520, DOI 10.1074/jbc.M905251199; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; BURSTIN SJ, 1982, VIROLOGY, V117, P146, DOI 10.1016/0042-6822(82)90514-1; Chappell JD, 1997, J VIROL, V71, P1834, DOI 10.1128/JVI.71.3.1834-1841.1997; Chappell JD, 2000, J VIROL, V74, P8472, DOI 10.1128/JVI.74.18.8472-8479.2000; CHOI AHC, 1990, VIROLOGY, V178, P316, DOI 10.1016/0042-6822(90)90412-K; Clarke H, 2000, ADV DRUG DELIVER REV, V41, P283, DOI 10.1016/S0169-409X(00)00047-8; CO MS, 1985, P NATL ACAD SCI USA, V82, P1494, DOI 10.1073/pnas.82.5.1494; Connolly JL, 2000, J VIROL, V74, P2981, DOI 10.1128/JVI.74.7.2981-2989.2000; Del Maschio A, 1999, J EXP MED, V190, P1351, DOI 10.1084/jem.190.9.1351; Ebnet K, 2000, J BIOL CHEM, V275, P27979; FRASER RDB, 1990, J VIROL, V64, P2990, DOI 10.1128/JVI.64.6.2990-3000.1990; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hopkins AM, 2000, ADV DRUG DELIVER REV, V41, P329, DOI 10.1016/S0169-409X(00)00050-8; Jensen VB, 1998, INFECT IMMUN, V66, P3758, DOI 10.1128/IAI.66.8.3758-3766.1998; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; KAYE KM, 1986, J VIROL, V59, P90, DOI 10.1128/JVI.59.1.90-97.1986; Lechner F, 2000, J INFECT DIS, V182, P978, DOI 10.1086/315765; LEONE G, 1992, CELL, V71, P479, DOI 10.1016/0092-8674(92)90516-F; LIU Y, 2000, J CELL SCI, V113, P1; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; McCormick BA, 1997, INFECT IMMUN, V65, P1414, DOI 10.1128/IAI.65.4.1414-1421.1997; NAGATA L, 1987, VIROLOGY, V160, P162, DOI 10.1016/0042-6822(87)90056-0; Neurath MF, 1998, GUT, V43, P856, DOI 10.1136/gut.43.6.856; NIBERT ML, 1995, J VIROL, V69, P5057, DOI 10.1128/JVI.69.8.5057-5067.1995; Norris JL, 1999, J BIOL CHEM, V274, P13841, DOI 10.1074/jbc.274.20.13841; NOSEWORTHY JH, 1983, J IMMUNOL, V131, P2533; O'Brien V, 1998, J GEN VIROL, V79, P1833, DOI 10.1099/0022-1317-79-8-1833; Oberhaus SM, 1997, J VIROL, V71, P2100, DOI 10.1128/JVI.71.3.2100-2106.1997; Obert G, 2000, J VIROL, V74, P4645, DOI 10.1128/JVI.74.10.4645-4651.2000; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Parkos CA, 1996, J CELL BIOL, V132, P437, DOI 10.1083/jcb.132.3.437; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; RUBIN DH, 1992, J CLIN INVEST, V90, P2536, DOI 10.1172/JCI116147; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; SHARPE AH, 1985, NEW ENGL J MED, V312, P486, DOI 10.1056/NEJM198502213120806; SPRIGGS DR, 1983, SCIENCE, V220, P505, DOI 10.1126/science.6301010; TARDIEU M, 1983, ANN NEUROL, V13, P602, DOI 10.1002/ana.410130604; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; TURNER DL, 1992, VIROLOGY, V186, P219, DOI 10.1016/0042-6822(92)90076-2; TYLER KL, 1995, J VIROL, V69, P6972, DOI 10.1128/JVI.69.11.6972-6979.1995; TYLER KL, 1986, SCIENCE, V233, P770, DOI 10.1126/science.3016895; TYLER KL, 1996, FIELDS VIROLOGY, P1597; VIRGIN HW, 1991, J VIROL, V65, P6772, DOI 10.1128/JVI.65.12.6772-6781.1991; VIRGIN HW, 1988, J VIROL, V62, P4594, DOI 10.1128/JVI.62.12.4594-4604.1988; WEINER HL, 1980, J INFECT DIS, V141, P609, DOI 10.1093/infdis/141.5.609; Williams LA, 1999, MOL IMMUNOL, V36, P1175, DOI 10.1016/S0161-5890(99)00122-4; WOLF JL, 1981, SCIENCE, V212, P471, DOI 10.1126/science.6259737	59	505	529	0	31	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2001	104	3					441	451		10.1016/S0092-8674(01)00231-8	http://dx.doi.org/10.1016/S0092-8674(01)00231-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239401	Bronze			2022-12-28	WOS:000167003100014
J	Heintzen, C; Loros, JJ; Dunlap, JC				Heintzen, C; Loros, JJ; Dunlap, JC			The PAS protein VIVID defines a clock-associated feedback loop that represses light input, modulates gating, and regulates clock resetting	CELL			English	Article							CIRCADIAN CLOCK; SUPRACHIASMATIC NUCLEUS; NEUROSPORA; GENES; TRANSCRIPTION; EXPRESSION; RHYTHMS; COMPLEX; OUTPUT; DBP	vvd, a gene regulating light responses in Neurospora, encodes a novel member of the PAS/LOV protein superfamily. VVD defines a circadian clock-associated autoregulatory feedback loop that influences light resetting, modulates circadian gating of input by connecting output and input, and regulates light adaptation. Rapidly light induced, vvd is an early repressor of light-regulated processes. Further, vvd is clock controlled; the clock gates light induction of vvd and the clock gene fro so identical signals yield greater induction in the morning. Mutation of vvd severely dampens gating, especially of fro, consistent with VVD modulating gating and phasing right-resetting responses. vvd null strains display distinct alterations in the phase-response curve to light. Thus VVD, although not part of the clock, contributes significantly to regulation within the Neurospora circadian system.	Dartmouth Coll, Sch Med, Dept Genet, Hanover, NH 03755 USA; Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Loros, JJ (corresponding author), Dartmouth Coll, Sch Med, Dept Genet, Hanover, NH 03755 USA.	jennifer.loros@dartmouth.edu; jay.c.dunalp@dartmouth.edu	Loros, Jennifer/B-6293-2014; Dunlap, Jay/L-6232-2013	Dunlap, Jay/0000-0003-1577-0457	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044651] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37-GM 34985] Funding Source: Medline; NIMH NIH HHS [MH44651] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; BellPedersen D, 1996, P NATL ACAD SCI USA, V93, P13096, DOI 10.1073/pnas.93.23.13096; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Bognar LK, 1999, P NATL ACAD SCI USA, V96, P14652, DOI 10.1073/pnas.96.25.14652; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Czeisler CA, 1999, RECENT PROG HORM RES, V54, P97; DAVIS RL, 1970, METHOD ENZYMOL, V72, P79; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; DHARMANANDA S, 1980, THESIS U CALIFORNIA; Dunlap J, 1998, SCIENCE, V280, P1548, DOI 10.1126/science.280.5369.1548; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Edmunds LN, 1988, CELLULAR MOL BASES B; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; FLEISSNER G, 1992, CIRCADIAN RHYTHMS, P79; Foulkes NS, 1996, P NATL ACAD SCI USA, V93, P14140, DOI 10.1073/pnas.93.24.14140; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gillette MU, 1999, RECENT PROG HORM RES, V54, P33; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Hall M.D., 1993, GEORGIA J SCI, V51, P27; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Iwasaki H, 2000, CURR OPIN MICROBIOL, V3, P189, DOI 10.1016/S1369-5274(00)00074-6; Jelinkova D, 2000, NEUROSCI LETT, V280, P143, DOI 10.1016/S0304-3940(00)00773-4; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; KAY SA, 1993, MOL GENETICS BIOL RH, P73; Lakin-Thomas PL, 2000, TRENDS GENET, V16, P135, DOI 10.1016/S0168-9525(99)01945-9; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Linden H, 1999, ADV GENET, V41, P35, DOI 10.1016/S0065-2660(08)60150-9; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; LOROS JJ, 1989, SCIENCE, V243, P385, DOI 10.1126/science.2563175; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; MROSOVSKY N, 1989, EXPERIENTIA, V45, P696, DOI 10.1007/BF01974561; Newby LM, 1996, J NEUROBIOL, V31, P117, DOI 10.1002/(SICI)1097-4695(199609)31:1<117::AID-NEU10>3.0.CO;2-I; ORBACH MJ, 1994, GENE, V150, P159, DOI 10.1016/0378-1119(94)90877-X; PERKINS DD, 1982, MICROBIOL REV, V46, P426, DOI 10.1128/MMBR.46.4.426-570.1982; PITTENDRIGH CS, 1981, HDB BEHAVIORAL NEURO, V4, P95; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ripperger JA, 2000, GENE DEV, V14, P679; Roenneberg T, 1999, REPROD NUTR DEV, V39, P277, DOI 10.1051/rnd:19990301; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; SHRODE L, 2001, IN PRESS FUNGAL GENE; SOMMER T, 1989, NUCLEIC ACIDS RES, V17, P5713, DOI 10.1093/nar/17.14.5713; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Wan YH, 1997, FUNGAL GENET BIOL, V21, P329, DOI 10.1006/fgbi.1997.0988; Winfree A.T., 1980, GEOMETRY BIOL TIME, V8; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000	50	257	262	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2001	104	3					453	464		10.1016/S0092-8674(01)00232-X	http://dx.doi.org/10.1016/S0092-8674(01)00232-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239402	Bronze			2022-12-28	WOS:000167003100015
J	Gonzales, R; Bartlett, JC; Besser, RE; Cooper, RJ; Hickner, JM; Hoffman, JR; Sande, MA				Gonzales, R; Bartlett, JC; Besser, RE; Cooper, RJ; Hickner, JM; Hoffman, JR; Sande, MA			Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: Background, specific aims, and methods	ANNALS OF INTERNAL MEDICINE			English	Article							RESISTANT STREPTOCOCCUS-PNEUMONIAE; CLINICAL-PRACTICE GUIDELINES; DAY-CARE-CENTER; MEDICAL LITERATURE; PNEUMOCOCCAL PNEUMONIA; UNITED-STATES; RISK-FACTORS; AMBULATORY PRACTICE; PENICILLIN; MENINGITIS	The need to decrease excess antibiotic use in ambulatory practice has been fueled by the epidemic increase in antibiotic-resistant Streptococcus pneumoniae. The majority of antibiotics prescribed to adults in ambulatory practice in the United States are for acute sinusitis, acute pharyngitis, acute bronchitis, and nonspecific upper respiratory tract infections (including the common cold). For each of these conditions-especially colds, nonspecific upper respiratory tract infections, and acute bronchitis (for which routine antibiotic treatment is not recommended)-a large proportion of the antibiotics prescribed are unlikely to provide clinical benefit to patients. Because decreasing community use of antibiotics is an important strategy for combating the increase in community-acquired antibiotic-resistant infections, the Centers for Disease Control and Prevention convened a panel of physicians representing the disciplines of internal medicine, family medicine, emergency medicine, and infectious diseases to develop a series of "Principles of Appropriate Antibiotic Use for Treatment of Acute Respiratory Tract Infections in Adults." These principles provide evidence-based recommendations far evaluation and treatment of adults with acute respiratory illnesses. This paper describes the background and specific aims of and methods used to develop these principles. The goal of the principles is to provide clinicians with practical strategies for limiting antibiotic use to the patients who are most likely to benefit from it. These principles should be used in conjunction with effective patient educational campaigns and enhancements to the health care delivery system that facilitate nonantibiotic treatment of the conditions in question.	Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Calif Los Angeles, Los Angeles, CA USA; Michigan State Univ, E Lansing, MI 48824 USA; Univ Utah, Salt Lake City, UT USA	Centers for Disease Control & Prevention - USA; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Johns Hopkins University; University of California System; University of California Los Angeles; Michigan State University; Utah System of Higher Education; University of Utah	Besser, RE (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, C-23,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	rbesser@cdc.gov			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS000134] Funding Source: NIH RePORTER; AHRQ HHS [F32 HS00134-1] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Arason VA, 1996, BMJ-BRIT MED J, V313, P387; Arnold KE, 1996, J PEDIATR-US, V128, P757, DOI 10.1016/S0022-3476(96)70326-8; AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759; Bauchner H, 1999, PEDIATRICS, V103, P395, DOI 10.1542/peds.103.2.395; BOKEN DJ, 1995, PEDIATR INFECT DIS J, V14, P879, DOI 10.1097/00006454-199510000-00012; Bradley JS, 1995, PEDIATR INFECT DIS J, V14, P1037, DOI 10.1097/00006454-199512000-00002; Butler JC, 1996, J INFECT DIS, V174, P986, DOI 10.1093/infdis/174.5.986; CHESNEY PJ, 1995, PEDIATR INFECT DIS J, V14, P1013; COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050; DELMAR CB, 2000, COCHRANE DATABASE SY, V4; Doone JL, 1997, CLIN PEDIATR, V36, P187, DOI 10.1177/000992289703600401; Dowell SF, 1997, AM FAM PHYSICIAN, V55, P1647; DUCHIN JS, 1995, PEDIATR INFECT DIS J, V14, P745, DOI 10.1097/00006454-199509000-00004; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; FRIEDLAND IR, 1992, LANCET, V339, P405, DOI 10.1016/0140-6736(92)90087-J; Gonzales R, 2000, J GEN INTERN MED, V15, P118; Gonzales R, 1999, JAMA-J AM MED ASSOC, V281, P1512, DOI 10.1001/jama.281.16.1512; GONZALES R, 2000, J GEN INTERN MED S, V15; GRECO PJ, 1993, NEW ENGL J MED, V329, P1271, DOI 10.1056/NEJM199310213291714; Guillemot D, 1998, JAMA-J AM MED ASSOC, V279, P365, DOI 10.1001/jama.279.5.365; Guyatt GH, 1999, JAMA-J AM MED ASSOC, V281, P1836, DOI 10.1001/jama.281.19.1836; GWALTNEY JM, 1975, J INFECT DIS, V132, P62, DOI 10.1093/infdis/132.1.62; Hamm RM, 1996, J FAM PRACTICE, V43, P56; Hayward RSA, 1996, J GEN INTERN MED, V11, P176, DOI 10.1007/BF02600272; HAYWARD RSA, 1995, JAMA-J AM MED ASSOC, V274, P570, DOI 10.1001/jama.274.7.570; HENDLEY JO, 1975, J INFECT DIS, V132, P55, DOI 10.1093/infdis/132.1.55; HOFMANN J, 1995, NEW ENGL J MED, V333, P481, DOI 10.1056/NEJM199508243330803; HOGE CW, 1994, NEW ENGL J MED, V331, P643, DOI 10.1056/NEJM199409083311004; HUTCHINSON JM, 1997, 37 INT C ANT AG CHEM; KUNIN CM, 1993, ANN INTERN MED, V118, P557, DOI 10.7326/0003-4819-118-7-199304010-00011; LONKS JR, 1995, NEW ENGL J MED, V332, P893, DOI 10.1056/NEJM199503303321317; Mainous AG, 2000, FAM MED, V32, P22; Mangione-Smith R, 1999, PEDIATRICS, V103, P711, DOI 10.1542/peds.103.4.711; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; MORENO F, 1995, J INFECT DIS, V172, P427, DOI 10.1093/infdis/172.2.427; Musher DM, 1995, MANDELL DOUGLAS BENN, P1811; NAVA JM, 1994, CLIN INFECT DIS, V19, P884, DOI 10.1093/clinids/19.5.884; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Nuorti JP, 1998, NEW ENGL J MED, V338, P1861, DOI 10.1056/NEJM199806253382601; O'Connor PJ, 1999, J FAM PRACTICE, V48, P690; OXMAN AD, 1994, JAMA-J AM MED ASSOC, V272, P1367, DOI 10.1001/jama.272.17.1367; PALLARES R, 1995, NEW ENGL J MED, V333, P474, DOI 10.1056/NEJM199508243330802; Poole Michael D., 1995, Pediatric Infectious Disease Journal, V14, pS23, DOI 10.1097/00006454-199504001-00005; POSES RM, 1995, MED DECIS MAKING, V15, P65, DOI 10.1177/0272989X9501500110; RADETSKY MS, 1981, LANCET, V2, P771; REICHLER MR, 1992, J INFECT DIS, V166, P1346, DOI 10.1093/infdis/166.6.1346; Reid R, 1995, PEDIATR INFECT DIS J, V14, P1104, DOI 10.1097/00006454-199512000-00016; Sackett DL., 2000, EVIDENCE BASED MED P, P173; SAINT S, 1995, JAMA-J AM MED ASSOC, V273, P957, DOI 10.1001/jama.273.12.957; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Shaneyfelt TM, 1999, JAMA-J AM MED ASSOC, V281, P1900, DOI 10.1001/jama.281.20.1900; WILSON MC, 1995, JAMA-J AM MED ASSOC, V274, P1630, DOI 10.1001/jama.274.20.1630; 1994, MMWR MORB MORTAL WKL, V43, P23	54	178	185	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					479	486		10.7326/0003-4819-134-6-200103200-00013	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00013			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409VF	11255524				2022-12-28	WOS:000167405800007
J	Hickner, JM; Bartlett, JG; Besser, RE; Gonzales, R; Hoffman, JR; Sande, MA				Hickner, JM; Bartlett, JG; Besser, RE; Gonzales, R; Hoffman, JR; Sande, MA			Principles of appropriate antibiotic use for acute rhinosinusitis in adults: Background	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MAXILLARY SINUSITIS; PLACEBO-CONTROLLED TRIAL; GENERAL-PRACTICE; DOUBLE-BLIND; COMMON COLD; CLINICAL-EVALUATION; ALLERGIC RHINITIS; ACUTE BRONCHITIS; INFECTIONS; DIAGNOSIS	The following principles of appropriate antibiotic use for adults with acute rhinosinusitis apply to the diagnosis and treatment of acute maxillary and ethmoid rhinosinusitis in adults who are not immunocompromised. 1. Most cases of acute rhinosinusitis diagnosed in ambulatory care are caused by uncomplicated viral upper respiratory tract infections. 2. Bacterial and viral rhinosinusitis are difficult to differentiate on clinical grounds. The clinical diagnosis of acute bacterial rhinosinusitis should be reserved for patients with rhinosinusitis symptoms lasting 7 days or more who have maxillary pain or tenderness in the face or teeth (especially when unilateral) and purulent nasal secretions. Patients with rhinosinusitis symptoms that last less than 7 days are unlikely to have bacterial infection, although rarely some patients with acute bacterial rhinosinusitis present with dramatic symptoms of severe unilateral maxillary pain, swelling, and fever. 3. Sinus radiography is not recommended for diagnosis in routine cases. 4. Acute rhinosinusitis resolves without antibiotic treatment in most cases. Symptomatic treatment and reassurance is the preferred initial management strategy for patients with mild symptoms. Antibiotic therapy should be reserved for patients with moderately severe symptoms who meet the criteria for the clinical diagnosis of acute bacterial rhinosinusitis and for those with severe rhinosinusitis symptoms-especially those with unilateral facial pain-regardless of duration of illness. For initial treatment, the most narrow-spectrum agent active against the likely pathogens, Streptococcus pneumoniae and Haemophilus influenzae, should be used.	Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA; Johns Hopkins Univ, Baltimore, MD USA; Michigan State Univ, E Lansing, MI 48824 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Univ Calif Los Angeles, Los Angeles, CA USA; Univ Utah, Salt Lake City, UT USA	Centers for Disease Control & Prevention - USA; Johns Hopkins University; Michigan State University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of California System; University of California Los Angeles; Utah System of Higher Education; University of Utah	Besser, RE (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, C-23,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	rbesser@cdc.gov						AXELSSON A, 1970, ACTA OTO-LARYNGOL, V70, P71, DOI 10.3109/00016487009181861; AXELSSON A, 1976, ORL J OTO-RHINO-LARY, V38, P298, DOI 10.1159/000275288; Beaumont J, 1995, EUR J GEN PRACT, V1, P155, DOI 10.3109/13814789509161629; BERG O, 1986, Rhinology (Utrecht), V24, P223; BERG O, 1988, ACTA OTO-LARYNGOL, V105, P343, DOI 10.3109/00016488809097017; Braun JJ, 1997, ALLERGY, V52, P650, DOI 10.1111/j.1398-9995.1997.tb01044.x; COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050; deBock GH, 1997, J CLIN EPIDEMIOL, V50, P881, DOI 10.1016/S0895-4356(97)00117-0; DINGLE JH, 1964, ILLNESS HOME STUDY 2, P347; Dosh SA, 2000, J FAM PRACTICE, V49, P407; Dowell SF, 1997, AM FAM PHYSICIAN, V55, P1647; Engels EA, 2000, J CLIN EPIDEMIOL, V53, P852, DOI 10.1016/S0895-4356(00)00209-2; EVANS FO, 1975, NEW ENGL J MED, V293, P735, DOI 10.1056/NEJM197510092931502; Gananca M, 1973, Curr Med Res Opin, V1, P362, DOI 10.1185/03007997309111694; Gonzales R, 2001, ANN INTERN MED, V134, P479, DOI 10.7326/0003-4819-134-6-200103200-00013; Gonzales R, 1999, JAMA-J AM MED ASSOC, V281, P1512, DOI 10.1001/jama.281.16.1512; Gwaltney JM, 1996, CLIN INFECT DIS, V23, P1209, DOI 10.1093/clinids/23.6.1209; GWALTNEY JM, 1994, NEW ENGL J MED, V330, P25, DOI 10.1056/NEJM199401063300105; GWALTNEY JM, 1967, J AMER MED ASSOC, V202, P494, DOI 10.1001/jama.202.6.494; HAMORY BH, 1979, J INFECT DIS, V139, P197, DOI 10.1093/infdis/139.2.197; HANSEN JG, 1995, BRIT MED J, V311, P233, DOI 10.1136/bmj.311.6999.233; HARRIS PG, 1971, PRACTITIONER, V207, P814; *INT RHIN ADV BOAR, 1997, EAR NOSE THROAT J S, V76, P1; KUNIN CM, 1993, ANN INTERN MED, V118, P557, DOI 10.7326/0003-4819-118-7-199304010-00011; Laine Karri, 1998, Rhinology (Utrecht), V36, P2; LEWISON E, 1970, EYE EAR NOSE THROAT, V49, P16; Lindbaek M, 1996, Fam Med, V28, P183; Lindbaek M, 1996, BMJ-BRIT MED J, V313, P325, DOI 10.1136/bmj.313.7053.325; MARCHANT CD, 1992, J PEDIATR-US, V120, P72, DOI 10.1016/S0022-3476(05)80601-8; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; McIsaac WJ, 1998, J FAM PRACTICE, V47, P366; MCNEILL R A, 1963, J Laryngol Otol, V77, P1009, DOI 10.1017/S0022215100061673; MELTZER EO, 1993, J ALLERGY CLIN IMMUN, V92, P812, DOI 10.1016/0091-6749(93)90058-N; Puhakka T, 1998, J ALLERGY CLIN IMMUN, V102, P403, DOI 10.1016/S0091-6749(98)70127-7; Revonta M, 1980, Acta Otolaryngol Suppl, V370, P1; Ryan R E, 1967, Headache, V7, P13, DOI 10.1111/j.1526-4610.1967.hed0701013.x; Savolainen S, 1997, ACTA OTO-LARYNGOL, P148; SELTZER AP, 1967, EYE EAR NOSE THROAT, V46, P1281; *SIN ALL HLTH PART, 2000, OTOLARYNGOL HEAD NEC, V123, P5; Stalman W, 1997, BRIT J GEN PRACT, V47, P794; STAMMBERGER H, 1986, OTOLARYNG HEAD NECK, V94, P143, DOI 10.1177/019459988609400202; TAUB SJ, 1967, EYE EAR NOSE THROAT, V46, P361; *US DEP HHS, 1996, NAT CTR HLTH STAT 13, V134; vanBuchem FL, 1997, LANCET, V349, P683, DOI 10.1016/S0140-6736(96)07585-X; VANDUIJN NP, 1992, BRIT MED J, V305, P684, DOI 10.1136/bmj.305.6855.684; WIKLUND L, 1994, ACTA OTO-LARYNGOL, P57; WILLETT LR, 1994, J GEN INTERN MED, V9, P38, DOI 10.1007/BF02599141; WILLIAMS JW, 1992, ANN INTERN MED, V117, P705, DOI 10.7326/0003-4819-117-9-705; WILLIAMS JW, 1997, ACUTE RESP INFECTION; WILLIAMS RB, 1972, ANN ALLERGY, V30, P189; ZUCHER DR, AGENCY HLTH CARE POL	51	154	168	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					498	505		10.7326/0003-4819-134-6-200103200-00017	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00017			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409VF	11255528				2022-12-28	WOS:000167405800011
J	Rauschenberger, R; Yantis, S				Rauschenberger, R; Yantis, S			Masking unveils pre-amodal completion representation in visual search	NATURE			English	Article							GUIDED SEARCH; PERCEPTION; SURFACES; MODEL	When one object is partly occluded by another, its occluded parts are perceptually 'filled in', that is, the occluded object appears to continue behind its occluder. This process is known as amodal completion(1). The completion of a partially occluded object takes about 200 ms (ref. 2), and pre-completion information (that is, information from before amodal completion has occurred) exists in the visual system for that duration(2,3). It has been suggested, however, that observers cannot make use of this information, even when it is beneficial to do so: visual search for a target that appears to be partly occluded, for example, is slower than for a target that does not undergo occlusion, despite both targets being physically identical(4-6). Here we show that visual search does have access to pre-completion representations, but only for a limited time that depends on the size of the occluded region.	Johns Hopkins Univ, Dept Psychol, Baltimore, MD 21218 USA	Johns Hopkins University	Rauschenberger, R (corresponding author), Johns Hopkins Univ, Dept Psychol, Baltimore, MD 21218 USA.		Yantis, Steven/A-7488-2009; Rauschenberger, Robert/G-6819-2011	Rauschenberger, Robert/0000-0003-4669-4223				Blake R, 1997, CURR DIR PSYCHOL SCI, V6, P157, DOI 10.1111/1467-8721.ep10772935; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Davis G, 1998, J EXP PSYCHOL HUMAN, V24, P169; DONNELLY N, 1991, J EXP PSYCHOL HUMAN, V17, P561, DOI 10.1037/0096-1523.17.2.561; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; GERBINO W, 1987, ACTA PSYCHOL, V65, P25, DOI 10.1016/0001-6918(87)90045-X; HE ZJ, 1992, NATURE, V359, P231, DOI 10.1038/359231a0; JULESZ B, 1981, NATURE, V290, P91, DOI 10.1038/290091a0; Rensink RA, 1998, VISION RES, V38, P2489, DOI 10.1016/S0042-6989(98)00051-0; RENSINK RA, 1995, PSYCHOL REV, V102, P101, DOI 10.1037/0033-295X.102.1.101; SEKULER AB, 1992, J EXP PSYCHOL GEN, V121, P95, DOI 10.1037/0096-3445.121.1.95; Shore DI, 1997, J EXP PSYCHOL HUMAN, V23, P980; Still A., 1991, COGNITIVISM ALTERNAT; TREISMAN A, 1985, COMPUT VISION GRAPH, V31, P156, DOI 10.1016/S0734-189X(85)80004-9; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016; Wolfe Jeremy M., 1998, IOVS, V39, pS872; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774	20	81	81	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					369	372		10.1038/35066577	http://dx.doi.org/10.1038/35066577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	410WM	11268213				2022-12-28	WOS:000167464100051
J	Aro, A				Aro, A			Complexity of issue of dietary trans fatty acids	LANCET			English	Editorial Material									Natl Publ Hlth Inst KTL, Dept Hlth & Funct Capac, FIN-00300 Helsinki, Finland	Finland National Institute for Health & Welfare	Aro, A (corresponding author), Natl Publ Hlth Inst KTL, Dept Hlth & Funct Capac, FIN-00300 Helsinki, Finland.	Antti.Aro@ktl.fi						Allison DB, 1999, J AM DIET ASSOC, V99, P166, DOI 10.1016/S0002-8223(99)00041-3; Aro A., 1998, Journal of Food Composition and Analysis, V11, P137, DOI 10.1006/jfca.1998.0569; Aro A, 1998, J AM OIL CHEM SOC, V75, P977, DOI 10.1007/s11746-998-0275-5; ARO A, 1998, T FATTY ACIDS HUMAN, P235; Griinari JM, 2000, J NUTR, V130, P2285, DOI 10.1093/jn/130.9.2285; Hulshof KFAM, 1999, EUR J CLIN NUTR, V53, P143, DOI 10.1038/sj.ejcn.1600692; Ip C, 1999, J NUTR, V129, P2135, DOI 10.1093/jn/129.12.2135; Katan MB, 2000, NUTR REV, V58, P188, DOI 10.1111/j.1753-4887.2000.tb01860.x; PARODI PW, 1976, J AM OIL CHEM SOC, V53, P530, DOI 10.1007/BF02586253; PARODI PW, 1976, J DAIRY SCI, V59, P1870, DOI 10.3168/jds.S0022-0302(76)84455-4; Salminen I, 1998, J NUTR BIOCHEM, V9, P93, DOI 10.1016/S0955-2863(97)00173-3	11	14	19	2	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2001	357	9258					732	733		10.1016/S0140-6736(00)04175-1	http://dx.doi.org/10.1016/S0140-6736(00)04175-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253958				2022-12-28	WOS:000167400900002
J	Platts-Mills, T; Vaughan, J; Squillace, S; Woodfolk, J; Sporik, R				Platts-Mills, T; Vaughan, J; Squillace, S; Woodfolk, J; Sporik, R			Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study	LANCET			English	Article							INNER-CITY CHILDREN; RISK FACTOR; IGG4 ANTIBODIES; SENSITIZATION; CHILDHOOD; MITE; IGE; LYMPHOCYTES; REACTIVITY; SUBCLASS	Background Although asthma is strongly associated with immediate hypersensitivity to indoor allergens, several studies have suggested that a cat in the house can decrease the risk of asthma. We investigated the immune response to cat and mite allergens, and asthma among children with a wide range of allergen exposure. Methods We did a population-based cross-sectional study of children (aged 12-14 years), some of whom had symptoms of asthma and bronchial hyper-reactivity, Antibodies to mite (Der f 1) and cat (Fel d 1) allergens measured by isotype (IgG and IgG4) specific radioimmunoprecipitation assays were compared with sensitisation and allergen concentrations in house dust. Findings 226 children were recruited, 47 of whom had symptoms of asthma and bronchial hyper-reactivity, Increasing exposure to mite was associated with increased prevalence of sensitisation and IgG antibody to Der f 1. By contrast, the highest exposure to cat was associated with decreased sensitisation, but a higher prevalence of IgG antibody to Fel d 1, Thus, among children with high exposure, the odds of sensitisation to mite rather than cat was 4.0 (99% CI 1.49-10.00). Furthermore. 31 of 76 children with 23 mug Fel d 1 at home, who were not sensitised to cat allergen had >125 units of IgG antibody to Fel d 1. Antibodies to Fel d 1 of the IgG4 isotype were strongly correlated with IgG antibody in both allergic and non-allergic children (r=0.84 and r=0.66, respectively). Sensitisation to mite or cat allergens was the strongest independent risk factor for asthma (p<0.001). Interpretation Exposure to cat allergen can produce an IgG and IgG4 antibody response without sensitisation or risk of asthma, This modified T-helper-2 cell response should be regarded as a form of tolerance and may be the correct objective of immunotherapy. The results may also explain the observation that animals in the house can decrease the risk of asthma.	Univ Virginia, Dept Med, Asthma & Allerg Dis Ctr, Charlottesville, VA 22908 USA	University of Virginia	Platts-Mills, T (corresponding author), Univ Virginia Hlth Syst, Asthma & Allerg Dis Ctr, POB 801355, Charlottesville, VA 22908 USA.			Platts-Mills, Thomas/0000-0002-1263-329X	NIAID NIH HHS [AI-20565, AI-34607] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020565, U19AI034607, R01AI020565, U01AI034607] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AALBERSE RC, 1983, J IMMUNOL, V130, P722; Agresti A, 1999, INT ARCH ALLERGY IMM, V118, P279, DOI 10.1159/000024099; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Borish L, 1997, J ALLERGY CLIN IMMUN, V99, P161, DOI 10.1016/S0091-6749(97)70090-3; CALL RS, 1992, J PEDIATR-US, V121, P862, DOI 10.1016/S0022-3476(05)80329-4; CHAPMAN MD, 1988, J IMMUNOL, V140, P812; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Halonen M, 1997, AM J RESP CRIT CARE, V155, P1356, DOI 10.1164/ajrccm.155.4.9105079; Hesselmar B, 1999, CLIN EXP ALLERGY, V29, P611; HUSSAIN R, 1992, J IMMUNOL, V148, P2731; ISHIZAKA K, 1967, J IMMUNOL, V98, P490; Jeannin P, 1998, J IMMUNOL, V160, P3555; Muller U, 1998, J ALLERGY CLIN IMMUN, V101, P747, DOI 10.1016/S0091-6749(98)70402-6; Peat JK, 1996, AM J RESP CRIT CARE, V153, P141, DOI 10.1164/ajrccm.153.1.8542107; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; PLATTSMILLS TAE, 1978, J IMMUNOL, V120, P1201; Prescott SL, 1998, J IMMUNOL, V160, P4730; Ronmark E, 1999, ALLERGY, V54, P926, DOI 10.1034/j.1398-9995.1999.00044.x; Roost HP, 1999, J ALLERGY CLIN IMMUN, V104, P941, DOI 10.1016/S0091-6749(99)70072-2; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; ROWNTREE S, 1987, J ALLERGY CLIN IMMUN, V80, P622, DOI 10.1016/0091-6749(87)90017-0; Sawyer G, 1998, J ALLERGY CLIN IMMUN, V102, P765, DOI 10.1016/S0091-6749(98)70016-8; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Sporik R, 1999, THORAX, V54, P675, DOI 10.1136/thx.54.8.675; SPORIK R, 1995, AM J RESP CRIT CARE, V151, P1388, DOI 10.1164/ajrccm.151.5.7735590; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Squillace SP, 1997, AM J RESP CRIT CARE, V156, P1760, DOI 10.1164/ajrccm.156.6.9704026; Strachan DP, 1996, ARCH DIS CHILD, V74, P422, DOI 10.1136/adc.74.5.422; von Mutius E, 2000, J ALLERGY CLIN IMMUN, V105, P9, DOI 10.1016/S0091-6749(00)90171-4; Wahn U, 1997, J ALLERGY CLIN IMMUN, V99, P763, DOI 10.1016/S0091-6749(97)80009-7; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; ZHANG K, 1994, J IMMUNOL, V152, P3427	33	627	641	0	29	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					752	756		10.1016/S0140-6736(00)04168-4	http://dx.doi.org/10.1016/S0140-6736(00)04168-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253969				2022-12-28	WOS:000167400900013
J	Gasser, SM				Gasser, SM			Positions of potential: Nuclear organization and gene expression	CELL			English	Review							CHROMATIN STRUCTURE; PERICENTROMERIC HETEROCHROMATIN; CENTROMERIC HETEROCHROMATIN; DNA-BINDING; LOCALIZATION; COMPLEXES; TELOMERES; PROTEINS; IKAROS; TRANSCRIPTION		Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland	Swiss Institute Experimental Cancer Research	Gasser, SM (corresponding author), Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland.			Gasser, Susan/0000-0003-3610-9123				Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; APARICIO OM, 1994, GENE DEV, V8, P1133, DOI 10.1101/gad.8.10.1133; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cavalli G, 1998, CURR OPIN CELL BIOL, V10, P354, DOI 10.1016/S0955-0674(98)80011-2; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0; Lundgren M, 2000, CELL, V103, P733, DOI 10.1016/S0092-8674(00)00177-X; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; Schubeler D, 2000, GENE DEV, V14, P940; Tyler JK, 1999, CELL, V99, P443, DOI 10.1016/S0092-8674(00)81530-5	20	109	113	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2001	104	5					639	642		10.1016/S0092-8674(01)00259-8	http://dx.doi.org/10.1016/S0092-8674(01)00259-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257217	Bronze, Green Published			2022-12-28	WOS:000167531100003
J	Butcher, SJ; Grimes, JM; Makeyev, EV; Bamford, DH; Stuart, DL				Butcher, SJ; Grimes, JM; Makeyev, EV; Bamford, DH; Stuart, DL			A mechanism for initiating RNA-dependent RNA polymerization	NATURE			English	Article							HEPATITIS-C VIRUS; PLUS-STRAND SYNTHESIS; CRYSTAL-STRUCTURE; DSRNA BACTERIOPHAGE-PHI-6; POLYMERASE-ACTIVITY; REPLICATION; RESOLUTION; SYSTEM; GENOME; MINUS	In most RNA viruses, genome replication and transcription are catalysed by a viral RNA-dependent RNA polymerase. Double-stranded RNA viruses perform these operations in a capsid (the polymerase complex), using an enzyme that can read both single- and double-stranded RNA. Structures have been solved for such viral capsids, but they do not resolve the polymerase subunits in any detail(1,2). Here we show that the 2 Angstrom resolution X-ray structure of the active polymerase subunit from the double-stranded RNA bacteriophage phi6 (refs 3, 4) is highly similar to that of the polymerase of hepatitis C virus, providing an evolutionary link between double-stranded RNA viruses and flaviviruses. By crystal soaking and co-crystallization, we determined a number of other structures, including complexes with oligonucleotide and/or nucleoside triphosphates (NTPs), that suggest a mechanism by which the incoming double-stranded RNA is opened up to feed the template through to the active site, while the substrates enter by another route. The template strand initially overshoots, locking into a specificity pocket, and then, in the presence of cognate NTPs, reverses to form the initiation complex; this process engages two NTPs, one of which acts with the carboxy-terminal domain of the protein to prime the reaction. Our results provide a working model for the initiation of replication and transcription.	Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England; Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland; Univ Helsinki, Dept Biosci, Viikkki Bioctr, Helsinki 00014, Finland; Oxford Ctr Mol Sci, Oxford OX1 3QT, England	University of Oxford; University of Helsinki; University of Helsinki; University of Oxford	Stuart, DL (corresponding author), Univ Oxford, Div Struct Biol, Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England.		Butcher, Sarah J/H-5579-2012	Bamford, Dennis/0000-0002-6438-8118; Butcher, Sarah/0000-0001-7060-5871; Makeyev, Eugene/0000-0001-6034-6896; Grimes, Jonathan Mark/0000-0001-9698-0389; Stuart, David/0000-0002-3426-4210				Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butcher SJ, 2000, ACTA CRYSTALLOGR D, V56, P1473, DOI 10.1107/S0907444900010702; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FRILANDER M, 1995, RNA, V1, P510; GOTTLIEB P, 1990, J BACTERIOL, V172, P5774, DOI 10.1128/jb.172.10.5774-5782.1990; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lohmann V, 1999, J BIOL CHEM, V274, P10807, DOI 10.1074/jbc.274.16.10807; Makeyev EV, 2000, EMBO J, V19, P124, DOI 10.1093/emboj/19.1.124; MERRITT EA, 1997, MACROMOLECULAR CRY B, P505; Mindich L, 1999, MICROBIOL MOL BIOL R, V63, P149, DOI 10.1128/MMBR.63.1.149-160.1999; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P164; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oh JW, 1999, J VIROL, V73, P7694, DOI 10.1128/JVI.73.9.7694-7702.1999; OLLIS DL, 1985, NATURE, V313, P818, DOI 10.1038/313818a0; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; VANDIJK AA, 1995, VIROLOGY, V211, P320, DOI 10.1006/viro.1995.1409; YAZAKI K, 1980, VIROLOGY, V105, P467, DOI 10.1016/0042-6822(80)90047-1; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000	26	418	442	0	33	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					235	240		10.1038/35065653	http://dx.doi.org/10.1038/35065653			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242087				2022-12-28	WOS:000167320500053
J	Cullinan, T				Cullinan, T			The problems of medical relief agencies	LANCET			English	Editorial Material									Merlin, London SE1 1DB, England		Cullinan, T (corresponding author), Merlin, 5-13 Trinity St, London SE1 1DB, England.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					713	714		10.1016/S0140-6736(00)04142-8	http://dx.doi.org/10.1016/S0140-6736(00)04142-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247573				2022-12-28	WOS:000167282400039
J	Dixon-Woods, M; Findlay, M; Young, B; Cox, H; Heney, D				Dixon-Woods, M; Findlay, M; Young, B; Cox, H; Heney, D			Parents' accounts of obtaining a diagnosis of childhood cancer	LANCET			English	Article							ILLNESS; HEALTH	Background Quick diagnosis and treatment of cancers is a UK government priority. However, the process of arriving at a diagnosis of childhood cancer has been neglected in comparison with the attention given to cancers in adults. We investigated parents' narratives about the period before their child's diagnosis. Methods We undertook semistructured interviews with 20 parents whose children (aged 4-18 years) had a confirmed diagnosis of cancer or brain tumour. All interviews were recorded and fully transcribed. Dates of consultations and investigations were noted from children's medical records. Data were analysed by the constant comparison method. Findings The time before diagnosis is very significant for parents and might affect their adaptation and reaction to their child's diagnosis. Parents were first alerted to their child's illness by a range of signs and symptoms, and by behavioural and affective changes, These early symptoms were often vague, non-specific, and common, and some older children were reluctant to disclose symptoms. Ten families' accounts of this period before diagnosis included a dispute with doctors. Disagreements between parents and doctors about the seriousness of children's symptoms and the need for investigations occurred in both primary and secondary care. Some parents felt that doctors discounted their special knowledge of their child. Interpretation Parents' accounts offer valuable insights into their experiences of obtaining a diagnosis of childhood cancer and into possible sources of delays in this complex process. If delays are to be avoided or reduced, attention must be given to the different roles of parents, children, general practitioners, hospital specialists, and type of cancer. Our findings have important implications for policy, practice, and research, and for the management of childhood illnesses.	Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; Univ Leicester, Fac Med & Biol Sci, Leicester LE1 6TP, Leics, England; Leicester Royal Infirm, Childrens Hosp, Leicester, Leics, England	University of Leicester; University of Leicester; University of Leicester	Dixon-Woods, M (corresponding author), Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England.	md11@ie.ac.uk	Young, Bridget/A-2184-2014	Dixon-Woods, Mary/0000-0002-5915-0041; Young, Bridget/0000-0001-6041-9901				Amir Z, 1999, EUR J CANCER CARE, V8, P198; Arksey H, 1999, SOC SCI MED, V49, P483, DOI 10.1016/S0277-9536(99)00143-4; Aynsley-Green A, 2000, BRIT MED J, V321, P229, DOI 10.1136/bmj.321.7255.229; Baruch G., 1981, SOCIOLOGY HLTH ILLNE, V3, P275, DOI DOI 10.1111/1467-9566.EP10486851; CUNNINGHAMBURLE.S, 1991, CHILD HLTH MATTERS, P29; CUNNINGHAMBURLEY S, 1987, BMJ-BRIT MED J, V295, P700, DOI 10.1136/bmj.295.6600.700; *DEP HLTH, 2000, REF GUID SUSP CANC; Dixon-Woods M, 1999, BRIT MED J, V319, P778, DOI 10.1136/bmj.319.7212.778; EISER C, 1994, PSYCHO-ONCOL, V3, P197, DOI 10.1002/pon.2960030306; Glaser B.G., 1965, AWARENESS DYING; HALLIDAY J, 1990, LISTEN MY CHILD HAS, P19; Hamre MR, 2000, MED PEDIATR ONCOL, V34, P343, DOI 10.1002/(SICI)1096-911X(200005)34:5<343::AID-MPO5>3.0.CO;2-B; Hyden LC, 1997, SOCIOL HEALTH ILL, V19, P48, DOI 10.1111/1467-9566.00040; IRVINE S, 1991, BRIT J GEN PRACT, V41, P371; Murphy E., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [DOI 10.3310/HTA2030, 10.3310/hta2030]; Neill SJ, 2000, J ADV NURS, V31, P821, DOI 10.1046/j.1365-2648.2000.01340.x; Pidgeon N., 1996, HDB QUALITATIVE RES, P86; POLNAY L, 1989, BRIT MED J, V299, P1351, DOI 10.1136/bmj.299.6712.1351; Ramirez AJ, 1999, LANCET, V353, P1127, DOI 10.1016/S0140-6736(99)02142-X; SAHA V, 1993, ARCH DIS CHILD, V68, P771, DOI 10.1136/adc.68.6.771	20	116	118	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2001	357	9257					670	674		10.1016/S0140-6736(00)04130-1	http://dx.doi.org/10.1016/S0140-6736(00)04130-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	407QN	11247550				2022-12-28	WOS:000167282400011
J	Jackson, M; Song, W; Liu, MY; Jin, L; Dykes-Hoberg, M; Lin, CLG; Bowers, WJ; Federoff, HJ; Sternweis, PC; Rothstein, JD				Jackson, M; Song, W; Liu, MY; Jin, L; Dykes-Hoberg, M; Lin, CLG; Bowers, WJ; Federoff, HJ; Sternweis, PC; Rothstein, JD			Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins	NATURE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; CEREBELLAR PURKINJE-CELLS; GATED CHLORIDE CHANNEL; SIMPLEX VIRUS VECTORS; RAT-BRAIN; SYNAPTIC TRANSMISSION; SURFACE EXPRESSION; PACKAGING SYSTEM; LOCALIZATION; RHO	Glutamate is the main excitatory neurotransmitter in the mammalian central nervous system and is removed from the synaptic cleft by sodium-dependent glutamate transporters. To date, five distinct glutamate transporters have been cloned from animal and human tissue: GLAST (EAAT1), GLT-1 (EAAT2), EAAC1 (EAAT3), EAAT4, and EAAT5 (refs 1-5). GLAST and GLT-1 are localized primarily in astrocytes(6,7), whereas EAAC1 (refs 8, 9), EAAT4 (refs 9-11) and EAAT5 (ref. 5) are neuronal. Studies of EAAT4 and EAAC1 indicate an extrasynaptic localization on perisynaptic membranes that are near release sites(8-10). This localization facilitates rapid glutamate binding, and may have a role in shaping the amplitude of postsynaptic responses in densely packed cerebellar terminals(12-15). We have used a yeast two-hybrid screen to identify interacting proteins that may be involved in regulating EAAT4- the glutamate transporter expressed predominately in the cerebellum-or in targeting and/or anchoring or clustering the transporter to the target site. Here we report the identification and characterization of two proteins, GTRAP41 and GTRAP48 (for glutamate transporter EAAT4 associated protein) that specifically interact with the intracellular carboxy-terminal domain of EAAT4 and modulate its glutamate transport activity.	Johns Hopkins Univ, Dept Neurol & Neurosci, Baltimore, MD 21287 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA; Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Ctr Aging & Dev Biol, Rochester, NY 14642 USA	Johns Hopkins University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Rochester; University of Rochester	Rothstein, JD (corresponding author), Johns Hopkins Univ, Dept Neurol & Neurosci, Baltimore, MD 21287 USA.		rothstein, jeffrey d/C-9470-2013; Lin, Chien-liang G/E-3513-2011					Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; Bowers WJ, 2000, MOL THER, V1, P294, DOI 10.1006/mthe.2000.0039; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; Davis KE, 1998, J NEUROSCI, V18, P2475; Dehnes Y, 1998, J NEUROSCI, V18, P3606; Diamond JS, 1997, J NEUROSCI, V17, P4672; Duan SM, 1999, J NEUROSCI, V19, P10193; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; GELLER AI, 1990, P NATL ACAD SCI USA, V87, P8950, DOI 10.1073/pnas.87.22.8950; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hart MJ, 1996, J BIOL CHEM, V271, P25452, DOI 10.1074/jbc.271.41.25452; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; He Y, 2000, J COMP NEUROL, V418, P255; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Nagao S, 1997, NEUROSCIENCE, V78, P929; Overstreet LS, 1999, J NEUROSCI, V19, P9663; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Stavropoulos TA, 1998, J VIROL, V72, P7137, DOI 10.1128/JVI.72.9.7137-7143.1998; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4	26	188	200	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					89	93		10.1038/35065091	http://dx.doi.org/10.1038/35065091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242047				2022-12-28	WOS:000167194300048
J	Lavington, S				Lavington, S			Tom Kilburn (1921-2001) - Obituary	NATURE			English	Biographical-Item									Univ Essex, Dept Comp Sci, Colchester CO4 3SQ, Essex, England	University of Essex	Lavington, S (corresponding author), Univ Essex, Dept Comp Sci, Colchester CO4 3SQ, Essex, England.							KILBURN T, PUBLICATION LIST	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					996	996		10.1038/35059201	http://dx.doi.org/10.1038/35059201			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11241994				2022-12-28	WOS:000167148800029
J	Oppenheimer, BR; Hambly, NC; Digby, AP; Hodgkin, ST; Saumon, D				Oppenheimer, BR; Hambly, NC; Digby, AP; Hodgkin, ST; Saumon, D			Direct detection of galactic halo dark matter	SCIENCE			English	Article							COOL WHITE-DWARFS; VERY-LOW LUMINOSITY; MODEL ATMOSPHERES; STARS; WD-0346+246; DISK; OLD; AGE	The Milky Way galaxy contains a large, spherical component which is believed to harbor a substantial amount of unseen matter. Recent observations indirectly suggest that as much as half of this "dark matter" may be in the form of old, very cool white dwarfs, the remnants of an ancient population of stars as old as the galaxy itself. We conducted a survey to find faint, cool white dwarfs with large space velocities, indicative of their membership in the galaxy's spherical halo component. The survey reveals a substantial, directly observed population of old white dwarfs, too faint to be seen in previous surveys. This newly discovered population accounts for at least 2 percent of the halo dark matter. It provides a natural explanation for the indirect observations, and represents a direct detection of galactic halo dark matter.	Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; Univ Edinburgh, Royal Observ, Inst Astron, Edinburgh EH9 3JH, Midlothian, Scotland; Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA	University of California System; University of California Berkeley; University of Edinburgh; University of Cambridge; Vanderbilt University	Oppenheimer, BR (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.			Oppenheimer, Rebecca/0000-0001-7130-7681; Digby, Andrew/0000-0002-1870-8811				Alcock C, 2000, ASTROPHYS J, V542, P281, DOI 10.1086/309512; BERGERON P, 1992, ASTROPHYS J, V394, P228, DOI 10.1086/171575; BERGERON P, 1995, ASTROPHYS J, V443, P764, DOI 10.1086/175566; Bergeron P, 1997, ASTROPHYS J SUPPL S, V108, P339, DOI 10.1086/312955; BERGERON P, IN PRESS ASTROPHYS J; BORYSOW A, 1990, ASTROPHYS J, V348, pL41, DOI 10.1086/185626; Chabrier G, 1999, ASTROPHYS J, V513, pL103, DOI 10.1086/311920; Chiba M, 2000, ASTRON J, V119, P2843, DOI 10.1086/301409; Flynn C, 2001, MON NOT R ASTRON SOC, V322, P553, DOI 10.1046/j.1365-8711.2001.04082.x; Fontaine G, 2001, PUBL ASTRON SOC PAC, V113, P409, DOI 10.1086/319535; GATES EI, 1995, ASTROPHYS J, V449, pL123, DOI 10.1086/309652; Gould A, 1998, ASTROPHYS J, V503, P798, DOI 10.1086/306023; Hambly NC, 1997, ASTROPHYS J, V489, pL157, DOI 10.1086/316797; Hambly NC, 1999, MON NOT R ASTRON SOC, V309, pL33, DOI 10.1046/j.1365-8711.1999.03085.x; HAMBLY NC, UNPUB; HAMBLY NC, IN PRESS 12 EUR C WH; Hansen BMS, 1999, ASTROPHYS J, V520, P680, DOI 10.1086/307476; Hansen BMS, 1998, NATURE, V394, P860, DOI 10.1038/29710; Harris HC, 2001, ASTROPHYS J, V549, pL109, DOI 10.1086/319146; Harris HC, 1999, ASTROPHYS J, V524, P1000, DOI 10.1086/307856; Hodgkin ST, 2000, NATURE, V403, P57, DOI 10.1038/47431; Ibata R, 2000, ASTROPHYS J, V532, pL41, DOI 10.1086/312566; Knox RA, 1999, MON NOT R ASTRON SOC, V306, P736, DOI 10.1046/j.1365-8711.1999.02625.x; Lasserre T, 2000, ASTRON ASTROPHYS, V355, pL39; Leggett SK, 1998, ASTROPHYS J, V497, P294, DOI 10.1086/305463; LUYTEN WJ, 1979, NLTT CATALOG; Maxted PFL, 1999, MON NOT R ASTRON SOC, V307, P122, DOI 10.1046/j.1365-8711.1999.02635.x; Monet DG, 2000, ASTRON J, V120, P1541, DOI 10.1086/301530; Oppenheimer BR, 2001, ASTROPHYS J, V550, P448, DOI 10.1086/319718; Saumon D, 1999, ASTROPHYS J, V511, pL107, DOI 10.1086/311851; Scholz RD, 2000, ASTRON ASTROPHYS, V353, P958; TAMANAHA CM, 1990, ASTROPHYS J, V358, P164, DOI 10.1086/168971; Wood MA, 1998, ASTROPHYS J, V497, P870, DOI 10.1086/305474	33	212	217	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					698	702		10.1126/science.1059954	http://dx.doi.org/10.1126/science.1059954			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11264524	Green Submitted			2022-12-28	WOS:000168478300043
J	Ross, J				Ross, J			Extracts from "Clinical Evidence" - Pelvic inflammatory disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							OUTPATIENT TREATMENT; ACUTE SALPINGITIS; RANDOMIZED TRIAL; DOXYCYCLINE; HOSPITALIZATION; EPIDEMIOLOGY; OFLOXACIN; CEFOXITIN; DIAGNOSIS; ETIOLOGY		Birmingham Specialist Community Hlth NHS Trust, Whittall St Clin, Birmingham, W Midlands, England		Ross, J (corresponding author), Birmingham Specialist Community Hlth NHS Trust, Whittall St Clin, Birmingham, W Midlands, England.	j.d.c.ross@bham.ac.uk		Ross, Jonathan/0000-0002-4193-6919				BEVAN CD, 1995, BRIT J OBSTET GYNAEC, V102, P407, DOI 10.1111/j.1471-0528.1995.tb11294.x; BRUNHAM RC, 1988, J INFECT DIS, V158, P510, DOI 10.1093/infdis/158.3.510; BUCHAN H, 1993, BRIT J OBSTET GYNAEC, V100, P558, DOI 10.1111/j.1471-0528.1993.tb15308.x; CURTIS AH, 1921, SURG GYNECOL OBSTET, V33, P621; GRODSTEIN F, 1994, EPIDEMIOLOGY, V5, P234, DOI 10.1097/00001648-199403000-00014; HEINONEN PK, 1989, SCAND J INFECT DIS, P66; Hillis SD, 1997, AM J OBSTET GYNECOL, V176, P103, DOI 10.1016/S0002-9378(97)80020-8; JACOBSON L, 1969, AM J OBSTET GYNECOL, V105, P1088, DOI 10.1016/0002-9378(69)90132-X; KELAGHAN J, 1982, JAMA-J AM MED ASSOC, V248, P184, DOI 10.1001/jama.248.2.184; MARTENS MG, 1993, SOUTHERN MED J, V86, P604, DOI 10.1097/00007611-199306000-00002; METTERS JS, 1998, CHLAMYDIA TRACHOMATI; MORCOS R, 1993, J REPROD MED, V38, P53; Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Centers for Disease Control and Prevention, 1998, MMWR RECOMMENDATIONS, V47, P1; Simms I, 1997, GENITOURIN MED, V73, P122; SOPER DE, 1992, AM J OBSTET GYNECOL, V167, P653, DOI 10.1016/S0002-9378(11)91566-X; VELEBIL P, 1995, OBSTET GYNECOL, V86, P764, DOI 10.1016/0029-7844(95)00252-M; WALKER CK, 1993, J INFECT DIS, V168, P969, DOI 10.1093/infdis/168.4.969; Walker CK, 1999, CLIN INFECT DIS, V28, pS29, DOI 10.1086/514720; WENDEL GD, 1991, AM J OBSTET GYNECOL, V164, P1390, DOI 10.1016/0002-9378(91)91479-G; WITTE EH, 1993, EUR J OBSTET GYN R B, V50, P153, DOI 10.1016/0028-2243(93)90180-K; WOLNERHANSSEN P, 1990, JAMA-J AM MED ASSOC, V263, P1936, DOI 10.1001/jama.263.14.1936; WOLNERHANSSEN P, 1990, JAMA-J AM MED ASSOC, V263, P54, DOI 10.1001/jama.263.1.54	22	33	43	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2001	322	7287					658	659		10.1136/bmj.322.7287.658	http://dx.doi.org/10.1136/bmj.322.7287.658			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413QE	11250853	Green Published			2022-12-28	WOS:000167622600028
J	Geissler, PL; Dellago, C; Chandler, D; Hutter, J; Parrinello, M				Geissler, PL; Dellago, C; Chandler, D; Hutter, J; Parrinello, M			Autoionization in liquid water	SCIENCE			English	Article							MOLECULAR-DYNAMICS SIMULATION; PROTON-TRANSFER; TRANSPORT; DISSOCIATION	The dissociation of a water molecule in Liquid water is the fundamental event in acid-base chemistry, determining the pH of water. Because of the short time scales and microscopic length scales involved, the dynamics of this autoionization have not been directly probed by experiment. Here, the autoionization mechanism is revealed by sampling and analyzing ab initio molecular dynamics trajectories. We identify the rare fluctuations in solvation energies that destabilize an oxygen-hydrogen bond, Through the transfer of protons along a hydrogen bond "wire," the nascent ions separate by three or more neighbors. If the hydrogen bond wire connecting the two ions is subsequently broken, a metastable charge-separated state is visited. The ions may then diffuse to Large separations. If, however, the hydrogen bond wire remains unbroken. the ions recombine rapidly. Because of their concomitant Large electric fields, the transient ionic species produced in this case may provide an experimentally detectable signal of the dynamics we report.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Rochester, Dept Chem, Rochester, NY 14627 USA; Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany	University of California System; University of California Berkeley; University of Rochester; Max Planck Society	Chandler, D (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	chandler@cchem.berkeley.edu	Hutter, Juerg/E-9244-2011; Dellago, Christoph/E-1625-2011	Dellago, Christoph/0000-0001-9166-6235; Hutter, Juerg/0000-0002-6887-8229				AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Ando K, 1999, ADV CHEM PHYS, V110, P381, DOI 10.1002/9780470141694.ch6; BADER JS, 1990, J CHEM PHYS, V93, P230, DOI 10.1063/1.459596; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bolhuis PG, 1998, FARADAY DISCUSS, V110, P421, DOI 10.1039/a801266k; BORGIS DC, 1989, CHEM PHYS LETT, V162, P19, DOI 10.1016/0009-2614(89)85059-6; Cheng Y.-N., 1986, SPECIAL PUBLICATION, V1, P1; de Grotthuss CJT, 2006, BBA-BIOENERGETICS, V1757, P871, DOI 10.1016/j.bbabio.2006.07.004; Dellago C, 1999, J CHEM PHYS, V110, P6617, DOI 10.1063/1.478569; Dellago C, 1998, J CHEM PHYS, V108, P9236, DOI 10.1063/1.476378; DOGONADZE RR, 1966, ELECT ACTA, V13, P1025; Du R, 1998, J CHEM PHYS, V108, P334, DOI 10.1063/1.475393; EIGEN M, 1955, Z ELEKTROCHEM, V59, P986; EIGEN M, 1964, ANGEW CHEM INT EDIT, V3, P1, DOI 10.1002/anie.196400011; Geissler PL, 2000, CHEM PHYS LETT, V321, P225, DOI 10.1016/S0009-2614(00)00381-X; Geissler PL, 2000, CHEM PHYS LETT, V324, P149, DOI 10.1016/S0009-2614(00)00479-6; Geissler PL, 1999, J PHYS CHEM B, V103, P3706, DOI 10.1021/jp984837g; KLOSEK MM, 1991, BER BUNSEN PHYS CHEM, V95, P331, DOI 10.1002/bbpc.19910950318; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LUZ Z, 1964, J AM CHEM SOC, V86, P4768, DOI 10.1021/ja01076a008; MARCUS RA, 1956, J CHEM PHYS, V24, P966, DOI 10.1063/1.1742723; MARCUS RA, 1979, PHYSICAL ELECTROCHEM, V80, P1; Marx D, 2000, J PHYS-CONDENS MAT, V12, pA153, DOI 10.1088/0953-8984/12/8A/317; NATZLE WC, 1985, J PHYS CHEM-US, V89, P2605, DOI 10.1021/j100258a035; RAPAPORT DC, 1983, MOL PHYS, V50, P1151, DOI 10.1080/00268978300102931; Schmitt UW, 1999, J CHEM PHYS, V111, P9361, DOI 10.1063/1.480032; Sprik M, 1996, J CHEM PHYS, V105, P1142, DOI 10.1063/1.471957; STILLINGER FH, 1975, ADV CHEM PHYS, V31, P1; Trout BL, 1999, J PHYS CHEM B, V103, P7340, DOI 10.1021/jp990548w; Trout BL, 1998, CHEM PHYS LETT, V288, P343, DOI 10.1016/S0009-2614(98)00286-3; TUCKERMAN M, 1995, J CHEM PHYS, V103, P150, DOI 10.1063/1.469654; Vuilleumier R, 1999, J CHEM PHYS, V111, P4251, DOI 10.1063/1.479723	33	584	588	3	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2001	291	5511					2121	2124		10.1126/science.1056991	http://dx.doi.org/10.1126/science.1056991			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251111				2022-12-28	WOS:000167563800031
J	Puntes, VF; Krishnan, KM; Alivisatos, AP				Puntes, VF; Krishnan, KM; Alivisatos, AP			Colloidal nanocrystal shape and size control: The case of cobalt	SCIENCE			English	Article							MAGNETIC-PROPERTIES; SUPERLATTICES; NANOSTRUCTURES; PARTICLES	We show that a relatively simple approach for controlling the colloidal synthesis of anisotropic cadmium selenide semiconductor nanorods can be extended to the size-controlled preparation of magnetic cobalt nanorods as well as spherically shaped nanocrystals. This approach helps define a minimum feature set needed to separately control the sizes and shapes of nanocrystals. The resulting cobalt nanocrystals produce interesting two- and three-dimensional superstructures, including ribbons of nanorods.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Puntes, VF (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.		Puntes, Victor/AAL-6081-2021; Alivisatos, Paul/N-8863-2015; Puntes, Víctor F./F-8407-2013	Puntes, Victor/0000-0001-8996-9499; Alivisatos, Paul/0000-0001-6895-9048; Puntes, Víctor F./0000-0001-8996-9499	NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR014891] Funding Source: NIH RePORTER; NCRR NIH HHS [1 R01 RR-14891-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		deCaro D, 1996, CHEM MATER, V8, P1987, DOI 10.1021/cm950599f; Dinega DP, 1999, ANGEW CHEM INT EDIT, V38, P1788, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1788::AID-ANIE1788>3.0.CO;2-2; Dormann JL, 1997, ADV CHEM PHYS, V98, P283, DOI 10.1002/9780470141571.ch4; HAMZAOUI S, 1980, J MAGN MAGN MATER, V22, P69, DOI 10.1016/0304-8853(80)90010-4; Himpsel FJ, 1998, ADV PHYS, V47, P511, DOI 10.1080/000187398243519; Lieber CM, 1998, SOLID STATE COMMUN, V107, P607, DOI 10.1016/S0038-1098(98)00209-9; Manna L, 2000, J AM CHEM SOC, V122, P12700, DOI 10.1021/ja003055+; OULD T, 2000, J PHYS CHEM B, V104, P165; Ould-Ely T, 1999, CHEM MATER, V11, P526, DOI 10.1021/cm980675p; Park SJ, 2000, J AM CHEM SOC, V122, P8581, DOI 10.1021/ja001628c; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Peng XG, 1998, J AM CHEM SOC, V120, P5343, DOI 10.1021/ja9805425; Petit C, 1999, J PHYS CHEM B, V103, P1805, DOI 10.1021/jp982755m; PUNTES V, IN PRESS IEEE T MAGN; PUNTES V, IN PRESS APPL PHYS L; Schmid G, 1998, ADV MATER, V10, P515, DOI 10.1002/(SICI)1521-4095(199805)10:7<515::AID-ADMA515>3.0.CO;2-Y; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; Sun SH, 1999, J APPL PHYS, V85, P4325, DOI 10.1063/1.370357; THOMAS JR, 1966, J APPL PHYS, V37, P2914, DOI 10.1063/1.1782154; THOMAS JR, 1966, Patent No. 3284358; Wang ZL, 1998, ADV MATER, V10, P13, DOI 10.1002/(SICI)1521-4095(199801)10:1<13::AID-ADMA13>3.0.CO;2-W; YANG MH, 1989, PHYS REV LETT, V62, P1476; Yin JS, 1997, PHYS REV LETT, V79, P2570, DOI 10.1103/PhysRevLett.79.2570	23	2237	2368	6	923	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2115	2117		10.1126/science.1057553	http://dx.doi.org/10.1126/science.1057553			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251109	Green Submitted			2022-12-28	WOS:000167563800029
J	Wuethrich, B				Wuethrich, B			Neurobiology - Does alcohol damage female brains more?	SCIENCE			English	News Item																			0	15	16	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2077	+		10.1126/science.291.5511.2077	http://dx.doi.org/10.1126/science.291.5511.2077			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11256400				2022-12-28	WOS:000167563800014
J	Young, L; Leonhard, K; Tatsuta, T; Trowsdale, L; Langer, T				Young, L; Leonhard, K; Tatsuta, T; Trowsdale, L; Langer, T			Role of the ABC transporter Mdl1 in peptide export from mitochondria	SCIENCE			English	Article							INNER MEMBRANE; PROTEIN TRANSLOCATION; AAA PROTEASES; DEGRADATION; IMPORT; IDENTIFICATION; PARAPLEGIN; TIM23	ATP-binding cassette (ABC) adenosine triphosphatases actively transport a wide variety of compounds across biological membranes. Here, the ABC protein Mdl1 was identified as an intracellular peptide transporter localized in the inner membrane of yeast mitochondria. Mdl1 was required for mitochondrial export of peptides with molecular masses of similar to 2100 to 600 daltons generated by proteolysis of inner-membrane proteins by the m-AAA protease in the mitochondrial matrix. Proteolysis by the I-AAA protease in the intermembrane space led to the release of similar-sited peptides independent of Mdl1. Thus, two pathways of peptide efflux from mitochondria exist that may allow communication between mitochondria and their cellular environment.	Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England; Univ Munich, Inst Physiol Chem, D-80336 Munich, Germany	University of Cambridge; University of Munich	Young, L (corresponding author), Univ Cambridge, Dept Pathol, Div Immunol, Tennis Court Rd, Cambridge CB2 1QP, England.	lesley.young@lorantis.co.uk; thomas.langer@uni-koeln.de		Langer, Thomas/0000-0003-1250-1462				Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; Bauer MF, 2000, TRENDS CELL BIOL, V10, P25, DOI 10.1016/S0962-8924(99)01684-0; BUTCHER GW, 2000, MOL B INT U, V8, P47; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Coppola M, 2000, GENOMICS, V66, P48, DOI 10.1006/geno.2000.6136; DAUM G, 1982, J BIOL CHEM, V257, P3075; DEAN M, 1994, YEAST, V10, P377, DOI 10.1002/yea.320100310; DESAUTELS M, 1982, P NATL ACAD SCI-BIOL, V79, P1869, DOI 10.1073/pnas.79.6.1869; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; Elliott T, 1997, ADV IMMUNOL, V65, P47, DOI 10.1016/S0065-2776(08)60741-5; FISCHERLINDAHL K, 1997, ANNU REV IMMUNOL, V15, P851; Guelin E, 1996, FEBS LETT, V381, P42, DOI 10.1016/0014-5793(96)00074-9; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hogue DL, 1999, J MOL BIOL, V285, P379, DOI 10.1006/jmbi.1998.2259; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; KUCHLER K, 1992, COLD SPRING HARB SYM, V57, P579, DOI 10.1101/SQB.1992.057.01.064; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Lankat-Buttgereit B, 1999, FEBS LETT, V464, P108, DOI 10.1016/S0014-5793(99)01676-2; LEIGHTON J, 1995, EMBO J, V14, P188, DOI 10.1002/j.1460-2075.1995.tb06989.x; Leonhard K, 1996, EMBO J, V15, P4218, DOI 10.1002/j.1460-2075.1996.tb00796.x; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; MANNELLA CA, 1992, TRENDS BIOCHEM SCI, V17, P315, DOI 10.1016/0968-0004(92)90444-E; Mitsuhashi N, 2000, J BIOL CHEM, V275, P17536, DOI 10.1074/jbc.275.23.17536; Shirihai OS, 2000, EMBO J, V19, P2492, DOI 10.1093/emboj/19.11.2492; UNGERMANN C, 1994, SCIENCE, V266, P1250, DOI 10.1126/science.7973708	28	169	174	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2001	291	5511					2135	2138		10.1126/science.1056957	http://dx.doi.org/10.1126/science.1056957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251115				2022-12-28	WOS:000167563800035
J	Lindsay, EA; Vitelli, F; Su, H; Morishima, M; Huynh, T; Pramparo, T; Jurecic, V; Ogunrinu, G; Sutherland, HF; Scambler, PJ; Bradley, A; Baldini, A				Lindsay, EA; Vitelli, F; Su, H; Morishima, M; Huynh, T; Pramparo, T; Jurecic, V; Ogunrinu, G; Sutherland, HF; Scambler, PJ; Bradley, A; Baldini, A			Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice	NATURE			English	Article							HOLT-ORAM SYNDROME; CHROMOSOMAL REGION; 22Q11 DELETION; NO OVERLAP; GENE; MOUSE; MUTATIONS; BRACHYURY; DEFICIENT; FAMILY	DiGeorge syndrome is characterized by cardiovascular, thymus and parathyroid defects and craniofacial anomalies, and is usually caused by a heterozygous deletion of chromosomal region 22q11.2 (del22q11) (ref. 1). A targeted, heterozygous deletion, named Df(16)1, encompassing around 1 megabase of the homologous region in mouse causes cardiovascular abnormalities characteristic of the human disease(2). Here we have used a combination of chromosome engineering and P1 artificial chromosome transgenesis to localize the haploinsufficient gene in the region, Tbx1. We show that Tbx1, a member of the T-box transcription factor family, is required for normal development of the pharyngeal arch arteries in a gene dosage-dependent manner. Deletion of one copy of Tbx1 affects the development of the fourth pharyngeal arch arteries, whereas homozygous mutation severely disrupts the pharyngeal arch artery system. Our data show that haploinsufficiency of Tbx1 is sufficient to generate at least one important component of the DiGeorge syndrome phenotype in mice, and demonstrate the suitability of the mouse for the genetic dissection of microdeletion syndromes.	Baylor Coll Med, Dept Pediat Cardiol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Miami, Sch Med, Miami, FL 33136 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Inst Child Hlth, London WC1N, England; Sanger Ctr, Cambridge CB10 1S, England; Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Miami; University of Texas System; UTMD Anderson Cancer Center; Wellcome Trust Sanger Institute; Howard Hughes Medical Institute	Baldini, A (corresponding author), Baylor Coll Med, Dept Pediat Cardiol, 1 Baylor Plaza, Houston, TX 77030 USA.		genes, anthony/F-2541-2012; Scambler, Peter J/C-4998-2008; Scambler, Peter/AAZ-6026-2020; Baldini, Antonio/M-2355-2015	Scambler, Peter J/0000-0002-1487-4628; Scambler, Peter/0000-0002-1487-4628; Bradley, Allan/0000-0002-2349-8839; Baldini, Antonio/0000-0002-5330-0256				Albrecht U, 1997, MOL CELLULAR METHODS, P23; Amati F, 1999, EUR J HUM GENET, V7, P903, DOI 10.1038/sj.ejhg.5200399; Baldini A, 1994, Methods Mol Biol, V33, P75; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Begbie J, 1999, DEVELOPMENT, V126, P895; Botta A, 1997, MAMM GENOME, V8, P890, DOI 10.1007/s003359900606; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chieffo C, 1997, GENOMICS, V43, P267, DOI 10.1006/geno.1997.4829; Galili N, 1997, GENOME RES, V7, P17, DOI 10.1101/gr.7.1.17; Gong LM, 2000, BBA-GENE STRUCT EXPR, V1494, P185, DOI 10.1016/S0167-4781(00)00189-5; Kirby ML, 1997, DEV DYNAM, V208, P34, DOI 10.1002/(SICI)1097-0177(199701)208:1<34::AID-AJA4>3.0.CO;2-2; Li QY, 1997, NAT GENET, V15, P21; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Lund J, 1999, MAMM GENOME, V10, P438, DOI 10.1007/s003359901019; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; MCKUSICK V, 2000, LINE MENDELIAN INHER; McQuade L, 1999, AM J MED GENET, V86, P27, DOI 10.1002/(SICI)1096-8628(19990903)86:1<27::AID-AJMG6>3.0.CO;2-7; ODonnell H, 1997, AM J HUM GENET, V60, P1544; Puech A, 1997, P NATL ACAD SCI USA, V94, P14608, DOI 10.1073/pnas.94.26.14608; Puech A, 2000, P NATL ACAD SCI USA, V97, P10090, DOI 10.1073/pnas.97.18.10090; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421; Smith J, 1997, CURR OPIN GENET DEV, V7, P474, DOI 10.1016/S0959-437X(97)80073-1; Su H, 2000, NAT GENET, V24, P92, DOI 10.1038/71756; Sutherland HF, 1998, GENOMICS, V52, P37, DOI 10.1006/geno.1998.5414	26	684	698	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					97	101		10.1038/35065105	http://dx.doi.org/10.1038/35065105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242049				2022-12-28	WOS:000167194300050
J	Mason, GJ; Cooper, J; Clarebrough, C				Mason, GJ; Cooper, J; Clarebrough, C			Frustrations of fur-farmed mink	NATURE			English	Article									Univ Oxford, Dept Zool, Oxford OX1 3PS, England; De Montfort Univ, Sch Agr & Hort, Caythorpe NG32 3EP, Lincoln, England	University of Oxford; De Montfort University	Mason, GJ (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.			Cooper, Jonathan/0000-0002-9014-4395				*AN AID, 1999, FUR TRAD FACTSH; DAWKINS MS, 1990, BEHAV BRAIN SCI, V13, P1, DOI 10.1017/S0140525X00077104; Dunstone N., 1993, MINK; Hartwick J.M., 1998, EC NATURAL RESOURCE, V2; HURSH SR, 1980, J EXP ANAL BEHAV, V34, P219, DOI 10.1901/jeab.1980.34-219; *INT FUR TRAD FED, FUR FARM; JOERGENSON G, 1985, MINK PRODUCTION; NG YK, 1983, WELFARE EC; Reilly S, 1999, PHARMACOL BIOCHEM BE, V63, P301, DOI 10.1016/S0091-3057(99)00009-X; Rolls ET, 2000, BEHAV BRAIN SCI, V23, P177, DOI 10.1017/S0140525X00002429; STEPHENS DW, 1998, FORAGING THEORY; Toates F., 1995, STRESS CONCEPTUAL BI; Varian H. R., 1996, INTERMEDIATE MICROEC	13	222	233	2	123	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					35	36		10.1038/35065157	http://dx.doi.org/10.1038/35065157			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242031	Green Accepted			2022-12-28	WOS:000167194300032
J	Tokumaru, H; Umayahara, K; Pellegrini, LL; Ishizuka, T; Saisu, H; Betz, H; Augustine, GJ; Abe, T				Tokumaru, H; Umayahara, K; Pellegrini, LL; Ishizuka, T; Saisu, H; Betz, H; Augustine, GJ; Abe, T			SNARE complex oligomerization by synaphin/complexin is essential for synaptic vesicle exocytosis	CELL			English	Article							PROTEIN-PROTEIN INTERACTIONS; NEUROTRANSMITTER RELEASE; MEMBRANE-FUSION; PRESYNAPTIC TERMINALS; CALCIUM CHANNELS; ALPHA-SNAP; DOCKING; SYNTAXIN; SYNAPTOBREVIN; NSF	Synaphin/complexin is a cytosolic protein that preferentially binds to syntaxin within the SNARE complex. We find that synaphin promotes SNAREs to form pre-complexes that oligomerize into higher order structures. A peptide from the central, syntaxin binding domain of synaphin competitively inhibits these two proteins from interacting and prevents SNARE complexes from oligomerizing. Injection of this peptide into squid giant presynaptic terminals inhibited neurotransmitter release at a late prefusion step of synaptic vesicle exocytosis. We propose that oligomerization of SNARE complexes into a higher order structure creates a SNARE scaffold for efficient, regulated fusion of synaptic vesicles.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Marine Biol Lab, Woods Hole, MA 02543 USA; Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata 9518585, Japan; Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany	Duke University; Marine Biological Laboratory - Woods Hole; Niigata University; Max Planck Society	Augustine, GJ (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.		Ishizuka, Toru/L-8191-2017; Augustine, George James/J-9228-2013	Ishizuka, Toru/0000-0003-4405-8792; 				Augustine GJ, 1999, J PHYSIOL-LONDON, V520, P33, DOI 10.1111/j.1469-7793.1999.00033.x; Banerjee A, 1996, J BIOL CHEM, V271, P20223, DOI 10.1074/jbc.271.34.20223; Bentz J, 2000, BIOPHYS J, V78, P886, DOI 10.1016/S0006-3495(00)76646-X; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Burns ME, 1998, J GEN PHYSIOL, V111, P243, DOI 10.1085/jgp.111.2.243; CHAMBERLAIN LH, 1995, J CELL BIOL, V130, P1063, DOI 10.1083/jcb.130.5.1063; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chernomordik LV, 1999, MOL MEMBR BIOL, V16, P33; Coorssen JR, 1998, J CELL BIOL, V143, P1845, DOI 10.1083/jcb.143.7.1845; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; DEBELLO WM, 1995, NATURE, V373, P626, DOI 10.1038/373626a0; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hohl TM, 1998, MOL CELL, V2, P539, DOI 10.1016/S1097-2765(00)80153-7; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241; Ishizuka T, 1997, NEUROSCI LETT, V232, P107, DOI 10.1016/S0304-3940(97)00586-7; KEE Y, 1995, NEURON, V14, P991, DOI 10.1016/0896-6273(95)90337-2; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; MORITA T, 1992, BIOMED RES-TOKYO, V13, P357, DOI 10.2220/biomedres.13.357; OConnor V, 1997, P NATL ACAD SCI USA, V94, P12186, DOI 10.1073/pnas.94.22.12186; Ono S, 1998, EUR J NEUROSCI, V10, P2143, DOI 10.1046/j.1460-9568.1998.00225.x; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; PELLEGRINI LL, 1995, EMBO J, V14, P4705, DOI 10.1002/j.1460-2075.1995.tb00152.x; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Poirier MA, 1998, J BIOL CHEM, V273, P11370, DOI 10.1074/jbc.273.18.11370; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Robinson LJ, 1998, CURR OPIN CELL BIOL, V10, P483, DOI 10.1016/S0955-0674(98)80063-X; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SANCHEZ ME, 1990, J EXP BIOL, V152, P369; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Schweizer FE, 1998, SCIENCE, V279, P1203, DOI 10.1126/science.279.5354.1203; SMITH SJ, 1993, J PHYSIOL-LONDON, V472, P573, DOI 10.1113/jphysiol.1993.sp019963; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; TAKAHASHI S, 1995, FEBS LETT, V368, P455, DOI 10.1016/0014-5793(95)00713-J; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925	59	121	126	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2001	104	3					421	432		10.1016/S0092-8674(01)00229-X	http://dx.doi.org/10.1016/S0092-8674(01)00229-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239399	Bronze			2022-12-28	WOS:000167003100012
J	McKinley, RK; Fraser, RC; Baker, R				McKinley, RK; Fraser, RC; Baker, R			Model for directly assessing and improving clinical competence and performance in revalidation of clinicians	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; CONSULTATIONS; EXPERIENCE		Univ Leicester, Leicester Gen Hosp, Dept Gen Practice & Primary Hlth Care, Leicester LE5 4PW, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	McKinley, RK (corresponding author), Univ Leicester, Leicester Gen Hosp, Dept Gen Practice & Primary Hlth Care, Leicester LE5 4PW, Leics, England.		McKinley, Robert Kee/H-9211-2013	McKinley, Robert Kee/0000-0002-3684-3435				Allen J, 1998, BRIT J GEN PRACT, V48, P1219; Baker R, 1997, QUAL HEALTH CARE, V6, P201, DOI 10.1136/qshc.6.4.201; Burrows PJ, 1999, BRIT J GEN PRACT, V49, P269; Coleman T, 1998, BRIT J GEN PRACT, V48, P971; Donaldson L., 1999, SUPPORTING DOCTORS P; Frankel S, 2000, BRIT MED J, V320, P489, DOI 10.1136/bmj.320.7233.489; *GEN MED COUNC, 1998, MAINT GOOD MED PRACT; General Medical Council, 2000, REV DOCT ENS STAND S; HARDEN RM, 1988, MED TEACH, V10, P19, DOI 10.3109/01421598809019321; Irvine D, 1997, BRIT MED J, V314, P1540, DOI 10.1136/bmj.314.7093.1540; Marshall EG, 1998, BRIT MED J, V316, P1701, DOI 10.1136/bmj.316.7146.1701; RETHANS JJ, 1991, BRIT MED J, V303, P1377, DOI 10.1136/bmj.303.6814.1377; RETHANS JJ, 1991, BRIT J GEN PRACT, V41, P94; Southgate L, 1999, BMJ-BRIT MED J, V319, P1180, DOI 10.1136/bmj.319.7218.1180; Southgate L, 1998, BMJ-BRIT MED J, V316, P697, DOI 10.1136/bmj.316.7132.697; Spence J, 1960, PURPOSE PRACTICE MED, P271; STREINER DL, 1985, ASSESSING CLIN COMPE, P119; Van der Vleuten CPM, 1996, ADV HEALTH SCI EDUC, V1, P41, DOI 10.1007/BF00596229	18	46	47	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 24	2001	322	7288					712	715		10.1136/bmj.322.7288.712	http://dx.doi.org/10.1136/bmj.322.7288.712			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416GB	11264212	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000167771000027
J	Rudd, PM; Elliott, T; Cresswell, P; Wilson, IA; Dwek, RA				Rudd, PM; Elliott, T; Cresswell, P; Wilson, IA; Dwek, RA			Glycosylation and the immune system	SCIENCE			English	Review							T-CELL-RECEPTOR; COMPLEMENT REGULATORY PROTEIN; ADHESION MOLECULE CD2; CRYSTAL-STRUCTURE; RHEUMATOID-ARTHRITIS; LINKED GLYCOPROTEINS; ANTIGEN PRESENTATION; PEPTIDE; BINDING; IMMUNOGLOBULIN	Almost all of the key molecules involved in the innate and adaptive immune response are glycoproteins. In the cellular immune system, specific glycoforms are involved in the folding, quality control, and assembly of peptide-loaded major histocompatibility complex (MHC) antigens and the T cell receptor complex. Although some glycopeptide antigens are presented by the MHC, the generation of peptide antigens from glycoproteins may require enzymatic removal of sugars before the protein can be cleaved. Oligosaccharides attached to glycoproteins in the junction between T cells and antigen-presenting cells help to orient binding faces, provide protease protection, and restrict nonspecific lateral protein-protein interactions. In the humoral immune system, all of the immunoglobulins and most of the complement components are glycosylated, Although a major function for sugars is to contribute to the stability of the proteins to which they are attached, specific glycoforms are involved in recognition events. For example, in rheumatoid arthritis, an autoimmune disease, agalactosylated glycoforms of aggregated immunoglobulin G may induce association with the mannose-binding Lectin and contribute to the pathology.	Univ Oxford, Dept Biochem, Glycobiol Inst, Oxford OX1 3QU, England; Univ Southampton, Southampton Gen Hosp, Sch Med,Canc Sci Div, CRC Med Oncol Unit, Southampton SO16 6YD, Hants, England; Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06510 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	University of Oxford; University of Southampton; Howard Hughes Medical Institute; Yale University; Scripps Research Institute; Scripps Research Institute	Rudd, PM (corresponding author), Univ Oxford, Dept Biochem, Glycobiol Inst, S Parks Rd, Oxford OX1 3QU, England.	pmr@glycob.ox.ac.uk; dwek@exeter.oxford.ac.uk		Elliott, Tim/0000-0003-1097-0222	NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042266, R37AI042266] Funding Source: NIH RePORTER; NCI NIH HHS [CA58896] Funding Source: Medline; NIAID NIH HHS [AI42266] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		APOSTOLOPOULOS V, 1995, CANCER LETT, V90, P21, DOI 10.1016/0304-3835(94)03673-7; BAENZIGER J, 1974, J BIOL CHEM, V249, P7270; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Bergeron JJM, 1998, ADV EXP MED BIOL, V435, P105; BLUMBERG RS, 1995, IMMUNOL REV, V147, P5, DOI 10.1111/j.1600-065X.1995.tb00085.x; BODIAN DL, 1994, STRUCTURE, V2, P755, DOI 10.1016/S0969-2126(94)00076-X; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Cabral CM, 2000, J BIOL CHEM, V275, P25015, DOI 10.1074/jbc.M910172199; Chapman HA, 1998, CURR OPIN IMMUNOL, V10, P93, DOI 10.1016/S0952-7915(98)80038-1; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; Corthay A, 1998, EUR J IMMUNOL, V28, P2580, DOI 10.1002/(SICI)1521-4141(199808)28:08<2580::AID-IMMU2580>3.0.CO;2-X; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; DECK B, 1995, J IMMUNOL, V155, P1074; Deck MB, 1999, J IMMUNOL, V162, P4740; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Dong X, 1999, J IMMUNOL, V163, P5427; DUDLER T, 1995, EUR J IMMUNOL, V25, P538, DOI 10.1002/eji.1830250235; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Elliott T, 1997, ADV IMMUNOL, V65, P47, DOI 10.1016/S0065-2776(08)60741-5; ELLIOTT T, 1995, J EXP MED, V181, P1481, DOI 10.1084/jem.181.4.1481; FIELD MC, 1994, BIOCHEM J, V299, P261, DOI 10.1042/bj2990261; Fischer PB, 1996, J VIROL, V70, P7143, DOI 10.1128/JVI.70.10.7143-7152.1996; FLETCHER CM, 1994, STRUCTURE, V2, P185, DOI 10.1016/S0969-2126(00)00020-4; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Garred P, 2000, J RHEUMATOL, V27, P26; GETTINS P, 1981, BIOCHEMISTRY-US, V20, P7463, DOI 10.1021/bi00529a021; Ghendler Y, 1998, J EXP MED, V187, P1529, DOI 10.1084/jem.187.9.1529; Glithero A, 1999, IMMUNITY, V10, P63, DOI 10.1016/S1074-7613(00)80007-2; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HART GW, 1989, ANNU REV BIOCHEM, V58, P841; Haurum JS, 1999, J EXP MED, V190, P145, DOI 10.1084/jem.190.1.145; HAURUM JS, 1994, J EXP MED, V180, P739, DOI 10.1084/jem.180.2.739; Haurum JS, 1995, EUR J IMMUNOL, V25, P3270, DOI 10.1002/eji.1830251211; Hudrisier D, 1999, J BIOL CHEM, V274, P36274, DOI 10.1074/jbc.274.51.36274; Hughes EA, 1998, CURR BIOL, V8, P709, DOI 10.1016/S0960-9822(98)70278-7; Jensen T, 1997, J IMMUNOL, V158, P3769; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; KuttnerKondo L, 1996, PROTEIN ENG, V9, P1143, DOI 10.1093/protein/9.12.1143; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Lindquist JA, 1998, EMBO J, V17, P2186, DOI 10.1093/emboj/17.8.2186; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Liu Y, 1997, J BIOL CHEM, V272, P7946, DOI 10.1074/jbc.272.12.7946; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; Mehta A, 1998, FEBS LETT, V430, P17, DOI 10.1016/S0014-5793(98)00525-0; Melian A, 1996, CURR OPIN IMMUNOL, V8, P82, DOI 10.1016/S0952-7915(96)80109-9; MERRY A, UNPUB; MESTECKY J, 1985, METHOD ENZYMOL, V116, P37; MICHAELSSON E, 1994, J EXP MED, V180, P745, DOI 10.1084/jem.180.2.745; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Morrice NA, 1998, CURR BIOL, V8, P713, DOI 10.1016/S0960-9822(98)70279-9; MOTAL UMA, 1996, EUR J IMMUNOL, V26, P544; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Porcelli SA, 1998, IMMUNOL TODAY, V19, P362, DOI 10.1016/S0167-5699(98)01289-4; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; RUDD PM, 1991, MOL IMMUNOL, V28, P1369, DOI 10.1016/0161-5890(91)90039-M; Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104; Rudd PM, 1999, GLYCOBIOLOGY, V9, P443, DOI 10.1093/glycob/9.5.443; Rudd PM, 1997, J BIOL CHEM, V272, P7229, DOI 10.1074/jbc.272.11.7229; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; SHOGREN R, 1989, BIOCHEMISTRY-US, V28, P5525, DOI 10.1021/bi00439a029; Skipper JCA, 1996, J EXP MED, V183, P527, DOI 10.1084/jem.183.2.527; Speir JA, 1999, IMMUNITY, V10, P51, DOI 10.1016/S1074-7613(00)80006-0; Speir JA, 2001, IMMUNITY, V14, P81, DOI 10.1016/S1074-7613(01)00091-7; Stock D, 1996, CURR OPIN BIOTECH, V7, P376, DOI 10.1016/S0958-1669(96)80111-X; Sugita M, 1998, CLIN IMMUNOL IMMUNOP, V87, P8, DOI 10.1006/clin.1997.4500; Suzuki T, 1998, J BIOL CHEM, V273, P10083, DOI 10.1074/jbc.273.17.10083; Trombetta ES, 1998, CURR OPIN STRUC BIOL, V8, P587, DOI 10.1016/S0959-440X(98)80148-6; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Watson M, 1999, ARTHRITIS RHEUM, V42, P1682, DOI 10.1002/1529-0131(199908)42:8<1682::AID-ANR17>3.0.CO;2-X; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wormald MR, 1997, BIOCHEMISTRY-US, V36, P1370, DOI 10.1021/bi9621472; Wormald MR, 1999, STRUCTURE, V7, pR155, DOI 10.1016/S0969-2126(99)80095-1; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; ZHAO XJ, 1995, J EXP MED, V182, P67, DOI 10.1084/jem.182.1.67	90	1305	1431	12	400	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2001	291	5512					2370	2376		10.1126/science.291.5512.2370	http://dx.doi.org/10.1126/science.291.5512.2370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11269318				2022-12-28	WOS:000167618700045
J	Andres, E; Askebjer, P; Bai, X; Barouch, G; Barwick, SW; Bay, TC; Becker, KH; Bergstrom, L; Bertrand, D; Bierenbaum, D; Biron, A; Booth, J; Botner, O; Bouchta, A; Boyce, MM; Carius, S; Chen, A; Chirkin, D; Conrad, J; Cooley, J; Costa, CGS; Cowen, DF; Dailing, J; Dalberg, E; DeYoung, T; Desiati, P; Dewulf, JP; Doksus, P; Edsjo, J; Ekstrom, P; Erlandsson, B; Feser, T; Gaug, M; Goldschmidt, A; Goobar, A; Gray, L; Haase, H; Hallgren, A; Halzen, F; Hanson, K; Hardtke, R; He, YD; Hellwig, M; Heukenkamp, H; Hill, GC; Hulth, PO; Hundertmark, S; Jacobsen, J; Kandhadai, V; Karle, A; Kim, J; Koci, B; Kopke, L; Kowalski, M; Leich, H; Leuthold, M; Lindal, P; Liubarsky, I; Loaiza, P; Lowder, DM; Ludvig, J; Madsen, J; Marciniewski, P; Matis, HS; Mihalyi, A; Mikolajski, T; Miller, TC; Minaeva, Y; Miocinovic, P; Mock, PC; Morse, R; Neunhoffer, T; Newcomer, FM; Niessen, P; Nygren, DR; Ogelman, H; de los Heros, CP; Porrata, R; Price, PB; Rawlins, K; Reed, C; Rhode, W; Richards, A; Richter, S; Martino, JR; Romenesko, P; Ross, D; Rubinstein, H; Sander, HG; Scheider, T; Schmidt, T; Schneider, D; Schneider, E; Schwarz, R; Silvestri, A; Solarz, M; Spiczak, GM; Spiering, C; Starinsky, N; Steele, D; Steffen, P; Stokstad, RG; Usechak, N; Vander Donckt, M; Walck, C; Weinheimer, C; Wiebusch, CH; Wischnewski, R; Wissing, H; Woschnagg, K; Wu, W; Yodh, G; Young, S				Andres, E; Askebjer, P; Bai, X; Barouch, G; Barwick, SW; Bay, TC; Becker, KH; Bergstrom, L; Bertrand, D; Bierenbaum, D; Biron, A; Booth, J; Botner, O; Bouchta, A; Boyce, MM; Carius, S; Chen, A; Chirkin, D; Conrad, J; Cooley, J; Costa, CGS; Cowen, DF; Dailing, J; Dalberg, E; DeYoung, T; Desiati, P; Dewulf, JP; Doksus, P; Edsjo, J; Ekstrom, P; Erlandsson, B; Feser, T; Gaug, M; Goldschmidt, A; Goobar, A; Gray, L; Haase, H; Hallgren, A; Halzen, F; Hanson, K; Hardtke, R; He, YD; Hellwig, M; Heukenkamp, H; Hill, GC; Hulth, PO; Hundertmark, S; Jacobsen, J; Kandhadai, V; Karle, A; Kim, J; Koci, B; Kopke, L; Kowalski, M; Leich, H; Leuthold, M; Lindal, P; Liubarsky, I; Loaiza, P; Lowder, DM; Ludvig, J; Madsen, J; Marciniewski, P; Matis, HS; Mihalyi, A; Mikolajski, T; Miller, TC; Minaeva, Y; Miocinovic, P; Mock, PC; Morse, R; Neunhoffer, T; Newcomer, FM; Niessen, P; Nygren, DR; Ogelman, H; de los Heros, CP; Porrata, R; Price, PB; Rawlins, K; Reed, C; Rhode, W; Richards, A; Richter, S; Martino, JR; Romenesko, P; Ross, D; Rubinstein, H; Sander, HG; Scheider, T; Schmidt, T; Schneider, D; Schneider, E; Schwarz, R; Silvestri, A; Solarz, M; Spiczak, GM; Spiering, C; Starinsky, N; Steele, D; Steffen, P; Stokstad, RG; Usechak, N; Vander Donckt, M; Walck, C; Weinheimer, C; Wiebusch, CH; Wischnewski, R; Wissing, H; Woschnagg, K; Wu, W; Yodh, G; Young, S			Observation of high-energy neutrinos using Cerenkov detectors embedded deep in Antarctic ice	NATURE			English	Article							ASTRONOMY; MUONS; FLUX	Neutrinos are elementary particles that carry no electric charge and have little mass. As they interact only weakly with other particles, they can penetrate enormous amounts of matter, and therefore have the potential to directly convey astrophysical information from the edge of the Universe and from deep inside the most cataclysmic high-energy regions(1). The neutrino's great penetrating power, however, also makes this particle difficult to detect. Underground detectors have observed low-energy neutrinos from the Sun and a nearby supernova(2), as well as neutrinos generated in the Earth's atmosphere. But the very low fluxes of high-energy neutrinos from cosmic sources can be observed only by much larger, expandable detectors in, for example, deep water(3,4) or ice(5). Here we report the detection of upwardly propagating atmospheric neutrinos by the ice-based Antarctic muon and neutrino detector array (AMANDA). These results establish a technology with which to build a kilometre-scale neutrino observatory necessary for astrophysical observations(1).	Univ Wisconsin, Dept Phys, Madison, WI 53706 USA; Univ Stockholm, Fysikum, S-11385 Stockholm, Sweden; Univ Delaware, Bartol Res Inst, Newark, DE 19716 USA; Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Berg Univ Gesamthsch Wuppertal, Fachbereich Phys 8, D-42097 Wuppertal, Germany; Free Univ Brussels, Fac Sci, B-1050 Brussels, Belgium; DESY Zeuthen, D-15735 Zeuthen, Germany; Univ Uppsala, Dept Radiat Sci, S-75121 Uppsala, Sweden; Kalmar Univ, Dept Technol, S-39129 Kalmar, Sweden; Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; Univ Mainz, Inst Phys, D-55099 Mainz, Germany; Univ Calif Berkeley, Lawrence Berkeley Lab, Inst Nucl & Particle Astrophys, Berkeley, CA 94720 USA	University of Wisconsin System; University of Wisconsin Madison; Stockholm University; University of Delaware; University of California System; University of California Irvine; University of California System; University of California Berkeley; University of Wuppertal; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Uppsala University; Linnaeus University; University of Kalmar; University of Pennsylvania; Johannes Gutenberg University of Mainz; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Halzen, F (corresponding author), Univ Wisconsin, Dept Phys, 1150 Univ Ave, Madison, WI 53706 USA.		Hallgren, Allan/A-8963-2013; Gaug, Markus/L-2340-2014; Hundertmark, Stephan/A-6592-2010; Botner, Olga/A-9110-2013; Matis, Howard/AAO-2082-2021; Wiebusch, Christopher H.V./G-6490-2012; Kowalski, Marek/G-5546-2012; DeYoung, Tyce/O-6895-2019; Diaz Velez, Juan Carlos/T-2788-2018	Gaug, Markus/0000-0001-8442-7877; Wiebusch, Christopher H.V./0000-0002-6418-3008; Kowalski, Marek/0000-0001-8594-8666; DeYoung, Tyce/0000-0003-4873-3783; Perez de los Heros, Carlos/0000-0002-2084-5866; Cooley, Jodi/0000-0001-6761-2042; Spiczak, Glenn/0000-0002-0030-0519; Taboada, Ignacio/0000-0003-3509-3457; Hill, Gary/0000-0001-8881-6802; Loaiza, Pia/0000-0003-3957-3204; Diaz Velez, Juan Carlos/0000-0002-0087-0693				Andres E, 2000, ASTROPART PHYS, V13, P1, DOI 10.1016/S0927-6505(99)00092-4; ASKJEBER P, 1995, SCIENCE, V267, P1147; Balkanov VA, 2000, ASTROPART PHYS, V14, P61, DOI 10.1016/S0927-6505(00)00110-9; BAY R, 1999, P 26 INT COSM RAY C, V2, P225; DALBERG E, 1999, P 26 INT COSM RAY C, V2, P348; Fukuda Y, 1999, PHYS REV LETT, V82, P2644, DOI 10.1103/PhysRevLett.82.2644; Gaisser T. K., 1995, Physics Reports, V258, P173, DOI 10.1016/0370-1573(95)00003-Y; Learned JG, 2000, ANNU REV NUCL PART S, V50, P679, DOI 10.1146/annurev.nucl.50.1.679; LOWDER DM, 1991, NATURE, V353, P331, DOI 10.1038/353331a0; Mannheim K, 2001, PHYS REV D, V63, DOI 10.1103/PhysRevD.63.023003; NELLEN L, 1993, PHYS REV D, V47, P5270, DOI 10.1103/PhysRevD.47.5270; NIESSEN P, 1999, P 26 INT COSM RAY C, V2, P344; Price PB, 1997, APPL OPTICS, V36, P1965, DOI 10.1364/AO.36.001965; ROBERTS A, 1992, REV MOD PHYS, V64, P259, DOI 10.1103/RevModPhys.64.259; Stecker FW, 1996, SPACE SCI REV, V75, P341; Szabo AP, 1994, ASTROPART PHYS, V2, P375, DOI 10.1016/0927-6505(94)90027-2; TOTSUKA Y, 1992, REP PROG PHYS, V55, P377, DOI 10.1088/0034-4885/55/3/002; WAXMAN E, 1999, PHYS REV D, V59; WAXMAN E, 1997, PHYS REV LETT, V78, P2992; WISCHNEWSKI R, 1999, P 26 INT COSM RAY C, V2, P229	20	161	163	0	13	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					441	443		10.1038/35068509	http://dx.doi.org/10.1038/35068509			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260705				2022-12-28	WOS:000167583800033
J	Cazeau, S; Leclercq, C; Lavergne, T; Walker, S; Varma, C; Linde, C; Garrigue, S; Kappenberger, L; Haywood, GA; Santini, M; Bailleul, C; Daubert, JC				Cazeau, S; Leclercq, C; Lavergne, T; Walker, S; Varma, C; Linde, C; Garrigue, S; Kappenberger, L; Haywood, GA; Santini, M; Bailleul, C; Daubert, JC		Multisite Stimulation Cardiomyopat	Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; BUNDLE-BRANCH-BLOCK; 6-MINUTE WALK TEST; PEAK OXYGEN-UPTAKE; DILATED CARDIOMYOPATHY; ATRIOVENTRICULAR DELAY; AMBULATORY PATIENTS; EXERCISE CAPACITY; SURVIVAL; CHAMBER	Background: One third of patients with chronic heart failure have electrocardiographic evidence of a major intraventricular conduction delay, which may worsen left ventricular systolic dysfunction through asynchronous ventricular contraction. Uncontrolled studies suggest that multisite biventricular pacing improves hemodynamics and well-being by reducing ventricular asynchrony. We assessed the clinical efficacy and safety of this new therapy. Methods: Sixty-seven patients with severe heart failure (New York Heart Association class III) due to chronic left ventricular systolic dysfunction, with normal sinus rhythm and a duration of the QRS interval of more than 150 msec, received transvenous atriobiventricular pacemakers (with leads in one atrium and each ventricle). This single-blind, randomized, controlled crossover study compared the responses of the patients during two periods: a three-month period of inactive pacing (ventricular inhibited pacing at a basic rate of 40 bpm) and a three-month period of active (atriobiventricular) pacing. The primary end point was the distance walked in six minutes; the secondary end points were the quality of life as measured by questionnaire, peak oxygen consumption, hospitalizations related to heart failure, the patients' treatment preference (active vs. inactive pacing), and the mortality rate. Results: Nine patients were withdrawn from the study before randomization, and 10 failed to complete both study periods. Thus, 48 patients completed both phases of the study. The mean (+/-SD) distance walked in six minutes was 23 percent greater with active pacing (399+/-100 m vs. 326+/-134 m, P<0.001), the quality-of-life score improved by 32 percent (P<0.001), peak oxygen uptake increased by 8 percent (P<0.03), hospitalizations were decreased by two thirds (P<0.05), and active pacing was preferred by 85 percent of the patients (P<0.001). Conclusions: Although it is technically complex, atriobiventricular pacing significantly improves exercise tolerance and quality of life in patients with chronic heart failure and intraventricular conduction delay. (N Engl J Med 2001;344:873-80.) Copyright (C) 2001 Massachusetts Medical Society.	CHU, Hop Pontchaillou, Ctr Cardiopneumol, Dept Cardiol & Malad Vasc, F-35033 Rennes, France; InParys, St Cloud, France; Hop Broussais, F-75674 Paris, France; Harefield Hosp, Harefield UB9 6JH, Middx, England; Univ London St Georges Hosp, London, England; Karolinska Hosp, S-10401 Stockholm, Sweden; Hop Cardiol Haut Leveque, Bordeaux, France; CHU Vaudois, CH-1011 Lausanne, Switzerland; Derriford Hosp, Plymouth PL6 8DH, Devon, England; Osped San Filippo Neri, Rome, Italy; ELA Rech, Le Plessis Robinson, France	CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; St Georges University London; Karolinska Institutet; Karolinska University Hospital; CHU Bordeaux; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Derriford Hospital; San Filippo Neri Hospital	Daubert, JC (corresponding author), CHU, Hop Pontchaillou, Ctr Cardiopneumol, Dept Cardiol & Malad Vasc, F-35033 Rennes, France.	jean-claude.daubert@CHU-rennes.fr		LInde, Cecilia/0000-0002-9039-6023				Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; Alonso C, 1999, AM J CARDIOL, V84, P1417, DOI 10.1016/S0002-9149(99)00588-3; Auricchio A, 1999, CIRCULATION, V99, P2993, DOI 10.1161/01.CIR.99.23.2993; Auricchio A, 1999, AM J CARDIOL, V83, p136D; Blanc JJ, 1997, CIRCULATION, V96, P3273; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Cahalin LP, 1996, CHEST, V110, P325, DOI 10.1378/chest.110.2.325; CAZEAU S, 1994, PACE, V17, P1974, DOI 10.1111/j.1540-8159.1994.tb03783.x; Cazeau S, 1996, PACE, V19, P1748, DOI 10.1111/j.1540-8159.1996.tb03218.x; Cleland JGF, 1998, LANCET, V352, P19; Daubert JC, 1999, EUR J HEART FAIL, V1, P281, DOI 10.1016/S1388-9842(99)00042-2; Daubert JC, 1998, PACE, V21, P239, DOI 10.1111/j.1540-8159.1998.tb01096.x; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; FOSTER AH, 1995, ANN THORAC SURG, V59, P294, DOI 10.1016/0003-4975(94)00878-B; GOLD MR, 1995, J AM COLL CARDIOL, V26, P967, DOI 10.1016/0735-1097(95)00292-0; Goldstein DJ, 1998, NEW ENGL J MED, V339, P1522, DOI 10.1056/NEJM199811193392107; Gras D, 1998, PACE, V21, P2249, DOI 10.1111/j.1540-8159.1998.tb01162.x; Gregoratos G, 1998, J AM COLL CARDIOL, V31, P1175; GRINES CL, 1989, CIRCULATION, V79, P845, DOI 10.1161/01.CIR.79.4.845; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Kass DA, 1999, CIRCULATION, V99, P1567, DOI 10.1161/01.CIR.99.12.1567; Kindermann M, 1997, PACE, V20, P2453, DOI 10.1111/j.1540-8159.1997.tb06085.x; Leclercq C, 1998, J AM COLL CARDIOL, V32, P1825, DOI 10.1016/S0735-1097(98)00492-6; LINDE C, 1995, AM J CARDIOL, V75, P919, DOI 10.1016/S0002-9149(99)80687-0; LIPKIN DP, 1986, BRIT MED J, V292, P653, DOI 10.1136/bmj.292.6521.653; MANCINI DM, 1991, CIRCULATION, V83, P778, DOI 10.1161/01.CIR.83.3.778; Narang R, 1996, EUR HEART J, V17, P120; Nelson GS, 2000, CIRCULATION, V101, P2703, DOI 10.1161/01.CIR.101.23.2703; NISHIMURA RA, 1995, J AM COLL CARDIOL, V25, P281, DOI 10.1016/0735-1097(94)00419-Q; Opasich C, 1998, AM J CARDIOL, V81, P1497, DOI 10.1016/S0002-9149(98)00218-5; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; RECTOR TS, 1993, AM J CARDIOL, V71, P1106, DOI 10.1016/0002-9149(93)90582-W; Rector TS, 1987, HEART FAIL, V3, P198; Shamim W, 1999, INT J CARDIOL, V70, P171, DOI 10.1016/S0167-5273(99)00077-7; STEVENSON WG, 1995, J AM COLL CARDIOL, V26, P1417, DOI 10.1016/0735-1097(95)00341-X; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; WEBER KT, 1982, CIRCULATION, V65, P1213, DOI 10.1161/01.CIR.65.6.1213; WILENSKY RL, 1988, AM J CARDIOL, V62, P276, DOI 10.1016/0002-9149(88)90225-1; XIAO HB, 1991, BRIT HEART J, V66, P443; XIAO HB, 1992, BRIT HEART J, V68, P403; Zugck C, 2000, EUR HEART J, V21, P540, DOI 10.1053/euhj.1999.1861	43	2010	2123	1	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2001	344	12					873	880		10.1056/NEJM200103223441202	http://dx.doi.org/10.1056/NEJM200103223441202			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412PN	11259720				2022-12-28	WOS:000167563700002
J	Sauvage, JP				Sauvage, JP			Chemistry - A light-driven linear motor at the molecular level	SCIENCE			English	Editorial Material							MOTION		Univ Strasbourg, Inst Le Bel, F-67070 Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sauvage, JP (corresponding author), Univ Strasbourg, Inst Le Bel, F-67070 Strasbourg, France.	sauvage@chimie.u-strasbg.fr						BALLARDINI R, 1993, ANGEW CHEM INT EDIT, V32, P1301, DOI 10.1002/anie.199313011; Balzani V, 2000, ANGEW CHEM INT EDIT, V39, P3348, DOI 10.1002/1521-3773(20001002)39:19<3348::AID-ANIE3348>3.0.CO;2-X; BISSELL RA, 1994, NATURE, V369, P133, DOI 10.1038/369133a0; Boyer PD, 1998, ANGEW CHEM INT EDIT, V37, P2297, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2296::AID-ANIE2296>3.0.CO;2-W; Brouwer AM, 2001, SCIENCE, V291, P2124, DOI 10.1126/science.1057886; Collier CP, 2000, SCIENCE, V289, P1172, DOI 10.1126/science.289.5482.1172; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Kelly TR, 1999, NATURE, V401, P150, DOI 10.1038/43639; Koumura N, 1999, NATURE, V401, P152, DOI 10.1038/43646; LIVOREIL A, 1994, J AM CHEM SOC, V116, P9399, DOI 10.1021/ja00099a095; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; Sauvage, 1999, MOL CATENANES ROTAXA; Schill G., 1971, CATENANES ROTAXANES	13	37	38	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2001	291	5511					2105	2106		10.1126/science.1059590	http://dx.doi.org/10.1126/science.1059590			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11256410				2022-12-28	WOS:000167563800026
J	Andersson, RE; Olaison, G; Tysk, C; Ekbom, A				Andersson, RE; Olaison, G; Tysk, C; Ekbom, A			Appendectomy and protection against ulcerative colitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLAMMATORY BOWEL-DISEASE; ACUTE APPENDICITIS; TONSILLECTOMY; EPIDEMIOLOGY; SMOKING; HYGIENE; SWEDEN; RISK	Background: A history of appendectomy is rare in patients with ulcerative colitis. This suggests a protective effect of appendectomy or that appendicitis and ulcerative colitis are alternative inflammatory responses. We sought to characterize this inverse relation further. Methods: We studied a cohort of 212,963 patients who underwent appendectomy before the age of 50 years between 1964 and 1993 and a cohort of matched controls who were identified from the Swedish Inpatient Register and the nationwide census. The cohort was followed until 1995 for any subsequent diagnosis of ulcerative colitis. Results: Patients who underwent appendectomy for appendicitis and mesenteric lymphadenitis had a low risk of ulcerative colitis (for patients with perforated appendicitis, the adjusted hazard ratio was 0.58 [95 percent confidence interval, 0.38 to 0.87]; for those with nonperforated appendicitis it was 0.76 [95 percent confidence interval, 0.65 to 0.90]; and for those with mesenteric lymphadenitis it was 0.57 [95 percent confidence interval, 0.36 to 0.89]). In contrast, patients who underwent appendectomy for nonspecific abdominal pain had the same risk of ulcerative colitis as the controls (adjusted hazard ratio, 1.06; 95 percent confidence interval, 0.74 to 1.52). For the patients who had appendicitis, an inverse relation with the risk of ulcerative colitis was found only for those who underwent surgery before the age of 20 years (P<0.001). Conclusions: Appendectomy for an inflammatory condition (appendicitis or lymphadenitis) but not for nonspecific abdominal pain is associated with a low risk of subsequent ulcerative colitis. This inverse relation is limited to patients who undergo surgery before the age of 20 years. (N Engl J Med 2001;344:808-14.) Copyright (C) 2001 Massachusetts Medical Society.	Linkoping Univ Hosp, Div Surg, S-58185 Linkoping, Sweden; Cty Hosp Ryhov, Dept Surg, Jonkoping, Sweden; Orebro Med Ctr Hosp, Dept Gastroenterol, S-70185 Orebro, Sweden; Karolinska Inst, Dept Med Epidemiol, Stockholm, Sweden; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Linkoping University; Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health	Andersson, RE (corresponding author), Ryhov Hosp, Dept Surg, S-55185 Jonkoping, Sweden.		Lowenfels, Albert/ABD-8388-2021; Maisonneuve, Patrick/U-9789-2018	Maisonneuve, Patrick/0000-0002-5309-4704; Andersson, Roland/0000-0002-1460-0248				ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; ANDERSSON R, 1994, BRIT MED J, V308, P107, DOI 10.1136/bmj.308.6921.107; ARNBJORNSSON E, 1982, ACTA CHIR SCAND, V148, P461; Breslin NP, 1997, INFLAMM BOWEL DIS, V3, P1, DOI 10.1002/ibd.3780030102; Butland BK, 1999, LANCET, V353, P1712, DOI 10.1016/S0140-6736(05)77025-2; Dasso JF, 1997, CELL IMMUNOL, V182, P29, DOI 10.1006/cimm.1997.1216; Derby LE, 1998, EPIDEMIOLOGY, V9, P205, DOI 10.1097/00001648-199803000-00018; Dijkstra B, 1999, DIS COLON RECTUM, V42, P334, DOI 10.1007/BF02236349; Duggan AE, 1998, GUT, V43, P494, DOI 10.1136/gut.43.4.494; EKBOM A, 1991, GASTROENTEROLOGY, V100, P350, DOI 10.1016/0016-5085(91)90202-V; GENT AE, 1994, LANCET, V343, P766, DOI 10.1016/S0140-6736(94)91841-4; Koutroubakis IE, 2000, AM J GASTROENTEROL, V95, P171; MCCAHY P, 1994, ANN ROY COLL SURG, V76, P282; *MED, 1964, KLASS SJUKD SJATT UP; Minocha A, 1997, DIGEST DIS SCI, V42, P1567, DOI 10.1023/A:1018847617560; Mizoguchi A, 1996, J EXP MED, V184, P707, DOI 10.1084/jem.184.2.707; Montgomery SM, 1999, LANCET, V353, P379, DOI 10.1016/S0140-6736(05)74951-5; Parrello T, 1997, ITAL J GASTROENTEROL, V29, P208; PENNY WJ, 1985, SOC SCI MED, V21, P287, DOI 10.1016/0277-9536(85)90103-0; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P166; Russel MG, 1997, GASTROENTEROLOGY, V113, P377, DOI 10.1053/gast.1997.v113.pm9247453; RUTGEERTS P, 1994, GASTROENTEROLOGY, V106, P1251, DOI 10.1016/0016-5085(94)90016-7; Schattner A, 1999, LANCET, V353, P674, DOI 10.1016/S0140-6736(05)75471-4; SMITHSON JE, 1995, J CLIN GASTROENTEROL, V21, P283, DOI 10.1097/00004836-199512000-00006; *SOC, 1986, KLASS SJUKD 1987; *SOC, 1984, KLASS OP; Socialstyrelsen, 1968, KLASS SJUKD 1968; TYSK C, 1992, SCAND J GASTROENTERO, V27, P945, DOI 10.3109/00365529209000168	28	288	296	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2001	344	11					808	814		10.1056/NEJM200103153441104	http://dx.doi.org/10.1056/NEJM200103153441104			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410LA	11248156				2022-12-28	WOS:000167440400004
J	Beerling, DJ; Osborne, CP; Chaloner, WG				Beerling, DJ; Osborne, CP; Chaloner, WG			Evolution of leaf-form in land plants linked to atmospheric CO2 decline in the Late Palaeozoic era	NATURE			English	Article							STOMATAL DENSITY; LEAVES; MODEL	The widespread appearance of megaphyll leaves, with their branched veins and planate form, did not occur until the close of the Devonian period at about 360 Myr ago. This happened about 40 Myr after simple leafless vascular plants first colonized the land in the Late Silurian/Early Devonian(1,2), but the reason for the slow emergence of this common feature of present-day plants is presently unresolved. Here we show, in a series of quantitative analyses using fossil leaf characters and biophysical principles, that the delay was causally linked with a 90% drop in atmospheric pCO(2) during the Late Palaeozoic era(3,4). In contrast to simulations for a typical Early Devonian land plant, possessing few stomata(5) on leafless stems, those for a planate leaf with the same stomatal characteristics indicate that it would have suffered lethal overheating, because of greater interception of solar energy and low transpiration. When planate leaves first appeared in the Late Devonian and subsequently diversified in the Carboniferous period, they possessed substantially higher stomatal densities(6). This observation is consistent with the effects of the pCO(2) on stomatal development(7) and suggests that the evolution of planate leaves could only have occurred after an increase in stomatal density, allowing higher transpiration rates that were sufficient to maintain cool and viable leaf temperatures.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ London, Royal Holloway & Bedford New Coll, Dept Geol, Egham TW20 0EK, Surrey, England	University of Sheffield; University of London; Royal Holloway University London	Beerling, DJ (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.		Beerling, David J/C-2840-2009	Beerling, David J/0000-0003-1869-4314				Algeo TJ, 1998, PHILOS T R SOC B, V353, P113, DOI 10.1098/rstb.1998.0195; Beerling DJ, 1997, BOT J LINN SOC, V124, P137, DOI 10.1006/bojl.1997.0098; Beerling DJ, 1998, PHILOS T R SOC B, V353, P131, DOI 10.1098/rstb.1998.0196; BEERLING DJ, 1993, BIOL J LINN SOC, V48, P343, DOI 10.1111/j.1095-8312.1993.tb02096.x; BEERLING DJ, 1995, GLOB CHANGE BIOL, V1, P289, DOI 10.1111/j.1365-2486.1995.tb00027.x; BERNER RA, 1994, AM J SCI, V294, P56, DOI 10.2475/ajs.294.1.56; Berner RA, 2000, SCIENCE, V287, P1630, DOI 10.1126/science.287.5458.1630; BOWES G, 1993, ANNU REV PLANT PHYS, V44, P309, DOI 10.1146/annurev.pp.44.060193.001521; Chaloner W.G., 1979, SPEC PAP PALAEONTOL, V23, P145; CHALONER WG, 1991, POLLEN SPORES PATTER, P151; Edwards D, 1998, PHILOS T ROY SOC B, V353, P141, DOI 10.1098/rstb.1998.0197; EDWARDS D, 1993, J EXP BOT, V49, P309; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Gensel P. G., 1984, PLANT LIFE DEVONIAN; GENSEL PG, 1984, NATURE, V309, P785, DOI 10.1038/309785a0; Hao S.-G., 1993, PALEONTOTGR ABT B, V230, P27; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; KNOLL AH, 1984, PALEOBIOLOGY, V10, P34, DOI 10.1017/S0094837300008009; Larcher W., 1994, ECOPHYSIOLOGY PHOTOS, P261; Martinelli LA, 1998, OECOLOGIA, V114, P170, DOI 10.1007/s004420050433; MCELWAIN JC, 1995, ANN BOT-LONDON, V76, P389, DOI 10.1006/anbo.1995.1112; Mora CI, 1996, SCIENCE, V271, P1105, DOI 10.1126/science.271.5252.1105; NIKLAS KJ, 1988, EVOLUTION, V42, P1, DOI 10.1111/j.1558-5646.1988.tb04103.x; NOVEL PS, 1991, PHYSICOCHEMICAL ENV; SCHULTE PJ, 1987, AM J BOT, V74, P1438, DOI 10.2307/2444320; VALDES PJ, 1998, PALAEOCLIMATES, V2, P219; VANCAEMMERER S, 1981, PLANTA, V153, P376; WOODWARD FI, 1987, NATURE, V327, P617, DOI 10.1038/327617a0; ZIMMERMANN W, 1979, PHYLOGENIE PFLANZEN	30	158	168	2	117	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					352	354		10.1038/35066546	http://dx.doi.org/10.1038/35066546			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268207	Green Accepted			2022-12-28	WOS:000167464100045
J	Dominy, NJ; Lucas, PW				Dominy, NJ; Lucas, PW			Ecological importance of trichromatic vision to primates	NATURE			English	Article							COLOR-VISION; TROPICAL FOREST; FRUIT; CHIMPANZEES; HERBIVORY; COMMUNITY; EVOLUTION; SELECTION; FRUGIVORY; MONKEYS	Trichromatic colour vision, characterized by three retinal photopigments tuned to peak wavelengths of similar to 430 nm, similar to 535 nm and similar to 562 nm (refs 1, 2), has evolved convergently in catarrhine primates and one genus of New World monkey, the howlers (genus Alouatta)(3). This uniform capacity to discriminate red- green colours, which is not found in other mammals, has been proposed as advantageous for the long-range detection of either ripe fruits(4,5) or young leaves(6) (which frequently flush red in the tropics(7)) against a background of mature foliage(8,9). Here we show that four trichromatic primate species in Kibale Forest, Uganda, eat leaves that are colour discriminated only by red-greenness, a colour axis correlated with high protein levels and low toughness. Despite their divergent digestive systems, these primates have no significant interspecific differences in leaf colour selection. In contrast, eaten fruits were generally discriminated from mature leaves on both red-green and yellow-blue channels and also by their luminance, with a significant difference between chimpanzees and monkeys in fruit colour choice. Our results implicate leaf consumption, a critical food resource when fruit is scarce(10), as having unique value in maintaining trichromacy in catarrhines.	Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Dominy, NJ (corresponding author), Univ Hong Kong, Dept Anat, 5 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.		Dominy, Nathaniel Jay/A-6151-2013	Dominy, Nathaniel Jay/0000-0001-5916-418X				ALLEN G, 1979, COLOUR SENSE ITS ORI; CHAPMAN CA, 1999, PRIMATE COMMUNITIES, P237; Clutton-Brock TH., 1977, PRIMATE ECOLOGY, P539; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Coley Phyllis D., 1996, P305; Darvell BW, 1996, MEAS SCI TECHNOL, V7, P954, DOI 10.1088/0957-0233/7/6/016; DAVIES AG, 1994, COLOBINE MONKEYS, P229; FISCHER KE, 1993, OIKOS, V66, P472, DOI 10.2307/3544942; GARTLAN JS, 1980, BIOCHEM SYST ECOL, V8, P401, DOI 10.1016/0305-1978(80)90044-7; GAUTIERHION A, 1985, OECOLOGIA, V65, P324, DOI 10.1007/BF00378906; Jacobs GH, 1999, P ROY SOC B-BIOL SCI, V266, P2023, DOI 10.1098/rspb.1999.0881; JUNIPER B, 1993, INT DENDROL SOC YB, P49; Kainz PM, 1998, VISION RES, V38, P3315, DOI 10.1016/S0042-6989(98)00078-9; Korine C, 2000, OECOLOGIA, V123, P560, DOI 10.1007/PL00008861; LEIGHTON M, 1993, INT J PRIMATOL, V14, P257, DOI 10.1007/BF02192635; Li Wen-Hsiung, 2000, P259; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; Lucas PW, 1998, FOLIA PRIMATOL, V69, P139, DOI 10.1159/000021576; Lucas PW, 2001, FOLIA PRIMATOL, V72, P11, DOI 10.1159/000049914; Newton-Fisher NE, 1999, AFR J ECOL, V37, P344, DOI 10.1046/j.1365-2028.1999.00186.x; Onishi A, 1999, NATURE, V402, P139, DOI 10.1038/45966; OPLER PA, 1980, J ECOL, V68, P167, DOI 10.2307/2259250; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Regan BC, 1998, VISION RES, V38, P3321, DOI 10.1016/S0042-6989(97)00462-8; STRUHSAKER T. T., 1997, ECOLOGY AFRICAN RAIN; Sumner P, 2000, J EXP BIOL, V203, P1987; Sumner P, 2000, J EXP BIOL, V203, P1963; Terborgh J., 1987, P205; Terborgh J, 1983, 5 NEW WORLD PRIMATES; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257	30	298	302	4	150	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					363	366		10.1038/35066567	http://dx.doi.org/10.1038/35066567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268211				2022-12-28	WOS:000167464100049
J	Hasan, S; Hassa, PO; Imhof, R; Hottiger, MO				Hasan, S; Hassa, PO; Imhof, R; Hottiger, MO			Transcription coactivator p300 binds PCNA and may have a role in DNA repair synthesis	NATURE			English	Article							NUCLEOTIDE EXCISION-REPAIR; CELL NUCLEAR ANTIGEN; NF-KAPPA-B; POLYMERASE-DELTA; MOUSE FIBROBLASTS; EUKARYOTIC CELLS; GROWTH-FACTORS; CALF THYMUS; PROTEIN; REPLICATION	The transcriptional coactivator p300 interacts with many transcription factors that participate in a broad spectrum of biological activities, such as cellular differentiation, homeostasis and growth control(1,2). Mouse embryos lacking both p300 alleles die around mid-gestation, with pleiotropic defects in morphogenesis, in cell differentiation and, unexpectedly, in cell proliferation because of reduced DNA synthesis(3). Here we show that p300 may have a role in DNA repair synthesis through its interaction with proliferating cell nuclear antigen (PCNA). We show that in vitro and in vivo p300 forms a complex with PCNA that does not depend on the S phase of cell cycle. A large fraction of both p300 and PCNA colocalize to speckled structures in the nucleus. Furthermore, the endogenous p300-PCNA complex stimulates DNA synthesis in vitro. Chromatin immunoprecipitation experiments indicate that p300 is associated with freshly synthesized DNA after ultraviolet irradiation. Our results suggest that p300 may participate in chromatin remodelling at DNA lesion sites to facilitate PCNA function in DNA repair synthesis.	Univ Zurich, Inst Vet Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Hottiger, MO (corresponding author), Univ Zurich, Inst Vet Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	hottiger@vetbio.unizh.ch	Hottiger, Michael O./J-7747-2013	Hottiger, Michael O./0000-0002-7323-2270				ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; BALDWIN AS, 1991, MOL CELL BIOL, V11, P4943, DOI 10.1128/MCB.11.10.4943; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Cleaver JE, 1997, BIOCHEM J, V328, P1, DOI 10.1042/bj3280001; COVERLEY D, 1992, NUCLEIC ACIDS RES, V20, P3873, DOI 10.1093/nar/20.15.3873; Dallas PB, 1998, MOL CELL BIOL, V18, P3596, DOI 10.1128/MCB.18.6.3596; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DRESLER SL, 1986, NUCLEIC ACIDS RES, V14, P7093, DOI 10.1093/nar/14.17.7093; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Guzder SN, 1997, J BIOL CHEM, V272, P21665, DOI 10.1074/jbc.272.35.21665; HUNTING DJ, 1991, BIOCHEM CELL BIOL, V69, P303, DOI 10.1139/o91-046; Jonsson ZO, 1997, BIOESSAYS, V19, P967, DOI 10.1002/bies.950191106; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; NICHOLS AF, 1992, NUCLEIC ACIDS RES, V20, P2441, DOI 10.1093/nar/20.10.2441; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pao GM, 2000, P NATL ACAD SCI USA, V97, P1020, DOI 10.1073/pnas.97.3.1020; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; PODUST VN, 1993, NUCLEIC ACIDS RES, V21, P841, DOI 10.1093/nar/21.4.841; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SHIVJI MKK, 1992, CELL, V69, P367, DOI 10.1016/0092-8674(92)90416-A; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WEISER T, 1991, J BIOL CHEM, V266, P10420; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	29	144	151	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2001	410	6826					387	391		10.1038/35066610	http://dx.doi.org/10.1038/35066610			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268218				2022-12-28	WOS:000167464100056
J	Pfennig, DW; Harcombe, WR; Pfennig, KS				Pfennig, DW; Harcombe, WR; Pfennig, KS			Frequency-dependent batesian mimicry - Predators avoid look-alikes of venomous snakes only when the real thing is around.	NATURE			English	Editorial Material							CORAL		Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ Texas, Sect Integrat Biol, Austin, TX 78712 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Austin	Pfennig, DW (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.							Bates H.W., 1862, T LINN SOC LOND, V23, P495; BRODIE ED, 1993, EVOLUTION, V47, P227, DOI 10.1111/j.1558-5646.1993.tb01212.x; Conant R., 1991, FIELD GUIDE REPTILES; GREENE HW, 1981, SCIENCE, V213, P1207, DOI 10.1126/science.213.4513.1207; King RB, 1997, BIOSCIENCE, V47, P279, DOI 10.2307/1313189; Madhi SA, 2021, SAFETY EFFICACY CHAD, DOI 10.1101/2021.02.10.21251247; Maynard Smith, 1998, EVOL GENET; Palmer W. M., 1995, REPTILES N CAROLINA; SMITH SM, 1975, SCIENCE, V187, P759, DOI 10.1126/science.187.4178.759; Stebbins R. C., 1985, W REPTILES AMPHIBIAN; WALDBAUER GP, 1988, EVOL BIOL, V22, P227; Wallace Alfred Russel, 1870, CONTRIBUTIONS THEORY	12	165	166	4	263	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					323	323		10.1038/35066628	http://dx.doi.org/10.1038/35066628			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268195	Bronze			2022-12-28	WOS:000167464100033
J	Cimbora, DM; Groudine, M				Cimbora, DM; Groudine, M			The control of mammalian DNA replication: A brief history of space and timing	CELL			English	Review							BETA-GLOBIN LOCUS; ORIGIN RECOGNITION COMPLEX; XENOPUS EGG EXTRACT; PREREPLICATION COMPLEXES; CELL-CYCLE; CHROMATIN; HETEROCHROMATIN; LOCALIZATION; ASSOCIATION; ABSENCE		Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Groudine, M (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.							Abdurashidova G, 1998, EMBO J, V17, P2961, DOI 10.1093/emboj/17.10.2961; Aladjem MI, 1998, SCIENCE, V281, P1005, DOI 10.1126/science.281.5379.1005; Bridger JM, 2000, CURR BIOL, V10, P149, DOI 10.1016/S0960-9822(00)00312-2; Cimbora DM, 2000, MOL CELL BIOL, V20, P5581, DOI 10.1128/MCB.20.15.5581-5591.2000; Dimitrova DS, 1998, J CELL SCI, V111, P2989; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Gilbert DM, 1998, CURR OPIN GENET DEV, V8, P194; HEUN P, 2001, IN PRESS J CELL BIOL; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; KREITZ S, 2000, IN PRESS J BIOL CHEM; Lu ZH, 1998, MOL BIOL CELL, V9, P1163, DOI 10.1091/mbc.9.5.1163; Maric C, 1998, CHROMOSOMA, V107, P155, DOI 10.1007/s004120050292; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; MIZHSIMA T, 2000, GENE DEV, V14, P1631; Natale DA, 2000, EMBO J, V19, P2728, DOI 10.1093/emboj/19.11.2728; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Raghuraman MK, 1997, SCIENCE, V276, P806, DOI 10.1126/science.276.5313.806; Schubeler D, 2000, GENE DEV, V14, P940; Stevenson JB, 1999, GENE DEV, V13, P146, DOI 10.1101/gad.13.2.146; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0	21	37	38	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2001	104	5					643	646		10.1016/S0092-8674(01)00260-4	http://dx.doi.org/10.1016/S0092-8674(01)00260-4			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257218	Bronze			2022-12-28	WOS:000167531100004
J	Dickson, BJ				Dickson, BJ			Developmental neuroscience - Moving on	SCIENCE			English	Editorial Material							REPULSIVE AXON GUIDANCE; RECEPTOR; NETRINS; TARGET; SLIT; OUTGROWTH; MIDLINE; CNS		Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	dickson@nt.imp.univie.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X				Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang H, 1999, NATURE, V401, P765, DOI 10.1038/44521; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	20	8	8	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2001	291	5510					1910	1911		10.1126/science.1059938	http://dx.doi.org/10.1126/science.1059938			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11245196				2022-12-28	WOS:000167401600031
J	Mowen, KA; Tang, J; Zhu, W; Schurter, BT; Shuai, K; Herschman, HR; David, M				Mowen, KA; Tang, J; Zhu, W; Schurter, BT; Shuai, K; Herschman, HR; David, M			Arginine methylation of STAT1 modulates IFN alpha/beta-induced transcription	CELL			English	Article							METHYLTHIOADENOSINE PHOSPHORYLASE-DEFICIENCY; FIBROBLAST GROWTH-FACTOR; PROTEIN-TYROSINE KINASE; GAMMA SIGNAL-TRANSDUCTION; PURINE METABOLIC ENZYME; INTERFERON-GAMMA; 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE; CELL-LINES; SUBCELLULAR-LOCALIZATION; N-METHYLTRANSFERASE	Transcriptional induction by interferons requires the tyrosine and serine phosphorylation of STAT transcription factors. The N-terminal region is highly homologous among the STAT proteins and surrounds a completely conserved arginine residue. Here we demonstrate arginine methylation of STAT1 by the protein arginine methyl-transferase PRMT1 as a novel requirement for IFN alpha/beta -induced transcription. Methylthioadenosine, a methyl-transferase inhibitor that accumulates in many transformed cells, inhibits STAT1-mediated IFN responses. This inhibition arises from impaired STAT1-DNA binding due to an increased association of the STAT inhibitor PIAS1 with phosphorylated STAT1 dimers in the absence of arginine methylation. Thus, arginine methylation of STAT1 is an additional posttranslational modification regulating transcription factor function, and alteration of arginine methylation might be responsible for the lack of interferon responsiveness observed in many malignancies.	Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles	David, M (corresponding author), Univ Calif San Diego, Div Biol, Bonner Hall 3138,9500 Gilman Dr, La Jolla, CA 92093 USA.				NATIONAL CANCER INSTITUTE [R01CA080105, T32CA009056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI034567, R01AI043438, U01AI034567, R21AI043438] Funding Source: NIH RePORTER; NCI NIH HHS [CA80105, T32 CA09056] Funding Source: Medline; NIAID NIH HHS [AI34567, AI43438] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; BURGESS WH, 1991, CELL REGUL, V2, P87, DOI 10.1091/mbc.2.2.87; Carson D A, 1988, Adv Exp Med Biol, V250, P179; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Cimato TR, 1997, J CELL BIOL, V138, P1089, DOI 10.1083/jcb.138.5.1089; Clarke S, 1993, CURR OPIN CELL BIOL, V5, P977, DOI 10.1016/0955-0674(93)90080-A; David M, 1996, J BIOL CHEM, V271, P4585; DAVID M, 1995, SCIENCE, V269, P1721, DOI 10.1126/science.7569900; DAVID M, 1995, MOL CELL BIOL, V15, P7050; David M, 1996, J BIOL CHEM, V271, P15862, DOI 10.1074/jbc.271.27.15862; DELLARAGIONE F, 1995, ONCOGENE, V10, P827; DELLARAGIONE F, 1992, BIOCHEM J, V281, P533, DOI 10.1042/bj2810533; DELLARAGIONE F, 1993, ADV EXP MED BIOL, V348, P31; FITCHEN JH, 1986, CANCER RES, V46, P5409; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432; KAMATANI N, 1981, P NATL ACAD SCI-BIOL, V78, P1219, DOI 10.1073/pnas.78.2.1219; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; LAW RE, 1992, MOL CELL BIOL, V12, P103, DOI 10.1128/MCB.12.1.103; Liao JY, 2000, P NATL ACAD SCI USA, V97, P5267, DOI 10.1073/pnas.97.10.5267; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; MAHER PA, 1993, J BIOL CHEM, V268, P4244; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; NAJBAUER J, 1993, J BIOL CHEM, V268, P10501; Nichols RC, 2000, EXP CELL RES, V256, P522, DOI 10.1006/excr.2000.4827; NOBORI T, 1991, CANCER RES, V51, P3193; Nobori T, 1996, P NATL ACAD SCI USA, V93, P6203, DOI 10.1073/pnas.93.12.6203; NOBORI T, 1993, CANCER RES, V53, P1098; Pintucci G, 1996, MOL BIOL CELL, V7, P1249, DOI 10.1091/mbc.7.8.1249; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Shuai K, 1996, MOL CELL BIOL, V16, P4932; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SMAALAND R, 1987, BREAST CANCER RES TR, V9, P53, DOI 10.1007/BF01806694; Strehlow I, 1998, J BIOL CHEM, V273, P28049, DOI 10.1074/jbc.273.43.28049; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; TRAWEEK ST, 1988, BLOOD, V71, P1568; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; WILLIAMSASHMAN HG, 1982, BIOCHEM PHARMACOL, V31, P277, DOI 10.1016/0006-2952(82)90171-X; WILSON KC, 1992, P NATL ACAD SCI USA, V89, P11964, DOI 10.1073/pnas.89.24.11964; Zhang J, 1996, INT J COMP INTEG M, V9, P22, DOI 10.1080/095119296131788	47	384	391	0	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2001	104	5					731	741		10.1016/S0092-8674(02)08085-6	http://dx.doi.org/10.1016/S0092-8674(02)08085-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257227	Bronze			2022-12-28	WOS:000167531100013
J	Visvanathan, R				Visvanathan, R			Is it truly dementia?	LANCET			English	Editorial Material									Queen Elizabeth Hosp, Adelaide, SA, Australia		Visvanathan, R (corresponding author), Queen Elizabeth Hosp, Adelaide, SA, Australia.			Visvanathan, Renuka/0000-0002-1303-9479				Espino DV, 1998, AM FAM PHYSICIAN, V57, P1358; LANDRIGAN PJ, 1994, TXB CLIN OCCUPATIONA, P745; Phan TG, 1998, MED J AUSTRALIA, V169, P644, DOI 10.5694/j.1326-5377.1998.tb123448.x; SARYAN SA, 1994, OCCUPATIONAL MED, P516; Staudinger K, 1998, AM FAM PHYSICIAN, V57, P719	5	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					684	684		10.1016/S0140-6736(00)04133-7	http://dx.doi.org/10.1016/S0140-6736(00)04133-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247553				2022-12-28	WOS:000167282400014
J	Walley, JD; Khan, MA; Newell, JN; Khan, MH				Walley, JD; Khan, MA; Newell, JN; Khan, MH			Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan	LANCET			English	Article							COMMUNITY	Background DOTS is the control strategy for tuberculosis promoted by WHO, Pakistan is currently developing its National Tuberculosis Programme, and requires guidance on types of direct observation of treatment appropriate for the local conditions. We did a randomised trial to assess the effectiveness of different packages for tuberculosis treatment under operational conditions in Pakistan. Methods We enrolled 497 adults with new sputum-positive tuberculosis. 170 were assigned DOTS with direct observation of treatment by health workers; 165 were assigned DOTS with direct observation of treatment by family members; and 162 were assigned self-administered treatment. The trial was done at three sites that provide tuberculosis services strengthened according to WHO guidelines for the purposes of the research, with a standard daily short-course drugs regimen (2 months of isoniazid, rifampicin, pyrazinamide, and ethambutol, followed by 6 months of isoniazid and ethambutol), The main outcome measures were cure. and cure or treatment completion. Analysis was by intention to treat. Findings Within the strengthened tuberculosis services, the health-worker DOTS, family-member DOTS, and self-administered treatment strategies gave very similar outcomes. with cure rates of 64%, 55%, and 62%, respectively, and cure or treatment-completed rates of 67%, 62%. and 65%, respectively. Interpretation None of the three strategies tested was shown to be superior to the others, and direct observation of treatment did not give any additional improvement in cure rates. The effectiveness of direct observation of treatment remains unclear, and further operational research is needed.	Univ Leeds, Nuffield Inst Hlth, Leeds LS2 9PL, W Yorkshire, England; Assoc Social Dev, Islamabad, Pakistan; Natl TB Programme, Rawalpindi, Pakistan	University of Leeds	Walley, JD (corresponding author), Univ Leeds, Nuffield Inst Hlth, Leeds LS2 9PL, W Yorkshire, England.		Walley, John D/AAY-1375-2021	Walley, John D/0000-0001-7290-0989				BARNHOORN F, 1992, SOC SCI MED, V34, P291, DOI 10.1016/0277-9536(92)90271-Q; Chowdhury AMR, 1997, LANCET, V350, P169, DOI 10.1016/S0140-6736(96)11311-8; Chowdhury AMR, 1999, LANCET, V353, P1003, DOI 10.1016/S0140-6736(99)02119-4; Enarson D.A., 2000, MANAGEMENT TUBERCULO; Garner P, 1998, LANCET, V352, P1326, DOI 10.1016/S0140-6736(05)60739-8; Kamolratanakul P, 1999, T ROY SOC TROP MED H, V93, P552, DOI 10.1016/S0035-9203(99)90379-6; Khan A, 2000, SOC SCI MED, V50, P247, DOI 10.1016/S0277-9536(99)00279-8; Liefooghe R, 1995, SOC SCI MED, V41, P1685, DOI 10.1016/0277-9536(95)00129-U; Maher D, 1997, TREATMENT TUBERCULOS; NGAMVITHAYAPONG.J, 1998, GENDER TUBERCULOSIS; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Volmink J, 1997, BMJ-BRIT MED J, V315, P1403, DOI 10.1136/bmj.315.7120.1403; *WHO, 1999, GLOB TUB CONTR WHO R; WILKINSON D, 1994, LANCET, V343, P647, DOI 10.1016/S0140-6736(94)92640-9; Zhao FZ, 1996, LANCET, V347, P358, DOI 10.1016/S0140-6736(96)90537-1; Zwarenstein M, 1998, LANCET, V352, P1340, DOI 10.1016/S0140-6736(98)04022-7; 1999, LANCET, V353, P145	17	175	183	2	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					664	669		10.1016/S0140-6736(00)04129-5	http://dx.doi.org/10.1016/S0140-6736(00)04129-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	407QN	11247549				2022-12-28	WOS:000167282400010
J	Fernandez-Chacon, R; Konigstorfer, A; Gerber, SH; Garcia, J; Matos, MF; Stevens, CF; Brose, N; Rizo, J; Rosenmund, C; Sudhof, TC				Fernandez-Chacon, R; Konigstorfer, A; Gerber, SH; Garcia, J; Matos, MF; Stevens, CF; Brose, N; Rizo, J; Rosenmund, C; Sudhof, TC			Synaptotagmin I functions as a calcium regulator of release probability	NATURE			English	Article							PROTEIN-KINASE-C; TRANSMITTER RELEASE; PHOSPHOLIPID-BINDING; GLUTAMATE RELEASE; C-2 DOMAIN; SENSOR; ASSOCIATION; SENSITIVITY; 1ST	In all synapses, Ca2+ triggers neurotransmitter release to initiate signal transmission. Ca2+ presumably acts by activating synaptic Ca2+ sensors, but the nature of these sensors-which are the gatekeepers to neurotransmission-remains unclear. One of the candidate Ca2+ sensors in release is the synaptic Ca2+-binding protein synaptotagmin I. Here we have studied a point mutation in synaptotagmin I that causes a twofold decrease in overall Ca2+ affinity without inducing structural or conformational changes. When introduced by homologous recombination into the endogenous synaptotagmin I gene in mice, this point mutation decreases the Ca2+ sensitivity of neurotransmitter release twofold, but does not alter spontaneous release or the size of the readily releasable pool of neurotransmitters. Therefore, Ca2+ binding to synaptotagmin I participates in triggering neurotransmitter release at the synapse.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Max Planck Inst Expt Med, D-37070 Gottingen, Germany; Max Planck Inst Biophys Chem, D-37070 Gottingen, Germany; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Howard Hughes Med Inst, La Jolla, CA 92037 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Max Planck Society; Max Planck Society; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Salk Institute; Howard Hughes Medical Institute	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA.	Thomas.Sudhof@UTSouthwestern.edu	Rosenmund, Christian/AAC-3596-2020; IBIS, FISIOLOGIA/O-9485-2015; Fernandez-Chacon, Rafael/E-6303-2010	Rosenmund, Christian/0000-0002-3905-2444; Fernandez-Chacon, Rafael/0000-0002-9845-9885				Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bennett MR, 1999, PROG NEUROBIOL, V59, P243, DOI 10.1016/S0301-0082(99)00004-0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Burgoyne RD, 1998, CELL CALCIUM, V24, P367, DOI 10.1016/S0143-4160(98)90060-4; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Edwards AS, 1997, BIOCHEMISTRY-US, V36, P15615, DOI 10.1021/bi9718752; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Garcia RA, 2000, P NATL ACAD SCI USA, V97, P5883, DOI 10.1073/pnas.100127197; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Katz B., 1969, RELEASE NEURAL TRANS; Kee Y, 1996, J NEUROSCI, V16, P1975; KELLY RB, 1995, CURR BIOL, V5, P257, DOI 10.1016/S0960-9822(95)00054-6; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; MOSIOR M, 1994, J BIOL CHEM, V269, P13798; Nalefski EA, 1998, BIOCHEMISTRY-US, V37, P17642, DOI 10.1021/bi982372e; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Sabatini BL, 1999, ANNU REV PHYSIOL, V61, P521, DOI 10.1146/annurev.physiol.61.1.521; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Seagar M, 1999, PHILOS T ROY SOC B, V354, P289, DOI 10.1098/rstb.1999.0380; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; TUGAL HB, 1991, BIOCHEM J, V279, P699, DOI 10.1042/bj2790699; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; von Gersdorff H, 1999, ANNU REV PHYSIOL, V61, P725, DOI 10.1146/annurev.physiol.61.1.725; Williams RL, 1996, STRUCTURE, V4, P1387, DOI 10.1016/S0969-2126(96)00146-3; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	49	704	719	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2001	410	6824					41	49		10.1038/35065004	http://dx.doi.org/10.1038/35065004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242035				2022-12-28	WOS:000167194300036
J	Eikelboom, JW; Mehta, SR; Pogue, J; Yusuf, S				Eikelboom, JW; Mehta, SR; Pogue, J; Yusuf, S			Safety outcomes in meta-analyses of phase 2 vs phase 3 randomized trials - Intracranial hemorrhage in trials of bolus thrombolytic therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ACUTE MYOCARDIAL-INFARCTION; TISSUE-PLASMINOGEN-ACTIVATOR; FRONT-LOADED ALTEPLASE; RECOMBINANT STAPHYLOKINASE; CORONARY THROMBOLYSIS; INTRAVENOUS UROKINASE; DOUBLE-BLIND; INFUSION; INJECTION; EFFICACY	Context Recent studies have reported disagreement between meta-analysis of small trials and subsequent large trials addressing the same question. However, disagreement for uncommon but serious adverse safety outcomes has not been examined. Objective To explore disagreement for serious adverse safety (intracranial hemorrhage [ICH]) and efficacy outcomes between mete-analysis of phase 2 (small) vs metaanalysis of phase 3 (large) randomized controlled trials comparing the efficacy of bolus thrombolytic therapy with infusion for acute myocardia[ infarction (AMI). Data Sources Electronic databases (MEDLINE, Cochrane Database of Clinical Trials) between January 1980 and December 1999 using the search terms thrombolysis, thrombolytic therapy, and myocardial infarction; conference proceedings; and reference lists. Study Selection Fifteen randomized trials comparing thrombolytic agents administered by bolus injection with standard infusion therapy in patients with AMI. Data Extraction Data on [CH, other causes of stroke, total mortality, and reinfarction were independently extracted from each study by 2 observers. Data Synthesis Meta-analysis of 9 phase 2 trials (n=3956) revealed a lower risk of ICH with bolus thrombolytic therapy (odds ratio [OR], 0.53; 95% confidence interval [CI], 0.27-1.01), which was not statistically significant, Meta-analysis of 6 phase 3 trials (n=62673) indicated a significant increase in risk of ICH (OR, 2.25; 95% CI, 1.06-1.49). These results were significantly different (P =.01). There was no disagreement for efficacy outcomes. Phase 2 trials included younger and heavier patients with lower baseline blood pressures, and were more often open-label. Subgroup analyses suggested that each of these factors was associated with a lower estimate of risk of ICH with bolus agents. Conclusions Our results suggest that when therapeutic interventions are associated with a potential for uncommon but serious adverse safety outcomes, there may be differences between small phase 2 and large phase 3 trials that result in their disagreement for safety but not necessarily efficacy outcomes. Further investigation of the frequency and causes of disagreement between small and large trials for safety outcomes is warranted.	McMaster Univ, Prevent Cardiol & Therapeut Program, Hamilton, ON, Canada; McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; McMaster University	Eikelboom, JW (corresponding author), McMaster Univ, Hamilton Gen Hosp, McMaster Clin, MBBS, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	johne@ccc.mcmaster.ca	Eikelboom, John/AAG-6117-2019	Eikelboom, John/0000-0003-4126-1285; Yusuf, Salim/0000-0003-4776-5601				APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Bar FW, 1998, CIRCULATION, V98, P505; Bar FW, 1998, J THROMB THROMBOLYS, V6, P147, DOI 10.1023/A:1008809907268; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bleich SD, 1998, AM HEART J, V136, P741, DOI 10.1016/S0002-8703(98)70024-9; Bode C, 1996, CIRCULATION, V94, P891, DOI 10.1161/01.CIR.94.5.891; Califf R, 2000, AM HEART J, V139, pS131, DOI 10.1016/S0002-8703(00)90059-0; Cannon CP, 1998, CIRCULATION, V98, P2805, DOI 10.1161/01.CIR.98.25.2805; Cannon CP, 1997, CIRCULATION, V95, P351; Cappelleri JC, 1996, JAMA-J AM MED ASSOC, V276, P1332, DOI 10.1001/jama.276.16.1332; CHALMERS TC, 1987, STAT MED, V6, P315, DOI 10.1002/sim.4780060320; den Heijer P, 1998, CIRCULATION, V98, P2117, DOI 10.1161/01.CIR.98.20.2117; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GEMMILL JD, 1991, BRIT HEART J, V66, P134; GIUGLIANO RP, 2000, CIRCULATION, V100, P1; *INT JOINT EFF COM, 1995, LANCET, V346, P329; Kawai C, 1997, J AM COLL CARDIOL, V29, P1447, DOI 10.1016/S0735-1097(97)00074-0; KAWAI C, 1992, CIRCULATION S, V86, P1; KHAN MI, 1990, AM J CARDIOL, V65, P1051, DOI 10.1016/0002-9149(90)90313-P; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; MANTEL N, 1959, J NATL CANCER I, V22, P719; MATHEY DG, 1985, AM J CARDIOL, V55, P878, DOI 10.1016/0002-9149(85)90710-6; Mehta SR, 2000, LANCET, V356, P449, DOI 10.1016/S0140-6736(00)02552-6; Morrison LJ, 2000, JAMA-J AM MED ASSOC, V283, P2686, DOI 10.1001/jama.283.20.2686; Park SJ, 1998, AM J CARDIOL, V82, P811, DOI 10.1016/S0002-9149(98)00444-5; Patel SC, 1999, PROG CARDIOVASC DIS, V42, P217, DOI 10.1016/S0033-0620(99)70004-6; Pocok SJ, 1983, CLIN TRIALS PRACTICA, P1; PURVIS JA, 1994, J AM COLL CARDIOL, V23, P6, DOI 10.1016/0735-1097(94)90495-2; PURVIS JA, 1991, AM J CARDIOL, V68, P1570, DOI 10.1016/0002-9149(91)90311-8; ROSSI P, 1991, AM J CARDIOL, V68, P585, DOI 10.1016/0002-9149(91)90348-O; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; Selker HP, 1997, ANN INTERN MED, V127, P538, DOI 10.7326/0003-4819-127-7-199710010-00006; SMALLING RW, 1995, CIRCULATION, V91, P2725, DOI 10.1161/01.CIR.91.11.2725; TEBBE U, 1989, AM J CARDIOL, V64, P448, DOI 10.1016/0002-9149(89)90419-0; Temple R, 2000, AM HEART J, V139, pS133, DOI 10.1016/S0002-8703(00)90060-7; Topol E, 1997, NEW ENGL J MED, V337, P1118; Van de Werf F, 1999, LANCET, V354, P716, DOI 10.1016/S0140-6736(99)07403-6; Van de Werf F, 1999, AM HEART J, V137, P786, DOI 10.1016/S0002-8703(99)70400-X; Vanderschueren S, 1997, AM HEART J, V134, P213, DOI 10.1016/S0002-8703(97)70127-3; Vanderschueren S, 1996, THROMB HAEMOSTASIS, V76, P541; VandeWerf F, 1997, NEW ENGL J MED, V337, P1124; VILLAR J, 1995, LANCET, V345, P772, DOI 10.1016/S0140-6736(95)90646-0; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Yusuf S, 2000, AM HEART J, V139, pS136, DOI 10.1016/S0002-8703(00)90061-9	45	17	19	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2001	285	4					444	450		10.1001/jama.285.4.444	http://dx.doi.org/10.1001/jama.285.4.444			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394CG	11242429				2022-12-28	WOS:000166506000032
J	Abo-Shaeer, JR; Raman, C; Vogels, JM; Ketterle, W				Abo-Shaeer, JR; Raman, C; Vogels, JM; Ketterle, W			Observation of vortex lattices in Bose-Einstein condensates	SCIENCE			English	Article							VORTICES; EXCITATIONS	Quantized vortices play a key role in superfluidity and superconductivity. We have observed the formation of highly ordered vortex lattices in a rotating Bose-condensed gas. These triangular lattices contained over 100 vortices with Lifetimes of several seconds. Individual vortices persisted up to 40 seconds. The Lattices could be generated over a wide range of rotation frequencies and trap geometries, shedding Light on the formation process. Our observation of dislocations, irregular structure, and dynamics indicates that gaseous Bose-Einstein condensates may be a model system for the study of vortex matter.	MIT, Dept Phys, Ctr Ultracold Atoms, Cambridge, MA 02139 USA; MIT, Elect Res Lab, Cambridge, MA 02139 USA; Harvard Univ, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Abo-Shaeer, JR (corresponding author), MIT, Dept Phys, Ctr Ultracold Atoms, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jamil@mit.edu						ABRIKOSOV AA, 1957, SOV PHYS JETP-USSR, V5, P1174; Andrews MR, 1997, SCIENCE, V275, P637, DOI 10.1126/science.275.5300.637; ANDREWS MR, 1998, THESIS MIT; ANGLIN JR, COMMUNICATION; BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; CAMPBELL LJ, 1979, PHYS REV B, V20, P1886, DOI 10.1103/PhysRevB.20.1886; Castin Y, 1999, EUR PHYS J D, V7, P399, DOI 10.1007/s100530050584; Dalfovo F, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.011601; Dalfovo F, 1997, PHYS REV A, V56, P3840, DOI 10.1103/PhysRevA.56.3840; Dalfovo F, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.023605; Donnelly R. J., 1991, QUANTIZED VORTICES H, V2; ESSMANN U, 1967, PHYS LETT A, VA 24, P526, DOI 10.1016/0375-9601(67)90819-5; Feder DL, 2001, PHYS REV LETT, V86, P564, DOI 10.1103/PhysRevLett.86.564; Fetter AL, 2001, J PHYS-CONDENS MAT, V13, pR135, DOI 10.1088/0953-8984/13/12/201; Isoshima T, 1999, PHYS REV A, V60, P3313, DOI 10.1103/PhysRevA.60.3313; Ketterle W, 1999, P INT SCH PHYS, V140, P67; Lundh E, 1997, PHYS REV A, V55, P2126, DOI 10.1103/PhysRevA.55.2126; Lundh E, 1998, PHYS REV A, V58, P4816, DOI 10.1103/PhysRevA.58.4816; Madison KW, 2000, PHYS REV LETT, V84, P806, DOI 10.1103/PhysRevLett.84.806; Madison KW, 2000, J MOD OPTIC, V47, P2715, DOI 10.1080/095003400750039645; Matthews MR, 1999, PHYS REV LETT, V83, P2498, DOI 10.1103/PhysRevLett.83.2498; Onofrio R, 2000, PHYS REV LETT, V84, P810, DOI 10.1103/PhysRevLett.84.810; Onofrio R, 2000, PHYS REV LETT, V85, P2228, DOI 10.1103/PhysRevLett.85.2228; Pines D., 1990, THEORY QUANTUM LIQUI, VI; Raman C, 1999, PHYS REV LETT, V83, P2502, DOI 10.1103/PhysRevLett.83.2502; Svidzinsky AA, 2000, PHYS REV LETT, V84, P5919, DOI 10.1103/PhysRevLett.84.5919; TKACHENK.VK, 1966, SOV PHYS JETP-USSR, V22, P1282; TKACHENKO VK, 1966, ZH EKSP TEOR FIZ, V23, P1049; TSAKADZE SD, 1978, SOV J LOW TEMP PHYS, V4, P72; YARMCHUK EJ, 1979, PHYS REV LETT, V43, P214, DOI 10.1103/PhysRevLett.43.214	30	1150	1164	4	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2001	292	5516					476	479		10.1126/science.1060182	http://dx.doi.org/10.1126/science.1060182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11264525				2022-12-28	WOS:000168187300038
J	Robert, A; Sirjean, O; Browaeys, A; Poupard, J; Nowak, S; Boiron, D; Westbrook, CI; Aspect, A				Robert, A; Sirjean, O; Browaeys, A; Poupard, J; Nowak, S; Boiron, D; Westbrook, CI; Aspect, A			A Bose-Einstein condensate of metastable atoms	SCIENCE			English	Article							POLARIZED TRIPLET HELIUM; GAS; COLLISIONS; COHERENCE; DECAY; LASER; TRAP	We report the realization of a Bose-Einstein condensate of metastable atoms (helium in the Lowest triplet state). The excitation energy of each atom with respect to the ground state is 20 electron volts, but inelastic processes that would destroy the sample are suppressed strongly enough in a spin-polarized sample to allow condensation. Our detection scheme takes advantage of the metastability to achieve detection of individual atoms as well as of the decay products of inelastic processes. This detection opens the way toward new studies in mesoscopic quantum statistical physics, as well as in atomic quantum optics.	Inst Opt, Lab Charles Fabry, CNRS, UMR 8501, F-91403 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP)	Aspect, A (corresponding author), Inst Opt, Lab Charles Fabry, CNRS, UMR 8501, Batiment 503,Campus Univ Orsay,Boite Postale 147, F-91403 Orsay, France.		Westbrook, Christoph I/B-6092-2009; Browaeys, Antoine/E-1547-2017	Westbrook, Christoph I/0000-0002-6490-0468; Browaeys, Antoine/0000-0001-9941-8869				ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Andrews MR, 1997, SCIENCE, V275, P637, DOI 10.1126/science.275.5300.637; Beijerinck HCW, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.023607; Bloch I, 2000, NATURE, V403, P166, DOI 10.1038/35003132; BRADLEY CC, 1995, PHYS REV LETT, V75, P1687, DOI 10.1103/PhysRevLett.75.1687; BROWAEYS A, UNPUB; Burt EA, 1997, PHYS REV LETT, V79, P337, DOI 10.1103/PhysRevLett.79.337; Castin Y, 1996, PHYS REV LETT, V77, P5315, DOI 10.1103/PhysRevLett.77.5315; DAFOLVO S, 1999, REV MOD PHYS, V71, P463; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; Dos Santos FP, 2001, PHYS REV LETT, V86, P3459, DOI 10.1103/PhysRevLett.86.3459; Ensher JR, 1996, PHYS REV LETT, V77, P4984, DOI 10.1103/PhysRevLett.77.4984; Fedichev PO, 1996, PHYS REV A, V53, P1447, DOI 10.1103/PhysRevA.53.1447; Fried DG, 1998, PHYS REV LETT, V81, P3811, DOI 10.1103/PhysRevLett.81.3811; GERBIER F, IN PRESS PHYS REV LE; Guery-Odelin D, 1998, EUROPHYS LETT, V44, P25, DOI 10.1209/epl/i1998-00425-9; Hagley EW, 1999, SCIENCE, V283, P1706, DOI 10.1126/science.283.5408.1706; Hau LV, 1998, PHYS REV A, V58, pR54, DOI [10.1103/PhysRevA.58, 10.1103/PhysRevA.58.R54]; Horak P, 1999, J PHYS B-AT MOL OPT, V32, P3421, DOI 10.1088/0953-4075/32/14/312; Inguscio M., 1999, P INT SCH PHYS E FER; Kumakura M, 1999, PHYS REV LETT, V82, P2848, DOI 10.1103/PhysRevLett.82.2848; LEO P, UNPUB; LEO P, COMMUNICATION; Mastwijk HC, 1998, PHYS REV LETT, V80, P5516, DOI 10.1103/PhysRevLett.80.5516; Mewes MO, 1996, PHYS REV LETT, V77, P416, DOI 10.1103/PhysRevLett.77.416; Orzel C, 1999, PHYS REV A, V59, P1926, DOI 10.1103/PhysRevA.59.1926; PEREIRA F, 2001, EUR PHYS J D, V14, P15; SCHRECK F, UNPUB; SHLYAPNIKOV GV, 1994, PHYS REV LETT, V73, P3247, DOI 10.1103/PhysRevLett.73.3247; Tol PJJ, 1999, PHYS REV A, V60, pR761, DOI 10.1103/PhysRevA.60.R761; TRUSCOTT AG, 2001, SCIENCE         0301; Vassen W, 1996, OSA TOPS ULTRACOLD A, P20; Venturi V, 1999, PHYS REV A, V60, P4635, DOI 10.1103/PhysRevA.60.4635; Yasuda M, 1996, PHYS REV LETT, V77, P3090, DOI 10.1103/PhysRevLett.77.3090	35	278	283	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					461	464		10.1126/science.1060622	http://dx.doi.org/10.1126/science.1060622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11264526				2022-12-28	WOS:000168187300034
J	Lehmann, W; Skupin, H; Tolksdorf, C; Gebhard, E; Zentel, R; Kruger, P; Losche, M; Kremer, F				Lehmann, W; Skupin, H; Tolksdorf, C; Gebhard, E; Zentel, R; Kruger, P; Losche, M; Kremer, F			Giant lateral electrostriction in ferroelectric liquid-crystalline elastomers	NATURE			English	Article							C-ASTERISK-ELASTOMERS; ELECTROMECHANICAL PROPERTIES; ORIENTATION; PHASE; LAYER	Mechanisms for converting electrical energy into mechanical energy are essential for the design of nanoscale transducers, sensors, actuators, motors, pumps, artificial muscles, and medical microrobots. Nanometre-scale actuation has to date been mainly achieved by using the (linear) piezoelectric effect in certain classes of crystals (for example, quartz), and 'smart' ceramics such as lead zirconate titanate. But the strains achievable in these materials are small-less than 0.1 per cent-so several alternative materials and approaches have been considered. These include grafted polyglutamates(1) (which have a performance comparable to quartz), silicone elastomers(2) (passive material-the constriction results from the Coulomb attraction of the capacitor electrodes between which the material is sandwiched) and carbon nanotubes(3) (which are slow). High and fast strains of up to 4 per cent within an electric field of 150 MV m(-1) have been achieved by electrostriction (this means that the strain is proportional to the square of the applied electric field) in an electron-irradiated poly(vinylidene fluoride-trifluoroethylene) copolymer(4). Here we report a material that shows a further increase in electrostriction by two orders of magnitude: ultrathin (less than 100 nanometres) ferroelectric liquid-crystalline elastomer films that exhibit 4 per cent strain at only 1.5 MV m(-1). This giant electrostriction was obtained by combining the properties of ferroelectric liquid crystals with those of a polymer network. We expect that these results, which can be completely understood on a molecular level, will open new perspectives for applications.	Univ Leipzig, Inst Expt Phys 1, D-04103 Leipzig, Germany; Univ Mainz, Inst Organ Chem, D-55099 Mainz, Germany	Leipzig University; Johannes Gutenberg University of Mainz	Kremer, F (corresponding author), Univ Leipzig, Inst Expt Phys 1, Linnestr 5, D-04103 Leipzig, Germany.		Lösche, Mathias/J-2986-2013; Zentel, Rudolf/D-4542-2011	Lösche, Mathias/0000-0001-6666-916X; 				Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; CLARK NA, 1980, APPL PHYS LETT, V36, P899, DOI 10.1063/1.91359; GAROFF S, 1977, PHYS REV LETT, V38, P848, DOI 10.1103/PhysRevLett.38.848; Gebhard E, 2000, MACROMOL CHEM PHYSIC, V201, P902, DOI 10.1002/(SICI)1521-3935(20000501)201:8<902::AID-MACP902>3.0.CO;2-9; Jakli A, 1996, PHYS REV E, V53, pR5580, DOI 10.1103/PhysRevE.53.R5580; Jaworek T, 1998, SCIENCE, V279, P57, DOI 10.1126/science.279.5347.57; Johnson PM, 1999, PHYS REV LETT, V83, P4073, DOI 10.1103/PhysRevLett.83.4073; Kremer F, 1998, POLYM ADVAN TECHNOL, V9, P672, DOI 10.1002/(SICI)1099-1581(1998100)9:10/11<672::AID-PAT848>3.0.CO;2-5; KREMER F, 1998, Patent No. 19636909; Lagerwall S. T., 1999, FERROELECTRIC ANTIFE; Lehmann W, 1998, FERROELECTRICS, V208, P373, DOI 10.1080/00150199808014887; Lehmann W, 1999, J APPL PHYS, V86, P1647, DOI 10.1063/1.370941; Mach P, 1998, PHYS REV LETT, V80, P732, DOI 10.1103/PhysRevLett.80.732; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; POTHS H, 1992, ADV MATER, V4, P792, DOI 10.1002/adma.19920041204; RAPPAPORT AG, 1995, APPL PHYS LETT, V67, P362, DOI 10.1063/1.114629; SCHURING H, UNPUB MACROMOLECULES; SEMMLER K, 1995, MACROMOL CHEM PHYSIC, V196, P3197, DOI 10.1002/macp.1995.021961010; TERENTJEV EM, 1994, J PHYS II, V4, P849, DOI 10.1051/jp2:1994169; Wong GCL, 1997, NATURE, V389, P576, DOI 10.1038/39271; ZENTEL R, 1989, ANGEW CHEM INT EDIT, V28, P1407, DOI 10.1002/anie.198914071; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101; ZHAO J, 1995, JPN J APPL PHYS 1, V34, P5658, DOI 10.1143/JJAP.34.5658	23	359	369	7	284	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					447	450		10.1038/35068522	http://dx.doi.org/10.1038/35068522			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260707				2022-12-28	WOS:000167583800035
J	Reichert, TA; Sugaya, N; Fedson, DS; Glezen, WP; Simonsen, L; Tashiro, M				Reichert, TA; Sugaya, N; Fedson, DS; Glezen, WP; Simonsen, L; Tashiro, M			The Japanese experience with vaccinating schoolchildren against influenza.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ELDERLY PERSONS; EFFICACY; MORTALITY; EPIDEMICS; IMPACT; LIVE; COUNTRIES; TRIVALENT; BENEFITS; UPDATE	Background: Influenza epidemics lead to increased mortality, principally among elderly persons and others at high risk, and in most developed countries, influenza-control efforts focus on the vaccination of this group. Japan, however, once based its policy for the control of influenza on the vaccination of schoolchildren. From 1962 to 1987, most Japanese schoolchildren were vaccinated against influenza. For more than a decade, vaccination was mandatory, but the laws were relaxed in 1987 and repealed in 1994; subsequently, vaccination rates dropped to low levels. When most schoolchildren were vaccinated, it is possible that herd immunity against influenza was achieved in Japan. If this was the case, both the incidence of influenza and mortality attributed to influenza should have been reduced among older persons. Methods: We analyzed the monthly rates of death from all causes and death attributed to pneumonia and influenza, as well as census data and statistics on the rates of vaccination for both Japan and the United States from 1949 through 1998. For each winter, we estimated the number of deaths per month in excess of a base-line level, defined as the average death rate in November. Results: The excess mortality from pneumonia and influenza and that from all causes were highly correlated in each country. In the United States, these rates were nearly constant over time. With the initiation of the vaccination program for schoolchildren in Japan, excess mortality rates dropped from values three to four times those in the United States to values similar to those in the United States. The vaccination of Japanese children prevented about 37,000 to 49,000 deaths per year, or about 1 death for every 420 children vaccinated. As the vaccination of schoolchildren was discontinued, the excess mortality rates in Japan increased. Conclusions: The effect of influenza on mortality is much greater in Japan than in the United States and can be measured about equally well in terms of deaths from all causes and deaths attributed to pneumonia or influenza. Vaccinating schoolchildren against influenza provides protection and reduces mortality from influenza among older persons. (N Engl J Med 2001;344:889-96.) Copyright (C) 2001 Massachusetts Medical Society.	Becton Dickinson & Entropy Ltd, Upper Saddle River, NJ USA; Nippon Kokan Ltd Co Hosp, Dept Pediat, Kawasaki, Kanagawa, Japan; Aventis Pasteur MSD, Lyon, France; Baylor Coll Med, Influenza Res Ctr, Houston, TX 77030 USA; NIAID, Bethesda, MD 20892 USA; Natl Inst Infect Dis, Tokyo, Japan	Becton Dickinson; Sanofi-Aventis; Sanofi France; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institute of Infectious Diseases (NIID)	Reichert, TA (corresponding author), 262 W Saddle River Rd, Upper Saddle River, NJ 07458 USA.	doctorm_us@yahoo.com	Simonsen, Lone/K-4531-2014	Simonsen, Lone/0000-0003-1535-8526				*ADV COMM PAND INF, 1997, PAND PREP REP; Ambrosch F, 1999, PHARMACOECONOMICS, V16, P47, DOI 10.2165/00019053-199916001-00007; Belshe RB, 2000, J PEDIATR-US, V136, P168, DOI 10.1016/S0022-3476(00)70097-7; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; CHOI K, 1981, AM J EPIDEMIOL, V113, P227, DOI 10.1093/oxfordjournals.aje.a113091; DOWDLE WR, 1980, J INFECT DIS, V141, P258, DOI 10.1093/infdis/141.2.258; ELVEBACK LR, 1976, AM J EPIDEMIOL, V103, P152, DOI 10.1093/oxfordjournals.aje.a112213; FEDSON DS, 1994, JAMA-J AM MED ASSOC, V271, P1578; Fedson DS, 1997, VACCINE, V15, P1506, DOI 10.1016/S0264-410X(97)00091-1; GLEZEN WP, 1982, EPIDEMIOL REV, V4, P25, DOI 10.1093/oxfordjournals.epirev.a036250; GLEZEN WP, 1982, J INFECT DIS, V146, P313, DOI 10.1093/infdis/146.3.313; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; HIROTA Y, 1994, LANCET, V344, P408, DOI 10.1016/S0140-6736(94)91436-2; HIROTA Y, 1992, INT J EPIDEMIOL, V21, P574, DOI 10.1093/ije/21.3.574; Hirota Y, 1996, NATURE, V380, P18, DOI 10.1038/380018a0; Inoue K, 1999, NAT MED, V5, P592, DOI 10.1038/9416; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; KOJIMA S, 1960, HIST ASIAN INFLUENZA, P38; LANGMUIR AD, 1964, AM J PUBLIC HEALTH N, V54, P563, DOI 10.2105/AJPH.54.4.563; LONGINI IM, 1978, MATH BIOSCI, V38, P141, DOI 10.1016/0025-5564(78)90023-8; Longini IM, 2000, VACCINE, V18, P1902, DOI 10.1016/S0264-410X(99)00419-3; LONGINI IM, 1988, AM J EPIDEMIOL, V128, P845, DOI 10.1093/oxfordjournals.aje.a115038; LUI KJ, 1987, AM J PUBLIC HEALTH, V77, P712, DOI 10.2105/AJPH.77.6.712; *MIN HLTH WELF, 2000, WHIT PAP ANN REP HLT; *MIN SECR MIN HLTH, 1998, VITA STAT JAP; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; *NAT CTR HLTH STAT, 1951, VIT STAT US 1949 1 A, V2; *NAT CTR HLTH STAT, 1999, MON VIT STAT REP 1 S, V44, P47; *NAT IMM PROGR, 1963, 1 CDCP NAT IMM PROGR; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Nichol KL, 1999, PHARMACOECONOMICS, V16, P63, DOI 10.2165/00019053-199916001-00009; OYA A, 1986, OPTIONS CONTROL INFL, P183; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; SUGAYA N, 1994, JAMA-J AM MED ASSOC, V272, P1122, DOI 10.1001/jama.272.14.1122; Sugaya N, 2000, J MED VIROL, V60, P102, DOI 10.1002/(SICI)1096-9071(200001)60:1&lt;102::AID-JMV17&gt;3.0.CO;2-D; SUGAYA N, 1993, JPN J SCH HLTH, V35, P537; SUGIURA A, 1970, J INFECT DIS, V122, P472, DOI 10.1093/infdis/122.6.472; White T, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e73; *WHO, 2000, WKLY EP REC, V35, P281; YAMAMOTO M, 1990, NIPPON IJI SHIMPO, V3442, P47	43	609	632	0	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2001	344	12					889	896		10.1056/NEJM200103223441204	http://dx.doi.org/10.1056/NEJM200103223441204			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412PN	11259722				2022-12-28	WOS:000167563700004
J	LeBlanc, ES; Janowsky, J; Chan, BKS; Nelson, HD				LeBlanc, ES; Janowsky, J; Chan, BKS; Nelson, HD			Hormone replacement therapy and cognition - Systematic review and meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ESTROGEN-RECEPTOR-ALPHA; POSTMENOPAUSAL ESTROGEN; ALZHEIMERS-DISEASE; RISK-FACTORS; OLDER WOMEN; MEMORY; DECLINE; HIPPOCAMPUS; TRIAL; MOTOR	Context Some observational data suggest that hormone replacement therapy (HRT) may reduce the risk of cognitive decline and dementia but results have been conflicting. Objective To review and evaluate studies of HRT for preventing cognitive decline and dementia in healthy postmenopausal women. Data Sources Studies with English-language abstracts identified in MEDLINE (1966-August 2000), HealthSTAR (1975-August 2000, PsychINFO (1984-August 2000); Cochrane Library databases; and articles listed in reference lists of key articles, Study Selection Randomized controlled trials and cohort studies were reviewed for the effects of HRT on cognitive decline; cohort and case-control studies were reviewed for dementia risk. No randomized controlled trials regarding dementia risk were identified. Data Extraction Twenty-nine studies met inclusion criteria and were rated, Two reviewers rated study quality independently and 100% agreement was reached on Jadad scores and 80% agreement was reached on US Preventive Services Task Force quality scores. A final score was reached th rough consensus if reviewers disagreed. Data Synthesis Studies of cognition were not combined quantitatively because of heterogeneous study design. Women symptomatic from menopause had improvements in verbal memory, vigilance, reasoning, and motor speed, but no enhancement of other cognitive functions. Generally, no benefits were observed in asymptomatic women. A meta-analysis of observational studies suggested that HRT was associated with a decreased risk of dementia (summary odds ratio, 0.66; 95% confidence interval, 0.53-0.82). However, possible biases and lack of control for potential confounders limit interpretation of these studies. Studies did not contain enough information to assess adequately the effects of progestin use, various estrogen preparations or doses, or duration of therapy. Conclusions in women with menopausal symptoms, HRT may have specific cognitive effects, and future studies should target these effects, The meta-analysis found a decreased risk of dementia in HRT users but most studies had important methodological limitations.	Oregon Hlth & Sci Univ, Evidence Based Practice Ctr, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Div Med Informat & Outcomes Res, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Med Serv, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	LeBlanc, ES (corresponding author), Oregon Hlth & Sci Univ, Evidence Based Practice Ctr, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA.	leblance@ohsu.edu			NATIONAL INSTITUTE ON AGING [R01AG012611] Funding Source: NIH RePORTER; NIA NIH HHS [AG12611] Funding Source: Medline; PHS HHS [290-97-0018] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; BARRETTCONNOR E, 1993, JAMA-J AM MED ASSOC, V269, P2637, DOI 10.1001/jama.269.20.2637; BARRETTCONNOR E, 1991, ANN INTERN MED, V115, P455, DOI 10.7326/0003-4819-115-6-455; BRENNER DE, 1994, AM J EPIDEMIOL, V140, P262, DOI 10.1093/oxfordjournals.aje.a117245; BRETELER MMB, 1992, EPIDEMIOL REV, V14, P59, DOI 10.1093/oxfordjournals.epirev.a036092; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; Carlson LE, 1999, NEUROBIOL AGING, V20, P315, DOI 10.1016/S0197-4580(99)00052-4; CHIARELLO C, 1989, BRAIN COGNITION, V11, P18, DOI 10.1016/0278-2626(89)90002-X; DERBY CA, 1993, AM J EPIDEMIOL, V137, P1125, DOI 10.1093/oxfordjournals.aje.a116616; DITKOFF EC, 1991, OBSTET GYNECOL, V78, P991; Duka T, 2000, PSYCHOPHARMACOLOGY, V149, P129, DOI 10.1007/s002139900324; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fedor-Freybergh P, 1977, Acta Obstet Gynecol Scand Suppl, V64, P1; FRISK V, 1990, NEUROPSYCHOLOGIA, V28, P349, DOI 10.1016/0028-3932(90)90061-R; Funk JL, 1991, DEMENTIA, V2, P268; Gordis L., 1996, EPIDEMIOLOGY, P183; GRAVES AB, 1990, ANN NEUROL, V28, P766, DOI 10.1002/ana.410280607; Hackman B W, 1976, Curr Med Res Opin, V4, P303, DOI 10.1185/03007997609109322; HAMPSON E, 1988, BEHAV NEUROSCI, V102, P456, DOI 10.1037/0735-7044.102.3.456; HAMPSON E, 1990, PSYCHONEUROENDOCRINO, V15, P97, DOI 10.1016/0306-4530(90)90018-5; HARRIS R, IN PRESS AM J PREV M; Harwood DG, 1999, NEUROLOGY, V52, P551, DOI 10.1212/WNL.52.3.551; Henderson Victor W., 1997, American Journal of Medicine, V103, p11S, DOI 10.1016/S0002-9343(97)00261-1; Henderson VW, 2000, NEUROLOGY, V54, P295, DOI 10.1212/WNL.54.2.295; HENDERSON VW, 1994, ARCH NEUROL-CHICAGO, V51, P896, DOI 10.1001/archneur.1994.00540210068014; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; Jacobs DM, 1998, NEUROLOGY, V50, P368, DOI 10.1212/WNL.50.2.368; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Janowsky JS, 2000, J COGNITIVE NEUROSCI, V12, P407, DOI 10.1162/089892900562228; KAMPEN DL, 1994, OBSTET GYNECOL, V83, P979, DOI 10.1097/00006250-199406000-00017; Kawas, 1998, NEUROLOGY, V51, P654; Kawas C, 1997, NEUROLOGY, V48, P1517, DOI 10.1212/WNL.48.6.1517; Keating NL, 1999, ANN INTERN MED, V130, P545, DOI 10.7326/0003-4819-130-7-199904060-00002; Keefover RW, 1996, NEUROL CLIN, V14, P337, DOI 10.1016/S0733-8619(05)70260-7; KIMURA D, 1995, HORM BEHAV, V29, P312, DOI 10.1006/hbeh.1995.1022; LAZAK M, 1995, NEUROPSYCHOLOGICAL A; Matthews K, 1999, J AM GERIATR SOC, V47, P518, DOI 10.1111/j.1532-5415.1999.tb02563.x; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; MORTEL KF, 1995, J NEUROPSYCH CLIN N, V7, P334; Mulnard RI, 2000, JAMA-J AM MED ASSOC, V283, P1007, DOI 10.1001/jama.283.8.1007; PaganiniHill A, 1996, ARCH INTERN MED, V156, P2213, DOI 10.1001/archinte.156.19.2213; PHILLIPS SM, 1992, PSYCHONEUROENDOCRINO, V17, P485, DOI 10.1016/0306-4530(92)90007-T; Polo-Kantola P, 1998, OBSTET GYNECOL, V91, P459, DOI 10.1016/S0029-7844(97)00700-X; Register TC, 1998, BRAIN RES, V788, P320, DOI 10.1016/S0006-8993(98)00036-5; Resnick SM, 1998, HORM BEHAV, V34, P171, DOI 10.1006/hbeh.1998.1476; Resnick SM, 1997, NEUROLOGY, V49, P1491, DOI 10.1212/WNL.49.6.1491; Rice MM, 2000, ARCH INTERN MED, V160, P1641, DOI 10.1001/archinte.160.11.1641; ROBINSON D, 1994, J AM GERIATR SOC, V42, P919, DOI 10.1111/j.1532-5415.1994.tb06580.x; Shaywitz SE, 1999, JAMA-J AM MED ASSOC, V281, P1197, DOI 10.1001/jama.281.13.1197; SHERWIN BB, 1988, PSYCHONEUROENDOCRINO, V13, P345, DOI 10.1016/0306-4530(88)90060-1; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Shumaker SA, 1998, CONTROL CLIN TRIALS, V19, P604, DOI 10.1016/S0197-2456(98)00038-5; Slavin Robert E., 1986, EDUC RESEARCHER, V15, P5, DOI [10.3102/0013189X015009005, DOI 10.3102/0013189X015009005]; Smith CA, 1999, BRAIN COGNITION, V39, P203, DOI 10.1006/brcg.1999.1078; Spiegelhalter DJ, 1999, WINBUGS VERSION 1 2; Szklo M, 1996, AM J EPIDEMIOL, V144, P1048; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; TERI L, 1997, W J MED, V4, P269; VANHULLE G, CONCENSUS MENOPAUSE; Wang PN, 2000, NEUROLOGY, V54, P2061, DOI 10.1212/WNL.54.11.2061; Waring SC, 1999, NEUROLOGY, V52, P965, DOI 10.1212/WNL.52.5.965; WATKINS R, IN PRESS J GERONTOL; Weiland NG, 1997, J COMP NEUROL, V388, P603, DOI 10.1002/(SICI)1096-9861(19971201)388:4<603::AID-CNE8>3.0.CO;2-6; Wren BG, 1998, DRUG AGING, V12, P343, DOI 10.2165/00002512-199812050-00001; Yaffe K, 2000, NEUROLOGY, V54, P1949, DOI 10.1212/WNL.54.10.1949; Yaffe K, 1998, JAMA-J AM MED ASSOC, V279, P688, DOI 10.1001/jama.279.9.688; Yaffe K, 1999, J AM GERIATR SOC, V47, P1176, DOI 10.1111/j.1532-5415.1999.tb05196.x; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	68	457	465	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1489	1499		10.1001/jama.285.11.1489	http://dx.doi.org/10.1001/jama.285.11.1489			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410VQ	11255426				2022-12-28	WOS:000167462100032
J	Ferrie, CD; Grunewald, RA				Ferrie, CD; Grunewald, RA			Panayiotopoulos syndrome: a common and benign childhood epilepsy	LANCET			English	Editorial Material							SEIZURE SUSCEPTIBILITY SYNDROME; OCCIPITAL PAROXYSMS		Gen Infirm, Dept Paediat Neurol, Leeds LS2 9NS, W Yorkshire, England; Royal Hallamshire Hosp, Dept Neurol, Sheffield S10 2JF, S Yorkshire, England	Leeds General Infirmary; University of Sheffield	Ferrie, CD (corresponding author), Gen Infirm, Dept Paediat Neurol, Leeds LS2 9NS, W Yorkshire, England.							Berg AT, 2000, NEUROLOGY, V55, P1073, DOI 10.1212/WNL.55.8.1073; Caraballo R, 2000, NEUROLOGY, V55, P1096, DOI 10.1212/WNL.55.8.1096; Ferrie CD, 1997, EPILEPSIA, V38, P285, DOI 10.1111/j.1528-1157.1997.tb01119.x; GRAM L, 1990, LANCET, V336, P161, DOI 10.1016/0140-6736(90)91672-W; Kivity S, 2000, EPILEPSIA, V41, P1522; Oguni H, 1999, EPILEPSIA, V40, P1020, DOI 10.1111/j.1528-1157.1999.tb00812.x; PANAYIOTOPOULOS CP, 1989, ANN NEUROL, V26, P51, DOI 10.1002/ana.410260108; PANAYIOTOPOULOS CP, 1981, NEUROLOGY, V31, P330; Panayiotopoulos CP, 1999, BENIGN CHILDHOOD PAR	9	34	37	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 17	2001	357	9259					821	823		10.1016/S0140-6736(00)04192-1	http://dx.doi.org/10.1016/S0140-6736(00)04192-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265947				2022-12-28	WOS:000167586300005
J	Lovejoy, CO; Heiple, KG; Meindl, RS				Lovejoy, CO; Heiple, KG; Meindl, RS			Palaeoanthropology - Did our ancestors knuckle-walk?	NATURE			English	Article							HEDGEHOG		Kent State Univ, Dept Anthropol, Div Biomed Sci, Kent, OH 44242 USA; Case Western Reserve Univ, Sch Med, Dept Orthopaed, Div Surg, Cleveland, OH 44206 USA	Kent State University; Kent State University Kent; Kent State University Salem; Case Western Reserve University	Lovejoy, CO (corresponding author), Kent State Univ, Dept Anthropol, Div Biomed Sci, Kent, OH 44242 USA.		, owen/N-7301-2019	, owen/0000-0003-0053-4523				Burstein AH, 1994, FUNDAMENTALS ORTHOPA; Frost HM, 1999, ANAT RECORD, V255, P162, DOI 10.1002/(SICI)1097-0185(19990601)255:2<162::AID-AR6>3.0.CO;2-1; Hamrick MW, 1999, J THEOR BIOL, V201, P201, DOI 10.1006/jtbi.1999.1025; Karp SJ, 2000, DEVELOPMENT, V127, P543; Lovejoy CO, 1999, P NATL ACAD SCI USA, V96, P13247, DOI 10.1073/pnas.96.23.13247; Martin RB, 1998, SKELETAL TISSUE MECH; OGDEN JA, 1980, FUNDAMENTAL CLIN BON, P108; Richmond BG, 2000, NATURE, V404, P382, DOI 10.1038/35006045; Roberts TJ, 1997, SCIENCE, V275, P1113, DOI 10.1126/science.275.5303.1113; SHADWICK RE, 1990, J APPL PHYSIOL, V68, P1033, DOI 10.1152/jappl.1990.68.3.1033; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; SUSMAN RL, 1979, AM J PHYS ANTHROPOL, V50, P565, DOI 10.1002/ajpa.1330500408; Thorogood P., 1997, EMBRYOS GENES BIRTH, P1	13	21	21	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					325	326		10.1038/35066636	http://dx.doi.org/10.1038/35066636			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268198				2022-12-28	WOS:000167464100036
J	Orsinger, WH				Orsinger, WH			The condition we don't discuss	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2001	285	10					1265	1266		10.1001/jama.285.10.1265	http://dx.doi.org/10.1001/jama.285.10.1265			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408QK	11255369				2022-12-28	WOS:000167339000001
J	Ferriby, D; Stojkovic, T				Ferriby, D; Stojkovic, T			Clinical picture: Bronchiolitis obliterans with organising pneumonia during interferon beta-1a treatment	LANCET			English	Article									Ctr Hosp Reg & Univ Lille, Hop R Salengro, Dept Neurol, F-59037 Lille, France	Universite de Lille - ISITE; CHU Lille	Ferriby, D (corresponding author), Ctr Hosp Reg & Univ Lille, Hop R Salengro, Dept Neurol, Pl Verdun, F-59037 Lille, France.								0	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2001	357	9258					751	751		10.1016/S0140-6736(00)04167-2	http://dx.doi.org/10.1016/S0140-6736(00)04167-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253968	Bronze			2022-12-28	WOS:000167400900012
J	Saitoh, E; Okamoto, S; Takahashi, KT; Tobe, K; Yamamoto, K; Kimura, T; Ishihara, S; Maekawa, S; Tokura, Y				Saitoh, E; Okamoto, S; Takahashi, KT; Tobe, K; Yamamoto, K; Kimura, T; Ishihara, S; Maekawa, S; Tokura, Y			Observation of orbital waves as elementary excitations in a solid	NATURE			English	Article							ELECTRONIC-STRUCTURE; NEUTRON-DIFFRACTION; RAMAN-SPECTROSCOPY; SPIN; TRANSITION; SCATTERING; MN	A basic concept in solid-state physics is that when some kind of symmetry in a solid is spontaneously broken, collective excitations will arise(1). For example, phonons are the collective excitations corresponding to lattice vibrations in a crystal, and magnons correspond to spin waves in a magnetically ordered compound. Modulations in the relative shape of the electronic clouds in an orbitally ordered state(2-9) could in principle give rise to orbital waves, or 'orbitons', but this type of elementary excitation has yet to be observed experimentally. Systems in which the electrons are strongly correlated-such as high-temperature superconductors and manganites exhibiting colossal magnetoresistivity-are promising candidates for supporting orbital waves, because they contain transition-metal ions in which the orbital degree of freedom is important(10,11). Orbitally ordered states have been found in several transition-metal compounds(12,13), and orbitons have been predicted theoretically for LaMnO3 (refs 4,5). Here we report experimental evidence for orbitons in LaMnO3, using Raman scattering measurements. We perform a model calculation of orbiton resonances which provides a good fit to the experimental data.	Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; Joint Res Ctr Atom Technol, Tsukuba, Ibaraki 3050046, Japan; Correlated Electron Res Ctr, Tsukuba, Ibaraki 3050046, Japan	University of Tokyo; Tohoku University; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Tokura, Y (corresponding author), Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan.	tokura@ap.t.u-tokyo.ac.jp	Saitoh, Eiji/C-1004-2011; Okamoto, Satoshi/G-5390-2011; Tokura, Yoshinori/C-7352-2009; Kimura, Tsuyoshi/F-8090-2018; Ishihara, Sumio/AAH-3346-2019; Maekawa, Sadamichi/J-6194-2018	Saitoh, Eiji/0000-0003-2675-0718; Okamoto, Satoshi/0000-0002-0493-7568; Tokura, Yoshinori/0000-0002-2732-4983; Maekawa, Sadamichi/0000-0002-4237-7741				Abrashev MV, 1999, PHYS REV B, V59, P4146, DOI 10.1103/PhysRevB.59.4146; Anderson P.W., 1984, BASIC NOTIONS CONDEN, DOI 10.4324/9780429494116; ARIMA TH, 1995, J PHYS SOC JPN, V64, P2488, DOI 10.1143/JPSJ.64.2488; CYROT M, 1975, J PHYS-PARIS, V36, P253, DOI 10.1051/jphys:01975003603025300; Feiner LF, 1998, J PHYS-CONDENS MAT, V10, pL555, DOI 10.1088/0953-8984/10/32/001; GOODENOUGH JB, 1955, PHYS REV, V100, P564, DOI 10.1103/PhysRev.100.564; Hirota K, 1996, J PHYS SOC JPN, V65, P3736, DOI 10.1143/JPSJ.65.3736; Iliev MN, 1998, PHYS REV B, V57, P2872, DOI 10.1103/PhysRevB.57.2872; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Inoue J, 1997, PHYSICA B, V237, P51, DOI 10.1016/S0921-4526(97)00045-8; Ishihara S, 1996, PHYSICA C, V263, P130, DOI 10.1016/0921-4534(96)00085-8; Ishihara S, 1997, PHYS REV B, V55, P8280, DOI 10.1103/PhysRevB.55.8280; ITO Y, 1976, J PHYS SOC JPN, V40, P1333, DOI 10.1143/JPSJ.40.1333; KANAMORI J, 1959, J PHYS CHEM SOLIDS, V10, P87, DOI 10.1016/0022-3697(59)90061-7; Kaplan M.D., 1995, COOPERATIVE PHENOMEN; Khaliullin G, 1997, PHYS REV B, V56, P14243, DOI 10.1103/PhysRevB.56.R14243; KOMAROV AG, 1976, SOV PHYS-SOLID STATE, V17, P1531; KUGEL KI, 1973, ZH EKSP TEOR FIZ+, V64, P1429; MATSUMOT.G, 1970, J PHYS SOC JPN, V29, P606, DOI 10.1143/JPSJ.29.606; Mitchell JF, 1996, PHYS REV B, V54, P6172, DOI 10.1103/PhysRevB.54.6172; Perebeinos V, 1999, PHYS STATUS SOLIDI B, V215, P607, DOI 10.1002/(SICI)1521-3951(199909)215:1<607::AID-PSSB607>3.0.CO;2-G; Podobedov VB, 1998, PHYS REV B, V58, P43, DOI 10.1103/PhysRevB.58.43; Rodriguez-Carvajal J, 1998, PHYS REV B, V57, pR3189, DOI 10.1103/PhysRevB.57.R3189; SAITOH T, 1995, PHYS REV B, V51, P13942, DOI 10.1103/PhysRevB.51.13942; Schaack G, 2000, TOP APPL PHYS, V75, P24; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; van den Brink J, 1998, PHYS REV B, V58, P10276, DOI 10.1103/PhysRevB.58.10276; WOLLAN EO, 1955, PHYS REV, V100, P545, DOI 10.1103/PhysRev.100.545; Yamamoto K, 2000, PHYS REV B, V61, P14706, DOI 10.1103/PhysRevB.61.14706	30	182	186	3	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2001	410	6825					180	183		10.1038/35065547	http://dx.doi.org/10.1038/35065547			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242071				2022-12-28	WOS:000167320500037
J	Stenestrand, U; Wallentin, L				Stenestrand, U; Wallentin, L		Swedish Register Cardiac Intensive	Early statin treatment following acute myocardial infarction and 1-year survival	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AVERAGE CHOLESTEROL LEVELS; C-REACTIVE PROTEIN; CORONARY EVENTS; PRAVASTATIN; INFLAMMATION; MANAGEMENT; HOSPITALS; REDUCTION; ISCHEMIA; RISK	Context Randomized trials have established statin treatment as secondary prevention in coronary artery disease, but it is unclear whether early treatment with statins following acute myocardial infarction (AMI) influences survival. Objective To evaluate the association between statin treatment initiated before or at the time of hospital discharge and 1-year mortality after AMI, Design and Setting Prospective cohort study using data from the Swedish Register of Cardiac intensive Care on patients admitted to the coronary care units of 58 Swedish hospitals in 1995-1998. One-year mortality data were obtain ed from the Swedish National Cause of Death Register. Patients Patients with first registry-recorded AMI who were younger than 80 years and who were discharged alive from the hospital, including 5528 who received statins at or before discharge and 14071 who did not. Main Outcome Measure Relative risk of 1-year mortality according to statin treatment. Results At 1 year, unadjusted mortality was 9.3% (1307 deaths) in the no-statin group and 4.0% (219 deaths) in the statin treatment group. In regression analysis adjusting for confounding factors and propensity score for statin use, early statin treatment was associated with a reduction in 1-year mortality (relative risk, 0.75; 95% confidence interval, 0.63-0.89; P=.001) in hospital survivors of AMI. This reduction in mortality was similar among all subgroups based on age. sex, baseline characteristics, previous disease manifestations, and medications. Conclusions Early initiation of statin treatment in patients with AMI is associated with reduced 1-year mortality. These results emphasize the importance of implementing the results of randomized statin trials in unselected AMI patients.	Linkoping Univ Hosp, Dept Cardiol, SE-58185 Linkoping, Sweden; Univ Uppsala Hosp, Dept Cardiol, Uppsala, Sweden	Linkoping University; Uppsala University; Uppsala University Hospital	Stenestrand, U (corresponding author), Linkoping Univ Hosp, Dept Cardiol, SE-58185 Linkoping, Sweden.	stenestrand@riks-hia.c.se						Arntz HR, 1999, ATHEROSCLEROSIS, V147, pS17, DOI 10.1016/S0021-9150(99)00251-8; Biasucci LM, 1999, CIRCULATION, V99, P855, DOI 10.1161/01.CIR.99.7.855; Chen J, 1999, NEW ENGL J MED, V340, P286, DOI 10.1056/NEJM199901283400407; COX DR, 1972, J R STAT SOC B, V34, P187; DENHARTOG FR, 1998, EUR HEART J, V19, pP2802; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Dupuis J, 1999, CIRCULATION, V99, P3227, DOI 10.1161/01.CIR.99.25.3227; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Lim LLY, 1999, AUST NZ J PUBL HEAL, V23, P61, DOI 10.1111/j.1467-842X.1999.tb01206.x; PEDERSEN TR, 1994, LANCET, V344, P1383; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schwartz GG, 1998, AM J CARDIOL, V81, P578, DOI 10.1016/S0002-9149(97)00963-6; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Tokgozoglu L, 2000, EUR HEART J, V21, P156; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; TURNSTALLPEDOE H, 1994, CIRCULATION, V90, P583; Wood D, 1998, EUR HEART J, V19, P1434	22	420	445	0	92	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2001	285	4					430	436		10.1001/jama.285.4.430	http://dx.doi.org/10.1001/jama.285.4.430			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394CG	11242427	Bronze			2022-12-28	WOS:000166506000030
J	Moon, M				Moon, M			Health policy 2001: Medicare.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Urban Inst, Washington, DC 20037 USA	Urban Institute	Moon, M (corresponding author), Urban Inst, Washington, DC 20037 USA.							AARON HJ, 1995, HLTH AFF MILLWOOD, V14, pS30; *BAR GROUP, 1999, MED HMO WITHDR AFF B; CASSIDY A, 2001, MED PLUS CHOICE MED; *FED HOSP INS TRUS, 2000, ANN REP FED HOSP INS; *FED HOSP INS TRUS, 1996, ANN REP BOARD TRUST; GLUCK M, 2000, FINANCING MED FUTURE; Lesser CS, 2000, HEALTH AFFAIR, V19, P206, DOI 10.1377/hlthaff.19.6.206; Levit K, 2000, HEALTH AFFAIR, V19, P124, DOI 10.1377/hlthaff.19.1.124; MANTON KG, 1993, J GERONTOL, V48, pS153, DOI 10.1093/geronj/48.4.S153; MAXWELL S, 2001, GROWTH MED OUT OF PO; *MED MED STAT SUPP, 1999, HLTH CAR FIN REV; Moon M, 2000, HEALTH CARE FINANC R, V22, P9; MOON M, 1999, BENEATH AVERAGES ANA; National Center for Health Statistics, 2000, HLTH US 2000; Riley GF, 1997, HEALTH AFFAIR, V16, P117, DOI 10.1377/hlthaff.16.5.117; Thomas J, 2000, NY TIMES        1231, pA14; Waidmann TA, 1998, HEALTH AFFAIR, V17, P156, DOI 10.1377/hlthaff.17.2.156; 1998, CONSUMER REPORTS SEP, P27	18	12	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2001	344	12					928	931		10.1056/NEJM200103223441211	http://dx.doi.org/10.1056/NEJM200103223441211			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412PN	11259729				2022-12-28	WOS:000167563700011
J	Schroeder, JI; Kwak, JM; Allen, GJ				Schroeder, JI; Kwak, JM; Allen, GJ			Guard cell abscisic acid signalling and engineering drought hardiness in plants	NATURE			English	Article							SLOW ANION CHANNELS; CYCLIC ADP-RIBOSE; ION CHANNELS; PROTEIN-KINASE; POTASSIUM CHANNELS; STOMATAL CLOSURE; PLASMA-MEMBRANE; K+ CHANNELS; BLUE-LIGHT; TRANSDUCTION	Guard cells are located in the epidermis of plant leaves, and in pairs surround stomatal pores. These control both the influx of CO2 as a raw material for photosynthesis and water loss from plants through transpiration to the atmosphere. Guard cells have become a highly developed system for dissecting early signal transduction mechanisms in plants. In response to drought, plants synthesize the hormone abscisic acid, which triggers closing of stomata, thus reducing water loss. Recently, central regulators of guard cell abscisic acid signalling have been discovered. The molecular understanding of the guard cell signal transduction network opens possibilities for engineering stomatal responses to control CO2 intake and plant water loss.	Univ Calif San Diego, Div Biol, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol, Cell & Dev Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Kwak, June M/G-8332-2011; CALLISTA, audrey/AAD-8511-2022	Kwak, June M/0000-0001-6948-5155; 				Allen GJ, 1997, ADV BOT RES, V25, P217, DOI 10.1016/S0065-2296(08)60154-8; Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; Allen GJ, 1999, PLANT J, V19, P735, DOI 10.1046/j.1365-313x.1999.00574.x; Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; ARMSTRONG F, 1995, P NATL ACAD SCI USA, V92, P9520, DOI 10.1073/pnas.92.21.9520; Assmann SM, 1999, PLANT PHYSIOL, V119, P809, DOI 10.1104/pp.119.3.809; Bewell MA, 1999, FEBS LETT, V458, P41, DOI 10.1016/S0014-5793(99)01109-6; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; Ferl RJ, 1996, ANNU REV PLANT PHYS, V47, P49, DOI 10.1146/annurev.arplant.47.1.49; GILROY S, 1991, PLANT CELL, V3, P333, DOI 10.1105/tpc.3.4.333; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Grabov A, 1998, J EXP BOT, V49, P351, DOI 10.1093/jexbot/49.suppl_1.351; Grabov A, 1998, P NATL ACAD SCI USA, V95, P4778, DOI 10.1073/pnas.95.8.4778; Hamilton DWA, 2000, P NATL ACAD SCI USA, V97, P4967, DOI 10.1073/pnas.080068897; Himmelbach A, 1998, PHILOS T R SOC B, V353, P1439, DOI 10.1098/rstb.1998.0299; Homann U, 1999, FEBS LETT, V460, P495, DOI 10.1016/S0014-5793(99)01396-4; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; Kinoshita T, 1999, EMBO J, V18, P5548, DOI 10.1093/emboj/18.20.5548; Knetsch MLW, 1996, PLANT CELL, V8, P1061, DOI 10.1105/tpc.8.6.1061; Leckie CP, 1998, P NATL ACAD SCI USA, V95, P15837, DOI 10.1073/pnas.95.26.15837; Lee S, 1999, PLANT PHYSIOL, V121, P147, DOI 10.1104/pp.121.1.147; Lemtiri-Chlieh F, 2000, P NATL ACAD SCI USA, V97, P8687, DOI 10.1073/pnas.140217497; Leonhardt N, 1997, P NATL ACAD SCI USA, V94, P14156, DOI 10.1073/pnas.94.25.14156; Leonhardt N, 1999, PLANT CELL, V11, P1141; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Leyman B, 1999, SCIENCE, V283, P537, DOI 10.1126/science.283.5401.537; Li JX, 1996, PLANT CELL, V8, P2359, DOI 10.1105/tpc.8.12.2359; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; MacRobbie EAC, 2000, P NATL ACAD SCI USA, V97, P12361, DOI 10.1073/pnas.220417197; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; MCAINSH MR, 1990, NATURE, V343, P186, DOI 10.1038/343186a0; McAinsh MR, 1997, PHYSIOL PLANTARUM, V100, P16, DOI 10.1034/j.1399-3054.1997.1000102.x; Mori IC, 1997, PLANT PHYSIOL, V113, P833, DOI 10.1104/pp.113.3.833; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Pei ZM, 1998, SCIENCE, V282, P287, DOI 10.1126/science.282.5387.287; Plesch G, 2000, GENE, V249, P83, DOI 10.1016/S0378-1119(00)00150-5; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Pottosin II, 1997, PLANT J, V12, P1387, DOI 10.1046/j.1365-313x.1997.12061387.x; SCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9535, DOI 10.1073/pnas.92.21.9535; SCHROEDER JI, 1989, TRENDS BIOCHEM SCI, V14, P187, DOI 10.1016/0968-0004(89)90272-7; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Sutton F, 2000, PLANT PHYSIOL, V124, P223, DOI 10.1104/pp.124.1.223; Torsethaugen G, 1999, P NATL ACAD SCI USA, V96, P13577, DOI 10.1073/pnas.96.23.13577; WARD JM, 1995, PLANT CELL, V7, P833, DOI 10.1105/tpc.7.7.833; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Yates JR, 2000, TRENDS GENET, V16, P5, DOI 10.1016/S0168-9525(99)01879-X	49	560	623	2	206	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					327	330		10.1038/35066500	http://dx.doi.org/10.1038/35066500			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268200				2022-12-28	WOS:000167464100038
J	Siddiqa, A; Sims-Mourtada, JC; Guzman-Rojas, L; Rangel, R; Guret, C; Madrid-Marina, V; Sun, Y; Martinez-Valdez, H				Siddiqa, A; Sims-Mourtada, JC; Guzman-Rojas, L; Rangel, R; Guret, C; Madrid-Marina, V; Sun, Y; Martinez-Valdez, H			Regulation of CD40 and CD40 ligand by the AT-hook transcription factor AKNA	NATURE			English	Article							GERMINAL-CENTERS; B-CELLS; IMMUNE-RESPONSE; BINDING; GENE; EXPRESSION; ACTIVATION; PROTEINS; COSTIMULATION; LYMPHOCYTES	Proteins containing AT hooks bind A/T-rich DNA through a nine-amino-acid motif and are thought to co-regulate transcription by modifying the architecture of DNA, thereby enhancing the accessibility of promoters to transcription factors(1,2). Here we describe AKNA, a human AT-hook protein that directly binds the A/T-rich regulatory elements of the promoters of CD40 and CD40 ligand (CD40L) and coordinately regulates their expression. Consistent with its function, AKNA is a nuclear protein that contains multiple PEST protein-cleavage motifs, which are common in regulatory proteins with high turnover rates(3). AKNA is mainly expressed by B and T lymphocytes, natural killer cells and dendritic cells. During B-lymphocyte differentiation, AKNA is mainly expressed by germinal centre B lymphocytes, a stage in which receptor and ligand interactions are crucial for B-lymphocyte maturation(4-12). Our findings show that an AT-hook molecule can coordinately regulate the expression of a key receptor and its ligand, and point towards a molecular mechanism that explains homotypic cell interactions.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Schering Plough, Lab Immunol Res, F-69571 Dardilly, France; Inst Nacl Salud Publ, Ctr Invest Sobre Enfermedades Infecciosas, Cuernavaca 62508, Morelos, Mexico	University of Texas System; UTMD Anderson Cancer Center; Merck & Company; Instituto Nacional de Salud Publica	Martinez-Valdez, H (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Box 178,1515 Holcombe Blvd, Houston, TX 77030 USA.		Rangel, Roberto/AHE-6583-2022	Rangel, Roberto/0000-0002-9088-7957				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; CHEVAILLIER P, 1993, INT J BIOCHEM, V25, P479, DOI 10.1016/0020-711X(93)90653-V; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; Clodi K, 1998, BRIT J HAEMATOL, V103, P270, DOI 10.1046/j.1365-2141.1998.01031.x; Craxton A, 1998, J IMMUNOL, V161, P3225; FRIEDMANN M, 1993, NUCLEIC ACIDS RES, V21, P4259, DOI 10.1093/nar/21.18.4259; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; Grammer AC, 1999, J IMMUNOL, V163, P4150; Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x; Guzman-Rojas L, 2000, INT IMMUNOL, V12, P607, DOI 10.1093/intimm/12.5.607; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; KRAMMER PH, 1994, IMMUNOL REV, V142, P175, DOI 10.1111/j.1600-065X.1994.tb00889.x; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X; Liu YJ, 1996, IMMUNITY, V4, P603, DOI 10.1016/S1074-7613(00)80486-0; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Lo HW, 1997, J BIOL CHEM, V272, P32743, DOI 10.1074/jbc.272.52.32743; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Martin G, 1996, ARCH SUICIDE RES, V2, P183, DOI 10.1080/13811119608259000; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; REEVES R, 1990, J BIOL CHEM, V265, P8573; RUDERT F, 1995, DNA CELL BIOL, V14, P931, DOI 10.1089/dna.1995.14.931; SCHUBERT LA, 1995, J BIOL CHEM, V270, P29624; THORBECKE GJ, 1994, FASEB J, V8, P832, DOI 10.1096/fasebj.8.11.8070632	30	62	64	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					383	387		10.1038/35066602	http://dx.doi.org/10.1038/35066602			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268217				2022-12-28	WOS:000167464100055
J	Slusky, JS; Rogado, N; Regan, KA; Hayward, MA; Khalifah, P; He, T; Inumaru, K; Loureiro, SM; Haas, MK; Zandbergen, HW; Cava, RJ				Slusky, JS; Rogado, N; Regan, KA; Hayward, MA; Khalifah, P; He, T; Inumaru, K; Loureiro, SM; Haas, MK; Zandbergen, HW; Cava, RJ			Loss of superconductivity with the addition of Al to MgB2 and a structural transition in Mg1-xAlx	NATURE			English	Article								The basic magnetic and electronic properties of most binary compounds have been well known for decades. The recent discovery(1) of superconductivity at 39 K in the simple binary ceramic compound magnesium diboride, MgB2, was therefore surprising. Indeed, this material has been known and structurally characterized since the mid 1950s (ref. 2), and is readily available from chemical suppliers (it is commonly used as a starting material for chemical metathesis reactions(3)). Here we show that the addition of electrons to MgB2, through partial substitution of Al for Mg, results in the loss of superconductivity. Associated with the Al substitution is a subtle but distinct structural transition, reflected in the partial collapse of the spacing between boron layers near an Al content of 10 per cent. This indicates that superconducting MgB2 is poised very near a structural instability at slightly higher electron concentrations.	Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Princeton Univ, Princeton Mat Inst, Princeton, NJ 08544 USA	Princeton University; Princeton University	Cava, RJ (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.		Hayward, Michael/B-8005-2008; Inumaru, Kei/J-9292-2015	Hayward, Michael/0000-0002-6248-2063; Inumaru, Kei/0000-0001-6876-3854; Khalifah, Peter/0000-0002-2216-0377; Slusky, Joanna/0000-0003-0842-6340				ARMSTRONG DR, 1979, J CHEM SOC FARAD T 2, V75, P12, DOI 10.1039/f29797500012; BUKO SL, 2001, CONDMAT0101463; Ivanovskii AL, 2000, RUSS J INORG CHEM+, V45, P1234; JONES ME, 1954, J AM CHEM SOC, V76, P1434, DOI 10.1021/ja01634a089; KILLIAN EG, 1996, CHEM MATER, V8, P333; KORTIS J, 2001, CONDMAT0101446; Massalski T. B., 1990, BINARY ALLOY PHASE D, P498; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; VEKSHINA NV, 1971, J APPL CHEM-USSR+, V44, P958; VILLARS P, 1991, PEARSONS HDB CRYSTAL, P127	10	423	435	0	63	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					343	345		10.1038/35066528	http://dx.doi.org/10.1038/35066528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268204				2022-12-28	WOS:000167464100042
J	Detmar, SB; Muller, MJ; Wever, LDV; Schornagel, JH; Aaronson, NK				Detmar, SB; Muller, MJ; Wever, LDV; Schornagel, JH; Aaronson, NK			Patient-physician communication during outpatient palliative treatment visits - An observational study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; CANCER-PATIENTS; CLINICAL-PRACTICE; CONSULTATION; CARE; SATISFACTION; PARTICIPATION; IMPACT; SKILLS	Context Improving health-related quality of life (HRQL) is an important goal of palliative treatment, but little is known about actual patient-physician communication regarding HRQL topics during palliative treatment. Objectives To investigate the content of routine communication regarding 4 specific HRQL issues between oncologists and their patients and to identify patient-, physician-, and visit-specific factors significantly associated with discussion of such issues. Design Observational study conducted between lune 1996 and January 1998, Setting Outpatient palliative chemotherapy clinic of a cancer hospital in the Netherlands, Participants Ten oncologists and 240 of their patients (72% female; mean age, 55 years) who had incurable cancer and were receiving outpatient palliative chemotherapy. Main outcome Measures Patient and physician questionnaires and audiotape analysis of communication regarding daily activities, emotional functioning, pain, and fatigue during an outpatient consultation using the Roter Interaction Analysis System. Results Physicians devoted 64% of their conversation to medical/technical issues and 23% to HRQL issues. Patients' communication behavior was divided more equally between medical/technical issues (41%) and HRQL topics (48%). Of the independent variables investigated, patients' self-reported HRQL was the most powerful predictor of discussing HRQL issues. Nevertheless, in 20% to 54% of the consultations in which patients were experiencing serious HRQL problems, no time was devoted to discussion of those problems. In particular, these patients' emotional functioning and fatigue were unaddressed 54% and 48% of the time, respectively. Discussion of HRQL issues was not more frequent in consultations in which tumor response was evaluated. Conclusion Despite increasing recognition of the importance of maintaining patients' HRQL as a goal of palliative treatment, the amount of patient-physician communication devoted to such issues remains limited and appears to make only a modest contribution, at least in an explicit sense, to the evaluation of treatment efficacy in daily clinical practice.	Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, NL-1066 CX Amsterdam, Netherlands; Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Med Oncol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Aaronson, NK (corresponding author), Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	naaron@nki.nl	Aaronson, Neil K/AAV-8194-2021					AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; [Anonymous], 1996, J Clin Oncol, V14, P671; Baile W F, 1997, J Cancer Educ, V12, P166; Boon H, 1998, PATIENT EDUC COUNS, V35, P161, DOI 10.1016/S0738-3991(98)00063-9; BUTOW PN, 1994, ANN ONCOL, V5, P199, DOI 10.1093/oxfordjournals.annonc.a058793; Byrne P.S., 1976, DOCTORS TALKING PATI; Cella D F, 1990, Oncology (Williston Park), V4, P29; Coulter A, 1997, J Health Serv Res Policy, V2, P112; CULL A, 1995, BRIT J CANCER, V72, P229, DOI 10.1038/bjc.1995.308; Curt GA, 2000, ONCOLOGIST S, V5, P9, DOI DOI 10.1634/THEONCOLOGIST.5-SUPPL_2-9; Davidoff F, 1997, ANN INTERN MED, V127, P483, DOI 10.7326/0003-4819-127-6-199709150-00011; Detmar SB, 2000, J CLIN ONCOL, V18, P3295, DOI 10.1200/JCO.2000.18.18.3295; FORD S, 1994, BRIT J CANCER, V70, P767, DOI 10.1038/bjc.1994.393; Ford S, 1996, SOC SCI MED, V42, P1511, DOI 10.1016/0277-9536(95)00265-0; FUNCH DP, 1988, MED CARE, V26, P1000, DOI 10.1097/00005650-198810000-00008; GANZ PA, 1994, CANCER, V74, P1445, DOI 10.1002/1097-0142(19940815)74:4+<1445::AID-CNCR2820741608>3.0.CO;2-#; Goldberg R, 1990, J Cancer Educ, V5, P193; Goldstein M., 1987, MULTILEVEL MODELS ED; GOUGH IR, 1991, CANCER, V68, P220, DOI 10.1002/1097-0142(19910701)68:1<220::AID-CNCR2820680140>3.0.CO;2-H; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; HALL JA, 1994, HEALTH PSYCHOL, V13, P384, DOI 10.1037/0278-6133.13.5.384; Hancock Barry W., 1993, Current Opinion in Oncology, V5, P655, DOI 10.1097/00001622-199307000-00006; HIGGINSON I, 1993, J PUBLIC HEALTH MED, V15, P3, DOI 10.1093/oxfordjournals.pubmed.a042817; LEVINSON W, 1995, J GEN INTERN MED, V10, P375, DOI 10.1007/BF02599834; MAGUIRE P, 1988, BRIT MED J, V297, P847, DOI 10.1136/bmj.297.6652.847; Maguire P, 1996, EUR J CANCER, V32A, P78, DOI 10.1016/0959-8049(95)00527-7; Marvel MK, 1998, J FAM PRACTICE, V47, P343; McCann S, 1996, PSYCHOL HEALTH, V11, P857, DOI 10.1080/08870449608400281; Montazeri A, 1996, EUR J CANCER, V32A, P2284, DOI 10.1016/S0959-8049(96)00288-2; NELSON E, 1987, J CHRON DIS, V40, pS55, DOI 10.1016/S0021-9681(87)80033-4; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Ong LML, 1998, PSYCHO-ONCOL, V7, P387, DOI 10.1002/(SICI)1099-1611(1998090)7:5<387::AID-PON316>3.3.CO;2-7; Ong LML, 2000, J CLIN ONCOL, V18, P3052, DOI 10.1200/JCO.2000.18.16.3052; Ong LML, 1999, PSYCHO-ONCOLOGY, V8, P155; Osoba D, 1996, CANCER TREAT REV, V22, P69, DOI 10.1016/S0305-7372(96)90066-3; PAYNE SA, 1992, SOC SCI MED, V35, P1505, DOI 10.1016/0277-9536(92)90053-S; PORZSOLT F, 1993, J CLIN ONCOL, V11, P378, DOI 10.1200/JCO.1993.11.2.378; Razavi D, 1997, EUR J CANCER, V33, pS15, DOI 10.1016/S0959-8049(97)00195-0; ROLAND MO, 1986, BRIT MED J, V292, P874, DOI 10.1136/bmj.292.6524.874; Roter D.L., 1992, DOCTORS TALKING PATI; Roter DL, 1997, JAMA-J AM MED ASSOC, V277, P350, DOI 10.1001/jama.277.4.350; ROTER DL, 1991, HUISARTS WET, V34, P295; SUTHERLAND HJ, 1990, J CLIN EPIDEMIOL, V43, P661, DOI 10.1016/0895-4356(90)90036-O; Taenzer P, 2000, PSYCHO-ONCOLOGY, V9, P203, DOI 10.1002/1099-1611(200005/06)9:3<203::AID-PON453>3.3.CO;2-P; Taylor KM, 1996, QUAL LIFE RES, V5, P5, DOI 10.1007/BF00435963; Till J E, 1994, Can J Oncol, V4, P243; van Dulmen AM, 2000, EUR J PEDIATR, V159, P489, DOI 10.1007/s004310051316; VANWIJK CMTG, 1991, WOMEN HEALTH, V17, P91; Wagner AK, 1997, QUAL LIFE RES, V6, P329, DOI 10.1023/A:1018479209369; WAITZKIN H, 1984, JAMA-J AM MED ASSOC, V252, P2441, DOI 10.1001/jama.252.17.2441; WAITZKIN H, 1985, J HEALTH SOC BEHAV, V26, P81, DOI 10.2307/2136599	51	131	132	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2001	285	10					1351	1357		10.1001/jama.285.10.1351	http://dx.doi.org/10.1001/jama.285.10.1351			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	408QK	11255393	Bronze			2022-12-28	WOS:000167339000030
J	Luce, JM; Luce, JA				Luce, JM; Luce, JA			Management of dyspnea in patients with far-advanced lung disease - "Once I lose it, it's kind of hard to catch it..."	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AIR-FLOW LIMITATION; OBSTRUCTIVE PULMONARY-DISEASE; EXERTIONAL BREATHLESSNESS; PRESSURE VENTILATION; EXERCISE TOLERANCE; REDUCES DYSPNEA; OUTCOMES; RELIEF; HYPOVENTILATION; REHABILITATION	Dyspnea is a common problem among patients with interstitial fibrosis, lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease. The slow but steady progression of such diseases, often punctuated by acute exacerbations or secondary illnesses, can lead to decisionmaking dilemmas among patients and their caregivers, such as when to accept mechanical ventilation, when to forgo aggressive therapies, and when to make formal end-of-life care plans. Two cases, a 74-year-old woman with dyspnea secondary to emphysema and a 65-year-old woman with recurrent lung cancer and severe exertional fatigue and dyspnea, illustrate how dyspneic patients approaching the end of life can be evaluated and treated. Four management strategies for dyspnea are discussed: reducing ventilatory impedance, reducing ventilatory demand, improving respiratory muscle function, and altering central perception. Physicians should encourage endstage lung disease patients and their families to discuss issues such as hospitalization and mechanical ventilation, to prepare advance directives, and to participate in a plan to manage their dyspnea.	San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Luce, JM (corresponding author), San Francisco Gen Hosp, Div Pulm & Crit Care Med, 1001 Potrero Ave,Room 5K1, San Francisco, CA 94110 USA.	john_luce@sfgh.org						AHMEDZAI S, 1998, OXFORD TXB PALLIATIV, P583; Altose MD, 2000, NEW ENGL J MED, V343, P1902; American Thoracic Society, 1999, AM J RESP CRIT CARE, V159, P1666; American Thoracic Society, 1995, AM J RESP CRIT CARE, V152, P577; [Anonymous], 1980, Ann Intern Med, V93, P391; Antony VB, 2000, AM J RESP CRIT CARE, V162, P1987, DOI 10.1164/ajrccm.162.5.ats8-00; AUBIER M, 1980, AM REV RESPIR DIS, V122, P747, DOI 10.1164/arrd.1980.122.5.747; BANZETT RB, 1987, J APPL PHYSIOL, V62, P567, DOI 10.1152/jappl.1987.62.2.567; BELMAN MJ, 1991, CHEST, V99, P566, DOI 10.1378/chest.99.3.566; Booth S, 1996, AM J RESP CRIT CARE, V153, P1515, DOI 10.1164/ajrccm.153.5.8630595; CASABURI R, 1991, AM REV RESPIR DIS, V143, P9, DOI 10.1164/ajrccm/143.1.9; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Cristiano LM, 1997, AM J RESP CRIT CARE, V155, P1552, DOI 10.1164/ajrccm.155.5.9154856; DALES RE, 1989, AM REV RESPIR DIS, V139, P1459, DOI 10.1164/ajrccm/139.6.1459; DEWAN NA, 1994, CHEST, V105, P1061, DOI 10.1378/chest.105.4.1061; EFTHIMIOU J, 1988, AM REV RESPIR DIS, V137, P1075, DOI 10.1164/ajrccm/137.5.1075; Garrod R, 2000, AM J RESP CRIT CARE, V162, P1335, DOI 10.1164/ajrccm.162.4.9912029; HARVER A, 1989, ANN INTERN MED, V111, P117, DOI 10.7326/0003-4819-111-2-117; Heffner JE, 1997, AM J RESP CRIT CARE, V155, P1055, DOI 10.1164/ajrccm.155.3.9116986; *HLTH CAR FIN ADM, 2001, HOM OX THER REQ MED; Jacox A, 1994, AHCPR PUBLICATION; Keller CA, 1997, AM J RESP CRIT CARE, V156, P60, DOI 10.1164/ajrccm.156.1.9609101; KIKUCHI Y, 1994, NEW ENGL J MED, V330, P1329, DOI 10.1056/NEJM199405123301901; Lee RB, 2000, SEMIN SURG ONCOL, V18, P173; LIGHT RW, 1989, AM REV RESPIR DIS, V139, P126, DOI 10.1164/ajrccm/139.1.126; Luce JM, 2000, AM J RESP CRIT CARE, V162, P2029, DOI 10.1164/ajrccm.162.6.1-00; Lynn J, 2000, J AM GERIATR SOC, V48, pS91, DOI 10.1111/j.1532-5415.2000.tb03147.x; MAN GCW, 1986, CHEST, V90, P832, DOI 10.1378/chest.90.6.832; Meek PM, 1999, AM J RESP CRIT CARE, V159, P321; Mejia R, 1999, AM J RESP CRIT CARE, V159, P1485, DOI 10.1164/ajrccm.159.5.9810039; Mercadante S, 2000, J PAIN SYMPTOM MANAG, V20, P104, DOI 10.1016/S0885-3924(00)00160-3; MOUNTAIN R, 1978, NEW ENGL J MED, V298, P521, DOI 10.1056/NEJM197803092981001; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Nishino T, 2000, AM J RESP CRIT CARE, V161, P1963, DOI 10.1164/ajrccm.161.6.9910009; ODonnell DE, 1997, AM J RESP CRIT CARE, V155, P530, DOI 10.1164/ajrccm.155.2.9032190; ODONNELL DE, 1993, AM REV RESPIR DIS, V148, P1351, DOI 10.1164/ajrccm/148.5.1351; ODonnell DE, 1997, AM J RESP CRIT CARE, V155, P109, DOI 10.1164/ajrccm.155.1.9001298; ODONNELL DE, 1995, AM J RESP CRIT CARE, V152, P2005, DOI 10.1164/ajrccm.152.6.8520769; Poole PJ, 1998, AM J RESP CRIT CARE, V157, P1877, DOI 10.1164/ajrccm.157.6.9711061; RIES AL, 1995, ANN INTERN MED, V122, P823, DOI 10.7326/0003-4819-122-11-199506010-00003; Robinson TD, 2000, AM J RESP CRIT CARE, V161, P1524, DOI 10.1164/ajrccm.161.5.9904119; SCHWARTZSTEIN RM, 1987, AM REV RESPIR DIS, V136, P58, DOI 10.1164/ajrccm/136.1.58; SHAPIRO SH, 1992, LANCET, V340, P1425, DOI 10.1016/0140-6736(92)92620-U; SHARP JT, 1980, AM REV RESPIR DIS, V122, P201; SILVERMAN M, 1988, AM REV RESPIR DIS, V137, P206, DOI 10.1164/ajrccm/137.1.206; SIMON PM, 1990, AM REV RESPIR DIS, V142, P1009, DOI 10.1164/ajrccm/142.5.1009; SMITH K, 1992, AM REV RESPIR DIS, V145, P533, DOI 10.1164/ajrccm/145.3.533; Smoller JW, 1996, AM J RESP CRIT CARE, V154, P6, DOI 10.1164/ajrccm.154.1.8680700; Smoller JW, 1998, PSYCHOSOMATICS, V39, P24, DOI 10.1016/S0033-3182(98)71377-5; STULBARG MS, 1989, CHEST, V95, P1123, DOI 10.1378/chest.95.5.1123; STULBARG MS, 2000, TXB RESP MED, P541; WOODCOCK AA, 1981, BRIT MED J, V283, P343, DOI 10.1136/bmj.283.6287.343	52	38	39	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2001	285	10					1331	1337		10.1001/jama.285.10.1331	http://dx.doi.org/10.1001/jama.285.10.1331			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408QK	11255389				2022-12-28	WOS:000167339000026
J	Fandrich, M; Fletcher, MA; Dobson, CM				Fandrich, M; Fletcher, MA; Dobson, CM			Amyloid fibrils from muscle myoglobin - Even an ordinary globular protein can assume a rogue guise if conditions are right.	NATURE			English	Article									Univ Oxford, New Chem Lab, Oxford Ctr Mol Sci, Oxford OX1 3QT, England	University of Oxford	Fandrich, M (corresponding author), Univ Oxford, New Chem Lab, Oxford Ctr Mol Sci, S Parks Rd, Oxford OX1 3QT, England.							ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Eliezer D, 1998, NAT STRUCT BIOL, V5, P148; EVANS SV, 1988, J BIOL CHEM, V263, P4263; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Smeller L, 1999, BIOCHEMISTRY-US, V38, P3816, DOI 10.1021/bi981693n; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; TAN SY, 1994, HISTOPATHOLOGY, V25, P403, DOI 10.1111/j.1365-2559.1994.tb00001.x; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X	12	697	715	4	114	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					165	166		10.1038/35065514	http://dx.doi.org/10.1038/35065514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242064				2022-12-28	WOS:000167320500030
J	Strogatz, SH				Strogatz, SH			Exploring complex networks	NATURE			English	Review							SMALL-WORLD NETWORKS; WEAKLY COUPLED OSCILLATORS; MEAN-FIELD THEORY; FUNCTIONAL CONNECTIVITY; DEGREE SEQUENCE; PHASE-LOCKING; RANDOM GRAPHS; LASER ARRAYS; SYNCHRONIZATION; TOPOLOGY	The study of networks pervades all of science, from neurobiology to statistical physics. The most basic issues are structural: how does one characterize the wiring diagram of a food web or the Internet or the metabolic network of the bacterium Escherichia coli? Are there any unifying principles underlying their topology? From the perspective of nonlinear dynamics, we would also like to understand how an enormous network of interacting dynamical systems - be they neurons, power stations or lasers - will behave collectively, given their individual dynamics and coupling architecture. Researchers are only now beginning to unravel the structure and dynamics of complex networks.	Cornell Univ, Dept Theoret & Appl Mech, Ithaca, NY 14853 USA; Cornell Univ, Ctr Appl Math, Ithaca, NY 14853 USA	Cornell University; Cornell University	Strogatz, SH (corresponding author), Cornell Univ, Dept Theoret & Appl Mech, 212 Kimball Hall, Ithaca, NY 14853 USA.		Xie, Jianjun/D-9838-2012; Ma, Jialin/ABG-2965-2021; Strogatz, Steven H/A-1641-2014	Strogatz, Steven H/0000-0003-2923-3118				ABBOTT LF, 1993, PHYS REV E, V48, P1483, DOI 10.1103/PhysRevE.48.1483; ABELLO J, 1998, LECT NOTES COMPUTER, V1461, P332; Adamic LA, 1999, LECT NOTES COMPUT SC, V1696, P443; AIELLO W, IN PRESS EXP MATH; Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; [Anonymous], 1992, AYS NEUROANATOMY C E; [Anonymous], 1995, HOME UNIVERSE SEARCH; Arbib MA, 1995, HDB BRAIN THEORY NEU; Ball F, 1997, ANN APPL PROBAB, V7, P46; Banavar JR, 2000, PHYS REV LETT, V84, P4745, DOI 10.1103/PhysRevLett.84.4745; Barabasi AL, 1999, PHYSICA A, V272, P173, DOI 10.1016/S0378-4371(99)00291-5; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BARBOUR AD, 2000, CONDMAT0006001; Barthelemy M, 1999, PHYS REV LETT, V82, P3180, DOI 10.1103/PhysRevLett.82.3180; BERNARD HR, 1988, ETHNOLOGY, V27, P155, DOI 10.2307/3773626; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bollobas B., 1985, RANDOM GRAPHS; Boots M, 1999, P ROY SOC B-BIOL SCI, V266, P1933, DOI 10.1098/rspb.1999.0869; BORNHOLDT S, 2000, CONDMAT0008465; Bressloff PC, 1999, PHYS REV E, V60, P2160, DOI 10.1103/PhysRevE.60.2160; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Campbell D., 1989, LECT SCI COMPLEXITY, P3; CHERNIAK C, 1994, J NEUROSCI, V14, P2418; Cohen J.E., 1990, COMMUNITY FOOD WEBS; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; DAIDO H, 1988, PHYS REV LETT, V61, P231, DOI 10.1103/PhysRevLett.61.231; Davis GF., 1996, CORPORATE GOVERNANCE, V4, P154, DOI DOI 10.1111/J.1467-8683.1996.TB00144.X; Dorogovtsev SN, 2000, PHYS REV E, V62, P1842, DOI 10.1103/PhysRevE.62.1842; ERDOS P, 1960, B INT STATIST INST, V38, P343; ERMENTROUT GB, 1984, SIAM J MATH ANAL, V15, P215, DOI 10.1137/0515019; FABINY L, 1993, PHYS REV A, V47, P4287, DOI 10.1103/PhysRevA.47.4287; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Golomb D, 2000, NEURAL COMPUT, V12, P1095, DOI 10.1162/089976600300015529; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HOPFIELD JJ, 1994, PHYS TODAY, V47, P40, DOI 10.1063/1.881412; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; KAPIVSKY PL, 2000, PHYS REV LETT, V85, P4629; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Kephart J. O., 1991, Proceedings. 1991 IEEE Computer Society Symposium on Research in Security and Privacy (Cat. No.91CH2986-8), P343, DOI 10.1109/RISP.1991.130801; KIRBY D, 1998, NY TIMES        0221; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; KOGUT B, IN PRESS AM SOCIOL R; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; KOPELL N, 1986, COMMUN PUR APPL MATH, V39, P623, DOI 10.1002/cpa.3160390504; KOURTCHATOV SY, 1995, PHYS REV A, V52, P4089, DOI 10.1103/PhysRevA.52.4089; Kozyreff G, 2000, PHYS REV LETT, V85, P3809, DOI 10.1103/PhysRevLett.85.3809; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Levin SA, 1997, SCIENCE, V275, P334, DOI 10.1126/science.275.5298.334; LI RD, 1992, PHYS REV A, V46, P4252, DOI 10.1103/PhysRevA.46.4252; May R.M., 1973, STABILITY COMPLEXITY; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; MITCHISON G, 1991, P ROY SOC B-BIOL SCI, V245, P151, DOI 10.1098/rspb.1991.0102; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Molloy M, 1998, COMB PROBAB COMPUT, V7, P295, DOI 10.1017/S0963548398003526; Newman MEJ, 2000, J STAT PHYS, V101, P819, DOI 10.1023/A:1026485807148; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2000, PHYS REV LETT, V84, P3201, DOI 10.1103/PhysRevLett.84.3201; NEWMAN MEJ, 2000, CONDMAT0007235; Pantaleone J, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.073002; Pecora LM, 1997, CHAOS, V7, P520, DOI 10.1063/1.166278; Perez CJ, 1996, INT J MOD PHYS B, V10, P1111, DOI 10.1142/S0217979296000416; Peskin C.S., 1975, MATH ASPECTS HEART P, P268; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; SAKAGUCHI H, 1987, PROG THEOR PHYS, V77, P1005, DOI 10.1143/PTP.77.1005; SEGLEN PO, 1992, J AM SOC INFORM SCI, V43, P628, DOI 10.1002/(SICI)1097-4571(199210)43:9<628::AID-ASI5>3.0.CO;2-0; Sigvardt K.A., 1992, Seminars in the Neurosciences, V4, P37, DOI 10.1016/1044-5765(92)90032-W; SIMON HA, 1955, BIOMETRIKA, V42, P425; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Stephan KE, 2000, PHILOS T R SOC B, V355, P111, DOI 10.1098/rstb.2000.0552; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Turcotte D. L., 1997, FRACTALS CHAOS GEOLO; *W SYST COORD COUN, 1996, DIST REP POW SYST OU; WAGNER A, 2000, SMALL WORLD LARGE ME; Wallinga J, 1999, TRENDS MICROBIOL, V7, P372, DOI 10.1016/S0966-842X(99)01546-2; WALSH T, P 16 INT JOINT C ART, P1172; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; WATTS D, 1999, SMALL WORLDS; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WATTS DJ, 2000, SIMPLE MODEL FADS CA; Weiss C. O., 1991, DYNAMICS OF LASERS; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; Wiesenfeld K, 1998, PHYS REV E, V57, P1563, DOI 10.1103/PhysRevE.57.1563; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Wilson E.O., 1998, CONSILIENCE UNITY KN, P85; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; WINFUL HG, 1988, APPL PHYS LETT, V53, P1894, DOI 10.1063/1.100363; 1999, NEWSWEEK        1011, P6	97	5573	5862	33	1163	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					268	276		10.1038/35065725	http://dx.doi.org/10.1038/35065725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11258382	Bronze			2022-12-28	WOS:000167320500061
J	Abercrombie, RE; Ekstrom, G				Abercrombie, RE; Ekstrom, G			Earthquake slip on oceanic transform faults	NATURE			English	Article							MACQUARIE RIDGE EARTHQUAKE; MOMENT TENSOR SOLUTIONS; NORTH-ATLANTIC; SLOW PRECURSOR; DEPTH; SEISMICITY; EVOLUTION; ZONE	Oceanic transform faults are one of the main types of plate boundary, but the manner in which they slip remains poorly understood. Early studies suggested that relatively slow earthquake rupture might be common(1,2); moreover, it has been reported that very slow slip precedes some oceanic transform earthquakes, including the 1994 Romanche earthquake(3-5). The presence of such detectable precursors would have obvious implications for earthquake prediction. Here we model broadband seismograms of body waves to obtain well-resolved depths and rupture mechanisms for 14 earthquakes on the Romanche and Chain transform faults in the equatorial Atlantic Ocean. We found that earthquakes on the longer Romanche transform are systematically deeper than those on the neighbouring Chain transform. These depths indicate that the maximum depth of brittle failure is at a temperature of similar to 600 degreesC in oceanic lithosphere. We rnd that the body waves from the Romanche 1994 earthquake can be well modelled with relatively deep slip on a single fault, and we use the mechanism and depth of this earthquake to recalculate its source spectrum. The previously reported slow precursor can be explained as an artefact of uncertainties in the assumed model parameters.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Abercrombie, RE (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.		Ekstrom, Goran/C-9771-2012	Ekstrom, Goran/0000-0001-6410-275X; Abercrombie, Rachel/0000-0003-4515-5420				ABERCROMBIE R, 1994, B SEISMOL SOC AM, V84, P725; Antolik M, 2000, J GEOPHYS RES-SOL EA, V105, P23825, DOI 10.1029/2000JB900246; BERGMAN EA, 1988, J GEOPHYS RES-SOLID, V93, P9027, DOI 10.1029/JB093iB08p09027; BRUNE JN, 1968, J GEOPHYS RES, V73, P777, DOI 10.1029/JB073i002p00777; CHEN YS, 1988, J GEOPHYS RES-SOLID, V93, P8839, DOI 10.1029/JB093iB08p08839; DEMETS C, 1990, GEOPHYS J INT, V101, P425, DOI 10.1111/j.1365-246X.1990.tb06579.x; DETRICK RS, 1993, REV GEOPHYS, V31, P439, DOI 10.1029/93RG01952; Dziewonski AM, 1999, PHYS EARTH PLANET IN, V115, P1, DOI 10.1016/S0031-9201(99)00062-X; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; DZIEWONSKI AM, 1983, J GEOPHYS RES, V88, P3247, DOI 10.1029/JB088iB04p03247; EKSTROM G, 1989, TECTONOPHYSICS, V166, P73, DOI 10.1016/0040-1951(89)90206-0; ENGELN JF, 1986, J GEOPHYS RES-SOLID, V91, P548, DOI 10.1029/JB091iB01p00548; Harris RA, 1999, GEOPHYS RES LETT, V26, P2089, DOI 10.1029/1999GL900377; IHMLE PF, 1994, SCIENCE, V266, P1547, DOI 10.1126/science.266.5190.1547; IHMLE PF, 1993, SCIENCE, V261, P177, DOI 10.1126/science.261.5118.177; KANAMORI H, 1976, PHYS EARTH PLANET IN, V11, P312, DOI 10.1016/0031-9201(76)90018-2; KANAMORI H, 1975, B SEISMOL SOC AM, V65, P1073; KANAMORI H, 1993, NATURE, V361, P714, DOI 10.1038/361714a0; KEDAR S, 1994, J GEOPHYS RES-SOL EA, V99, P17893, DOI 10.1029/94JB01251; McGuire JJ, 1996, SCIENCE, V274, P82, DOI 10.1126/science.274.5284.82; MCKENZIE DP, 1969, GEOPHYS J ROY ASTR S, V18, P1, DOI 10.1111/j.1365-246X.1969.tb00259.x; Okal E.A., 1992, EARTH PLANET SC LETT, V57, P75; SIBSON RH, 1982, B SEISMOL SOC AM, V72, P151; SILVER PG, 1983, J GEOPHYS RES, V88, P3273, DOI 10.1029/JB088iB04p03273; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; VELASCO AA, 1995, J GEOPHYS RES-SOL EA, V100, P3989, DOI 10.1029/94JB02767; WESNOUSKY SG, 1988, NATURE, V335, P340, DOI 10.1038/335340a0; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; WIENS DA, 1983, J GEOPHYS RES, V88, P6455, DOI 10.1029/JB088iB08p06455; WILCOCK WSD, 1990, J GEOPHYS RES-SOLID, V95, P15439, DOI 10.1029/JB095iB10p15439	30	129	131	2	21	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					74	77		10.1038/35065064	http://dx.doi.org/10.1038/35065064			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242043				2022-12-28	WOS:000167194300044
J	Bannister, AJ; Zegerman, P; Partridge, JF; Miska, EA; Thomas, JO; Allshire, RC; Kouzarides, T				Bannister, AJ; Zegerman, P; Partridge, JF; Miska, EA; Thomas, JO; Allshire, RC; Kouzarides, T			Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain	NATURE			English	Article							FISSION YEAST CENTROMERES; POSITION-EFFECT VARIEGATION; DNA-REPLICATION; PROTEIN; ACETYLTRANSFERASE; HETEROCHROMATIN; BROMODOMAIN; MUTATIONS; DISRUPT; COMPLEX	Heterochromatin protein 1 (HP1) is localized at heterochromatin sites where it mediates gene silencing(1,2). The chromo domain of HP1 is necessary for both targeting and transcriptional repression(3,4). In the fission yeast Schizosaccharomyces pombe, the correct localization of Swi6 (the HP1 equivalent) depends on Clr4, a homologue of the mammalian SUV39H1 histone methylase(5,6). Both Clr4 and SUV39H1 methylate specifically lysine 9 of histone H3 (ref. 6). Here we show that HP1 can bind with high affinity to histone H3 methylated at lysine 9 but not at lysine 4. The chromo domain of HP1 is identified as its methyl-lysine-binding domain. A point mutation in the chromo domain, which destroys the gene silencing activity of HP1 in Drosophila(3), abolishes methyl-lysine-binding activity. Genetic and biochemical analysis in S. pombe shows that the methylase activity of Clr4 is necessary for the correct localization of Swi6 at centromeric heterochromatin and for gene silencing. These results provide a stepwise model for the formation of a transcriptionally silent heterochromatin: SUV39H1 places a 'methyl marker' on histone H3, which is then recognized by HP1 through its chromo domain. This model may also explain the stable inheritance of the heterochromatic state.	Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QR, England; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge; University of Cambridge; University of Edinburgh; University of Cambridge	Kouzarides, T (corresponding author), Univ Cambridge, Wellcome CRC Inst, Tennis Court Rd, Cambridge CB2 1QR, England.		Partridge, Janet/M-9352-2018; Hu, Ruogu/B-2203-2008	Partridge, Janet/0000-0003-1102-6305; Kouzarides, Tony/0000-0002-8918-4162; Allshire, Robin/0000-0002-8005-3625; Zegerman, Philip/0000-0002-5707-1083; Bannister, Andrew/0000-0002-6312-4436; Miska, Eric/0000-0002-4450-576X				ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Cavalli G, 1998, CURR OPIN CELL BIOL, V10, P354, DOI 10.1016/S0955-0674(98)80011-2; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Ekwall K, 1996, J CELL SCI, V109, P2637; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Krude T, 2000, J BIOL CHEM, V275, P13699, DOI 10.1074/jbc.275.18.13699; Krude T, 1999, EXP CELL RES, V247, P148, DOI 10.1006/excr.1998.4342; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Partridge JF, 2000, GENE DEV, V14, P783; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thompson J. F., 1998, CHROMATIN PRACTICAL, V21567, P1	21	2078	2137	5	168	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					120	124		10.1038/35065138	http://dx.doi.org/10.1038/35065138			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242054				2022-12-28	WOS:000167194300055
J	Liu, JH; Akoulitchev, S; Weber, A; Ge, H; Chuikov, S; Libutti, D; Wang, XW; Conaway, JW; Harris, CC; Conaway, RC; Reinberg, D; Levens, D				Liu, JH; Akoulitchev, S; Weber, A; Ge, H; Chuikov, S; Libutti, D; Wang, XW; Conaway, JW; Harris, CC; Conaway, RC; Reinberg, D; Levens, D			Defective interplay of activators and repressors with TFIIH in xeroderma pigmentosum	CELL			English	Article							RNA-POLYMERASE-II; GENERAL TRANSCRIPTION FACTORS; FAR UPSTREAM ELEMENT; C-MYC; PROMOTER ESCAPE; TERMINAL DOMAIN; IN-VIVO; DNA; INITIATION; COMPLEX	Inherited mutations of the TFIIH helicase subunits xeroderma pigmentosum (XP) B or XPD yield overlapping DNA repair and transcription syndromes. The high risk of cancer in these patients is not fully explained by the repair defect. The transcription defect is subtle and has proven more difficult to evaluate. Here, XPB and XPD mutations are shown to block transcription activation by the FUSE Binding Protein (FBP), a regulator of c-myc expression, and repression by the FBP Interacting Repressor (FIR). Through TFIIH, FBP facilitates transcription until promoter escape, whereas after initiation, FIR uses TFIIH to delay promoter escape. Mutations in TFIIH that impair regulation by FBP and FIR affect proper regulation of c-myc expression and have implications in the development of malignancy.	NCI, Gene Regulat Sect, Pathol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Mol Embryol Lab, NIH, Bethesda, MD 20892 USA; NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Div Nucl Acids Enzymol,HHMI, Piscataway, NJ 08854 USA; Oklahoma Med Res Fdn, Program Mol & Cell Biol, Oklahoma City, OK 73104 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Oklahoma Medical Research Foundation	Levens, D (corresponding author), NCI, Gene Regulat Sect, Pathol Lab, NIH, Bethesda, MD 20892 USA.		Wang, Xin Wei/B-6162-2009; Levens, David/C-9216-2009	Wang, Xin Wei/0000-0001-9735-606X; Levens, David/0000-0002-7616-922X; Reinberg, Danny/0000-0003-4288-2016; Weber, Achim/0000-0003-0073-3637; Conaway, Joan/0000-0002-2786-0663	NIGMS NIH HHS [R37 GM41628, GM37120, GM48518] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037120, R01GM048518, R37GM041628, R01GM037120] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKOULITCHEV S, 1995, NATURE, V377, P557, DOI 10.1038/377557a0; Albert T, 1997, MOL CELL BIOL, V17, P4363, DOI 10.1128/MCB.17.8.4363; Araujo SJ, 2000, GENE DEV, V14, P349; AVIGAN MI, 1990, J BIOL CHEM, V265, P18538; BAZAR L, 1995, J BIOL CHEM, V270, P8241, DOI 10.1074/jbc.270.14.8241; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Berneburg M, 2000, CANCER RES, V60, P431; Blau J, 1996, MOL CELL BIOL, V16, P2044; Bradsher J, 2000, J BIOL CHEM, V275, P2532, DOI 10.1074/jbc.275.4.2532; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Cleaver JE, 2000, J DERMATOL SCI, V23, P1, DOI 10.1016/S0923-1811(99)00088-2; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; Conaway RC, 1996, METHOD ENZYMOL, V273, P194; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; de Boer J, 1998, CANCER RES, V58, P89; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; DRAPKIN R, 1994, TRENDS BIOCHEM SCI, V19, P504, DOI 10.1016/0968-0004(94)90139-2; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; Duncan R, 1996, MOL CELL BIOL, V16, P2274; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Dvir A, 1997, P NATL ACAD SCI USA, V94, P9006, DOI 10.1073/pnas.94.17.9006; Fiedler U, 2000, BIOESSAYS, V22, P316, DOI 10.1002/(SICI)1521-1878(200004)22:4<316::AID-BIES2>3.0.CO;2-B; FLORES O, 1992, J BIOL CHEM, V267, P2786; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Ge H, 1996, METHOD ENZYMOL, V274, P57; GERARD M, 1991, J BIOL CHEM, V266, P20940; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Goodrich JA, 1996, CELL, V84, P825, DOI 10.1016/S0092-8674(00)81061-2; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; Guzman E, 1999, MOL CELL BIOL, V19, P5652; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He LS, 2000, EMBO J, V19, P1034, DOI 10.1093/emboj/19.5.1034; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; Kugel JF, 1998, P NATL ACAD SCI USA, V95, P9232, DOI 10.1073/pnas.95.16.9232; Kumar KP, 1998, P NATL ACAD SCI USA, V95, P9767, DOI 10.1073/pnas.95.17.9767; LeRoy G, 1998, J BIOL CHEM, V273, P7134, DOI 10.1074/jbc.273.12.7134; Lis JT, 1994, TRANSCRIPTION MECH R, P459; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; Moreland RJ, 1999, J BIOL CHEM, V274, P22127, DOI 10.1074/jbc.274.32.22127; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Qadri I, 1996, P NATL ACAD SCI USA, V93, P10578, DOI 10.1073/pnas.93.20.10578; Reardon JT, 1996, P NATL ACAD SCI USA, V93, P6482, DOI 10.1073/pnas.93.13.6482; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Rossignol M, 1997, EMBO J, V16, P1628, DOI 10.1093/emboj/16.7.1628; Samkurashvili I, 1998, MOL CELL BIOL, V18, P5343, DOI 10.1128/MCB.18.9.5343; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; TONG X, 1995, P NATL ACAD SCI USA, V92, P3259, DOI 10.1073/pnas.92.8.3259; van Steeg H, 1999, MOL MED TODAY, V5, P86, DOI 10.1016/S1357-4310(98)01394-X; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; Wang XW, 1996, GENE DEV, V10, P1219, DOI 10.1101/gad.10.10.1219; Winkler GS, 2000, J BIOL CHEM, V275, P4258, DOI 10.1074/jbc.275.6.4258; XIAO H, 1994, MOL CELL BIOL, V14, P7013, DOI 10.1128/MCB.14.10.7013; Yan M, 1997, EMBO J, V16, P7457, DOI 10.1093/emboj/16.24.7457; Yan Q, 1999, J BIOL CHEM, V274, P35668, DOI 10.1074/jbc.274.50.35668; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479	70	104	112	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2001	104	3					353	363		10.1016/S0092-8674(01)00223-9	http://dx.doi.org/10.1016/S0092-8674(01)00223-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239393	Bronze			2022-12-28	WOS:000167003100006
J	Hartley, D				Hartley, D			From the foot of the gurney	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		American Heart Association in collaboration with the International Liaison Committee on Resuscitation, 2000, CIRCULATION S8, V102, pI12; BELENGER M, 1997, J EMERG NURS, V23, P238; Rattrie E, 2000, Nurs Stand, V14, P32; Robinson SM, 1998, LANCET, V352, P614, DOI 10.1016/S0140-6736(97)12179-1	4	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2001	285	4					380	380		10.1001/jama.285.4.380	http://dx.doi.org/10.1001/jama.285.4.380			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394CG	11242401				2022-12-28	WOS:000166506000001
J	Bobrow, M; Thomas, S				Bobrow, M; Thomas, S			Patents in a genetic age - The present patent system risks becoming a barrier to medical progress.	NATURE			English	Editorial Material									Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2XQ, England; Nuffield Council Bioeth, London WC1 3JS, England	Addenbrooke's Hospital; University of Cambridge	Bobrow, M (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Wellcome MRC Bldg, Cambridge CB2 2XQ, England.							Barton JH, 2000, SCIENCE, V287, P1933, DOI 10.1126/science.287.5460.1933; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Meyers TC, 2000, NAT STRUCT BIOL, V7, P950, DOI 10.1038/80723; 5835382	4	21	22	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					763	764		10.1038/35057480	http://dx.doi.org/10.1038/35057480			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236975				2022-12-28	WOS:000166938800013
